RUN 12

1344

151955

8.9

(O35851) P160 myb-binding protein

*	TK040203_NMyc_nuclei2_step09.3738.3738.3	1.1851	0.1284	2004.55	3	2030.0%	1	R.QVVRSVFGHICPHLTPR.C
*	TK040203_NMyc_nuclei2_step10.1759.1759.2	3.3433	0.4615	1713.64	1	5360.0%	1	K.ILSQHPNHLQGQPIK.A
*	TK040203_NMyc_nuclei2_step06.1597.1597.1	1.2467	0.1644	978.58	8	5000.0%	1	R.HSLLEHSR.E
*	TK040203_NMyc_nuclei2_step08.1777.1777.2	0.9374	0.0085	1855.91	88	2060.0%	1	K.LSQVNGATPVSPIEPESK.K

EML4_HUMAN

99.6%

981

108903

6.3

(Q9HC35) Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120)

*	TK040203_NMyc_nuclei2_step03.4073.4073.1	0.7445	0.0157	642.47	9	3000.0%	1	K.GQPSPR.A
*	TK040203_NMyc_nuclei2_step02.2570.2570.2	1.3417	0.0158	1842.25	74	2500.0%	1	K.SHIFFWTWSGNSLTR.K
*	TK040203_NMyc_nuclei2_step11.1576.1576.2	1.2299	0.1402	2786.19	40	1800.0%	2	K.YSAHSSHVTNVSFTHNDSHLISTGGK.D

COPE_MOUSE

99.6%

37.5%

144

16280

5.6

(O89079) Coatomer epsilon subunit (Epsilon-coat protein) (Epsilon-COP) (Fragment)

	TK040203_NMyc_nuclei2_step06.3271.3271.2	3.0453	0.5529	2968.39	1	3270.0%	2	K.DSGHPETLINLIVLSQHLGKPPEVTNR.Y
	TK040203_NMyc_nuclei2_step02.3507.3507.2	1.6055	0.1357	2935.39	4	1730.0%	1	K.KMQDQDEDATLTQLATAWVNLAVGGEK.L

PAB1_MOUSE

99.6%

636

70643

9.5

(P29341) Polyadenylate-binding protein 1 (Poly(A)-binding protein 1) (PABP 1) (PABP1)

	TK040203_NMyc_nuclei2_step08.2360.2360.3	5.9251	0.5875	4460.38	1	2690.0%	1	R.NPQQHLNAQPQVTMQQPAVHVQGQEPLTASMLASAPPQEQK.Q
	TK040203_NMyc_nuclei2_step06.2134.2134.1	0.8606	0.0687	1573.64	18	2310.0%	1	R.HEDAQKAVDEMNGK.E

RL30_HUMAN

99.6%

16.7%

114

12653

9.6

(P04645) 60S ribosomal protein L30 (P04645) 60S ribosomal protein L30

	TK040203_NMyc_nuclei2_step04.1779.1779.2	4.2261	0.6286	2014.85	1	5830.0%	2	K.TGVHHYSGNNIELGTACGK.Y

Q9CZ56

99.6%

53.0%

132

14193

9.2

(Q9CZ56) 2810405J23Rik protein

	TK040203_NMyc_nuclei2_step08.3188.3188.2	2.6763	0.5703	2852.62	1	2880.0%	1	K.GAHNGQGLGNAFLSHISACDGIFHLTR.K
	TK040203_NMyc_nuclei2_step02.3544.3544.2	1.4106	0.1713	3193.58	2	1670.0%	1	K.STFFNVLTNSQASAENFPFCTIDPNESR.V
	TK040203_NMyc_nuclei2_step01.4466.4466.3	2.3072	0.1402	4404.8	17	1220.0%	1	K.IPAFLNVVDIAGLVKGAHNGQGLGNAFLSHISACDGIFHLTR.K

MTE1_MOUSE

99.6%

453

49652

7.4

(Q9QYR9) Acyl coenzyme A thioester hydrolase, mitochondrial precursor (EC 3.1.2.2) (Very-long-chain acyl-CoA thioesterase) (MTE-I)

*	TK040203_NMyc_nuclei2_step06.3218.3218.2	5.9714	0.5656	2227.25	1	7780.0%	2	R.AHAVAQVDAWQQLQTFFHK.Q

MCM6_MOUSE

99.6%

821

92867

5.5

(P97311) DNA replication licensing factor MCM6 (Mis5 homolog)

	TK040203_NMyc_nuclei2_step06.2165.2165.1	1.3132	0.0617	1174.37	78	4580.0%	1	K.ASSAAGLTAAVVR.D
*	TK040203_NMyc_nuclei2_step07.2937.2937.2	1.4075	0.0042	2653.79	6	2270.0%	1	R.THPVHPELVSGTFLCLDCQTVIK.D
	TK040203_NMyc_nuclei2_step05.2972.2972.2	2.8644	0.5478	1952.81	1	5620.0%	2	R.LTHYDHVLIELTQAGLK.G
	TK040203_NMyc_nuclei2_step04.2454.2454.3	1.8926	0.0607	3315.71	2	1880.0%	1	R.DEESHEFVIEAGALMLADNGVCCIDEFDK.M

HCDH_MOUSE

99.6%

314

34464

8.6

(Q61425) Short chain 3-hydroxyacyl-CoA dehydrogenase, mitochondrial precursor (EC 1.1.1.35) (HCDH) (Medium and short chain L-3-hydroxyacyl-coenzyme A dehydrogenase)

*	TK040203_NMyc_nuclei2_step03.3591.3591.3	3.6124	0.2482	3161.79	1	2410.0%	1	K.TLSCLSTSTDAASVVHSTDLVVEAIVENLK.L

SPCO_MOUSE

99.6%

2363

274421

6.0

(Q62261) Spectrin beta chain, brain 1 (Spectrin, non-erythroid beta chain 1) (Beta-II spectrin) (Fodrin beta chain)

	TK040203_NMyc_nuclei2_step05.3124.3124.2	5.6597	0.5527	2487.51	1	5950.0%	6	K.SNAHYNLQNAFNLAEQHLGLTK.L
	TK040203_NMyc_nuclei2_step08.1604.1604.3	1.6004	1.0E-4	2804.52	19	1800.0%	1	R.VDTVNNMADELINSGHSDAATIAEWK.D
	TK040203_NMyc_nuclei2_step11.3202.3202.2	1.5025	0.0542	2613.11	93	1820.0%	1	K.KSNAHYNLQNAFNLAEQHLGLTK.L

Q9DBR1

99.6%

951

108687

7.6

(Q9DBR1) 5'-3' exoribonuclease 2

	TK040203_NMyc_nuclei2_step06.1961.1961.1	2.8026	0.4353	1470.77	1	5420.0%	2	R.KPATVLKPGDWEK.S
	TK040203_NMyc_nuclei2_step10.1929.1929.2	3.0612	0.3545	1310.81	1	6500.0%	1	R.RPVHLDQAAFR.T
	TK040203_NMyc_nuclei2_step09.1231.1231.1	1.0194	0.0187	882.48	1	7500.0%	1	K.DDEDSFR.R

CYPB_MOUSE

99.6%

23.1%

208

22713

9.5

(P24369) Peptidyl-prolyl cis-trans isomerase B precursor (EC 5.2.1.8) (PPIase) (Rotamase) (Cyclophilin B) (S-cyclophilin) (SCYLP) (CYP-S1)

	TK040203_NMyc_nuclei2_step04.2171.2171.1	2.6773	0.4532	1474.56	1	4620.0%	2	K.HYGPGWVSMANAGK.D
*	TK040203_NMyc_nuclei2_step01.2294.2294.1	1.3659	0.0576	866.68	4	5710.0%	1	R.VVFGLFGK.T
*	TK040203_NMyc_nuclei2_step11.2719.2719.2	1.457	0.0474	2613.17	2	2000.0%	1	K.VLFAAALIVGSVVFLLLPGPSVANDK.K

Q922D8

99.6%

19.1%

935

101256

7.1

(Q922D8) Similar to C1-tetrahydrofolate synthase

*	TK040203_NMyc_nuclei2_step03.4291.4291.3	0.8344	0.1164	3774.79	3	1180.0%	1	K.CTHWAEGGQGALALAQAVQRASQAPSSFQLLYDLK.L
	TK040203_NMyc_nuclei2_step05.2275.2275.1	2.0035	0.0989	1533.54	1	4330.0%	2	K.MHGGGPTVTAGLPLPK.A
*	TK040203_NMyc_nuclei2_step03.3330.3330.2	1.1583	0.0922	2530.08	8	2050.0%	3	K.THLSLSHNPEQKGVPTGFVLPIR.D
	TK040203_NMyc_nuclei2_step04.3427.3427.3	2.2787	0.1706	4680.33	20	890.0%	2	R.ASVGAGFLYPLVGTMSTMPGLPTRPCFYDIDLDPETEQVNGLF.-
	TK040203_NMyc_nuclei2_step06.3002.3002.2	3.925	0.4968	2579.34	1	4320.0%	1	K.IVGAPMHDLLLWNNATVTTCHSK.T
*	TK040203_NMyc_nuclei2_step09.1921.1921.3	1.5395	0.0534	4213.88	27	1120.0%	1	K.YVISLNEDASVHGFIVQLPLDSENSINTEAVINAIAPEK.D
	TK040203_NMyc_nuclei2_step04.1659.1659.2	3.4424	0.2248	1392.84	1	8640.0%	1	K.THLSLSHNPEQK.G

COPB_MOUSE

99.6%

953

107066

6.0

(Q9JIF7) Coatomer beta subunit (Beta-coat protein) (Beta-COP)

*	TK040203_NMyc_nuclei2_step03.1879.1879.1	0.6152	0.0171	1090.44	61	2780.0%	1	R.QSLSQMLSAK.L
	TK040203_NMyc_nuclei2_step12.1931.1931.3	1.5698	0.1344	4165.26	8	990.0%	1	K.EAGELKPEEEITVGPVQKLVTEMGTYATQSALSSSRPTK.K
	TK040203_NMyc_nuclei2_step05.2687.2687.2	3.2777	0.5612	2091.63	1	5280.0%	2	K.LVEKPSPLTLAPHDFANIK.A
	TK040203_NMyc_nuclei2_step02.3919.3919.2	1.2693	0.0498	2088.56	1	3160.0%	1	R.GFLLDGDFFVAASLATTLTK.I

IF3A_MOUSE

99.6%

1344

161950

6.8

(P23116) Eukaryotic translation initiation factor 3 subunit 10 (eIF-3 theta) (eIF3 p167) (eIF3 p180) (eIF3 p185) (p162 protein) (Centrosomin)

	TK040203_NMyc_nuclei2_step07.1457.1457.1	1.0911	0.1454	992.67	4	4380.0%	1	R.RVPPPALSR.D
	TK040203_NMyc_nuclei2_step07.1981.1981.1	2.4541	0.3259	1410.77	1	4170.0%	2	K.SGNALFHASTLHR.L
	TK040203_NMyc_nuclei2_step10.2120.2120.2	4.9968	0.5887	2659.83	1	5450.0%	2	R.HHNQSTAINLNNPESQSMHLETR.L
*	TK040203_NMyc_nuclei2_step07.3750.3750.3	1.6377	0.078	2861.69	62	1500.0%	1	R.NQLTAMSSVLAKAIEVIRPAHILQEK.E
	TK040203_NMyc_nuclei2_step06.1178.1178.1	0.7652	0.0176	541.59	2	6250.0%	2	R.GPPLR.S
	TK040203_NMyc_nuclei2_step07.3597.3597.2	1.4852	0.173	3088.4	4	1540.0%	1	K.AVEDIHGLFSLSKKPPKPQLMANYYNK.V
	TK040203_NMyc_nuclei2_step09.1330.1330.1	1.0171	0.1467	695.48	1	7000.0%	1	R.RGPPLR.S
	TK040203_NMyc_nuclei2_step07.4356.4356.3	1.8829	0.0593	4403.77	1	1410.0%	1	K.TEAAKEESQQMVLDIEDLDNIQTPESVLLSAVSGEDTQDR.T

Q99KD0

99.6%

216

24424

5.6

(Q99KD0) Hypothetical 24.4 kDa protein (Fragment)

	TK040203_NMyc_nuclei2_step05.1450.1450.2	3.4326	0.5629	2504.91	1	4320.0%	2	R.RPGAAEPSPDGTTGHTYNQYTQR.Y

Q8R016

99.6%

455

52511

6.5

(Q8R016) Similar to bleomycin hydrolase

*	TK040203_NMyc_nuclei2_step02.2154.2154.2	0.824	0.057	2108.41	27	2500.0%	1	K.VERCYFFLNAFVDTAQK.K
*	TK040203_NMyc_nuclei2_step11.1986.1986.2	1.3157	0.0145	2503.97	263	1390.0%	1	K.KFNIEEFEFSQSYLFFWDK.V
*	TK040203_NMyc_nuclei2_step10.2161.2161.2	3.6269	0.5007	2728.32	1	3960.0%	2	R.ATVQGAQHVFQHVVPQEGKPVTNQK.S

Q91YE4

99.6%

564

66647

6.4

(Q91YE4) 67 kDa polymerase-associated factor PAF67

	TK040203_NMyc_nuclei2_step04.2438.2438.2	3.2902	0.5596	2141.84	1	4710.0%	3	K.FLSPVVPNYDNVHPNYHK.E
	TK040203_NMyc_nuclei2_step10.3627.3627.2	4.3088	0.5641	1959.92	1	6880.0%	1	K.VWNVHSVLNVLHSLVDK.S

Q91W48

99.6%

511

57230

6.2

(Q91W48) Archain 1

	TK040203_NMyc_nuclei2_step03.1241.1241.1	1.3749	0.0564	1234.61	137	3750.0%	1	K.VAPAPARPSGPSK.A
*	TK040203_NMyc_nuclei2_step10.2149.2149.1	2.681	0.4646	1589.54	1	5000.0%	1	K.VHAPPINMESVHMK.I

Q9DBT6

99.6%

624

65369

9.5

(Q9DBT6) 1200014E20Rik protein

*	TK040203_NMyc_nuclei2_step12.1631.1631.2	3.0487	0.5772	2592.96	1	4200.0%	2	R.HPVGSHQVPGLHSSVVTTPGSPSLGR.H
*	TK040203_NMyc_nuclei2_step12.1654.1654.2	1.6522	0.164	2751.34	25	1480.0%	2	R.HPGAHQGNLASSLHSNAVISPGSPSLGR.H

ATPA_MOUSE

99.6%

553

59753

9.2

(Q03265) ATP synthase alpha chain, mitochondrial precursor (EC 3.6.3.14)

*	TK040203_NMyc_nuclei2_step05.3207.3207.2	4.7774	0.6722	2413.34	1	5250.0%	2	K.FENAFLSHVISQHQSLLGNIR.S
	TK040203_NMyc_nuclei2_step05.1298.1298.1	1.2465	0.0108	581.38	11	7500.0%	1	R.VHGLR.N
	TK040203_NMyc_nuclei2_step11.3452.3452.3	1.8889	0.0271	3805.76	5	1470.0%	1	K.YTIVVSATASDAAPLQYLAPYSGCSMGEYFRDNGK.H

DD21_MOUSE

99.6%

851

93582

9.1

(Q9JIK5) Nucleolar RNA helicase II (Nucleolar RNA helicase Gu) (RH II/Gu) (DEAD-box protein 21)

	TK040203_NMyc_nuclei2_step08.1497.1497.1	2.3305	0.4196	1077.64	3	6250.0%	4	K.TFHHVYSGK.D
	TK040203_NMyc_nuclei2_step11.2159.2159.2	1.1275	7.0E-4	2107.69	3	2620.0%	1	K.GAVEALAAALAHISGATSVDQR.S

Q9QXT0

99.6%

17.0%

182

20767

5.1

(Q9QXT0) Putative secreted protein ZSIG9 (5330432A10RIK protein) (Transmembrane protein 4)

*	TK040203_NMyc_nuclei2_step07.1560.1560.1	2.0106	0.3518	1394.72	1	5000.0%	1	K.RTDLCDHALHR.S
	TK040203_NMyc_nuclei2_step05.3591.3591.2	3.4054	0.2973	2515.08	1	3950.0%	3	K.FACESIVEEYEDELIEFFSR.E

G3P_MOUSE

99.6%

25.3%

332

35679

8.2

(P16858) Glyceraldehyde 3-phosphate dehydrogenase (EC 1.2.1.12) (GAPDH)

	TK040203_NMyc_nuclei2_step08.2720.2720.2	4.1478	0.5846	2370.36	1	5240.0%	1	K.RVIISAPSADAPMFVMGVNHEK.Y
	TK040203_NMyc_nuclei2_step02.3496.3496.2	2.7692	0.5405	2599.9	2	3040.0%	5	K.VIHDNFGIVEGLMTTVHAITATQK.T
*	TK040203_NMyc_nuclei2_step02.3020.3020.3	2.3507	0.1144	4052.88	1	1350.0%	1	K.GILGYTEDQVVSCDFNSNSHSSTFDAGAGIALNDNFVK.L

U2AF_MOUSE

99.6%

475

53517

9.1

(P26369) Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (U2 snRNP auxiliary factor large subunit)

	TK040203_NMyc_nuclei2_step11.2504.2504.3	5.2145	0.5904	3561.98	1	2970.0%	1	R.RPHDYQPLPGMSENPSVYVPGVVSTVVPDSAHK.L

RS3_MOUSE

99.6%

243

26674

9.7

(P17073) 40S ribosomal protein S3

	TK040203_NMyc_nuclei2_step02.1673.1673.1	1.2713	0.1416	637.57	1	7500.0%	1	R.HVLLR.Q
	TK040203_NMyc_nuclei2_step01.2574.2574.1	1.4442	0.2078	1029.87	7	5620.0%	1	R.TEIIILATR.T
	TK040203_NMyc_nuclei2_step07.3446.3446.1	1.259	0.0198	1462.52	87	2920.0%	8	K.KPLPDHVSIVEPK.D
	TK040203_NMyc_nuclei2_step01.1768.1768.1	1.2763	0.1534	896.56	2	6430.0%	1	K.FVADGIFK.A

NUCL_MOUSE

99.6%

706

76592

4.8

(P09405) Nucleolin (Protein C23)

	TK040203_NMyc_nuclei2_step01.2272.2272.1	1.4116	0.1419	1563.52	2	3460.0%	1	K.GFGFVDFNSEEDAK.A
	TK040203_NMyc_nuclei2_step01.0730.0730.1	0.9331	0.057	845.61	2	5000.0%	1	K.ALELTGLK.V
*	TK040203_NMyc_nuclei2_step10.1198.1198.1	1.9165	0.3455	1103.45	1	6670.0%	2	K.VPQNPHGKPK.G
*	TK040203_NMyc_nuclei2_step09.1382.1382.1	1.1151	0.0026	1123.56	106	4380.0%	1	K.ETLEEVFEK.A
*	TK040203_NMyc_nuclei2_step01.2079.2079.1	1.4882	0.1842	1422.96	2	4090.0%	1	K.NLSFNITEDELK.E
	TK040203_NMyc_nuclei2_step01.3522.3522.1	1.4849	0.1681	1597.67	3	3080.0%	3	K.GYAFIEFASFEDAK.E
*	TK040203_NMyc_nuclei2_step01.2671.2671.1	1.7089	0.1731	1027.65	1	6880.0%	1	K.FAISELFAK.N

TS24_MOUSE

99.6%

1944

216085

6.4

(P53995) Protein TSG24 (Meiotic check point regulator)

*	TK040203_NMyc_nuclei2_step10.1909.1909.2	2.6127	0.6036	1623.91	1	5000.0%	1	R.AHSPALGVHSFSGAQR.F
	TK040203_NMyc_nuclei2_step03.1669.1669.1	1.1738	0.2564	1033.58	10	5710.0%	1	R.RFQTGMHR.E
*	TK040203_NMyc_nuclei2_step05.3395.3395.3	1.5828	0.0082	3189.79	24	1730.0%	1	R.DSSKLNDSLYNEDCTFQQLGTYIHSVR.D
	TK040203_NMyc_nuclei2_step09.2709.2709.3	2.0505	0.2493	4608.71	6	1190.0%	1	R.ESYSLAAGLALGMVCLGHGSNLIGMSDLNVPEQLYQYMVGGHR.R
*	TK040203_NMyc_nuclei2_step06.1706.1706.1	1.1304	0.0083	1282.59	52	4000.0%	1	K.VFITTDLCGQK.F

RS4_HUMAN

99.6%

16.4%

262

29467

10.2

(P12750) 40S ribosomal protein S4, X isoform (Single copy abundant mRNA protein) (SCR10) (P12750) 40S ribosomal protein S4, X isoform (Single copy abundant mRNA protein) (SCR10)

	TK040203_NMyc_nuclei2_step09.1878.1878.1	1.8376	0.2745	1509.66	1	4170.0%	2	R.ERHPGSFDVVHVK.D
	TK040203_NMyc_nuclei2_step06.1811.1811.1	1.5204	0.1051	1218.56	1	5500.0%	2	K.GIPHLVTHDAR.T
	TK040203_NMyc_nuclei2_step02.2286.2286.1	1.0596	0.0244	1168.48	7	3890.0%	2	K.GNKPWISLPR.G
	TK040203_NMyc_nuclei2_step06.1929.1929.1	2.5171	0.4597	1223.6	1	6000.0%	4	R.HPGSFDVVHVK.D
	TK040203_NMyc_nuclei2_step04.3934.3934.2	0.6904	0.1167	833.78	59	2500.0%	1	R.LTIAEER.D
	TK040203_NMyc_nuclei2_step07.1777.1777.1	0.8787	0.0264	1356.54	41	3640.0%	1	K.GNKPWISLPRGK.G

Q8R1K5

99.6%

150

222

21634

9.4

(Q8R1K5) Similar to heterogeneous nuclear ribonucleoprotein A3 (H. sapiens)

	TK040203_NMyc_nuclei2_step08.2107.2107.2	1.0645	0.0275	1873.49	7	2670.0%	1	K.RGFAFVTFDDHDTVDK.I
	TK040203_NMyc_nuclei2_step01.0172.0172.1	1.1602	0.049	881.11	15	5000.0%	2	R.GGYGGGGGGSR.G
	TK040203_NMyc_nuclei2_step01.0276.0276.1	2.1887	0.3464	1474.71	1	5000.0%	12	K.YHTINGHNCEVK.K

Q9Z2X1

99.6%

415

45730

5.5

(Q9Z2X1) Ribonucleoprotein F

	TK040203_NMyc_nuclei2_step12.3047.3047.2	1.2326	0.1182	2773.99	1	2390.0%	1	R.YGDSEFTVQSTTGHCVHMRGLPYK.A
	TK040203_NMyc_nuclei2_step11.1370.1370.2	1.2459	0.0423	1936.39	153	1880.0%	2	K.FMSVQRPGPYDRPGTAR.R
	TK040203_NMyc_nuclei2_step01.1082.1082.1	1.5052	0.0672	800.53	4	8000.0%	3	R.YIEVFK.S
	TK040203_NMyc_nuclei2_step02.3492.3492.2	3.4021	0.4054	2829.51	1	3800.0%	2	K.EEIVQFFSGLEIVPNGITLPVDPEGK.I

Q91VL2

99.6%

382

44318

9.6

(Q91VL2) Unknown (Protein for IMAGE:3669867) (Fragment)

	TK040203_NMyc_nuclei2_step09.1823.1823.2	3.1063	0.552	1625.17	1	7310.0%	1	K.EHHFGSSGMTLHER.F
	TK040203_NMyc_nuclei2_step04.2103.2103.1	2.336	0.2377	1531.72	1	4580.0%	3	R.SIFQHIQSAQSQR.S
	TK040203_NMyc_nuclei2_step11.2818.2818.2	4.3217	0.5301	2042.22	1	6180.0%	1	R.SPSELFAQHIVTIVHHVK.E
	TK040203_NMyc_nuclei2_step08.1215.1215.1	0.9074	0.0223	1193.57	48	3330.0%	1	R.RIDISPSTFR.K

O43163

99.6%

689

78728

5.4

(O43163) Hypothetical protein KIAA0436 (Fragment)

*	TK040203_NMyc_nuclei2_step04.2150.2150.1	1.1801	0.0050	800.74	20	5000.0%	1	K.KITAQIK.F
*	TK040203_NMyc_nuclei2_step05.3354.3354.2	2.1412	0.0357	3050.82	1	2960.0%	2	K.DTGEGYQTPNIILDIQPGGNHVIEDSHK.K

Q9DBI6

99.6%

669

69485

9.7

(Q9DBI6) 1300007E16Rik protein

	TK040203_NMyc_nuclei2_step10.1923.1923.2	2.3471	0.3307	1558.17	1	6150.0%	2	R.AIEALHGHELRPGR.A
	TK040203_NMyc_nuclei2_step04.1466.1466.1	2.1915	0.4471	1302.6	1	5000.0%	4	R.RLPDAHSDYAR.Y
	TK040203_NMyc_nuclei2_step09.2170.2170.2	1.1574	0.0238	2408.04	230	1520.0%	1	R.AQPSVSLGAAYRAQPSASLGVGYR.T
	TK040203_NMyc_nuclei2_step11.1242.1242.1	1.4657	0.1511	1185.54	11	4550.0%	1	K.KGPALAIQSGDK.T

PMGE_MOUSE

99.6%

16.7%

258

29847

7.1

(P15327) Bisphosphoglycerate mutase (EC 5.4.2.4) (2,3-bisphosphoglycerate mutase, erythrocyte) (2,3-bisphosphoglycerate synthase) (BPGM) (EC 5.4.2.1) (EC 3.1.3.13) (BPG-dependent PGAM)

*	TK040203_NMyc_nuclei2_step03.2427.2427.2	3.461	0.3236	1992.92	1	5280.0%	2	R.AVGPHQFLGNQEAIQAAIK.K
	TK040203_NMyc_nuclei2_step07.3712.3712.2	2.6341	0.4391	2868.1	1	3040.0%	3	R.SIHTAWLILEELGQEWVPVESSWR.L

COF1_MOUSE

99.6%

166

18560

8.1

(P18760) Cofilin, non-muscle isoform

*	TK040203_NMyc_nuclei2_step10.3444.3444.2	4.6713	0.6096	2020.28	1	5940.0%	2	K.KEDLVFIFWAPENAPLK.S

TPP2_MOUSE

99.6%

1262

139878

6.6

(Q64514) Tripeptidyl-peptidase II (EC 3.4.14.10) (TPP-II) (Tripeptidyl aminopeptidase)

	TK040203_NMyc_nuclei2_step07.4300.4300.2	1.5116	0.1433	2624.5	35	1480.0%	2	R.GPSADGALGVSISAPGGAIASVPNWTLR.G
	TK040203_NMyc_nuclei2_step07.2858.2858.2	1.3303	0.0985	2227.19	1	3330.0%	1	K.CDLVNYSYGEATHWPNSGR.I
	TK040203_NMyc_nuclei2_step07.1549.1549.2	1.4598	0.0484	2050.33	7	3240.0%	1	R.QMGSGDAYPHQYSLKLEK.G
*	TK040203_NMyc_nuclei2_step10.3877.3877.1	0.6774	0.0732	854.57	285	3330.0%	1	K.VLIFAYK.H
	TK040203_NMyc_nuclei2_step05.2660.2660.2	4.5283	0.5743	2561.74	1	5710.0%	1	K.VNESSHYDLAFTDVHFKPGQIR.R

Q9CZN7

99.6%

8.5%

504

55759

8.5

(Q9CZN7) Serine hydroxymethyltransferase (EC 2.1.2.1) (Serine methylase) (Glycine hydroxymethyltransferase) (SHMT)

	TK040203_NMyc_nuclei2_step06.2990.2990.2	5.419	0.6691	1718.99	1	7810.0%	1	R.AHLLADMAHISGLVAAK.V
	TK040203_NMyc_nuclei2_step03.3258.3258.2	1.4188	0.0636	2642.96	24	2000.0%	1	R.INFAVFPSLQGGPHNHAIAAVAVALK.Q

RTN4_MOUSE

99.6%

26.6%

199

22466

9.4

(Q99P72) Reticulon 4 (Neurite outgrowth inhibitor) (Nogo protein)

	TK040203_NMyc_nuclei2_step05.2204.2204.2	3.3895	0.5503	1609.87	1	6150.0%	1	R.HQAQIDHYLGLANK.S
	TK040203_NMyc_nuclei2_step07.2474.2474.3	2.0687	0.2493	4092.51	1	1580.0%	1	K.TGVVFGASLFLLLSLTVFSIVSVTAYIALALLSVTISFR.I

GTFI_MOUSE

99.6%

998

112380

6.4

(Q9ESZ8) General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated protein-135) (BTK-associated protein-135) (BAP-135)

	TK040203_NMyc_nuclei2_step09.4190.4190.2	1.2863	0.0818	2971.09	33	1430.0%	1	R.SPGSNSKVPEIEVTVEGPNNSSPQTSAVR.T
	TK040203_NMyc_nuclei2_step07.1590.1590.1	1.7491	0.1009	1097.63	1	7500.0%	1	K.KHELLNSTR.E
	TK040203_NMyc_nuclei2_step06.1838.1838.2	4.5695	0.6156	1865.33	1	7670.0%	1	K.RPELLTHSTTEVTQPR.T
	TK040203_NMyc_nuclei2_step05.1980.1980.1	1.968	0.2648	1324.57	1	6000.0%	1	K.HPEHYDLATLK.W
	TK040203_NMyc_nuclei2_step07.3949.3949.2	0.812	0.0116	1444.09	12	3640.0%	1	R.GREFSFEAWNAK.I

NPM_MOUSE

99.6%

292

32560

4.8

(Q61937) Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Numatrin) (Nucleolar protein NO38)

	TK040203_NMyc_nuclei2_step01.2811.2811.2	2.1479	0.2856	2934.07	1	2410.0%	3	R.TVSLGAGAKDELHIVEAEAMNYEGSPIK.V
	TK040203_NMyc_nuclei2_step01.2139.2139.1	1.5576	0.0395	1571.85	14	3750.0%	1	K.VDNDENEHQLSLR.T

O88306

99.6%

173

18352

6.3

(O88306) DJ-1

	TK040203_NMyc_nuclei2_step07.3750.3750.2	1.7148	0.2997	1908.13	1	3060.0%	2	R.GPGTSFEFALAIVEALVGK.D

RL9_MOUSE

99.6%

39.6%

192

21881

10.0

(P51410) 60S ribosomal protein L9

	TK040203_NMyc_nuclei2_step06.2773.2773.2	3.6768	0.377	1757.17	1	6430.0%	2	R.RDFNHINVELSLLGK.K
*	TK040203_NMyc_nuclei2_step07.3665.3665.3	2.4815	0.1944	4101.05	1	1580.0%	1	R.TGVACSVSQAQKDELILEGNDIELVSNSAALIQQATTVK.N
	TK040203_NMyc_nuclei2_step08.3109.3109.2	3.1972	0.4804	2487.03	1	3810.0%	4	R.SVYAHFPINVVIQENGSLVEIR.N
	TK040203_NMyc_nuclei2_step02.3374.3374.2	2.9883	0.4206	2886.0	1	3270.0%	1	K.DELILEGNDIELVSNSAALIQQATTVK.N

EZRI_MOUSE

99.6%

585

69215

6.1

(P26040) Ezrin (p81) (Cytovillin) (Villin 2)

	TK040203_NMyc_nuclei2_step05.1606.1606.1	2.3321	0.4499	1473.68	2	4550.0%	2	R.RKPDTIEVQQMK.A
	TK040203_NMyc_nuclei2_step07.1988.1988.1	2.2373	0.0865	1088.52	1	7500.0%	1	K.KFVIKPIDK.K
	TK040203_NMyc_nuclei2_step07.1817.1817.1	1.3856	0.0967	1177.6	11	4380.0%	1	R.IQVWHAEHR.G
	TK040203_NMyc_nuclei2_step06.3553.3553.2	1.4914	0.0857	3027.52	19	1920.0%	1	R.VTTMDAELEFAIQPNTTGKQLFDQVVK.T

DD15_MOUSE

99.6%

758

86611

7.2

(O35286) Putative pre-mRNA splicing factor RNA helicase (DEAH box protein 15)

	TK040203_NMyc_nuclei2_step10.3087.3087.2	4.4886	0.5952	2211.52	1	5560.0%	1	R.FAHIDGDHLTLLNVYHAFK.Q
	TK040203_NMyc_nuclei2_step02.1883.1883.2	1.115	0.0542	1984.61	1	3060.0%	1	K.ELRASTNAMLISAGLPPLK.A

Q99LC2

99.6%

431

48382

6.6

(Q99LC2) RIKEN cDNA 1700057K18 gene

	TK040203_NMyc_nuclei2_step07.2862.2862.2	4.337	0.6066	2311.04	1	5750.0%	2	R.SISFHPSGDFILVGTQHPTLR.L

Q921M3

99.6%

1217

135550

5.3

(Q921M3) Similar to splicing factor 3b, subunit 3, 130kD

	TK040203_NMyc_nuclei2_step01.1832.1832.1	1.5332	0.0404	1284.53	1	5000.0%	1	R.IVPGQFLAVDPK.G
	TK040203_NMyc_nuclei2_step01.3388.3388.3	1.4291	0.0881	4658.22	17	1160.0%	1	R.IISLDPSDCLQPLSMQALPAQPESLCIVEMGGTEKQDELGER.G
	TK040203_NMyc_nuclei2_step06.2705.2705.2	4.0768	0.5695	2999.44	1	3600.0%	4	R.KFVIHPESNNLIIIETDHNAYTEATK.A

Q924H7

99.6%

22.8%

646

70690

9.5

(Q924H7) WAC

*	TK040203_NMyc_nuclei2_step08.1959.1959.3	1.3321	0.0647	2884.39	162	1350.0%	1	K.QGPVSHSATQQPVTADKQQSHDPVSPR.S
	TK040203_NMyc_nuclei2_step08.2008.2008.3	1.7246	0.0905	2134.74	3	2500.0%	1	K.INEVLTAAVTQASLQSIIHK.F
*	TK040203_NMyc_nuclei2_step09.2962.2962.3	1.9016	0.1098	3916.38	1	1390.0%	1	R.EVMQATATSGFTSGMEDKHSSDASSLLPQNILSQTSR.H
	TK040203_NMyc_nuclei2_step03.2978.2978.2	1.1187	0.0634	2385.39	28	2140.0%	1	K.TSDAPYDSADDWSEHISSSGKK.Y
	TK040203_NMyc_nuclei2_step12.1867.1867.3	4.4564	0.6374	4355.67	1	1810.0%	1	R.AETHSSSTPVQHPIKPVVHPTATPSTVPSSPFTLQSDHQPK.K

CABA_MOUSE

99.6%

285

30831

7.9

(Q99020) CARG-binding factor-A (CBF-A)

	TK040203_NMyc_nuclei2_step01.1540.1540.1	1.7767	0.1759	1503.9	2	4620.0%	1	K.IFVGGLNPEATEEK.I
*	TK040203_NMyc_nuclei2_step03.3245.3245.2	3.533	0.4812	2196.62	1	5280.0%	3	R.EYFGQFGEIEAIELPIDPK.L
	TK040203_NMyc_nuclei2_step09.1407.1407.1	2.2981	0.3765	992.57	1	8120.0%	3	K.KFHTVSGSK.C

CHD4_HUMAN

99.6%

1912

217989

5.9

(Q14839) Chromodomain helicase-DNA-binding protein 4 (CHD-4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta)

*	TK040203_NMyc_nuclei2_step04.3956.3956.1	0.6093	0.0014	663.51	15	3330.0%	1	K.LGGFGSK.R
*	TK040203_NMyc_nuclei2_step09.3650.3650.3	4.6323	0.5588	3758.23	1	1790.0%	4	K.GSSGASVAAAAAAAVAVVESMVTATEVAPPPPPVEVPIRK.A
*	TK040203_NMyc_nuclei2_step12.2187.2187.3	1.6118	0.0345	3557.56	6	1610.0%	1	R.FSWAQGTDTILADEMGLGKTVQTAVFLYSLYK.E

TCPZ_MOUSE

99.6%

30.1%

531

58004

7.1

(P80317) T-complex protein 1, zeta subunit (TCP-1-zeta) (CCT-zeta) (CCT-zeta-1)

*	TK040203_NMyc_nuclei2_step11.2184.2184.3	1.8398	0.0303	4025.3	9	1390.0%	1	K.VQAEHSESGQLVGVDLSTGEPMVAAEMGVWDNYCVKK.Q
*	TK040203_NMyc_nuclei2_step12.4315.4315.2	1.5173	0.1524	2750.67	16	1670.0%	1	R.AVKNAIDDGCVVPGAGAVEVALAEALIK.Y
*	TK040203_NMyc_nuclei2_step06.3693.3693.2	5.176	0.3188	2237.61	1	5250.0%	3	K.VHAELADVLTEAVVDSILAIR.K
	TK040203_NMyc_nuclei2_step10.3004.3004.3	2.3528	0.1491	4028.86	12	1150.0%	1	K.VATAQDDITGDGTTSNVLIIGELLKQADLYISEGLHPR.I
*	TK040203_NMyc_nuclei2_step02.3828.3828.3	2.3482	0.1104	3927.4	3	1430.0%	1	R.LTLACGGIALNSFDDLNPDCLGHAGLVYEYTLGEEK.F

Q9CY02

99.6%

36.3%

102

11832

4.7

(Q9CY02) 13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510041L04, full insert sequence (Erythroid differentiation related factor)

*	TK040203_NMyc_nuclei2_step08.3747.3747.3	2.3159	0.0362	4508.99	1	1530.0%	5	K.EFNVLLDQQVFDDPLISEEDMVIVVHDWVNLYTNYYK.K

EFTU_HUMAN

99.6%

452

49542

7.6

(P49411) Elongation factor Tu, mitochondrial precursor (P43)

*	TK040203_NMyc_nuclei2_step07.1548.1548.2	3.3176	0.516	1772.49	1	6430.0%	2	R.HYAHTDCPGHADYVK.N

KPYR_MOUSE

99.6%

13.2%

574

62309

7.1

(P53657) Pyruvate kinase, isozymes R/L (EC 2.7.1.40) (L-PK)

	TK040203_NMyc_nuclei2_step10.1181.1181.3	0.7975	0.0065	1856.12	39	1830.0%	1	K.MQHAIAREAEAAVYHR.Q
*	TK040203_NMyc_nuclei2_step09.2255.2255.2	4.967	0.6699	2186.26	1	6670.0%	4	R.LNFSHGSHEYHAESIANIR.E
	TK040203_NMyc_nuclei2_step01.0162.0162.1	1.2827	0.0195	733.43	185	5830.0%	1	K.AGMNIAR.L
*	TK040203_NMyc_nuclei2_step03.3305.3305.3	2.0796	0.1331	3452.31	1	1670.0%	1	R.AETSDVANAVLDGADCIMLSGETAKGSFPVEAVK.M

MAT3_HUMAN

99.6%

847

94623

6.3

(P43243) Matrin 3

	TK040203_NMyc_nuclei2_step04.2445.2445.2	5.0849	0.5707	2041.09	1	6670.0%	5	R.VIHLSNLPHSGYSDSAVLK.L
	TK040203_NMyc_nuclei2_step07.1494.1494.2	2.403	0.3761	1474.14	1	5450.0%	1	K.NTHCSSLPHYQK.L
	TK040203_NMyc_nuclei2_step09.3906.3906.2	1.1068	0.0691	2619.19	28	1740.0%	1	K.QELGRVIHLSNLPHSGYSDSAVLK.L
*	TK040203_NMyc_nuclei2_step07.2109.2109.2	0.9013	0.106	2868.28	3	1850.0%	1	R.GPLPLSSQHRGDADQASNILASFGLSAR.D

R10A_MOUSE

99.6%

27.6%

217

24916

10.0

(P53026) 60S ribosomal protein L10a (CSA-19) (NEDD-6)

	TK040203_NMyc_nuclei2_step01.2008.2008.1	2.8396	0.3702	1484.73	1	6250.0%	1	K.KYDAFLASESLIK.Q
	TK040203_NMyc_nuclei2_step01.2014.2014.1	2.8791	0.3977	1452.62	1	5420.0%	1	K.AVDIPHMDIEALK.K
	TK040203_NMyc_nuclei2_step04.3667.3667.2	1.7325	0.1752	2549.23	1	2620.0%	2	K.MTDDELVYNIHLAVNFLVSLLK.K
	TK040203_NMyc_nuclei2_step04.1164.1164.3	1.0546	0.0248	3794.26	15	910.0%	1	K.VLCLAVAVGHVKMTDDELVYNIHLAVNFLVSLLK.K

P2G4_MOUSE

99.6%

394

43699

6.9

(P50580) Proliferation-associated protein 2G4 (Proliferation-associated protein 1) (Protein p38-2G4)

	TK040203_NMyc_nuclei2_step06.2763.2763.2	4.4901	0.6675	2172.19	1	5830.0%	2	K.VAHSFNCTPIEGMLSHQLK.Q
	TK040203_NMyc_nuclei2_step02.3758.3758.2	3.2082	0.6392	2268.15	1	4250.0%	6	K.AEFEVHEVYAVDVLVSSGEGK.A

FBRL_MOUSE

99.6%

38.8%

327

34439

10.3

(P35550) Fibrillarin (Nucleolar protein 1)

	TK040203_NMyc_nuclei2_step03.3349.3349.3	6.0884	0.4992	3420.15	1	3280.0%	2	K.VLYLGAASGTTVSHVSDIVGPDGLVYAVEFSHR.S
	TK040203_NMyc_nuclei2_step06.3974.3974.1	0.7546	0.1657	607.53	2	3000.0%	2	R.GGFGDR.G
	TK040203_NMyc_nuclei2_step08.3304.3304.2	1.0908	0.0509	2524.14	9	2110.0%	1	K.KMQQENMKPQEQLTLEPYER.D
	TK040203_NMyc_nuclei2_step05.2655.2655.2	4.928	0.5652	1872.77	1	5830.0%	2	K.LAAAILGGVDQIHIKPGAK.V
	TK040203_NMyc_nuclei2_step05.3917.3917.1	0.6694	0.0637	665.0	2	3570.0%	5	R.GGGGGGFR.G
	TK040203_NMyc_nuclei2_step10.3647.3647.2	2.3902	0.4184	2235.5	1	3680.0%	1	R.MLIAMVDVIFADVAQPDQTR.I
	TK040203_NMyc_nuclei2_step04.3954.3954.1	0.6258	0.0803	607.39	11	2500.0%	1	R.GGGFGGR.G
	TK040203_NMyc_nuclei2_step03.1783.1783.2	4.802	0.6921	1535.96	1	8080.0%	3	R.DHAVVVGVYRPPPK.V

HS7C_MOUSE

99.6%

3340

646

70871

5.5

(P08109) Heat shock cognate 71 kDa protein

	TK040203_NMyc_nuclei2_step08.3823.3823.2	1.6102	0.2946	2914.15	1	2310.0%	3	R.NVLIFDLGGGTFDVSILTIEDGIFEVK.S
	TK040203_NMyc_nuclei2_step01.3564.3564.3	1.5576	8.0E-4	4587.33	2	1250.0%	1	R.NVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNR.M
	TK040203_NMyc_nuclei2_step01.1656.1656.1	1.0267	0.081	1482.84	1	3460.0%	2	K.SQIHDIVLVGGSTR.I
	TK040203_NMyc_nuclei2_step01.1856.1856.1	1.7321	0.3007	1238.29	1	5560.0%	2	R.MVNHFIAEFK.R
	TK040203_NMyc_nuclei2_step01.2127.2127.1	1.7627	0.2345	1254.63	1	6110.0%	1	R.FEELNADLFR.G
	TK040203_NMyc_nuclei2_step05.3691.3691.2	2.1004	0.4285	3002.18	1	1920.0%	45	R.TLSSSTQASIEIDSLYEGIDFYTSITR.A
	TK040203_NMyc_nuclei2_step05.3730.3730.2	3.3338	0.5128	2518.74	1	3700.0%	36	R.GVPQIEVTFDIDANGILNVSAVDK.S

GBLP_HUMAN

99.6%

1546

24.9%

317

35077

7.7

(P25388) Guanine nucleotide-binding protein beta subunit-like protein 12.3 (P205) (Receptor of activated protein kinase C 1) (RACK1) (Receptor for activated C kinase) (P25388) Guanine nucleotide-binding protein beta subunit-like protein 12.3 (P205) (Receptor of activated protein kinase C 1) (RACK1) (Receptor for activated C kinase)

	TK040203_NMyc_nuclei2_step03.3753.3753.2	2.178	0.3611	2966.18	1	3150.0%	39	R.GHSHFVSDVVISSDGQFALSGSWDGTLR.L
	TK040203_NMyc_nuclei2_step03.2201.2201.2	4.221	0.6745	2745.0	1	4040.0%	4	K.TNHIGHTGYLNTVTVSPDGSLCASGGK.D
	TK040203_NMyc_nuclei2_step04.3140.3140.2	2.7817	0.4285	2630.87	1	3700.0%	3	K.GHNGWVTQIATTPQFPDMILSASR.D

PDI_MOUSE

99.6%

509

57144

4.9

(P09103) Protein disulfide isomerase precursor (PDI) (EC 5.3.4.1) (Prolyl 4-hydroxylase beta subunit) (Cellular thyroid hormone binding protein) (P55) (ERP59)

	TK040203_NMyc_nuclei2_step01.2755.2755.1	1.7069	0.1604	966.64	1	6430.0%	1	R.ILEFFGLK.K
	TK040203_NMyc_nuclei2_step09.3185.3185.2	1.1972	0.0092	2326.74	4	2500.0%	1	K.DHENIIIAKMDSTANEVEAVK.V
	TK040203_NMyc_nuclei2_step02.1922.1922.1	1.018	0.0184	929.87	62	5000.0%	3	K.VHSFPTLK.F
	TK040203_NMyc_nuclei2_step01.1795.1795.1	1.5617	0.1001	1208.51	1	5560.0%	1	R.LITLEEEMTK.Y
	TK040203_NMyc_nuclei2_step02.2927.2927.2	2.0777	0.2764	1837.22	1	4640.0%	2	K.ILFIFIDSDHTDNQR.I
	TK040203_NMyc_nuclei2_step09.3605.3605.2	4.1347	0.5945	3143.95	1	3170.0%	2	K.RTGPAATTLSDTAAAESLVDSSEVTVIGFFK.D
	TK040203_NMyc_nuclei2_step01.4270.4270.2	2.34	0.3577	2989.03	1	2410.0%	5	R.TGPAATTLSDTAAAESLVDSSEVTVIGFFK.D
	TK040203_NMyc_nuclei2_step05.2319.2319.2	3.3037	0.3607	1953.14	1	7330.0%	2	K.IKPHLMSQEVPEDWDK.Q

Q9CSR5

99.6%

370

42894

5.4

(Q9CSR5) 2610511G16Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step11.3640.3640.2	1.6009	0.196	3107.57	4	1920.0%	1	K.VMLMASPSMEDLYHKSCALAEDPQDLR.D
	TK040203_NMyc_nuclei2_step08.1147.1147.1	0.8196	0.0145	745.65	4	6000.0%	1	K.QQLVEK.L
	TK040203_NMyc_nuclei2_step10.3584.3584.2	3.5862	0.5865	2720.89	1	4090.0%	1	R.TVPAHVETVVLFFPDVWHCLPTR.S

WDR1_MOUSE

99.6%

18.0%

606

66407

6.6

(O88342) WD-repeat protein 1 (Actin interacting protein 1) (AIP1)

*	TK040203_NMyc_nuclei2_step12.3886.3886.3	1.819	0.078	2480.32	61	2160.0%	1	R.EKFGAVFLWDTGSSVGEITGHNK.V
	TK040203_NMyc_nuclei2_step11.2442.2442.2	4.4003	0.6007	2784.04	1	4580.0%	2	R.LHHVSSLAWLDEHTLVTTSHDASVK.E
*	TK040203_NMyc_nuclei2_step10.3343.3343.2	1.1932	0.0196	3095.07	16	1430.0%	1	K.FGAVFLWDTGSSVGEITGHNKVINSVDIK.Q
*	TK040203_NMyc_nuclei2_step03.3566.3566.2	1.7031	0.0828	2861.78	3	2080.0%	1	K.DHLLSISLSGYINYLDKNNPSKPLR.V
	TK040203_NMyc_nuclei2_step01.4431.4431.2	1.5429	0.1103	2905.2	12	1670.0%	1	K.AHDGGIYAISWSPDSTHLLSASGDKTSK.I

RS15_HUMAN

99.6%

36.1%

144

16909

10.4

(P11174) 40S ribosomal protein S15 (RIG protein) (P11174) 40S ribosomal protein S15 (RIG protein)

	TK040203_NMyc_nuclei2_step02.3268.3268.3	1.6852	0.0117	4488.08	22	1090.0%	2	K.TFNQVEIKPEMIGHYLGEFSITYKPVKHGRPGIGATHSSR.F
	TK040203_NMyc_nuclei2_step03.1486.1486.1	1.1998	0.1338	714.51	2	7500.0%	1	R.KFTYR.G
	TK040203_NMyc_nuclei2_step09.3286.3286.2	1.6638	0.0618	3171.16	1	2120.0%	3	K.TFNQVEIKPEMIGHYLGEFSITYKPVK.H
	TK040203_NMyc_nuclei2_step10.1670.1670.1	1.4097	0.1709	853.63	1	6670.0%	1	R.KQHSLLK.R

HMG1_MOUSE

99.6%

214

24763

5.7

(P07155) High mobility group protein 1 (HMG-1) (Amphoterin) (Heparin-binding protein p30)

	TK040203_NMyc_nuclei2_step05.2047.2047.1	2.8979	0.4377	1523.79	1	5710.0%	6	K.IKGEHPGLSIGDVAK.K
	TK040203_NMyc_nuclei2_step05.2082.2082.1	2.9881	0.4115	1593.63	1	5380.0%	2	K.KHPDASVNFSEFSK.K

CLI5_HUMAN

99.6%

251

28110

5.8

(Q9NZA1) Chloride intracellular channel protein 5

*	TK040203_NMyc_nuclei2_step12.2394.2394.2	3.1897	0.5523	2590.05	1	3480.0%	4	R.KPADLHNLAPGTHPPFLTFNGDVK.T

Q62189

99.6%

287

31835

9.8

(Q62189) Small nuclear RNA (Small nuclear ribonucleoprotein polypeptide A)

*	TK040203_NMyc_nuclei2_step02.4096.4096.2	2.0374	0.0587	2652.74	1	2410.0%	2	K.AVQGGAAAPVVGAVQPVPGMPPMPQAPR.I

AAC2_MOUSE

99.6%

894

103653

5.5

(Q9JI91) Alpha-actinin 2 (Alpha actinin skeletal muscle isoform 2) (F-actin cross linking protein)

	TK040203_NMyc_nuclei2_step01.2767.2767.1	1.7045	0.0685	1421.65	3	4500.0%	1	K.GYEEWLLNEIR.R
	TK040203_NMyc_nuclei2_step01.2207.2207.1	1.8836	0.2114	1199.5	2	5560.0%	1	R.DLLLDPAWEK.Q
	TK040203_NMyc_nuclei2_step12.2778.2778.3	1.9714	0.248	4422.58	3	1280.0%	1	R.AAPFNNWMEGAMEDLQDMFIVHSIEEIQSLITAHEQFK.A
	TK040203_NMyc_nuclei2_step06.1653.1653.1	1.605	0.085	1303.64	2	5000.0%	2	K.HTNYTMEHIR.V
	TK040203_NMyc_nuclei2_step02.2099.2099.1	1.4182	0.2173	1252.72	5	4500.0%	1	K.ASTHETWAYGK.E
	TK040203_NMyc_nuclei2_step05.1743.1743.2	5.31	0.6546	1754.09	1	8210.0%	1	R.KHEAFESDLAAHQDR.V
	TK040203_NMyc_nuclei2_step12.3301.3301.3	1.87	0.0769	4581.88	216	720.0%	5	K.RAAPFNNWMEGAMEDLQDMFIVHSIEEIQSLITAHEQFK.A

Q922S1

99.6%

508

57645

8.0

(Q922S1) Similar to phenylalanine-tRNA synthetase-like

	TK040203_NMyc_nuclei2_step06.2458.2458.2	3.2858	0.4986	1483.34	1	5380.0%	1	R.GVLPDSGHLHPLLK.V
	TK040203_NMyc_nuclei2_step07.3137.3137.2	1.2771	0.0575	2616.28	95	1520.0%	1	K.AFSTSVSKQEAELSPEMISSGSWR.D

DDX5_HUMAN

99.6%

614

69148

8.9

(P17844) Probable RNA-dependent helicase p68 (DEAD-box protein p68) (DEAD-box protein 5)

*	TK040203_NMyc_nuclei2_step10.3357.3357.2	3.9708	0.6483	2365.65	1	5000.0%	3	K.TLSYLLPAIVHINHQPFLER.G

CPSC_MOUSE

99.6%

684

77529

5.6

(Q9QXK7) Cleavage and polyadenylation specificity factor, 73 kDa subunit (CPSF 73 kDa subunit)

	TK040203_NMyc_nuclei2_step11.0780.0780.1	0.901	0.1281	1012.41	11	2860.0%	1	R.SCIILEFK.G
	TK040203_NMyc_nuclei2_step06.1946.1946.1	1.3445	0.1285	1440.73	20	3640.0%	1	R.TFMTHATKAIYR.W
	TK040203_NMyc_nuclei2_step04.3133.3133.3	2.0847	0.0455	3721.19	8	1610.0%	1	K.VSNISADDMLYTETDLEESMDKIETINFHEVK.E
*	TK040203_NMyc_nuclei2_step07.1956.1956.3	2.0128	0.1817	2762.23	7	2100.0%	1	K.SMDHFDDIGPSVVMASPGMIQNGLSR.E
	TK040203_NMyc_nuclei2_step12.1770.1770.2	3.3604	0.4643	2139.72	1	4440.0%	1	R.ALKPPHVILVHGEQNEMAR.L

RL4_MOUSE

99.6%

419

47154

11.0

(Q9D8E6) 60S ribosomal protein L4 (L1)

	TK040203_NMyc_nuclei2_step01.2190.2190.1	1.9443	0.1914	1270.72	1	5910.0%	2	R.NIPGITLLNVSK.L
	TK040203_NMyc_nuclei2_step01.1780.1780.1	1.1328	0.2181	990.57	2	5620.0%	2	K.NVTLPAVFK.A
	TK040203_NMyc_nuclei2_step11.2431.2431.2	3.2537	0.4995	1862.76	1	4670.0%	2	K.APIRPDIVNFVHTNLR.K

GR78_MOUSE

99.6%

25.8%

655

72422

5.2

(P20029) 78 kDa glucose-regulated protein precursor (GRP 78) (Immunoglobulin heavy chain binding protein) (BIP)

	TK040203_NMyc_nuclei2_step06.1373.1373.1	1.3207	0.0635	981.44	1	6250.0%	1	K.ETAEAYLGK.K
	TK040203_NMyc_nuclei2_step06.1958.1958.2	1.3392	0.0947	1733.77	38	2670.0%	1	K.KTKPYIQVDIGGGQTK.T
	TK040203_NMyc_nuclei2_step07.2394.2394.2	3.4856	0.5844	2016.51	1	5290.0%	1	K.KVTHAVVTVPAYFNDAQR.Q
	TK040203_NMyc_nuclei2_step04.3663.3663.2	2.1916	0.2741	2001.76	2	3240.0%	6	R.GVPQIEVTFEIDVNGILR.V
	TK040203_NMyc_nuclei2_step06.3802.3802.3	2.2031	0.276	4570.86	1	1310.0%	1	K.NILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQR.V
*	TK040203_NMyc_nuclei2_step02.3088.3088.2	4.0614	0.61	2151.71	1	6180.0%	5	R.IEIESFFEGEDFSETLTR.A
	TK040203_NMyc_nuclei2_step01.2604.2604.1	1.8523	0.3665	1539.81	1	4620.0%	1	K.TFAPEEISAMVLTK.M
	TK040203_NMyc_nuclei2_step01.1991.1991.1	1.7615	0.0165	1397.73	1	6820.0%	1	K.ELEEIVQPIISK.L
*	TK040203_NMyc_nuclei2_step02.2751.2751.2	1.0696	0.0149	2182.07	41	2000.0%	1	K.LYGSGGPPPTGEEDTSEKDEL.-

IF5A_HUMAN

99.6%

48.4%

153

16701

5.2

(P10159) Initiation factor 5A (eIF-5A) (eIF-4D) (Rev-binding factor) (P10159) Initiation factor 5A (eIF-5A) (eIF-4D) (Rev-binding factor)

	TK040203_NMyc_nuclei2_step07.3744.3744.2	3.5751	0.534	2630.02	1	3480.0%	9	K.YDCGEEILITVLSAMTEEAAVAIK.A
	TK040203_NMyc_nuclei2_step11.3112.3112.3	1.9179	0.0662	2778.36	1	2200.0%	1	-.ADDLDFETGDAGASATFPMQCSALRK.N
	TK040203_NMyc_nuclei2_step02.3267.3267.2	1.5693	0.0024	2737.96	17	1960.0%	1	K.RNDFQLIGIQDGYLSLLQDSGEVR.E

O54789

99.6%

199

22398

7.4

(O54789) Protein L (Fragment)

	TK040203_NMyc_nuclei2_step11.3827.3827.3	6.1834	0.6076	3775.84	1	2820.0%	3	R.IQHPSNVLHFFNAPLEVTEENFFEICDELGVK.R

Q99KP6

99.6%

52.8%

504

55239

6.6

(Q99KP6) Hypothetical 55.2 kDa protein (Putative nuclear matrix protein SNEV)

	TK040203_NMyc_nuclei2_step11.2810.2810.2	1.4216	0.0521	2889.92	43	1520.0%	1	K.ALQDEWDAVMLHSFTLRQQLQTTR.Q
*	TK040203_NMyc_nuclei2_step06.2743.2743.2	5.0201	0.6913	2617.61	1	5220.0%	2	K.KVTSVVFHPSQELVFSASPDATIR.I
	TK040203_NMyc_nuclei2_step06.2682.2682.3	1.7666	0.0719	4129.14	65	1110.0%	1	K.VTDETSGCSLTCAQFHPDGLIFGTGTMDSQIKIWDLK.E
	TK040203_NMyc_nuclei2_step11.2967.2967.2	2.7025	0.4871	2806.08	1	2710.0%	1	K.QWTEILHFTEHSGLTTGVAFGHHAK.F
*	TK040203_NMyc_nuclei2_step01.1065.1065.1	1.3379	0.0633	1105.37	34	5000.0%	1	K.STEQILATLK.G
	TK040203_NMyc_nuclei2_step11.3684.3684.3	2.0614	0.1046	4109.41	61	1180.0%	1	K.VAHPIRPKPPSATSIPAILKALQDEWDAVMLHSFTLR.Q
	TK040203_NMyc_nuclei2_step12.3181.3181.3	1.9358	0.0054	4767.57	30	920.0%	1	R.EALATLKPQAGLIVPQAVPSSQPSVVGAGEPMDLGELVGMTPEIIQK.L
	TK040203_NMyc_nuclei2_step05.3148.3148.3	2.128	0.2577	3902.85	1	1430.0%	4	R.AHESAVTGLSLHATGDYLLSSSDDQYWAFSDIQTGR.V
	TK040203_NMyc_nuclei2_step06.3063.3063.2	3.852	0.5281	2904.51	1	3700.0%	5	R.QVASHVGLHSASIPGILALDLCPSDTNK.I
	TK040203_NMyc_nuclei2_step12.2593.2593.3	1.7496	0.062	2658.55	8	1900.0%	1	R.QQLQTTRQELSHALYQHDAACR.V

CH60_MOUSE

99.6%

573

60956

6.2

(P19226) 60 kDa heat shock protein, mitochondrial precursor (Hsp60) (60 kDa chaperonin) (CPN60) (Heat shock protein 60) (HSP-60) (Mitochondrial matrix protein P1) (HSP-65)

*	TK040203_NMyc_nuclei2_step08.1623.1623.2	1.1316	0.0315	1908.28	225	2060.0%	1	K.ISSVQSIVPALEIANAHR.K
	TK040203_NMyc_nuclei2_step07.3754.3754.2	1.8766	0.4103	2368.95	1	3330.0%	8	R.KPLVIIAEDVDGEALSTLVLNR.L
*	TK040203_NMyc_nuclei2_step05.2759.2759.2	3.31	0.5906	2035.01	1	5560.0%	3	K.KISSVQSIVPALEIANAHR.K
	TK040203_NMyc_nuclei2_step09.4004.4004.1	0.6337	0.014	619.6	17	4000.0%	1	K.GVITVK.D
*	TK040203_NMyc_nuclei2_step01.3955.3955.2	4.114	0.6643	2841.98	1	3330.0%	2	R.TALLDAAGVASLLTTAEAVVTEIPKEEK.D

ROA1_MOUSE

99.6%

125

31.3%

319

34065

9.2

(P49312) Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein) (Single-strand binding protein) (hnRNP core protein A1) (HDP-1) (Topoisomerase-inhibitor suppressed)

	TK040203_NMyc_nuclei2_step01.2684.2684.1	1.2033	0.1962	1220.68	1	5000.0%	1	K.IEVIEIMTDR.G
	TK040203_NMyc_nuclei2_step03.2151.2151.1	1.8244	0.2122	863.87	8	5710.0%	3	K.KIFVGGIK.E
	TK040203_NMyc_nuclei2_step05.2222.2222.2	4.0921	0.6191	1881.72	1	5670.0%	1	K.IFVGGIKEDTEEHHLR.D
	TK040203_NMyc_nuclei2_step01.0236.0236.1	1.4955	0.1573	734.44	3	6670.0%	2	K.IFVGGIK.E
	TK040203_NMyc_nuclei2_step06.1355.1355.1	1.7451	0.1027	1488.63	1	5000.0%	9	K.YHTVNGHNCEVR.K
	TK040203_NMyc_nuclei2_step07.2861.2861.2	1.8311	0.0388	2756.18	1	2500.0%	1	R.SRGFGFVTYATVEEVDAAMNARPHK.V
	TK040203_NMyc_nuclei2_step04.3866.3866.1	0.7568	0.0218	663.51	5	3330.0%	1	K.GGNFGGR.S
	TK040203_NMyc_nuclei2_step01.0989.0989.1	1.9819	0.2149	1439.69	1	5000.0%	5	R.EDSQRPGAHLTVK.K
	TK040203_NMyc_nuclei2_step03.2695.2695.2	3.6295	0.6177	1967.87	1	6000.0%	1	R.SHFEQWGTLTDCVVMR.D

HXB3_MOUSE

99.6%

907

433

44353

9.2

(P09026) Homeobox protein Hox-B3 (Hox-2.7) (MH-23)

*	TK040203_NMyc_nuclei2_step11.4151.4151.2	1.3912	0.0101	2599.77	1	2390.0%	2	K.GHQNAYALPSNYQPPLKGCGAPQK.Y
*	TK040203_NMyc_nuclei2_step03.3542.3542.2	1.3668	0.0204	2881.84	1	1790.0%	1	K.NSSPGTAEGCGGGGGGGGGGGGGGGGSSGGGGGGGGGGDK.S
*	TK040203_NMyc_nuclei2_step09.3407.3407.2	2.2846	0.3439	3124.97	1	2070.0%	30	K.LKNSSPGTAEGCGGGGGGGGGGGGGGGGSSGGGGGGGGGGDK.S

IF32_MOUSE

99.6%

325

36461

5.6

(Q9QZD9) Eukaryotic translation initiation factor 3 subunit 2 (eIF-3 beta) (eIF3 p36) (TGF-beta receptor interacting protein 1) (TRIP-1)

	TK040203_NMyc_nuclei2_step10.3251.3251.2	1.5118	0.026	1726.09	105	2690.0%	1	K.LFDSTTLEHQKTFR.T
	TK040203_NMyc_nuclei2_step07.2333.2333.2	3.5546	0.3812	1680.02	1	6330.0%	2	K.GHFGPINSVAFHPDGK.S

H11_MOUSE

99.6%

232

212

21654

10.9

(P43275) Histone H1.1 (H1 VAR.3) (H1A)

*	TK040203_NMyc_nuclei2_step10.2947.2947.2	4.974	0.6116	2015.83	1	6580.0%	6	R.KKPAGPSVSELIVQAVSSSK.E
*	TK040203_NMyc_nuclei2_step06.2998.2998.2	5.5615	0.5437	1887.47	1	6940.0%	14	K.KPAGPSVSELIVQAVSSSK.E

Q9D1I8

99.6%

513

57501

7.0

(Q9D1I8) 2610203K23Rik protein

	TK040203_NMyc_nuclei2_step07.3286.3286.3	2.0322	0.0099	4546.15	119	790.0%	1	R.ALATLQEETTVSLNTVDSIESFVADINSGHWDTVLQAIQSLK.L
	TK040203_NMyc_nuclei2_step10.3368.3368.2	1.495	0.0926	1734.48	6	3240.0%	1	R.AAIAQALAGEVSVVPPSR.L
	TK040203_NMyc_nuclei2_step10.3643.3643.2	3.331	0.5745	2864.73	1	3400.0%	1	R.FSPDGQYLVTGSVDGFIEVWNFTTGK.I
	TK040203_NMyc_nuclei2_step11.2350.2350.2	3.2249	0.5176	2642.17	1	3480.0%	2	K.DVIGIAHHPHQNLIATYSEDGLLK.L

RL15_MOUSE

99.6%

21.5%

214

24668

11.1

(Q9CZM2) 60S ribosomal protein L15

	TK040203_NMyc_nuclei2_step11.0482.0482.1	1.0079	0.2231	724.8	2	6000.0%	1	R.KRPVPK.G
	TK040203_NMyc_nuclei2_step05.1923.1923.1	1.9964	0.3391	1566.58	3	3330.0%	5	R.NPDTQWITKPVHK.H
	TK040203_NMyc_nuclei2_step11.1160.1160.2	2.5805	0.4578	1707.05	1	4000.0%	1	K.GATYGKPVHHGVNQLK.F
	TK040203_NMyc_nuclei2_step10.1941.1941.2	3.3004	0.5715	1722.17	1	6150.0%	2	R.RNPDTQWITKPVHK.H
	TK040203_NMyc_nuclei2_step05.1112.1112.1	0.8949	0.0063	596.55	19	6250.0%	1	K.RPVPK.G
	TK040203_NMyc_nuclei2_step07.1612.1612.1	1.0689	0.0491	1078.58	11	5000.0%	3	R.EMRGLTSAGR.K

Q9WTX8

99.6%

717

83541

5.6

(Q9WTX8) Mitotic checkpoint protein isoform MAD1a (Mitotic arrest deficient 1-like 1)

*	TK040203_NMyc_nuclei2_step06.1831.1831.2	1.1749	0.1089	1895.82	88	1880.0%	1	R.EQEDSLASAREMISSLK.G
*	TK040203_NMyc_nuclei2_step06.3162.3162.2	4.5706	0.5681	2522.16	1	4770.0%	1	K.VHAHSSEMEAQLSQALEELGVQK.Q
*	TK040203_NMyc_nuclei2_step12.3562.3562.3	2.0636	0.3433	4616.58	1	1410.0%	1	K.MQLLETEFSRSVPELIELHLLQQDSIPAFLSALTIELFSR.Q
*	TK040203_NMyc_nuclei2_step01.3350.3350.1	1.1911	0.0552	1252.76	4	5000.0%	1	K.MQLLETEFSR.S

EF11_MOUSE

99.6%

2147

31.6%

462

50164

9.0

(P10126) Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor 1 A-1) (eEF1A-1) (Elongation factor Tu) (EF-Tu)

	TK040203_NMyc_nuclei2_step05.3650.3650.2	1.9753	0.0779	2914.18	1	2140.0%	43	K.NMITGTSQADCAVLIVAAGVGEFEAGISK.N
	TK040203_NMyc_nuclei2_step01.2546.2546.2	3.7405	0.6051	2515.78	1	4130.0%	2	R.VETGVLKPGMVVTFAPVNVTTEVK.S
	TK040203_NMyc_nuclei2_step04.3385.3385.2	1.3425	0.0989	1996.62	6	2810.0%	1	K.FETSKYYVTIIDAPGHR.D
	TK040203_NMyc_nuclei2_step01.2166.2166.1	1.8537	0.2085	1315.49	1	5000.0%	1	R.EHALLAYTLGVK.Q
	TK040203_NMyc_nuclei2_step06.3137.3137.3	5.0571	0.5364	4389.83	1	1750.0%	3	K.NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDCHTAHIACK.F
	TK040203_NMyc_nuclei2_step01.1189.1189.1	1.285	0.0672	975.59	1	7140.0%	1	R.LPLQDVYK.I
	TK040203_NMyc_nuclei2_step07.2457.2457.1	2.144	0.3825	1592.69	1	4640.0%	16	K.THINIVVIGHVDSGK.S

EF1G_MOUSE

99.6%

437

50061

6.7

(Q9D8N0) Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)

	TK040203_NMyc_nuclei2_step12.1902.1902.2	2.4091	0.4817	1710.94	1	5000.0%	3	R.VLSAPPHFHFGQTNR.T
	TK040203_NMyc_nuclei2_step03.3333.3333.2	1.6022	0.0629	2686.99	1	2380.0%	1	R.GQELAFPLSPDWQVDYESYTWR.K
	TK040203_NMyc_nuclei2_step06.3483.3483.3	1.5534	0.065	3703.89	56	1330.0%	1	K.FPAGKVPAFEGDDGFCVFESNAIAYYVSNEELR.G

IQG1_MOUSE

99.6%

1657

188755

6.5

(Q9JKF1) Ras GTPase-activating-like protein IQGAP1

	TK040203_NMyc_nuclei2_step09.2541.2541.2	1.1854	0.0167	2739.1	72	1670.0%	1	K.FVHLLDQSDQDFQEELDLMKMR.E
*	TK040203_NMyc_nuclei2_step05.3378.3378.3	2.1419	0.1519	3871.5	2	1560.0%	1	K.AQAHAENNAFITWNDIQACVDHVNLVVHEEHER.I
*	TK040203_NMyc_nuclei2_step03.3341.3341.2	2.4394	0.4045	2847.0	1	2920.0%	1	K.AQETQDESAVLWLDEIQGGIWQSNK.D
*	TK040203_NMyc_nuclei2_step08.1779.1779.1	3.1434	0.4915	1540.85	1	5830.0%	2	R.LAYLHSHKDEVVK.I

U186_MOUSE

99.6%

10119

6.4

(Q923D4) Hypothetical protein MGC11596

	TK040203_NMyc_nuclei2_step03.2007.2007.2	3.745	0.6011	1585.84	1	7080.0%	1	R.YTIHSQLEHLQSK.Y

AATM_MOUSE

99.6%

430

47411

9.0

(P05202) Aspartate aminotransferase, mitochondrial precursor (EC 2.6.1.1) (Transaminase A) (Glutamate oxaloacetate transaminase-2)

*	TK040203_NMyc_nuclei2_step05.2966.2966.2	3.2074	0.5051	2323.8	1	3860.0%	2	R.ISVAGVTSGNVGYLAHAIHQVTK.-
	TK040203_NMyc_nuclei2_step03.3481.3481.2	1.1103	0.0142	1753.05	7	3750.0%	1	K.SGRFVTVQTISGTGALR.V
	TK040203_NMyc_nuclei2_step01.2491.2491.1	1.3464	0.1443	1496.11	1	4580.0%	1	K.EYLPIGGLAEFCK.A

Q924V8

99.6%

18.8%

565

61810

6.8

(Q924V8) Carboxylesterase MH1 (EC 3.1.1.1)

	TK040203_NMyc_nuclei2_step02.2939.2939.3	1.8321	0.0785	3479.94	10	1530.0%	1	-.MGLYPLIWLSLAACTAWGYPSSPPVVNTVKGK.V
	TK040203_NMyc_nuclei2_step02.3542.3542.2	3.465	0.4865	3147.15	1	3060.0%	2	R.AISESGVSLTAALITTDVKPIAGLVATLSGCK.T
	TK040203_NMyc_nuclei2_step02.4216.4216.3	1.3867	0.0159	4603.24	9	1160.0%	1	K.YVNLEGFTQPVAVFLGVPFAKPPLGSLRFAPPQPAEPWSFVK.N

TCPE_MOUSE

99.6%

541

59624

6.0

(P80316) T-complex protein 1, epsilon subunit (TCP-1-epsilon) (CCT-epsilon)

	TK040203_NMyc_nuclei2_step04.3647.3647.2	2.7919	0.3983	3115.17	1	2070.0%	2	K.SQDDEIGDGTTGVVVLAGALLEEAEQLLDR.G
*	TK040203_NMyc_nuclei2_step09.3053.3053.2	1.4051	0.0605	2746.2	3	2170.0%	1	-.MASVGTLAFDEYGRPFLIIKDQDR.K

Q9D0E1

99.6%

729

77649

8.6

(Q9D0E1) 2610023M21Rik protein

*	TK040203_NMyc_nuclei2_step12.2589.2589.3	5.2402	0.5331	3795.02	1	2360.0%	1	K.GDFFPPERPQQLPHGLGGIGMGLGPGGQPIDANHLSK.G
	TK040203_NMyc_nuclei2_step02.2199.2199.2	3.2079	0.3652	2038.1	1	3640.0%	2	R.GNFGGSFAGSFGGAGGHAPGVAR.K
*	TK040203_NMyc_nuclei2_step06.2781.2781.2	2.5873	0.2296	2027.39	1	3330.0%	1	K.QGGGGAGGSVPGIERMGPGIDR.I
*	TK040203_NMyc_nuclei2_step11.3143.3143.3	1.6081	0.0466	4668.82	29	940.0%	1	R.AMQKVMATTGGMGMGPGGPGMINIPPSILNNPNIPNEIIHALQAGR.L

Q9CT05

99.6%

654

75395

5.3

(Q9CT05) 2610027H02Rik protein (Fragment)

	TK040203_NMyc_nuclei2_step05.2574.2574.2	2.3571	0.3574	2243.57	1	3530.0%	2	R.QEFAQHANAFHQWIQETR.T
	TK040203_NMyc_nuclei2_step09.3282.3282.2	1.7817	0.2866	2929.32	1	2390.0%	4	R.LEESLEYQQFVANVEEEEAWINEK.M
	TK040203_NMyc_nuclei2_step06.2009.2009.1	2.9113	0.4604	1588.7	1	5830.0%	1	K.KHEAFETDFTVHK.D

PGCV_MOUSE

99.6%

3358

366944

4.6

(Q62059) Versican core protein precursor (Large fibroblast proteoglycan) (Chondroitin sulfate proteoglycan core protein 2) (PG-M)

*	TK040203_NMyc_nuclei2_step04.1367.1367.1	1.1641	0.0326	1078.59	1	5500.0%	1	K.SASGEPTTGDR.F
*	TK040203_NMyc_nuclei2_step03.3262.3262.3	2.254	0.0036	3125.25	70	1250.0%	1	K.QPKPVPLFPEESSGEGAIEQASQETILSR.A
*	TK040203_NMyc_nuclei2_step12.3185.3185.2	1.3943	0.1073	2937.9	2	2120.0%	1	K.DKEIPSFTDGGGEYTLFPDGTPKPLEK.V
	TK040203_NMyc_nuclei2_step07.3044.3044.2	4.3388	0.4953	2311.66	1	5260.0%	2	R.LQGAHLTSILSHEEQMFVNR.V
*	TK040203_NMyc_nuclei2_step08.3808.3808.3	1.6443	0.1053	4487.4	5	1340.0%	1	K.THRPQTMSGLISNENSSASEAEEGATSPTAFLPQTYSVEMTK.H
*	TK040203_NMyc_nuclei2_step12.3739.3739.2	1.5391	0.0823	3129.38	3	1610.0%	2	K.HPEVSKTEAGATDVSPTASAMFLHHSEYK.S

ZAP3_MOUSE

99.6%

1386

155131

6.7

(Q9R0I7) Nuclear protein ZAP3

	TK040203_NMyc_nuclei2_step03.2079.2079.2	1.2867	0.0355	1990.31	39	3000.0%	1	R.EQHLAQLQQLQQMHQK.Q
	TK040203_NMyc_nuclei2_step05.1364.1364.1	0.7647	0.0552	1124.33	148	3750.0%	1	R.QHLLSLQQR.T
*	TK040203_NMyc_nuclei2_step12.1831.1831.2	2.7515	0.5539	1776.68	1	4690.0%	1	R.MPLPAPALGHQPPPVPR.V

FLNA_HUMAN

99.6%

814

2647

280759

6.1

(P21333) Filamin A (Alpha-filamin) (Filamin 1) (Endothelial actin-binding protein) (ABP-280) (Nonmuscle filamin)

*	TK040203_NMyc_nuclei2_step09.1357.1357.2	3.9863	0.6126	1635.71	1	6670.0%	2	R.VHGPGIQSGTTNKPNK.F
*	TK040203_NMyc_nuclei2_step12.3522.3522.2	1.2296	0.0607	3019.46	5	1730.0%	2	R.TFSVWYVPEVTGTHKVTVLFAGQHIAK.S
*	TK040203_NMyc_nuclei2_step04.3335.3335.2	1.7307	0.1609	2699.57	1	2880.0%	28	K.SADFVVEAIGDDVGTLGFSVEGPSQAK.I
*	TK040203_NMyc_nuclei2_step07.2209.2209.2	1.4	0.0674	1423.17	1	5420.0%	1	R.LRNGHVGISFVPK.E
*	TK040203_NMyc_nuclei2_step06.3142.3142.3	1.6973	0.1276	3492.65	6	1360.0%	1	R.MSHLKVGSAADIPINISETDLSLLTATVVPPSGR.E
*	TK040203_NMyc_nuclei2_step05.2327.2327.3	1.8532	7.0E-4	3193.92	76	1390.0%	1	K.THIQDNHDGTYTVAYVPDVTGRYTILIK.Y
*	TK040203_NMyc_nuclei2_step04.2823.2823.2	3.1619	0.6245	2687.2	1	3910.0%	4	R.CSYQPTMEGVHTVHVTFAGVPIPR.S
*	TK040203_NMyc_nuclei2_step09.3519.3519.3	2.111	0.0742	4108.22	2	1400.0%	1	R.AVPTGDASKCTVTVSIGGHGLGAGIGPTIQIGEETVITVDTK.A
*	TK040203_NMyc_nuclei2_step01.1678.1678.1	1.4431	0.1594	1284.76	2	4550.0%	1	K.VTVLFAGQHIAK.S
*	TK040203_NMyc_nuclei2_step08.2259.2259.3	1.6931	0.0863	3961.94	13	1500.0%	1	K.VTCTVCTPDGSEVDVDVVENEDGTFDIFYTAPQPGK.Y

Q9DBD5

99.6%

8.5%

1123

118054

4.4

(Q9DBD5) Adult male liver cDNA, RIKEN full-length enriched library, clone:1300017A15, full insert sequence

*	TK040203_NMyc_nuclei2_step10.3383.3383.3	3.2296	0.1211	3248.39	1	2320.0%	1	R.LHDLVLPLVMSVQQGEVLGSSPYNSSCCR.L
*	TK040203_NMyc_nuclei2_step10.1254.1254.2	1.0843	0.1778	1629.25	5	2860.0%	1	K.LKLDMGEALAPPSQR.K
*	TK040203_NMyc_nuclei2_step12.1393.1393.2	0.9285	0.0046	2504.56	7	2050.0%	1	R.SIQQVLQSQDSPSTMELAVAVLR.D
	TK040203_NMyc_nuclei2_step10.3263.3263.2	4.4882	0.6251	2786.54	1	3570.0%	1	R.LHGTAGGAQNLSALGALVNLSNAHLGSIK.T

NAL1_HUMAN

99.6%

1473

165865

6.8

(Q9C000) NACHT-, LRR- and PYD-containing protein 2 (Death effector filament-forming ced-4-like apoptosis protein) (Nucleotide-binding domain and caspase recruitment domain) (Caspase recruitment domain protein 7)

*	TK040203_NMyc_nuclei2_step11.4408.4408.2	1.2152	0.0147	3122.74	101	1250.0%	1	K.TLEAYGIHGLFGASTTRFLLGLLSDEGER.E
	TK040203_NMyc_nuclei2_step11.3703.3703.3	2.2381	0.202	4072.45	40	1180.0%	1	R.EAVTVEIEFCVWDQFLGEINPQHSWMVAGPLLDIK.A
*	TK040203_NMyc_nuclei2_step09.4184.4184.2	1.3648	0.086	2567.48	80	1750.0%	1	R.FLLGLLSDEGEREMENIFHCR.L
	TK040203_NMyc_nuclei2_step11.2563.2563.2	1.3571	0.078	2541.1	57	2000.0%	1	R.VHPEEVTFHLYLIPSDCSIRK.A
	TK040203_NMyc_nuclei2_step05.3166.3166.2	1.1822	0.0491	2652.0	17	1880.0%	1	R.RKPSVMTPTEGLDTGEMSNSTSSLK.R
*	TK040203_NMyc_nuclei2_step03.3017.3017.2	3.2788	0.3005	2282.3	1	4740.0%	9	R.IAVPSPLDAPQLLHFVDQYR.E
*	TK040203_NMyc_nuclei2_step07.3273.3273.1	1.3631	0.0927	1390.72	9	3890.0%	1	R.FQHVFYFSCR.E

O08817

99.6%

653

70408

8.8

(O08817) CW17 protein

	TK040203_NMyc_nuclei2_step09.2887.2887.2	1.0559	0.0439	2811.23	106	1460.0%	1	R.WNQDTMEQKTVIPGMPTVIPPGLTR.E
*	TK040203_NMyc_nuclei2_step02.4099.4099.3	1.8559	0.0116	2817.07	68	1600.0%	1	R.IPPRGSDGPSHESEDFPRPLVTLPGR.Q
	TK040203_NMyc_nuclei2_step06.3009.3009.2	3.6064	0.517	2924.18	1	4000.0%	1	R.HTLITEMVALNPDFKPPADYKPPATR.V

HS47_MOUSE

99.6%

417

46590

8.8

(P19324) 47 kDa heat shock protein precursor (Collagen-binding protein 1) (Serine protease inhibitor J6)

	TK040203_NMyc_nuclei2_step08.3011.3011.2	3.6834	0.4161	1986.64	1	6250.0%	5	K.LSSLIILMPHHVEPLER.L
*	TK040203_NMyc_nuclei2_step01.3984.3984.2	1.4463	0.1236	2579.89	27	1800.0%	1	K.DQAVENILLSPLVVASSLGLVSLGGK.A
	TK040203_NMyc_nuclei2_step01.1912.1912.1	2.1809	0.2121	1338.74	1	5830.0%	2	K.HLAGLGLTEAIDK.N

CAH2_MOUSE

99.6%

170

17.0%

259

28960

7.0

(P00920) Carbonic anhydrase II (EC 4.2.1.1) (Carbonate dehydratase II) (CA-II)

	TK040203_NMyc_nuclei2_step07.1389.1389.1	2.0227	0.2202	1120.53	2	6250.0%	3	K.HNGPENWHK.D
	TK040203_NMyc_nuclei2_step11.2470.2470.2	3.0725	0.4227	2515.25	1	3330.0%	8	R.LIQFHFHWGSSDGQGSEHTVNK.K
	TK040203_NMyc_nuclei2_step04.2561.2561.2	3.8107	0.5438	1584.0	1	8750.0%	4	K.YAAELHLVHWNTK.Y

TFR1_MOUSE

99.6%

763

85731

6.6

(Q62351) Transferrin receptor protein 1 (TfR1) (TR) (TfR) (Trfr)

*	TK040203_NMyc_nuclei2_step10.3269.3269.2	2.171	0.3368	2099.33	1	3330.0%	2	R.HIFWGSGSHTLSALVENLK.L
*	TK040203_NMyc_nuclei2_step08.3712.3712.2	1.1144	0.0337	2588.78	46	1820.0%	1	K.LAETEETDKSETMETEDVPTSSR.L

HBB1_MOUSE

99.6%

219

5015

95.9%

146

15709

7.6

(P02088) Hemoglobin beta-1 chain (B1) (Major)

	TK040203_NMyc_nuclei2_step01.2343.2343.1	1.3774	0.0228	1138.99	47	4090.0%	34	K.VVAGVATALAHK.Y
	TK040203_NMyc_nuclei2_step01.2203.2203.2	3.8936	0.5376	1758.32	1	7330.0%	3	K.VITAFNDGLNHLDSLK.G
	TK040203_NMyc_nuclei2_step01.0901.0901.1	2.6654	0.4193	1468.04	1	5000.0%	30	K.GTFASLSELHCDK.L
	TK040203_NMyc_nuclei2_step06.2103.2103.1	2.1125	0.1967	1439.65	1	5000.0%	9	K.VVAGVATALAHKYH.-
*	TK040203_NMyc_nuclei2_step01.1097.1097.1	1.0033	0.0955	993.56	2	5620.0%	33	K.AAVSCLWGK.V
	TK040203_NMyc_nuclei2_step01.1436.1436.1	1.2757	0.1137	1129.59	7	4380.0%	3	K.LHVDPENFR.L
	TK040203_NMyc_nuclei2_step01.1225.1225.1	2.5037	0.3941	1296.61	1	5910.0%	23	K.DFTPAAQAAFQK.V
*	TK040203_NMyc_nuclei2_step04.2510.2510.2	1.4375	0.0084	2278.49	1	2620.0%	1	K.AAVSCLWGKVNSDEVGGEALGR.L
	TK040203_NMyc_nuclei2_step05.2718.2718.2	3.2162	0.6106	2576.51	1	5240.0%	19	K.GTFASLSELHCDKLHVDPENFR.L
	TK040203_NMyc_nuclei2_step12.4318.4318.2	3.2215	0.5968	1716.69	1	5670.0%	11	R.LLGNMIVIVLGHHLGK.D
	TK040203_NMyc_nuclei2_step08.1245.1245.1	1.7027	0.2335	914.75	4	5710.0%	20	-.VHLTDAEK.A
	TK040203_NMyc_nuclei2_step01.4282.4282.2	3.2768	0.4875	1984.81	1	3890.0%	16	R.YFDSFGDLSSASAIMGNAK.V
	TK040203_NMyc_nuclei2_step05.2636.2636.2	5.0689	0.5436	1887.57	1	6560.0%	7	K.KVITAFNDGLNHLDSLK.G
	TK040203_NMyc_nuclei2_step02.1316.1316.1	1.2282	0.089	1303.67	1	4580.0%	2	K.VNSDEVGGEALGR.L
	TK040203_NMyc_nuclei2_step01.2290.2290.1	1.1442	0.0244	1276.66	4	5000.0%	1	R.LLVVYPWTQR.Y

OAT_MOUSE

99.6%

439

48355

6.6

(P29758) Ornithine aminotransferase, mitochondrial precursor (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)

*	TK040203_NMyc_nuclei2_step06.2934.2934.2	2.8558	0.4788	2314.46	1	3680.0%	3	R.QYFDFLSAYGAVSQGHCHPK.I
	TK040203_NMyc_nuclei2_step10.2323.2323.2	3.6015	0.5203	1738.2	1	6070.0%	1	K.YGAHNYHPLPVALER.G

CLH1_HUMAN

99.6%

1675

191613

5.7

(Q00610) Clathrin heavy chain 1 (CLH-17)

*	TK040203_NMyc_nuclei2_step01.3900.3900.2	2.4834	0.5114	3190.46	1	2680.0%	2	R.FQSVPAQPGQTSPLLQYFGILLDQGQLNK.Y
*	TK040203_NMyc_nuclei2_step06.1483.1483.3	1.7726	0.0547	2867.54	26	1770.0%	1	K.LLLPWLEARIHEGCEEPATHNALAK.I
*	TK040203_NMyc_nuclei2_step03.2489.2489.2	2.0948	0.341	1947.81	1	3820.0%	1	K.LHIIEVGTPPTGNQPFPK.K
*	TK040203_NMyc_nuclei2_step02.3554.3554.2	2.0522	0.3959	3076.24	2	1920.0%	6	R.LDNYDAPDIANIAISNELFEEAFAIFR.K
*	TK040203_NMyc_nuclei2_step06.3301.3301.2	1.4655	0.0129	2042.84	146	1940.0%	2	R.LPVVIGGLLDVDCSEDVIK.N
	TK040203_NMyc_nuclei2_step08.2839.2839.3	1.72	0.1941	1764.88	1	3570.0%	1	K.EDKLECSEELGDLVK.S
*	TK040203_NMyc_nuclei2_step05.3526.3526.2	5.6392	0.6338	2369.65	1	6250.0%	1	R.KFDVNTSAVQVLIEHIGNLDR.A

Q9CRK7

99.6%

47.5%

118

12862

6.8

(Q9CRK7) 9430095H01Rik protein (Fragment)

	TK040203_NMyc_nuclei2_step03.4109.4109.2	1.3864	0.0996	2457.19	2	2620.0%	1	R.AELATEEFLPVTPILEGFVILR.K
	TK040203_NMyc_nuclei2_step05.2468.2468.2	4.2922	0.6396	2082.9	1	5000.0%	2	K.TITGFQTHTTPVLLAHGER.A
	TK040203_NMyc_nuclei2_step12.1197.1197.3	1.8784	0.1525	3513.69	7	1590.0%	1	R.VGQAVDVVGQAGKPKTITGFQTHTTPVLLAHGER.A

ENPL_MOUSE

99.6%

20.7%

802

92476

4.8

(P08113) Endoplasmin precursor (Endoplasmic reticulum protein 99) (94 kDa glucose-regulated protein) (GRP94) (ERP99) (Polymorphic tumor rejection antigen 1) (Tumor rejection antigen gp96)

	TK040203_NMyc_nuclei2_step05.2936.2936.3	1.3911	0.0831	3956.78	16	1250.0%	1	K.MTEAQEDGQSTSELIGQFGVGFYSAFLVADKVIVTSK.H
	TK040203_NMyc_nuclei2_step04.1537.1537.1	1.2206	0.0793	635.51	4	7500.0%	1	R.HPLIR.D
	TK040203_NMyc_nuclei2_step02.3214.3214.2	1.5605	0.0994	2289.59	1	3160.0%	2	K.ESDDPMAYIHFTAEGEVTFK.S
*	TK040203_NMyc_nuclei2_step02.2226.2226.2	4.8474	0.6598	2250.81	1	6110.0%	1	R.FQSSHHSTDITSLDQYVER.M
*	TK040203_NMyc_nuclei2_step11.2171.2171.3	1.7147	0.1326	3554.44	4	1720.0%	1	K.YSQFINFPIYVWSSKTETVEEPLEEDEAAK.E
*	TK040203_NMyc_nuclei2_step02.2343.2343.2	0.9989	0.0524	2028.39	9	2220.0%	1	R.LISLTDENALAGNEELTVK.I
	TK040203_NMyc_nuclei2_step06.2678.2678.2	1.2364	0.1347	2544.26	20	2110.0%	1	K.TVWDWELMNDIKPIWQRPSK.E
*	TK040203_NMyc_nuclei2_step09.3655.3655.2	2.9832	0.3986	1781.36	1	6000.0%	2	K.TVMDLAVVLFETATLR.S

MYHA_HUMAN

99.6%

1976

228937

5.5

(P35580) Myosin heavy chain, nonmuscle type B (Cellular myosin heavy chain, type B) (Nonmuscle myosin heavy chain-B) (NMMHC-B)

*	TK040203_NMyc_nuclei2_step08.3763.3763.2	1.4174	0.0277	2968.45	1	2290.0%	1	K.DNFQETMEAMHIMGFSHEEILSMLK.V
	TK040203_NMyc_nuclei2_step09.3367.3367.2	4.4135	0.4336	1961.85	1	6880.0%	1	R.TFHIFYQLLSGAGEHLK.S
*	TK040203_NMyc_nuclei2_step10.2080.2080.2	1.5786	0.1236	3099.99	1	1920.0%	1	K.SDLLLEGFNNYRFLSNGYIPIPGQQDK.D

Q9CY40

99.6%

711

26.2%

122

13184

8.8

(Q9CY40) Hemoglobin, beta adult major chain

	TK040203_NMyc_nuclei2_step06.4339.4339.2	0.8858	0.0911	2996.32	13	1380.0%	23	K.KVADALANAAGHLDDLPGALSALSDLHAHK.L
	TK040203_NMyc_nuclei2_step11.3206.3206.2	1.7716	0.0886	3135.58	2	2170.0%	1	K.VADALANAAGHLDDLPGALSALSDLHAHKLR.V
	TK040203_NMyc_nuclei2_step04.2083.2083.3	2.0653	0.2108	2867.3	3	1790.0%	1	K.VADALANAAGHLDDLPGALSALSDLHAHK.L

Q99KQ2

99.6%

26.6%

512

54007

7.0

(Q99KQ2) Hypothetical 54.0 kDa protein (Fragment)

	TK040203_NMyc_nuclei2_step04.2621.2621.2	5.258	0.6504	2202.24	1	5790.0%	3	R.LVSNHSLHETSSVFVDSLTK.V
	TK040203_NMyc_nuclei2_step11.2390.2390.2	3.261	0.487	2304.76	1	4550.0%	1	K.GQHVPGSPFQFTVGPLGEGGAHK.V
*	TK040203_NMyc_nuclei2_step01.2183.2183.1	1.5819	0.2414	1506.16	2	3850.0%	2	R.AEAGVPAEFGIWTR.E
	TK040203_NMyc_nuclei2_step11.1760.1760.2	1.1548	6.0E-4	2747.37	84	1730.0%	1	R.LTVSSLQESGLKVNQPASFAVSLNGAK.G
*	TK040203_NMyc_nuclei2_step02.3730.3730.3	2.8245	0.3322	4796.83	1	1320.0%	1	R.VGEPGHGGDPGLVSAYGAGLEGGVTGSPAEFIVNTSNAGAGALSVTIDGPSK.V

DDX9_MOUSE

99.6%

1380

149582

6.9

(O70133) ATP-dependent RNA helicase A (Nuclear DNA helicase II) (NDH II) (DEAD-box protein 9) (mHEL-5)

*	TK040203_NMyc_nuclei2_step02.1539.1539.1	1.2738	0.0445	1084.71	11	5620.0%	1	K.LAHFEPSQR.Q
	TK040203_NMyc_nuclei2_step09.4042.4042.1	0.5534	0.0101	705.94	121	2500.0%	1	R.GSGGFQR.R
	TK040203_NMyc_nuclei2_step03.2253.2253.1	2.0406	0.1684	1503.69	1	5000.0%	1	R.GISHVIVDEIHER.D
*	TK040203_NMyc_nuclei2_step09.1549.1549.3	1.2676	0.0385	3560.81	114	1130.0%	1	R.AAMEALVVEVSKQPNIISQLDPVNEHMLNTIR.Q
*	TK040203_NMyc_nuclei2_step06.3597.3597.2	1.1046	0.2134	2122.16	2	3330.0%	1	K.KFEAEILEAISSNSVVIIR.G
	TK040203_NMyc_nuclei2_step04.3527.3527.2	4.6173	0.5873	2078.27	1	6470.0%	1	R.FSDHVALLSVFQAWDDAR.M
*	TK040203_NMyc_nuclei2_step07.1452.1452.1	1.7172	0.2686	1435.66	3	4090.0%	3	K.HLENNSHFGSHR.Y

PPOL_MOUSE

99.6%

1012

112969

9.0

(P11103) Poly [ADP-ribose] polymerase-1 (EC 2.4.2.30) (PARP-1) (ADPRT) (NAD(+) ADP-ribosyltransferase-1) (Poly[ADP-ribose] synthetase-1) (msPARP)

	TK040203_NMyc_nuclei2_step06.3093.3093.2	5.5455	0.6823	2205.95	1	6670.0%	5	K.NTHATTHNAYDLEVIDIFK.I
	TK040203_NMyc_nuclei2_step12.3911.3911.2	1.528	0.1268	2604.49	83	1430.0%	1	K.NTHATTHNAYDLEVIDIFKIER.E
	TK040203_NMyc_nuclei2_step08.1384.1384.1	1.424	0.161	971.71	25	5000.0%	1	K.KLTVKPGTK.S
*	TK040203_NMyc_nuclei2_step09.3221.3221.3	2.0145	0.1054	4046.01	1	1450.0%	1	R.IFPPESSAPITVHWPLSVTSAPTAVNSSAPADKPLSNMK.I

Q8VCF4

99.6%

476

57088

10.8

(Q8VCF4) Similar to hypothetical protein FLJ13213

	TK040203_NMyc_nuclei2_step08.2788.2788.1	1.1636	0.1929	533.39	11	6250.0%	1	R.ASLDK.K
*	TK040203_NMyc_nuclei2_step10.1873.1873.2	3.3538	0.4857	1642.14	1	6150.0%	1	R.TVILHDRPEVAHPR.H

VIME_MOUSE

99.6%

21.9%

465

53557

5.1

(P20152) Vimentin

*	TK040203_NMyc_nuclei2_step01.2928.2928.1	1.5411	0.1707	1559.85	14	3080.0%	1	R.ISLPLPTFSSLNLR.E
	TK040203_NMyc_nuclei2_step04.3237.3237.2	1.4119	0.2262	2126.93	4	2780.0%	3	R.LLQDSVDFSLADAINTEFK.N
	TK040203_NMyc_nuclei2_step01.2615.2615.1	2.1942	0.2599	1171.8	2	6670.0%	1	K.ILLAELEQLK.G
	TK040203_NMyc_nuclei2_step01.2250.2250.1	2.3874	0.3398	1535.82	4	4170.0%	2	R.KVESLQEEIAFLK.K
*	TK040203_NMyc_nuclei2_step03.3205.3205.3	1.8377	0.09	3912.16	97	1140.0%	1	K.LHDEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.D
*	TK040203_NMyc_nuclei2_step07.2994.2994.3	7.3564	0.6552	4041.81	1	3090.0%	8	K.KLHDEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.D
	TK040203_NMyc_nuclei2_step01.3474.3474.1	1.197	0.2291	1296.64	10	3500.0%	1	K.MALDIEIATYR.K

Q99K86

99.6%

650

70858

6.5

(Q99K86) Lutheran blood group (Auberger b antigen included)

	TK040203_NMyc_nuclei2_step06.1775.1775.2	1.3266	0.1819	2153.89	84	2220.0%	1	R.DANFHCAAHYDLPSGQHGR.L
	TK040203_NMyc_nuclei2_step09.3299.3299.2	3.7954	0.5688	2256.18	1	4720.0%	2	R.EHPEHYVLEWFLVDGTGAR.H

HBA_HUMAN

99.6%

104

30.5%

141

15126

8.7

(P01922) Hemoglobin alpha chain

*	TK040203_NMyc_nuclei2_step07.2130.2130.3	1.5308	0.1286	3026.89	1	1940.0%	2	K.LLSHCLLVTLAAHLPAEFTPAVHASLDK.F
*	TK040203_NMyc_nuclei2_step07.1717.1717.1	2.632	0.0041	1531.79	2	5360.0%	10	K.VGAHAGEYGAEALER.M

RAN_HUMAN

99.6%

216

24423

7.5

(P17080) GTP-binding nuclear protein RAN (TC4) (Ran GTPase) (Androgen receptor-associated protein 24) (P17080) GTP-binding nuclear protein RAN (TC4) (Ran GTPase) (Androgen receptor-associated protein 24)

	TK040203_NMyc_nuclei2_step04.2799.2799.2	2.4908	0.4689	2056.05	1	4120.0%	4	K.YVATLGVEVHPLVFHTNR.G
	TK040203_NMyc_nuclei2_step07.1665.1665.1	1.7439	0.2293	1118.58	2	6880.0%	2	K.RHLTGEFEK.K

ROA2_MOUSE

99.6%

143

27.9%

341

35993

8.6

(O88569) Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2 / hnRNP B1)

	TK040203_NMyc_nuclei2_step01.0006.0006.1	1.4855	0.0392	600.27	6	7500.0%	1	K.IVLQK.Y
	TK040203_NMyc_nuclei2_step05.2222.2222.2	4.0921	0.6191	1881.72	1	5670.0%	1	K.LFVGGIKEDTEEHHLR.D
	TK040203_NMyc_nuclei2_step10.3040.3040.2	1.2315	0.0675	2828.52	1	2310.0%	1	R.GFGFVTFSSMAEVDAAMAARPHSIDGR.V
	TK040203_NMyc_nuclei2_step01.0917.0917.2	1.4169	0.0977	1413.79	2	5000.0%	2	K.YHTINGHNAEVR.K
	TK040203_NMyc_nuclei2_step02.2972.2972.2	3.6372	0.3752	1801.97	1	7000.0%	1	K.LFIGGLSFETTEESLR.N
	TK040203_NMyc_nuclei2_step01.0236.0236.1	1.4955	0.1573	734.44	3	6670.0%	2	K.LFVGGIK.E
	TK040203_NMyc_nuclei2_step02.2763.2763.2	1.7372	0.1532	2221.87	3	2940.0%	1	R.DYFEEYGKIDTIEIITDR.Q
	TK040203_NMyc_nuclei2_step03.2151.2151.1	1.8244	0.2122	863.87	8	5710.0%	3	K.KLFVGGIK.E

O08583

99.6%

25.5%

255

26940

11.2

(O08583) ALY

	TK040203_NMyc_nuclei2_step09.4183.4183.2	1.7345	0.1577	2845.99	1	2800.0%	8	K.LLVSNLDFGVSDADIQELFAEFGTLK.K
	TK040203_NMyc_nuclei2_step01.2974.2974.1	1.0962	0.0269	1447.63	125	2920.0%	1	R.RPAQSINRGGMTR.N
	TK040203_NMyc_nuclei2_step05.3552.3552.2	1.4819	0.1567	2704.16	48	1600.0%	1	K.QLPDKWQHDLFDSGFGGGAGVETGGK.L

Q9D1L0

99.6%

15.7%

153

15661

9.6

(Q9D1L0) Ethanol induced 6

*	TK040203_NMyc_nuclei2_step10.1469.1469.2	3.7463	0.633	2154.24	1	4780.0%	3	R.RAPAAQPPAAAAPSAVGSPAAAPR.Q

Q9D0K2

99.6%

520

55989

8.5

(Q9D0K2) 2610008O03Rik protein (RIKEN cDNA 2610008O03 gene)

	TK040203_NMyc_nuclei2_step02.3394.3394.2	3.4628	0.5407	2380.88	1	4750.0%	1	R.EFNGQHFILEEAITGDFALVK.A

IMB1_MOUSE

99.6%

876

97152

4.8

(P70168) Importin beta-1 subunit (Karyopherin beta-1 subunit) (Nuclear factor P97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG)

	TK040203_NMyc_nuclei2_step11.4502.4502.2	1.1971	0.1072	2009.14	30	2110.0%	1	R.VLANPGNSQVARVAAGLQIK.N
	TK040203_NMyc_nuclei2_step07.3721.3721.2	5.2231	0.602	2292.33	1	6190.0%	4	R.SVKPQILSVFGDIALAIGGEFK.K

PDA4_MOUSE

99.6%

638

71973

5.3

(P08003) Protein disulfide isomerase A4 precursor (EC 5.3.4.1) (Protein ERp-72) (ERp72)

*	TK040203_NMyc_nuclei2_step09.1887.1887.1	2.0878	0.3903	1316.03	1	5000.0%	3	K.FHHTFSPEIAK.F
*	TK040203_NMyc_nuclei2_step02.3340.3340.2	1.4478	0.1084	1993.4	2	3330.0%	1	R.SPPIPLAKVDATEQTDLAK.R
*	TK040203_NMyc_nuclei2_step11.1467.1467.1	1.7059	0.2825	1001.67	1	6880.0%	1	K.HALPLVGHR.K

Q9QXG5

99.6%

381

43431

7.0

(Q9QXG5) Lysophosphatidic acid phosphatase

*	TK040203_NMyc_nuclei2_step07.2357.2357.2	3.1759	0.5511	2669.34	1	2950.0%	2	R.FDYTVTNLAGGPKPHSHYDTEYR.K

CBR2_MOUSE

99.6%

32.4%

244

25958

9.0

(P08074) Lung carbonyl reductase [NADPH] (EC 1.1.1.184) (NADPH-dependent carbonyl reductase) (LCR) (Adipocyte P27 protein) (AP27)

*	TK040203_NMyc_nuclei2_step07.3757.3757.2	3.5499	0.5278	2068.22	1	4410.0%	1	K.FAEVEDVVNSILFLLSDR.S
*	TK040203_NMyc_nuclei2_step09.2586.2586.2	1.3288	0.1676	2910.3	3	1850.0%	1	R.GVPGSIVNVSSMVAHVTFPNLITYSSTK.G
*	TK040203_NMyc_nuclei2_step03.3219.3219.3	1.6286	0.0161	3512.94	29	1330.0%	1	K.ALGGIGPVDLLVNNAALVIMQPFLEVTKEAFDR.S

RL7_MOUSE

99.6%

270

31420

10.9

(P14148) 60S ribosomal protein L7

	TK040203_NMyc_nuclei2_step02.1731.1731.1	1.3104	0.0282	1081.69	1	5560.0%	1	K.KVPAVPETLK.K
	TK040203_NMyc_nuclei2_step03.1474.1474.1	2.8469	0.3495	1489.57	1	6540.0%	1	K.KTTHFVEGGDAGNR.E

Q91VC3

99.6%

411

46840

6.7

(Q91VC3) Unknown (Protein for MGC:6715) (Hypothetical 46.8 kDa protein)

	TK040203_NMyc_nuclei2_step04.1670.1670.1	2.7228	0.2972	1598.68	1	4640.0%	2	R.KLDYGQHVVAGTPGR.V
	TK040203_NMyc_nuclei2_step07.3709.3709.2	3.5959	0.5466	2754.0	1	4090.0%	2	K.FDTLCDLYDTLTITQAVIFCNTK.R

Q9R0U5

99.6%

15.7%

306

34104

6.9

(Q9R0U5) Matrin3

	TK040203_NMyc_nuclei2_step01.3700.3700.3	1.4286	0.0613	3111.44	20	1610.0%	1	R.DSQGHGRDLSAAGIGLLAAATQSLSMPASLGR.M
	TK040203_NMyc_nuclei2_step05.2030.2030.2	4.5814	0.5438	2001.14	1	6670.0%	1	R.CRDDSFFGETSHNYHK.F

ILK1_HUMAN

99.6%

452

51419

8.1

(Q13418) Integrin-linked protein kinase 1 (EC 2.7.1.-) (ILK-1) (59 kDa serine/threonine protein kinase) (p59ILK)

	TK040203_NMyc_nuclei2_step11.2230.2230.2	3.226	0.5129	2143.94	1	3680.0%	1	K.VALEGLRPTIPPGISPHVCK.L

FUS_MOUSE

99.6%

518

52673

9.4

(P56959) RNA-binding protein FUS (Pigpen protein)

	TK040203_NMyc_nuclei2_step05.3304.3304.3	3.9887	0.3967	3590.32	1	2020.0%	4	R.HDSEQDNSDNNTIFVQGLGENVTIESVADYFK.Q
	TK040203_NMyc_nuclei2_step05.1367.1367.2	4.0646	0.5893	2254.69	1	5220.0%	3	K.APKPDGPGGGPGGSHMGGNYGDDR.R

O88568

99.6%

315

20.3%

798

87892

6.3

(O88568) Heterogenous nuclear ribonucleoprotein U

	TK040203_NMyc_nuclei2_step06.4387.4387.1	0.6367	0.1799	1260.65	23	1670.0%	1	K.MCLFAGFQRK.A
	TK040203_NMyc_nuclei2_step05.3543.3543.2	2.5435	0.155	2603.44	1	3100.0%	2	K.GNFTLPEVAECFDEITYVELQK.E
	TK040203_NMyc_nuclei2_step01.0206.0206.1	1.1145	0.174	661.37	1	7500.0%	1	R.HLYTK.D
*	TK040203_NMyc_nuclei2_step10.3015.3015.2	3.0275	0.5811	3100.25	1	2800.0%	1	K.EVLADRPLFPHVLCHNCAVEFNFGQK.E
	TK040203_NMyc_nuclei2_step01.0014.0014.1	1.3722	0.1224	773.23	4	6670.0%	1	K.AVVVCPK.D
*	TK040203_NMyc_nuclei2_step05.3316.3316.3	4.0567	0.529	4347.78	1	1790.0%	3	K.TCNCETEDYGEKFDENDVITCFANFETDEVELSYAK.N
*	TK040203_NMyc_nuclei2_step01.2654.2654.2	1.4817	0.1718	2711.02	44	1670.0%	1	K.EKPYFPIPEDCTFIQNVPLEDR.V
	TK040203_NMyc_nuclei2_step07.3933.3933.2	1.0937	0.0878	2672.57	1	2390.0%	14	R.IGWSLTTSGMLLGEEEFSYGYSLK.G
*	TK040203_NMyc_nuclei2_step09.3169.3169.3	1.7066	0.0028	3886.58	3	1360.0%	1	K.FDENDVITCFANFETDEVELSYAKNGQDLGVAFK.I
*	TK040203_NMyc_nuclei2_step05.3387.3387.2	2.0906	0.2016	2860.93	2	2170.0%	10	K.FDENDVITCFANFETDEVELSYAK.N

G3BP_MOUSE

99.6%

465

51829

5.6

(P97855) Ras-GTPase-activating protein binding protein 1 (GAP SH3-domain binding protein 1) (G3BP-1)

*	TK040203_NMyc_nuclei2_step01.3928.3928.2	1.6543	0.2749	2834.3	1	1920.0%	1	R.FYGKNSSYAHGGLDSNGKPADAVYGQK.E
	TK040203_NMyc_nuclei2_step12.2555.2555.2	1.1993	0.0039	2539.94	4	2380.0%	1	R.HPDSHQLFIGNLPHEVDKSELK.D
	TK040203_NMyc_nuclei2_step08.2409.2409.2	3.3929	0.5597	2084.86	1	5000.0%	2	R.HPDSHQLFIGNLPHEVDK.S

ACTB_HUMAN

99.6%

530

375

41737

5.5

(P02570) Actin, cytoplasmic 1 (Beta-actin) (P02570) Actin, cytoplasmic 1 (Beta-actin)

	TK040203_NMyc_nuclei2_step10.2389.2389.1	2.0178	0.3003	1519.58	1	6000.0%	14	K.IWHHTFYNELR.V
	TK040203_NMyc_nuclei2_step01.1607.1607.2	3.2311	0.4811	1956.42	1	5000.0%	1	R.VAPEEHPVLLTEAPLNPK.A
	TK040203_NMyc_nuclei2_step05.3167.3167.2	3.4381	0.5772	2554.58	1	4320.0%	18	K.LCYVALDFEQEMATAASSSSLEK.S

RS5_MOUSE

99.6%

27.5%

204

22889

9.7

(P97461) 40S ribosomal protein S5

	TK040203_NMyc_nuclei2_step03.1341.1341.1	1.0799	0.0872	900.62	5	5710.0%	1	K.YLPHSAGR.Y
	TK040203_NMyc_nuclei2_step02.2810.2810.2	3.241	0.4216	2325.14	1	4470.0%	4	K.WSTDDVQINDISLQDYIAVK.E
	TK040203_NMyc_nuclei2_step07.3769.3769.2	3.8477	0.5654	3069.79	1	2780.0%	7	K.HAFEIIHLLTGENPLQVLVNAIINSGPR.E

H2AG_HUMAN

99.6%

27.9%

129

13976

10.9

(P20671) Histone H2A.g (H2A/g) (H2A.3) (P20671) Histone H2A.g (H2A/g) (H2A.3)

	TK040203_NMyc_nuclei2_step04.3701.3701.2	1.1709	0.0097	2917.86	25	1430.0%	3	R.VGAGAPVYLAAVLEYLTAEILELAGNAAR.D
	TK040203_NMyc_nuclei2_step02.2039.2039.1	1.3299	0.2007	850.66	2	7500.0%	1	R.HLQLAIR.N

Q8TCZ5

99.6%

851

96798

9.3

(Q8TCZ5) Eukaryotic initiation factor 2C2

*	TK040203_NMyc_nuclei2_step10.2952.2952.2	3.6192	0.5379	3137.93	1	3270.0%	1	R.RPASHQTFPLQQESGQTVECTVAQYFK.D

Q91WP2

99.6%

1023

116449

6.8

(Q91WP2) Hypothetical 116.4 kDa protein

*	TK040203_NMyc_nuclei2_step08.2693.2693.2	1.2286	0.0396	2705.39	167	1300.0%	1	K.VFHLPTTTFIGGQEPALPLREIIR.R
	TK040203_NMyc_nuclei2_step10.1490.1490.1	2.7916	0.3045	1342.56	1	7000.0%	1	R.HHVLHDQNVDK.R
	TK040203_NMyc_nuclei2_step10.2587.2587.2	1.3224	0.0031	2605.42	159	1460.0%	1	R.NITLSLVANPSHLEAADPVVMGKTK.A
	TK040203_NMyc_nuclei2_step12.2446.2446.2	1.2747	0.0117	2506.45	4	2380.0%	1	R.VVNAPIFHVNSDDPEAVMYVCK.V
*	TK040203_NMyc_nuclei2_step10.3041.3041.3	1.7693	0.1681	4677.25	1	1220.0%	1	R.GHHVAQLDPLGILDADLDSSVPADIISSTDKLGFYGLHESDLDK.V
*	TK040203_NMyc_nuclei2_step08.0321.0321.3	1.0692	0.2288	2310.23	1	1500.0%	1	K.TIIDMSSANGVDYVIMGMPHR.G
	TK040203_NMyc_nuclei2_step07.1636.1636.1	1.4995	0.0313	1125.76	1	6880.0%	1	K.KTHLTELQR.F

HBAZ_MOUSE

99.6%

31.9%

141

16104

7.6

(P06467) Hemoglobin zeta chain

*	TK040203_NMyc_nuclei2_step01.2648.2648.2	1.3606	0.1962	2707.98	1	2390.0%	1	R.AIIMSMWEKMAAQAEPIGTETLER.L
*	TK040203_NMyc_nuclei2_step11.2122.2122.2	3.3878	0.6102	1984.24	1	5330.0%	1	K.TYFPHFDLHHGSQQLR.A
*	TK040203_NMyc_nuclei2_step03.1293.1293.1	0.9517	0.167	559.34	1	6250.0%	1	R.AHGFK.I

ACTA_HUMAN

99.6%

20.4%

377

42009

5.4

(P03996) Actin, aortic smooth muscle (Alpha-actin 2) (P03996) Actin, aortic smooth muscle (Alpha-actin 2)

	TK040203_NMyc_nuclei2_step01.0154.0154.1	0.8008	0.1026	644.34	7	6000.0%	1	R.GILTLK.Y
	TK040203_NMyc_nuclei2_step01.0092.0092.1	1.2393	0.0109	1161.59	1	6500.0%	1	K.EITALAPSTMK.I
	TK040203_NMyc_nuclei2_step09.2538.2538.3	1.6417	0.0285	3251.55	8	1610.0%	1	K.MTQIMFETFNVPAMYVAIQAVLSLYASGR.T
	TK040203_NMyc_nuclei2_step01.2042.2042.1	1.6699	0.0821	998.39	3	6430.0%	1	R.DLTDYLMK.I
	TK040203_NMyc_nuclei2_step02.2082.2082.1	1.4294	0.1635	801.04	273	5000.0%	1	K.RGILTLK.Y
	TK040203_NMyc_nuclei2_step10.2377.2377.1	2.1792	0.2796	1503.73	1	6000.0%	4	K.IWHHSFYNELR.V
	TK040203_NMyc_nuclei2_step05.1587.1587.1	3.0275	0.4851	1173.53	1	7500.0%	5	R.HQGVMVGMGQK.D

DD17_HUMAN

99.6%

650

72372

8.6

(Q92841) Probable RNA-dependent helicase p72 (DEAD-box protein p72) (DEAD-box protein 17)

*	TK040203_NMyc_nuclei2_step09.3278.3278.2	3.285	0.4444	2364.25	1	4210.0%	2	K.TLAYLLPAIVHINHQPYLER.G
*	TK040203_NMyc_nuclei2_step09.2363.2363.3	2.0368	0.0372	3711.92	8	1560.0%	1	K.TLAYLLPAIVHINHQPYLERGDGPICLVLAPTR.E
*	TK040203_NMyc_nuclei2_step06.3984.3984.1	0.7113	0.0359	666.21	2	4170.0%	5	R.GGGFGDR.D

Q99K48

99.6%

19.5%

473

54541

8.9

(Q99K48) Non-POU-domain-containing, octamer-binding protein

	TK040203_NMyc_nuclei2_step08.1792.1792.1	1.8793	0.3343	1182.55	1	6880.0%	2	R.HEHQVMLMR.Q
	TK040203_NMyc_nuclei2_step02.1460.1460.2	1.456	0.0948	1542.67	17	4090.0%	1	R.RMEELHNQEVQK.R
*	TK040203_NMyc_nuclei2_step04.2937.2937.3	1.4752	0.0829	3244.45	1	1950.0%	1	R.FGQAATMEGIGAIGGTPPAFNRPAPGAEFAPNK.R
	TK040203_NMyc_nuclei2_step08.2197.2197.1	1.5742	0.0131	1538.65	3	3930.0%	1	R.MGQMAMGGAMGINNR.G
	TK040203_NMyc_nuclei2_step04.3597.3597.2	1.7143	0.336	2672.41	1	2500.0%	6	R.NLPQYVSNELLEEAFSVFGQVER.A

HBD_HUMAN

99.6%

411

146

15924

8.0

(P02042) Hemoglobin delta chain

*	TK040203_NMyc_nuclei2_step01.1404.1404.1	1.9887	0.3325	1524.62	1	5000.0%	11	K.GTFSQLSELHCDK.L
*	TK040203_NMyc_nuclei2_step03.2702.2702.2	2.9065	0.4902	2633.72	1	3330.0%	17	K.GTFSQLSELHCDKLHVDPENFR.L

KC21_MOUSE

99.6%

391

45162

8.0

(Q60737) Casein kinase II, alpha chain (CK II) (EC 2.7.1.37)

	TK040203_NMyc_nuclei2_step10.1701.1701.2	2.2779	0.2539	1727.92	1	6150.0%	2	R.DVKPHNVMIDHEHR.K

Q91VA7

99.6%

16.9%

384

42195

8.6

(Q91VA7) Tumor-related protein (Unknown) (Protein for MGC:6572)

*	TK040203_NMyc_nuclei2_step11.1352.1352.1	1.6338	0.4405	1112.36	1	5500.0%	1	K.SVIGHLHPHGG.-
	TK040203_NMyc_nuclei2_step10.2917.2917.2	1.3464	0.0099	2958.96	34	1300.0%	1	R.VEGAFPVTMLPGDGVGPELMHAVKEVFK.A
*	TK040203_NMyc_nuclei2_step06.3775.3775.3	1.5989	0.0119	3010.71	62	1600.0%	1	R.HNNLDLVIIREQTEGEYSSLEHESAK.G

RS7_HUMAN

99.6%

15.5%

194

22127

10.1

(P23821) 40S ribosomal protein S7 (S8) (P23821) 40S ribosomal protein S7 (S8)

	TK040203_NMyc_nuclei2_step02.1894.1894.1	1.0691	0.0759	970.88	11	5000.0%	1	K.HVVFIAQR.R
	TK040203_NMyc_nuclei2_step01.3556.3556.2	4.8143	0.6054	2368.33	1	5480.0%	1	R.TLTAVHDAILEDLVFPSEIVGK.R

Q922L5

99.6%

910

102088

7.4

(Q922L5) Unknown (Protein for MGC:5677)

	TK040203_NMyc_nuclei2_step09.3279.3279.2	1.5468	0.1096	2019.51	29	2810.0%	1	R.ANNPEQNRLSECEEQAK.A
	TK040203_NMyc_nuclei2_step12.1731.1731.2	4.6495	0.6646	2264.74	1	6390.0%	1	R.HFVDSHHQKPVNAIIEHVR.D

Q9NPI4

99.6%

17.9%

145

16084

6.4

(Q9NPI4) hnRNP 2H9D

	TK040203_NMyc_nuclei2_step12.1685.1685.2	4.7587	0.6401	2545.51	1	4800.0%	1	R.GMGGHGYGGAGDASSGFHGGHFVHMR.G

RS1A_HUMAN

99.6%

27.1%

129

14708

10.1

(P39027) 40S ribosomal protein S15a

*	TK040203_NMyc_nuclei2_step04.3260.3260.3	3.9358	0.4091	3333.38	1	2320.0%	1	K.WQNNLLPSRQFGFIVLTTSAGIMDHEEAR.R
*	TK040203_NMyc_nuclei2_step01.3699.3699.1	0.9109	0.2605	743.34	1	8000.0%	1	K.ILGFFF.-
*	TK040203_NMyc_nuclei2_step04.3259.3259.2	3.6525	0.5364	2225.65	1	3950.0%	8	R.QFGFIVLTTSAGIMDHEEAR.R

ETFA_HUMAN

99.6%

333

35080

8.4

(P13804) Electron transfer flavoprotein alpha-subunit, mitochondrial precursor (Alpha-ETF)

*	TK040203_NMyc_nuclei2_step05.3607.3607.2	2.9154	0.4455	2353.35	1	3640.0%	3	K.IVAPELYIAVGISGAIQHLAGMK.D

HNT1_MOUSE

99.6%

125

13646

6.9

(P70349) Histidine triad nucleotide-binding protein 1 (Adenosine 5'-monophosphoramidase) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1)

	TK040203_NMyc_nuclei2_step07.2962.2962.2	3.3106	0.4706	2292.31	1	4740.0%	2	R.CLAFHDISPQAPTHFLVIPK.K

Q8QZT1

99.6%

23.1%

424

44816

8.5

(Q8QZT1) Similar to acetyl-Co A acetyltransferase 1, mitochondrial

*	TK040203_NMyc_nuclei2_step06.3113.3113.3	2.2676	0.0673	3549.28	4	1540.0%	1	K.TVFQKENGTITAANASTLNDGAAALVLMTAEAAQR.L
*	TK040203_NMyc_nuclei2_step09.3522.3522.3	1.6732	0.1064	4542.03	25	1070.0%	1	K.AIMMASQSLMCGHQDVMVAGGMESMSNVPYVMSRGATPYGGVK.L
*	TK040203_NMyc_nuclei2_step10.2219.2219.2	4.2095	0.6775	1934.03	1	6050.0%	4	K.VNIHGGAVSLGHPIGMSGAR.I

MEC2_MOUSE

99.6%

14.5%

484

52308

10.0

(Q9Z2D6) Methyl-CpG-binding protein 2 (MeCP-2 protein) (MeCP2)

*	TK040203_NMyc_nuclei2_step09.1631.1631.2	1.3238	0.1293	1640.96	12	3750.0%	1	K.EHHHHHHHSESTK.A
*	TK040203_NMyc_nuclei2_step03.3546.3546.3	2.0359	0.0735	4113.38	182	950.0%	2	K.APMPLLPSPPPPEPESSEDPISPPEPQDLSSSICKEEK.M
*	TK040203_NMyc_nuclei2_step07.1516.1516.2	3.4367	0.548	1994.63	1	5000.0%	1	K.HEPLQPSAHHSAEPAEAGK.A

HBB2_MOUSE

99.6%

1228

46.6%

146

15747

8.1

(P02089) Hemoglobin beta-2 chain (B2) (Minor)

*	TK040203_NMyc_nuclei2_step04.3363.3363.2	2.3058	0.4186	1656.95	1	5330.0%	16	R.LLGNAIVIVLGHHLGK.D
*	TK040203_NMyc_nuclei2_step02.2035.2035.1	2.449	0.334	1221.69	1	7000.0%	5	K.KVITAFNEGLK.N
*	TK040203_NMyc_nuclei2_step01.1288.1288.1	1.6366	0.1903	1023.72	4	5000.0%	6	K.SAVSCLWAK.V
*	TK040203_NMyc_nuclei2_step01.0078.0078.1	1.6952	0.2076	1312.57	1	5000.0%	1	K.VNPDEVGGEALGR.L
*	TK040203_NMyc_nuclei2_step01.0284.0284.1	1.3481	0.0462	1094.51	1	6110.0%	30	K.VITAFNEGLK.N
*	TK040203_NMyc_nuclei2_step04.2766.2766.2	3.9066	0.5469	2008.15	1	6390.0%	3	R.YFDSFGDLSSASAIMGNPK.V
*	TK040203_NMyc_nuclei2_step03.2830.2830.2	1.8665	0.2639	2317.02	1	3100.0%	1	K.SAVSCLWAKVNPDEVGGEALGR.L

Q9NPL8

99.6%

206

285

32193

8.2

(Q9NPL8) C3orf1 hypothetical protein

	TK040203_NMyc_nuclei2_step07.2352.2352.2	1.5247	0.1383	2356.36	1	2920.0%	1	R.GLVAGGIIGALLGTPVGGLLMAFQK.Y
	TK040203_NMyc_nuclei2_step08.3227.3227.2	1.9242	0.0075	3009.56	20	1500.0%	3	R.INVGLRGLVAGGIIGALLGTPVGGLLMAFQK.Y

Q921P5

99.6%

661

72326

7.4

(Q921P5) Unknown (Protein for IMAGE:3981915) (Fragment)

	TK040203_NMyc_nuclei2_step11.1946.1946.2	4.2798	0.4635	2168.76	1	5880.0%	1	K.DHVYLQLHHLPPEQLATR.L
*	TK040203_NMyc_nuclei2_step10.2919.2919.3	2.3191	0.0275	3479.76	4	1560.0%	1	K.GQVLKHVNGQDQIVPGLYACGEAACASVHGANR.L

HBA_MOUSE

99.6%

297

23613

90.8%

141

14954

8.2

(P01942) Hemoglobin alpha chain

	TK040203_NMyc_nuclei2_step01.4595.4595.1	1.0688	0.0479	1256.38	95	3180.0%	13	K.FLASVSTVLTSK.Y
	TK040203_NMyc_nuclei2_step11.2786.2786.3	1.6865	0.0204	3853.21	6	1320.0%	3	R.VDPVNFKLLSHCLLVTLASHHPADFTPAVHASLDK.F
	TK040203_NMyc_nuclei2_step03.3422.3422.2	2.6357	0.5171	3055.44	1	2410.0%	135	K.LLSHCLLVTLASHHPADFTPAVHASLDK.F
	TK040203_NMyc_nuclei2_step09.1183.1183.1	1.087	0.0325	532.42	1	6250.0%	2	K.AAWGK.I
*	TK040203_NMyc_nuclei2_step10.2068.2068.3	2.0103	0.0878	2967.78	32	1550.0%	1	K.KVADALASAAGHLDDLPGALSALSDLHAHK.L
	TK040203_NMyc_nuclei2_step01.1421.1421.1	1.4081	0.2717	1032.51	1	5000.0%	8	R.MFASFPTTK.T
	TK040203_NMyc_nuclei2_step01.0070.0070.1	1.3004	0.1376	819.38	1	5830.0%	2	R.VDPVNFK.L
	TK040203_NMyc_nuclei2_step10.2900.2900.2	3.0027	0.5203	2832.22	1	2920.0%	1	R.MFASFPTTKTYFPHFDVSHGSAQVK.G
	TK040203_NMyc_nuclei2_step09.2318.2318.2	3.6711	0.5336	2201.24	1	4470.0%	2	K.TYFPHFDVSHGSAQVKGHGK.K
	TK040203_NMyc_nuclei2_step01.0136.0136.1	1.4858	0.213	1088.75	6	5000.0%	1	K.LRVDPVNFK.L
	TK040203_NMyc_nuclei2_step10.2880.2880.2	1.4672	0.0197	1823.39	1	4000.0%	31	K.TYFPHFDVSHGSAQVK.G
	TK040203_NMyc_nuclei2_step02.1477.1477.2	3.7989	0.1132	1532.0	1	7140.0%	4	K.IGGHGAEYGAEALER.M

RL11_MOUSE

99.6%

32.8%

177

20152

9.6

(Q9CXW4) 60S ribosomal protein L11

	TK040203_NMyc_nuclei2_step02.2860.2860.2	1.1794	0.0334	2552.29	21	2050.0%	1	R.KNNFSDTGNFGFGIQEHIDLGIK.Y
	TK040203_NMyc_nuclei2_step01.1289.1289.1	1.2738	0.1417	975.45	12	5620.0%	1	K.YDGIILPGK.-
*	TK040203_NMyc_nuclei2_step05.4265.4265.1	1.0174	0.0595	1580.47	15	3080.0%	1	K.VLEQLTGQTQVFSK.A
	TK040203_NMyc_nuclei2_step02.2864.2864.2	1.9177	0.1524	2426.79	1	3330.0%	7	K.NNFSDTGNFGFGIQEHIDLGIK.Y
	TK040203_NMyc_nuclei2_step10.2400.2400.1	1.6728	0.1001	1402.66	20	3640.0%	1	-.AQDQGEKENPMR.E

Q8VCW8

99.6%

615

67951

8.2

(Q8VCW8) Similar to hypothetical protein FLJ20920

*	TK040203_NMyc_nuclei2_step09.2227.2227.2	3.5379	0.3139	2062.22	1	4720.0%	1	K.GATLSHHNIVNNSMLIGQR.L
	TK040203_NMyc_nuclei2_step07.2137.2137.1	1.1303	0.0393	1240.76	32	3330.0%	1	R.MGEEICACIR.L

FINC_MOUSE

99.6%

2477

273215

5.3

(P11276) Fibronectin precursor (FN) (Fragments)

*	TK040203_NMyc_nuclei2_step01.3991.3991.2	1.5796	0.0847	2974.71	1	1850.0%	1	R.EVTSDSGSIVVSGLTPGVEYTYTIQVLR.D
*	TK040203_NMyc_nuclei2_step10.4263.4263.2	1.3932	0.0076	2877.46	6	1540.0%	1	K.TGLDSPTGFDSSDITANSFTVHWVAPR.A
*	TK040203_NMyc_nuclei2_step04.3147.3147.2	2.6108	0.383	2548.64	1	3260.0%	6	R.NSITLTNLNPGTEYVVSIIAVNGR.E
*	TK040203_NMyc_nuclei2_step06.2771.2771.2	3.0238	0.4549	2331.85	1	3500.0%	4	K.GLTPGVIYEGQLISIQQYGHR.E

SPCN_HUMAN

99.6%

2472

284281

5.3

(Q13813) Spectrin alpha chain, brain (Spectrin, non-erythroid alpha chain) (Alpha-II spectrin) (Fodrin alpha chain)

	TK040203_NMyc_nuclei2_step04.2123.2123.1	1.403	0.2214	847.64	2	7000.0%	3	R.LHQFFR.D
	TK040203_NMyc_nuclei2_step04.1307.1307.3	1.7372	0.095	2108.52	4	2780.0%	1	K.LLVGSEDYGRDLTGVQNLR.K
*	TK040203_NMyc_nuclei2_step09.2430.2430.2	0.9839	6.0E-4	2077.58	8	2860.0%	1	R.RQQYEQCMDLQLFYR.D
*	TK040203_NMyc_nuclei2_step05.2806.2806.2	5.0931	0.6276	2179.54	1	6320.0%	3	K.KHEALMSDLSAYGSSIQALR.E
*	TK040203_NMyc_nuclei2_step03.1777.1777.1	2.3599	0.3349	1556.58	1	4620.0%	1	K.HQALQAEIAGHEPR.I
*	TK040203_NMyc_nuclei2_step02.1568.1568.1	1.1327	0.0774	867.64	9	5830.0%	1	R.KHEGLER.D

Q99LI7

99.6%

25.0%

717

82877

8.1

(Q99LI7) Hypothetical 82.9 kDa protein

	TK040203_NMyc_nuclei2_step06.2337.2337.2	3.5766	0.5793	2201.16	1	5590.0%	1	R.KPEYPKPDTQQMIPFQPR.H
*	TK040203_NMyc_nuclei2_step09.2742.2742.2	1.4801	0.1568	2710.56	5	1850.0%	1	R.IITGGAPELAVEGNGPVESSAVLTKAVK.R
	TK040203_NMyc_nuclei2_step07.2864.2864.3	1.9282	0.2566	3728.43	15	1370.0%	1	K.IGMEIMSYQIWVDYINFLKGVEAVGSYAENQR.I
	TK040203_NMyc_nuclei2_step01.3324.3324.3	1.5984	0.0075	4778.95	1	1280.0%	1	R.KPEYPKPDTQQMIPFQPRHLAPPGLHPVPGGVFPVPPAAVVLMK.L
	TK040203_NMyc_nuclei2_step10.2583.2583.2	1.4343	0.0634	2536.34	2	2270.0%	1	K.SGEIWARFLAFESNIGDLASILK.V
	TK040203_NMyc_nuclei2_step02.2779.2779.2	1.8336	0.0504	2280.22	1	3820.0%	1	R.VYQRGCVNPMINIEQLWR.D
	TK040203_NMyc_nuclei2_step06.3235.3235.2	0.9829	0.0284	2530.46	7	1960.0%	1	K.LAAIIPDPVVAPSIVPVLKDEVDR.K
	TK040203_NMyc_nuclei2_step10.0018.0018.1	0.5792	0.0023	1204.69	13	1110.0%	1	R.TEDQTLITKR.V

2AAA_HUMAN

99.6%

13.8%

588

65092

5.1

(P30153) Serine/threonine protein phosphatase 2A, 65 KDA regulatory subunit A, alpha isoform (PP2A, subunit A, PR65-alpha isoform) (PP2A, subunit A, R1-alpha isoform) (Medium tumor antigen-associated 61 KDA protein)

	TK040203_NMyc_nuclei2_step05.1263.1263.1	1.3362	0.0952	1241.35	3	4500.0%	1	K.ELVSDANQHVK.S
	TK040203_NMyc_nuclei2_step06.3802.3802.2	1.5674	0.029	3047.58	1	2120.0%	1	K.VLELDNVKSEIIPMFSNLASDEQDSVR.L
	TK040203_NMyc_nuclei2_step06.2657.2657.2	4.5214	0.6235	2213.72	1	5530.0%	1	R.AISHEHSPSDLEAHFVPLVK.R
	TK040203_NMyc_nuclei2_step05.3215.3215.2	0.9504	0.0493	2609.97	278	1590.0%	1	R.LAGGDWFTSRTSACGLFSVCYPR.V

H32_BOVIN

99.6%

23.7%

135

15257

11.3

(P16105) Histone H3 (H3.2)

*	TK040203_NMyc_nuclei2_step09.3633.3633.3	6.1766	0.6208	3516.08	1	3150.0%	1	R.FQSSAVMALQEASEAYLVGLFEDTNLCAIHAK.R

Q9D8X5

99.6%

292

17.8%

292

33574

4.8

(Q9D8X5) 1810022F04Rik protein (RIKEN cDNA 1810022F04 gene)

	TK040203_NMyc_nuclei2_step10.3213.3213.3	1.9071	0.1058	3089.86	1	2020.0%	1	R.EIVLSYSYIAMDTEFPGVVVRPIGEFR.S
	TK040203_NMyc_nuclei2_step01.3663.3663.2	1.8167	0.029	2881.92	1	2500.0%	17	K.FNLTEDMYSQDSIDLLANSGLQFQK.H

RLA0_MOUSE

99.6%

317

34216

6.2

(P14869) 60S acidic ribosomal protein P0 (L10E)

	TK040203_NMyc_nuclei2_step01.2747.2747.1	1.6157	0.1683	1314.55	1	4550.0%	1	K.TSFFQALGITTK.I
*	TK040203_NMyc_nuclei2_step01.2198.2198.2	3.4679	0.5582	2699.14	1	3000.0%	1	K.AFLADPSAFAAAAPAAAATTAAPAAAAAPAK.A

143E_HUMAN

99.6%

24.3%

255

29174

4.7

(P42655) 14-3-3 protein epsilon (Mitochondrial import stimulation factor L subunit) (Protein kinase C inhibitor protein-1) (KCIP-1) (14-3-3E) (P42655) 14-3-3 protein epsilon (Mitochondrial import stimulation factor L subunit) (Protein kinase C inhibitor protein-1) (KCIP-1) (14-3-3E)

	TK040203_NMyc_nuclei2_step01.2856.2856.1	2.7748	0.3449	1477.39	2	5450.0%	1	K.LICCDILDVLDK.H
	TK040203_NMyc_nuclei2_step08.1440.1440.3	1.3278	0.1361	1819.53	36	2340.0%	1	K.AASDIAMTELPPTHPIR.L
	TK040203_NMyc_nuclei2_step06.3011.3011.2	2.0111	0.259	2340.1	24	2000.0%	1	K.VAGMDVELTVEERNLLSVAYK.N
	TK040203_NMyc_nuclei2_step01.3872.3872.2	1.3136	0.0511	2698.06	3	1960.0%	2	K.LICCDILDVLDKHLIPAANTGESK.V

Q9CQX8

99.6%

36.3%

102

11101

10.0

(Q9CQX8) 1110018B13Rik protein (RIKEN cDNA 1110018B13 gene)

*	TK040203_NMyc_nuclei2_step11.1630.1630.1	1.6162	0.0813	1430.6	8	3750.0%	1	R.VVQVVKPHAPLIK.F
*	TK040203_NMyc_nuclei2_step08.3176.3176.2	1.2999	0.029	2335.43	11	2170.0%	1	K.LSASEALGSAALPSHSSAISQHSK.G

CACP_MOUSE

99.6%

627

70835

8.2

(P47934) Carnitine O-acetyltransferase (EC 2.3.1.7) (Carnitine acetylase) (CAT)

*	TK040203_NMyc_nuclei2_step11.4147.4147.3	2.2174	0.0084	4002.45	14	1210.0%	2	K.MENWLSEWWLKTAYLQLPDKPVVIYSSPGVILPK.Q
*	TK040203_NMyc_nuclei2_step07.1537.1537.1	2.3246	0.5104	1392.74	1	5380.0%	1	R.NHVAGQMLHGGGSK.F

O08794

99.6%

966

109404

6.2

(O08794) Alpha glucosidase II, alpha subunit

	TK040203_NMyc_nuclei2_step05.3592.3592.2	2.1098	0.2026	2511.02	1	2500.0%	2	R.DLGIFWLNAAETWVDISSNTAGK.T
	TK040203_NMyc_nuclei2_step07.1308.1308.1	1.3703	0.1668	976.54	12	5620.0%	1	R.AHAHLDTGR.R
	TK040203_NMyc_nuclei2_step12.3139.3139.2	2.8559	0.4176	2391.59	1	4250.0%	1	K.HHGPQTLYLPVTLSSIPVFQR.G
*	TK040203_NMyc_nuclei2_step07.3048.3048.2	1.4998	0.0988	2667.13	13	2050.0%	1	R.DGSDYEGWCWPGSASYPDFTNPR.M
*	TK040203_NMyc_nuclei2_step12.1618.1618.3	1.7532	0.0319	3857.15	1	1560.0%	1	R.DEADVLEVDQGFDDHNMPCDVIWLDIEHADGKR.Y
*	TK040203_NMyc_nuclei2_step03.3269.3269.2	5.0418	0.5408	2401.09	1	5500.0%	1	R.DIHNIYGLYVHMATADGLIQR.S
	TK040203_NMyc_nuclei2_step09.3425.3425.1	1.3139	0.0047	1430.39	5	4550.0%	1	R.QRSIRPGLSPYR.A

SPCB_MOUSE

99.6%

2128

245248

5.3

(P15508) Spectrin beta chain, erythrocyte (Beta-I spectrin)

	TK040203_NMyc_nuclei2_step04.3381.3381.2	1.9321	0.1318	2083.5	2	3240.0%	1	R.ELHLLGVQVQQFQDVATR.L
	TK040203_NMyc_nuclei2_step04.1969.1969.2	2.6061	0.4055	1930.66	1	5000.0%	2	R.VHLENMGSHDIVDGNHR.L
*	TK040203_NMyc_nuclei2_step02.1616.1616.1	0.9893	0.013	1100.69	18	3750.0%	1	R.EKLQQVISR.R
*	TK040203_NMyc_nuclei2_step03.3791.3791.2	1.1699	0.0681	2926.03	9	1730.0%	1	K.EELEELFADAPSLGAEAGDTDMSIEKR.F
	TK040203_NMyc_nuclei2_step04.2281.2281.1	2.1611	0.259	1257.64	4	5560.0%	3	K.HRPDLIDFDK.L
*	TK040203_NMyc_nuclei2_step04.1197.1197.1	0.8203	0.0108	627.44	4	7500.0%	1	K.RIIAR.K
	TK040203_NMyc_nuclei2_step01.3499.3499.1	1.1552	0.072	1137.2	4	5620.0%	1	R.FDILDQEMK.T
	TK040203_NMyc_nuclei2_step04.1870.1870.2	1.142	0.0017	2338.95	2	2750.0%	1	R.LPLAQSADYGTNLQTVQLFMK.K
*	TK040203_NMyc_nuclei2_step08.1916.1916.1	1.4579	0.0605	1323.33	3	4170.0%	1	K.AITAATLQFAEGK.G
*	TK040203_NMyc_nuclei2_step12.4054.4054.3	1.4944	0.1053	3555.13	14	1450.0%	1	K.AVASEDMPESLPEAEQLLQQHAAIKEEIDAHR.D

WDR5_HUMAN

99.6%

13.5%

334

36589

8.3

(Q9UGP9) WD-repeat protein 5 (WD repeat protein BIG-3) (Q9UGP9) WD-repeat protein 5 (WD repeat protein BIG-3)

	TK040203_NMyc_nuclei2_step03.2069.2069.2	2.9064	0.5552	1748.84	1	5330.0%	1	K.TLPAHSDPVSAVHFNR.D
	TK040203_NMyc_nuclei2_step12.2469.2469.2	1.0641	0.0018	1969.34	131	2060.0%	1	K.FSPNGKYILAATLDNTLK.L
	TK040203_NMyc_nuclei2_step06.1869.1869.1	1.7131	0.0883	1265.53	17	4500.0%	1	K.LIKIWGAYDGK.F

Q922Y7

99.6%

464

51028

5.3

(Q922Y7) Unknown (Protein for MGC:6388)

	TK040203_NMyc_nuclei2_step01.4487.4487.1	2.8024	0.3372	1522.09	1	5360.0%	7	R.LLIHQSLAGGIIGVK.G
	TK040203_NMyc_nuclei2_step08.3085.3085.3	1.6703	0.0577	4188.28	1	1740.0%	2	K.KIIPTLEEGLQLPSPTATSQLPLESDAVECLNYQHYK.G

Q9UEV9

99.6%

2602

278190

5.7

(Q9UEV9) Actin-binding protein homolog ABP-278

	TK040203_NMyc_nuclei2_step02.1473.1473.2	1.1739	0.0186	1626.96	100	1920.0%	1	R.YAPTEVGLHEMHIK.Y
	TK040203_NMyc_nuclei2_step12.2171.2171.2	2.5976	0.3389	1635.74	1	7310.0%	1	K.RLPNNHIGISFIPR.E
	TK040203_NMyc_nuclei2_step02.3702.3702.2	1.3278	0.088	2681.45	41	1540.0%	1	R.SADFVVESIGSEVGSLGFAIEGPSQAK.I
	TK040203_NMyc_nuclei2_step09.3610.3610.3	2.4533	0.1834	4198.95	7	1180.0%	1	K.DLDIIDNYDYSHTVKYTPTQQGNMQVLVTYGGDPIPK.S
	TK040203_NMyc_nuclei2_step08.3539.3539.3	1.5011	0.1436	4503.48	59	1150.0%	1	K.IECSDNGDGTCSVSYLPTKPGEYFVNILFEEVHIPGSPFK.A
	TK040203_NMyc_nuclei2_step07.2661.2661.2	4.9242	0.4971	2308.22	1	5230.0%	1	R.GQHVTGSPFQFTVGPLGEGGAHK.V
	TK040203_NMyc_nuclei2_step03.2531.2531.2	2.7023	0.4941	2196.14	1	3810.0%	2	K.AHGPGLEGGLVGKPAEFTIDTK.G
	TK040203_NMyc_nuclei2_step12.1291.1291.3	1.9774	0.2069	3659.63	53	1450.0%	1	K.DFLDGVYAFEYYPSTPGRYSIAITWGGHHIPK.S
	TK040203_NMyc_nuclei2_step03.2202.2202.1	1.9867	0.2134	1276.86	1	5000.0%	1	R.AWGPGLHGGIVGR.S
	TK040203_NMyc_nuclei2_step06.1193.1193.3	1.4388	0.1067	2315.46	9	2380.0%	1	K.DGTCTVTYLPTLPGDYSILVK.Y

RS20_HUMAN

99.6%

119

13373

9.9

(P17075) 40S ribosomal protein S20 (P17075) 40S ribosomal protein S20

	TK040203_NMyc_nuclei2_step03.2479.2479.2	1.344	0.2641	1509.55	2	4170.0%	2	K.RLIDLHSPSEIVK.Q
	TK040203_NMyc_nuclei2_step01.1627.1627.1	1.9607	0.165	1350.68	2	5000.0%	1	R.LIDLHSPSEIVK.Q

DDX5_MOUSE

99.6%

614

69320

8.9

(Q61656) Probable RNA-dependent helicase p68 (DEAD-box protein p68) (DEAD-box protein 5) (DEAD-box RNA helicase DEAD1) (mDEAD1)

	TK040203_NMyc_nuclei2_step01.1572.1572.1	1.7572	0.3167	1226.81	1	5910.0%	1	K.APILIATDVASR.G
	TK040203_NMyc_nuclei2_step01.2162.2162.1	1.5282	0.1289	1050.63	1	7860.0%	1	R.DWVLNEFK.H
	TK040203_NMyc_nuclei2_step05.1652.1652.1	1.1147	0.0498	956.6	44	5000.0%	2	K.RGGFNTFR.D
	TK040203_NMyc_nuclei2_step12.4239.4239.2	2.0623	0.1281	1375.49	22	5000.0%	1	R.DWVLNEFKHGK.A
	TK040203_NMyc_nuclei2_step10.3583.3583.3	6.8126	0.5852	3817.02	1	3440.0%	3	K.DYIHINIGALELSANHNILQIVDVCHDVEKDEK.L

Q91V86

99.6%

113

9909

17.7%

147

15748

7.7

(Q91V86) 11 days embryo cDNA, RIKEN full-length enriched library, clone:2700082N11, full insert sequence (Adult male kidney cDNA, RIKEN full-length enriched library, clone:0610006O05, full insert sequence) (Adult male kidney cDNA, RIKEN full-length enriched library, clone:0610009G19, full insert sequence) (Adult male spleen cDNA, RIKEN full-length enriched library, clone:0910001P14, full insert sequence) (18 days embryo cDNA, RIKEN full-length enriched library, clone:1110005K11, full insert sequence) (Adult female placenta cDNA, RIKEN full-length enriched library, clone:1600013K09, full insert sequence) (Adult female placenta cDNA, RIKEN full-length enriched library, clone:1600019A13, full insert sequence) (Adult female placenta cDNA, RIKEN full-length enriched library, clone:1600019I13, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510004F04, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510019E11, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510019H05, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510022J06, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510023M22, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510027H07, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510028E09, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510028J08, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510029L07, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510031C09, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510039C10, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510039D08, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510039M06, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510040I07, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510040K10, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510040P08, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510041H16, full insert sequence) (13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510044F14, full insert sequence)

*	TK040203_NMyc_nuclei2_step08.2193.2193.1	2.3691	0.3561	1409.58	1	6150.0%	10	K.VVAGVAAALAHKYH.-
*	TK040203_NMyc_nuclei2_step01.0190.0190.1	2.3135	0.1702	1109.73	1	5910.0%	99	K.VVAGVAAALAHK.Y
*	TK040203_NMyc_nuclei2_step10.3632.3632.2	1.278	0.0501	2384.28	5	2390.0%	2	K.DFTPAAQAAFQKVVAGVAAALAHK.Y

A2A2_MOUSE

99.6%

938

104101

6.9

(P17427) Adaptor-related protein complex 2 alpha 2 subunit (Alpha-adaptin C) (Clathrin assembly protein complex 2 alpha-C large chain) (100 kDa coated vesicle protein C) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)

	TK040203_NMyc_nuclei2_step07.1492.1492.3	1.3461	0.0454	3369.84	44	1550.0%	1	K.VQHSNAKNAVLFEAISLIIHHDSEPNLLVR.A
	TK040203_NMyc_nuclei2_step02.0478.0478.1	0.8364	0.0142	1549.61	10	2920.0%	1	R.GRLTECLETILNK.A
	TK040203_NMyc_nuclei2_step08.3651.3651.2	3.9207	0.5465	2602.01	1	4320.0%	1	K.NAVLFEAISLIIHHDSEPNLLVR.A
	TK040203_NMyc_nuclei2_step10.2612.2612.2	1.4096	0.1096	2746.52	14	1400.0%	5	R.VVHLLNDQHLGVVTAATSLITTLAQK.N

Q9D6U5

99.6%

18.5%

173

19759

6.2

(Q9D6U5) 2310057C03Rik protein

	TK040203_NMyc_nuclei2_step02.3483.3483.2	2.1659	0.2337	2744.28	1	2610.0%	7	R.SVEGWILFVTGVHEEATEEDIHDK.F
	TK040203_NMyc_nuclei2_step02.1919.1919.1	1.4484	0.2047	995.79	3	6430.0%	1	K.NIHLNLDR.R

ZO1_MOUSE

99.6%

12.6%

1745

194710

6.7

(P39447) Tight junction protein ZO-1 (Zonula occludens 1 protein) (Zona occludens 1 protein) (Tight junction protein 1)

	TK040203_NMyc_nuclei2_step10.2239.2239.2	5.2806	0.636	2178.78	1	6390.0%	1	K.FNHNLLPSETVHKPELSSK.T
*	TK040203_NMyc_nuclei2_step03.2757.2757.3	2.15	0.0409	3602.09	69	1300.0%	1	R.IPTYEDQWSYYDDKQPYQPRPFENQHPR.D
	TK040203_NMyc_nuclei2_step06.1937.1937.2	3.9464	0.5577	1970.48	1	7190.0%	1	R.LPEPQKPQVKPPEDIVR.S
*	TK040203_NMyc_nuclei2_step11.2315.2315.3	1.8031	0.0839	4460.25	1	1350.0%	1	R.EDSSGMHHENQTYPPYSPQAQPQAIHRIDSPGLKPASQQK.A
	TK040203_NMyc_nuclei2_step09.2481.2481.3	1.6872	0.1162	3749.49	10	1320.0%	1	K.RYDPAQATPPPPPLPSQYSQPAPPLSSSSLHIHSK.G
	TK040203_NMyc_nuclei2_step10.3048.3048.2	2.4584	0.2713	2762.35	1	2830.0%	1	K.NNHHLFTTTINLNSMNDGWYGALK.E
	TK040203_NMyc_nuclei2_step03.3071.3071.3	1.4048	0.0103	3120.95	125	1250.0%	1	K.TWQNKCLPGDPNYLVGANCVSVLIDHF.-
*	TK040203_NMyc_nuclei2_step02.3286.3286.3	1.8145	0.0709	3317.9	2	1880.0%	1	K.VQIPVSHPDPEPVSDNEDDSYDEEVHDPR.A

CATC_MOUSE

99.6%

462

52376

6.9

(P97821) Dipeptidyl-peptidase I precursor (EC 3.4.14.1) (DPP-I) (DPPI) (Cathepsin C) (Cathepsin J) (Dipeptidyl transferase)

*	TK040203_NMyc_nuclei2_step09.3055.3055.2	3.9663	0.6	2529.35	1	4760.0%	2	R.GHTAISYCHETMTGWVHDVLGR.N
*	TK040203_NMyc_nuclei2_step11.1227.1227.3	1.8875	0.0432	2072.12	7	2500.0%	1	R.GTDECAIESIAVAAIPIPKL.-

Q9CZB7

99.6%

313

34357

8.3

(Q9CZB7) Protein kinase, interferon inducible double stranded RNA dependent activator

	TK040203_NMyc_nuclei2_step04.2299.2299.2	1.3433	0.1361	1966.1	4	3670.0%	1	R.EYTTICRLESFMETGK.G
	TK040203_NMyc_nuclei2_step09.3182.3182.2	1.855	0.3319	2186.39	1	3890.0%	2	K.NQLNPIGSLQELAIHHGWR.L

PDX2_MOUSE

99.6%

44.4%

198

21779

5.4

(Q61171) Peroxiredoxin 2 (EC 1.11.1.-) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thiol-specific antioxidant protein) (TSA)

	TK040203_NMyc_nuclei2_step09.2566.2566.3	1.4464	0.0050	4443.35	61	990.0%	1	R.LVQAFQYTDEHGEVCPAGWKPGSDTIKPNVDDSKEYFSK.H
	TK040203_NMyc_nuclei2_step03.3762.3762.2	1.6499	0.1097	2702.67	5	1960.0%	6	K.LGCEVLGVSVDSQFTHLAWINTPR.K
	TK040203_NMyc_nuclei2_step06.3158.3158.2	4.0196	0.5536	2829.61	1	3960.0%	3	R.KLGCEVLGVSVDSQFTHLAWINTPR.K
*	TK040203_NMyc_nuclei2_step01.2723.2723.1	1.603	0.1797	1599.49	2	3330.0%	3	K.SAPDFTATAVVDGAFK.E
*	TK040203_NMyc_nuclei2_step01.2036.2036.1	1.54	0.0525	876.47	1	7140.0%	1	R.GLFIIDAK.G

UBPA_MOUSE

99.6%

13.7%

793

87093

5.2

(P52479) Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.1.2.15) (Ubiquitin thiolesterase 10) (Ubiquitin-specific processing protease 10) (Deubiquitinating enzyme 10)

*	TK040203_NMyc_nuclei2_step12.2445.2445.3	1.451	0.0533	4636.33	9	1010.0%	1	R.IEFGVDEVIEPSEGLPPTPSYSISSTLNPQAPEFILGCTTSKK.I
*	TK040203_NMyc_nuclei2_step06.3118.3118.2	3.1917	0.4705	2257.85	1	4210.0%	1	K.IAELLETVTLIHKPVSLQPR.G
	TK040203_NMyc_nuclei2_step12.1419.1419.3	1.9295	0.1266	2853.57	127	1520.0%	1	K.GNWCYINATLQALVACPPMYHLMK.F
*	TK040203_NMyc_nuclei2_step05.2686.2686.2	1.3615	0.02	2426.27	8	2380.0%	1	K.HSVSNGPRSDLIEDEELEDTGK.G

IF36_HUMAN

99.6%

445

52221

6.0

(Q64252) Eukaryotic translation initiation factor 3 subunit 6 (eIF-3 p48) (Mammary tumor-associated protein INT-6) (Viral integration site protein INT-6) (Q64252) Eukaryotic translation initiation factor 3 subunit 6 (eIF-3 p48) (Mammary tumor-associated protein INT-6) (Viral integration site protein INT-6)

	TK040203_NMyc_nuclei2_step07.2810.2810.3	2.1987	0.0921	3240.26	15	1730.0%	1	K.FQYECGNYSGAAEYLYFFRVLVPATDR.N
	TK040203_NMyc_nuclei2_step07.3732.3732.2	2.8007	0.4958	2893.12	1	3040.0%	4	R.ECESVLVNDFFLVACLEDFIENAR.L

TCPG_MOUSE

99.5%

545

60630

6.7

(P80318) T-complex protein 1, gamma subunit (TCP-1-gamma) (CCT-gamma) (Matricin)

	TK040203_NMyc_nuclei2_step05.3642.3642.3	3.4512	0.35	4605.6	1	1890.0%	1	R.TQDEEVGDGTTSVIILAGEMLSVAEHFLEQQMHPTVVISAYR.M

Q9JKR6

99.5%

999

111181

5.2

(Q9JKR6) 170 kDa glucose regulated protein GRP170 precursor

*	TK040203_NMyc_nuclei2_step04.2222.2222.2	3.142	0.4822	1724.41	1	5770.0%	1	R.SRFPEHELIVDPQR.Q
*	TK040203_NMyc_nuclei2_step10.3489.3489.3	2.2681	0.0437	3227.18	9	1770.0%	1	K.EETGTEPADSEPLELGGPGAGPEQEEQSAGQK.R
	TK040203_NMyc_nuclei2_step12.1419.1419.2	1.4293	0.0827	1902.72	53	2500.0%	1	K.LYQPEYQEVSTEEQR.E
*	TK040203_NMyc_nuclei2_step05.3084.3084.3	1.3637	0.0605	3623.27	3	1520.0%	1	R.LLCWALVAVLLADLLALSDTLAVMSVDLGSESMK.V
*	TK040203_NMyc_nuclei2_step04.3552.3552.2	1.4933	0.0988	2669.18	6	1960.0%	1	K.MVEEIGVELAVLDLPDLPEDELAR.S
	TK040203_NMyc_nuclei2_step08.2331.2331.2	1.4526	0.0588	2252.31	2	2890.0%	1	K.VLQLINDNTATALSYGVFRR.K

HBB_HUMAN

99.5%

362

23.3%

146

15867

7.3

(P02023) Hemoglobin beta chain

	TK040203_NMyc_nuclei2_step09.2578.2578.2	1.35	0.01	2589.58	1	3100.0%	1	K.GTFATLSELHCDKLHVDPENFR.L
	TK040203_NMyc_nuclei2_step01.2612.2612.1	2.5578	0.2072	1151.78	2	4550.0%	19	K.VVAGVANALAHK.Y

Q9D7E5

99.5%

29.9%

134

14600

6.7

(Q9D7E5) 2310011I02Rik protein

*	TK040203_NMyc_nuclei2_step08.3239.3239.3	3.4271	0.3476	4488.88	1	1670.0%	1	R.HQCCEQDLCNAAASQPPPNLPLMTLLPLAAMIGWGVHDFL.-

Q9Z1Y4

99.5%

480

50934

7.3

(Q9Z1Y4) Zyxin related protein-1 (Thyroid hormone receptor interactor 6) (TRIP6)

*	TK040203_NMyc_nuclei2_step12.1277.1277.2	3.1301	0.4848	1778.56	1	5590.0%	1	R.GALGPPTAHGATLQPHPR.V

Q99JX4

99.5%

374

42517

5.7

(Q99JX4) Similar to dendritic cell protein

	TK040203_NMyc_nuclei2_step04.3627.3627.2	3.024	0.5175	3039.81	1	3080.0%	1	K.EISFDTMQQELQIGADDVEAFVIDAVR.T
	TK040203_NMyc_nuclei2_step01.2879.2879.1	2.099	0.3355	1517.84	1	4580.0%	1	R.LQLLSNLFHGMDK.N

GR75_MOUSE

99.4%

679

73528

6.2

(P38647) Stress-70 protein, mitochondrial precursor (75 kDa glucose regulated protein) (GRP 75) (Peptide-binding protein 74) (PBP74) (P66 MOT) (Mortalin)

	TK040203_NMyc_nuclei2_step05.2875.2875.2	1.3045	0.0767	2409.7	47	1520.0%	1	K.GAVVGIDLGTTNSCVAVMEGKQAK.V
	TK040203_NMyc_nuclei2_step02.3335.3335.2	2.5425	0.3942	2312.46	1	3100.0%	3	R.GVPQIEVTFDIDANGIVHVSAK.D
	TK040203_NMyc_nuclei2_step09.2867.2867.3	1.8486	0.0422	3886.49	5	1390.0%	1	K.LLGQFTLIGIPPAPRGVPQIEVTFDIDANGIVHVSAK.D

ANX4_MOUSE

99.4%

11.6%

318

35859

5.6

(P97429) Annexin A4 (Annexin IV)

	TK040203_NMyc_nuclei2_step09.3125.3125.3	2.0153	0.0871	2981.34	3	2100.0%	1	R.SLEEDICSDTSFMFQRVLVFLSAAGR.D
	TK040203_NMyc_nuclei2_step06.2601.2601.1	2.4071	0.3852	1416.59	1	7000.0%	2	R.NHLLHVFDEYK.R

Q96A90

99.4%

12.0%

217

23573

8.5

(Q96A90) G6b-C protein precursor

*	TK040203_NMyc_nuclei2_step07.3608.3608.3	3.1256	0.187	3011.49	2	2300.0%	4	R.FDHSLDLLCPPHIAPLVKTEPQRPVK.E

Q96JM3

99.4%

821

90139

8.5

(Q96JM3) Hypothetical protein KIAA1802 (Fragment)

*	TK040203_NMyc_nuclei2_step09.1814.1814.1	1.9003	0.2305	1088.47	2	5560.0%	1	K.GAVLHHLVNK.H
*	TK040203_NMyc_nuclei2_step07.1744.1744.1	2.0821	0.4055	1276.43	1	5910.0%	3	K.NHVAAHGQSLLK.C
*	TK040203_NMyc_nuclei2_step11.0782.0782.1	1.2278	0.0049	1216.78	75	4000.0%	1	K.KGAVLHHLVNK.H
*	TK040203_NMyc_nuclei2_step03.4257.4257.2	0.9932	0.0106	2272.72	1	3060.0%	1	K.MDMTSPEQSRNVLQFTEEK.E
*	TK040203_NMyc_nuclei2_step09.2690.2690.2	1.2925	0.0166	2413.68	9	2270.0%	1	R.RPAPAVSPGSWKPGPPGSPRPWK.S

Q8VC94

99.4%

167

19024

9.8

(Q8VC94) Hypothetical 19.0 kDa protein

	TK040203_NMyc_nuclei2_step01.1828.1828.1	2.4156	0.3828	1546.69	1	5770.0%	1	K.VLEQLTGQTPVFSK.A

Q9UQ35

99.4%

2752

299676

12.1

(Q9UQ35) RNA binding protein

	TK040203_NMyc_nuclei2_step12.2453.2453.2	1.3149	0.064	1945.14	11	2650.0%	1	R.QSHSESPSLQSKSQTSPK.G
*	TK040203_NMyc_nuclei2_step06.2014.2014.1	1.1346	0.0677	1352.54	196	2690.0%	1	R.SAHATAPVNIAGSR.T
	TK040203_NMyc_nuclei2_step01.4119.4119.3	1.8541	0.2081	3745.85	1	1500.0%	1	K.DSLVQSCPGSLSLCAGVKSSTPPGESYFGVSSLQLK.G
	TK040203_NMyc_nuclei2_step12.2690.2690.2	1.2809	0.0401	2853.98	312	1110.0%	1	R.HGGSPQPLATTPLSQEPVNPPSEASPTR.D
*	TK040203_NMyc_nuclei2_step08.4303.4303.3	1.9961	0.0223	4088.16	4	1310.0%	1	R.IALALTAISLGTARPPPSMSAAGLAARMSQVPAPVPLMSLR.T
	TK040203_NMyc_nuclei2_step09.1707.1707.2	1.5223	0.0376	2026.8	17	2780.0%	1	R.GEFSASPMLKSGMSPEQSR.F
	TK040203_NMyc_nuclei2_step09.1473.1473.1	0.8737	0.0085	738.58	26	5000.0%	1	R.ASPATHR.R
	TK040203_NMyc_nuclei2_step04.2617.2617.3	1.8074	0.1119	2877.68	30	1670.0%	1	K.EDLNGPFLNQLETDPSLDMKEQSTR.S
	TK040203_NMyc_nuclei2_step08.2440.2440.2	1.2593	0.1319	1373.8	37	3750.0%	1	R.RSPSVSSPEPAEK.S
*	TK040203_NMyc_nuclei2_step12.2066.2066.2	1.4517	0.0561	2560.58	27	1540.0%	1	R.TPAALAALSLTGSGTPPTAANYPSSSR.T
	TK040203_NMyc_nuclei2_step04.1254.1254.2	1.2472	0.1187	1224.37	2	4500.0%	1	R.SPSPKPRGLQR.S
	TK040203_NMyc_nuclei2_step06.1690.1690.1	2.2125	0.4118	1364.51	1	5500.0%	4	K.RPNPDILDHER.K

Q9CWW1

99.4%

379

42158

8.6

(Q9CWW1) 2410003B16Rik protein

	TK040203_NMyc_nuclei2_step06.2669.2669.2	2.9313	0.5035	2715.14	1	2710.0%	1	K.VSGLPTPDLSWQLDGKPIRPDSAHK.M

GLYM_HUMAN

99.4%

18.3%

504

55993

8.5

(P34897) Serine hydroxymethyltransferase, mitochondrial precursor (EC 2.1.2.1) (Serine methylase) (Glycine hydroxymethyltransferase) (SHMT)

	TK040203_NMyc_nuclei2_step08.1751.1751.3	1.692	0.0457	3212.51	1	1900.0%	1	R.AMADALLERGYSLVSGGTDNHLVLVDLRPK.G
*	TK040203_NMyc_nuclei2_step04.4093.4093.3	0.9857	0.0218	2581.62	9	1200.0%	2	R.EVCDEVKAHLLADMAHISGLVAAK.V
*	TK040203_NMyc_nuclei2_step10.2711.2711.3	2.1373	0.0038	4128.62	1	1690.0%	1	R.ALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDR.I

Q8R081

99.4%

22.0%

555

60123

7.1

(Q8R081) Similar to heterogeneous nuclear ribonucleoprotein L

*	TK040203_NMyc_nuclei2_step11.3140.3140.2	1.9537	0.3195	3083.86	1	2730.0%	1	R.LKTENAGDQHGGGGGGGSGAAGGGGGENYDDPHK.T
	TK040203_NMyc_nuclei2_step12.0696.0696.3	1.2992	0.1141	4176.42	23	1080.0%	1	R.QPPLLGDHPAEYGGPHGGYHSHYHDEGYGPPPPHYEGR.R
	TK040203_NMyc_nuclei2_step03.1691.1691.1	1.5534	0.165	1076.62	1	5560.0%	3	K.TPASPVVHIR.G
	TK040203_NMyc_nuclei2_step09.3282.3282.3	2.8311	0.3795	4393.48	1	1600.0%	4	R.QALVEFEDVLGACNAVNYAADNQIYIAGHPAFVNYSTSQK.I

HS71_MOUSE

99.4%

23.4%

641

69994

5.6

(P17879) Heat shock 70 kDa protein 1 (HSP70.1) (HSP70-1/HSP70-2)

	TK040203_NMyc_nuclei2_step10.2752.2752.2	1.7506	0.1772	2775.16	16	1920.0%	1	R.DLNKSINPDEAVAYGAAVQAAILMGDK.S
	TK040203_NMyc_nuclei2_step12.1359.1359.3	1.8189	0.0859	2977.08	201	1350.0%	1	K.EIAEAYLGHPVTNAVITVPAYFNDSQR.Q
	TK040203_NMyc_nuclei2_step10.2465.2465.3	2.1797	0.0894	3548.79	19	1480.0%	1	K.NTAIGIDLGTTYSCVGVFQHGKVEIIANDQGNR.T
	TK040203_NMyc_nuclei2_step01.1779.1779.1	1.2505	0.0368	1199.56	4	4090.0%	1	K.DAGVIAGLNVLR.I
	TK040203_NMyc_nuclei2_step09.3445.3445.2	1.2845	0.0151	2983.67	67	1150.0%	1	R.TLSSSTQASLEIDSLFEGIDFYTSITR.A
	TK040203_NMyc_nuclei2_step02.2520.2520.2	3.0867	0.4879	2776.06	1	3260.0%	1	K.QTQTFTTYSDNQPGVLIQVYEGER.A

O94894

99.4%

1032

117461

9.3

(O94894) Hypothetical protein KIAA0801

*	TK040203_NMyc_nuclei2_step07.2501.2501.2	3.1008	0.4817	2296.57	3	3000.0%	1	K.HGYEKPTPIQTQAIPAIMSGR.D
*	TK040203_NMyc_nuclei2_step09.1818.1818.3	1.2684	0.0059	3940.74	21	1290.0%	1	K.GELMENDQDAMEYSSEEEEVDLQTALTGYQTKQR.K
*	TK040203_NMyc_nuclei2_step01.0354.0354.1	1.415	0.0027	1138.52	63	4440.0%	1	R.KLLEPVDHGK.I

BMP1_MOUSE

99.4%

20.6%

991

111608

7.7

(P98063) Bone morphogenetic protein 1 precursor (EC 3.4.24.19) (BMP-1) (Procollagen C-proteinase) (PCP) (Mammalian tolloid protein) (mTld)

*	TK040203_NMyc_nuclei2_step11.3592.3592.3	3.1468	0.409	4145.16	4	1530.0%	1	R.LHLRPGRGGRPGAPQLQRPLQGGCLPWDIALDEEDLR.A
	TK040203_NMyc_nuclei2_step06.2326.2326.3	1.5435	0.0619	2618.14	75	1740.0%	1	R.VWPDGVIPFVIGGNFTGSQRAVFR.Q
	TK040203_NMyc_nuclei2_step12.3674.3674.2	0.68	0.0133	2599.71	6	1670.0%	1	K.LHGKFCGSEKPEVITSQYNNMR.V
*	TK040203_NMyc_nuclei2_step05.2704.2704.2	1.8926	0.2405	2783.37	1	2830.0%	1	R.HDSCAYDYLEVRDGHSESSNLIGR.Y
	TK040203_NMyc_nuclei2_step06.2535.2535.3	1.8294	0.0193	4221.31	3	1430.0%	1	K.LYKCPACGETLQDSTGNFSSPEYPNGYSAHMHCVWR.I
*	TK040203_NMyc_nuclei2_step03.2654.2654.2	1.1901	0.0011	1895.23	23	2670.0%	1	R.YCGYENPDDIKSTSSR.L
*	TK040203_NMyc_nuclei2_step03.3722.3722.2	1.25	0.0476	2787.8	22	1800.0%	1	-.MPGVARPPLPLLSLPLLLLLLLLPAR.R
*	TK040203_NMyc_nuclei2_step08.3245.3245.2	1.5851	0.0453	2032.46	19	2500.0%	1	K.GFQASHSTECGGQVRADVK.T

Q9QWJ7

99.3%

1.0%

2154

250928

5.5

(Q9QWJ7) Non-erythrocyte beta spectrin

	TK040203_NMyc_nuclei2_step04.2737.2737.2	2.954	0.429	2320.8	1	4000.0%	5	R.MPLATSTDHGHNLQTVQLLIK.K

MCM2_MOUSE

99.3%

904

102047

5.8

(P97310) DNA replication licensing factor MCM2

*	TK040203_NMyc_nuclei2_step03.2726.2726.1	1.3506	0.0646	1463.28	7	3460.0%	1	R.ISDPLTSSPGRSSR.R
	TK040203_NMyc_nuclei2_step10.1592.1592.1	1.2892	0.1317	989.77	75	4290.0%	1	R.ITNHIHVR.I
*	TK040203_NMyc_nuclei2_step05.1388.1388.2	0.9766	0.0371	1470.01	15	4550.0%	1	R.VRPKLNQMDQDK.V
*	TK040203_NMyc_nuclei2_step07.2698.2698.2	1.4683	0.234	2634.73	1	2620.0%	1	R.DNNDLLLFILKQLVAEQVTYQR.N
	TK040203_NMyc_nuclei2_step09.1639.1639.1	2.2374	0.3871	1379.56	1	5450.0%	3	R.THVDSHGHNVFK.E
*	TK040203_NMyc_nuclei2_step05.3491.3491.2	2.0609	0.2243	2026.23	5	3120.0%	1	R.QINIHNLSAFYDSDLFK.F
*	TK040203_NMyc_nuclei2_step10.4208.4208.2	1.4737	0.118	3059.01	1	2000.0%	1	R.HVERATEDGEEDEEMIESIENLEDLK.G

EGR2_MOUSE

99.3%

470

49819

8.8

(P08152) Early growth response protein 2 (EGR-2) (Krox-20 protein)

*	TK040203_NMyc_nuclei2_step12.2559.2559.3	2.9882	0.4236	3789.13	1	1460.0%	1	K.SSAPSAPPSAQSSASGPGGSQAGGSLCGNSAIGGPLASCTSR.T
	TK040203_NMyc_nuclei2_step10.3101.3101.2	1.219	0.1049	2885.98	6	1960.0%	1	K.YPNRPSKTPVHERPYPCPAEGCDR.R

AAC4_MOUSE

99.3%

9.5%

912

104977

5.4

(P57780) Alpha-actinin 4 (Non-muscle alpha-actinin 4) (F-actin cross linking protein)

	TK040203_NMyc_nuclei2_step03.1593.1593.1	2.0216	0.2185	1327.67	1	6000.0%	4	K.RDHALLEEQSK.Q
	TK040203_NMyc_nuclei2_step11.4488.4488.2	1.3791	0.0593	2202.06	8	2630.0%	1	R.ASFNHFDKDHGGALGPEEFK.A
	TK040203_NMyc_nuclei2_step10.1341.1341.3	1.815	0.1036	1922.22	168	2190.0%	1	K.AGTQIENIDEDFRDGLK.L
	TK040203_NMyc_nuclei2_step09.1377.1377.1	1.0713	0.0588	894.42	21	4290.0%	1	R.EAILAIHK.E
	TK040203_NMyc_nuclei2_step06.1839.1839.1	1.6446	0.0571	1301.66	32	4440.0%	2	R.HRPELIEYDK.L
	TK040203_NMyc_nuclei2_step11.3672.3672.2	1.4058	0.1265	2511.73	192	1500.0%	1	K.DGLAFNALIHRHRPELIEYDK.L
	TK040203_NMyc_nuclei2_step01.2914.2914.1	1.9689	0.354	1216.72	1	6110.0%	1	R.LASDLLEWIR.R

Q96DL5

99.3%

123

12910

12.0

(Q96DL5) Hypothetical protein FLJ32865 (Hypothetical gene LOC125965)

*	TK040203_NMyc_nuclei2_step06.2063.2063.1	1.7291	0.3841	1479.64	2	4230.0%	1	R.ARSPASTISACTTR.C

Q925Q1

99.3%

1902

206283

6.7

(Q925Q1) Osa1 nuclear protein

*	TK040203_NMyc_nuclei2_step06.1559.1559.1	2.131	0.3385	1447.5	1	4170.0%	3	R.ANHEGPWPSHGTR.Q
*	TK040203_NMyc_nuclei2_step12.2514.2514.3	1.6889	0.029	2719.53	3	2200.0%	1	R.KHLTTVEGTPGTTEQEGPPPDGLPEK.R
	TK040203_NMyc_nuclei2_step12.1269.1269.1	1.0633	0.0095	1357.68	125	3180.0%	1	R.ITATMDDMLSTR.S
	TK040203_NMyc_nuclei2_step06.2325.2325.2	1.2919	0.0588	2603.33	32	1740.0%	1	R.SLSFVPGNDFEMSKHPGLLLILGK.L

Q96GK8

99.3%

371

41361

4.9

(Q96GK8) cAMP responsive element binding protein 3 (Luman)

*	TK040203_NMyc_nuclei2_step09.3609.3609.3	1.918	0.0356	4406.45	2	1380.0%	1	K.TSSSSTCILVLLVSFCLLLVPAIYSSDTRGSLPAEHGVLSR.Q
*	TK040203_NMyc_nuclei2_step10.3467.3467.3	3.2671	0.3853	3205.85	3	2230.0%	1	K.TSSSSTCILVLLVSFCLLLVPAIYSSDTR.G

S3B1_MOUSE

99.2%

1304

145816

7.1

(Q99NB9) Splicing factor 3B subunit 1 (Spliceosome associated protein 155) (SAP 155) (SF3b155) (Pre-mRNA splicing factor SF3b 155 kDa subunit)

	TK040203_NMyc_nuclei2_step08.2981.2981.3	1.8349	0.018	3517.96	4	1580.0%	1	K.KPGYHAPVALLNDIPQSTEQYDPFAEHRPPK.I
	TK040203_NMyc_nuclei2_step01.3935.3935.2	2.9622	0.4908	2816.28	1	2500.0%	1	R.EFGAGPLFNQILPLLMSPTLEDQER.H
	TK040203_NMyc_nuclei2_step01.2495.2495.1	1.4142	0.0346	1093.69	2	5620.0%	1	K.TEILPPFFK.H

Q9JHJ3

99.2%

494

404

43804

6.1

(Q9JHJ3) Kidney predominant protein (RIKEN cDNA 0610031J06 gene)

*	TK040203_NMyc_nuclei2_step02.3175.3175.2	1.7303	0.0556	2881.98	1	2310.0%	22	R.LLEFDSTNASEGAQPPGKPYPPYSLAK.F
*	TK040203_NMyc_nuclei2_step11.3832.3832.3	1.6296	0.0584	4301.08	10	1280.0%	1	K.SSIQFSSALVFTRLLEFDSTNASEGAQPPGKPYPPYSLAK.F

Q99KT9

99.2%

44.3%

9615

7.4

(Q99KT9) Hypothetical 9.6 kDa protein

*	TK040203_NMyc_nuclei2_step01.3627.3627.3	2.971	0.4522	4554.22	1	1380.0%	3	-.MNQPHLAFLHICTHAFFKAILFICSGSIIHSLADEQDIR.K

Q91X94

99.2%

257

29283

9.3

(Q91X94) Similar to heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA-binding protein 1, 37kD)

	TK040203_NMyc_nuclei2_step06.2075.2075.1	1.1129	0.0198	1178.5	21	4380.0%	1	R.RGFCFITFK.E
	TK040203_NMyc_nuclei2_step09.1511.1511.1	1.7133	0.3308	918.61	1	7860.0%	1	K.YHNVGLSK.C
	TK040203_NMyc_nuclei2_step01.1600.1600.1	1.2093	0.0991	1490.91	70	3460.0%	1	K.IFVGGLSPDTPEEK.I
	TK040203_NMyc_nuclei2_step09.1505.1505.1	2.4273	0.3578	1047.63	1	6880.0%	3	K.KYHNVGLSK.C
	TK040203_NMyc_nuclei2_step01.2352.2352.1	0.9675	0.0549	1019.86	1	6430.0%	1	R.GFCFITFK.E

Q9NYF8

99.2%

869

100216

10.0

(Q9NYF8) Bcl-2-associated transcription factor short form

	TK040203_NMyc_nuclei2_step11.3474.3474.2	2.5049	0.4893	2049.11	1	5000.0%	2	K.STSESFIQHIVSLVHHVK.E
	TK040203_NMyc_nuclei2_step04.0317.0317.1	0.6921	0.0085	1095.39	20	1880.0%	1	R.ESDGFREEK.N
	TK040203_NMyc_nuclei2_step09.1678.1678.2	1.0759	0.1246	2608.87	22	2140.0%	1	K.SQEEPKDTFEHDPSESIDEFNK.S

RBB7_MOUSE

99.2%

425

47790

5.0

(Q60973) Histone acetyltransferase type B subunit 2 (Retinoblastoma binding protein p46) (Retinoblastoma-binding protein 7) (RBBP-7)

	TK040203_NMyc_nuclei2_step05.3179.3179.3	2.5816	0.4181	4113.77	1	1760.0%	1	R.SNTTSKPSHLVDAHTAEVNCLSFNPYSEFILATGSADK.T
	TK040203_NMyc_nuclei2_step05.1356.1356.2	2.8608	0.4748	1791.47	1	4670.0%	1	K.HPAKPDPSGECNPDLR.L

Q9DC30

99.2%

466

51828

6.4

(Q9DC30) 1200004M23Rik protein

*	TK040203_NMyc_nuclei2_step05.4224.4224.3	2.2026	0.2336	3322.38	12	1670.0%	1	R.AADVLVYLADDTVVPLAVENLSSISAHELHR.A
*	TK040203_NMyc_nuclei2_step06.2666.2666.2	2.8401	0.4871	1949.08	1	4120.0%	1	R.KPVTVAISLEGVHVIDNR.E

RBB4_MOUSE

99.2%

461

51771

5.1

(Q60972) Chromatin assembly factor 1 subunit C (CAF-1 subunit C) (Chromatin assembly factor I p48 subunit) (CAF-I 48 kDa subunit) (CAF-Ip48) (Retinoblastoma binding protein p48) (Retinoblastoma-binding protein 4) (RBBP-4)

	TK040203_NMyc_nuclei2_step12.3082.3082.2	1.5478	0.2094	2877.1	1	2120.0%	1	K.IGEEQSPEDAEDGPPELLFIHGGHTAK.I
	TK040203_NMyc_nuclei2_step03.3547.3547.3	3.3234	0.3708	3439.83	1	1920.0%	1	K.TIFTGHTAVVEDVSWHLLHESLFGSVADDQK.L
	TK040203_NMyc_nuclei2_step05.1351.1351.2	2.5713	0.2886	1807.98	1	5330.0%	2	K.HPSKPDPSGECNPDLR.L

Q9UPZ9

99.1%

632

71427

9.8

(Q9UPZ9) Hypothetical protein KIAA0936 (MAK-related kinase) (DJ132F22.2)

*	TK040203_NMyc_nuclei2_step06.2477.2477.3	2.8521	0.2191	2859.26	3	1830.0%	3	K.GILEKAGPPPYIKPVPPAQPPAKPHTR.I

RS17_MOUSE

99.1%

31.3%

134

15393

9.8

(P06584) 40S ribosomal protein S17

	TK040203_NMyc_nuclei2_step02.2760.2760.2	1.979	0.4093	2492.54	1	3570.0%	2	R.DNYVPEVSALDQEIIEVDPDTK.E
	TK040203_NMyc_nuclei2_step01.1554.1554.1	0.96	0.0017	900.49	33	5000.0%	1	K.AARVIIEK.Y
	TK040203_NMyc_nuclei2_step12.0946.0946.2	0.7312	0.0172	1376.31	63	2270.0%	1	R.NKIAGYVTHLMK.R

O43149

99.1%

986

110793

6.3

(O43149) Hypothetical protein KIAA0399 (Fragment)

	TK040203_NMyc_nuclei2_step06.3681.3681.3	2.1937	0.2625	4499.07	1	1450.0%	4	K.HTNIFTLLVLVGFPQVLCVGTRCVYMDNANEPHNVIILK.H

TBA1_HUMAN

99.1%

451

50152

5.1

(P05209) Tubulin alpha-1 chain (Alpha-tubulin 1) (P05209) Tubulin alpha-1 chain (Alpha-tubulin 1)

	TK040203_NMyc_nuclei2_step01.2539.2539.1	2.1506	0.3749	1584.66	1	4170.0%	1	R.SIQFVDWCPTGFK.V

LA_MOUSE

99.1%

415

47756

9.8

(P32067) Lupus La protein homolog (La ribonucleoprotein) (La autoantigen homolog)

	TK040203_NMyc_nuclei2_step06.1842.1842.2	2.722	0.4637	1774.49	2	4640.0%	1	R.RSPSRPLPEVTDEYK.N

RL3_MOUSE

99.1%

124

402

45993

10.2

(P27659) 60S ribosomal protein L3 (J1 protein)

	TK040203_NMyc_nuclei2_step05.3714.3714.2	0.8914	0.0377	2887.23	42	1540.0%	11	K.EVVEAVTIVETPPMVVVGIVGYVETPR.G
*	TK040203_NMyc_nuclei2_step04.1431.1431.1	1.4989	0.0309	970.68	5	5710.0%	1	R.IIAHTQMR.L
	TK040203_NMyc_nuclei2_step02.2230.2230.1	1.3553	0.0117	983.77	4	5620.0%	1	R.HGSLGFLPR.K
*	TK040203_NMyc_nuclei2_step11.3992.3992.2	1.3566	0.141	3151.86	186	1070.0%	1	K.SINPLGGFVHYGEVTNDFIMLKGCVVGTK.K

Q9UBG8

99.1%

473

51268

5.0

(Q9UBG8) Keratin 16

*	TK040203_NMyc_nuclei2_step05.1874.1874.1	1.9486	0.3643	1261.59	1	5560.0%	3	R.TKYEHELALR.Q

Q9CT41

99.1%

561

63738

4.8

(Q9CT41) 2600017A12Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step07.1688.1688.1	2.134	0.3672	1431.56	1	5450.0%	1	R.HFSEHPSMSNMK.A
*	TK040203_NMyc_nuclei2_step08.1367.1367.1	0.9935	0.0043	1219.38	130	3890.0%	1	K.MDYEKNGFSK.E
*	TK040203_NMyc_nuclei2_step04.2786.2786.2	1.2056	0.3313	2550.4	2	2050.0%	1	R.ALEPEEGNPQTEAQENGPEREAR.K

Q9CXZ2

99.1%

1004

13.5%

163

17403

7.1

(Q9CXZ2) 13 days embryo liver cDNA, RIKEN full-length enriched library, clone:2510049H02, full insert sequence

	TK040203_NMyc_nuclei2_step02.1903.1903.1	2.0232	0.2564	890.88	1	6250.0%	26	K.AAVSGLWGK.V
	TK040203_NMyc_nuclei2_step01.1053.1053.1	1.9296	0.2278	1289.07	2	4580.0%	18	K.VNADEVGGEALGR.L

PDA3_MOUSE

99.1%

16.9%

504

56621

6.4

(P27773) Protein disulfide isomerase A3 precursor (EC 5.3.4.1) (Disulfide isomerase ER-60) (ERp60) (58 kDa microsomal protein) (p58) (ERp57)

	TK040203_NMyc_nuclei2_step06.3407.3407.2	1.3469	0.0631	2463.84	1	2620.0%	1	K.VDCTANTNTCNKYGVSGYPTLK.I
*	TK040203_NMyc_nuclei2_step10.3148.3148.3	1.4309	0.0228	2282.07	19	2500.0%	1	K.KFIQDSIFGLCPHMTEDNK.D
	TK040203_NMyc_nuclei2_step01.2022.2022.1	2.0422	0.3711	1343.63	1	5910.0%	2	K.GFPTIYFSPANK.K
	TK040203_NMyc_nuclei2_step05.1590.1590.1	2.1996	0.1988	916.65	1	7140.0%	2	K.KFLDAGHK.L
*	TK040203_NMyc_nuclei2_step05.2622.2622.2	1.2771	0.0183	2622.25	40	1960.0%	1	K.TFSHELSDFSLESTTGEVPVVAIR.T

CYC_MOUSE

99.1%

104

11474

9.6

(P00009) Cytochrome c, somatic

	TK040203_NMyc_nuclei2_step05.2426.2426.1	1.8238	0.3763	1170.63	1	6000.0%	3	K.TGPNLHGLFGR.K

K1CS_MOUSE

99.1%

28.5%

403

44542

5.4

(P19001) Keratin, type I cytoskeletal 19 (Cytokeratin 19) (K19) (CK 19)

*	TK040203_NMyc_nuclei2_step04.2861.2861.2	1.9356	0.1571	1897.05	1	3680.0%	1	R.GGSFSGTLAVSDGLLSGNEK.I
*	TK040203_NMyc_nuclei2_step03.1770.1770.1	2.2899	0.1378	1340.88	1	5000.0%	3	K.KNHEEEITALR.S
*	TK040203_NMyc_nuclei2_step05.3574.3574.2	1.9855	0.2781	2525.01	2	2950.0%	1	R.YGVQLSQIQSVISGFEAQLSDVR.A
*	TK040203_NMyc_nuclei2_step03.1659.1659.1	1.4071	0.1233	1002.76	1	6430.0%	1	K.FETEHALR.L
*	TK040203_NMyc_nuclei2_step03.1663.1663.1	2.0316	0.3366	1233.77	1	6110.0%	3	R.TKFETEHALR.L
*	TK040203_NMyc_nuclei2_step05.2598.2598.2	1.8857	0.0975	1911.64	1	4060.0%	1	R.SLLEGQEAHYNNLPTPK.A
*	TK040203_NMyc_nuclei2_step08.2435.2435.2	1.6933	0.116	2359.77	5	2290.0%	1	R.QTSAMSSFGGTGGGSVRIGSGGVFR.A
*	TK040203_NMyc_nuclei2_step04.4193.4193.3	2.3601	0.2785	2981.83	4	1880.0%	1	R.GGSFSGTLAVSDGLLSGNEKITMQNLNDR.L

SYD_MOUSE

99.1%

501

57117

6.5

(Q922B2) Aspartyl-tRNA synthetase (EC 6.1.1.12) (Aspartate--tRNA ligase) (AspRS)

	TK040203_NMyc_nuclei2_step05.1735.1735.1	1.914	0.3606	1132.58	1	6110.0%	2	R.ALHHGIDLEK.I
	TK040203_NMyc_nuclei2_step11.4384.4384.2	1.4223	0.0907	2860.04	20	1670.0%	2	K.QCFLVLRQQQFNVQALVAVGDHASK.Q

SSRP_MOUSE

99.0%

708

80746

6.5

(Q08943) Structure-specific recognition protein 1 (SSRP1) (Recombination signal sequence recognition protein) (T160)

	TK040203_NMyc_nuclei2_step12.1855.1855.2	2.6226	0.4694	1563.98	1	6670.0%	1	R.GFIYVHKPPVHIR.F
*	TK040203_NMyc_nuclei2_step08.1228.1228.1	1.1244	0.0872	1041.43	3	5000.0%	1	R.QLSDSFKSK.E

TR16_HUMAN

99.0%

427

45183

4.7

(P08138) Tumor necrosis factor receptor superfamily member 16 precursor (Low-affinity nerve growth factor receptor) (NGF receptor) (Gp80-LNGFR) (p75 ICD) (Low affinity neurotrophin receptor p75NTR)

*	TK040203_NMyc_nuclei2_step05.3500.3500.3	3.2704	0.3575	3126.68	2	1960.0%	1	R.GTTDNLIPVYCSILAAVVVGLVAYIAFKR.W

PGBM_MOUSE

99.0%

3707

398295

6.3

(Q05793) Basement membrane-specific heparan sulfate proteoglycan core protein precursor (HSPG) (Perlecan) (PLC)

*	TK040203_NMyc_nuclei2_step06.3557.3557.1	1.4952	0.0323	1544.65	12	3850.0%	1	R.KIPGDQIVSVVFIK.E
*	TK040203_NMyc_nuclei2_step10.2196.2196.2	1.2	0.0151	1902.91	30	2810.0%	1	R.HPTPLALGQFHTVTLLR.S
*	TK040203_NMyc_nuclei2_step03.2085.2085.2	1.1186	0.0613	2288.18	210	1360.0%	1	R.ALSSAGQHVARAMLQVHGGSGPR.V
*	TK040203_NMyc_nuclei2_step04.1915.1915.3	1.4998	0.0918	3089.98	57	1440.0%	1	R.SVVPQGGPHSLRCQVSGSPPHYFYWSR.E
*	TK040203_NMyc_nuclei2_step03.4079.4079.2	1.1702	0.1959	2176.56	7	2370.0%	1	R.WLKEGGQLPPGHSVQDGVLR.I
*	TK040203_NMyc_nuclei2_step10.1422.1422.2	2.2916	0.4807	1417.88	1	6250.0%	1	R.GHTPTHPGTLNQR.Q
*	TK040203_NMyc_nuclei2_step03.2987.2987.3	1.8252	0.1863	4129.4	2	1310.0%	1	R.VGSAEAFAQVLVQGSSSNLPDTSIPGGSTPTVQVTPQLETR.N
*	TK040203_NMyc_nuclei2_step06.2359.2359.3	1.7452	0.076	2993.13	4	1770.0%	1	R.EVEQCTCPPGYRGPSCQDCDTGYTR.V

RECK_HUMAN

99.0%

971

106457

6.7

(O95980) Reversion-inducing cysteine-rich protein with Kazal motifs precursor (hRECK) (Suppressor of tumorigenicity 15) (ST15)

*	TK040203_NMyc_nuclei2_step12.2807.2807.3	1.4819	0.1279	3924.52	8	1250.0%	1	R.GALLLLLAVAGVAEVAGGLAPGSAGALCCNHSKDNQMCR.D
*	TK040203_NMyc_nuclei2_step05.3362.3362.3	3.0444	0.1789	3121.83	3	1950.0%	5	R.GALLLLLAVAGVAEVAGGLAPGSAGALCCNHSK.D
*	TK040203_NMyc_nuclei2_step12.1994.1994.3	1.5866	0.0163	3861.76	6	1420.0%	1	K.IESLINSDSPTLASHVPLSALIISQVQVSSSVPSAGVR.A

Q9R190

98.9%

668

75030

9.7

(Q9R190) Metastasis associated protein MTA2 (Mta2 protein)

*	TK040203_NMyc_nuclei2_step11.4096.4096.2	1.5429	0.0866	3168.76	6	1770.0%	1	R.SYETMAGAGVPFSANGRPLASGIRSSSQPAAK.R
	TK040203_NMyc_nuclei2_step07.1677.1677.1	1.3651	0.0322	837.81	5	7500.0%	2	R.RPNLPLK.V
	TK040203_NMyc_nuclei2_step08.1737.1737.2	2.8566	0.462	2174.63	1	4210.0%	2	R.GHLSRPEAQSLSPYTTSANR.A

U5S1_MOUSE

98.9%

971

109361

5.0

(O08810) 116 kDa U5 small nuclear ribonucleoprotein component (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)

	TK040203_NMyc_nuclei2_step11.1231.1231.1	1.756	0.1987	1372.55	1	4550.0%	1	R.NVTLCGHLHHGK.T
	TK040203_NMyc_nuclei2_step02.3543.3543.2	1.3239	0.075	2250.13	1	2750.0%	1	R.ISDGVVLFIDAAEGVMLNTER.L
*	TK040203_NMyc_nuclei2_step09.2734.2734.3	1.8128	0.065	3739.33	4	1450.0%	1	K.DLDEDEDEDEDDVGEHEDDHPGMEVVLHEDKK.Y
	TK040203_NMyc_nuclei2_step04.3277.3277.2	1.4197	0.2369	2050.06	1	3060.0%	1	R.RGHVTQDAPIPGSPLYTIK.A
	TK040203_NMyc_nuclei2_step11.1967.1967.2	2.8911	0.4457	1894.13	1	4060.0%	1	K.SIVIRPLEPQPAPHLAR.E

Q9CWI5

98.9%

204

24047

11.6

(Q9CWI5) Ribosomal protein L15

	TK040203_NMyc_nuclei2_step11.1155.1155.1	1.9444	0.34	1013.39	1	8120.0%	2	K.FHHTIGGSR.R

RL31_HUMAN

98.9%

125

14463

10.5

(P12947) 60S ribosomal protein L31 (P12947) 60S ribosomal protein L31

	TK040203_NMyc_nuclei2_step02.1677.1677.1	1.8716	0.1147	760.0	1	8330.0%	8	R.IHGVGFK.K
	TK040203_NMyc_nuclei2_step12.4423.4423.1	0.6576	0.1291	911.83	60	2860.0%	1	K.RIHGVGFK.K

Q9Z1N5

98.8%

20.6%

428

49035

5.7

(Q9Z1N5) Nuclear RNA helicase BAT1 (Similar to DNA segment, CHR 17, human D6S81E 1)

	TK040203_NMyc_nuclei2_step12.3153.3153.2	1.055	0.0827	3001.45	19	1670.0%	1	R.GMDIERVNIAFNYDMPEDSDTYLHR.V
	TK040203_NMyc_nuclei2_step09.2731.2731.3	1.939	0.0049	3555.43	1	1640.0%	1	K.ILNDVQDRFEVNISELPDEIDISSYIEQTR.-
	TK040203_NMyc_nuclei2_step10.1700.1700.2	2.5751	0.3587	1435.74	1	6670.0%	1	K.KNCPHIVVGTPGR.I
	TK040203_NMyc_nuclei2_step04.1615.1615.1	1.7827	0.1083	1307.52	9	4550.0%	1	K.NCPHIVVGTPGR.I
	TK040203_NMyc_nuclei2_step02.3226.3226.2	2.4213	0.2818	2598.67	1	3570.0%	1	R.FEVNISELPDEIDISSYIEQTR.-
	TK040203_NMyc_nuclei2_step03.3487.3487.2	2.1308	0.1948	2279.26	1	3420.0%	1	R.CIALAQLLVEQNFPAIAIHR.G

CALU_MOUSE

98.7%

315

37064

4.7

(O35887) Calumenin precursor

	TK040203_NMyc_nuclei2_step05.1368.1368.1	2.2747	0.3342	1191.5	1	7220.0%	2	R.VHHEPQLSDK.V

CPV1_MOUSE

98.6%

15.3%

503

58015

8.0

(P28649) Cytochrome P450 19 (Aromatase) (EC 1.14.14.1) (CYPXIX) (Estrogen synthetase) (P-450AROM)

*	TK040203_NMyc_nuclei2_step09.1722.1722.1	2.1905	0.3471	1371.56	1	5000.0%	1	K.DLKDEIAVLVEK.K
*	TK040203_NMyc_nuclei2_step03.4215.4215.3	1.8437	0.0109	3233.75	1	2300.0%	2	K.IQGYFNAWQALLIKPNIFFKISWLYR.K
*	TK040203_NMyc_nuclei2_step10.1824.1824.3	1.5883	0.1314	2104.14	4	2500.0%	1	K.LEDCMDFATDLIFAERR.G
*	TK040203_NMyc_nuclei2_step04.3137.3137.2	1.3946	0.0088	2570.62	121	1670.0%	1	R.GLQCIGMHENGIIFNNNPSLWR.T

RL7A_MOUSE

98.6%

12.8%

265

29845

10.6

(P12970) 60S ribosomal protein L7a (Surfeit locus protein 3)

	TK040203_NMyc_nuclei2_step10.1493.1493.1	1.1063	4.0E-4	737.53	3	6000.0%	2	K.RPPVLR.A
	TK040203_NMyc_nuclei2_step09.1675.1675.1	1.28	0.0799	1141.69	10	4500.0%	1	K.GALAKLVEAIR.T
	TK040203_NMyc_nuclei2_step11.1194.1194.1	1.3023	0.2747	831.49	2	6670.0%	1	R.LGHLVHR.K
	TK040203_NMyc_nuclei2_step02.1924.1924.1	2.1592	0.3394	1066.69	1	6110.0%	3	R.HWGGNVLGPK.S

CYC_HUMAN

98.6%

900

104

11618

9.6

(P00001) Cytochrome c

*	TK040203_NMyc_nuclei2_step12.2953.2953.1	1.5327	0.0972	1470.68	1	4170.0%	30	K.YIPGTKMIFVGIK.K

Q9NR99

98.6%

2828

312293

8.3

(Q9NR99) Adlican

*	TK040203_NMyc_nuclei2_step05.2355.2355.1	1.2616	0.0478	1475.14	1	4290.0%	1	K.CVASNAAGADSLAIR.L
*	TK040203_NMyc_nuclei2_step06.1275.1275.2	1.0373	0.0957	2209.52	153	1750.0%	1	R.INLGFNSIQALSETSFAGLTK.L
*	TK040203_NMyc_nuclei2_step08.1515.1515.2	1.4425	0.2023	1981.99	1	4120.0%	1	K.SDSVQLVCMARNEGGEAR.L
*	TK040203_NMyc_nuclei2_step12.2419.2419.2	1.4664	0.1296	2861.9	2	1920.0%	1	R.TAQPGRLQTDIPVTTSGENLTDPPLLK.E
*	TK040203_NMyc_nuclei2_step01.1739.1739.1	1.3818	0.072	1308.71	1	4550.0%	1	K.SSLSTQDTLLIK.K
*	TK040203_NMyc_nuclei2_step04.3132.3132.3	1.5106	0.077	3500.34	12	1440.0%	1	K.EPASSSPSTILMSLGQTTTTKPALPSPRISQASR.D
*	TK040203_NMyc_nuclei2_step04.2802.2802.2	1.5086	0.0659	2284.81	5	2500.0%	1	R.EDIVEDEGGSGMGDEENTSRR.L
*	TK040203_NMyc_nuclei2_step06.1615.1615.1	1.713	0.2961	1104.53	1	6110.0%	1	K.EPETNVAEGR.R
*	TK040203_NMyc_nuclei2_step12.1779.1779.2	1.4871	0.1877	2036.79	5	2630.0%	1	K.INGNPNPITTVREIAAGGSR.K
*	TK040203_NMyc_nuclei2_step04.0777.0777.1	1.0216	0.0175	818.67	7	5000.0%	1	K.SQPDEDK.M
*	TK040203_NMyc_nuclei2_step03.1675.1675.1	1.7496	0.2581	1446.58	1	5000.0%	7	R.RVWQTVSPVESR.I
*	TK040203_NMyc_nuclei2_step08.1799.1799.1	1.1329	0.046	1288.28	2	4500.0%	1	R.VWQTVSPVESR.I
*	TK040203_NMyc_nuclei2_step04.3109.3109.2	1.3126	7.0E-4	2294.34	24	2370.0%	1	R.SIEEEQEQEEDGGSQLILEK.F

HEM3_MOUSE

98.6%

20.8%

361

39302

7.1

(P22907) Porphobilinogen deaminase (EC 4.3.1.8) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase) (PBG-D)

*	TK040203_NMyc_nuclei2_step08.4254.4254.2	1.9281	0.0793	3036.68	2	2220.0%	1	K.NEVDLVVHSLKDVPTILPPGFTIGAICK.R
*	TK040203_NMyc_nuclei2_step08.3849.3849.2	0.8146	0.078	2884.44	8	1730.0%	1	K.ALYPGIQFEIIAMSTTGDKIVDTALSK.I
*	TK040203_NMyc_nuclei2_step04.3604.3604.2	1.5911	0.1192	2071.9	1	3060.0%	1	K.LDELQEFSAIVLAVAGLQR.M
*	TK040203_NMyc_nuclei2_step07.3710.3710.2	2.9507	0.4379	2201.23	1	3950.0%	1	R.KLDELQEFSAIVLAVAGLQR.M

HEM4_MOUSE

98.4%

37.7%

265

28504

6.5

(P51163) Uroporphyrinogen-III synthase (EC 4.2.1.75) (UROS) (Uroporphyrinogen-III cosynthetase) (Hydroxymethylbilane hydrolyase [cyclizing]) (UROIIIS)

*	TK040203_NMyc_nuclei2_step10.4207.4207.3	1.7911	0.0738	3994.11	14	1220.0%	1	K.IGLDAEGAGSGNAEKLAEYICSKPSSELPLLFPCGTIK.G
*	TK040203_NMyc_nuclei2_step03.2890.2890.3	1.7084	0.1472	4338.88	1	1450.0%	1	K.SYYEDQGIPASITFFSPSGLKYSLEYIQALSGSSFDQIK.F
*	TK040203_NMyc_nuclei2_step10.2544.2544.2	2.8278	0.432	2507.84	1	3180.0%	1	K.GIPMESMHVYQTVPHPGIQGSLK.S

Q99ME3

98.3%

915

99934

6.3

(Q99ME3) Synphilin-1

*	TK040203_NMyc_nuclei2_step11.3434.3434.3	3.3309	0.2627	3393.41	1	1920.0%	1	R.SFHLQSSAAGAKTEEPINGMNWTNTQGTEER.T
*	TK040203_NMyc_nuclei2_step08.1468.1468.3	1.2894	0.0652	2651.83	4	2280.0%	1	K.TCPIASTENSTPNMTPFCVLSPVK.S
*	TK040203_NMyc_nuclei2_step03.3902.3902.3	1.1343	0.0221	3807.05	15	1330.0%	1	-.MEAPEYLDLDEIDFSDDISYSVTSLKTIPALCR.R

Q99LX7

98.2%

288

31257

8.5

(Q99LX7) Hypothetical 31.3 kDa protein (Fragment)

*	TK040203_NMyc_nuclei2_step08.2519.2519.2	1.1984	0.0437	3176.27	95	1380.0%	1	K.KPVIAAVNGYALGGGCELAMMCDIIYAGEK.A
*	TK040203_NMyc_nuclei2_step07.2256.2256.1	1.948	0.3065	1313.68	1	5560.0%	1	K.FLSHWDHITR.V

Q9QYB1

98.2%

19.4%

253

28729

5.6

(Q9QYB1) Intracellular chloride channel protein

	TK040203_NMyc_nuclei2_step10.2745.2745.2	2.7243	0.435	2625.25	1	3040.0%	1	R.KPADLQNLAPGTHPPFITFNSEVK.T
	TK040203_NMyc_nuclei2_step07.2461.2461.2	1.3334	0.0226	2750.09	7	2290.0%	1	K.EPLIELFVKAGSDGESIGNCPFSQR.L

Q9CUR8

98.2%

296

33761

9.7

(Q9CUR8) 4833427E09Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step07.3506.3506.2	1.5662	0.0418	2081.04	3	2730.0%	5	R.GPLAAAVAGVALAGAGAAWHHGR.V

Q99K37

98.2%

20.9%

406

45770

6.4

(Q99K37) Similar to HNOEL-iso protein

*	TK040203_NMyc_nuclei2_step03.2945.2945.3	1.956	0.0394	4416.21	10	1120.0%	1	R.TVVDSSVFPAESLIPPYGLTADTYIDLAADEEGLWAVYATR.D
	TK040203_NMyc_nuclei2_step02.3202.3202.2	1.7444	0.0281	2922.46	3	1960.0%	1	R.HLCLAKLDPQTLDTEQQWDTPCPR.E
*	TK040203_NMyc_nuclei2_step06.2649.2649.2	3.0213	0.4171	1990.55	1	3420.0%	1	R.RPPGGPGGGGELENTLQLIK.F

TRF2_MOUSE

98.2%

495

55716

9.4

(O35144) Telomeric repeat binding factor 2 (TTAGGG repeat binding factor 2) (Telomeric DNA binding protein)

*	TK040203_NMyc_nuclei2_step10.2428.2428.3	1.5837	0.056	4168.84	12	1250.0%	1	R.LLLEEDSQSTEPSPGLNSSHEAMSASKPRALNQPHPGEK.K
*	TK040203_NMyc_nuclei2_step01.1456.1456.1	1.9936	0.3303	1341.55	2	3750.0%	1	K.ALKSESAASSTMR.E

CYPH_MOUSE

98.2%

163

17840

7.9

(P17742) Peptidyl-prolyl cis-trans isomerase A (EC 5.2.1.8) (PPIase) (Rotamase) (Cyclophilin A) (Cyclosporin A-binding protein) (SP18)

	TK040203_NMyc_nuclei2_step01.0322.0322.1	1.1951	0.0822	686.33	5	6000.0%	3	K.HVVFGK.V

Q9DAW6

98.2%

521

58370

7.3

(Q9DAW6) 1600015H11Rik protein

	TK040203_NMyc_nuclei2_step09.2091.2091.1	1.7876	0.2146	1491.59	4	3850.0%	2	R.GHNTNVGAIVFHPK.S
	TK040203_NMyc_nuclei2_step11.1915.1915.2	1.1933	0.023	2946.3	45	1460.0%	1	R.SLNNFCSQIGDDRPISYCHFSPNSK.M

IF2G_MOUSE

98.1%

471

50934

8.4

(Q9Z0N1) Eukaryotic translation initiation factor 2 subunit 3, X-linked (Eukaryotic translation initiation factor 2 gamma subunit, X-linked) (eIF-2-gamma X)

	TK040203_NMyc_nuclei2_step02.3499.3499.2	2.4428	0.4471	3014.24	1	2960.0%	1	K.EQYEQILAFVQGTVAEGAPIIPISAQLK.Y

P97398

98.1%

323

37709

8.0

(P97398) NIPI-like protein

	TK040203_NMyc_nuclei2_step12.2255.2255.2	2.4459	0.4493	1989.96	1	5330.0%	1	R.TCAILCHIYHHALHSR.W
	TK040203_NMyc_nuclei2_step12.3825.3825.3	1.8333	0.0121	4243.8	15	1360.0%	1	R.DLMLMSHLQDNIQHADPPVQILYNRTMVQLGICAFR.Q

Q9WV39

98.1%

2.7%

1140

126881

5.3

(Q9WV39) Damage-specific DNA binding protein 1

	TK040203_NMyc_nuclei2_step12.3834.3834.2	1.7259	0.0541	1772.72	27	3120.0%	2	R.NGIGIHEHASIDLPGIK.G
	TK040203_NMyc_nuclei2_step09.2571.2571.2	2.6551	0.4318	2156.01	1	4470.0%	2	R.IIRNGIGIHEHASIDLPGIK.G
*	TK040203_NMyc_nuclei2_step12.1858.1858.1	1.4319	0.0165	1254.68	5	5000.0%	1	K.GLWPLRSDPGR.E

Q9D6X9

98.1%

227

24960

7.1

(Q9D6X9) 2310046A06Rik protein

*	TK040203_NMyc_nuclei2_step01.2608.2608.1	1.5894	0.3488	1381.56	4	4090.0%	2	K.EPQGMQKGDLFK.A

G6PI_MOUSE

98.1%

557

62637

7.9

(P06745) Glucose-6-phosphate isomerase (EC 5.3.1.9) (GPI) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Neuroleukin) (NLK)

	TK040203_NMyc_nuclei2_step06.2945.2945.3	3.2407	0.3324	3319.93	1	2410.0%	2	R.VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.M

Q9CZ66

98.0%

225

25372

9.7

(Q9CZ66) 2810052G09Rik protein

*	TK040203_NMyc_nuclei2_step04.2426.2426.3	1.4841	0.0025	2756.82	1	2400.0%	1	R.HDIAFVEFEYDGQAGAARDALQGFK.I
	TK040203_NMyc_nuclei2_step03.3591.3591.2	2.961	0.4273	2108.2	1	3610.0%	1	R.SLYALFSQFGHVVDIVALK.T

EGF_MOUSE

97.9%

1217

133144

6.5

(P01132) Pro-epidermal growth factor precursor (EGF) [Contains: Epidermal growth factor]

*	TK040203_NMyc_nuclei2_step10.3284.3284.2	1.2505	0.0384	2982.13	1	2310.0%	1	R.IDPDGTNHQQLVVDAGISADMDIHYKK.E

SX10_HUMAN

97.9%

466

49911

6.7

(P56693) Transcription factor SOX-10

*	TK040203_NMyc_nuclei2_step08.2752.2752.3	2.8759	0.4597	3935.07	1	1490.0%	1	K.SAHLDHRHPGEGSPMSDGNPEHPSGQSHGPPTPPTTPK.T

Q9C0E0

97.9%

1554

173549

6.3

(Q9C0E0) Hypothetical protein KIAA1723 (Fragment)

*	TK040203_NMyc_nuclei2_step10.3543.3543.3	3.3282	0.1111	2981.33	10	1960.0%	1	K.QDLVPGSPDDSLPKDGPSPGGTLMDLSER.Q
	TK040203_NMyc_nuclei2_step06.1934.1934.2	1.3447	0.0199	2176.04	3	3240.0%	1	R.STCNVVHDEFLDIPCTNR.G
*	TK040203_NMyc_nuclei2_step12.4021.4021.3	2.1067	0.2284	4410.08	24	1150.0%	2	R.SWEEHVTHWMGQPFNSDDRNTACHHGLVADSLQASMEK.D
	TK040203_NMyc_nuclei2_step07.3538.3538.2	0.9379	0.0237	1322.79	5	4000.0%	1	R.KPDPPKDENER.S

TCPH_MOUSE

97.9%

544

59652

7.8

(P80313) T-complex protein 1, eta subunit (TCP-1-eta) (CCT-eta)

	TK040203_NMyc_nuclei2_step10.3415.3415.2	1.8155	0.1808	2518.94	18	2140.0%	1	R.GGAEQFMEETERSLHDAIMIVR.R
	TK040203_NMyc_nuclei2_step09.2906.2906.2	1.3242	0.0935	1991.39	1	3160.0%	1	R.AIKNDSVVAGGGAIEMELSK.Y
	TK040203_NMyc_nuclei2_step05.2564.2564.2	2.513	0.4419	2019.38	1	3750.0%	1	K.QVKPYVEEGLHPQIIIR.A

Q8R3E9

97.8%

238

27378

11.8

(Q8R3E9) Similar to splicing factor, arginine/serine-rich 7 (35kD)

	TK040203_NMyc_nuclei2_step05.1311.1311.1	1.83	0.3168	1180.51	1	6250.0%	3	K.GHYAYDCHR.Y

Q9CQR1

97.8%

564

65146

8.9

(Q9CQR1) DNA segment, Chr 6, Wayne state University 157, expressed

	TK040203_NMyc_nuclei2_step11.1183.1183.1	1.6557	0.2584	1099.53	1	7220.0%	1	R.IHVLHHGTGK.W
	TK040203_NMyc_nuclei2_step06.1805.1805.1	2.3978	0.2617	1373.73	1	7270.0%	1	K.KLPHPDLPAEEK.E
*	TK040203_NMyc_nuclei2_step12.0934.0934.2	0.7751	0.0279	1872.41	43	1760.0%	1	R.EAEPAAREVPAPALPVVR.V

ROK_MOUSE

97.8%

464

50993

5.4

(Q60577) Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (65 kDa phosphoprotein)

	TK040203_NMyc_nuclei2_step01.2824.2824.1	2.5033	0.2567	1342.95	1	6820.0%	2	K.IILDLISESPIK.G
	TK040203_NMyc_nuclei2_step02.3898.3898.2	1.1452	0.0321	2590.44	18	1820.0%	2	R.IITITGTQDQIQNAQYLLQNSVK.Q
	TK040203_NMyc_nuclei2_step02.3110.3110.2	1.8811	0.2192	3061.24	1	1880.0%	1	R.AQPYDPNFYDETYDYGGFTMMFDDR.R
	TK040203_NMyc_nuclei2_step04.1922.1922.1	1.2295	0.1704	1196.8	32	3000.0%	7	R.NLPLPPPPPPR.G
	TK040203_NMyc_nuclei2_step01.1422.1422.1	0.9429	0.0070	876.5	8	5000.0%	1	K.DLAGSIIGK.G

Q9NVS8

97.7%

20.2%

519

58434

4.8

(Q9NVS8) Hypothetical protein FLJ10539

*	TK040203_NMyc_nuclei2_step01.2956.2956.1	2.3504	0.3117	1397.65	2	5000.0%	1	K.SAVLKCLLDIHK.I
*	TK040203_NMyc_nuclei2_step12.4030.4030.2	1.4149	0.2103	2945.38	46	1460.0%	1	K.MMAFLEKSQEQENHATLVSFSEEEK.Y
*	TK040203_NMyc_nuclei2_step02.2994.2994.3	1.8283	0.06	3368.41	3	1580.0%	1	K.EVSLTKAQLGLELEELEAAALLVQEEETALK.A
*	TK040203_NMyc_nuclei2_step08.3721.3721.3	1.4578	0.0286	3907.61	1	1390.0%	1	R.RNTAIQESDASQGKPLASSWPLGVSGPLIEELGEQLK.T

TBBX_HUMAN

97.7%

444

49671

4.9

(P05218) Class I beta tubulin. Tubulin beta-5 chain (P05218) Class I beta tubulin. Tubulin beta-5 chain

	TK040203_NMyc_nuclei2_step02.3098.3098.2	2.4577	0.4385	2798.57	1	2800.0%	1	R.SGPFGQIFRPDNFVFGQSGAGNNWAK.G

Q9R1C7

97.6%

953

108481

7.7

(Q9R1C7) Formin binding protein 11

	TK040203_NMyc_nuclei2_step12.1666.1666.3	1.5835	0.0424	4062.68	77	1290.0%	1	R.ESFQIFLDELHEHGQLHSMSSWMELYPTISSDIR.F
	TK040203_NMyc_nuclei2_step11.1938.1938.2	2.8235	0.4112	2070.98	1	5000.0%	1	K.DFMHVLEHECQHHHSK.N

Q91YX4

97.6%

356

38475

9.6

(Q91YX4) Similar to thioredoxin reductase 2

	TK040203_NMyc_nuclei2_step07.2272.2272.2	2.2882	0.4369	2203.08	1	4710.0%	1	R.DAHHYGWEVAQPVQHNWK.T

Q9DAB4

97.6%

18.7%

391

42890

6.7

(Q9DAB4) 1700015E05Rik protein

	TK040203_NMyc_nuclei2_step01.3883.3883.2	1.7081	0.094	2638.73	2	2390.0%	1	R.ALDLFSDNAPPPELLEIINEDIAK.K
	TK040203_NMyc_nuclei2_step06.3094.3094.2	2.7189	0.4271	2776.3	1	2920.0%	1	K.KTCEEHQLCVVAVLPHILDTGAAGR.N
	TK040203_NMyc_nuclei2_step03.3115.3115.2	0.9567	0.0075	2530.32	190	1300.0%	1	K.NKPEDYQGGRTGEAIVDAALSALR.Q

Q96PQ0

97.6%

417

45913

6.5

(Q96PQ0) VPS10 domain protein (Fragment)

	TK040203_NMyc_nuclei2_step01.3836.3836.3	2.9585	0.373	4647.92	2	1310.0%	1	K.DHVFWSVSGVDADPDLVHVEAQDLGGDFRYVTCAIHNCSEK.M

Q9UIB8

97.6%

345

38782

7.1

(Q9UIB8) Leukocyte differentiation antigen CD84 isoform CD84a

	TK040203_NMyc_nuclei2_step05.4198.4198.2	1.2277	0.0916	2546.34	55	1820.0%	2	K.ITQSLMASVNSTCNVTLTCSVEK.E
	TK040203_NMyc_nuclei2_step04.1727.1727.1	1.2022	0.114	1127.53	10	5000.0%	3	K.RYNLQIYR.R

RL13_MOUSE

97.4%

210

24174

11.5

(P47963) 60S ribosomal protein L13 (A52)

	TK040203_NMyc_nuclei2_step01.1978.1978.1	1.3881	0.0428	758.44	5	8000.0%	1	K.LILFPR.K
*	TK040203_NMyc_nuclei2_step11.1646.1646.1	2.2136	0.1298	1324.67	2	5000.0%	2	R.NGMILKPHFHK.D

ACF7_MOUSE

97.3%

5327

607984

5.5

(Q9QXZ0) Actin cross-linking family protein 7 (Microtubule actin crosslinking factor) (MACF)

*	TK040203_NMyc_nuclei2_step03.1710.1710.2	1.0428	0.0423	1440.31	28	3330.0%	1	R.YADITLTSSKALR.T
*	TK040203_NMyc_nuclei2_step08.0272.0272.1	0.8318	0.0294	1460.48	4	3180.0%	3	R.TWLDEKQSQQAK.N
	TK040203_NMyc_nuclei2_step10.1477.1477.1	1.0613	0.0686	1362.4	131	3750.0%	1	R.GEELIGRSQGADK.D
	TK040203_NMyc_nuclei2_step03.1185.1185.1	0.866	0.1114	1090.67	30	2780.0%	1	R.NDDITDGNPK.L
*	TK040203_NMyc_nuclei2_step01.4575.4575.2	1.3581	0.1348	3144.63	5	1670.0%	1	K.ENLDTLEHLVTTLGSCGFALDLSQHQDK.I
*	TK040203_NMyc_nuclei2_step09.2085.2085.2	1.0118	0.0472	2323.98	6	2370.0%	1	K.EEEELACDWSDSNPNISAKK.T
	TK040203_NMyc_nuclei2_step08.2173.2173.1	0.6574	0.01	1288.88	7	3330.0%	1	K.HINDLYEDLR.D
	TK040203_NMyc_nuclei2_step09.2305.2305.2	1.8437	0.1338	2292.97	9	2630.0%	1	R.SQQYEQAADAELAWVAETKR.K
*	TK040203_NMyc_nuclei2_step09.1634.1634.3	1.8383	0.2096	2801.47	16	1700.0%	1	K.NCDVQGLEHDMDEINTRWNTLNK.K
	TK040203_NMyc_nuclei2_step11.0940.0940.1	0.7357	0.0335	848.59	42	3330.0%	1	K.EQLIQSK.S
*	TK040203_NMyc_nuclei2_step10.1131.1131.2	0.9683	0.0639	1440.16	46	2920.0%	1	R.NPDHVLKSTLSVK.A
	TK040203_NMyc_nuclei2_step05.1510.1510.1	1.6865	0.2987	1403.52	1	5450.0%	1	R.ESIAEHKPHIDK.I
*	TK040203_NMyc_nuclei2_step06.2754.2754.2	2.7349	0.4084	2168.95	1	3680.0%	1	K.GHFSSLELVPPSTLTTTHLK.A
	TK040203_NMyc_nuclei2_step01.2508.2508.3	1.5054	0.1032	3561.29	13	1450.0%	1	R.AEWGNDLPSVELQLETQQHIHTSVEELGSSVK.E

Q99P31

97.3%

357

39167

5.4

(Q99P31) Hsp70 binding protein (RIKEN cDNA 1500019G21 gene)

	TK040203_NMyc_nuclei2_step10.3420.3420.2	2.7246	0.4106	2934.16	1	2800.0%	1	R.TEHSPFHEHVLGALCSLVTDFPQGVR.E

SRC8_MOUSE

97.3%

546

61260

5.4

(Q60598) Src substrate cortactin

	TK040203_NMyc_nuclei2_step08.1495.1495.2	2.9606	0.3647	1685.42	1	5360.0%	1	K.TVQGSGHQEHINIHK.L
*	TK040203_NMyc_nuclei2_step03.1329.1329.2	0.849	0.0504	1501.98	21	3330.0%	1	R.QDSSAVGFDYKER.L
	TK040203_NMyc_nuclei2_step01.1270.1270.1	1.1822	0.071	1073.19	1	5560.0%	1	K.SAVGFDYQGK.T

O88473

97.3%

4836

527380

6.2

(O88473) HERC2 protein

*	TK040203_NMyc_nuclei2_step06.3964.3964.2	1.035	0.0462	1755.11	6	2000.0%	1	K.DGGFWTVIDGKVYGIK.D
*	TK040203_NMyc_nuclei2_step07.2602.2602.3	1.671	0.0085	3940.56	2	1290.0%	2	R.NIHPTAMMLTSVINLLQTLCLSVGVHADIMQSEATK.T
	TK040203_NMyc_nuclei2_step04.4252.4252.1	0.6987	0.028	1413.3	221	2270.0%	1	R.VQWDTGSTNSYR.M
*	TK040203_NMyc_nuclei2_step04.2139.2139.2	1.1871	0.0726	1760.25	13	3210.0%	1	R.RLLTTEFGQSININR.L
*	TK040203_NMyc_nuclei2_step07.3034.3034.2	1.1642	1.0E-4	2877.63	2	2120.0%	1	K.ISGANNCKPNRPSLAKILLSLEGNLAK.Q
	TK040203_NMyc_nuclei2_step07.1461.1461.1	1.3927	0.0773	1069.57	98	3750.0%	1	R.KADLENHNK.D
*	TK040203_NMyc_nuclei2_step12.2085.2085.2	1.2465	0.0167	2500.27	28	1750.0%	1	R.LRFLFNELRPAVCSDLSIMSK.F
	TK040203_NMyc_nuclei2_step01.3036.3036.1	0.8692	0.1136	1021.42	65	3120.0%	1	K.LVEALQGHR.V
	TK040203_NMyc_nuclei2_step02.3611.3611.2	1.423	0.0652	2460.26	7	2140.0%	1	R.LGHSDSEDQLKPKLVEALQGHR.V
*	TK040203_NMyc_nuclei2_step06.3678.3678.3	2.0902	0.1663	4734.65	13	1010.0%	1	R.VCPLNQLKPLPAVAFSVNNLPFTEPMLSVWAELVNLAGSKLEK.H
*	TK040203_NMyc_nuclei2_step12.2686.2686.3	1.5455	0.0368	3866.15	88	1080.0%	2	R.DPLGASYLGVPSDADSSSSSNKISGANNCKPNRPSLAK.I
*	TK040203_NMyc_nuclei2_step05.3071.3071.3	2.139	0.1256	3373.6	2	1720.0%	1	K.QNVQGLYPQSALLNTIVEFALKEEPVDVEK.M
	TK040203_NMyc_nuclei2_step01.1831.1831.1	1.098	0.1155	1187.7	2	5000.0%	1	R.DVDLIPPFNR.M
	TK040203_NMyc_nuclei2_step09.1197.1197.1	0.6504	0.1021	636.58	17	6250.0%	1	R.SLFLR.F
*	TK040203_NMyc_nuclei2_step11.2192.2192.2	1.4683	0.029	2506.96	9	1960.0%	1	R.ARPQASLTATHSSTLAEEVVGLLR.T
	TK040203_NMyc_nuclei2_step11.2482.2482.2	1.4689	0.2115	2475.18	1	2830.0%	1	R.GNYGRLGHGSSEDEAIPMLVAGLK.G
*	TK040203_NMyc_nuclei2_step08.2920.2920.3	1.8251	0.1462	3018.91	80	1390.0%	1	K.LVELPVSSQPSAEDSDTEDDSEAEQGER.N
	TK040203_NMyc_nuclei2_step10.0259.0259.1	0.6512	0.1074	1224.59	73	1670.0%	1	K.DFIPGLMYIR.D
	TK040203_NMyc_nuclei2_step11.3539.3539.3	2.9413	0.3806	2658.28	2	2500.0%	2	R.LGIGGTESVSTPTLLESIQHVFIKK.V

Q8VFD6

97.3%

12.9%

310

34635

7.9

(Q8VFD6) Olfactory receptor MOR275-2

*	TK040203_NMyc_nuclei2_step09.3526.3526.3	2.9464	0.3879	4501.51	5	1350.0%	1	K.ISAAACGMQMFLYLSIGGSEFLLLAAMSYDRYVAICHPLR.Y
*	TK040203_NMyc_nuclei2_step12.2261.2261.3	1.9439	0.0628	3391.05	15	1580.0%	2	K.ISAAACGMQMFLYLSIGGSEFLLLAAMSYDR.Y

HS9A_MOUSE

97.2%

732

84657

5.0

(P07901) Heat shock protein HSP 90-alpha (HSP 86) (Tumor specific transplantation 86 kDa antigen) (TSTA)

	TK040203_NMyc_nuclei2_step01.1939.1939.1	1.9959	0.3143	1350.72	1	4580.0%	1	R.TLTIVDTGIGMTK.A

HS9B_MOUSE

97.2%

723

83194

5.0

(P11499) Heat shock protein HSP 90-beta (HSP 84) (Tumor specific transplantation 84 kDa antigen) (TSTA)

	TK040203_NMyc_nuclei2_step05.3610.3610.2	1.8132	0.2754	2989.79	3	2120.0%	1	K.DLVVLLFETALLSSGFSLEDPQTHSNR.I
	TK040203_NMyc_nuclei2_step05.1948.1948.1	1.0949	0.0381	1240.58	267	2730.0%	1	R.ADHGEPIGRGTK.V
	TK040203_NMyc_nuclei2_step01.1939.1939.1	1.9959	0.3143	1350.72	1	4580.0%	1	R.TLTLVDTGIGMTK.A

Q9HAW4

97.2%

1332

150175

4.8

(Q9HAW4) Hu-Claspin

*	TK040203_NMyc_nuclei2_step08.2032.2032.1	1.6433	0.3089	1425.63	1	4550.0%	1	R.FWKHANPAAKPR.A
*	TK040203_NMyc_nuclei2_step08.4208.4208.3	1.1918	0.0208	2609.72	50	1480.0%	1	K.ESSHNSSFELIGSTIPSYQPCNR.Q
*	TK040203_NMyc_nuclei2_step07.2909.2909.2	1.7324	0.2986	2165.83	16	2220.0%	2	R.LYQERYLADGDLHSDGPGR.M

Q923S6

97.2%

1.9%

574

61778

8.4

(Q923S6) Neuralized 1

	TK040203_NMyc_nuclei2_step07.2022.2022.1	2.1454	0.3104	1235.56	1	6000.0%	1	R.FHALRAGAHVR.I

Q9CQF3

97.2%

227

26240

8.8

(Q9CQF3) 3110048P04Rik protein (RIKEN cDNA 3110048P04 gene)

	TK040203_NMyc_nuclei2_step05.2112.2112.1	1.7634	0.3113	1388.73	1	5000.0%	2	R.TVEGVLIVHEHR.L
	TK040203_NMyc_nuclei2_step10.1641.1641.1	1.1773	0.0257	1137.68	10	4440.0%	1	K.DSSVAARFQR.M

Q9Z103

97.2%

828

92063

6.1

(Q9Z103) Activity-dependent neuroprotective protein

	TK040203_NMyc_nuclei2_step04.1669.1669.1	2.1305	0.3054	1414.8	1	5910.0%	2	R.HQVIQTVHPVEK.K
*	TK040203_NMyc_nuclei2_step03.1898.1898.3	1.5164	0.0453	2818.54	11	1830.0%	1	R.YSLQTANTSLPPGQVKSPSVSQSQASR.V

ACDS_MOUSE

97.1%

412

44947

8.8

(Q07417) Acyl-CoA dehydrogenase, short-chain specific, mitochondrial precursor (EC 1.3.99.2) (SCAD) (Butyryl-CoA dehydrogenase)

*	TK040203_NMyc_nuclei2_step05.2518.2518.2	2.0189	0.3552	2182.79	1	3240.0%	2	R.LHTVYQSVELPETHQMLR.Q
	TK040203_NMyc_nuclei2_step03.2541.2541.2	1.0614	0.022	2210.18	62	1820.0%	1	K.IGCFALSEPGNGSDAGAASTTAR.E
*	TK040203_NMyc_nuclei2_step01.4190.4190.3	1.179	0.0601	3570.25	5	1360.0%	1	K.MGELGLLAMDVPEELSGAGLGYLAYSIALEEISR.A

IDHP_MOUSE

97.1%

14.3%

523

58749

8.7

(P54071) Isocitrate dehydrogenase [NADP], mitochondrial precursor (EC 1.1.1.42) (Oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) (ICD-M)

	TK040203_NMyc_nuclei2_step01.2924.2924.1	2.2906	0.2675	1156.6	2	6250.0%	2	K.DIFQEIFDK.H
*	TK040203_NMyc_nuclei2_step03.1273.1273.1	1.1764	0.0186	890.46	88	5000.0%	1	R.RGVDLGDR.R
	TK040203_NMyc_nuclei2_step01.2663.2663.1	1.7587	0.0557	1245.77	1	5500.0%	1	R.LIDDMVAQVLK.S
*	TK040203_NMyc_nuclei2_step10.2563.2563.3	1.9635	0.2503	4028.3	1	1620.0%	1	R.FLSPEAAAVAAAEVEAAACSDLACSEWPATAGCELLCR.A
	TK040203_NMyc_nuclei2_step01.1887.1887.1	1.1606	0.1703	1094.72	1	6250.0%	1	K.YFDLGLPNR.D

RL19_HUMAN

97.1%

196

23466

11.5

(P14118) 60S ribosomal protein L19 (P14118) 60S ribosomal protein L19

	TK040203_NMyc_nuclei2_step06.1818.1818.1	1.3546	0.0645	1022.51	21	5000.0%	1	R.ILMEHIHK.L
	TK040203_NMyc_nuclei2_step10.2153.2153.1	2.304	0.2904	1193.65	1	7500.0%	1	R.HMYHSLYLK.V

Q8VDM6

97.0%

859

96002

6.6

(Q8VDM6) Similar to E1B-55 kDa-associated protein 5

	TK040203_NMyc_nuclei2_step07.1169.1169.1	0.8959	0.0154	695.44	5	5830.0%	1	K.AGPPPEK.R
	TK040203_NMyc_nuclei2_step01.2975.2975.1	1.8047	0.2124	1355.66	3	5000.0%	2	K.YNILGTNAIMDK.M
*	TK040203_NMyc_nuclei2_step02.2084.2084.2	2.0051	0.3586	2110.64	2	3120.0%	3	R.RPLDMEPQQQVYHPELK.T

FKBX_MOUSE

96.9%

581

64669

5.6

(Q61576) 65 kDa FK506-binding protein precursor (EC 5.2.1.8) (FKBP65) (FKBPRP) (Peptidyl-prolyl cis-trans isomerase) (PPiase) (Rotamase) (Immunophilin FKBP65)

*	TK040203_NMyc_nuclei2_step04.3441.3441.2	2.2815	0.4322	2860.22	1	2600.0%	1	K.IPGSAVLIFDVHVIDFHNPSDPVEIK.T
*	TK040203_NMyc_nuclei2_step06.3378.3378.2	0.6583	0.0132	2183.31	1	2220.0%	1	R.YHYNGTLLDGTGFDNSYSR.G

Q920S3

96.9%

28.2%

266

28505

9.4

(Q920S3) ODAG protein

*	TK040203_NMyc_nuclei2_step11.2682.2682.3	2.807	0.1971	3660.56	3	1280.0%	3	R.GGGGAGVAGGTGGGGGGGGGFGTATFATTSAGPSQSNGGGGGKQSK.Q
	TK040203_NMyc_nuclei2_step01.4216.4216.2	1.0236	0.0478	3180.15	5	1790.0%	1	R.SSPFPTVPTRPEKGYIWTHVGPTPAITIK.E

Q9CXY6

96.8%

17.9%

390

43062

5.3

(Q9CXY6) 6230405A16Rik protein (Interleukin enhancer binding factor 2) (Similar to interleukin enhancer binding factor 2, 45kD)

	TK040203_NMyc_nuclei2_step01.2620.2620.1	1.951	0.3079	1409.84	1	4230.0%	1	K.ILPTLEAVAALGNK.V
	TK040203_NMyc_nuclei2_step02.3204.3204.2	2.0787	0.2676	2966.16	1	2590.0%	1	K.ILGQEGDASYLASEISTWDGVIVTPSEK.A
	TK040203_NMyc_nuclei2_step07.2648.2648.2	1.2434	0.2071	3049.68	65	1480.0%	1	R.RCLQILAAGLFLPGSVGITDPCESGNFR.V

R37A_HUMAN

96.8%

10144

10.4

(P12751) 60S ribosomal protein L37a (P12751) 60S ribosomal protein L37a

	TK040203_NMyc_nuclei2_step03.1515.1515.1	2.1571	0.2956	1055.74	1	7500.0%	3	K.KIEISQHAK.Y

ILK_MOUSE

96.8%

452

51347

8.1

(O55222) Integrin-linked protein kinase (EC 2.7.1.-)

	TK040203_NMyc_nuclei2_step07.1844.1844.1	2.2166	0.2894	1585.72	1	4290.0%	2	R.GDDTPLHLAASHGHR.D
	TK040203_NMyc_nuclei2_step08.1185.1185.2	1.2513	0.2104	1200.65	7	4380.0%	1	R.IPYKDTFWK.G

Q8VHH5

96.8%

910

97965

7.8

(Q8VHH5) MR1-interacting protein

*	TK040203_NMyc_nuclei2_step01.1234.1234.1	1.2426	0.049	1233.47	143	4000.0%	1	K.LEPPPSPHSNR.K
	TK040203_NMyc_nuclei2_step08.3160.3160.2	1.2194	0.0052	2081.89	90	2220.0%	1	R.AVVEDDLRLLVMLLAHGSK.E
	TK040203_NMyc_nuclei2_step12.4238.4238.2	2.5133	0.4262	2966.14	2	2120.0%	2	K.LFLAPLPSSDVPLGQQLLRAVVEDDLR.L

TKT_MOUSE

96.8%

623

67631

7.5

(P40142) Transketolase (EC 2.2.1.1) (TK) (P68)

*	TK040203_NMyc_nuclei2_step06.2675.2675.2	2.5493	0.4074	2644.84	1	3330.0%	1	K.RCEAFGWHTIIVDGHSVEELCK.A
*	TK040203_NMyc_nuclei2_step05.1619.1619.1	1.5447	0.0772	1162.78	1	6110.0%	3	K.EAWHGKPLPK.N
*	TK040203_NMyc_nuclei2_step09.2250.2250.2	1.4012	0.0323	2197.38	9	2500.0%	1	R.LGQSDPAPLQHQVDIYQKR.C

Q9QZF1

96.8%

579

65298

6.6

(Q9QZF1) Glypican-3

*	TK040203_NMyc_nuclei2_step11.3223.3223.3	1.6669	0.0048	3891.1	21	1250.0%	1	K.DNEITTSHSVGNMPSPLKILISVAIYVACLFFLVH.-
	TK040203_NMyc_nuclei2_step06.3667.3667.2	2.5306	0.4078	2024.64	1	3530.0%	2	K.WVPETPVPGSDLQVCLPK.G

CD14_MOUSE

96.7%

366

39204

5.2

(P10810) Monocyte differentiation antigen CD14 precursor (Myeloid cell-specific leucine-rich glycoprotein)

*	TK040203_NMyc_nuclei2_step05.2196.2196.3	2.8406	0.4244	2905.79	1	2130.0%	2	K.FPTLQVLALRNAGMETPSGVCSALAAAR.V
*	TK040203_NMyc_nuclei2_step08.0212.0212.1	0.7047	0.107	1070.69	35	1670.0%	1	R.GLISALCPLK.F

Q91WK2

96.6%

352

39832

6.7

(Q91WK2) Similar to eukaryotic translation initiation factor 3, subunit 3 (Gamma, 40kD)

	TK040203_NMyc_nuclei2_step05.3310.3310.2	2.6284	0.3937	2656.04	1	3260.0%	2	K.HYQEEGQGTEVVQGVLLGLVVEDR.L
*	TK040203_NMyc_nuclei2_step11.1182.1182.1	1.6923	0.1381	1165.32	19	4440.0%	1	K.LFKPHQAPAR.M

Q9DCC6

96.5%

291

32884

8.8

(Q9DCC6) 2010012D11Rik protein

	TK040203_NMyc_nuclei2_step02.2999.2999.2	1.1314	0.0975	1585.58	386	2500.0%	1	K.TCEDWVDGISQFK.H
	TK040203_NMyc_nuclei2_step07.2658.2658.1	2.2608	0.2701	1354.61	1	7000.0%	1	R.FHADFLLQHVK.G
	TK040203_NMyc_nuclei2_step11.1176.1176.1	1.3229	0.1133	789.36	6	7000.0%	1	K.HNLHLR.F

ZF94_MOUSE

96.5%

520

59155

7.7

(Q9Z1D9) Zinc finger protein 94 (Zfp-94)

	TK040203_NMyc_nuclei2_step07.3117.3117.2	2.9622	0.3258	2308.63	1	4440.0%	3	R.YQEVAGPEEALSRLWELCR.R
	TK040203_NMyc_nuclei2_step07.3696.3696.3	2.0701	0.0745	4167.84	5	1250.0%	1	K.NNESENSGSSVLGQHIQTAEGLGTNSQCGDDHKQGFHVK.C

SUCA_MOUSE

96.5%

333

34994

9.4

(Q9WUM5) Succinyl-CoA ligase [GDP-forming] alpha-chain, mitochondrial precursor (EC 6.2.1.4) (Succinyl-CoA synthetase, alpha chain) (SCS-alpha)

	TK040203_NMyc_nuclei2_step11.4018.4018.2	1.1855	0.0829	1727.12	274	2000.0%	1	R.LIGPNCPGVINPGECK.I
*	TK040203_NMyc_nuclei2_step04.2811.2811.2	2.9726	0.3361	1682.41	1	5620.0%	1	K.AKPVVSFIAGITAPPGR.R

O75218

96.4%

1684

190925

8.6

(O75218) WUGSC:H_DJ1186C01.1 protein (Fragment)

	TK040203_NMyc_nuclei2_step05.2210.2210.3	1.6338	0.1066	2367.83	6	2500.0%	1	R.LMTFAWPCLLSKACVDPACK.Y
	TK040203_NMyc_nuclei2_step11.1302.1302.1	1.9618	0.2932	1347.58	1	5000.0%	1	K.SFHHVTHDLVR.E
	TK040203_NMyc_nuclei2_step04.2634.2634.2	1.2288	0.0018	1778.79	49	2810.0%	1	R.AIVRQAMAILTPAVPAR.M

Q9CVL7

96.3%

282

32145

9.5

(Q9CVL7) 1810019E15Rik protein (Fragment)

	TK040203_NMyc_nuclei2_step04.1346.1346.1	1.3914	0.1163	885.62	2	6670.0%	1	K.KKPDELR.N
	TK040203_NMyc_nuclei2_step01.2015.2015.1	1.6397	0.3042	1356.73	1	5000.0%	1	K.NVGQFSGFPFEK.G

FA8_MOUSE

96.3%

2319

266147

7.3

(Q06194) Coagulation factor VIII precursor (Procoagulant component)

*	TK040203_NMyc_nuclei2_step12.2571.2571.3	1.2664	0.0791	4441.79	21	1110.0%	1	K.NNNEEMEDYDDDLYSEMDMFTLDYDSSPFIQIRSVAK.K
*	TK040203_NMyc_nuclei2_step06.3366.3366.3	1.867	0.0192	3888.07	129	1060.0%	1	K.DQLFNIAKPRPPWMGLLGPTIWTEVHDTVVITLK.N
*	TK040203_NMyc_nuclei2_step09.1462.1462.1	1.6929	0.2941	1158.36	5	5000.0%	1	K.RFHGIALLTK.D
*	TK040203_NMyc_nuclei2_step06.3337.3337.3	1.6237	0.2362	4594.45	3	1250.0%	1	K.HKMVYEDTLTLFPFSGETVFMSMENPGLWVLGCHNSDFR.K

Q925M9

96.3%

1051

121647

8.1

(Q925M9) DNA-dependent ATPase SNF2H

*	TK040203_NMyc_nuclei2_step08.2275.2275.3	1.6376	0.016	3032.43	27	1640.0%	1	-.MSSAVEPPPPPPPESAPSKPSAAGAGGSSSGNK.G
	TK040203_NMyc_nuclei2_step10.3071.3071.2	1.3062	0.1756	3066.42	100	1400.0%	1	K.MGESSLRNFTMDTESSVYNFEGEDYR.E
	TK040203_NMyc_nuclei2_step08.1528.1528.1	1.7351	0.2989	1055.55	1	5560.0%	2	R.HGATHVFASK.E

Q9Z1X5

96.3%

1.7%

701

78642

6.0

(Q9Z1X5) GLUT4 vesicle protein (Fragment)

	TK040203_NMyc_nuclei2_step07.1917.1917.1	1.6682	0.3044	1406.72	1	5450.0%	1	R.KPHAESLELQVR.G

Q9CQR6

96.3%

305

35159

5.7

(Q9CQR6) 2310003C10Rik protein (Similar to protein phosphatase 6, catalytic subunit)

	TK040203_NMyc_nuclei2_step06.1487.1487.1	1.7645	0.3017	1181.5	1	6110.0%	1	R.AHQLVHEGYK.F

Z277_HUMAN

96.3%

438

51615

5.2

(Q9NRM2) Zinc finger protein 277

	TK040203_NMyc_nuclei2_step02.1656.1656.1	1.3918	0.0055	910.85	6	6670.0%	2	K.HMIIEHK.I
	TK040203_NMyc_nuclei2_step04.2054.2054.1	1.673	0.2015	1264.69	3	5000.0%	3	K.LLKHMIIEHK.I

Q91XF0

96.3%

261

30114

8.2

(Q91XF0) Similar to pyridoxine 5'-phosphate oxidase (Expressed sequence AI415282)

*	TK040203_NMyc_nuclei2_step01.0969.0969.1	2.2194	0.2726	1377.59	2	5000.0%	1	K.EAENYFHSRPK.S

GB11_MOUSE

96.2%

359

42024

6.0

(P21278) Guanine nucleotide-binding protein, alpha-11 subunit

*	TK040203_NMyc_nuclei2_step06.2951.2951.2	2.6785	0.3805	2172.05	1	4410.0%	1	K.ILHSHLVDYFPEFDGPQR.D

Q96PZ5

96.2%

476

52585

9.0

(Q96PZ5) Hypothetical protein KIAA1892 (Fragment)

*	TK040203_NMyc_nuclei2_step07.3088.3088.3	2.3717	0.2367	3890.59	1	1760.0%	3	K.DWIFSIAWISDTMAVSGSRDGSMGLWEVTDDVLTK.S

LSM8_HUMAN

96.2%

62.1%

10271

4.5

(O95777) U6 snRNA-associated Sm-like protein LSm8

*	TK040203_NMyc_nuclei2_step02.2952.2952.2	2.9985	0.229	2517.03	1	3910.0%	2	R.GDNVAVIGEIDEETDSALDLGNIR.A
*	TK040203_NMyc_nuclei2_step02.3259.3259.3	2.5216	0.2367	3953.01	5	1620.0%	1	K.GFDQTINLILDESHERVFSSSQGVEQVVLGLYIVR.G

NCB1_MOUSE

96.1%

459

53409

5.1

(Q02819) Nucleobindin 1 precursor (CALNUC)

	TK040203_NMyc_nuclei2_step03.3553.3553.2	2.6524	0.3914	2896.91	1	3120.0%	1	K.TFFILHDINSDGVLDEQELEALFTK.E
	TK040203_NMyc_nuclei2_step05.2208.2208.1	1.1003	0.1048	1380.67	16	3500.0%	1	R.RYLESLGEEQR.K

P2Y6_HUMAN

96.0%

328

36429

9.5

(Q15077) P2Y purinoceptor 6 (P2Y6)

*	TK040203_NMyc_nuclei2_step11.3435.3435.3	3.2368	0.0561	3448.16	2	1920.0%	1	R.RAAWLVCVAVWLAVTTQCLPTAIFAATGIQR.N
*	TK040203_NMyc_nuclei2_step02.0256.0256.1	0.5496	0.0131	1432.7	91	1360.0%	1	R.RPHELLQKLTAK.W

ARH6_HUMAN

95.9%

776

87499

6.0

(Q15052) Rho guanine nucleotide exchange factor 6 (PAK-interacting exchange factor alpha) (Alpha-Pix) (COOL-2)

*	TK040203_NMyc_nuclei2_step06.1758.1758.1	1.6185	0.2927	1249.61	3	5000.0%	1	R.KPSEEEYVIR.K
*	TK040203_NMyc_nuclei2_step11.1327.1327.1	1.0112	0.1319	1357.54	167	2730.0%	1	K.LINRLMPGSVEK.F
*	TK040203_NMyc_nuclei2_step01.1074.1074.1	1.4473	0.0367	888.43	62	5000.0%	1	R.ELKQENK.R
*	TK040203_NMyc_nuclei2_step09.1559.1559.1	1.3041	0.1127	1520.48	139	2920.0%	1	K.ATEDQLSERPCGR.S
*	TK040203_NMyc_nuclei2_step01.0916.0916.1	1.2565	0.1025	1002.39	154	5000.0%	1	K.SSERPLSPK.A

VGR3_HUMAN

95.9%

1298

145598

6.3

(P35916) Vascular endothelial growth factor receptor 3 precursor (EC 2.7.1.112) (VEGFR-3) (Tyrosine-protein kinase receptor FLT4)

*	TK040203_NMyc_nuclei2_step06.2699.2699.3	1.6578	0.0779	3789.15	1	1670.0%	1	R.LTQNLTDLLVNVSDSLEMQCLVAGAHAPSIVWYK.D
*	TK040203_NMyc_nuclei2_step06.2202.2202.2	1.3853	0.0192	2079.95	64	1880.0%	1	R.VAPEHEGHYVCEVQDRR.S
*	TK040203_NMyc_nuclei2_step01.0949.0949.3	1.5955	0.0455	2164.99	13	2380.0%	1	K.VVEASAFGIHKGSSCDTVAVK.M
*	TK040203_NMyc_nuclei2_step05.2670.2670.3	1.506	0.0761	3837.31	1	1450.0%	1	R.DCEGTDARPYCKVLLLHEVHANDTGSYVCYYK.Y
*	TK040203_NMyc_nuclei2_step11.0935.0935.2	0.8118	5.0E-4	1449.84	2	3330.0%	1	K.LVIQNANVSAMYK.C
*	TK040203_NMyc_nuclei2_step05.3492.3492.3	3.1875	0.0974	3110.13	9	1920.0%	1	R.DWRAVTTQDAVNPIESLDTWTEFVEGK.N

BAC1_MOUSE

95.9%

739

81374

5.0

(P97302) Transcription regulator protein BACH1 (BTB and CNC homolog 1)

*	TK040203_NMyc_nuclei2_step02.1469.1469.2	2.17	0.1537	1574.1	6	4170.0%	7	K.FLDSTSEQQECAR.K
*	TK040203_NMyc_nuclei2_step10.2232.2232.3	1.7795	0.2183	4091.56	53	1110.0%	2	R.DVHTASVQPNETSELECFGGAQGCADLHVILKCEGMK.A
*	TK040203_NMyc_nuclei2_step06.2195.2195.3	1.9299	0.0739	3374.54	28	1540.0%	1	K.DNVDEVCRCVEFLSVHNIEESCFQFLK.F

O35114

95.9%

478

54044

5.1

(O35114) CD36 antigen (Collagen type I receptor, thrombospondin receptor)-like 2 (MLGP85/LIMP II)

*	TK040203_NMyc_nuclei2_step01.0483.0483.1	1.3975	0.0374	804.41	130	6670.0%	1	K.ETANQLK.S
*	TK040203_NMyc_nuclei2_step09.3257.3257.2	2.7536	0.3659	2746.8	1	3040.0%	1	K.GMHPNKEEHESFVDINPLTGIILR.G

DGK_MOUSE

95.8%

277

32223

8.1

(Q9QX60) Deoxyguanosine kinase, mitochondrial precursor (EC 2.7.1.113) (dGK)

*	TK040203_NMyc_nuclei2_step08.3636.3636.2	2.3391	0.4156	2953.04	1	2200.0%	1	K.LHFEALQHVPVLVLDVTEDFSENAAR.Q

Q9JJF4

95.8%

22.9%

393

42872

4.7

(Q9JJF4) Brain cDNA, clone MNCb-5873, similar to AF151022 HSPC188 (Homo sapiens)

*	TK040203_NMyc_nuclei2_step12.0798.0798.2	0.9084	0.0293	2610.21	7	2080.0%	1	R.GLLEQEAGADTEAVELLPFLVLGAR.A
*	TK040203_NMyc_nuclei2_step04.2393.2393.1	2.0936	0.2673	1431.68	1	5000.0%	2	K.QVRDQGAYLILR.E
*	TK040203_NMyc_nuclei2_step07.2433.2433.3	1.8029	0.1321	4506.06	24	940.0%	1	R.LVNALCTPSYNAAAPLHCLGPLLSNLSQQAEVRAFLLDPDR.C
*	TK040203_NMyc_nuclei2_step05.3550.3550.3	2.3576	0.139	3701.5	54	1320.0%	1	R.GPGVGSGFSGERGLLEQEAGADTEAVELLPFLVLGAR.A

HRA4_HUMAN

95.7%

476

50979

8.0

(P83105) Probable serine protease HTRA4 precursor (EC 3.4.21.-)

*	TK040203_NMyc_nuclei2_step03.2925.2925.2	2.4678	0.2978	2282.32	1	3500.0%	4	R.DHDVIVNINGKPITTTTDVVK.A

Q8VHA6

95.7%

29.3%

467

50700

6.0

(Q8VHA6) SOCS box protein ASB-18

*	TK040203_NMyc_nuclei2_step10.2319.2319.3	1.5279	0.02	3203.74	34	1760.0%	1	K.ESVHLVPQLPLPETLQNYLLLEPEGVLC.-
*	TK040203_NMyc_nuclei2_step02.3912.3912.3	1.5578	0.0927	4372.07	2	1280.0%	1	R.GALHEACLGNHTACARLLLQHGADPDLLNSEGLAPLHLCR.T
*	TK040203_NMyc_nuclei2_step02.2495.2495.2	1.0957	0.0526	2559.95	4	2380.0%	1	K.LICTEVEPVDAVIELANDDWMK.E
*	TK040203_NMyc_nuclei2_step05.3268.3268.2	1.601	0.0093	2259.71	1	2630.0%	1	R.SPLHKACGHARPGLCTLLLR.H
*	TK040203_NMyc_nuclei2_step01.4502.4502.2	1.8875	0.0371	2854.07	2	2500.0%	2	R.ELLEHGATVQLEGGPGRDTPLHVAAQR.G

ELV1_MOUSE

95.7%

326

36069

9.2

(P70372) ELAV-like protein 1 (Hu-antigen R) (HuR) (Elav-like generic protein) (MelG)

	TK040203_NMyc_nuclei2_step01.2060.2060.1	1.7512	0.2904	1354.72	1	5420.0%	1	R.SLFSSIGEVESAK.L

ITA3_MOUSE

95.7%

257

1053

116745

6.6

(Q62470) Integrin alpha-3 precursor (Galactoprotein B3) (GAPB3) (VLA-3 alpha chain) (CD49c)

	TK040203_NMyc_nuclei2_step08.3556.3556.1	2.2559	0.2485	1432.76	3	4170.0%	16	R.TGAVYLCPLTAHK.D
*	TK040203_NMyc_nuclei2_step12.2558.2558.2	1.5169	0.2221	2253.49	1	3160.0%	1	R.HQHMGAVFLLKQESGGDLQR.K

Q9BTV9

95.6%

317

34849

7.4

(Q9BTV9) Hypothetical protein

*	TK040203_NMyc_nuclei2_step05.2295.2295.1	2.0506	0.2713	1456.61	1	5910.0%	1	R.GHTDYIHCLALR.E
*	TK040203_NMyc_nuclei2_step12.2059.2059.2	1.2647	0.0502	1834.17	18	3330.0%	1	R.VDVFTNLGYRAFSLSF.-

Z147_MOUSE

95.3%

634

71772

8.3

(Q61510) Zinc finger protein 147 (Tripartite motif protein 25) (Estrogen responsive finger protein) (Efp)

*	TK040203_NMyc_nuclei2_step11.1992.1992.3	1.7869	0.0459	3981.57	63	1410.0%	1	K.TCLVCMASFCQEHLRPHFDSPAFQDHPLQSPIR.D
*	TK040203_NMyc_nuclei2_step11.1720.1720.2	1.3275	0.0602	2024.45	46	2330.0%	1	R.LGRNPNSWCVEWFNNK.I
*	TK040203_NMyc_nuclei2_step07.1569.1569.1	2.0535	0.2607	1532.69	1	3930.0%	1	K.TPVAPGPPSHFSPNK.L
*	TK040203_NMyc_nuclei2_step07.1268.1268.1	1.1839	0.1849	1086.45	27	5000.0%	1	K.CTQHNRLR.E

MEPB_HUMAN

95.2%

700

79459

5.8

(Q16820) Meprin A beta-subunit precursor (EC 3.4.24.18) (Endopeptidase-2) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase beta subunit) (PABA peptide hydrolase) (PPH beta)

*	TK040203_NMyc_nuclei2_step05.3092.3092.3	1.646	0.0331	3874.02	17	1320.0%	2	K.GDDVYILLTVEDISHLNSTQIQLTPAPSVQDLCSK.T
*	TK040203_NMyc_nuclei2_step01.1932.1932.1	1.5691	0.2974	1080.46	1	6250.0%	1	R.NSIIGEKYR.W
*	TK040203_NMyc_nuclei2_step12.2319.2319.3	1.9455	0.0043	3156.86	8	1700.0%	1	R.DTIVIAVSSTVAVFALMLIITLVSVYCTR.K

CLK3_MOUSE

95.1%

490

58513

9.5

(O35492) Protein kinase CLK3 (EC 2.7.1.-) (CDC-like kinase 3)

	TK040203_NMyc_nuclei2_step10.3305.3305.3	3.0854	0.3174	3902.65	1	1850.0%	1	R.FLHENQLTHTDLKPENILFVNSEFETLYNEHK.S
	TK040203_NMyc_nuclei2_step05.1172.1172.1	0.6848	0.0748	473.28	1	6670.0%	1	R.NPSR.-
	TK040203_NMyc_nuclei2_step07.1180.1180.1	0.8027	3.0E-4	1098.43	2	3750.0%	1	K.VVECLDHAR.G

SHX2_HUMAN

95.1%

331

34964

8.6

(O60902) Short stature homeobox protein 2 (Paired-related homeobox protein SHOT) (Homeobox protein Og12X)

*	TK040203_NMyc_nuclei2_step06.2073.2073.1	1.1572	0.0322	1334.55	43	3330.0%	1	R.GAKEPTGCTEAGR.D
*	TK040203_NMyc_nuclei2_step12.1690.1690.2	2.2213	0.4121	2755.6	1	1790.0%	1	R.SSPAVRAAGGGGGGGGGGGGGGGGGGVGGGGAGGGAGGGR.S

THIM_HUMAN

95.0%

397

42039

8.3

(P42765) 3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Beta-ketothiolase) (Acetyl-CoA acyltransferase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)

*	TK040203_NMyc_nuclei2_step07.1942.1942.1	1.9518	0.2869	1192.14	2	5000.0%	2	R.ITAHLVHELR.R
*	TK040203_NMyc_nuclei2_step08.3467.3467.2	1.4337	0.0065	3009.24	4	2070.0%	1	K.TNVNGGAIALGHPLGGSGSRITAHLVHELR.R
*	TK040203_NMyc_nuclei2_step11.2818.2818.3	1.8535	0.0247	3062.82	4	1700.0%	1	K.QTMQVDEHARPQTTLEQLQKLPPVFK.K
*	TK040203_NMyc_nuclei2_step01.1955.1955.1	1.5105	0.1764	1124.56	3	5000.0%	1	R.TPFGAYGGLLK.D
*	TK040203_NMyc_nuclei2_step04.1415.1415.1	1.084	0.0175	581.38	61	5000.0%	2	R.HVGLR.V

Q8VH51

95.0%

530

59494

10.1

(Q8VH51) Transcription coactivator CAPER

	TK040203_NMyc_nuclei2_step01.2083.2083.1	1.9483	0.2767	1552.51	1	4640.0%	1	R.VLGVPIIVQASQAEK.N

DHAM_MOUSE

95.0%

519

56538

7.6

(P47738) Aldehyde dehydrogenase, mitochondrial precursor (EC 1.2.1.3) (ALDH class 2) (AHD-M1) (ALDHI) (ALDH-E2)

*	TK040203_NMyc_nuclei2_step03.2606.2606.2	1.5024	0.1758	1773.07	121	2690.0%	1	R.TFVQENVYDEFVER.S
*	TK040203_NMyc_nuclei2_step02.3115.3115.3	2.1377	0.0717	4133.85	7	1250.0%	1	R.LLSAAATSAVPAPNHQPEVFCNQIFINNEWHDAVSRK.T
*	TK040203_NMyc_nuclei2_step01.2371.2371.1	1.4916	0.1459	1472.67	7	3750.0%	2	R.GYFIQPTVFGDVK.D

Q8QZT7

94.9%

16.3%

541

59617

5.5

(Q8QZT7) Similar to Ca+/calmodulin-dependent protein kinase kinase beta (CaM-kinase kinase beta)

*	TK040203_NMyc_nuclei2_step07.0620.0620.3	0.9541	0.029	2617.88	165	1520.0%	1	R.GLSSLSIHLGMESFIVVTECEPGR.G
	TK040203_NMyc_nuclei2_step02.0426.0426.1	0.9513	0.1761	1095.41	10	3330.0%	1	R.SFGNPFEGSR.R
	TK040203_NMyc_nuclei2_step08.3105.3105.3	1.7078	0.0496	4584.7	113	830.0%	1	K.LVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR.F
*	TK040203_NMyc_nuclei2_step06.1477.1477.1	1.6399	0.2671	1330.65	2	4230.0%	1	R.VAPQDELGSGGGSR.E

Q9DCE5

94.9%

414

45813

8.4

(Q9DCE5) 5930415H02Rik protein (P21-activated protein kinase-interacting protein 1)

*	TK040203_NMyc_nuclei2_step08.2247.2247.1	1.7784	0.2803	1381.29	1	5420.0%	2	R.GHVTFLSIHPSGK.L
*	TK040203_NMyc_nuclei2_step11.3946.3946.3	1.5373	0.0512	3556.99	63	1420.0%	1	K.DMVSFEVPDHHVLVTASNDGFIKMWTLPQDK.K
*	TK040203_NMyc_nuclei2_step01.0572.0572.1	1.4814	0.0566	926.48	3	6430.0%	1	R.KMATMSEK.K
*	TK040203_NMyc_nuclei2_step07.3085.3085.2	1.4256	0.044	2267.03	13	2380.0%	2	R.GHVTFLSIHPSGKLALSVGTDK.T

RS23_HUMAN

94.9%

22.4%

143

15808

10.5

(P39028) 40S ribosomal protein S23 (P39028) 40S ribosomal protein S23

	TK040203_NMyc_nuclei2_step08.1713.1713.1	1.8709	0.1389	1205.69	1	5000.0%	1	R.KGHAVGDIPGVR.F
	TK040203_NMyc_nuclei2_step04.1554.1554.1	1.4681	0.2368	810.43	1	5710.0%	1	K.AHLGTALK.A
	TK040203_NMyc_nuclei2_step02.1505.1505.1	1.6488	0.23	1057.42	24	4000.0%	2	K.ANPFGGASHAK.G
	TK040203_NMyc_nuclei2_step10.1656.1656.1	1.5833	0.088	941.68	1	6250.0%	3	K.KAHLGTALK.A

Q9H059

94.9%

942

99042

9.3

(Q9H059) Hypothetical protein

	TK040203_NMyc_nuclei2_step11.3740.3740.2	1.2835	0.0686	2674.13	52	1600.0%	1	K.NAFPLGAPTLVTSQATTLSTFQPANK.L
	TK040203_NMyc_nuclei2_step01.1907.1907.1	1.7177	0.2798	1445.47	1	5450.0%	1	K.YPSLLLHSQEEK.T
*	TK040203_NMyc_nuclei2_step12.3369.3369.3	2.7895	0.1247	3333.88	3	1880.0%	1	K.VIQNSTECTDAQQIWPGTWAPHIGNMHLK.Y

RS16_MOUSE

94.9%

144

16225

10.2

(P14131) 40S ribosomal protein S16

	TK040203_NMyc_nuclei2_step01.2687.2687.1	1.7029	0.2809	1095.97	1	6110.0%	1	K.LLEPVLLLGK.E

ECEL_HUMAN

94.9%

775

87781

7.1

(O95672) Endothelin-converting enzyme-like 1 (EC 3.4.24.-) (Xce protein)

*	TK040203_NMyc_nuclei2_step09.3817.3817.3	1.1496	0.0097	2574.81	150	1310.0%	1	K.LQYMMVMVGYPDFLLKPDAVDK.E
*	TK040203_NMyc_nuclei2_step08.1665.1665.1	1.8539	0.2719	1535.48	1	4000.0%	1	R.RLLARPGGGPGGAAQR.K

Q9JJY5

94.9%

2062

237465

6.3

(Q9JJY5) Myosin X

*	TK040203_NMyc_nuclei2_step07.2049.2049.1	1.7662	0.2835	1424.72	4	4170.0%	1	R.YSVGTYNSSGAYR.F
*	TK040203_NMyc_nuclei2_step04.2166.2166.3	1.0712	0.0395	3458.04	110	1250.0%	1	K.VPHPGSVGNLYSWQILTCLSCTFLPSLGILK.Y
*	TK040203_NMyc_nuclei2_step07.1821.1821.3	1.3659	0.0271	3080.61	21	1730.0%	1	K.DSLHSLMATLSSSNPFFVRCIKPNTQK.M
*	TK040203_NMyc_nuclei2_step05.1431.1431.2	1.2464	0.0355	1711.86	2	3460.0%	1	-.MDSFFPEGARVWLR.E
*	TK040203_NMyc_nuclei2_step09.3711.3711.3	1.9172	0.2042	4298.67	1	1390.0%	1	R.LLALINEESHFPQATDSTLLEKLHSQHANNHFYVKPR.V
*	TK040203_NMyc_nuclei2_step05.2483.2483.3	1.5551	0.0396	3866.95	92	1060.0%	1	K.VPHPGSVGNLYSWQILTCLSCTFLPSLGILKYLK.F

Q9CSK8

94.9%

265

30109

5.4

(Q9CSK8) 1810019E15Rik protein (Fragment)

	TK040203_NMyc_nuclei2_step04.2575.2575.1	1.7256	0.2767	891.59	1	7500.0%	1	R.IHFFLSK.K

O60466

94.9%

860

97177

6.6

(O60466) TGF beta receptor associated protein-1

*	TK040203_NMyc_nuclei2_step04.1426.1426.1	0.9385	0.0344	1092.62	71	3330.0%	1	K.AFTLVSAVER.E
*	TK040203_NMyc_nuclei2_step07.1845.1845.1	1.8845	0.275	1217.64	1	5500.0%	1	R.RTMQVALGLAR.S
*	TK040203_NMyc_nuclei2_step08.3541.3541.3	1.8045	0.07	3998.1	3	1400.0%	1	K.KYFALGLLYHYNNQDAAAVQLWVNIVNGDVQDSTR.S

Q9D6R2

94.9%

366

39639

6.7

(Q9D6R2) 1500012E04Rik protein

	TK040203_NMyc_nuclei2_step02.4156.4156.3	1.783	0.0432	2957.29	40	1730.0%	1	K.DMANPTALLLSAVMMLRHMGLFDHAAK.I
	TK040203_NMyc_nuclei2_step06.2215.2215.2	1.2209	0.1903	1423.76	49	3330.0%	1	K.IEAACFATIKDGK.S
	TK040203_NMyc_nuclei2_step06.2085.2085.1	1.6836	0.2787	1126.56	1	5560.0%	1	R.HMGLFDHAAK.I

Z229_HUMAN

94.9%

420

48023

6.8

(Q9UJW7) Zinc finger protein 229 (Fragment)

*	TK040203_NMyc_nuclei2_step07.1198.1198.2	1.1661	0.0514	2440.14	11	2110.0%	1	R.QLYQDVMQENFRNLLSVGER.N
	TK040203_NMyc_nuclei2_step05.2232.2232.1	1.0096	0.0417	1097.55	6	4380.0%	2	R.CDVCGKGFR.Y

MCM3_MOUSE

94.9%

812

91546

5.6

(P25206) DNA replication licensing factor MCM3 (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3)

	TK040203_NMyc_nuclei2_step04.1869.1869.1	1.206	0.0961	1424.45	1	4170.0%	2	R.SLAPSIHGHDYVK.K
*	TK040203_NMyc_nuclei2_step05.2347.2347.2	1.2101	0.0734	2348.13	3	2750.0%	1	K.AILCLLLGGVERELENGSHIR.G
	TK040203_NMyc_nuclei2_step09.3551.3551.2	1.2599	0.0287	2000.78	59	2500.0%	1	K.DEENNPLETEYGLSVYK.D
	TK040203_NMyc_nuclei2_step09.1990.1990.1	1.3122	0.0407	1302.38	12	4550.0%	1	K.DFVASIDATYAK.Q

Q8TD54

94.9%

116

13138

7.5

(Q8TD54) Protein phosphatase 1 regulatory subunit 1A

	TK040203_NMyc_nuclei2_step10.3060.3060.2	2.4429	0.3969	2359.24	2	3250.0%	4	R.RPTPASLVILNEHNPPEIDDK.R

Q61167

94.7%

12.0%

225

25678

5.7

(Q61167) APC-binding protein EB2 (Fragment)

*	TK040203_NMyc_nuclei2_step06.2467.2467.3	2.8435	0.3774	2945.44	1	2020.0%	1	K.NPPSARNGGHEADAQILELNQQLLDLK.L

Q9CRV0

94.7%

218

24271

9.2

(Q9CRV0) 3110033D18Rik protein (Fragment)

	TK040203_NMyc_nuclei2_step05.2474.2474.2	2.5531	0.3803	2462.18	1	2620.0%	1	R.IKKPDYVTTGIVPDWGDSIEVK.D

O35405

94.6%

488

54389

6.5

(O35405) Schwannoma-associated protein

*	TK040203_NMyc_nuclei2_step02.2768.2768.3	1.4925	0.0090	3433.85	3	1640.0%	1	R.ASYIGTSNWSGSYFTETAGTSLLVTQNGHGGLR.S
	TK040203_NMyc_nuclei2_step08.1541.1541.1	2.0338	0.2519	1005.62	2	6250.0%	1	K.LTHGVLHTK.F

HMG2_MOUSE

94.4%

209

24031

7.3

(P30681) High mobility group protein 2 (HMG-2)

*	TK040203_NMyc_nuclei2_step04.2079.2079.1	1.3226	0.0091	1578.75	2	3930.0%	2	K.IKIEHPGLSIGDTAK.K

A2A1_MOUSE

94.4%

12.0%

977

107664

7.0

(P17426) Adapter-related protein complex 2 alpha 1 subunit (Alpha-adaptin A) (Adaptor protein complex AP-2 alpha-1 subunit) (Clathrin assembly protein complex 2 alpha-A large chain) (100 kDa coated vesicle protein A) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit)

	TK040203_NMyc_nuclei2_step05.3576.3576.2	1.4795	0.2048	2778.76	1	1880.0%	1	R.VVHLLNDQHMGVVTAAVSLITCLCK.K
	TK040203_NMyc_nuclei2_step12.1181.1181.2	1.1687	0.0641	1894.03	343	2500.0%	1	R.VLQIVTNRDDVQGYAAK.T
*	TK040203_NMyc_nuclei2_step12.2429.2429.2	1.3763	0.0742	2278.64	5	2630.0%	1	K.NSGVLFENQLLQIGVKSEFR.Q
	TK040203_NMyc_nuclei2_step10.3661.3661.2	2.3149	0.3976	2669.5	1	2730.0%	1	K.NAILFETISLIIHYDSEPNLLVR.A
*	TK040203_NMyc_nuclei2_step02.3238.3238.3	2.2058	0.1797	3243.71	7	1610.0%	1	R.RDTSSNDINGGVEPTPSTVSTPSPSADLLGLR.A

P97412

94.4%

3788

425289

6.6

(P97412) Lysosomal trafficking regulator (CHS1 homolog)

*	TK040203_NMyc_nuclei2_step08.3784.3784.2	1.5985	0.1219	2910.95	9	2080.0%	1	R.SMNNTNIQWSAILSWGYADNILRLK.S
*	TK040203_NMyc_nuclei2_step06.1507.1507.2	1.3297	0.016	2237.76	74	1820.0%	1	R.SQSTVASLGLAFPSQNGSAVASR.W
*	TK040203_NMyc_nuclei2_step08.1343.1343.3	1.7916	0.1399	2289.51	26	2250.0%	2	R.TVLHLMSVDVSTAEAMPESLR.K
*	TK040203_NMyc_nuclei2_step08.1548.1548.2	0.9857	0.0175	2216.02	26	2000.0%	1	K.AIQGILHEIGGAGTFVFLFAR.V
	TK040203_NMyc_nuclei2_step10.2448.2448.1	1.397	0.0984	1032.56	10	3890.0%	1	R.ETAGELLLGK.C
*	TK040203_NMyc_nuclei2_step11.1844.1844.2	1.234	0.0234	1692.8	78	2860.0%	1	K.EVTHPSPLSWIKGLK.W
*	TK040203_NMyc_nuclei2_step06.3370.3370.2	1.5786	0.0401	2583.59	15	1740.0%	5	R.IIQADILLVLVNHPSPAIQQGVIK.L
*	TK040203_NMyc_nuclei2_step03.3301.3301.2	1.5327	0.0582	2025.38	24	2330.0%	1	R.TCSEDLTLLWRIFLEK.S
*	TK040203_NMyc_nuclei2_step10.1625.1625.3	1.1783	0.1153	4108.1	71	1000.0%	1	K.SKQSEPPINFIQSSQQHQVTSCAWVPDSCQLFTGSK.C
	TK040203_NMyc_nuclei2_step02.4038.4038.3	1.5164	0.163	2549.16	48	2000.0%	1	R.MPPFTKMFLAYQDQSFDIPDR.T
*	TK040203_NMyc_nuclei2_step12.2458.2458.3	2.2335	0.1559	3696.99	13	1500.0%	1	K.QLLNAHVVHHFLLTCQVLQEHREGQLTSMPR.E
*	TK040203_NMyc_nuclei2_step04.3281.3281.3	1.5085	0.0656	3824.77	23	1410.0%	1	K.AVSLAQVESQENIFFPSKWQHLVLTYIQHPQGK.K
*	TK040203_NMyc_nuclei2_step08.2528.2528.3	1.8889	0.0123	4135.6	6	1180.0%	1	K.DAAVLDVDGLDIQQELPSLSVGPSLHKQQASSDSPCSLR.K

RUXE_HUMAN

94.4%

27.2%

10804

9.4

(P08578) Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE) (P08578) Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE)

	TK040203_NMyc_nuclei2_step02.3498.3498.2	2.4769	0.3875	2911.58	1	2500.0%	2	R.IEGCIIGFDEYMNLVLDDAEEIHSK.T

NLD2_MOUSE

94.4%

257

29081

9.2

(Q9CZR2) N-acetylated-alpha-linked acidic dipeptidase II (EC 3.4.17.21) (NAALADase II) (Fragment)

	TK040203_NMyc_nuclei2_step01.4234.4234.1	1.5985	0.2875	1252.7	1	6000.0%	2	R.HIIFAPSSHNK.Y

DTD_HUMAN

94.3%

739

81649

8.4

(P50443) Sulfate transporter (Diastrophic dysplasia protein)

*	TK040203_NMyc_nuclei2_step04.2689.2689.3	2.4401	0.0797	2794.79	10	1850.0%	1	R.NIHKTNLCDLITSLLCLLVLLPTK.E
*	TK040203_NMyc_nuclei2_step07.2809.2809.3	2.8084	0.3771	4095.01	1	1640.0%	1	R.MDTVIWFVTMLSSALLSTEIGLLVGVCFSIFCVILR.T

Z198_MOUSE

94.3%

18.6%

237

27783

5.4

(Q9CU65) Zinc finger protein 198 (Fragment)

	TK040203_NMyc_nuclei2_step09.2899.2899.3	2.3816	0.1705	4113.43	21	1180.0%	1	K.SPQNLNQRMDVFYLQPECSSSTDSPVWYTSTSLDR.N
	TK040203_NMyc_nuclei2_step02.1324.1324.1	1.6416	0.2653	1076.7	2	5620.0%	1	K.KNPLTMENK.A

143B_MOUSE

94.3%

245

27955

4.8

(Q9CQV8) 14-3-3 protein beta/alpha (Protein kinase C inhibitor protein-1) (KCIP-1)

	TK040203_NMyc_nuclei2_step01.2871.2871.1	2.2894	0.1384	1191.77	1	6670.0%	2	K.DSTLIMQLLR.D

CGD3_MOUSE

94.3%

292

32411

6.5

(P30282) G1/S-specific cyclin D3

*	TK040203_NMyc_nuclei2_step11.2167.2167.1	1.9389	0.1704	1074.67	1	6250.0%	9	R.EWEVLVLGK.L
	TK040203_NMyc_nuclei2_step04.2126.2126.1	0.9131	0.0135	909.76	13	5830.0%	1	K.EIKPHMR.K

Q9ESX5

94.2%

509

57502

9.2

(Q9ESX5) DYSKERIN

	TK040203_NMyc_nuclei2_step02.2264.2264.3	1.4091	0.1592	3489.23	5	1560.0%	2	R.LHNAIEGGTQLSRALETLTGALFQRPPLIAAVK.R
	TK040203_NMyc_nuclei2_step10.1489.1489.2	1.1481	0.1489	1393.76	3	3750.0%	1	R.LHNAIEGGTQLSR.A
	TK040203_NMyc_nuclei2_step05.1788.1788.1	1.6274	0.2647	785.2	1	7500.0%	1	R.KWGLGPK.A

Q99K76

94.2%

296

31169

9.4

(Q99K76) Hypothetical 31.2 kDa protein

	TK040203_NMyc_nuclei2_step05.2250.2250.2	2.8163	0.2248	2249.65	1	3250.0%	1	R.VLAGQTLDINMAGEPKPNRPK.G

Q61482

94.2%

763

86716

4.8

(Q61482) CDE1-binding protein CDEBP

*	TK040203_NMyc_nuclei2_step10.1847.1847.2	1.9071	0.0378	1779.3	3	3820.0%	1	K.KGSGMAEQDGGLIGAEEK.V
*	TK040203_NMyc_nuclei2_step03.1722.1722.2	2.7964	0.2309	1651.52	1	5940.0%	1	K.GSGMAEQDGGLIGAEEK.V
	TK040203_NMyc_nuclei2_step01.4220.4220.3	2.4659	0.3007	4375.14	1	1400.0%	1	K.LLVLLLLGLTAPAAALAGYIEALAANAGTGFAVAEPQIAMFCGK.L

Q61164

94.1%

736

83729

6.9

(Q61164) 11-zinc-finger transcription factor

*	TK040203_NMyc_nuclei2_step08.2731.2731.3	2.2312	0.0805	4090.49	75	1080.0%	1	K.KEPDAEPAEGEEEEAQAATTDAPNGDLTPEMILSMMDR.-
	TK040203_NMyc_nuclei2_step02.2070.2070.1	1.2395	0.0708	1550.7	12	3330.0%	1	K.MHILQKHTENVAK.F
	TK040203_NMyc_nuclei2_step08.1647.1647.1	2.3256	0.2253	1513.52	8	4090.0%	2	K.FHCPHCDTVIAR.K

CES2_HUMAN

94.1%

1484

164215

7.0

(Q9BXF3) Cat eye syndrome critical region protein 2

*	TK040203_NMyc_nuclei2_step10.2981.2981.3	1.4536	0.0513	4335.07	63	1000.0%	1	R.EVGTSNGRGFSHPLHCGGTPSQAPFLNQMRPAVPGTFGPLR.G
*	TK040203_NMyc_nuclei2_step01.2695.2695.1	1.1876	0.0319	1435.68	12	3640.0%	1	R.EASFQDLPLRTR.V
*	TK040203_NMyc_nuclei2_step07.2313.2313.2	1.2525	0.1546	2822.58	5	1670.0%	1	R.LPGPFPQVAHPMSVTVSAPKPALGNPGR.A
*	TK040203_NMyc_nuclei2_step09.2222.2222.3	1.4677	0.1076	2759.41	4	2160.0%	1	R.VEPLGEDNSGALYWYFYGTRMYK.E
*	TK040203_NMyc_nuclei2_step03.3145.3145.2	1.8146	0.0998	2229.34	4	2940.0%	3	R.DITPQTFHSYLEDIINYR.W
*	TK040203_NMyc_nuclei2_step12.1809.1809.2	1.1975	0.0011	2700.84	31	1520.0%	1	R.AWLLAQGKELPPELSHLDPNSPMR.E
*	TK040203_NMyc_nuclei2_step05.2634.2634.3	1.4184	0.13	3889.77	107	1030.0%	1	R.TPYYACPQSFSDWQRPLHPQGSPSGPPASQPPPPR.S
*	TK040203_NMyc_nuclei2_step03.3766.3766.3	2.1848	0.1831	4553.86	1	1340.0%	2	R.LQPPPVPAPSSLFGAPAQALRGVQGGDSMMDSPEMIAMQQLSSR.V

ENOL_HUMAN

93.9%

458

49477

6.1

(Q05524) Alpha enolase, lung specific (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (HLE1)

*	TK040203_NMyc_nuclei2_step03.2078.2078.2	1.1137	0.1172	1816.34	3	3120.0%	1	K.AVEHIINKTIAPALISK.N
*	TK040203_NMyc_nuclei2_step04.4185.4185.3	1.9201	0.0099	3822.59	3	1390.0%	2	K.GVPLYRHIADLAGNNPEVILPVPAFNVINGGSHAGNK.L
*	TK040203_NMyc_nuclei2_step01.4050.4050.1	1.1345	0.0863	1297.69	92	3640.0%	3	K.GVSKAVEHIINK.T

COXE_MOUSE

93.8%

16.2%

111

12352

10.0

(P43024) Cytochrome c oxidase polypeptide VIa-liver, mitochondrial precursor (EC 1.9.3.1)

	TK040203_NMyc_nuclei2_step12.1774.1774.2	2.1129	0.4251	2257.74	3	2650.0%	1	K.SRHEEHERPPFVAYPHLR.I
	TK040203_NMyc_nuclei2_step12.1771.1771.2	2.0956	0.0333	2016.23	1	4000.0%	1	R.HEEHERPPFVAYPHLR.I

Q9Y6X6

93.8%

1045

114166

8.3

(Q9Y6X6) Hypothetical protein KIAA0865 (Fragment)

*	TK040203_NMyc_nuclei2_step09.2179.2179.1	1.4069	0.0548	1587.55	23	3460.0%	1	R.EAEGFETNMNISSR.D
*	TK040203_NMyc_nuclei2_step10.2593.2593.2	1.4991	0.0403	2174.22	35	2500.0%	1	K.KPEGASCNRLPSELWDTTI.-
*	TK040203_NMyc_nuclei2_step08.3696.3696.3	1.8985	0.0070	3832.04	4	1320.0%	1	R.NANNHGIQLSNSLSSAITAENGNSISNGLPEEDGYSR.L
*	TK040203_NMyc_nuclei2_step09.1334.1334.1	1.1001	0.1462	1221.65	220	3890.0%	1	K.NYLELSKLLK.K
	TK040203_NMyc_nuclei2_step04.1160.1160.1	1.1997	0.1453	793.68	40	5000.0%	4	K.QPPPKPK.R

CPSB_MOUSE

93.8%

782

88383

5.1

(O35218) Cleavage and polyadenylation specificity factor, 100 kDa subunit (CPSF 100 kDa subunit)

*	TK040203_NMyc_nuclei2_step06.2634.2634.2	1.4335	0.1422	2313.32	10	2370.0%	1	R.HNTEDFTLFTLDDVDAAFDK.I
	TK040203_NMyc_nuclei2_step07.2410.2410.1	2.2434	0.2197	1479.54	1	5000.0%	1	R.HLSLCHGLSDLAR.V
	TK040203_NMyc_nuclei2_step11.1212.1212.2	1.2514	0.0381	1361.16	29	3080.0%	1	R.GDGNVLIAVDTAGR.V

Q61033

93.7%

12.9%

692

75200

8.3

(Q61033) Thymopoietin alpha

*	TK040203_NMyc_nuclei2_step09.2486.2486.2	2.6594	0.3317	2445.82	1	2950.0%	1	K.SVVSHSLTTLGVEVSKPPPQHDK.I
*	TK040203_NMyc_nuclei2_step07.2666.2666.2	1.7534	0.1996	1968.79	42	2500.0%	1	R.TYDAASYLCDAAFDEVR.M
*	TK040203_NMyc_nuclei2_step10.3524.3524.3	1.8366	0.083	3572.71	17	1330.0%	1	R.DCVPFSELASTPSGAFFQGISFPEISTRPPLGR.T
*	TK040203_NMyc_nuclei2_step12.2597.2597.3	2.1758	0.2177	4222.01	12	1250.0%	1	K.SVVSHSLTTLGVEVSKPPPQHDKIEASEPSFPLHESILK.V

Q96SB3

93.7%

817

89451

5.0

(Q96SB3) Neurabin II protein

*	TK040203_NMyc_nuclei2_step05.1736.1736.1	2.0484	0.2414	1291.39	1	5000.0%	1	R.GPGGPLRSASPHR.S
*	TK040203_NMyc_nuclei2_step11.1219.1219.1	0.6738	0.0736	654.43	4	5000.0%	1	R.GPGGPLR.S
*	TK040203_NMyc_nuclei2_step11.1198.1198.1	1.4601	0.0421	833.46	3	5830.0%	1	K.YGSNVHR.I

Q9D8B4

93.6%

35.7%

143

15185

8.4

(Q9D8B4) 2010012C24Rik protein

*	TK040203_NMyc_nuclei2_step03.3126.3126.3	2.9138	0.3674	3512.12	1	1670.0%	1	K.TYITTALGGICGIIGSAYRVSLNPADSTLEAVAR.V
*	TK040203_NMyc_nuclei2_step09.3877.3877.3	1.1738	0.0752	2165.24	5	1880.0%	1	K.RFFESYHEVPDGTQCHR.K

GALT_HUMAN

93.5%

198

15.8%

368

39573

10.2

(O60755) Galanin receptor type 3 (GAL3-R) (GALR3)

*	TK040203_NMyc_nuclei2_step09.2286.2286.3	2.1658	0.0096	3113.91	11	1450.0%	1	R.VRPASSGPPGCPGDARPSGRLLAGGGQGPEPR.E
*	TK040203_NMyc_nuclei2_step09.4210.4210.2	2.3046	0.289	3009.1	1	3000.0%	14	R.LASHCLAYANSCLNPLVYALASRHFR.A

Q8VIJ6

93.4%

699

75442

9.4

(Q8VIJ6) PTB-associated splicing factor

	TK040203_NMyc_nuclei2_step02.1759.1759.1	0.9921	0.0106	1144.44	23	4500.0%	3	R.FATHAAALSVR.N
*	TK040203_NMyc_nuclei2_step11.1939.1939.2	1.3484	0.0876	2881.82	1	1830.0%	1	K.MPGGPKPGGGPGMGAPGGHPKPPHRGGGEPR.G

Q9CQ99

93.3%

115

11651

4.5

(Q9CQ99) 2700049I22Rik protein (RIKEN cDNA 2700049I22 gene)

*	TK040203_NMyc_nuclei2_step01.1931.1931.1	1.6215	0.1604	1244.56	1	5450.0%	2	K.NIEDVIAQGVGK.L

Q9CYY9

93.3%

741

84962

6.3

(Q9CYY9) Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3

	TK040203_NMyc_nuclei2_step07.1709.1709.1	1.6154	0.2584	1424.74	1	4090.0%	2	R.LTHYHEGLPTTR.G

PUR9_MOUSE

93.2%

592

64157

6.8

(Q9CWJ9) Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (Inosinicase) (IMP synthetase) (ATIC)]

	TK040203_NMyc_nuclei2_step11.1663.1663.1	2.2481	0.1988	1356.59	1	5000.0%	1	K.TLHPAVHAGILAR.N

K2C8_MOUSE

93.2%

488

54318

5.6

(P11679) Keratin, type II cytoskeletal 8 (Cytokeratin 8) (Cytokeratin endo A)

	TK040203_NMyc_nuclei2_step04.2902.2902.3	1.9763	0.0207	3142.96	7	1730.0%	1	R.QIHEEEIRELQSQISDTSVVLSMDNSR.S
	TK040203_NMyc_nuclei2_step08.1256.1256.3	1.0491	0.0375	1793.32	53	1500.0%	1	K.LEAELGNMQGLVEDFK.N
	TK040203_NMyc_nuclei2_step01.2632.2632.1	2.2562	0.1948	1420.78	1	5450.0%	1	R.LEGLTDEINFLR.Q
	TK040203_NMyc_nuclei2_step12.1817.1817.2	1.5961	0.114	2443.91	8	2370.0%	1	R.EYQELMNVKLALDIEITTYR.K

Q9Z332

93.0%

553

59335

7.9

(Q9Z332) Keratin 6 alpha

	TK040203_NMyc_nuclei2_step06.2377.2377.2	1.1025	0.0897	2401.45	23	2370.0%	1	K.EYQELMNVKLALDVEIATYR.K
	TK040203_NMyc_nuclei2_step01.2816.2816.1	1.8037	0.2531	1303.84	1	5450.0%	1	R.SLDLDSIIAEVK.A

Q99LJ3

93.0%

400

45918

5.0

(Q99LJ3) Hypothetical 45.9 kDa protein (Fragment)

	TK040203_NMyc_nuclei2_step04.2279.2279.2	2.2167	0.3927	2290.68	1	3420.0%	1	R.ASFNHFDRDHSGTLGPEEFK.A
	TK040203_NMyc_nuclei2_step09.3983.3983.2	0.85	0.1363	1500.57	11	1820.0%	1	R.QYEKSIVNYKPK.I
*	TK040203_NMyc_nuclei2_step07.1632.1632.1	1.9719	0.1965	1314.65	1	6110.0%	1	K.HTNYNMEHIR.V
	TK040203_NMyc_nuclei2_step03.2083.2083.3	1.5898	0.1972	3585.01	11	1500.0%	1	K.IVQTYHVNMAGTNPYTTITPQEINGKWDHVR.Q

Q9CX86

92.9%

305

30530

9.3

(Q9CX86) 3010025E17Rik protein

*	TK040203_NMyc_nuclei2_step09.3011.3011.2	1.1242	0.1541	2863.96	8	1730.0%	1	K.LFVGGLKGDVAEGDLIEHFSQFGAVEK.A
	TK040203_NMyc_nuclei2_step01.0236.0236.1	1.4955	0.1573	734.44	3	6670.0%	2	K.LFVGGLK.G
	TK040203_NMyc_nuclei2_step02.2739.2739.2	1.9158	0.1923	2322.24	1	3000.0%	2	R.GHFEAFGTLTDCVVVVNPQTK.R
*	TK040203_NMyc_nuclei2_step06.1179.1179.1	1.1567	0.0061	1037.56	30	4550.0%	1	R.GGYGGGYGGGSF.-
	TK040203_NMyc_nuclei2_step03.2151.2151.1	1.8244	0.2122	863.87	8	5710.0%	3	K.KLFVGGLK.G

H12_MOUSE

92.9%

211

21135

11.0

(P15864) Histone H1.2 (H1 VAR.1) (H1C)

*	TK040203_NMyc_nuclei2_step03.1205.1205.1	1.2059	0.0575	858.64	1	5620.0%	4	K.KPAAAAVTK.K
	TK040203_NMyc_nuclei2_step01.0106.0106.1	1.7556	0.2193	1198.6	1	5450.0%	1	K.ASGPPVSELITK.A

CIA1_HUMAN

92.8%

339

37840

5.0

(O76071) WD-repeat containing protein Ciao 1

*	TK040203_NMyc_nuclei2_step05.3075.3075.2	2.5947	0.1977	2412.45	1	3000.0%	8	R.CWFLAWNPAGTLLASCGGDRR.I

C61A_MOUSE

92.7%

291

33340

5.8

(P46737) C6.1A protein

	TK040203_NMyc_nuclei2_step05.1930.1930.1	1.5722	0.2658	1350.74	1	4550.0%	1	R.IHSLTHLDSVTK.I

LMG2_HUMAN

92.7%

1193

130990

6.2

(Q13753) Laminin gamma-2 chain precursor (Kalinin/nicein/epiligrin 100 kDa subunit) (Laminin B2t chain)

*	TK040203_NMyc_nuclei2_step09.2381.2381.1	2.2374	0.1358	1575.42	4	3930.0%	1	R.HPSAHDVILEGAGLR.I
*	TK040203_NMyc_nuclei2_step09.1914.1914.2	1.5161	0.1102	1933.55	57	2060.0%	1	R.GHLHLLETSIDGILADVK.N
*	TK040203_NMyc_nuclei2_step05.3634.3634.2	1.0236	0.1076	2583.68	5	2050.0%	1	R.AQEALSMGNATFYEVESILKNLR.E
*	TK040203_NMyc_nuclei2_step09.1251.1251.3	1.4048	0.0011	1913.75	87	2350.0%	1	R.ITAPLMPLGKTLPCGLTK.T
*	TK040203_NMyc_nuclei2_step04.1218.1218.1	0.6953	0.0141	787.46	4	5830.0%	1	K.QALSLVR.K
*	TK040203_NMyc_nuclei2_step04.3361.3361.3	1.7174	0.0549	3434.63	16	1430.0%	1	R.CRSGYYNLDGGNPEGCTQCFCYGHSASCR.S

VGR1_MOUSE

92.6%

1333

149876

8.3

(P35969) Vascular endothelial growth factor receptor 1 precursor (EC 2.7.1.112) (VEGFR-1) (Tyrosine-protein kinase receptor FLT) (FLT-1) (Embryonic receptor kinase 2)

	TK040203_NMyc_nuclei2_step05.4137.4137.2	1.0754	0.2308	2946.12	3	2080.0%	1	R.DNRQFCSTLTLDTAQANHTGLYTCR.Y
*	TK040203_NMyc_nuclei2_step12.3426.3426.3	3.1337	0.1139	3362.73	1	1980.0%	1	K.IQQEPGIILGPGNSTLFIERVTEEDEGVYR.C
	TK040203_NMyc_nuclei2_step09.3238.3238.3	2.062	0.0576	3449.18	11	1550.0%	1	R.LLHGQTLVLNCTATTELNTRVQMSWNYPGK.A
*	TK040203_NMyc_nuclei2_step09.2963.2963.2	1.1962	0.0293	2513.71	325	1360.0%	1	K.TVSTLVVADSQTPGIYSCRAFNK.I
	TK040203_NMyc_nuclei2_step02.2834.2834.2	1.0228	0.0349	2884.04	64	1400.0%	1	K.KAESSIYIFVSDAGSPFIEMHTDIPK.L

Q9UHY0

92.6%

554

61436

9.6

(Q9UHY0) HP1-BP74 protein

*	TK040203_NMyc_nuclei2_step05.2414.2414.3	2.7472	0.3959	3057.69	2	2050.0%	3	-.MATDTSQGELVHPKALPLIVGAQLIHADK.L

Q921B9

92.3%

1200

138973

5.4

(Q921B9) Nuclear pore complex-associated protein Tpr (Fragment)

	TK040203_NMyc_nuclei2_step06.1766.1766.1	1.7268	0.1925	1222.68	1	6670.0%	2	K.FHNELNAHIK.L
*	TK040203_NMyc_nuclei2_step02.2807.2807.2	1.6571	0.2402	1842.75	2	3570.0%	1	K.ELLHNQNSWLNTELK.T
	TK040203_NMyc_nuclei2_step04.1953.1953.1	0.7107	0.0672	1116.46	5	5000.0%	1	R.QHLEETTQK.A

RL6_MOUSE

92.3%

287

32612

10.8

(P47911) 60S ribosomal protein L6 (TAX-responsive enhancer element binding protein 107) (TAXREB107)

*	TK040203_NMyc_nuclei2_step01.0004.0004.1	0.8452	0.0786	731.36	4	6670.0%	1	K.VLATVTK.T
	TK040203_NMyc_nuclei2_step11.1142.1142.1	1.3829	0.0649	998.54	1	6430.0%	1	K.KPFSQHVR.R
	TK040203_NMyc_nuclei2_step09.1465.1465.1	1.9525	0.2416	784.54	1	6670.0%	2	R.KLLSHGK.K

Q9DAN1

92.2%

604

69486

5.7

(Q9DAN1) 1700007B13Rik protein

*	TK040203_NMyc_nuclei2_step09.3438.3438.1	1.7442	0.1895	1419.2	2	4090.0%	8	R.FHVILDSVLVFK.K
*	TK040203_NMyc_nuclei2_step01.0462.0462.2	1.5958	0.1951	3060.4	12	1800.0%	1	K.SRPLVIVGFFQDLEEEVAELFYDTIK.D

RL1X_MOUSE

92.2%

176

20732

10.7

(P11249) 60S ribosomal protein L18a

	TK040203_NMyc_nuclei2_step08.3093.3093.2	0.8689	0.019	1221.22	127	3120.0%	1	R.FWYFVSQLK.K
	TK040203_NMyc_nuclei2_step02.1713.1713.1	1.7963	0.2008	927.64	1	7860.0%	3	R.AHSIQIMK.V

AAC1_HUMAN

92.2%

892

102974

5.4

(P12814) Alpha-actinin 1 (Alpha-actinin cytoskeletal isoform) (Non-muscle alpha-actinin 1) (F-actin cross linking protein)

	TK040203_NMyc_nuclei2_step02.1400.1400.1	1.528	0.064	1416.51	15	3640.0%	2	R.VPENTMHAMQQK.L
	TK040203_NMyc_nuclei2_step11.4404.4404.2	1.4277	0.0218	2742.04	94	1590.0%	1	K.NVNIQNFHISWKDGLGFCALIHR.H
	TK040203_NMyc_nuclei2_step05.3262.3262.3	2.248	0.0969	4598.74	30	980.0%	1	R.ELPPDQAEYCIARMAPYTGPDSVPGALDYMSFSTALYGESDL.-
	TK040203_NMyc_nuclei2_step06.1875.1875.1	1.9679	0.1469	1229.47	1	6110.0%	2	R.HRPELIDYGK.L
	TK040203_NMyc_nuclei2_step04.3443.3443.2	1.0917	0.0531	1752.86	2	3570.0%	1	K.ILAGDKNYITMDELR.R

RL26_HUMAN

91.8%

145

17258

10.6

(Q02877) 60S ribosomal protein L26 (Q02877) 60S ribosomal protein L26

	TK040203_NMyc_nuclei2_step04.1534.1534.1	2.0282	0.2333	1418.46	1	5000.0%	1	K.ANGTTVHVGIHPSK.V
	TK040203_NMyc_nuclei2_step10.1666.1666.2	2.4854	0.2829	1079.44	1	7500.0%	1	R.HFNAPSHIR.R

Q9CWP2

91.8%

13.2%

326

35630

8.2

(Q9CWP2) Expressed sequence tag mouse EST 55

	TK040203_NMyc_nuclei2_step10.2279.2279.2	2.6717	0.2336	2129.49	1	3890.0%	2	K.THELTNPGIAEVTIRPDHK.I
*	TK040203_NMyc_nuclei2_step09.3852.3852.3	1.4361	0.1091	2488.63	6	1520.0%	1	K.GISGSAGKVLAVWSLDDQQSLQVK.K

ZN29_HUMAN

91.7%

25.0%

6368

9.4

(P17037) Zinc finger protein 29 (Zinc finger protein KOX26) (Fragment)

*	TK040203_NMyc_nuclei2_step01.2044.2044.1	1.622	0.2533	1548.05	3	3460.0%	1	K.ECGEAFSQSSTLTK.H

TERA_MOUSE

91.7%

14.6%

806

89308

5.3

(Q01853) Transitional endoplasmic reticulum ATPase (TER ATPase) (15S Mg(2+)-ATPase p97 subunit) (Valosin containing protein) (VCP) [Contains: Valosin]

	TK040203_NMyc_nuclei2_step05.1543.1543.1	1.1963	0.0433	1193.57	6	4380.0%	1	R.RDHFEEAMR.F
	TK040203_NMyc_nuclei2_step12.1191.1191.3	1.1742	0.01	3871.01	23	1150.0%	1	R.GFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG.-
	TK040203_NMyc_nuclei2_step01.2598.2598.1	2.161	0.1402	1556.69	1	5420.0%	1	R.LDQLIYIPLPDEK.S
	TK040203_NMyc_nuclei2_step02.1769.1769.1	1.7099	0.184	712.37	1	8000.0%	2	R.HPALFK.A
	TK040203_NMyc_nuclei2_step02.1447.1447.1	1.0826	0.0527	837.76	20	5710.0%	2	K.AIGVKPPR.G
	TK040203_NMyc_nuclei2_step07.3060.3060.2	1.6495	0.1816	2519.15	4	2270.0%	1	K.NVFIIGATNRPDIIDPAILRPGR.L
	TK040203_NMyc_nuclei2_step11.4094.4094.2	1.0153	0.0542	2161.74	2	3060.0%	1	K.MTNGFSGADLTEICQRACK.L

Q9D4J7

91.7%

364

41139

8.7

(Q9D4J7) 4931428F02Rik protein

	TK040203_NMyc_nuclei2_step04.1442.1442.1	1.5515	0.2725	1407.41	1	5000.0%	1	K.TYHYHCGVQDK.A
	TK040203_NMyc_nuclei2_step03.2474.2474.2	1.1646	0.0837	1762.06	16	2690.0%	2	R.EKPSQGIYMVYCRK.H

Q8VED2

91.5%

215

23112

5.1

(Q8VED2) Similar to hypothetical protein FLJ11230

*	TK040203_NMyc_nuclei2_step02.3759.3759.3	2.8203	0.348	4368.32	2	1370.0%	3	R.EVSTEEAEPLGAAWSGDSGHVSQSHSSASGPWDDDGPEDAPGR.D

Q9NV98

91.4%

140

16474

8.2

(Q9NV98) Hypothetical protein FLJ10853

*	TK040203_NMyc_nuclei2_step10.2581.2581.2	2.6113	0.268	1832.22	1	4670.0%	1	-.MDCAHLVKANSIQGCK.M

Q8TAP6

91.4%

12.1%

659

74414

6.8

(Q8TAP6) Hypothetical protein

*	TK040203_NMyc_nuclei2_step07.2600.2600.2	1.3806	0.0888	2609.89	12	2140.0%	1	R.SKPVPCACEPDFHDGFLLEVHR.E
*	TK040203_NMyc_nuclei2_step03.2898.2898.3	2.1425	0.1078	3317.04	2	1720.0%	1	R.SVLGSENGVTSLTVELMGVGTESKVSVGILNIK.L
*	TK040203_NMyc_nuclei2_step01.3396.3396.2	2.2512	0.2399	2939.61	3	2080.0%	6	K.ELNFVTDSVEQELPSSPKQPICFDR.Q

ACDL_MOUSE

91.4%

430

48082

8.2

(P51174) Acyl-CoA dehydrogenase, long-chain specific, mitochondrial precursor (EC 1.3.99.13) (LCAD)

*	TK040203_NMyc_nuclei2_step04.1462.1462.1	1.9136	0.2816	1262.58	10	4500.0%	3	K.TVAHIQTVQHK.L

SYR_MOUSE

91.4%

660

75674

7.6

(Q9D0I9) Arginyl-tRNA synthetase (EC 6.1.1.19) (Arginine--tRNA ligase) (ArgRS)

	TK040203_NMyc_nuclei2_step03.3473.3473.2	2.2961	0.3834	2382.75	1	4250.0%	2	R.LNHVGDWGTQFGMLIAHLQDK.F

DJB5_MOUSE

91.3%

348

39119

9.0

(O89114) DnaJ homolog subfamily B member 5 (Heat shock protein Hsp40-3) (Heat shock protein cognate 40) (Hsc40)

	TK040203_NMyc_nuclei2_step08.1839.1839.1	1.9193	0.022	1451.55	1	4580.0%	2	K.EIAEAYDVLSDPK.K
*	TK040203_NMyc_nuclei2_step09.3607.3607.3	2.0287	0.1133	4365.1	11	1130.0%	1	K.TGGGSSGGSGGSFHYTFHGDPHATFASFFGGSNPFDIFFASSR.S

Q96KR8

91.0%

2567

285239

6.9

(Q96KR8) Myosin heavy chain

	TK040203_NMyc_nuclei2_step09.1782.1782.1	1.043	0.0026	1337.71	120	2500.0%	1	K.SGNAGEARSQTEK.G
	TK040203_NMyc_nuclei2_step05.3232.3232.3	1.339	0.1015	3396.83	7	1480.0%	1	R.IADLQAALEEVASSDSDTESVQTAVDCGSSGRK.E
	TK040203_NMyc_nuclei2_step05.2580.2580.2	1.0627	0.139	2798.18	39	2080.0%	1	R.TELNLHQMADSSSFGMGVWSKPEDK.Q
	TK040203_NMyc_nuclei2_step04.2779.2779.2	1.0584	0.0384	2665.64	2	2080.0%	1	K.QKAAAAFAQLQGAMEMLGISESEQR.A
	TK040203_NMyc_nuclei2_step10.2635.2635.3	1.5957	0.138	2575.82	5	2280.0%	1	K.VDFDDFLPAIRKPQTPTSLAGSAK.G
	TK040203_NMyc_nuclei2_step06.3101.3101.3	1.6202	0.0924	3657.08	38	1520.0%	1	R.TCEQPLQCEIFHQLGWDPVRYDLTGWLHR.A
	TK040203_NMyc_nuclei2_step07.2889.2889.2	1.6971	0.0738	2019.05	1	3610.0%	1	R.EIPEISISQPNSKSSSGTR.S
	TK040203_NMyc_nuclei2_step04.2483.2483.1	1.7254	0.2409	1404.7	2	4230.0%	5	K.EVSTMVESPAAPGK.G
	TK040203_NMyc_nuclei2_step05.3366.3366.2	1.4644	0.036	2034.17	69	2350.0%	1	K.AQLLHTCTGPDLIVLQPR.G
	TK040203_NMyc_nuclei2_step11.3276.3276.2	1.2679	0.0207	2954.15	3	1610.0%	1	R.SGSQQISQDDQSSSPGSSDILGKESEGSR.S
	TK040203_NMyc_nuclei2_step06.2579.2579.2	1.2402	6.0E-4	2638.05	9	1800.0%	1	K.EDPAHLSDSSSSSGSIVSFKSADSIK.S

Q8TDX7

91.0%

302

34551

8.3

(Q8TDX7) NEK7

*	TK040203_NMyc_nuclei2_step01.2610.2610.1	2.153	0.076	1560.98	1	5420.0%	1	R.QLVNMCINPDPEK.R

EF2_MOUSE

90.8%

857

95183

6.8

(P58252) Elongation factor 2 (EF-2)

	TK040203_NMyc_nuclei2_step01.2416.2416.1	1.3617	0.1233	1309.8	7	4090.0%	1	K.DSVVAGFQWATK.E
	TK040203_NMyc_nuclei2_step04.1798.1798.1	1.8586	0.2349	1308.56	1	5450.0%	1	R.NMSVIAHVDHGK.S
	TK040203_NMyc_nuclei2_step12.0792.0792.2	0.9561	0.1047	2023.49	61	2350.0%	1	R.ETVSEESNVLCLSKSPNK.H
	TK040203_NMyc_nuclei2_step11.0868.0868.1	0.6001	0.0302	444.88	4	3330.0%	1	K.SPNK.H
*	TK040203_NMyc_nuclei2_step01.1524.1524.1	0.9744	0.0414	1095.58	13	4500.0%	1	R.VFSGVVSTGLK.V
	TK040203_NMyc_nuclei2_step01.4308.4308.2	2.3108	0.3004	2994.13	1	3000.0%	1	R.LMEPIYLVEIQCPEQVVGGIYGVLNR.K
	TK040203_NMyc_nuclei2_step05.1183.1183.1	1.0366	0.0446	513.61	1	8330.0%	1	K.KLPR.T
	TK040203_NMyc_nuclei2_step02.3746.3746.2	2.4881	0.3372	2578.98	2	2170.0%	1	R.VTDGALVVVDCVSGVCVQTETVLR.Q

Q9D3U4

90.8%

1.4%

565

62564

8.3

(Q9D3U4) 4933434H11Rik protein

	TK040203_NMyc_nuclei2_step01.2782.2782.1	1.8452	0.2358	914.42	2	7860.0%	1	R.GFGFVLFK.D

NAP1_HUMAN

90.7%

420

45387

6.6

(O96009) Napsin 1 precursor (EC 3.4.23.-) (Napsin A) (NAPA) (TA01/TA02) (Aspartyl protease 4) (Asp 4) (ASP4)

*	TK040203_NMyc_nuclei2_step03.4263.4263.3	1.7795	0.186	4760.96	7	1010.0%	2	R.DPEEPDGGELVLGGSDPAHYIPPLTFVPVTVPAYWQIHMERVK.V

Q8VD36

90.6%

546

62096

5.9

(Q8VD36) Similar to hypothetical protein FLJ12168

*	TK040203_NMyc_nuclei2_step12.2321.2321.2	2.0778	0.3468	2414.24	2	2890.0%	1	R.EAWKFLLGYLSWESSAEEHK.A
	TK040203_NMyc_nuclei2_step04.3484.3484.3	2.9622	0.1163	3064.86	20	1670.0%	3	R.RSKPGLSWAYLVLVTQAGGSLPALHFHR.G

CATA_MOUSE

90.6%

526

59634

7.9

(P24270) Catalase (EC 1.11.1.6)

	TK040203_NMyc_nuclei2_step03.1570.1570.1	1.6777	0.2389	1279.53	1	5000.0%	2	R.HMNGYGSHTFK.L
*	TK040203_NMyc_nuclei2_step02.2887.2887.2	1.3781	0.0742	2601.57	26	2050.0%	1	R.HMNGYGSHTFKLVNADGEAVYCK.F
*	TK040203_NMyc_nuclei2_step04.1498.1498.1	1.1672	0.0815	812.67	1	5830.0%	1	K.RTPIAVR.F
*	TK040203_NMyc_nuclei2_step10.3797.3797.3	1.3645	0.2059	3902.58	5	1520.0%	1	R.VANYQRDGPMCMHDNQGGAPNYYPNSFSAPEQQR.S

Q61123

90.4%

754

86823

5.6

(Q61123) MEM3

	TK040203_NMyc_nuclei2_step12.2465.2465.3	1.8868	0.0182	4344.22	3	1280.0%	1	R.NILPDEGEPTDEETTGDISDSMDFVLLNFAEMNKLWVR.M
*	TK040203_NMyc_nuclei2_step04.1782.1782.2	1.0844	0.1309	2007.8	31	2810.0%	1	K.LFDIFSQQVATVIQSRR.D
*	TK040203_NMyc_nuclei2_step03.3309.3309.2	1.5566	0.1287	2043.43	13	2810.0%	1	-.MPPICLESSGPLCCHQR.V
	TK040203_NMyc_nuclei2_step11.1422.1422.1	1.8327	0.1799	1305.68	1	5560.0%	2	K.HFHNTLEHLR.T
	TK040203_NMyc_nuclei2_step08.1273.1273.1	1.1507	0.0046	807.69	201	4170.0%	2	R.GVQHPLR.G

VINE_MOUSE

90.4%

14.5%

733

82349

9.2

(Q9R1Z8) Vinexin (SH3-containing adapter molecule-1) (SCAM-1) (SH3 domain-containing protein SH3P3)

*	TK040203_NMyc_nuclei2_step12.4149.4149.3	1.7674	0.0405	3951.83	4	1320.0%	1	R.VHTKEQLAHPASSNLDPSMQGLPAGLSLDDFIPGHLR.T
	TK040203_NMyc_nuclei2_step04.1907.1907.1	1.457	0.073	1235.36	2	5000.0%	2	K.NWLEGEHHGR.L
*	TK040203_NMyc_nuclei2_step06.1730.1730.1	1.6366	0.2413	1318.6	1	5560.0%	1	R.KVNEHWYEGR.I
*	TK040203_NMyc_nuclei2_step11.4022.4022.3	1.8743	0.0489	4631.73	65	990.0%	1	R.ATSRPINLGPSSPNTEIHWTPYRAMYQYRPQNEDELELR.E
*	TK040203_NMyc_nuclei2_step09.1322.1322.1	1.1177	0.0056	1198.37	53	5000.0%	1	R.RDFVYPSSAR.E

Q9Y520

90.4%

2701

295829

9.0

(Q9Y520) Hypothetical protein

*	TK040203_NMyc_nuclei2_step04.2738.2738.2	1.3232	0.0625	2199.31	53	2140.0%	1	R.STTPTSSPSGLLLQVRTASPAK.-
*	TK040203_NMyc_nuclei2_step07.2288.2288.3	1.5876	0.0317	3447.88	7	1500.0%	3	K.EATPVVHETEPESGSQPRPAVLSGYFKQFQK.S
*	TK040203_NMyc_nuclei2_step07.2320.2320.1	1.6409	0.2399	1575.51	3	3640.0%	1	R.RPAYRDNQWNPR.Q
*	TK040203_NMyc_nuclei2_step03.2023.2023.1	0.6773	0.0296	1455.55	212	3000.0%	1	R.DYPQYRDNKPR.A

CUL1_MOUSE

90.2%

776

89691

8.0

(Q9WTX6) Cullin homolog 1 (CUL-1)

	TK040203_NMyc_nuclei2_step01.3727.3727.1	1.4726	0.3186	1335.16	1	5500.0%	1	K.MYVQTVLDVHK.K
	TK040203_NMyc_nuclei2_step04.3189.3189.2	1.1793	0.0104	2387.78	1	2750.0%	1	K.CGEAALNDPKMYVQTVLDVHK.K
	TK040203_NMyc_nuclei2_step07.3266.3266.1	1.3913	0.0429	1461.7	3	4090.0%	1	K.MYVQTVLDVHKK.Y

Q9D1Q6

90.2%

2.0%

406

46853

5.3

(Q9D1Q6) 1110001E24Rik protein (RIKEN cDNA 1110001E24 gene)

	TK040203_NMyc_nuclei2_step11.1451.1451.1	1.9143	0.2285	987.39	2	7140.0%	1	R.HPLLHIQK.T

Q921R2

90.2%

140

16142

10.7

(Q921R2) Similar to ribosomal protein S13

	TK040203_NMyc_nuclei2_step04.2586.2586.2	1.6397	0.1482	1383.0	1	6250.0%	1	K.KGLTPSQIGVILR.D
	TK040203_NMyc_nuclei2_step01.2764.2764.1	1.9171	0.2245	1256.65	1	5450.0%	3	K.GLTPSQIGVILR.D

Q9CPT4

89.9%

166

17982

6.8

(Q9CPT4) DNA segment, Chr 17, Wayne state University 104, expressed (Stromal cell-derived growth factor SF20/IL25)

*	TK040203_NMyc_nuclei2_step10.1574.1574.1	1.4884	0.3059	1172.63	4	5500.0%	4	K.TAVSHRPGAFK.A

TCPB_MOUSE

89.7%

535

57447

6.4

(P80314) T-complex protein 1, beta subunit (TCP-1-beta) (CCT-beta)

	TK040203_NMyc_nuclei2_step03.3369.3369.2	2.4027	0.3595	2289.64	1	3330.0%	1	R.VQDDEVGDGTTSVTVLAAELLR.E
	TK040203_NMyc_nuclei2_step03.2594.2594.3	1.3921	0.0074	2045.14	10	2640.0%	1	K.KLGGSLADSYLDEGFLLDK.K
	TK040203_NMyc_nuclei2_step07.1225.1225.1	1.1217	0.0679	1017.55	4	5710.0%	1	K.RVPDHHPC.-
	TK040203_NMyc_nuclei2_step04.2690.2690.2	1.334	0.0554	1846.89	22	2810.0%	1	R.IENAKILIANTGMDTDK.I

Q15598

89.6%

4650

522075

7.9

(Q15598) Titin (Fragment)

	TK040203_NMyc_nuclei2_step03.2475.2475.1	1.4327	0.1405	1256.52	48	4000.0%	1	K.YSFRVAAVNVK.G
	TK040203_NMyc_nuclei2_step10.3592.3592.3	1.6041	0.0315	4438.94	4	1150.0%	1	R.IPGPPETLQIFDVSRDGMTLTWYPPEDDGGSQVTGYIVER.K
	TK040203_NMyc_nuclei2_step11.1483.1483.3	1.7038	0.0693	2744.93	73	1770.0%	1	R.DSVTITWEIPTIDGGAPINNYIVEK.R
	TK040203_NMyc_nuclei2_step03.3557.3557.2	1.9307	0.1925	2444.38	1	3100.0%	3	K.VRVIGSPNSPEGPLEYDDIQVR.S
	TK040203_NMyc_nuclei2_step02.3895.3895.2	1.2569	0.1779	2879.72	2	1670.0%	1	R.GSGKPSRPSKPIVAMDPIAPPGKPQNPR.V
	TK040203_NMyc_nuclei2_step02.0513.0513.1	0.8154	0.0231	1341.91	58	2500.0%	1	K.SELDFMSKEEK.S
	TK040203_NMyc_nuclei2_step02.3336.3336.2	2.0424	0.2183	2938.17	1	2800.0%	1	K.DGQPLSLGPNIEIIHEGLDYYALHIR.D
	TK040203_NMyc_nuclei2_step09.2279.2279.3	1.6273	0.0343	3343.83	1	1690.0%	1	K.TIHVPAGRPVELVIPIAGRPPPAASWFFAGSK.L
	TK040203_NMyc_nuclei2_step07.2764.2764.2	1.4672	0.0042	2368.74	29	1820.0%	1	R.AGSDLVLDAAVGGKPEPKIIWTK.G
	TK040203_NMyc_nuclei2_step01.1623.1623.1	1.1864	0.0143	1240.55	3	5000.0%	1	K.YTIEAENQSGK.K
	TK040203_NMyc_nuclei2_step04.3229.3229.2	1.4432	0.0060	2004.59	385	1750.0%	1	R.ATNQGGSVSGTASLEVEVPAK.I
*	TK040203_NMyc_nuclei2_step08.3807.3807.2	1.1274	0.0739	2702.19	2	2200.0%	1	K.NVTGTTLETIKVIILDKPGPPTGPIK.I
	TK040203_NMyc_nuclei2_step10.0264.0264.1	0.5333	0.0050	809.5	6	2500.0%	1	R.KETSTDK.V
	TK040203_NMyc_nuclei2_step04.4223.4223.2	1.207	0.0635	2624.82	5	1960.0%	1	K.QGIDLASRAIIDTTESYSLLIVDK.V
	TK040203_NMyc_nuclei2_step10.1837.1837.1	1.2582	0.1306	1094.85	17	4290.0%	1	K.ENVEYHFR.V

AKAC_HUMAN

89.4%

1781

191438

4.4

(Q02952) A-kinase anchor protein 12 (A-kinase anchor protein 250 kDa) (AKAP 250) (Myasthenia gravis autoantigen gravin)

*	TK040203_NMyc_nuclei2_step02.2951.2951.2	1.7054	0.1082	2286.32	8	2500.0%	1	R.EQSHAEISPPAESGQAVEECK.E
*	TK040203_NMyc_nuclei2_step07.2693.2693.3	1.498	0.0601	4145.38	42	1050.0%	1	R.SPEQPPEGSSTPAEPEPSGGGPSAEAAPDTTADPAIAASDPATK.L
*	TK040203_NMyc_nuclei2_step05.2659.2659.2	1.2966	0.0985	2599.02	15	1460.0%	1	K.LEEKSEDSIAGSGVEHSTPDTEPGK.E
*	TK040203_NMyc_nuclei2_step03.3457.3457.3	2.2621	0.1405	2937.24	58	1670.0%	1	K.IEVHQEEVVAEVHVSTVEERTEEQK.T
*	TK040203_NMyc_nuclei2_step09.2033.2033.2	1.4771	0.146	2103.18	134	2000.0%	1	K.SEDSIAGSGVEHSTPDTEPGK.E
*	TK040203_NMyc_nuclei2_step04.1589.1589.1	2.1353	0.044	889.62	4	7500.0%	1	K.KEQEPEK.V

P70304

89.3%

724

83501

6.3

(P70304) Phosphoinositide 3-kinase p85alpha

*	TK040203_NMyc_nuclei2_step08.3520.3520.1	1.5791	0.2456	1319.49	1	5000.0%	1	K.MHGDYTLTPRK.G

Q9HC82

89.2%

838

94781

5.6

(Q9HC82) Rb-associated protein

	TK040203_NMyc_nuclei2_step05.1394.1394.1	1.1183	0.0286	1092.54	10	5000.0%	1	K.ANQIHKLLR.E
	TK040203_NMyc_nuclei2_step11.1763.1763.1	2.1229	0.2576	1533.73	10	3750.0%	1	R.EEKTTTTLIEPIR.L

Q9H491

89.1%

145

18.8%

170

19189

9.3

(Q9H491) BA346K17.1.2 (Novel protein similar to MAP1ALC3 (Micotubule-associated proteins 1A/1B light chain 3) from Rat, isoform 2) (Fragment)

*	TK040203_NMyc_nuclei2_step01.1072.1072.1	1.5265	0.0636	1050.47	3	6250.0%	12	R.AMPSDRPFK.Q
*	TK040203_NMyc_nuclei2_step09.4174.4174.2	0.6634	0.1738	2250.24	209	1140.0%	1	-.ELPPAAAAAVLSASPGALEREAR.S

SCP1_MOUSE

89.1%

732

993

115962

5.8

(Q62209) Synaptonemal complex protein 1 (SCP-1 protein)

*	TK040203_NMyc_nuclei2_step05.1831.1831.1	0.6511	0.0337	1089.24	5	3120.0%	1	K.EAQMEELNK.A
*	TK040203_NMyc_nuclei2_step08.2807.2807.2	1.0571	0.0043	3178.93	49	1250.0%	1	K.TAFEFDVNSDSSETADLLSLVSEEDVSNR.L
*	TK040203_NMyc_nuclei2_step09.2629.2629.1	1.7255	0.2299	939.65	1	6880.0%	27	K.YIPTGGSNK.K
*	TK040203_NMyc_nuclei2_step10.2424.2424.2	1.2996	0.0852	1719.83	25	3080.0%	1	-.MEKQKPFTLFVPPR.L

MYPR_HUMAN

88.9%

276

29946

8.4

(P06905) Myelin proteolipid protein (PLP) (Lipophilin) [Contains: Myelin protein DM-20] (P06905) Myelin proteolipid protein (PLP) (Lipophilin) [Contains: Myelin protein DM-20]

	TK040203_NMyc_nuclei2_step10.2215.2215.1	1.5221	0.1279	1465.82	11	3750.0%	2	R.GSRGQHQAHSLER.V

Q9CX98

88.9%

501

57321

8.0

(Q9CX98) 8430436A10Rik protein

*	TK040203_NMyc_nuclei2_step07.3485.3485.1	1.3428	0.0317	1348.18	309	2730.0%	1	R.ETFIPFGIGQLK.L
*	TK040203_NMyc_nuclei2_step04.2825.2825.2	1.7572	0.0355	2482.88	18	1900.0%	3	R.APSLTDKAQMPYTEATIMEVQR.L

Q9BTR0

88.8%

256

22.2%

3911

7.3

(Q9BTR0) Hypothetical protein

*	TK040203_NMyc_nuclei2_step04.2470.2470.1	1.3033	0.0535	883.81	10	5000.0%	16	R.RGILPGLR.-

Q96RB1

88.7%

34.7%

216

23659

7.6

(Q96RB1) Olfactory receptor (Fragment)

*	TK040203_NMyc_nuclei2_step11.1826.1826.3	1.5722	0.0071	3627.62	19	1370.0%	2	K.TISFVGCAAQFFFFVGMGLSECLLLTAMAYDR.Y
*	TK040203_NMyc_nuclei2_step05.3515.3515.3	2.8091	0.3407	4639.99	1	1490.0%	2	R.YAAISSPLLYPTIMTQGLCTRMVVGAYVGGFLSSLIQASSIFR.L

RS2_MOUSE

88.7%

15.0%

293

31217

10.2

(P25444) 40S ribosomal protein S2 (S4) (LLREP3 protein)

	TK040203_NMyc_nuclei2_step10.1394.1394.1	1.5406	0.1748	1136.59	30	4440.0%	1	K.IGKPHTVPCK.V
	TK040203_NMyc_nuclei2_step08.1583.1583.1	1.4628	0.0096	1135.77	16	5000.0%	1	K.CSKEVATAIR.G
	TK040203_NMyc_nuclei2_step01.2231.2231.1	1.7612	0.2214	1388.7	1	4500.0%	2	K.TYSYLTPDLWK.E
	TK040203_NMyc_nuclei2_step01.4310.4310.1	1.2943	0.0071	1552.74	3	5000.0%	1	K.SLEEIYLFSLPIK.E

KPCB_MOUSE

88.6%

671

76751

7.0

(P04410) Protein kinase C, beta type (EC 2.7.1.-) (PKC-beta) (PKC-B)

	TK040203_NMyc_nuclei2_step05.3507.3507.2	1.9233	0.0902	1829.82	2	3330.0%	6	R.DLKLDNVMLDSEGHIK.I
*	TK040203_NMyc_nuclei2_step06.2603.2603.2	1.3949	0.0227	3176.16	1	2040.0%	1	K.LLSQEEGEYFNVPVPPEGSEGNEELRQK.F

CA21_HUMAN

88.6%

1366

129456

8.9

(P08123) Collagen alpha 2(I) chain precursor

	TK040203_NMyc_nuclei2_step04.2987.2987.2	1.2642	0.0508	1949.84	2	3250.0%	1	K.GEPGSAGPQGPPGPSGEEGKR.G
	TK040203_NMyc_nuclei2_step06.2503.2503.2	1.7511	0.2044	2366.95	1	3000.0%	2	K.GESGNKGEPGSAGPQGPPGPSGEEGK.R
	TK040203_NMyc_nuclei2_step12.4333.4333.3	2.0946	0.1947	4235.76	5	1310.0%	1	R.GPQGHQGPAGPPGPPGPPGPPGVSGGGYDFGYDGDFYRADQPR.S
*	TK040203_NMyc_nuclei2_step10.2807.2807.3	1.7652	0.0436	4273.2	2	1360.0%	1	K.GEQGPDGPPGFQGLPGPSGPAGEVGKPGERGLHGEFGLPGPAGPR.G
	TK040203_NMyc_nuclei2_step12.3385.3385.2	2.2358	0.2161	2026.75	3	2860.0%	1	K.HGNRGETGPSGPVGPAGAVGPR.G
	TK040203_NMyc_nuclei2_step11.2315.2315.2	1.9685	0.4456	2973.84	1	2900.0%	1	R.DGEDGPTGPPGPPGPPGPPGLGGNFAAQYDGK.G

Q8WUC7

88.5%

104

10540

11.6

(Q8WUC7) Hypothetical protein (Fragment)

*	TK040203_NMyc_nuclei2_step01.2910.2910.1	1.6362	0.2251	1599.49	1	4000.0%	2	R.RPGGAAMLAESPSVPR.L

MYO6_MOUSE

88.5%

1265

146409

8.8

(Q64331) Myosin VI

*	TK040203_NMyc_nuclei2_step06.1794.1794.2	1.837	0.3851	1846.15	1	4670.0%	1	R.LPQPSDQHFTSVVHQK.H
	TK040203_NMyc_nuclei2_step11.0913.0913.2	0.9144	0.0342	1223.05	48	3640.0%	1	K.AGKLSFISVGNK.F
*	TK040203_NMyc_nuclei2_step03.1450.1450.1	1.6393	0.2291	1286.45	5	4500.0%	1	K.DGKPEVNRQIK.N
	TK040203_NMyc_nuclei2_step08.2912.2912.2	1.3371	0.1159	2026.14	1	3420.0%	1	K.MSQSIIVSGESGAGKTENTK.F

CO1A_MOUSE

88.4%

461

50975

6.5

(O89053) Coronin-like protein p57 (Coronin 1A)

	TK040203_NMyc_nuclei2_step11.1340.1340.2	2.4048	0.3337	2118.12	3	3330.0%	1	K.DRPHEGTRPVHAVFVSEGK.I

Q8R3B4

88.4%

1085

124966

7.0

(Q8R3B4) Similar to dysferlin (Fragment)

	TK040203_NMyc_nuclei2_step08.1657.1657.1	1.6277	0.2263	1399.58	1	4090.0%	1	K.ILHQHLGAPEER.L
*	TK040203_NMyc_nuclei2_step04.3161.3161.2	1.8628	0.2242	2489.33	2	2860.0%	1	K.GWEYGITIPPDNKPKSWVAAEK.M
*	TK040203_NMyc_nuclei2_step03.3802.3802.3	1.7167	0.1508	4098.41	1	1290.0%	2	K.WVIIGLLLLLILLLFVAVLLYSLPNYLSMKIVRPNA.-
*	TK040203_NMyc_nuclei2_step09.2441.2441.2	1.6406	0.2661	2732.94	2	2270.0%	1	K.IYDCELEDVADFEGLTDFSDTFK.L

TANK_MOUSE

88.0%

448

50939

5.9

(P70347) TRAF family member-associated NF-kappa-b activator (TRAF-interacting protein) (I-TRAF)

*	TK040203_NMyc_nuclei2_step01.3864.3864.3	1.6806	0.1116	4571.83	1	1280.0%	1	K.TNPSNLRATCLPAGDHNVFYVNTFPLQDPPDAPFPSLDSPGK.A
*	TK040203_NMyc_nuclei2_step01.2908.2908.2	1.7065	0.1513	2908.59	1	2400.0%	3	K.TEETLFEIQGIDPITSAIQNLKTTDK.T

SPCP_HUMAN

88.0%

2390

271293

6.1

(O15020) Spectrin beta chain, brain 2 (Spectrin, non-erythroid beta chain 2) (Beta-III spectrin)

*	TK040203_NMyc_nuclei2_step04.3609.3609.3	1.6628	0.0065	3147.25	91	1380.0%	1	R.QAEGVLSSQEYVLSHTEMPGTLQAADAAIK.K
*	TK040203_NMyc_nuclei2_step12.1423.1423.2	1.2241	0.034	1777.34	2	2780.0%	1	R.VDSANALANGLIAGGHAAR.A
*	TK040203_NMyc_nuclei2_step02.2278.2278.1	1.6418	0.2194	1309.66	1	5450.0%	2	R.QLVSEGNIHADK.I
*	TK040203_NMyc_nuclei2_step02.1206.1206.1	0.8878	0.062	811.89	13	5000.0%	1	R.AQQFYR.D
*	TK040203_NMyc_nuclei2_step01.2428.2428.1	1.601	0.0894	1266.68	1	5000.0%	1	R.SHYAAEEISEK.L
*	TK040203_NMyc_nuclei2_step02.3312.3312.2	1.476	0.0333	2543.32	15	1740.0%	1	K.EVEAIQAQAKALAQEDQGAGEVER.T
*	TK040203_NMyc_nuclei2_step08.3549.3549.2	1.6424	0.0611	3053.85	17	1400.0%	1	K.AALTSALSIQNYHLECTETQAWMREK.T
*	TK040203_NMyc_nuclei2_step01.3531.3531.1	0.8218	0.0212	1340.84	24	3330.0%	1	R.STESAHAATLPPR.G
*	TK040203_NMyc_nuclei2_step10.1380.1380.3	1.708	0.0156	2538.19	2	1980.0%	1	R.LEHSSFPEGPGPGSGDEANGPRGER.Q

Q9ERN6

87.9%

174

4967

564908

6.1

(Q9ERN6) Cardiac Ca2+ release channel

	TK040203_NMyc_nuclei2_step05.1887.1887.1	1.3111	0.076	1488.61	36	2690.0%	1	R.VGDDLILVSVSSER.Y
*	TK040203_NMyc_nuclei2_step04.2394.2394.2	1.2145	0.1179	2557.64	2	2270.0%	1	K.NHRLYFLSAASRPLCTGGHASNK.E
	TK040203_NMyc_nuclei2_step02.1950.1950.3	1.6671	0.2294	2174.6	1	2640.0%	1	K.NYQLTSGYKPAPMDLSFIK.L
	TK040203_NMyc_nuclei2_step10.3391.3391.2	2.0257	0.0423	3191.7	1	2500.0%	3	R.ISLFGNDATSIVNCLHILGQTLDARTVMK.T
	TK040203_NMyc_nuclei2_step01.2258.2258.1	1.4405	0.0436	980.22	12	6430.0%	11	K.RAVVACFR.M
	TK040203_NMyc_nuclei2_step05.3504.3504.2	1.4516	0.0209	3177.16	11	1670.0%	1	K.DVGFFQSLAGLMQSCSVLDLNAFERQNK.A
	TK040203_NMyc_nuclei2_step03.1519.1519.1	1.2033	0.0722	1075.69	34	4380.0%	1	K.EETKSEPEK.A
	TK040203_NMyc_nuclei2_step07.2836.2836.3	1.7077	0.0355	3703.13	2	1450.0%	1	K.AAMVLFLDRVYGIEVQDFLLHLLEVGFLPDLR.A
	TK040203_NMyc_nuclei2_step11.2744.2744.3	1.7982	0.0162	2591.85	71	1880.0%	1	K.NRQNLFQEEGMINLVLECIDR.L
	TK040203_NMyc_nuclei2_step02.2606.2606.2	1.0256	0.0373	2560.0	19	1400.0%	1	R.GAAEMVLQTISASKGETGPMVAATLK.L
	TK040203_NMyc_nuclei2_step10.3597.3597.2	2.1502	0.0029	3006.52	4	2040.0%	4	R.ALGMHETVMEVMVNVLGGGESKEITFPK.M
	TK040203_NMyc_nuclei2_step04.3010.3010.2	2.1213	0.1061	2339.23	7	2750.0%	1	R.TQTGNNTTVNIIISTVDYLLR.V
*	TK040203_NMyc_nuclei2_step08.2469.2469.2	1.2282	0.08	2146.83	5	2780.0%	1	R.VGWSRPGCQPDLELGSDDR.A
	TK040203_NMyc_nuclei2_step07.2288.2288.2	1.0468	0.0205	2298.92	331	1880.0%	1	K.MYQERCWEFFPAGDCFR.K
	TK040203_NMyc_nuclei2_step02.2443.2443.2	1.1525	0.1961	2848.23	22	1670.0%	1	K.QLVLTVGLLAVVVYLYTVVAFNFFR.K
	TK040203_NMyc_nuclei2_step04.2094.2094.3	1.6281	0.072	2963.85	5	2070.0%	1	R.NFYNMRMLALFVAFAINFILLFYK.V
	TK040203_NMyc_nuclei2_step03.3318.3318.2	1.6419	0.1721	3013.49	1	2290.0%	2	K.QMVDMLVESSNNVEMILKFFDMFLK.L
	TK040203_NMyc_nuclei2_step06.1163.1163.1	0.8355	0.0937	924.45	14	4170.0%	1	K.LEYFINK.Y
*	TK040203_NMyc_nuclei2_step07.1873.1873.3	1.7212	0.1152	3932.78	26	1500.0%	1	R.TYTRDLLGPTVSLTQAAFTPVPVDTSQIVLPPHLER.I

Q9R0E2

87.8%

728

83595

6.5

(Q9R0E2) Lysyl hydroxylase 1 (Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1)

*	TK040203_NMyc_nuclei2_step03.3134.3134.2	1.3563	0.1075	2577.7	2	2620.0%	1	R.IQGGYENVPTIDIHMNQITFER.E
*	TK040203_NMyc_nuclei2_step05.1668.1668.1	1.6163	0.2228	1396.48	1	4090.0%	1	R.LTHYHEGLPTTK.G
*	TK040203_NMyc_nuclei2_step10.3180.3180.3	1.4457	0.018	3176.1	69	1430.0%	1	K.GIGDEALPTVLVGVFIEQPTPFLSLFFLR.L

Q9EPS8

87.5%

13.0%

300

34125

8.9

(Q9EPS8) Pheromone receptor V3R4

*	TK040203_NMyc_nuclei2_step07.3705.3705.3	2.8093	0.3377	4477.99	5	1250.0%	1	R.GHAETRAAHTILMLVVTFVSLYILNCITILFHISFVESR.L

Q9D3R2

87.4%

410

45329

5.3

(Q9D3R2) 4933440L20Rik protein

	TK040203_NMyc_nuclei2_step03.1513.1513.1	1.8495	0.0457	1053.72	6	5620.0%	4	R.QLEFEATSK.T

Q9Y4D4

87.4%

851

94792

8.5

(Q9Y4D4) Hypothetical protein KIAA0648 (Fragment)

*	TK040203_NMyc_nuclei2_step01.0488.0488.1	1.0282	0.022	867.33	8	6670.0%	1	R.ELLDLHK.Q
*	TK040203_NMyc_nuclei2_step02.0490.0490.1	1.5483	0.2417	1493.33	1	4230.0%	1	K.VDESGPPAPSKPRR.G

Q9D168

87.4%

14.3%

461

48568

9.7

(Q9D168) 1110020M19Rik protein

*	TK040203_NMyc_nuclei2_step10.1875.1875.2	2.1555	0.3685	2105.24	1	3680.0%	1	K.TQKPPQKPAPTVVSVTPTVK.D
*	TK040203_NMyc_nuclei2_step04.3931.3931.3	1.3576	0.1931	3597.56	7	1360.0%	1	K.RTEVKPSTVISGNSSSNNVSSSVTSGLTGWAAFAAK.T
*	TK040203_NMyc_nuclei2_step11.3520.3520.3	1.7552	0.037	4334.58	16	1080.0%	1	R.TEVKPSTVISGNSSSNNVSSSVTSGLTGWAAFAAKTSSAGPSTAK.L

Q9CX41

87.3%

285

33142

6.0

(Q9CX41) 8030491N06Rik protein

*	TK040203_NMyc_nuclei2_step05.1202.1202.1	1.4859	0.294	1219.48	1	5500.0%	1	R.VSNMSVELLTK.G

Q15058

87.2%

1648

186490

7.9

(Q15058) Hypothetical protein KIAA0042

*	TK040203_NMyc_nuclei2_step09.1467.1467.3	1.7181	0.1302	3782.73	45	1250.0%	1	-.MSLHSTHNRNNSGDILDIPSSQNSSSLNALTHSSR.L
*	TK040203_NMyc_nuclei2_step09.3521.3521.3	1.6577	0.2365	4508.93	43	960.0%	1	K.AGIMFQMDNHLPNLVNLNEDPQLSEMLLYMIKEGTTTVGK.Y
*	TK040203_NMyc_nuclei2_step09.3579.3579.3	2.3499	0.0462	3162.46	7	1700.0%	1	R.IVNNAKNSFVASSVPLDEDPQVIEMMADK.K
*	TK040203_NMyc_nuclei2_step12.1199.1199.2	1.2102	0.0237	1672.15	24	3750.0%	1	K.LHQQERDMAEMQR.V
*	TK040203_NMyc_nuclei2_step08.3324.3324.2	1.4115	0.0195	3067.17	5	1900.0%	9	K.ESLGGNSKTAMIATISPAASNIEETLSTLR.Y

SUR4_MOUSE

87.2%

269

30381

7.8

(Q64310) Surfeit locus protein 4

	TK040203_NMyc_nuclei2_step10.3425.3425.3	2.7452	0.3433	3812.51	1	1610.0%	1	R.NFVQYACFGLFGIIALQTIAYSILWDLKFLMR.N

Q9D3V8

87.1%

25.1%

625

72581

9.0

(Q9D3V8) 4933432B09Rik protein

*	TK040203_NMyc_nuclei2_step01.2792.2792.2	1.1068	0.2005	2154.14	14	1940.0%	1	K.LPNGVDFCDMVGNVIRSEK.N
*	TK040203_NMyc_nuclei2_step04.2165.2165.1	1.1403	0.0303	958.64	24	5000.0%	3	R.NYASLLFK.M
*	TK040203_NMyc_nuclei2_step03.1503.1503.2	1.0995	0.0806	1600.2	20	3570.0%	1	K.NRVVSSTSLFESSGK.K
*	TK040203_NMyc_nuclei2_step01.3726.3726.3	1.6976	0.0758	4375.5	5	1400.0%	1	K.SEICNTMNLWVSGMYPCLQSYNNWDYSELDPERFR.Q
*	TK040203_NMyc_nuclei2_step10.2508.2508.3	1.6381	0.0697	3671.08	18	1480.0%	1	K.LRQLDQMHENEWNCFNNYLTELQENFER.E
*	TK040203_NMyc_nuclei2_step01.4268.4268.2	1.3443	0.0431	2840.33	1	1880.0%	1	R.IMEVELGSSLMISTLAIEDYELEKK.S
*	TK040203_NMyc_nuclei2_step07.1585.1585.3	1.4888	0.187	2861.64	200	1630.0%	1	K.SPSSEGSSSISTIKQDMLFQLSPSSME.-

Q9EQJ0

87.0%

817

94496

8.5

(Q9EQJ0) Calcium channel

*	TK040203_NMyc_nuclei2_step08.2320.2320.1	1.9254	0.2123	1409.49	1	4290.0%	3	R.GSVPGPAAQQPPGSR.Q

Q9CZT3

86.9%

27.5%

335

37970

9.8

(Q9CZT3) 2610529C04Rik protein

	TK040203_NMyc_nuclei2_step07.2925.2925.2	1.4827	0.1901	2202.45	2	2780.0%	1	K.APPRNYSVVVMFTALQLHR.Q
	TK040203_NMyc_nuclei2_step11.2328.2328.3	1.4744	0.1095	2579.4	6	2160.0%	1	-.MASPRWFWSVCAIAAVALLLVSK.V
*	TK040203_NMyc_nuclei2_step01.3410.3410.2	2.1694	0.1154	2751.58	4	2500.0%	2	R.RMMCIAGNGLVVLFFSWMLSIFR.S
	TK040203_NMyc_nuclei2_step10.1819.1819.2	1.7001	0.0562	1776.26	25	3930.0%	1	R.NYSVVVMFTALQLHR.Q
	TK040203_NMyc_nuclei2_step09.2866.2866.2	1.0558	0.0245	2881.46	1	1730.0%	1	R.VIRPPNYAGPLMLGLLLAVIGGLVYLR.R

MLEY_HUMAN

86.9%

30.3%

208

22764

5.7

(P14649) Myosin light chain 1, slow-twitch muscle A isoform (MLC1sa) (Alkali)

*	TK040203_NMyc_nuclei2_step04.1155.1155.2	0.9456	0.1397	1538.14	17	2920.0%	1	R.GQGTYEDYLEGFR.V
*	TK040203_NMyc_nuclei2_step01.2734.2734.2	1.2595	0.0932	2086.13	179	1820.0%	3	K.KPAGPSISKPAAKPAAAGAPPAK.T
*	TK040203_NMyc_nuclei2_step05.3452.3452.2	1.4237	0.0080	3086.72	15	1730.0%	1	K.MTEEEVETVLAGHEDSNGCINYEAFLK.H

MY1C_MOUSE

86.7%

1028

118156

9.4

(Q9WTI7) Myosin Ic (Myosin I beta) (MMIb)

	TK040203_NMyc_nuclei2_step07.3654.3654.2	1.9658	0.2009	2737.71	1	2500.0%	1	R.IDYANLTGISVSSLSDSLFVLHVQR.E
*	TK040203_NMyc_nuclei2_step05.2504.2504.2	0.9574	0.0316	2359.79	134	2000.0%	1	R.VLQSLGSEPIQYAVPVVKYDR.K
	TK040203_NMyc_nuclei2_step10.3648.3648.2	1.4197	0.1524	2612.94	4	2050.0%	2	R.VGVQDFVLLENFTSEAAFIENLR.R
*	TK040203_NMyc_nuclei2_step12.1409.1409.2	2.2055	0.1286	1800.64	1	4290.0%	1	K.LEDTVKPHPHFLTHK.L

Q9CTK6

86.7%

641

70796

6.5

(Q9CTK6) 1110001J12Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step06.2530.2530.3	1.779	0.0947	2297.59	3	2390.0%	1	K.SPQLGVQAGLEPILSSATVDSTK.R
*	TK040203_NMyc_nuclei2_step10.1701.1701.3	3.0101	0.2593	2591.37	1	3260.0%	2	K.KYSNSISVGAFLDGDDDSSLEEIK.N

E4L2_MOUSE

86.5%

988

109833

5.5

(O70318) Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G)

	TK040203_NMyc_nuclei2_step04.2006.2006.1	1.3057	0.0607	910.59	1	7140.0%	6	R.KVEPVAHK.D
	TK040203_NMyc_nuclei2_step07.1564.1564.1	1.4313	0.1304	1384.72	3	4170.0%	1	K.EMSPGHGPGETRK.V
*	TK040203_NMyc_nuclei2_step06.2875.2875.2	1.7	0.1243	2237.89	4	2500.0%	1	R.EEQEECDEELEEEPGQGAK.V
	TK040203_NMyc_nuclei2_step06.1743.1743.1	2.0727	0.1552	1347.6	1	6670.0%	1	K.VCVEHHTFYR.L
*	TK040203_NMyc_nuclei2_step08.2485.2485.3	1.5812	0.1186	3314.37	35	1370.0%	1	R.EAAVPDAVPDRQAGASVLPVETEAQEHVVAQK.L
*	TK040203_NMyc_nuclei2_step07.3338.3338.3	1.7035	0.0571	2891.21	9	1900.0%	1	R.VNGEVPHLDLDGLPEIICCSEPPVVK.T

CRTC_MOUSE

86.4%

21.6%

416

47995

4.5

(P14211) Calreticulin precursor (CRP55) (Calregulin) (HACBP) (ERp60)

*	TK040203_NMyc_nuclei2_step10.3640.3640.3	2.8002	0.2109	4138.14	1	1790.0%	1	K.GTWIHPEIDNPEYSPDANIYAYDSFAVLGLDLWQVK.S
*	TK040203_NMyc_nuclei2_step12.2598.2598.3	2.2536	0.125	2498.27	3	2390.0%	1	-.MLLSVPLLLGLLGLAAADPAIYFK.E
	TK040203_NMyc_nuclei2_step11.3823.3823.2	1.1795	0.0306	2581.55	4	2140.0%	1	R.DEDEDEEDEKEEDEEESPGQAK.D
	TK040203_NMyc_nuclei2_step02.2126.2126.1	1.8871	0.206	1019.77	1	7860.0%	2	K.VHVIFNYK.G

RU17_MOUSE

86.4%

378

43723

10.1

(Q62376) U1 small nuclear ribonucleoprotein 70 kDa (U1 SNRNP 70 kDa) (snRNP70) (Fragment)

	TK040203_NMyc_nuclei2_step02.1334.1334.1	1.8784	0.2094	958.68	2	6250.0%	1	R.RGGADVNIR.H
	TK040203_NMyc_nuclei2_step03.1345.1345.1	1.0745	0.0226	700.59	58	6000.0%	1	K.RSGKPR.G
	TK040203_NMyc_nuclei2_step05.1528.1528.1	1.5473	0.1477	1522.74	1	4580.0%	3	R.YDERPGPSPLPHR.D

MATK_MOUSE

86.3%

505

56057

8.8

(P41242) Megakaryocyte-associated tyrosine-protein kinase (EC 2.7.1.112) (Tyrosine-protein kinase CTK) (Protein kinase NTK)

*	TK040203_NMyc_nuclei2_step02.2440.2440.1	1.5768	0.2274	1368.45	1	5000.0%	2	R.LFGAWHPAPAAAR.M

IF41_HUMAN

86.2%

19.0%

406

46154

5.5

(P04765) Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (P04765) Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I)

	TK040203_NMyc_nuclei2_step03.2895.2895.2	1.3863	0.1948	2148.32	4	2780.0%	2	R.GIDVQQVSLVINYDLPTNR.E
	TK040203_NMyc_nuclei2_step04.3788.3788.3	1.2459	0.0258	3924.95	1	1540.0%	1	R.DNGPDGMEPEGVIESNWNEIVDSFDDMNLSESLLR.G
	TK040203_NMyc_nuclei2_step11.2531.2531.2	1.2523	0.0080	2715.84	1	2270.0%	1	K.LDTLCDLYETLTITQAVIFINTR.R

Q9QXB7

86.1%

464

49226

6.2

(Q9QXB7) Deafness locus associated putative guanine nucleotide exchange factor

*	TK040203_NMyc_nuclei2_step06.2795.2795.2	2.0203	0.3766	2816.0	1	2610.0%	1	R.IEAHYFQDEKVTAVWSGWTHLVAK.T

Q96AA2

85.7%

169

6620

721701

5.8

(Q96AA2) Obscurin

*	TK040203_NMyc_nuclei2_step04.3731.3731.3	1.3706	0.0646	3953.22	22	1140.0%	1	K.EQSVHNEVQAEAGASAMLSCEVAQAQTEVTWYKDGK.K
*	TK040203_NMyc_nuclei2_step02.4110.4110.3	2.0641	0.1558	3901.82	10	1210.0%	1	R.RSADSGQSSFTTELSTQTVNFGTVGETVTLHICPDR.D
*	TK040203_NMyc_nuclei2_step09.3038.3038.3	1.7181	8.0E-4	3869.27	9	1290.0%	1	R.QHQGTYTCIASNAAGQALCSASLHVSGLPKVEEQEK.V
*	TK040203_NMyc_nuclei2_step12.1811.1811.3	1.4903	0.0629	3874.13	3	1360.0%	1	K.LLEEDDHYMINEDQQGGHQLIITAVVPADMGVYR.C
*	TK040203_NMyc_nuclei2_step09.2194.2194.3	1.8204	0.2462	2435.12	36	2140.0%	1	R.LHEEAQLLAELSDQAAAVTWLK.D
	TK040203_NMyc_nuclei2_step05.3099.3099.3	1.6394	0.0674	4023.04	7	1390.0%	1	R.QDGAVCELQICGLAVADAGEYSCVCGEERTSATLTVK.A
*	TK040203_NMyc_nuclei2_step10.1832.1832.1	1.0777	0.0849	1092.95	27	5000.0%	1	R.LMPADAGVYR.C
*	TK040203_NMyc_nuclei2_step03.1466.1466.1	1.2729	0.0421	897.53	8	5000.0%	1	R.DGGTYEVR.A
*	TK040203_NMyc_nuclei2_step10.1873.1873.3	1.6129	0.0925	2462.7	24	2020.0%	1	R.FQEMFATLGIGVEIKLVEQGPR.R
*	TK040203_NMyc_nuclei2_step09.2149.2149.3	1.6351	0.0822	3376.63	31	1480.0%	1	R.DIGRFHSSFLQELQQCDTDDDVAMCFIK.N
*	TK040203_NMyc_nuclei2_step05.1886.1886.1	1.327	0.0501	1470.61	7	3750.0%	1	R.WYKDGALLTTGNK.F
*	TK040203_NMyc_nuclei2_step05.3119.3119.3	1.5185	0.0286	3462.21	50	1410.0%	1	K.FGQVTHSACVVVSGSESEAESSSGGELDDAFRR.A
*	TK040203_NMyc_nuclei2_step12.3823.3823.2	1.4943	0.1296	3022.35	1	1850.0%	12	K.AFVVSVGKDATLSCQIVGNPTPQVSWEK.D
	TK040203_NMyc_nuclei2_step11.4343.4343.3	1.4407	0.0738	3216.17	3	1880.0%	1	K.TPLHANELNEIDAQPGGYHVLTLRQLALK.D
*	TK040203_NMyc_nuclei2_step01.2618.2618.1	1.1188	0.0146	1311.75	18	4500.0%	1	R.LSFHLDVKEPK.V
*	TK040203_NMyc_nuclei2_step12.3465.3465.3	1.9083	0.1979	4388.8	40	1120.0%	1	R.EPLQSLQAEEGSTATLQCELSEPTATVVWSKGGLQLQANGR.R
*	TK040203_NMyc_nuclei2_step05.2687.2687.3	1.7705	0.1302	3136.95	14	1640.0%	3	R.GVLWIGPDTPGYTVASSAQQHSLVLLDVGR.Q
*	TK040203_NMyc_nuclei2_step04.2973.2973.3	1.8491	0.0376	3550.23	41	1290.0%	1	K.DMAGSCVDAVAGGPAQFECETSEAHVHVHWYK.D

Q8TDN5

85.6%

5183

573909

6.0

(Q8TDN5) Retinoblastoma-associated factor 600

*	TK040203_NMyc_nuclei2_step02.1210.1210.1	0.7803	0.0433	976.98	72	3570.0%	1	K.NLDADIWK.K
	TK040203_NMyc_nuclei2_step06.2255.2255.2	1.2895	0.0271	2623.39	99	1520.0%	1	K.AVEMTDQLMVPTLGSQEGAFENVR.M
	TK040203_NMyc_nuclei2_step04.3296.3296.2	1.3936	0.2491	2097.48	2	2940.0%	1	R.APSYIEIFGRTMQLNLSR.S
*	TK040203_NMyc_nuclei2_step03.3974.3974.3	0.9878	0.0288	2625.1	8	1350.0%	1	R.ASVVTASSGSALQYDTLISLMEHLK.A
*	TK040203_NMyc_nuclei2_step09.3035.3035.3	2.0798	0.0264	4127.96	3	1390.0%	1	R.EEWESAALQNANTKCNGLLPVWGPHVPESAFATCLAR.H
*	TK040203_NMyc_nuclei2_step01.2550.2550.1	1.6688	0.0484	1181.66	26	5000.0%	5	R.KLLLFICGSK.E
	TK040203_NMyc_nuclei2_step01.2823.2823.1	1.3397	0.0404	1559.69	36	2860.0%	1	K.AEHASSLLELASTTK.C
*	TK040203_NMyc_nuclei2_step05.2376.2376.3	1.9727	0.1334	2766.77	73	1520.0%	1	K.ICQDCDLVALLEDDSGMELLVNNK.I
*	TK040203_NMyc_nuclei2_step04.3275.3275.2	2.5053	0.2398	3011.12	1	2600.0%	3	K.NKICQDCDLVALLEDDSGMELLVNNK.I
*	TK040203_NMyc_nuclei2_step01.0700.0700.2	1.1493	0.1977	1648.07	239	2690.0%	1	K.TPVVVENITLMCLR.I
*	TK040203_NMyc_nuclei2_step03.4162.4162.2	1.2748	0.0025	3106.91	48	1350.0%	1	R.CALSLFLMAVNIKTPVVVENITLMCLR.I
	TK040203_NMyc_nuclei2_step09.3651.3651.3	1.779	0.0035	3992.43	13	1180.0%	1	R.TLLPLLLESSTESVAEISSNSLERILGPAESDEFLAR.V

Q9QYC4

85.6%

910

101043

9.2

(Q9QYC4) HepA-related protein Harp

*	TK040203_NMyc_nuclei2_step06.1519.1519.2	1.2418	0.0732	3032.32	6	1800.0%	1	R.FTWEQAFLRWLPSLSPENINVVVTGK.G
*	TK040203_NMyc_nuclei2_step04.2685.2685.2	1.302	0.0185	1936.31	21	3120.0%	1	K.IGYNQELIAVFKSLPSR.H
*	TK040203_NMyc_nuclei2_step12.3046.3046.2	2.1786	0.3423	2926.37	1	2410.0%	1	K.TQGEMSTACPKPNPSPPGASNQPLLGYK.S
*	TK040203_NMyc_nuclei2_step04.3767.3767.3	1.7615	0.0921	3772.84	1	1560.0%	1	K.QQNLSNSFPTDQRPHSSRCSQPSPAEETTGLWK.T
*	TK040203_NMyc_nuclei2_step01.0917.0917.3	1.6668	0.0298	2120.18	66	2350.0%	1	K.IPCVVEYILDLLDSGREK.F
*	TK040203_NMyc_nuclei2_step12.4055.4055.3	2.4369	0.2522	4600.38	21	1070.0%	1	R.CSQPSPAEETTGLWKTQGEMSTACPKPNPSPPGASNQPLLGYK.S

Q9EQ36

85.3%

19.1%

303

34965

9.7

(Q9EQ36) Vomeronasal receptor V1RC7

*	TK040203_NMyc_nuclei2_step03.2246.2246.3	2.8876	0.3188	4466.62	2	1420.0%	1	K.IYMINALFYIWTFNLSLSSNLIFYVGGFTNMSQTKQLK.V
*	TK040203_NMyc_nuclei2_step08.2335.2335.2	1.2351	0.1286	2194.52	4	2370.0%	1	K.LVVNAYPAITPFVQISSDTR.V

Q9H8F1

85.3%

875

97135

6.6

(Q9H8F1) Hypothetical protein FLJ13687

*	TK040203_NMyc_nuclei2_step12.3987.3987.3	2.312	0.1638	4586.63	1	1420.0%	3	R.AAVSENDSDELLIDLERPQSNSSAVTGTSGSIMENGVSSSNTADK.S
*	TK040203_NMyc_nuclei2_step04.1390.1390.1	1.0901	0.017	1038.52	21	5560.0%	1	K.AAYSLLGSQK.S

O08847

85.1%

196

1966

216760

7.5

(O08847) RNA polymerase II largest subunit

*	TK040203_NMyc_nuclei2_step10.3460.3460.2	1.5365	0.1073	3098.12	2	1720.0%	14	K.GSTYSPTSPGYSPTSPTYSLTSPAISDEEN.-

Q9NZ71

84.9%

1400

152374

8.3

(Q9NZ71) Helicase-like protein NHL (BK3184A7.3.5) (LOC51750), isoform 5 (Hypothetical protein KIAA1088)

*	TK040203_NMyc_nuclei2_step08.3193.3193.2	1.8151	0.1343	3064.93	22	1560.0%	3	K.DHEGAGGARPVAAVPGVGAACPAAGAGCTRSGR.N

Q9HDA4

84.8%

1909

206846

6.4

(Q9HDA4) Plexin-B3

	TK040203_NMyc_nuclei2_step08.3199.3199.2	1.2185	0.0295	2592.23	76	1670.0%	1	R.LCYTAGGRGPSGAEEATVEYGVTSR.C
	TK040203_NMyc_nuclei2_step12.4234.4234.3	2.4154	0.2541	3951.87	10	1430.0%	3	R.GSTISQSLAQRCPLGENIPTLEDGEEGGVCLWHLVK.A
	TK040203_NMyc_nuclei2_step12.2281.2281.3	1.9438	0.2506	4440.08	10	1100.0%	1	R.YGPLCPPGAVELLCPAPSIDAVEPLTGPPEGGLALTILGSNLGR.A
	TK040203_NMyc_nuclei2_step04.3359.3359.3	2.2786	0.0301	3068.41	8	1850.0%	1	R.VAIKSQPPGISSQHFTYQDPVLLSLSPR.W
	TK040203_NMyc_nuclei2_step09.3262.3262.3	1.8445	0.0958	4509.92	17	1070.0%	1	R.VCLGDTNLYSYVEVPLACQGQGLIQAAFLAPGTLLGVFAAGPR.G
	TK040203_NMyc_nuclei2_step01.3735.3735.2	1.1297	0.1201	2560.31	245	1360.0%	1	R.LNTLQHYKVPDGATVGLVPQLHR.G
	TK040203_NMyc_nuclei2_step09.2973.2973.2	1.1895	0.1021	2709.38	2	2080.0%	1	R.TLLASPFRYTANPQLVAAEPSASFR.G

Q8QZU6

84.8%

264

29185

6.7

(Q8QZU6) Similar to unknown (Protein for IMAGE:3534875) (Fragment)

*	TK040203_NMyc_nuclei2_step01.1154.1154.1	1.6735	0.017	1588.58	8	3460.0%	6	R.VVAPHQLHSEANER.L

O75199

84.8%

15.0%

367

42559

10.6

(O75199) Hypothetical protein

*	TK040203_NMyc_nuclei2_step10.3580.3580.3	1.9102	0.1057	4571.53	8	1220.0%	1	K.ECPLAPLPPSPLPPSVDDNLKECLFVPLPPSPLPPSVDDNLK.E
*	TK040203_NMyc_nuclei2_step01.0116.0116.1	1.7747	0.212	1522.54	1	5000.0%	1	R.QREAEAQQLPKPK.R

Q9WV02

84.8%

391

42301

10.1

(Q9WV02) Heterogeneous nuclear ribonucleoprotein G (RNA binding motif protein, X chromosome)

	TK040203_NMyc_nuclei2_step01.2487.2487.1	1.5798	0.1301	1488.65	1	4230.0%	3	R.GFAFVTFESPADAK.D

MOES_MOUSE

84.2%

576

67636

6.6

(P26041) Moesin (Membrane-organizing extension spike protein)

	TK040203_NMyc_nuclei2_step03.1786.1786.1	1.703	0.1128	1235.65	2	5000.0%	3	R.IQVWHEEHR.G

O55189

83.9%

407

43664

6.5

(O55189) Ameloblastin

*	TK040203_NMyc_nuclei2_step01.1113.1113.1	1.9452	0.1907	1570.63	2	3670.0%	6	K.GEGPEGSPLQEANPGK.R

RGS3_HUMAN

83.9%

519

56602

4.9

(P49796) Regulator of G-protein signaling 3 (RGS3) (RGP3)

	TK040203_NMyc_nuclei2_step01.2256.2256.1	2.0882	0.0095	1182.73	3	5000.0%	1	R.RNESPGAPPAGK.A
	TK040203_NMyc_nuclei2_step09.2398.2398.2	1.3946	0.1031	2389.77	4	2270.0%	1	R.SSMIETGQGAEGGLSLRVQNSLR.R

Q8VDN3

83.8%

1024

105246

9.0

(Q8VDN3) Hypothetical 105.2 kDa protein (Fragment)

*	TK040203_NMyc_nuclei2_step03.2189.2189.1	1.8144	0.2008	1478.77	4	3330.0%	4	K.GSGLGLHGAVPDIGVK.G
*	TK040203_NMyc_nuclei2_step12.1494.1494.2	1.4177	0.1102	2827.96	3	1430.0%	1	K.VHIGADGVKMSGIDATTALSVGAPDVTLK.G

ANX2_MOUSE

83.5%

338

38545

7.7

(P07356) Annexin II (Lipocortin II) (Calpactin I heavy chain) (Chromobindin 8) (P36) (Protein I) (Placental anticoagulant protein IV) (PAP-IV)

	TK040203_NMyc_nuclei2_step04.3039.3039.1	1.4593	0.2263	1542.7	2	3460.0%	1	K.GVDEVTIVNILTNR.S
*	TK040203_NMyc_nuclei2_step01.2459.2459.1	1.4758	0.1122	1434.44	2	4090.0%	1	K.SYSPYDMLESIK.K
*	TK040203_NMyc_nuclei2_step01.1359.1359.1	1.6396	0.2108	888.46	1	6430.0%	2	K.KELPSALK.S

Q96RX3

83.5%

486

53271

5.0

(Q96RX3) Sperm-specific thioredoxin

*	TK040203_NMyc_nuclei2_step10.0178.0178.1	0.8527	0.0394	1571.4	5	1790.0%	1	K.ASVKPSQPKEGDISK.S
*	TK040203_NMyc_nuclei2_step08.1932.1932.1	1.3424	0.0211	1392.41	19	3640.0%	1	K.EEKVDELCGALK.E
*	TK040203_NMyc_nuclei2_step01.2496.2496.1	1.6548	0.2162	1553.64	3	3570.0%	1	K.SSAKPIQPKLGNIAK.T

Q8VCC5

83.4%

415

45390

8.3

(Q8VCC5) Hypothetical 45.4 kDa protein (Fragment)

*	TK040203_NMyc_nuclei2_step05.2703.2703.3	1.6485	0.0919	4383.19	13	1220.0%	1	R.CSIDSQASLCQLVASATPYVRDVGDGSSTSSTGSTDSPDHHK.H
*	TK040203_NMyc_nuclei2_step06.1369.1369.1	1.4971	0.2475	1140.52	2	5000.0%	1	K.QHYGASPDHK.H

OST4_MOUSE

83.4%

21.8%

441

49014

5.8

(O54734) Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit precursor (EC 2.4.1.119) (Oligosaccharyl transferase 48 kDa subunit) (DDOST 48 kDa subunit)

	TK040203_NMyc_nuclei2_step12.1914.1914.2	1.3147	0.1015	2236.06	45	2220.0%	1	R.YSQTGNYELAVALSRWVFK.E
*	TK040203_NMyc_nuclei2_step04.4279.4279.3	1.2239	0.1282	4367.5	25	1000.0%	1	R.GVGMVADPDNPLVLDILTGSSTSYSFFPDKPITQYPHAVGR.N
*	TK040203_NMyc_nuclei2_step06.2893.2893.3	1.9289	0.0879	3902.5	52	1140.0%	4	K.TAVIDHHNYDVSDLGQHTLIVADTENLLKAPTIVGK.S

Q8TCU4

83.4%

4169

461195

6.3

(Q8TCU4) ALMS1 protein

*	TK040203_NMyc_nuclei2_step04.2175.2175.3	1.8086	0.1279	2462.59	16	2140.0%	1	R.GKPSIFYQQGLPDSHLTEEALK.V
*	TK040203_NMyc_nuclei2_step07.2673.2673.3	2.0062	0.1669	3779.37	90	1070.0%	1	R.VVTKASLPVGEKPLQNENADASVQVLITGDENLSDK.K
*	TK040203_NMyc_nuclei2_step05.2847.2847.2	1.3048	0.2028	2504.44	1	2500.0%	1	K.VSAVSGPADQKTGTATVLSTPHSHR.E
*	TK040203_NMyc_nuclei2_step12.1481.1481.2	1.0316	0.0971	2345.43	7	2110.0%	1	R.EKPIVSYQRELPHFTEAGLK.I
*	TK040203_NMyc_nuclei2_step03.2094.2094.2	1.1201	0.0576	1484.13	3	4580.0%	1	R.VFLAIQKNKPISK.K
*	TK040203_NMyc_nuclei2_step07.4305.4305.3	1.6189	0.0153	4765.77	77	830.0%	1	K.VSAFPGPADQMTDTPAVPSTFYSQREKPGIFYQQTLPESHLPK.E
*	TK040203_NMyc_nuclei2_step12.3615.3615.3	2.1543	0.1859	3874.12	10	1320.0%	1	R.EEEGVSESEDGGGSSVDSLAAHVKNLLQCESSLNHAK.E
*	TK040203_NMyc_nuclei2_step04.3736.3736.2	1.2004	0.0619	2004.06	73	2190.0%	1	K.NVTITPDLPSCIFLEQR.E
*	TK040203_NMyc_nuclei2_step10.1277.1277.1	1.3151	0.2445	1042.52	37	4000.0%	1	K.VSAVAGPADQK.T
*	TK040203_NMyc_nuclei2_step07.1801.1801.3	1.4894	0.0421	3480.01	17	1480.0%	1	K.ASLPVGEKPLQNENADASVQVLITGDENLSDKK.Q
*	TK040203_NMyc_nuclei2_step03.1975.1975.2	0.8915	0.0029	1673.83	172	2330.0%	1	K.TGIPIGLSSSYSHSHK.E
*	TK040203_NMyc_nuclei2_step04.1722.1722.2	1.2756	0.0316	1614.24	4	3750.0%	1	R.EEKMLFTGYPEDR.K
*	TK040203_NMyc_nuclei2_step11.3319.3319.3	1.5117	0.0698	2539.5	83	1670.0%	1	K.VSAAPGLADQTTGMSTLTSTSYSHR.E
*	TK040203_NMyc_nuclei2_step03.2642.2642.2	2.0668	0.3529	2888.13	2	1880.0%	1	R.ELDSDSHYGPQHLESIDDEEDEEAK.A
*	TK040203_NMyc_nuclei2_step08.3079.3079.3	2.0873	0.0177	2595.99	1	2400.0%	1	K.VSVAPGPVGQTTGAPTITSPSYSQHR.A
*	TK040203_NMyc_nuclei2_step12.2783.2783.2	0.9512	0.0146	2232.66	7	2370.0%	1	R.SDFTGSHSEPSTRANCSNFK.E
*	TK040203_NMyc_nuclei2_step02.3496.3496.3	1.8732	0.1458	3899.34	34	1290.0%	1	K.TVPTPTVPSGSFSHREKPSIFYQQEWPDSYATEK.A

Q9Y5L8

83.3%

114

12951

9.4

(Q9Y5L8) Apoptosis related protein APR-4 (Fragment)

*	TK040203_NMyc_nuclei2_step02.1499.1499.1	1.6334	0.0764	1571.74	3	4170.0%	2	K.GHQPWKFSLAWGR.S

Q9DC86

83.3%

23.2%

263

27821

5.2

(Q9DC86) 2200008D09Rik protein

	TK040203_NMyc_nuclei2_step02.2242.2242.3	3.0276	0.2111	2849.62	1	2310.0%	1	K.DGVWTLAGIVSWGSGFCSTSTPAVYAR.V
	TK040203_NMyc_nuclei2_step08.2403.2403.3	2.5457	0.2363	3532.93	1	1820.0%	1	K.ESWGSKITDVMICAGASGVSSCMGDSGGPLVCQK.D

Q13127

83.2%

1097

121888

6.7

(Q13127) REST protein

*	TK040203_NMyc_nuclei2_step11.3610.3610.2	2.4493	0.274	3104.21	2	2220.0%	1	K.IELSPPIEVVQKEPVQMELSPPMGVVQK.E
*	TK040203_NMyc_nuclei2_step08.2495.2495.2	1.3786	0.0364	2622.22	2	1880.0%	1	K.EPVEKGSAQMDPPQMGPAPTEAVQK.G

SG2_MOUSE

83.2%

617

70644

4.8

(Q03517) Secretogranin II precursor (SGII) (Chromogranin C)

*	TK040203_NMyc_nuclei2_step03.4022.4022.2	1.1594	0.0345	2944.14	8	1920.0%	1	K.AYRLGAVLLLIHLIFLISGAEAASFQR.N
*	TK040203_NMyc_nuclei2_step01.1750.1750.1	1.328	0.0056	1292.69	46	4440.0%	1	K.NEQINEEMKR.S
*	TK040203_NMyc_nuclei2_step09.3447.3447.2	2.2958	0.3178	2556.38	1	2610.0%	2	R.LGAVLLLIHLIFLISGAEAASFQR.N

Q8R1S2

83.1%

17.7%

549

60346

8.1

(Q8R1S2) Similar to aldehyde dehydrogenase 4 family, member A1 (Fragment)

*	TK040203_NMyc_nuclei2_step08.2313.2313.3	1.7834	0.0137	4420.89	6	1160.0%	1	R.EAGLPPNIIQFVPADGPTFGDTVTSSEHLCGINFTGSVPTFK.H
*	TK040203_NMyc_nuclei2_step05.3600.3600.3	2.2068	0.1155	3957.69	23	1250.0%	1	K.GQTEAIPCVVGDEEVWTSDIQYQLSPFNHAHKVAK.F
*	TK040203_NMyc_nuclei2_step04.2639.2639.2	1.9124	0.4257	2174.57	1	3420.0%	1	K.NFHFVHSSADVDSVVSGTLR.S

Q91W33

83.1%

206

20897

9.1

(Q91W33) Hypothetical 20.9 kDa protein (Fragment)

*	TK040203_NMyc_nuclei2_step02.4094.4094.2	2.3886	0.2933	2956.54	1	2780.0%	1	R.DLQKLLHLNQASVAQTALTGAASAGCWK.E

Q8WZ42

82.9%

116

152

34350

3816111

6.3

(Q8WZ42) Titin

	TK040203_NMyc_nuclei2_step12.4137.4137.2	1.2296	0.1247	3084.4	1	2400.0%	1	K.MHFRNNVATLVFNQVDINDSGEYICK.A
	TK040203_NMyc_nuclei2_step08.1413.1413.1	1.01	0.1438	1232.37	1	5000.0%	1	R.VNKKPVYDLR.V
	TK040203_NMyc_nuclei2_step11.3968.3968.2	1.2483	0.0733	1871.52	9	2810.0%	1	K.YDVPGPPLNVTITDVNR.F
	TK040203_NMyc_nuclei2_step06.1977.1977.3	1.7091	0.0866	2911.42	23	1440.0%	1	K.VEDSGSYSCEAVNDVGSDSCSTEIVIK.E
	TK040203_NMyc_nuclei2_step12.0746.0746.2	1.2925	0.2697	1827.52	1	3570.0%	1	K.ISWYKEEQLLSTGFK.C
	TK040203_NMyc_nuclei2_step01.4056.4056.2	1.1924	0.1561	2805.07	1	2120.0%	1	K.VSGLKIINVAPSDSGVYSFEVQNPVGK.D
	TK040203_NMyc_nuclei2_step11.4400.4400.2	1.2932	0.1654	2485.38	2	2500.0%	1	K.AQNRYGVGPGITSACIVANYPFK.V
	TK040203_NMyc_nuclei2_step08.2508.2508.2	1.5271	0.2892	2644.1	3	1880.0%	1	R.LAPVDAVVGESADFECHVTGTQPIK.V
	TK040203_NMyc_nuclei2_step04.3173.3173.2	1.6165	0.0686	2082.2	1	3610.0%	1	K.DPIEPPGPPTNFRVVDTTK.H
	TK040203_NMyc_nuclei2_step03.3127.3127.2	1.3513	0.03	2700.3	9	2080.0%	1	K.GFCQVNVVDRPGPPVGPVSFDEVTK.D
	TK040203_NMyc_nuclei2_step07.2566.2566.3	1.4813	0.0189	3899.24	99	1030.0%	1	R.VSAVNIVGQGKPSFCTKPITCKDELAPPTLHLDFR.D
	TK040203_NMyc_nuclei2_step07.3054.3054.2	1.437	3.0E-4	2415.03	228	1500.0%	1	R.CNTAPHQIPQEEYTATGLEEK.A
	TK040203_NMyc_nuclei2_step04.1483.1483.3	2.3352	0.1975	3756.4	12	1520.0%	1	R.NLEVTETFDGEVSLAWEEPLTDGGSKIIGYVVER.R
	TK040203_NMyc_nuclei2_step02.2547.2547.3	1.4744	0.0568	3504.21	34	1470.0%	1	R.AGIGPPSEASDSVLMKDAAYPPGPPSNPHVTDTTK.K
	TK040203_NMyc_nuclei2_step04.4280.4280.2	0.9274	0.0117	3191.62	38	1300.0%	1	K.VNKDCIFVAWDRPDSDGGSPIIGYLIER.K
	TK040203_NMyc_nuclei2_step11.1983.1983.3	1.6345	0.0355	2623.24	255	1400.0%	1	K.NAAGAISKPSDSTGPITAKDEVELPR.I
	TK040203_NMyc_nuclei2_step09.4057.4057.1	0.9386	0.0477	636.7	28	5000.0%	1	R.SAPAYK.M
	TK040203_NMyc_nuclei2_step09.1686.1686.2	1.2158	0.0171	1439.7	1	4550.0%	1	K.EEQLLSTGFKCK.F
	TK040203_NMyc_nuclei2_step02.3892.3892.1	0.6606	0.0435	614.6	90	4000.0%	1	R.ATPPTK.A
	TK040203_NMyc_nuclei2_step08.1399.1399.1	1.2584	0.0982	879.75	12	5000.0%	1	K.KVPLVVPK.K
	TK040203_NMyc_nuclei2_step04.3293.3293.2	1.215	0.042	2860.83	9	2270.0%	1	R.LCPTTSFLVENLDEHQMYEFRVK.A
	TK040203_NMyc_nuclei2_step02.0335.0335.1	0.8665	0.1118	1582.95	6	2690.0%	1	R.ITFVENVATLQFAK.A
	TK040203_NMyc_nuclei2_step04.3612.3612.3	1.8121	0.1033	4110.14	18	1360.0%	1	R.EYERYEEHEEYITEPEKPIPVKPVPEEPVPTKPK.A
	TK040203_NMyc_nuclei2_step06.4234.4234.2	1.4392	0.1842	1841.74	27	2330.0%	1	R.YRIAFVEGTASLEIIR.V
	TK040203_NMyc_nuclei2_step02.0377.0377.1	0.9494	0.1179	1497.51	13	2920.0%	1	K.LTVLNMMKDDEGK.Y
	TK040203_NMyc_nuclei2_step09.2171.2171.3	1.9721	0.1267	3677.95	22	1290.0%	1	K.APEVTTVTKDSMIVVWERPASDGGSEILGYVLEK.R
*	TK040203_NMyc_nuclei2_step03.3763.3763.3	1.9769	0.1147	4787.94	6	1020.0%	1	R.DDENLQTSFVDNVATLKILQTDLSHSGQYSCSASNPLGTASSSAR.L
	TK040203_NMyc_nuclei2_step11.3452.3452.2	1.4984	0.0349	2537.51	17	1590.0%	1	K.VYGSPPISVSWFHEGNEISSGRK.Y
	TK040203_NMyc_nuclei2_step12.2038.2038.2	0.9858	0.0691	2188.31	175	1580.0%	1	R.VLAENEIGIGEPCETTEPVK.A
	TK040203_NMyc_nuclei2_step07.1087.1087.1	0.5624	0.0059	679.56	29	3750.0%	1	K.EYVLR.V
	TK040203_NMyc_nuclei2_step07.3504.3504.1	1.3363	0.0752	1335.66	63	3640.0%	1	R.AGVTMRLYVPVK.G
	TK040203_NMyc_nuclei2_step04.1151.1151.2	0.8756	0.0192	1248.43	3	3500.0%	1	R.VPGLIEGNEYR.F
	TK040203_NMyc_nuclei2_step12.2130.2130.2	1.4222	0.063	2019.82	6	2780.0%	1	K.NPFVLPGPPKSLEVTNIAK.D
	TK040203_NMyc_nuclei2_step06.2447.2447.3	1.7177	0.0094	3608.05	29	1360.0%	1	K.YGVGEPLESEPVLAVNPYGPPDPPKNPEVTTITK.D
	TK040203_NMyc_nuclei2_step03.2761.2761.2	1.1133	0.0153	2179.18	1	3500.0%	1	K.SSATFQSTVAGSPPISITWLK.D
	TK040203_NMyc_nuclei2_step06.2731.2731.3	2.0348	0.2371	4040.08	28	1180.0%	1	R.IAAENSIGMGPFVETSEALVIREPITVPERPEDLEVK.E
	TK040203_NMyc_nuclei2_step01.0683.0683.1	1.2571	0.0518	908.9	8	5710.0%	2	K.KPELPPVK.V
	TK040203_NMyc_nuclei2_step03.2289.2289.3	1.7105	0.0214	2816.31	91	1560.0%	1	R.SSISVILTVEAVEHQVKPMFVEKLK.N
	TK040203_NMyc_nuclei2_step01.0380.0380.1	0.9923	0.0106	1013.51	31	4000.0%	1	K.AGPGKPSDASK.A
	TK040203_NMyc_nuclei2_step02.3695.3695.3	2.0619	0.2175	3592.77	7	1500.0%	1	R.IDEVSCDSITISWNPPEYDGGCQISNYIVEK.K
	TK040203_NMyc_nuclei2_step12.1489.1489.3	1.9174	0.0705	2851.9	6	1980.0%	1	K.DSALVTWNKPHDGGKPITNYILEKR.E
	TK040203_NMyc_nuclei2_step03.1385.1385.1	0.7936	0.0447	1148.77	232	2780.0%	1	K.ITGYVIEAQR.K
	TK040203_NMyc_nuclei2_step03.2375.2375.1	1.0209	0.0533	1309.44	314	2730.0%	1	K.STFQGSTPLTIR.W
	TK040203_NMyc_nuclei2_step12.1882.1882.2	1.241	0.1097	3090.04	125	1430.0%	1	R.VLAENEIGIGEPCETTEPVKAAEVPAPIR.D
	TK040203_NMyc_nuclei2_step11.1139.1139.3	1.6611	0.0202	3719.55	104	1290.0%	1	R.IDEVSCDSITISWNPPEYDGGCQISNYIVEKK.E
	TK040203_NMyc_nuclei2_step10.2171.2171.3	1.5102	0.0831	3266.65	15	1500.0%	1	K.VGLGEATSVPGTVKPEDKLEAPELDLDSELR.K
	TK040203_NMyc_nuclei2_step03.3213.3213.2	2.1003	0.2149	2228.04	40	2110.0%	4	K.EPEPLEVLPGKNVTFTSVIR.G
	TK040203_NMyc_nuclei2_step02.3216.3216.3	2.2856	0.1466	3802.84	2	1820.0%	1	K.EIKDIILTESEFVGSSAIFECLVSPSTAITTWMK.D
	TK040203_NMyc_nuclei2_step10.1373.1373.2	1.5072	0.2559	1579.82	5	3460.0%	1	K.YDGGHKLTGYIVEK.R
	TK040203_NMyc_nuclei2_step06.3858.3858.2	1.1633	0.0824	2381.59	9	2370.0%	1	K.QIVPSRYFSMSFENNVASFR.I
	TK040203_NMyc_nuclei2_step02.3303.3303.2	1.5874	0.2223	2870.31	8	2000.0%	1	R.GTVTLLWDPPLIDGGSPIINYVIEKR.D
	TK040203_NMyc_nuclei2_step04.1974.1974.2	1.2475	0.1453	2017.9	1	3530.0%	1	R.MTFENNVASLYLSGIEVK.H
	TK040203_NMyc_nuclei2_step12.1378.1378.3	1.6274	0.0413	2873.65	17	1920.0%	1	K.EDGTQSLIIVPATPSDSGEWTVVAQNR.A
	TK040203_NMyc_nuclei2_step09.2238.2238.2	1.4091	0.0433	3062.61	76	1380.0%	1	K.VTGLTEGNEYEFHVMAENAAGVGPASGISR.L
	TK040203_NMyc_nuclei2_step02.3664.3664.3	2.3852	0.0968	4050.27	34	1110.0%	1	K.CTVTPLTEGSLYVFRVAAENAIGQSDYTEIEDSVLAK.D
	TK040203_NMyc_nuclei2_step01.0052.0052.1	1.061	0.1278	831.11	13	5000.0%	1	K.RAVPEEK.V
	TK040203_NMyc_nuclei2_step08.3139.3139.3	1.6273	0.1373	2518.75	41	2070.0%	1	R.IYAMNSEGLGEPALVPGTPKAEDR.M
	TK040203_NMyc_nuclei2_step06.3661.3661.3	1.6713	0.0323	3349.17	62	1420.0%	1	K.QLEPVKVSVGDSASLQCQLAGTPEIGVSWYK.G
	TK040203_NMyc_nuclei2_step08.1715.1715.2	1.2832	0.0603	1830.83	14	2940.0%	1	R.RDSGAYTLTATNPGGFAK.H
	TK040203_NMyc_nuclei2_step07.2469.2469.3	1.8466	0.0106	3492.8	68	1470.0%	1	R.EFLCINGSIHFQPLKEPSPNLQLQIVQSQK.T
	TK040203_NMyc_nuclei2_step01.3679.3679.2	1.9396	0.0524	2921.73	3	2600.0%	3	K.DSAYVTWEPPIIDGGSPIINYVVQKR.D
	TK040203_NMyc_nuclei2_step03.2826.2826.3	2.1958	0.2297	3318.47	1	2070.0%	1	R.EAFSSVIIKEPQIEPTADLTGITNQLITCK.A
	TK040203_NMyc_nuclei2_step02.3647.3647.2	1.53	0.1808	2731.69	3	2080.0%	1	R.DSVTITWEIPTIDGGAPVNNYIVEK.R
	TK040203_NMyc_nuclei2_step06.1177.1177.1	1.0206	0.1477	1003.66	11	4380.0%	1	K.GMHISSQIK.K
	TK040203_NMyc_nuclei2_step04.1914.1914.2	0.985	0.019	2189.87	17	2000.0%	2	K.VLDRPGPPEGPLAVTEVTSEK.C
	TK040203_NMyc_nuclei2_step12.2831.2831.3	1.1794	0.0668	4250.69	11	1120.0%	1	R.IGVGKPSAATPFVKVADPIERPSPPVNLTSSDQTQSSVQLK.W
	TK040203_NMyc_nuclei2_step05.1850.1850.1	0.7282	0.0856	1085.8	17	3750.0%	1	K.QEKIEGDLR.A
	TK040203_NMyc_nuclei2_step05.1420.1420.3	1.2714	0.035	2240.38	10	2240.0%	1	K.ELSSTAQLKVLEADPYFTVK.L
	TK040203_NMyc_nuclei2_step06.3707.3707.2	1.0933	0.1019	1909.02	39	2330.0%	1	K.YTLTDRVSVFNLHITK.C
	TK040203_NMyc_nuclei2_step10.3424.3424.2	1.4851	0.0201	2005.89	4	3160.0%	1	K.SVNKVGASDPSDSSDPQIAK.E
	TK040203_NMyc_nuclei2_step04.1406.1406.1	1.6555	0.2048	1584.65	3	4090.0%	1	K.MHTWRQPIETER.S
	TK040203_NMyc_nuclei2_step02.1515.1515.1	1.1261	0.1215	982.95	72	4380.0%	1	R.EAFAEDSGR.F
	TK040203_NMyc_nuclei2_step04.2717.2717.2	1.2045	0.0145	2034.46	5	3120.0%	1	R.IHIPFKGRPTPEITWSR.E
	TK040203_NMyc_nuclei2_step04.2397.2397.1	1.5855	0.0496	1410.64	145	2920.0%	1	K.AGHNQCSGHLTVK.E
	TK040203_NMyc_nuclei2_step08.4275.4275.2	1.4172	0.0269	3042.69	1	1850.0%	2	K.HSITLGWGKPVYDGGAPIIGYVVEMRPK.I
	TK040203_NMyc_nuclei2_step03.3230.3230.2	1.2607	0.0726	3151.1	24	1610.0%	1	K.ASNEYGSVSCTATLTVTEAYPPTFLSRPK.S
	TK040203_NMyc_nuclei2_step02.1918.1918.1	1.1575	0.0782	837.88	3	6430.0%	1	K.KEPAAPPK.V
	TK040203_NMyc_nuclei2_step01.1030.1030.1	0.9925	0.0235	883.4	21	5000.0%	1	K.YDVIADGK.K
	TK040203_NMyc_nuclei2_step10.1839.1839.2	1.3379	0.0105	1703.95	2	4230.0%	1	R.LLWTVVSEDIQSCR.H
	TK040203_NMyc_nuclei2_step11.1304.1304.3	1.66	0.0565	3098.97	20	1730.0%	1	K.QLCTSVYYTIIHNPNGSGTFIVNDPQR.E
	TK040203_NMyc_nuclei2_step04.2141.2141.2	1.1483	0.1112	1714.35	11	3080.0%	1	K.TGCEYQFRIAAENR.Y
	TK040203_NMyc_nuclei2_step07.1536.1536.3	1.3231	0.0097	3335.6	64	1370.0%	1	K.ILQTDLSHSGQYSCSASNPLGTASSSARLTAR.E
	TK040203_NMyc_nuclei2_step09.2979.2979.2	1.7801	0.2517	2640.1	2	2500.0%	1	R.ILVIQNAHLEDAGNYNCRLPSSR.T
	TK040203_NMyc_nuclei2_step03.3362.3362.2	1.124	0.0281	3194.4	9	1670.0%	1	K.NVTVIEGESVTLECHISGYPSPTVTWYR.E
	TK040203_NMyc_nuclei2_step07.2820.2820.2	0.8686	0.0072	2875.11	7	2000.0%	1	K.DHMTVSWKPPADDGGSPITGYLLEKR.E
	TK040203_NMyc_nuclei2_step05.2938.2938.1	0.9593	0.0238	793.55	14	5830.0%	1	K.EPATFVK.R
	TK040203_NMyc_nuclei2_step10.1907.1907.3	1.8141	0.0657	2908.49	27	1540.0%	1	K.AENSVGEVSASTFLTVQEQKLPPSFSR.Q
	TK040203_NMyc_nuclei2_step04.3033.3033.2	1.0656	0.018	1981.93	87	1880.0%	2	K.DTITFEVTVNYEGISYK.W
	TK040203_NMyc_nuclei2_step12.2071.2071.3	1.7329	0.0909	2677.62	158	1600.0%	1	R.NAAGVFSEPSESTGAITARDEVDPPR.I
	TK040203_NMyc_nuclei2_step08.2261.2261.3	1.1319	0.0186	3373.72	9	1330.0%	1	K.FGDITKDSVHLTWEPPDDDGGSPLTGYVVEK.R
	TK040203_NMyc_nuclei2_step09.3610.3610.2	1.6172	0.0765	2799.63	115	1400.0%	1	K.LRPGSGGEKPPDEAPFTYQLKAVPLK.F
	TK040203_NMyc_nuclei2_step01.1855.1855.1	1.172	0.0873	770.52	1	6670.0%	3	K.EVAPPVR.V
	TK040203_NMyc_nuclei2_step12.1294.1294.3	1.825	0.0076	3312.34	11	1580.0%	1	R.NKCGPGEPAYVDEPVNMSTPATVPDPPENVK.W
	TK040203_NMyc_nuclei2_step09.4089.4089.1	0.566	0.0361	648.46	4	4000.0%	2	K.GTPPFK.I
	TK040203_NMyc_nuclei2_step08.2357.2357.2	1.2625	0.0265	2406.48	19	1900.0%	1	K.DIRPSDITQITSTPTSSMLTIK.Y
	TK040203_NMyc_nuclei2_step06.2569.2569.2	1.5302	0.0395	2229.55	72	1940.0%	1	R.VNEPDKLITTCECVVPNLK.E
	TK040203_NMyc_nuclei2_step12.2759.2759.2	1.1247	0.0162	3095.82	2	1610.0%	1	K.SKPSKPSEPMLALDPIDPPGKPVPLNITR.H
	TK040203_NMyc_nuclei2_step01.4380.4380.3	2.273	0.0458	4586.49	18	990.0%	1	K.ASEASRPIMAQNPVDAPGRPEVTDVTRSTVSLIWSAPAYDGGSK.V
	TK040203_NMyc_nuclei2_step01.0036.0036.1	0.9944	0.0196	790.48	33	5000.0%	1	R.KDGQTLK.E
	TK040203_NMyc_nuclei2_step11.3520.3520.2	1.3266	0.0464	2890.06	13	1800.0%	1	K.NSMTVVWSRPIADGGSDISGYFLEKR.D
	TK040203_NMyc_nuclei2_step11.0792.0792.1	1.0763	0.0712	1204.66	36	4000.0%	1	K.FVMTIENPAGK.K
*	TK040203_NMyc_nuclei2_step07.1705.1705.2	2.2032	0.2531	1890.07	1	3610.0%	2	K.ADNSVGAVASSAVLVIKER.K
	TK040203_NMyc_nuclei2_step12.2475.2475.3	1.8927	0.1218	4712.84	3	1130.0%	1	R.ISGLVEGTMYYFRVLPENIYGIGEPCETSDAVLVSEVPLVPAK.L

Q9UH48

82.8%

332

38865

9.2

(Q9UH48) Gastric cancer-related protein GCYS-20

*	TK040203_NMyc_nuclei2_step03.2971.2971.2	2.3832	0.0818	2213.41	1	3530.0%	5	K.IVDWMDNFKLVGLLNNYR.Y

Q9EQ00

82.8%

230

25942

5.1

(Q9EQ00) cAMP-dependent protein kinase regulatory subunit

*	TK040203_NMyc_nuclei2_step05.2732.2732.2	2.177	0.039	1943.66	4	3530.0%	3	K.FLALGCSSLGRTLNTAMK.N

Q61291

82.8%

4545

504769

5.4

(Q61291) AM2 receptor

*	TK040203_NMyc_nuclei2_step04.2130.2130.1	1.4947	0.2536	1552.61	1	4230.0%	2	K.QGLNNAVALAFDYR.E
	TK040203_NMyc_nuclei2_step02.2236.2236.3	1.9513	0.113	2538.16	45	1930.0%	1	R.TGLSNPDGLAVDWVGGNLYWCDK.G
*	TK040203_NMyc_nuclei2_step01.4220.4220.2	1.5289	0.0773	2917.1	15	1670.0%	1	R.DNHCVDGSDEPANCTQMTCGVDEFR.C
*	TK040203_NMyc_nuclei2_step09.3501.3501.3	1.7947	0.1323	4594.48	98	950.0%	2	R.ETVITMSGDDHPRAFVLDECQNLMFWTNWNELHPSIMR.A
*	TK040203_NMyc_nuclei2_step10.2305.2305.3	1.3836	0.0108	3795.2	7	1440.0%	1	K.GDYSVLVPGLRNTIALDFHLSQSALYWTDAVEDK.I
*	TK040203_NMyc_nuclei2_step11.3590.3590.3	2.1249	0.0537	4536.52	1	1320.0%	1	R.AFVLDECQNLMFWTNWNELHPSIMRAALSGANVLTLIEK.D
	TK040203_NMyc_nuclei2_step02.2758.2758.3	1.6866	0.1086	3927.08	64	1060.0%	1	R.EVVLSSNNMDMFSVSVFEDFIYWSDRTHANGSIK.R
	TK040203_NMyc_nuclei2_step07.2390.2390.2	1.1775	0.0337	2954.14	39	1600.0%	1	R.HTVDQTRPGAFERETVITMSGDDHPR.A

Q9H0E3

82.8%

1048

110324

9.8

(Q9H0E3) Hypothetical protein

*	TK040203_NMyc_nuclei2_step12.1639.1639.2	2.0427	0.3499	1722.45	1	4690.0%	1	R.SNAPGPPLHIGASHLPR.G
	TK040203_NMyc_nuclei2_step10.3225.3225.3	1.7128	0.0185	4574.54	4	1120.0%	1	R.SDNRPSVPVQFQYFLPTYPPSAYPLAAHTYTPITSSVSTIR.Q

RBL1_MOUSE

82.7%

1063

119499

7.6

(Q64701) Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (PRB1) (P107)

*	TK040203_NMyc_nuclei2_step05.2027.2027.2	1.6192	0.1064	2171.39	2	3240.0%	1	R.RLHGMDMSVLLEQDIFHK.S
*	TK040203_NMyc_nuclei2_step08.2263.2263.3	2.6788	0.3434	2329.69	1	3330.0%	2	K.LAEILYYKILETIMVQETR.R

Q91WS7

82.4%

511

58479

7.6

(Q91WS7) Hypothetical 58.5 kDa protein

*	TK040203_NMyc_nuclei2_step02.3403.3403.2	2.0593	0.0231	2935.01	1	2600.0%	2	K.SDSLEDLWENLSLKPASSPHIHISTR.L

KFMS_HUMAN

82.4%

1.3%

972

107984

6.4

(P07333) Macrophage colony stimulating factor I receptor precursor (CSF-1-R) (EC 2.7.1.112) (Fms proto-oncogene) (c-fms) (CD115 antigen)

*	TK040203_NMyc_nuclei2_step09.1989.1989.1	1.7497	0.2008	1424.63	2	4170.0%	1	K.DGYQMAQPAFAPK.N

O2B3_HUMAN

82.4%

313

35543

8.4

(O76000) Olfactory receptor 2B3 (Olfactory receptor 6-4) (OR6-4) (Hs6M1-1)

*	TK040203_NMyc_nuclei2_step05.3175.3175.2	1.9971	0.2304	2665.77	5	2270.0%	4	K.MVSLFYGIITSMLNSLIYSLRNK.D
*	TK040203_NMyc_nuclei2_step11.1523.1523.3	1.8622	0.2115	3774.98	2	1590.0%	2	R.QKAFGTCGSHMIVVSLFYGTAIYMYLQPPSSTSK.D

Q9CZ09

82.2%

362

40478

6.6

(Q9CZ09) 2810422O20Rik protein

*	TK040203_NMyc_nuclei2_step12.1490.1490.2	1.9364	0.3811	2190.56	1	3100.0%	1	K.CSSLGNAASSEDTGSPPPIADR.S
*	TK040203_NMyc_nuclei2_step02.2066.2066.2	1.2542	0.0108	1839.36	54	2690.0%	1	K.IWECTFDLLTYFTK.A
*	TK040203_NMyc_nuclei2_step11.3567.3567.2	1.4342	0.1036	3090.55	39	1550.0%	1	K.CSSLGNAASSEDTGSPPPIADRSDDPEACK.H

Z219_HUMAN

82.1%

722

76876

9.5

(Q9P2Y4) Zinc finger protein 219

*	TK040203_NMyc_nuclei2_step04.3167.3167.2	1.5764	0.149	3052.61	1	1900.0%	3	R.APQPPDLGLLAYEPLGPALLLAPAPTPAER.R
*	TK040203_NMyc_nuclei2_step04.2535.2535.2	1.7578	0.0805	2274.22	3	2500.0%	3	R.YSNGPAVSAGSLGMGAVSWSESR.A
*	TK040203_NMyc_nuclei2_step06.1538.1538.1	1.2103	0.0392	1079.61	228	3890.0%	1	K.VHASKLGPLR.A

Q9JMH9

82.0%

2035

230906

6.2

(Q9JMH9) Myosin containing PDZ domain

*	TK040203_NMyc_nuclei2_step02.2935.2935.3	1.5229	0.0063	2981.66	20	1630.0%	1	K.SSQHSLCSMMIVDTPGFQNPEWGGSAR.G
	TK040203_NMyc_nuclei2_step06.2386.2386.1	1.5896	0.2099	1296.7	3	5500.0%	1	R.RFDVLAPHLTK.K
*	TK040203_NMyc_nuclei2_step02.2680.2680.3	1.4271	0.1304	4373.28	2	1250.0%	1	R.QGPEESGLGEGTKLSALECLEGMASGLYSELFTLLISLVNR.A
*	TK040203_NMyc_nuclei2_step09.3323.3323.3	2.0916	0.2003	4635.52	56	930.0%	1	R.DESASETSTPSEHSAAPSPQVEVRTLEGQLMQHPGLGIPRPGPR.S
*	TK040203_NMyc_nuclei2_step12.2630.2630.2	1.5	0.1497	1909.24	16	3000.0%	1	K.VQPIPELSELSRSWLR.T

Q9BXP8

82.0%

1791

198537

5.5

(Q9BXP8) Pregnancy-associated plasma preproprotein-A2

*	TK040203_NMyc_nuclei2_step05.2383.2383.1	1.5893	0.2107	1495.94	3	4170.0%	1	R.EPEPTSDTCGFTR.F
*	TK040203_NMyc_nuclei2_step12.3795.3795.3	1.6939	0.028	4704.78	50	930.0%	1	K.FTDVEVTPGQMYQYQVLAEAGGELGEASPPLNHIHGAPYCGDGK.V
*	TK040203_NMyc_nuclei2_step01.1620.1620.3	1.8786	0.1469	3875.04	25	1210.0%	1	R.ASPQHHLFGVYPSRAGNYLRPYPVGEQEIHHTGR.S
*	TK040203_NMyc_nuclei2_step12.3437.3437.2	1.9457	0.2658	2296.07	2	2890.0%	1	R.AGNYLRPYPVGEQEIHHTGR.S

NOA1_HUMAN

82.0%

510

52056

8.9

(P51513) Onconeural ventral antigen-1 (NOVA-1) (Paraneoplastic Ri antigen) (Ventral neuron-specific protein 1)

*	TK040203_NMyc_nuclei2_step07.2837.2837.2	2.2949	0.3181	2272.73	1	3500.0%	7	R.VCLIQGTVEALNAVHGFIAEK.I

Q9ULI6

81.9%

199

727

79153

8.7

(Q9ULI6) Hypothetical protein KIAA1234 (Fragment)

*	TK040203_NMyc_nuclei2_step12.3994.3994.2	1.7329	4.0E-4	2034.36	8	2500.0%	1	R.LSLFCIAAPVLLPSAAEMK.M
*	TK040203_NMyc_nuclei2_step10.1984.1984.1	1.5015	0.0312	1471.61	14	3460.0%	14	K.QRPAVGAEKSNPSK.R
*	TK040203_NMyc_nuclei2_step11.3355.3355.2	1.4233	0.211	2267.07	119	1960.0%	1	R.QPAAGAPSPGDSCPLAGSAVLEGR.L
*	TK040203_NMyc_nuclei2_step09.1530.1530.3	1.902	0.0238	2658.93	21	1850.0%	1	R.LNAELDHLASLLPFPPDIISKLDK.L

GB01_MOUSE

81.8%

8.5%

353

39953

5.5

(P18872) Guanine nucleotide-binding protein G(O), alpha subunit 1

	TK040203_NMyc_nuclei2_step09.2359.2359.3	2.7217	0.3228	3523.88	1	2070.0%	1	R.MEDTEPFSAELLSAMMRLWGDSGIQECFNR.S

Q9QYZ6

81.8%

504

56787

9.4

(Q9QYZ6) Hypothetical 56.8 kDa protein (Fragment)

*	TK040203_NMyc_nuclei2_step03.3471.3471.2	1.9908	0.2084	2043.91	34	2500.0%	2	K.QLLSAINYCRNQGIVHR.D
*	TK040203_NMyc_nuclei2_step07.3677.3677.3	2.2231	0.2172	4365.51	2	1350.0%	3	K.GSGVFPDPCEEQIPLKPDPAIVKAMGHIGFQAQDIEDSLR.Q

Q9D9D4

81.8%

310

35034

8.9

(Q9D9D4) 1700095G12Rik protein

*	TK040203_NMyc_nuclei2_step01.2712.2712.1	2.0402	0.1162	1529.35	3	4620.0%	1	K.ETSTSLGKLVQPLR.K

Q9CR25

81.7%

489

52365

5.5

(Q9CR25) 9130020C19Rik protein

*	TK040203_NMyc_nuclei2_step04.2303.2303.1	1.7006	0.2014	1522.8	4	4290.0%	3	R.VVGLLAGTLGVARHR.E

Z236_HUMAN

81.5%

1845

203658

8.1

(Q9UL36) Zinc finger protein 236

	TK040203_NMyc_nuclei2_step02.2356.2356.2	1.0377	0.0328	1839.12	312	2140.0%	1	K.NGPTYNCTECSCVFK.S
*	TK040203_NMyc_nuclei2_step02.1279.1279.3	0.7634	0.0143	2646.03	392	1250.0%	1	R.HMATHMSMKPYKCPFCEEGFR.T
	TK040203_NMyc_nuclei2_step12.1590.1590.2	1.0517	0.076	3166.97	1	1670.0%	1	K.HTGEKPHACAFCPAAFSQKGNLQSHVQR.V
*	TK040203_NMyc_nuclei2_step06.2715.2715.2	1.0439	0.0808	1567.6	2	4170.0%	1	K.QHVRSHTGEKPYK.C
*	TK040203_NMyc_nuclei2_step08.1755.1755.3	1.7273	0.0234	3378.31	24	1720.0%	1	K.SRPEVITFTEEETAQLAKIRPQESATVSEK.V
*	TK040203_NMyc_nuclei2_step08.3619.3619.3	2.7734	0.3195	4483.16	1	1350.0%	1	-.MGLCGLLERCWLHHDPDGVLTLNAENTNYAYQVPNFHK.C

RB1A_HUMAN

81.2%

18.5%

205

22678

6.2

(P11476) Ras-related protein Rab-1A (YPT1-related protein) (P11476) Ras-related protein Rab-1A (YPT1-related protein)

	TK040203_NMyc_nuclei2_step02.2131.2131.2	1.319	0.0101	1815.15	2	2810.0%	1	K.LLLIGDSGVGKSCLLLR.F
	TK040203_NMyc_nuclei2_step05.2619.2619.2	1.8856	0.4092	2307.99	1	2750.0%	3	R.GAHGIIVVYDVTDQESFNNVK.Q

Q9NP08

81.2%

373

39225

11.6

(Q9NP08) H6 homeodomain protein

*	TK040203_NMyc_nuclei2_step04.3800.3800.2	1.1136	0.0121	2969.81	18	1480.0%	5	R.HVAAELEAASLSPPGAHAWSACRCSTTK.A

Q8WTR8

81.2%

524

56808

9.1

(Q8WTR8) Hypothetical protein (Fragment)

*	TK040203_NMyc_nuclei2_step05.2266.2266.1	1.9908	0.1655	1416.64	1	4640.0%	1	R.VEFGGQAGLAAAGLR.G

Q9CUC4

81.2%

278

32201

6.7

(Q9CUC4) 4933424D07Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step06.2105.2105.1	1.3467	0.0504	1495.67	18	3180.0%	6	R.RYIDANAWSWGR.A

Q8TD57

81.1%

4116

470774

6.4

(Q8TD57) Axonemal heavy chain dynein type 3

*	TK040203_NMyc_nuclei2_step07.1928.1928.3	1.6524	0.0963	3815.06	6	1410.0%	1	K.EVKTSLTFPGSRPMSPEQQLDVMLQQEMEMESK.E
*	TK040203_NMyc_nuclei2_step02.2339.2339.2	0.8639	0.0437	1835.97	5	2500.0%	1	R.VEVVSMCKYFQESVK.K
*	TK040203_NMyc_nuclei2_step03.2842.2842.2	0.9725	0.067	2887.13	39	1820.0%	1	K.ENDYYCSLMKSIVDYILMDPMER.K
*	TK040203_NMyc_nuclei2_step10.1149.1149.3	1.2038	0.2562	2594.46	2	1190.0%	1	R.DFSRVIQGVLLCPHTHLQDVEK.C
*	TK040203_NMyc_nuclei2_step09.2006.2006.1	1.2626	0.022	1373.63	2	3640.0%	2	K.LAFKTSIFSPMK.K
	TK040203_NMyc_nuclei2_step01.1960.1960.1	1.3917	0.0407	1362.66	1	4580.0%	1	R.HGYMIVGDPMGGK.T
*	TK040203_NMyc_nuclei2_step06.4314.4314.2	1.27	0.0647	2403.65	32	2370.0%	1	K.IFSSIVDWHFGKGFDVMFLR.Y
*	TK040203_NMyc_nuclei2_step06.3090.3090.2	1.1829	0.1019	2868.95	23	1670.0%	1	K.LEFTDNLEIVGMISSEKETVPFIQK.I

Q9D7N9

81.1%

415

46434

6.3

(Q9D7N9) 2310001A20Rik protein (Integral plasma membrane protein)

*	TK040203_NMyc_nuclei2_step11.2498.2498.3	1.5879	0.0525	3451.0	148	1210.0%	1	R.RSLHDPDGQVVTYVSEAHEHDGYLYLGSFR.S
*	TK040203_NMyc_nuclei2_step05.1582.1582.1	1.2378	0.081	1230.47	1	5000.0%	1	K.EGSSFSGRVFR.M
*	TK040203_NMyc_nuclei2_step10.1905.1905.2	2.4428	0.3054	2034.89	7	3240.0%	1	R.RPLRPQVVTDDGQVPEVK.E

Q91XY5

81.1%

928

100174

5.0

(Q91XY5) Protocadherin gamma A3

*	TK040203_NMyc_nuclei2_step03.2621.2621.2	2.4335	0.2032	1973.03	7	3240.0%	1	R.YSVPEELDKGSFVGNISK.D
*	TK040203_NMyc_nuclei2_step07.1293.1293.1	1.024	0.0678	933.36	1	6880.0%	1	R.SGSLVTRGR.I
*	TK040203_NMyc_nuclei2_step06.2823.2823.3	2.2604	0.0863	3911.59	10	1690.0%	1	K.LCIQVIVSDANDNPPVFTKPEYHVSVLENVPVGTR.L
*	TK040203_NMyc_nuclei2_step06.4275.4275.3	2.3513	0.1715	4729.97	7	1250.0%	1	R.WYSSRLQASGNGLAGIPASHFVGLDGVQAFLQTYSQEVSLTAGSR.K

Q8TAX2

81.1%

306

34551

7.5

(Q8TAX2) Similar to hypothetical protein FLJ11175

	TK040203_NMyc_nuclei2_step07.2297.2297.1	1.7523	0.0531	1522.7	15	3570.0%	4	K.VLKAADLLAADFSGK.S

EPC_MOUSE

81.1%

19.7%

421

47321

7.5

(P06336) Ig epsilon chain C region

*	TK040203_NMyc_nuclei2_step10.2268.2268.3	2.5499	0.1046	3643.62	4	1480.0%	2	R.GVITYLIPPSPLDLYQNGAPKLTCLVVDLESEK.N
*	TK040203_NMyc_nuclei2_step11.3388.3388.3	2.3631	0.0186	4713.19	8	1070.0%	1	K.GTASMTLGCLVKDYFPNPVTVTWYSDSLNMSTVNFPALGSELK.V
*	TK040203_NMyc_nuclei2_step11.3976.3976.2	1.1653	0.0402	2257.89	2	2500.0%	1	R.GVITYLIPPSPLDLYQNGAPK.L
*	TK040203_NMyc_nuclei2_step06.3357.3357.2	1.7314	0.1905	3152.36	4	2040.0%	1	R.CPDHEPRGVITYLIPPSPLDLYQNGAPK.L

CLN3_HUMAN

81.1%

438

47623

6.4

(Q13286) CLN3 protein (Battenin) (Batten disease protein)

	TK040203_NMyc_nuclei2_step09.3577.3577.3	3.0721	0.0788	3377.92	6	1810.0%	1	K.NAVGFWLLGLCNNFSYVVMLSAAHDILSHK.R
	TK040203_NMyc_nuclei2_step04.4145.4145.2	1.5093	0.0068	2344.17	7	2380.0%	1	R.QPLIRTEAPESKPGSSSSLSLR.E

MAOX_MOUSE

81.1%

572

63999

7.4

(P06801) NADP-dependent malic enzyme (EC 1.1.1.40) (NADP-ME) (Malic enzyme 1)

	TK040203_NMyc_nuclei2_step05.4224.4224.2	1.2207	0.0612	2215.26	2	2620.0%	1	K.IKPTALIGVAAIGGAFTEQILK.D
	TK040203_NMyc_nuclei2_step05.3350.3350.3	3.0645	0.0789	3110.3	8	1640.0%	1	K.NLEAIVQKIKPTALIGVAAIGGAFTEQILK.D
	TK040203_NMyc_nuclei2_step12.4015.4015.2	1.7215	0.037	1771.76	119	2650.0%	2	R.ILGLGDLGCNGMGIPVGK.L
*	TK040203_NMyc_nuclei2_step11.2136.2136.2	0.9776	0.0189	1409.54	348	3180.0%	1	R.KPRGLFISIHDK.G
*	TK040203_NMyc_nuclei2_step07.0391.0391.3	1.1373	0.0528	2262.09	400	1320.0%	1	R.VRGPEYDAFLDEFMEAASSK.Y

Q9DCV9

81.1%

352

39883

7.9

(Q9DCV9) 0610009K11Rik protein

*	TK040203_NMyc_nuclei2_step04.3455.3455.3	3.0399	0.0485	3121.66	5	1790.0%	1	K.GIQETEEMLKVGATLTGIGELVLDNNAFR.L

RFX5_HUMAN

81.0%

1158

616

65323

9.3

(P48382) DNA-binding protein RFX5 (Regulatory factor X subunit 5)

*	TK040203_NMyc_nuclei2_step10.1166.1166.3	1.3846	0.016	1594.49	36	2670.0%	1	R.EVGIGGDQGPHDKGVK.R
*	TK040203_NMyc_nuclei2_step11.2878.2878.2	1.4452	0.0086	3107.02	11	1550.0%	1	K.TLVSMPPLPGLDLKGSESPEMGPEVTPAPR.D
*	TK040203_NMyc_nuclei2_step01.3335.3335.1	1.7665	0.098	1166.0	15	5000.0%	34	K.KPERLAQPPK.D

SFR1_HUMAN

81.0%

247

27613

10.4

(Q07955) Splicing factor, arginine/serine-rich 1 (pre-mRNA splicing factor SF2, P33 subunit) (Alternative splicing factor ASF-1)

*	TK040203_NMyc_nuclei2_step01.1756.1756.1	1.561	0.2173	1030.51	1	7140.0%	1	K.DIEDVFYK.Y

Q9DBL4

81.0%

12.1%

494

54851

6.3

(Q9DBL4) 1300003M23Rik protein

*	TK040203_NMyc_nuclei2_step07.2769.2769.2	1.3655	0.1334	2499.14	14	1820.0%	1	R.LQLLPPIRPPPASEPEPGTMVEK.G
	TK040203_NMyc_nuclei2_step06.1246.1246.1	1.5585	0.2103	965.42	1	7500.0%	1	K.QRNEDFR.K
	TK040203_NMyc_nuclei2_step12.2102.2102.2	1.2021	0.0738	3066.53	7	1720.0%	1	R.EELLTDTSNSSSSTGEEGDLAALLPDLSGR.L

Q96BZ3

81.0%

31.0%

203

22143

11.4

(Q96BZ3) Similar to hypothetical protein MGC2605

	TK040203_NMyc_nuclei2_step09.2274.2274.2	1.3241	0.0613	2103.59	80	2110.0%	1	R.GNPELARLRPGLAVLGADER.I
*	TK040203_NMyc_nuclei2_step05.2019.2019.1	1.2347	0.0575	1355.56	1	4580.0%	3	R.SACSSAAVRGHPR.A
	TK040203_NMyc_nuclei2_step12.2805.2805.2	1.0562	0.0654	1221.02	92	4500.0%	1	R.DEGVLRPRAHA.-
	TK040203_NMyc_nuclei2_step11.3406.3406.2	1.1367	0.0548	2907.32	61	1400.0%	1	R.EGVSLTAVLTTHHHWDHARGNPELAR.L

Q96JB1

80.9%

1.7%

4490

514818

6.3

(Q96JB1) Axonemal dynein heavy chain 8

*	TK040203_NMyc_nuclei2_step04.2059.2059.3	1.9926	0.0817	3147.49	7	1760.0%	1	R.QTKEEITSPPGEGVYIYGLYMDGAAWDR.R
*	TK040203_NMyc_nuclei2_step04.2618.2618.2	1.8404	0.1107	2225.96	5	3060.0%	3	K.LTQVIENWTNQNLSFAAFK.G
*	TK040203_NMyc_nuclei2_step09.3115.3115.3	2.2845	0.1268	3578.3	1	1580.0%	3	R.TEFDTDFLDFMTKINGLEVQIQAFMNSSFGK.I

C11A_MOUSE

80.9%

526

60315

9.4

(Q9QZ82) Cytochrome P450 11A1, mitochondrial precursor (EC 1.14.15.6) (CYPXIA1) (P450(scc)) (Cholesterol side-chain cleavage enzyme) (Cholesterol desmolase)

*	TK040203_NMyc_nuclei2_step05.3280.3280.3	2.8467	0.0058	3111.01	6	1850.0%	1	K.LGTLESVYIVDPKDASILFSCEGPNPER.F
*	TK040203_NMyc_nuclei2_step01.1982.1982.1	1.6618	0.2003	989.67	1	6250.0%	1	-.MLAKGLSLR.S

AC48_MOUSE

80.6%

439

50560

8.6

(Q9R0X4) 48 kDa acyl-CoA thioester hydrolase, mitochondrial precursor (EC 3.1.2.-) (p48) (Mt-ACT48) (Protein U8)

	TK040203_NMyc_nuclei2_step12.4504.4504.1	0.4627	0.0453	431.32	2	3330.0%	1	R.AAIR.L
*	TK040203_NMyc_nuclei2_step11.1588.1588.3	1.5581	0.0839	2811.09	128	1700.0%	3	K.MFQLHNDEKYWPVLDATFVMVAR.D
*	TK040203_NMyc_nuclei2_step07.1882.1882.1	1.7773	0.1962	1328.56	1	5500.0%	1	K.ISEPLHIHQVR.D

Q8VHE6

80.6%

4621

527508

6.1

(Q8VHE6) Axonemal dynein heavy chain 5

*	TK040203_NMyc_nuclei2_step12.3697.3697.2	1.6805	0.0934	2935.47	6	1880.0%	1	K.ETEVLEEARELLSHFNHQNTDALLK.V
*	TK040203_NMyc_nuclei2_step10.2292.2292.2	2.2552	0.3176	2071.44	2	3890.0%	1	R.ITALTGHSLDVGNETFKLR.N
*	TK040203_NMyc_nuclei2_step11.4024.4024.3	1.2915	0.0886	4346.76	6	1180.0%	1	K.IMTRAHEIPNVVQCCVGDETMGQLLPHLLDQLEICQK.S
*	TK040203_NMyc_nuclei2_step12.2707.2707.3	1.718	0.0096	3659.42	10	1330.0%	1	K.QNHLPIFRASVTLAIPNIAMTPALEDIQQTLNK.A
*	TK040203_NMyc_nuclei2_step08.2735.2735.3	1.762	0.1543	3986.37	6	1360.0%	1	K.FGPLGWNIPYEFNQADFNATVQFIQNHLDDMDVK.K
*	TK040203_NMyc_nuclei2_step06.2573.2573.3	1.8045	0.122	2879.08	15	1900.0%	1	K.AGYPELETAISKQVEEAGLINHPPWK.L
*	TK040203_NMyc_nuclei2_step03.2649.2649.1	1.1052	0.0383	1309.69	45	4000.0%	1	K.TAQAPEHWVLR.G
	TK040203_NMyc_nuclei2_step01.1491.1491.1	1.4393	0.1069	1078.44	11	5620.0%	1	R.QWSSELLSK.R
*	TK040203_NMyc_nuclei2_step10.3063.3063.3	1.7609	0.0069	4109.39	84	1080.0%	1	K.LEAAKPALEEAEAALQTIKPSDIATVRTLGRPPHLIMR.I
*	TK040203_NMyc_nuclei2_step03.3422.3422.3	1.5955	0.0066	4582.65	118	790.0%	1	K.IPFGNGLNLNEMLIDAPTISEWNLQGLPNDDLSIQNGIIVTK.A
	TK040203_NMyc_nuclei2_step06.2434.2434.1	1.463	0.0181	1408.68	10	4090.0%	1	K.EEIEDICISAVK.E
*	TK040203_NMyc_nuclei2_step04.3605.3605.3	1.8401	0.055	3651.78	357	920.0%	1	K.VLLEFEVLYHRAWLQQIEEIHAGLEASLLVK.A

G25B_HUMAN

80.5%

191

21311

6.0

(P21181) G25K GTP-binding protein, brain isoform (GP) (CDC42 homolog) (P21181) G25K GTP-binding protein, brain isoform (GP) (CDC42 homolog)

	TK040203_NMyc_nuclei2_step06.1962.1962.1	1.476	0.2443	1403.48	1	4500.0%	1	K.WVPEITHHCPK.T

Q99K01

80.3%

787

87292

5.5

(Q99K01) Hypothetical 87.3 kDa protein

*	TK040203_NMyc_nuclei2_step05.2622.2622.3	1.7571	0.0091	3932.88	3	1500.0%	1	R.LKELCEQYGIWLHVEGVNLATLALGYVSSSVLAATK.C
*	TK040203_NMyc_nuclei2_step10.1968.1968.1	1.5522	0.1105	1525.65	3	3850.0%	3	K.SDPEGEKIHTGLLK.K

Q96BT7

80.0%

238

27440

7.9

(Q96BT7) Hypothetical protein

*	TK040203_NMyc_nuclei2_step01.2322.2322.1	1.9216	0.1824	1055.52	4	6880.0%	1	R.NQLLPVLEK.C

Q9CW46

80.0%

756

80194

8.9

(Q9CW46) 1300006N24Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step09.2641.2641.2	1.9251	0.0796	2469.98	10	2000.0%	1	R.GRRPAEPPLPSPAVPGGGSGSNNGNK.A
	TK040203_NMyc_nuclei2_step05.2888.2888.2	1.89	0.3788	2280.74	1	3160.0%	2	R.TLYVHWTDAGQLTPALLHSR.C
*	TK040203_NMyc_nuclei2_step11.1391.1391.3	1.547	0.0259	3368.36	109	1290.0%	1	K.QSHLNKAVGSSPMGSSEGLLGLGPGPNGHSHLLK.T

Q9NQC1

79.8%

1.9%

576

63404

6.8

(Q9NQC1) Hypothetical protein KIAA0239

*	TK040203_NMyc_nuclei2_step04.2337.2337.1	1.4866	0.2353	1182.27	3	5500.0%	1	R.DPSLRPGDPAR.K

Q9CQI9

79.8%

30.3%

178

20358

8.3

(Q9CQI9) 2510044J04Rik protein (1810038N03Rik protein) (RIKEN cDNA 1810038N03 gene)

*	TK040203_NMyc_nuclei2_step02.3739.3739.2	1.5413	0.0032	2527.01	1	2600.0%	1	-.MSTPPLAPTGMASGPFGGPQAQQAAR.E
	TK040203_NMyc_nuclei2_step03.1613.1613.1	2.0551	0.0268	887.64	1	7500.0%	1	K.QKNQQLK.Q
	TK040203_NMyc_nuclei2_step09.2661.2661.2	1.2985	0.0853	2554.07	41	1750.0%	1	R.IGQETVQDIVYRTMEIFQLLR.N

KICH_MOUSE

79.8%

435

49920

7.4

(O54804) Choline kinase (EC 2.7.1.32) (CK) (CHETK-alpha)

*	TK040203_NMyc_nuclei2_step01.4584.4584.1	2.0584	0.0253	1109.95	5	5620.0%	1	R.EARVQQLHK.I

IMA2_MOUSE

79.7%

529

57928

5.7

(P52293) Importin alpha-2 subunit (Karyopherin alpha-2 subunit) (SRP1-alpha) (RAG cohort protein 1) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (Importin alpha P1)

*	TK040203_NMyc_nuclei2_step07.3204.3204.2	2.4032	0.0832	3120.71	1	2410.0%	1	K.LLGATELPIVTPALRAIGNIVTGTDEQTQK.V

RSP4_MOUSE

79.7%

295

32719

4.8

(P14206) 40S ribosomal protein SA (P40) (34/67 kDa laminin receptor)

	TK040203_NMyc_nuclei2_step03.2487.2487.1	2.0203	0.1215	1263.47	2	6000.0%	1	R.KSDGIYIINLK.R

Q96K74

79.7%

439

49042

5.0

(Q96K74) Hypothetical protein FLJ14461

*	TK040203_NMyc_nuclei2_step11.3152.3152.2	1.9791	0.3546	2488.78	1	2860.0%	1	R.NEQGSTCASLQESAVHPREIFK.Q

Q9H8K0

79.5%

57.9%

133

14647

4.2

(Q9H8K0) Hypothetical protein FLJ13520

*	TK040203_NMyc_nuclei2_step02.2760.2760.3	1.6872	0.1613	3738.3	18	1210.0%	1	R.LECSGTILAQCNLCLLGSSDSPASASQVAGIIGACR.H
*	TK040203_NMyc_nuclei2_step12.3579.3579.3	2.6145	0.4098	4694.16	1	1310.0%	1	-.MSEAENEFINWVATAAIEANCSQCWLCVELPEAAGNGLPWR.I

FA8_HUMAN

79.3%

2351

267007

7.4

(P00451) Coagulation factor VIII precursor (Procoagulant component) (Antihemophilic factor) (AHF)

	TK040203_NMyc_nuclei2_step08.2487.2487.3	1.9259	0.0384	2975.39	130	1500.0%	1	K.VFQGNQDSFTPVVNSLDPPLLTRYLR.I
*	TK040203_NMyc_nuclei2_step03.3383.3383.3	1.6164	0.0393	4195.02	7	1350.0%	1	K.ENGPMASDPLCLTYSYLSHVDLVKDLNSGLIGALLVCR.E
*	TK040203_NMyc_nuclei2_step12.2362.2362.3	1.6564	0.0272	3947.86	9	1410.0%	1	R.AEVEDNIMVTFRNQASRPYSFYSSLISYEEDQR.Q
*	TK040203_NMyc_nuclei2_step03.2782.2782.2	1.3616	0.0634	1822.44	8	3120.0%	1	K.VENTVLPKPDLPKTSGK.V
*	TK040203_NMyc_nuclei2_step10.2873.2873.3	1.4815	0.0057	3305.23	14	1500.0%	1	R.GNSTGTLMVFFGNVDSSGIKHNIFNPPIIAR.Y
*	TK040203_NMyc_nuclei2_step08.1669.1669.1	1.5504	0.2184	1504.86	4	4170.0%	1	K.SQYLNNGPQRIGR.K

HIPR_HUMAN

79.3%

0.9%

1068

119388

6.7

(O75146) Huntingtin interacting protein 1 related (Hip1-related) (Hip 12)

*	TK040203_NMyc_nuclei2_step05.1666.1666.1	1.5578	0.118	1187.68	11	4440.0%	9	R.YGQLVNVYTK.L

FCMD_HUMAN

79.2%

461

53696

8.3

(O75072) Fukutin precursor (Fukuyama-type congenital muscular dystrophy protein)

	TK040203_NMyc_nuclei2_step07.2654.2654.3	2.6205	0.3887	3579.26	1	2140.0%	1	K.FTLCWTEFVDMKVHVPCETLEYIEANYGK.T
	TK040203_NMyc_nuclei2_step07.2348.2348.2	1.5498	0.3369	2840.48	3	1960.0%	1	K.RSPPNVQPNGIWPISEWDEVIQLY.-

Q8TC84

79.2%

339

37614

8.7

(Q8TC84) Similar to RIKEN cDNA 1700007B22

*	TK040203_NMyc_nuclei2_step01.3666.3666.2	1.0458	0.1071	2639.72	1	2500.0%	1	K.MHTYGIIYTGYATKHVVEGLEPR.T
*	TK040203_NMyc_nuclei2_step04.2215.2215.1	1.5945	0.2027	1330.71	2	4440.0%	1	K.RQGPQEQWFR.F

Q9JIX7

79.0%

582

63776

8.1

(Q9JIX7) Putative GTP-binding protein

	TK040203_NMyc_nuclei2_step01.4379.4379.2	1.6997	0.0854	2993.15	1	2220.0%	2	R.GEAVYQIGVEDNGLLVGLAEEEMRASLK.T
*	TK040203_NMyc_nuclei2_step03.3441.3441.2	1.0431	0.0524	2178.34	8	2380.0%	1	K.GIGHVTDVQAITAGEAQATMGF.-
	TK040203_NMyc_nuclei2_step05.3202.3202.2	1.7117	0.0287	2594.67	2	2610.0%	2	R.GEAVYQIGVEDNGLLVGLAEEEMR.A
	TK040203_NMyc_nuclei2_step08.1897.1897.3	1.0532	0.1359	4147.39	3	1390.0%	1	K.EQEELMQQLTEFQVDEIYTVPEVGTVVGGTLSSGICR.E

Q923D2

79.0%

206

22197

7.0

(Q923D2) Similar to biliverdin reductase B (Flavin reductase (NADPH)) (Hypothetical 22.2 kDa protein)

	TK040203_NMyc_nuclei2_step07.2324.2324.1	1.4984	0.2028	1127.68	1	6880.0%	2	K.HDLGHFMLR.C
	TK040203_NMyc_nuclei2_step08.3888.3888.2	0.9578	0.0737	1708.37	97	1790.0%	1	K.VVACTSAFLLWDPTK.V

Q9CQ07

78.7%

262

29520

9.7

(Q9CQ07) 4930442L21Rik protein

*	TK040203_NMyc_nuclei2_step01.1883.1883.1	1.8863	0.1618	1407.46	2	4500.0%	1	R.WLDLHSNYIDK.L
*	TK040203_NMyc_nuclei2_step05.2631.2631.2	1.2475	0.1568	1938.81	268	2190.0%	1	R.NPFPNADESEMFVDSIK.R

Q9C0I9

78.6%

538

60926

9.6

(Q9C0I9) Hypothetical protein KIAA1674 (Fragment)

*	TK040203_NMyc_nuclei2_step10.4236.4236.2	2.0187	0.3344	3036.98	1	2220.0%	1	K.GVGGIIFSSSPILDLSESGLCRLEEVFR.I

Q9UHN7

78.6%

1004

111597

6.4

(Q9UHN7) C-Cbl-associated protein SH3P12

	TK040203_NMyc_nuclei2_step07.2742.2742.3	2.1786	0.1853	3190.65	5	1760.0%	1	R.HTGVIPTHHQFITNERFGDLLNIDDTAK.R
	TK040203_NMyc_nuclei2_step11.1534.1534.2	2.2547	0.3094	1886.13	1	5000.0%	1	R.HTGVIPTHHQFITNER.F

O54816

78.4%

27.7%

278

31180

9.2

(O54816) Cell surface molecule OX-2

*	TK040203_NMyc_nuclei2_step08.2248.2248.3	1.3484	0.0364	4272.35	15	1040.0%	2	R.INVTELGLWNSSITFWNTHIGDGGCYMCLFNTFGSQK.V
*	TK040203_NMyc_nuclei2_step07.3620.3620.3	2.8638	0.2767	4514.04	4	1220.0%	4	-.MGSLVFRRPFCHLSTYSLIWGIAAVALSTAQVEVVTQDER.K

IP3R_MOUSE

78.4%

2749

313196

6.1

(P11881) Inositol 1,4,5-trisphosphate receptor type 1 (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor) (IP3 receptor isoform 1) (InsP3R1) (Inositol 1,4,5-trisphosphate-binding protein P400) (Purkinje cell protein 1)

	TK040203_NMyc_nuclei2_step02.3848.3848.3	1.4549	0.0238	3024.52	59	1670.0%	1	K.LTFEVVNLARNLIYFGFYNFSDLLR.L
*	TK040203_NMyc_nuclei2_step07.3777.3777.3	1.9287	0.0311	4529.89	2	1200.0%	2	R.ESLTSFGNGPLSPGGPSKPGGGGGGPGSSSTSRGEMSLAEVQCHLDK.E
	TK040203_NMyc_nuclei2_step06.0375.0375.2	1.1144	0.1198	1253.82	6	3500.0%	1	R.DSVLAASRDYR.N
	TK040203_NMyc_nuclei2_step06.1849.1849.1	1.1831	0.0107	1321.65	279	3500.0%	1	R.NLQEKLESTMK.L
	TK040203_NMyc_nuclei2_step02.2922.2922.2	1.7547	0.288	2838.0	38	1740.0%	1	K.NAMRVTLDEAGNEGSWFYIQPFYK.L
*	TK040203_NMyc_nuclei2_step02.4128.4128.3	1.3354	0.0215	3088.8	16	1360.0%	1	R.RESLTSFGNGPLSPGGPSKPGGGGGGPGSSSTSR.G
	TK040203_NMyc_nuclei2_step01.1891.1891.1	1.1776	0.0424	1132.69	8	5000.0%	1	K.QLLEENEEK.L
	TK040203_NMyc_nuclei2_step07.1464.1464.1	1.3065	0.0956	1302.6	13	4090.0%	1	R.DQLLEASAATRK.A
	TK040203_NMyc_nuclei2_step03.3150.3150.2	2.3848	0.0962	2183.14	3	3420.0%	1	K.AVLNPTNADILIETKLVLSR.F

LONM_HUMAN

78.4%

2.7%

959

106489

6.4

(P36776) Lon protease homolog, mitochondrial precursor (EC 3.4.21.-) (Lon protease-like protein) (LONP) (LONHs)

*	TK040203_NMyc_nuclei2_step04.4177.4177.2	1.7284	0.0959	3014.14	1	2000.0%	1	K.YSNENLDLARAQAVLEEDHYGMEDVK.K
*	TK040203_NMyc_nuclei2_step07.1613.1613.1	1.6252	0.1927	1196.5	1	5560.0%	1	K.YSNENLDLAR.A

O60275

78.2%

1560

170438

8.7

(O60275) Hypothetical protein KIAA0522 (Fragment)

*	TK040203_NMyc_nuclei2_step05.3051.3051.2	0.9526	0.0080	2459.44	26	2220.0%	1	R.RLVCCCQLYEVPDPNRPQR.L
*	TK040203_NMyc_nuclei2_step03.2425.2425.1	1.222	0.0016	1254.75	78	3890.0%	1	R.YCVCNPALVR.Q
*	TK040203_NMyc_nuclei2_step01.2666.2666.1	1.519	0.0465	1570.73	1	3570.0%	3	R.SSLEDTYGAGDGLKR.G
*	TK040203_NMyc_nuclei2_step12.4170.4170.2	1.3328	0.0052	3026.92	23	1410.0%	1	R.HYPAPEGPAPAPPGPLPPAPNSGTGPSGVAGGR.R
*	TK040203_NMyc_nuclei2_step11.3735.3735.3	2.2816	0.1821	3433.65	2	1590.0%	1	K.SDGENSRTVSVEGDAPGSDLSTAVDSPGSQPPYR.L

CA1F_HUMAN

78.2%

16.8%

1603

157693

7.9

(Q07092) Collagen alpha 1(XVI) chain precursor

*	TK040203_NMyc_nuclei2_step11.2026.2026.1	1.2544	0.0952	1187.46	12	4090.0%	1	R.DSNVTLAPSGPK.G
*	TK040203_NMyc_nuclei2_step02.1855.1855.1	1.0352	0.0658	1148.52	50	3180.0%	1	K.GKTGHPGLPGPK.G
*	TK040203_NMyc_nuclei2_step05.2600.2600.2	1.6253	0.08	1973.13	3	2500.0%	1	R.MQFPMEMAAAPGRPGPPGK.D
*	TK040203_NMyc_nuclei2_step07.1381.1381.1	1.8586	0.1716	1047.7	1	6110.0%	1	K.QGFYGPPGPK.G
*	TK040203_NMyc_nuclei2_step04.1535.1535.2	1.3904	0.1042	3060.06	24	1250.0%	1	R.GVQGPQGEPGAPGLPGIQGLPGPRGPPGPTGEK.G
*	TK040203_NMyc_nuclei2_step08.2024.2024.3	1.6531	0.1357	3107.68	12	1250.0%	1	R.GLAGLPGQPGPPGHPGPPGEPGTDGAAGKEGPPGK.Q
*	TK040203_NMyc_nuclei2_step02.3466.3466.3	1.8432	0.0612	3756.98	3	1380.0%	1	K.GEPCLSCSSVVGAQHLVSSTGASGDVGSPGFGLPGLPGR.A
*	TK040203_NMyc_nuclei2_step09.1938.1938.3	1.6124	0.093	4376.16	28	1000.0%	1	K.GEPCLSCSSVVGAQHLVSSTGASGDVGSPGFGLPGLPGRAGVPGLK.G
*	TK040203_NMyc_nuclei2_step11.3527.3527.3	2.1831	0.2278	3389.6	33	1400.0%	1	R.GDNSEGDPGCVGSPGLPGPPGLPGQRGEEGPPGMR.G
*	TK040203_NMyc_nuclei2_step12.2739.2739.2	1.4552	0.0592	2197.0	22	1960.0%	1	K.GEPGPPGQPGYPGATGPPGLPGIK.G
*	TK040203_NMyc_nuclei2_step12.2975.2975.3	2.2461	0.2002	3203.1	3	1720.0%	1	K.VHQETAADECPPCVHGARDSNVTLAPSGPK.G
*	TK040203_NMyc_nuclei2_step05.4256.4256.2	0.765	0.0059	2959.6	81	1250.0%	1	R.AQGQDGDFVSCIFPVPQLFDLRWHK.L

Q9JIX4

78.2%

743

83107

8.7

(Q9JIX4) DNA binding protein DESRT

*	TK040203_NMyc_nuclei2_step04.2383.2383.1	1.8335	0.1782	1391.73	1	4580.0%	1	K.QPLASPSTQMDSK.Q
*	TK040203_NMyc_nuclei2_step11.4454.4454.2	1.2876	0.0433	2860.18	5	1960.0%	1	K.EKADLGEDEEETNVIVLSYPQYCR.Y
*	TK040203_NMyc_nuclei2_step11.1671.1671.3	1.7225	0.0203	3893.79	160	1170.0%	1	R.NPQILYCRDTFDHPTLIENESVVLMSFPAQILK.G
*	TK040203_NMyc_nuclei2_step07.3205.3205.2	1.1885	0.0392	2417.0	16	1820.0%	1	K.EAEEMGDKGLAPLLPSPPLPPEK.D

Q99KG3

78.2%

930

103494

5.9

(Q99KG3) Similar to RNA binding motif protein 10

	TK040203_NMyc_nuclei2_step08.1416.1416.1	1.1441	0.1289	1049.56	1	6880.0%	2	R.HQQLSGLHK.Q
	TK040203_NMyc_nuclei2_step11.0964.0964.2	0.8011	0.041	1384.08	1	4090.0%	1	R.EKYGIPEPPEPK.R

Q9D8P9

78.2%

117

12760

5.5

(Q9D8P9) 1810047K05Rik protein

	TK040203_NMyc_nuclei2_step05.2666.2666.2	2.3804	0.24	1840.21	1	4410.0%	2	K.GFTTASSIANLKVSLLSK.E

Q9CQ83

78.1%

145

17086

9.4

(Q9CQ83) 2410011G03Rik protein

	TK040203_NMyc_nuclei2_step10.1492.1492.1	1.5661	0.2018	947.54	5	6670.0%	1	K.QFFGRHR.W

Q8R3G1

78.1%

20.8%

351

38528

7.4

(Q8R3G1) Similar to protein phosphatase 1, regulatory (Inhibitor) subunit 8

*	TK040203_NMyc_nuclei2_step10.1581.1581.3	1.4211	0.0594	3434.26	47	1330.0%	1	-.MAAAVNSGSSLPLFDCPTWAGKPPPGLHLDVVK.G
	TK040203_NMyc_nuclei2_step05.2287.2287.2	2.1406	0.3176	2408.34	5	2140.0%	1	R.LEPHKPQQIPIDSTVSFGASTR.A
	TK040203_NMyc_nuclei2_step03.2205.2205.2	1.0079	0.1307	2086.64	1	2650.0%	1	R.ISTLTIEEGNLDIQRPKR.K

Q8R3I3

77.9%

605

67855

6.1

(Q8R3I3) Similar to KIAA1134 protein

*	TK040203_NMyc_nuclei2_step03.2198.2198.2	1.4009	0.1253	2014.17	1	3530.0%	3	K.VRIEQVILAEPGAVLLYK.I

NCR1_HUMAN

77.7%

1.9%

2440

270262

7.1

(O75376) Nuclear receptor co-repressor 1 (N-CoR1) (N-CoR)

*	TK040203_NMyc_nuclei2_step05.1644.1644.1	1.4216	0.3179	1249.45	1	4500.0%	1	K.IDGTAEETEER.E
*	TK040203_NMyc_nuclei2_step04.2515.2515.3	1.5491	0.0965	3513.01	20	1360.0%	1	R.KLNSSGGGDSDMAAAQPGTEIFNLPAVTTSGSVSSR.G
*	TK040203_NMyc_nuclei2_step05.3311.3311.3	1.6474	0.0267	3382.77	2	1470.0%	1	K.LNSSGGGDSDMAAAQPGTEIFNLPAVTTSGSVSSR.G

CG1_HUMAN

77.7%

701

74475

8.0

(Q13495) CG1 protein (F18)

*	TK040203_NMyc_nuclei2_step03.2918.2918.3	2.6928	0.3117	3550.67	1	1720.0%	1	R.HPQVSLGRQPPSCQALGSESFLPGSSFAHELAR.V

Q8TF68

77.6%

576

63091

9.0

(Q8TF68) Nuclear matrix transcription factor4

*	TK040203_NMyc_nuclei2_step02.2223.2223.1	2.0276	0.1094	1521.78	2	4170.0%	1	K.TFANTSYLAQHLR.I
*	TK040203_NMyc_nuclei2_step05.2815.2815.3	1.8049	0.1032	3905.17	1	1880.0%	1	-.MEESHFNSNPYFWPSIPTVSGQIENTMFINKMK.D

Q9D3N7

77.6%

29.1%

175

18978

9.5

(Q9D3N7) 5430401F13Rik protein

*	TK040203_NMyc_nuclei2_step12.1173.1173.2	1.5862	0.1659	2871.67	63	1670.0%	1	R.SSDDDNLEVQDHQSGNEQAGGGQGGRGR.S
*	TK040203_NMyc_nuclei2_step10.2624.2624.2	1.2402	0.0102	2441.04	6	2500.0%	4	-.MASSRILLVLLSIALLALTSAQR.V

Z174_HUMAN

77.3%

407

46455

9.6

(Q15697) Zinc finger protein 174 (AW-1)

*	TK040203_NMyc_nuclei2_step10.2047.2047.2	2.2489	0.1155	1746.85	2	4290.0%	5	R.SLSNRLQHLGHQPTR.S
*	TK040203_NMyc_nuclei2_step10.1382.1382.2	1.2587	0.0206	1903.34	11	2650.0%	1	K.SPLLQEPTPKLAGTEAPR.M

P97462

77.3%

535

59998

8.9

(P97462) Embryonic ECTODERM development (Embryonic ECTODERM development protein)

	TK040203_NMyc_nuclei2_step01.2527.2527.1	1.2166	0.0636	1248.77	1	5560.0%	1	K.YSFKCVNSLK.E
	TK040203_NMyc_nuclei2_step06.1742.1742.1	1.866	0.1658	1451.33	1	4580.0%	1	K.HYVGHGNAINELK.F
	TK040203_NMyc_nuclei2_step02.3076.3076.2	1.9426	0.051	2264.05	1	4210.0%	1	K.MEDDIDKIKPSESNVTILGR.F
*	TK040203_NMyc_nuclei2_step05.3407.3407.3	2.3424	0.0853	3040.85	1	1950.0%	1	R.LGAICDSGGSGGGGGAGSFAAGSGRACLTAVWR.R

O00535

77.3%

204

23220

6.6

(O00535) TTF-I interacting peptide 12 (Fragment)

	TK040203_NMyc_nuclei2_step06.3718.3718.2	1.8016	0.4257	2583.74	1	2390.0%	1	R.RGSSPDVHALLEITEESDAVLVDK.S

O88207

77.2%

1838

183692

5.0

(O88207) Collagen a1(V)

*	TK040203_NMyc_nuclei2_step02.2398.2398.1	1.0301	0.0146	923.58	3	5000.0%	1	R.IALSVYKK.N
*	TK040203_NMyc_nuclei2_step12.4262.4262.2	1.5674	0.0732	2559.79	4	2120.0%	1	R.GDPGPSGPPGIPGDDGERGDDGEVGPR.G
	TK040203_NMyc_nuclei2_step04.2891.2891.2	1.3236	0.0051	2469.61	24	1820.0%	1	K.GPMVSAQESQAQAILQQARLALR.G
*	TK040203_NMyc_nuclei2_step01.1298.1298.1	1.5899	0.195	1251.69	4	3930.0%	1	K.GEAGPSGAAGPPGPK.G
	TK040203_NMyc_nuclei2_step07.2842.2842.2	1.1565	0.0471	2466.05	97	1540.0%	1	R.GLLGPKGPPGPPGPPGVTGMDGQPGPK.G
*	TK040203_NMyc_nuclei2_step08.2393.2393.3	1.5005	0.0524	4091.06	1	1190.0%	1	K.TGPPGPPGVVGPQGPTGETGPMGERGHPGPPGPPGEQGLPGAAGK.E
*	TK040203_NMyc_nuclei2_step09.1769.1769.2	1.1749	0.119	2172.16	9	2780.0%	1	K.QLYPESGFPEDFSILTTVK.A
	TK040203_NMyc_nuclei2_step10.2085.2085.2	1.3909	0.2113	3050.17	5	1720.0%	1	K.GDKGEQGPPGPTGPQGPIGQPGPSGADGEPGPR.G

Q9ER97

77.2%

18.5%

151

17037

5.9

(Q9ER97) Neuroglobin

*	TK040203_NMyc_nuclei2_step01.3583.3583.2	1.8486	0.3622	3066.06	3	2220.0%	1	K.VMLVIDAAVTNVEDLSSLEEYLTSLGRK.H

O60331

77.1%

687

75283

5.6

(O60331) Hypothetical protein KIAA0589 (Fragment)

*	TK040203_NMyc_nuclei2_step03.3849.3849.3	1.456	0.0146	4067.74	8	1190.0%	1	R.RPRAAMELEVPDEAESAEAGAVPSEAAWAAESGAAAGLAQK.K
*	TK040203_NMyc_nuclei2_step05.3300.3300.2	1.2883	0.1283	2156.4	2	3240.0%	2	K.IMDYSLLLGVHNIDQHER.E
*	TK040203_NMyc_nuclei2_step05.3562.3562.2	1.7227	0.0377	2439.95	18	2370.0%	2	K.IMDYSLLLGVHNIDQHERER.Q
*	TK040203_NMyc_nuclei2_step02.3783.3783.2	0.9789	0.0591	2439.54	32	1880.0%	1	R.GGALLAVKPLGPTAAFSASQIPSER.E

CUT1_HUMAN

77.0%

1505

164353

6.1

(P39880) CCAAT displacement protein (CDP) (Cut-like 1)

	TK040203_NMyc_nuclei2_step06.3038.3038.3	2.6631	0.3327	3443.02	1	1850.0%	1	K.ELNILKSMEFAPSEGAGTQDAAKPLEVLLLEK.N
	TK040203_NMyc_nuclei2_step11.1982.1982.3	2.0799	0.0423	3404.57	38	1500.0%	1	R.EQLSSANHSLQLASQIQKAPDVEQAIEVLTR.S

CTA2_HUMAN

76.9%

1331

148167

6.6

(Q9UHC6) Contactin associated protein-like 2 precursor (Cell recognition molecule Caspr2)

*	TK040203_NMyc_nuclei2_step12.3474.3474.3	1.3512	0.0359	2296.43	4	2240.0%	1	K.HYYWGGSGPGIQKCACGIER.N
*	TK040203_NMyc_nuclei2_step12.1301.1301.2	1.045	0.0308	2515.47	19	1590.0%	1	K.HLGQTSNYYWIDPDGSGPLGPLK.V
*	TK040203_NMyc_nuclei2_step04.3283.3283.2	2.3742	0.1829	3064.55	5	2200.0%	1	K.CTCDETGYSGATCHNSIYEPSCEAYK.H
*	TK040203_NMyc_nuclei2_step08.3420.3420.3	1.5187	0.0079	3315.66	19	1760.0%	1	R.IGLRIEVYGCSYWADVINFDGHVVLPYR.F

E2BG_HUMAN

76.8%

452

50240

6.5

(Q9NR50) Translation initiation factor eIF-2B gamma subunit (eIF-2B GDP-GTP exchange factor)

*	TK040203_NMyc_nuclei2_step12.2803.2803.2	1.5841	0.2336	1987.93	1	3440.0%	3	K.KYIVDFLMENGSITSIR.S

LV6D_HUMAN

76.7%

26.1%

111

11966

4.8

(P06318) Ig lambda chain V-VI region WLT

*	TK040203_NMyc_nuclei2_step04.2985.2985.3	2.6293	0.3579	3341.66	1	1790.0%	6	K.TEDEADYYCQSYDNNNHVVFGGTRLTVLG.-

Q8VIM5

76.6%

935

101373

6.4

(Q8VIM5) Transcription factor myocardin

	TK040203_NMyc_nuclei2_step02.1511.1511.1	1.7852	0.1719	940.87	2	5710.0%	4	K.KPKDPKPK.V
	TK040203_NMyc_nuclei2_step12.1587.1587.2	1.2942	0.217	2201.65	94	1750.0%	1	K.GTEVSLSKAADAFAFEDDSSR.D

RM56_MOUSE

76.5%

551

60706

8.9

(Q9EP89) Mitochondrial 39S ribosomal protein L56 (MRP-L56) (Serine beta lactamase-like protein LACTB)

	TK040203_NMyc_nuclei2_step09.3437.3437.2	1.8191	0.0799	3037.77	1	2220.0%	2	R.GIIVSIICNMQSVGLNSTALKIALEFDK.D
	TK040203_NMyc_nuclei2_step07.1466.1466.2	1.2169	0.0676	2914.15	21	1540.0%	1	R.LVNTPYVDNSYKWAGGGFLSTVGDLLK.F

ZWIN_HUMAN

76.5%

277

31194

5.1

(O95229) ZW10 interactor (ZW10 interacting protein-1) (Zwint-1)

*	TK040203_NMyc_nuclei2_step08.3493.3493.1	1.369	0.0478	1193.66	1	6110.0%	6	R.EAFEQLQAKK.Q

Q9H1Q2

76.5%

1540

175333

7.0

(Q9H1Q2) BA165F24.1.2 (Novel protein similar to Drosophila CG6630 and CG11376, KIAA1058, rat TRG (Isoform 2)) (Fragment)

*	TK040203_NMyc_nuclei2_step08.2737.2737.3	1.7439	0.1539	4422.96	26	1110.0%	1	R.ALIAKFGDLLFEEEVEQCFDLCHQVLHHCSSSMDVTR.S
*	TK040203_NMyc_nuclei2_step11.1414.1414.1	1.647	0.1872	1247.65	1	5500.0%	1	K.LSNLPTLISMR.L
*	TK040203_NMyc_nuclei2_step10.2853.2853.2	0.7779	0.0032	2604.87	142	1140.0%	1	K.MQVTMSLASLVGRAPDFNEEHLR.R
*	TK040203_NMyc_nuclei2_step11.2008.2008.2	1.4986	0.0349	2808.93	1	2310.0%	1	R.VMSSSNPDLAGTHSAADEEVKNIMSSK.I
*	TK040203_NMyc_nuclei2_step08.2016.2016.1	1.3629	0.0605	1552.57	7	3460.0%	1	R.DVPKCAPTALLDPR.S

Q96LJ6

76.4%

251

27767

9.7

(Q96LJ6) Hypothetical protein FLJ25431

*	TK040203_NMyc_nuclei2_step04.2003.2003.2	1.8956	0.3444	2132.51	2	3060.0%	1	R.ILEVFLLGKLLIGWMLSGK.Q

Q9UI26

76.4%

975

112535

5.3

(Q9UI26) Ran binding protein 11

	TK040203_NMyc_nuclei2_step01.3306.3306.2	1.6277	0.1168	2887.44	3	2080.0%	1	K.DAVYNAVGLAAYELFDSVDFDQWFK.N
	TK040203_NMyc_nuclei2_step07.1826.1826.3	1.5136	0.0032	2903.66	4	1980.0%	1	K.LTVNGFVEPHKNMEVMGFLHGIFER.L
	TK040203_NMyc_nuclei2_step03.3495.3495.2	1.8953	0.3528	2182.81	2	2500.0%	1	R.VLLQNTSFFSSLLNEMAHK.F

P2CB_MOUSE

76.4%

9.5%

390

42795

5.2

(P36993) Protein phosphatase 2C beta isoform (EC 3.1.3.16) (PP2C-beta) (IA) (Protein phosphatase 1B)

	TK040203_NMyc_nuclei2_step10.2843.2843.2	1.1513	0.0575	2600.77	17	2050.0%	1	K.CVDGKGPTEQLVSPEPEVYEIVR.A
	TK040203_NMyc_nuclei2_step10.1956.1956.2	2.2722	0.2713	1463.43	2	4620.0%	1	K.TEKHNAHGAGNGLR.Y

FMN1_MOUSE

76.2%

294

1468

163809

8.6

(Q05860) Formin 1 isoforms I/II/III (Limb deformity protein)

*	TK040203_NMyc_nuclei2_step12.1754.1754.2	1.1662	0.0627	2624.48	77	1670.0%	1	K.KPTPQVPTALGMVFNNSSPQSSAHK.R
*	TK040203_NMyc_nuclei2_step03.1855.1855.2	1.0396	0.0696	1795.11	59	2330.0%	1	K.GRVAYGPETQTEFIPK.A
	TK040203_NMyc_nuclei2_step01.4062.4062.1	0.6639	0.0094	846.1	74	3330.0%	1	K.DTTQQKK.K
	TK040203_NMyc_nuclei2_step10.2013.2013.2	1.1988	0.1104	2419.76	3	2500.0%	1	K.EVTPSYVFMVWFEFCSDFK.T
	TK040203_NMyc_nuclei2_step01.1732.1732.1	1.6908	0.0392	1195.68	9	5560.0%	17	K.KKPLSEAYEK.K
*	TK040203_NMyc_nuclei2_step03.1709.1709.3	1.5311	0.2307	2903.1	338	1060.0%	1	K.ADFLTLPGGETETHSSGRLEEEQPGIK.S

E2F5_MOUSE

76.2%

335

36784

5.3

(Q61502) Transcription factor E2F5 (E2F-5)

	TK040203_NMyc_nuclei2_step01.2135.2135.1	1.8876	0.1416	1227.7	3	5500.0%	1	R.HEKSLGLLTTK.F
*	TK040203_NMyc_nuclei2_step06.1431.1431.3	1.1404	0.0662	3445.7	23	1330.0%	1	K.ESSSSKPVVFPVPPPDDLTQPSSQSSTSVTPQK.S

Q62412

76.1%

1190

137774

8.7

(Q62412) Nebulin (Fragment)

*	TK040203_NMyc_nuclei2_step12.3906.3906.3	1.0601	0.0202	1996.5	78	1620.0%	1	K.SKGIYNTPLDMMSIVQAK.K
	TK040203_NMyc_nuclei2_step01.0186.0186.1	1.1669	0.0276	932.24	4	6670.0%	2	K.YKEAYEK.Q
	TK040203_NMyc_nuclei2_step04.1625.1625.1	1.0699	0.0293	808.3	2	5830.0%	1	R.QAMEEAK.K
*	TK040203_NMyc_nuclei2_step02.0353.0353.1	0.8402	0.0263	1551.9	126	1920.0%	1	K.FTSITDSLEQVLAK.N

Q9CRI0

76.1%

139

16002

5.7

(Q9CRI0) ES cells cDNA, RIKEN full-length enriched library, clone:2410013L13, full insert sequence (Fragment)

	TK040203_NMyc_nuclei2_step01.0062.0062.1	1.8443	0.0863	1381.48	2	5000.0%	4	R.EDSVKPGAHLTVK.K

Q9QXV0

75.9%

22.1%

258

27285

5.8

(Q9QXV0) ProSAAS precursor

*	TK040203_NMyc_nuclei2_step05.2351.2351.2	1.0082	0.0038	2377.45	160	1430.0%	3	R.RSVDQDLGPEVPPENVLGALLR.V
*	TK040203_NMyc_nuclei2_step11.2578.2578.2	1.3403	0.0507	2293.81	55	2140.0%	1	R.GEAAGAVQELARALAHLQEAER.Q
*	TK040203_NMyc_nuclei2_step04.1666.1666.1	0.9715	0.1005	1465.61	348	2080.0%	1	R.VLAQLLRAWGSPR.A

Q9H8N5

75.9%

17.3%

462

53864

7.4

(Q9H8N5) Hypothetical protein FLJ13373

*	TK040203_NMyc_nuclei2_step08.2885.2885.2	0.9533	0.0202	2921.35	5	1740.0%	1	K.SSTASEWLDLFCDCLGCNLIFPRR.D
*	TK040203_NMyc_nuclei2_step02.3240.3240.2	1.4605	0.0824	2902.26	8	1820.0%	1	K.HILFSLAEEENFDNYWEYLHNSK.S
*	TK040203_NMyc_nuclei2_step10.2676.2676.2	1.4144	0.0913	2484.15	6	2140.0%	1	K.LTPAVSTTIWEDMTFKIAGDMR.A
*	TK040203_NMyc_nuclei2_step08.1993.1993.1	1.6173	0.1881	1423.77	1	4500.0%	1	K.MLSEHLCGCWK.Q

KCN4_HUMAN

75.9%

427

47696

9.8

(O15554) Intermediate conductance calcium-activated potassium channel protein 4 (SK4) (KCa4) (IK1) (IKCa1) (Putative Gardos channel)

*	TK040203_NMyc_nuclei2_step01.3635.3635.1	1.2104	0.1118	1314.1	3	4440.0%	2	R.VLQEAWMFYK.H
*	TK040203_NMyc_nuclei2_step06.1801.1801.1	1.6125	0.1906	1272.59	1	5420.0%	2	-.MGGDLVLGLGALR.R
*	TK040203_NMyc_nuclei2_step04.1671.1671.1	1.2114	0.124	1288.64	61	3640.0%	1	R.ALEKQIDTLAGK.L

Q9CSF2

75.8%

159

18284

9.2

(Q9CSF2) 2810405K07Rik protein (Fragment)

	TK040203_NMyc_nuclei2_step08.3910.3910.1	0.4294	0.0043	590.42	41	3750.0%	1	K.QGIDR.G
*	TK040203_NMyc_nuclei2_step01.1344.1344.1	1.8081	0.0855	1588.67	1	5000.0%	3	R.DCGKAFYGVTSLNR.H

Q8VG71

75.7%

310

34942

8.0

(Q8VG71) Olfactory receptor MOR165-5

*	TK040203_NMyc_nuclei2_step12.4195.4195.1	0.9329	0.0407	762.14	1	6670.0%	6	K.KTITIGK.F

Q15673

75.7%

645

70410

8.0

(Q15673) TYL protein

	TK040203_NMyc_nuclei2_step10.2679.2679.3	1.8454	0.2233	3028.57	132	1420.0%	1	R.ISGGSGSGSSPFLDLTPEPGAAVYKHGALVR.K
	TK040203_NMyc_nuclei2_step05.2138.2138.1	1.1869	0.0315	1297.58	11	3330.0%	8	R.HSSEPRPGAGSGR.R

Q9HDA5

75.5%

437

46363

6.3

(Q9HDA5) Cell surface receptor

*	TK040203_NMyc_nuclei2_step04.3500.3500.2	1.841	0.0784	3038.74	2	2500.0%	3	R.QEDFCNNLVNSLPLWAPQPPADPGSLR.C

MYM1_MOUSE

75.4%

1666

185330

6.2

(Q62234) Myomesin 1 (Skelemin)

*	TK040203_NMyc_nuclei2_step10.2089.2089.2	1.1246	0.0788	2136.39	5	2500.0%	1	K.DPVAVPSAPYDITCLESFR.D
*	TK040203_NMyc_nuclei2_step01.0806.0806.1	1.0936	0.103	826.44	22	5710.0%	1	K.AVSDAAYK.I
*	TK040203_NMyc_nuclei2_step12.2510.2510.2	1.1001	0.0468	2284.64	14	1820.0%	1	R.DADAEIEGAPAAPLDVVSLDANK.D
*	TK040203_NMyc_nuclei2_step01.2883.2883.1	1.4504	0.2609	1540.78	1	4170.0%	1	R.FWMQAEKLSSNAK.V
*	TK040203_NMyc_nuclei2_step04.2389.2389.1	1.5125	0.025	1408.64	4	5000.0%	1	K.LHCSVAGWPEPR.L
*	TK040203_NMyc_nuclei2_step11.2426.2426.3	1.8224	0.0908	3065.7	5	1570.0%	1	K.ENTLYQFQVSAMNIAGLGAPSTVSECFK.C

Q9BW24

75.3%

391

43142

4.8

(Q9BW24) Hypothetical protein

*	TK040203_NMyc_nuclei2_step03.2241.2241.2	1.9156	0.3399	2191.83	1	3060.0%	1	K.EFVTGMSGMYHGYLTEKLK.V

FGFF_MOUSE

75.2%

218

25236

7.4

(O35622) Fibroblast growth factor-15 precursor (FGF-15)

*	TK040203_NMyc_nuclei2_step12.2623.2623.2	1.9491	0.3324	2940.74	2	2080.0%	2	K.MFSLPLESDSMDPFRMVEDVDHLVK.S

O15395

75.2%

554

61154

6.8

(O15395) Organic cation transporter 1

	TK040203_NMyc_nuclei2_step01.4516.4516.2	1.9649	0.3288	2942.33	1	2800.0%	1	R.NLGVMVCSSLCDIGGIITPFIVFRLR.E
	TK040203_NMyc_nuclei2_step12.2287.2287.2	1.2431	0.0665	2768.89	2	2390.0%	1	R.RYEVDWNQSALSCVDPLASLATNR.S
	TK040203_NMyc_nuclei2_step09.2469.2469.3	2.1452	0.1042	3317.38	3	1720.0%	1	K.LCLLGTVLVNAVSGVLMAFSPNYMSMLLFR.L

Q9D5K4

75.1%

20.2%

396

44473

5.6

(Q9D5K4) 4930429A08Rik protein

*	TK040203_NMyc_nuclei2_step11.1678.1678.2	2.3127	0.2206	2038.14	1	3240.0%	1	K.KPTPVFSQISNHSEVPNR.K
*	TK040203_NMyc_nuclei2_step12.3123.3123.3	1.6022	0.0429	4705.15	4	1100.0%	1	K.VIAHIEDPGDSNQGTLGELDALMDQVHMQHPDWQHPSDLTTR.N
*	TK040203_NMyc_nuclei2_step06.2201.2201.2	1.3983	0.2701	2075.09	9	2630.0%	1	K.LPQLSTSVGHGPTPSKSLNR.H

O88737

75.0%

3942

418751

7.7

(O88737) Bassoon

*	TK040203_NMyc_nuclei2_step10.2728.2728.3	1.5506	0.0545	3047.15	40	1470.0%	1	R.ASQPVAESTPAGLGAAVYEEILQTSQSIAR.M
*	TK040203_NMyc_nuclei2_step12.1273.1273.2	1.3983	0.2063	1358.61	1	4550.0%	1	R.GPANYNTCTACK.L
*	TK040203_NMyc_nuclei2_step08.2111.2111.2	1.251	0.0471	2644.07	19	1820.0%	1	R.SMESNGRPSTHYYGDSDYRHGAR.A
*	TK040203_NMyc_nuclei2_step04.3171.3171.3	1.7774	0.1091	4488.96	2	1190.0%	1	R.ATAEFSTQTPSLTLSSDIPRSPGPPSPMVAQGTQTPHRPSTPR.L
*	TK040203_NMyc_nuclei2_step11.3588.3588.3	2.8222	0.3059	4698.81	1	1380.0%	1	R.VSPQPPLSTKPSTAEPRPPAGEAQGKSATTVPSGLGAGEQTQEGLTGK.L
*	TK040203_NMyc_nuclei2_step02.3211.3211.3	2.0705	0.1202	4576.36	12	1060.0%	1	K.EAPVAPAPGPAPAPPPGQKPAGEAAAGSGSGVLSRPASEKEEASQEDR.Q
*	TK040203_NMyc_nuclei2_step09.3187.3187.2	1.4014	0.2025	3124.81	1	1550.0%	1	R.RDILITQMGTAQGVGLKPGPVPEPGAEPHR.A
*	TK040203_NMyc_nuclei2_step11.3274.3274.3	1.7835	0.0183	4781.58	155	760.0%	1	R.TQGVVGPGPHEEQRPYPQGLPGRLYSSMSDTNLAEAGLNYHAQR.L
*	TK040203_NMyc_nuclei2_step09.2714.2714.3	1.8224	0.0235	3942.58	10	1120.0%	1	R.FPIASSVPPAEGPVYLGKPAATKASGAGGPPRPELPAGVAR.E
*	TK040203_NMyc_nuclei2_step06.3487.3487.2	1.2574	0.0063	3014.92	2	1730.0%	1	R.EPVLHRGLPSSASDMSLQTEEQWEAGR.S
*	TK040203_NMyc_nuclei2_step11.3918.3918.3	1.8658	0.2081	2631.69	101	1850.0%	1	K.IVFSDASKEAGPRPPGSGPGPGPTPGAK.T
*	TK040203_NMyc_nuclei2_step06.3045.3045.3	2.0153	0.0929	3491.81	15	1360.0%	2	R.LEPLGPGGVSGRPGKDPGEPAVLEGPTLPCCYGR.G

Q9H5R9

74.9%

268

30680

4.7

(Q9H5R9) Hypothetical protein FLJ23129

*	TK040203_NMyc_nuclei2_step01.3366.3366.1	1.2703	0.0952	1370.41	81	3180.0%	2	R.MMQTFNGAPKNK.D

O5P2_HUMAN

74.9%

322

35786

7.8

(Q8WZ92) Olfactory receptor 5P2 (Olfactory receptor-like protein JCG3)

*	TK040203_NMyc_nuclei2_step11.1256.1256.3	2.8131	0.2596	2635.99	1	2610.0%	1	K.VVSVLYTVVIPMLNPLIYSLRNK.E

Q99L28

74.9%

121

163

19611

10.0

(Q99L28) Similar to 60S ribosomal protein L30 isolog

	TK040203_NMyc_nuclei2_step08.3421.3421.1	1.7846	0.0441	1434.52	17	3750.0%	11	K.QNIHLIRAPLAGK.G

Q8WWZ6

74.9%

1617

184254

7.4

(Q8WWZ6) ATP-binding cassette A6

*	TK040203_NMyc_nuclei2_step12.3827.3827.3	2.0152	0.0972	4004.34	2	1640.0%	1	K.LIFFQGYNSPLWKEDFSAHCWDGYGEFSCTLTK.Y
*	TK040203_NMyc_nuclei2_step05.1931.1931.1	1.1308	0.0034	1163.65	85	3890.0%	1	K.ENLSLFAKIK.G
*	TK040203_NMyc_nuclei2_step10.2173.2173.3	1.9664	0.273	4013.91	1	1430.0%	1	K.GTSVIGAPNKTHMDEILLENLPYAMGIIFNETFSYK.L
*	TK040203_NMyc_nuclei2_step09.2055.2055.3	2.2534	0.0733	3045.75	38	1670.0%	1	K.LTFGITILGDPQILLLDEPTTGLDPFSR.D
*	TK040203_NMyc_nuclei2_step08.2855.2855.2	1.5095	0.0662	2889.6	17	1670.0%	1	K.GCSSVLGHLGYCPQENVLWPMLTLR.E
*	TK040203_NMyc_nuclei2_step03.2705.2705.2	1.8878	0.3079	2653.37	1	2270.0%	2	R.ILLELDMQNIQDNLAKHLSEGQK.R

O43423

74.9%

234

26762

4.2

(O43423) Pp32r1

*	TK040203_NMyc_nuclei2_step12.4169.4169.2	2.2251	0.2841	1318.14	1	5000.0%	1	K.INGGLTSISDLPK.L

SFR2_MOUSE

74.7%

221

25476

11.9

(Q62093) Splicing factor, arginine/serine-rich 2 (Splicing factor SC35) (SC-35) (Splicing component, 35 kDa) (PR264 protein)

	TK040203_NMyc_nuclei2_step10.1346.1346.1	1.3302	0.0512	1310.55	1	5500.0%	1	R.YGRPPDSHHSR.R
	TK040203_NMyc_nuclei2_step06.4206.4206.1	0.4962	0.0184	684.56	44	3750.0%	1	R.DRYTK.E

Q96M91

74.6%

399

48369

8.4

(Q96M91) Hypothetical protein FLJ32743

*	TK040203_NMyc_nuclei2_step12.3605.3605.2	1.7896	0.3605	2873.54	1	2610.0%	1	K.MCLDKVQEVLSTHQVLPQNIHPMR.K

O88349

74.6%

1713

186907

6.1

(O88349) Latent TGF beta binding protein

*	TK040203_NMyc_nuclei2_step08.3503.3503.2	1.4331	0.0778	3029.53	13	1730.0%	3	R.CSCKMGFGPDPTFSSCVPDPPVISEEK.G
	TK040203_NMyc_nuclei2_step09.2337.2337.2	1.4047	0.077	1877.49	17	2810.0%	2	K.EICPGGMGYTVSGVHRR.R
*	TK040203_NMyc_nuclei2_step01.3495.3495.2	2.3069	0.0305	2936.88	4	2120.0%	6	R.LEPGQPQLSPGVSTIHLHPQFPVVVEK.T
	TK040203_NMyc_nuclei2_step12.2345.2345.2	1.2008	0.0466	2845.71	12	1670.0%	1	K.FPPNIVNIHVKHPPEASVQIHQVSR.I

O00370

74.6%

1275

149011

9.7

(O00370) Putative p150

*	TK040203_NMyc_nuclei2_step09.3138.3138.2	1.4532	0.0648	2586.58	9	2140.0%	1	K.VNKDTQELNSALHQTDLIDIYR.T
*	TK040203_NMyc_nuclei2_step01.2830.2830.2	1.9377	0.1917	3110.5	2	1600.0%	1	R.MFIAALFTIAKTWNQPNCPTMIDWIK.K
*	TK040203_NMyc_nuclei2_step04.3156.3156.2	1.7126	0.0092	2249.33	4	2780.0%	8	K.DTQELNSALHQTDLIDIYR.T

Q15424

74.4%

915

102640

5.5

(Q15424) HSP27 ERE-TATA-binding protein (HET) (Scaffold attachment factor B)

	TK040203_NMyc_nuclei2_step04.3252.3252.3	1.2673	0.0469	4642.8	5	1140.0%	1	R.TDCEPVGLEPAVEQSSAASELAEASSEELAEAPTEAPSPEARDSK.E
	TK040203_NMyc_nuclei2_step03.1555.1555.1	1.686	0.1763	975.54	1	6670.0%	3	R.FHDFDHR.D

CA11_HUMAN

74.4%

1464

138884

5.9

(P02452) Collagen alpha 1(I) chain precursor

	TK040203_NMyc_nuclei2_step11.2051.2051.2	0.9787	0.0161	2852.18	54	1290.0%	1	R.GPPGPMGPPGLAGPPGESGREGAPGAEGSPGR.D
	TK040203_NMyc_nuclei2_step06.3006.3006.2	1.2078	0.102	2871.11	334	1090.0%	1	R.GEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAK.G
	TK040203_NMyc_nuclei2_step06.1698.1698.3	1.5742	0.0934	3202.34	13	1570.0%	1	K.GLTGSPGSPGPDGKTGPPGPAGQDGRPGPPGPPGAR.G
	TK040203_NMyc_nuclei2_step11.3586.3586.2	1.7841	0.3888	2935.91	1	2190.0%	1	K.GSPGADGPAGAPGTPGPQGIAGQRGVVGLPGQR.G
	TK040203_NMyc_nuclei2_step02.2142.2142.3	1.3744	0.0747	2658.39	1	2160.0%	1	R.GFSGLQGPPGPPGSPGEQGPSGASGPAGPR.G
	TK040203_NMyc_nuclei2_step12.2329.2329.3	1.4327	0.0292	4444.71	3	1300.0%	1	R.GPAGPPGRDGIPGQPGLPGPPGPPGPPGPPGLGGNFAPQLSYGYDEK.S

COPP_MOUSE

74.4%

905

102449

5.3

(O55029) Coatomer beta' subunit (Beta'-coat protein) (Beta'-COP) (p102)

	TK040203_NMyc_nuclei2_step05.2444.2444.2	0.9777	0.0307	2260.02	77	1580.0%	1	K.SFGSAQEFAWAHDSSEYAIR.E
	TK040203_NMyc_nuclei2_step04.2209.2209.1	1.5392	0.1963	1505.66	1	4090.0%	1	R.VHMFEAHSDYIR.C

Q91VM8

74.0%

13.2%

539

62669

8.6

(Q91VM8) Similar to zinc finger protein 97

*	TK040203_NMyc_nuclei2_step09.3482.3482.3	1.6645	0.0543	3529.52	29	1480.0%	1	R.GGECDTSLQVLGFPVSVGIHQNTDRGEKPSVDK.E
*	TK040203_NMyc_nuclei2_step06.1579.1579.1	1.5763	0.1869	1154.4	5	5560.0%	1	K.AFACNSNLQK.H
*	TK040203_NMyc_nuclei2_step10.2184.2184.3	1.4826	0.0277	3522.71	208	1200.0%	1	K.AFTCPSYLQIYERIHTEEKPYECSQCGR.A

Q96QE3

73.7%

1204

135837

9.3

(Q96QE3) ATP/GTP-binding protein

*	TK040203_NMyc_nuclei2_step12.2077.2077.2	1.5625	0.2616	2664.45	8	1960.0%	2	K.TAAVYACAQELGFKIFEVNASSQR.S
*	TK040203_NMyc_nuclei2_step03.2990.2990.2	2.0426	0.0387	2368.18	3	2630.0%	2	K.EDYSLNNDFVESSTSVLRYK.K
*	TK040203_NMyc_nuclei2_step04.1571.1571.2	1.0672	0.204	1624.03	19	3850.0%	1	R.DEKHEDFSGGIDFK.G
*	TK040203_NMyc_nuclei2_step06.3782.3782.2	1.0517	0.084	2510.5	28	1750.0%	2	K.QKQFEMENSLSDPENEQTVQK.R
*	TK040203_NMyc_nuclei2_step08.2552.2552.2	1.5466	0.0617	2538.66	6	2380.0%	1	K.QGVNSQKPCFFNSYYIGKSPSK.-
*	TK040203_NMyc_nuclei2_step03.0539.0539.1	0.7904	0.0904	1436.68	18	2500.0%	1	K.SQPNTMTSLQNSK.K
*	TK040203_NMyc_nuclei2_step04.2570.2570.1	0.9948	0.0983	735.52	12	5830.0%	1	R.KASNTSK.N

FLIH_HUMAN

73.7%

146

1269

144751

6.1

(Q13045) Flightless-I protein homolog

*	TK040203_NMyc_nuclei2_step09.2397.2397.1	0.9878	0.0945	670.31	4	8000.0%	1	R.HATVSR.S
*	TK040203_NMyc_nuclei2_step07.3297.3297.2	1.0558	0.0845	3067.34	5	1600.0%	12	K.LTNLEEFMAANNNLELVPESLCRCPK.L
*	TK040203_NMyc_nuclei2_step08.2485.2485.2	1.4638	0.1732	2209.92	315	1250.0%	1	R.LAGASPATVAAAAAAGSGPKDPMAR.K

RFA2_HUMAN

73.7%

270

29247

6.1

(P15927) Replication protein A 32 kDa subunit (RP-A) (RF-A) (Replication factor-A protein 2)

*	TK040203_NMyc_nuclei2_step07.2697.2697.2	2.3393	0.1001	2540.5	8	2380.0%	2	K.QAVDFLSNEGHIYSTVDDDHFK.S
*	TK040203_NMyc_nuclei2_step10.1622.1622.3	1.0744	0.0519	3673.89	1	1690.0%	1	K.SLVAFKIMPLEDMNEFTTHILEVINAHMVLSK.A

AMYP_MOUSE

73.7%

508

57417

7.5

(P00688) Alpha-amylase, pancreatic precursor (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)

	TK040203_NMyc_nuclei2_step02.2758.2758.2	1.1864	0.1199	2618.39	1	2250.0%	1	K.EVTINADTTCGNDWVCEHRWR.Q
	TK040203_NMyc_nuclei2_step05.3294.3294.2	1.8639	0.0955	3011.57	5	2000.0%	4	R.NVVNGQPFSNWWDNNSNQVAFSRGNR.G

Q9EQW2

73.7%

332

38777

9.1

(Q9EQW2) Cis-AB transferase

*	TK040203_NMyc_nuclei2_step07.2081.2081.1	1.4428	0.2399	1515.77	2	4550.0%	1	R.RPQSQAYIPWDR.G
*	TK040203_NMyc_nuclei2_step09.2721.2721.3	1.9838	0.1255	4218.64	1	1460.0%	1	K.LFLETAEQHFMVGHKVIYYVFTDRPADVPQVILGAGR.Q
*	TK040203_NMyc_nuclei2_step11.2608.2608.3	1.5354	0.0585	3926.8	61	1140.0%	1	R.RPQSQAYIPWDRGDFYYGGAFFGGSVLEVYHLTK.A

RB6A_MOUSE

73.7%

19.2%

208

23590

5.5

(P35279) Ras-related protein Rab-6A

	TK040203_NMyc_nuclei2_step11.2230.2230.3	1.8533	0.0030	3215.41	1	1940.0%	1	R.DSTVAVVVYDITNVNSFQQTTKWIDDVR.T
	TK040203_NMyc_nuclei2_step01.2835.2835.1	1.4395	0.2391	1247.48	1	5000.0%	1	R.GSDVIIMLVGNK.T
	TK040203_NMyc_nuclei2_step02.3778.3778.3	1.3096	0.041	2429.56	126	1900.0%	1	R.DSTVAVVVYDITNVNSFQQTTK.W

Q8VGB4

73.7%

311

34667

8.5

(Q8VGB4) Olfactory receptor MOR171-4

*	TK040203_NMyc_nuclei2_step10.3685.3685.3	2.6123	0.3401	4451.88	1	1550.0%	4	K.LNSQLHTPMYYFLSSLSFLDFCYSSVVTPKMLVGFLSR.D

CN2A_MOUSE

73.6%

21.9%

365

42357

6.3

(Q922S4) cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) (Fragment)

*	TK040203_NMyc_nuclei2_step04.3479.3479.3	2.7683	0.2974	3839.74	5	1620.0%	1	R.GLPSNNSLDFLDEEYEVPDLDGTRAPVNGCCSLEG.-
	TK040203_NMyc_nuclei2_step11.2019.2019.2	1.6208	0.2594	2384.49	22	2110.0%	1	R.LLLCLLMTSCDLSDQTKGWK.T
	TK040203_NMyc_nuclei2_step09.3211.3211.2	1.2327	0.0748	2890.33	3	2080.0%	1	R.SLPEDDTSMAILSMLQDMNFINNYK.I

Q8VCJ5

73.6%

551

61549

7.7

(Q8VCJ5) Hypothetical 61.5 kDa protein (Fragment)

*	TK040203_NMyc_nuclei2_step11.1936.1936.2	1.3424	0.1355	3025.1	14	1540.0%	1	R.ARLAGELAGQEEEEALEGLEVMYVFLR.F
*	TK040203_NMyc_nuclei2_step03.3683.3683.2	1.4441	0.0652	2929.95	88	1400.0%	4	K.EESPAFLSAFAVHPVPEGTLMYRLHK.R
*	TK040203_NMyc_nuclei2_step09.4222.4222.2	1.528	0.0206	3118.6	8	1550.0%	1	R.VQLVLPLLVAEAPAALAFLEAFAASVLEPR.E

KC2B_HUMAN

73.2%

215

24942

5.6

(P13862) Casein kinase II beta chain (CK II) (Phosvitin) (G5a) (P13862) Casein kinase II beta chain (CK II) (Phosvitin) (G5a)

	TK040203_NMyc_nuclei2_step06.1558.1558.1	1.4198	0.291	1084.69	1	5620.0%	3	K.RPANQFVPR.L

Q96MA4

73.1%

701

79823

6.6

(Q96MA4) Hypothetical protein FLJ32706 (Fragment)

*	TK040203_NMyc_nuclei2_step11.4279.4279.2	1.7769	0.1331	1772.11	14	3210.0%	5	R.YFHHVLLVASEGIKR.Y
*	TK040203_NMyc_nuclei2_step04.1495.1495.1	1.1772	0.0133	1110.58	55	5000.0%	1	R.EKMADIYLK.H

GCS1_HUMAN

73.1%

836

91840

9.1

(Q13724) Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Processing A-glucosidase I)

	TK040203_NMyc_nuclei2_step09.1766.1766.3	1.5487	0.0123	2759.22	160	1740.0%	1	K.YGSYNVFWTSNPGLPLLTEMVKSR.L
*	TK040203_NMyc_nuclei2_step09.0258.0258.3	1.5941	0.0313	4391.28	1	1220.0%	1	R.GPSGQGQGQFLIQQVTLKIPFSIEFVFESGSAQAGGNQALPR.L
*	TK040203_NMyc_nuclei2_step07.2388.2388.3	1.6616	0.1415	4137.1	4	1400.0%	1	K.GLSSGEQALGQAALSGLLGGIGYFYGQGLVLPDIGVEGSEQK.V
	TK040203_NMyc_nuclei2_step06.1637.1637.1	1.2373	0.0316	956.44	13	5620.0%	3	R.RAVPAEGVR.T

RL17_MOUSE

73.1%

16.8%

184

21423

10.2

(Q9CPR4) 60S ribosomal protein L17 (L23)

	TK040203_NMyc_nuclei2_step09.3971.3971.1	0.5462	0.0029	611.97	4	3750.0%	1	K.GMHIR.K
	TK040203_NMyc_nuclei2_step01.2600.2600.1	1.8186	0.1327	1189.1	3	5560.0%	1	K.SAEFLLHMLK.N
	TK040203_NMyc_nuclei2_step03.3153.3153.2	1.5688	0.0221	1778.53	37	3000.0%	2	K.GLDVDSLVIEHIQVNK.A

Q9HA19

73.1%

672

75072

6.3

(Q9HA19) Hypothetical protein FLJ12389

*	TK040203_NMyc_nuclei2_step06.3531.3531.1	1.504	0.0126	1264.29	8	4090.0%	3	R.QGVALFAAAMRK.M

Q8TF29

73.0%

1176

132564

8.3

(Q8TF29) Hypothetical protein KIAA1973 (Fragment)

*	TK040203_NMyc_nuclei2_step03.2825.2825.3	1.8556	0.131	3512.94	1	1530.0%	1	R.TEGLPLGLIAHGKTTQSVFEHYVQDAMELVAR.A
*	TK040203_NMyc_nuclei2_step12.3610.3610.3	2.732	0.2823	3522.35	1	1810.0%	1	R.VKGSTIVSSENNFFIWNLQHDPMGKPMWTR.L
*	TK040203_NMyc_nuclei2_step07.4344.4344.2	1.3534	0.0691	3035.61	8	2000.0%	1	R.KYIFSDEEGQNQLGIQIHQDIPLPPR.R

Q9H101

72.9%

235

25957

5.6

(Q9H101) DJ776F14.2 (A novel protein member of the PTPNS (Protein tyrosine phosphatase,non-receptor type substrate) family) (Fragment)

*	TK040203_NMyc_nuclei2_step02.3474.3474.2	1.8465	0.3383	2522.55	1	2750.0%	1	R.EHTGTYHCVRFDGLSEHSEMK.S

UBF1_MOUSE

72.8%

765

89509

5.8

(P25976) Nucleolar transcription factor 1 (Upstream binding factor 1) (UBF-1)

	TK040203_NMyc_nuclei2_step04.2327.2327.1	1.8584	0.1354	1410.64	2	4550.0%	2	R.EDHPDLIQNAKK.S
	TK040203_NMyc_nuclei2_step02.1416.1416.3	1.2404	0.0284	2241.11	58	2210.0%	1	K.GQDRWSQEDMLTLLECMK.N
	TK040203_NMyc_nuclei2_step07.1135.1135.1	1.2484	0.1731	1430.46	2	3000.0%	2	K.TPQQLWYTHEK.K

Q9D9G4

72.7%

284

32127

6.0

(Q9D9G4) 1700080O16Rik protein

*	TK040203_NMyc_nuclei2_step06.1933.1933.1	1.2098	0.0231	1121.27	3	5620.0%	1	K.QDPRSYPTR.Y
*	TK040203_NMyc_nuclei2_step03.2961.2961.3	2.9976	0.1827	3639.6	2	1740.0%	1	R.ASFPSTAGVPSVEASGSQIEFYPDILRQQILNSK.T

RS18_HUMAN

72.7%

21.7%

152

17719

11.0

(P25232) 40S ribosomal protein S18 (KE-3) (KE3) (P25232) 40S ribosomal protein S18 (KE-3) (KE3)

	TK040203_NMyc_nuclei2_step10.3479.3479.1	1.5418	0.0319	1404.62	18	4090.0%	1	K.RAGELTEDEVER.V
	TK040203_NMyc_nuclei2_step03.1799.1799.1	1.3148	0.0423	813.68	1	7000.0%	3	K.FQHILR.V
	TK040203_NMyc_nuclei2_step03.1729.1729.1	1.1489	0.0642	857.66	2	5830.0%	1	R.YAHVVLR.K
	TK040203_NMyc_nuclei2_step10.1402.1402.1	1.2254	0.0216	988.4	9	5000.0%	1	R.YAHVVLRK.A
	TK040203_NMyc_nuclei2_step01.0011.0011.1	1.2184	0.1212	903.51	2	6430.0%	1	R.KADIDLTK.R

RAC1_HUMAN

72.5%

192

21450

8.5

(P15154) Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) (Ras-like protein TC25) (P15154) Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) (Ras-like protein TC25)

	TK040203_NMyc_nuclei2_step11.1771.1771.1	1.6223	0.1727	1586.83	1	3850.0%	1	R.HHCPNTPIILVGTK.L

Q96MN7

72.4%

600

68633

8.6

(Q96MN7) Hypothetical protein FLJ32110 (Fragment)

*	TK040203_NMyc_nuclei2_step09.3378.3378.2	1.6044	0.1642	2951.57	21	1880.0%	1	R.ESQVSGLTEDQQKLIQEDYQYPKPK.T
*	TK040203_NMyc_nuclei2_step09.0411.0411.1	0.7978	0.1077	662.32	2	6000.0%	1	K.NNSSEN.-
*	TK040203_NMyc_nuclei2_step11.1854.1854.2	1.0666	0.0037	2259.94	13	2110.0%	1	R.CLFGNQVLQTSSDLSNANHR.T
*	TK040203_NMyc_nuclei2_step01.1774.1774.1	1.8275	0.0391	1571.84	8	4170.0%	7	R.STMPNRHQLQSDR.R
*	TK040203_NMyc_nuclei2_step07.1436.1436.1	1.1629	0.1985	1126.54	8	4440.0%	1	K.STVHLNPNSR.I
*	TK040203_NMyc_nuclei2_step04.1419.1419.1	1.1539	0.0937	881.66	2	6670.0%	1	R.HQLQSDR.R
*	TK040203_NMyc_nuclei2_step01.2436.2436.1	1.2592	0.1148	1147.81	6	4500.0%	1	K.NGSPSPDFAEK.K

Q8VDD5

72.1%

1960

226355

5.7

(Q8VDD5) Nonmuscle heavy chain myosin II-A

	TK040203_NMyc_nuclei2_step02.3836.3836.2	1.1902	0.097	2504.42	2	2500.0%	5	K.LQLQEQLQAETELCAEAEELR.A
	TK040203_NMyc_nuclei2_step06.4352.4352.1	0.7518	0.0716	1224.6	41	2500.0%	1	R.AGVLAHLEEER.D
	TK040203_NMyc_nuclei2_step03.1270.1270.1	0.9959	0.1401	571.46	40	5000.0%	1	R.SHAQK.N
*	TK040203_NMyc_nuclei2_step08.0621.0621.2	1.4469	0.0738	1976.65	43	2810.0%	1	K.VKPLLNSIRHEDELLAK.E
	TK040203_NMyc_nuclei2_step11.2543.2543.2	1.2075	0.0677	3018.32	212	1000.0%	1	K.NMDPLNDNIATLLHQSSDKFVSELWK.D
	TK040203_NMyc_nuclei2_step01.3968.3968.1	1.7452	0.0804	1404.74	13	4090.0%	1	R.EEILAQAKENEK.K
*	TK040203_NMyc_nuclei2_step06.1731.1731.2	1.1147	0.0465	2048.51	9	3120.0%	1	R.ELETQISELQEDLESER.A
	TK040203_NMyc_nuclei2_step07.1786.1786.2	1.1791	0.111	2617.57	7	1960.0%	1	R.KLEGDSTDLSDQIAELQAQIAELK.M
	TK040203_NMyc_nuclei2_step02.2934.2934.2	1.3179	0.1032	2210.13	5	2630.0%	1	K.VSHLLGINVTDFTRGILTPR.I

Q8VHD9

72.1%

20.2%

712

77935

9.2

(Q8VHD9) Diversin

*	TK040203_NMyc_nuclei2_step12.3679.3679.2	1.2615	0.0933	3146.62	4	1790.0%	1	R.LLLNAFCSVHEKNQAGDTALHVAAALNHK.K
*	TK040203_NMyc_nuclei2_step03.3162.3162.2	1.3299	0.177	2505.02	1	2290.0%	2	R.DEVAQSKGSVSAGDTPSSEQAVPQK.E
*	TK040203_NMyc_nuclei2_step01.2260.2260.1	1.4036	0.0105	998.51	32	4380.0%	1	R.LQQHAAAEK.Q
*	TK040203_NMyc_nuclei2_step11.2483.2483.3	2.6037	0.329	4634.88	1	1340.0%	1	R.GQQPTASSPSGQQPSAASSDVRDASQALELTQYFFEAVSAQMEK.W
*	TK040203_NMyc_nuclei2_step04.3595.3595.3	1.9351	0.0522	3947.41	1	1460.0%	1	K.VLLEAGADTTIVNNAGQTPLETARYHNNPEVALLLTK.A

Q9CQG9

72.1%

134

14504

9.5

(Q9CQG9) 1810057C19Rik protein

*	TK040203_NMyc_nuclei2_step01.2408.2408.1	1.721	0.1686	1403.83	3	4550.0%	1	R.RESQTALVVNQR.C

Q8WYW2

72.0%

19.7%

366

39636

9.6

(Q8WYW2) Hypothetical protein

*	TK040203_NMyc_nuclei2_step08.2443.2443.3	1.5215	4.0E-4	4764.18	2	1220.0%	5	R.SCSESTLYPMPVLVPLAVAPQESHRTSAQALFPFEASLLTSVAR.R
*	TK040203_NMyc_nuclei2_step09.2755.2755.2	1.1414	0.0931	3142.85	42	1480.0%	1	K.HSAECDPRFPSVIPETSEGESSDHTTNR.F

Q91Z34

72.0%

156

17504

5.3

(Q91Z34) Hypothetical 17.5 kDa protein

*	TK040203_NMyc_nuclei2_step08.3299.3299.2	2.2443	0.2606	3036.6	1	2710.0%	1	-.MVCSTGWRPLLLLQIWDTAGQERFR.T

Q9Y4D1

71.9%

1085

124245

7.0

(Q9Y4D1) Hypothetical protein KIAA0666 (Fragment)

*	TK040203_NMyc_nuclei2_step07.2750.2750.2	1.3996	0.0656	2462.09	44	1820.0%	1	R.AHVLAHSESINVIAQSLSTENIK.T
*	TK040203_NMyc_nuclei2_step12.1570.1570.1	1.8025	0.1375	1431.64	5	4550.0%	1	R.AQNCNILLSRLK.L
*	TK040203_NMyc_nuclei2_step01.3348.3348.1	1.5697	0.1311	1386.46	1	5000.0%	1	K.EEMMQTLNKMK.E

CYRB_HUMAN

71.6%

897

97336

5.5

(P32927) Cytokine receptor common beta chain precursor (CDw131 antigen)

*	TK040203_NMyc_nuclei2_step12.1854.1854.3	1.5757	0.0266	3960.06	5	1430.0%	1	R.LQDSWEDAAILLSNTSQATLGPEHLMPSSTYVARVR.T
*	TK040203_NMyc_nuclei2_step08.1683.1683.3	1.9535	0.029	2805.0	9	1800.0%	1	R.FPELEGVFPVGFGDSEVSPLTIEDPK.H
*	TK040203_NMyc_nuclei2_step04.2113.2113.3	1.2725	0.0337	2165.62	41	2240.0%	1	K.TETLQNAHSMALPALEPSTR.Y
*	TK040203_NMyc_nuclei2_step09.2751.2751.3	1.6432	0.0656	4463.68	32	1050.0%	1	R.DLQISTDQDHFLLTWSVALGSPQSHWLSPGDLEFEVVYK.R
*	TK040203_NMyc_nuclei2_step05.2858.2858.2	1.3043	0.021	2891.8	24	1600.0%	1	K.NLDQAFQVKKPPGQAVPQVPVIQLFK.A
*	TK040203_NMyc_nuclei2_step04.2789.2789.2	2.0635	0.2451	2373.92	5	2200.0%	3	R.RPSQGAAGSPSLESGGGPAPPALGPR.V
*	TK040203_NMyc_nuclei2_step04.3397.3397.2	1.0856	0.0487	2156.68	3	2630.0%	1	K.KPPGQAVPQVPVIQLFKALK.Q

Q8TEF4

71.5%

503

53812

5.5

(Q8TEF4) FLJ00243 protein (Fragment)

*	TK040203_NMyc_nuclei2_step11.3442.3442.2	1.5869	0.1076	2335.96	2	2860.0%	1	R.RQPPVSPLTLSPGPEANQGFSR.Q
	TK040203_NMyc_nuclei2_step12.3229.3229.3	1.922	0.0277	4687.38	1	1250.0%	1	K.TVLSSSLNNHPQTSVPNASALHPSLRLFSLSNPSLSTTNLSGPSR.R
*	TK040203_NMyc_nuclei2_step06.1955.1955.1	1.9437	0.1085	1491.79	2	4580.0%	1	K.EENLLNVPKPLPK.Q
	TK040203_NMyc_nuclei2_step11.3198.3198.3	1.9311	0.1541	3885.7	34	1250.0%	1	R.SNPSIQATLNKTVLSSSLNNHPQTSVPNASALHPSLR.L

Q9CW63

71.5%

226

590

65634

7.2

(Q9CW63) 1200009A02Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step07.2257.2257.3	1.6532	0.0783	3751.14	1	1880.0%	1	R.NLSYTSSEEDLEKLFSAYGPLSELHYPIDSLTK.K
*	TK040203_NMyc_nuclei2_step02.1567.1567.1	1.7989	0.0992	1571.75	14	3330.0%	15	K.ILVRNIPFQANQR.E

ADA_HUMAN

71.5%

363

40764

5.9

(P00813) Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)

*	TK040203_NMyc_nuclei2_step11.3587.3587.3	2.9472	0.2341	3092.68	4	1900.0%	1	R.GIALPANTAEGLLNVIGMDKPLTLPDFLAK.F

RL29_MOUSE

71.5%

159

17456

11.8

(P47915) 60S ribosomal protein L29

*	TK040203_NMyc_nuclei2_step10.1720.1720.1	1.3146	0.0152	1194.97	15	4000.0%	2	K.ALVKPQAIKPK.M

Q91VZ7

71.4%

20.5%

195

21541

5.7

(Q91VZ7) Similar to alkaline phosphodiesterase

*	TK040203_NMyc_nuclei2_step12.2569.2569.3	2.6548	0.3143	4497.32	1	1470.0%	1	K.TVCQGESPWVTEACASSQEPQCPPGFDLPPVILFSMDGFR.A

Q9H1I8

71.3%

757

86364

5.1

(Q9H1I8) ASC-1 complex subunit P100

	TK040203_NMyc_nuclei2_step11.1607.1607.2	2.2291	0.2614	2065.57	1	3820.0%	1	R.TAYILQAVESAWEGVDRR.K

Q8TAB1

71.2%

296

34016

9.3

(Q8TAB1) BA351K23.5 (Novel protein) (Fragment)

*	TK040203_NMyc_nuclei2_step10.3121.3121.2	1.0194	0.0571	1447.57	33	3330.0%	1	R.EYVMSTGACSVSR.S
*	TK040203_NMyc_nuclei2_step05.2915.2915.3	2.7024	0.2997	3774.73	2	1520.0%	1	R.MALQHGVPLIPAYAFGETDLYDQHIFTPGGFVNR.F

Q9DAM2

71.2%

216

26067

8.8

(Q9DAM2) 1700007I06Rik protein

	TK040203_NMyc_nuclei2_step05.3500.3500.2	1.6082	0.0212	2084.79	1	3440.0%	3	R.DLFHDFDITGDRLLNYK.E

MSH6_HUMAN

70.9%

1360

152857

6.8

(P52701) DNA mismatch repair protein MSH6 (MutS-alpha 160 kDa subunit) (G/T mismatch binding protein) (GTBP) (GTMBP) (P160)

	TK040203_NMyc_nuclei2_step09.1773.1773.1	1.2941	0.1377	1417.45	15	3330.0%	1	R.AYGVCFVDTSLGK.F
	TK040203_NMyc_nuclei2_step04.3225.3225.2	1.1124	1.0E-4	2852.16	82	1200.0%	1	K.TILKSSLSCSLQEGLIPGSQFWDASK.T
	TK040203_NMyc_nuclei2_step01.1138.1138.1	1.682	0.1651	1052.58	3	5560.0%	1	K.QATSISSETK.N

COG2_HUMAN

70.9%

738

83208

6.6

(Q14746) Conserved oligomeric Golgi complex component 2 (Low density lipoprotein receptor defect C-complementing protein)

*	TK040203_NMyc_nuclei2_step12.2778.2778.2	1.3999	0.1542	2948.72	1	2120.0%	2	K.EVPTTASSYVDSALKPLFQLQSGHKDK.L
*	TK040203_NMyc_nuclei2_step10.3716.3716.2	2.0718	0.3036	2703.69	1	2920.0%	1	K.EVPTTASSYVDSALKPLFQLQSGHK.D
*	TK040203_NMyc_nuclei2_step08.1107.1107.1	0.9126	0.0321	1055.53	65	2500.0%	2	K.GPDTLCFDK.D

Q9CVJ7

70.8%

20.3%

177

20555

9.6

(Q9CVJ7) 1810048F22Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step04.2969.2969.2	2.3	0.059	2370.16	1	3950.0%	1	K.SLYKNVMLETFSNLFSVGYR.V
*	TK040203_NMyc_nuclei2_step02.2754.2754.2	1.7043	0.0969	1952.89	36	2670.0%	1	K.CGQAFYKNEDLTIHQK.V

TRP1_MOUSE

70.6%

809

92728

8.1

(Q61056) Short transient receptor potential channel 1 (TrpC1) (Transient receptor protein 1) (Mtrp1) (Trp-related protein 1)

	TK040203_NMyc_nuclei2_step04.3840.3840.1	0.7027	0.1501	636.15	2	5000.0%	1	R.KPTCK.K
	TK040203_NMyc_nuclei2_step10.2540.2540.3	2.1485	0.0828	3451.52	25	1480.0%	1	K.YNQKEFVSQSNCQQFLNTVWFGQMSGYR.R
	TK040203_NMyc_nuclei2_step01.4080.4080.2	1.9163	0.3204	2984.63	1	2400.0%	1	R.KDWDAFHPTLVAEGLFAFANVLSYLR.L

Q8R0B9

70.5%

550

61669

6.0

(Q8R0B9) Similar to KIAA0445 gene product (Fragment)

*	TK040203_NMyc_nuclei2_step12.3059.3059.2	1.2904	0.0437	2900.97	24	1730.0%	1	K.VQSLTDALTQSSASLSSTQDKNLHLQK.A
*	TK040203_NMyc_nuclei2_step08.1371.1371.1	1.4853	0.2071	1151.66	5	5000.0%	1	K.AQLHQELRR.S

O75189

70.3%

1115

125106

5.8

(O75189) Hypothetical protein KIAA0710

*	TK040203_NMyc_nuclei2_step10.2257.2257.2	1.258	0.0031	2917.84	1	2400.0%	1	K.EFALADWKELGSPEGVLVCPSIEELK.N
*	TK040203_NMyc_nuclei2_step01.3766.3766.2	1.2865	0.0117	2646.02	6	1900.0%	1	R.HLPDILVINCEVNSSKEADFWR.M
*	TK040203_NMyc_nuclei2_step12.1777.1777.3	1.9564	0.2265	3651.98	1	1640.0%	1	R.TFKVEHEFDAFSGSLSDFDVHGNLLAACGFSSR.L
*	TK040203_NMyc_nuclei2_step08.3517.3517.1	1.2557	0.0477	1321.55	47	3640.0%	1	K.KVGFIGYAPNPR.T
*	TK040203_NMyc_nuclei2_step12.1826.1826.2	1.2531	0.0286	2403.2	52	1900.0%	1	R.YNLNIKNPIEASVLLAEASLAR.K
*	TK040203_NMyc_nuclei2_step03.1575.1575.1	1.5449	0.1842	1191.65	4	4500.0%	2	K.VGFIGYAPNPR.T
*	TK040203_NMyc_nuclei2_step01.3496.3496.1	1.2314	0.0977	1337.58	1	4500.0%	1	R.EEEPHLHMVSK.K

Q9Y6G9

70.3%

523

56627

6.6

(Q9Y6G9) Dynein light chain-A

*	TK040203_NMyc_nuclei2_step06.2403.2403.2	1.3124	0.0739	1875.82	310	2000.0%	1	K.AEDNFEDIITKPPVRK.F
*	TK040203_NMyc_nuclei2_step04.3305.3305.2	1.3509	0.1536	2524.63	13	1500.0%	1	K.TGSPGGPGVSGGSPAGGAGGGSSGLPPSTKK.S
*	TK040203_NMyc_nuclei2_step01.3804.3804.2	1.7982	0.3356	3138.53	1	2120.0%	1	K.IGILHENFQTLKAEDNFEDIITKPPVR.K

Q924S0

70.3%

161

17748

9.0

(Q924S0) Nucleoporin-like protein-1 isoformT

*	TK040203_NMyc_nuclei2_step09.1362.1362.1	1.8468	0.1233	1400.59	1	5500.0%	1	-.MTICQFFLQGR.C
*	TK040203_NMyc_nuclei2_step08.1915.1915.1	0.9672	0.0738	840.5	13	5830.0%	1	K.LCSTACK.S

Q9QYC1

70.2%

1446

161895

6.9

(Q9QYC1) Pecanex 1

	TK040203_NMyc_nuclei2_step03.3403.3403.2	1.5308	0.0388	2608.19	13	1820.0%	1	K.YILEGYSITDNSAASMLQVFDLR.R
	TK040203_NMyc_nuclei2_step03.4099.4099.3	2.0538	0.2197	4647.92	41	960.0%	2	K.LHQDHFTSPDEYDDPTVLYEAIVSHEKNLVIAHEGDPAWR.S
*	TK040203_NMyc_nuclei2_step03.2921.2921.3	2.6955	0.2721	3818.7	1	1880.0%	1	R.WLAWEVVVTKYILEGYSITDNSAASMLQVFDLR.R
*	TK040203_NMyc_nuclei2_step11.4444.4444.2	1.302	0.1581	2912.93	6	1820.0%	1	K.QLPWHCFSRPLLRTAEHSQYEVR.N

NDK7_MOUSE

70.1%

395

44434

7.1

(Q9QXL8) Nucleoside diphosphate kinase 7 (EC 2.7.4.6) (NDK 7) (NDP kinase 7) (nm23-M7)

*	TK040203_NMyc_nuclei2_step11.1619.1619.2	2.1006	0.2969	1884.65	1	3890.0%	1	R.LLGPANSGLSRTDAPGSIR.A
*	TK040203_NMyc_nuclei2_step12.4327.4327.3	2.4828	0.3095	4699.78	2	1190.0%	1	R.ANVEEFYEVYKGVVSEYNDMVTELCSGPCVAIEIQQSNPTK.T

CD69_HUMAN

70.1%

199

22559

6.6

(Q07108) Early activation antigen CD69 (Early T-cell activation antigen p60) (GP32/28) (Leu-23) (MLR-3) (EA1) (BL-AC/P26) (Activation inducer molecule) (AIM)

*	TK040203_NMyc_nuclei2_step01.0794.0794.1	1.4823	0.2143	1148.41	1	5620.0%	1	R.KCYFISTVK.R

Q9CW42

70.1%

362

39270

8.0

(Q9CW42) 1300013F15Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step04.2407.2407.1	1.4814	0.21	1232.44	1	5000.0%	1	R.VSGPGPAAVHLAR.R

Q9QYF4

70.1%

561

62544

7.6

(Q9QYF4) SYNCRIP protein

	TK040203_NMyc_nuclei2_step06.3729.3729.1	0.7223	0.0577	618.39	2	3000.0%	1	R.GVRGAR.G
	TK040203_NMyc_nuclei2_step08.2821.2821.3	1.606	0.1707	4511.53	1	1280.0%	1	-.MATEHVNGNGTEEPMDTTSAVIHSENFQTLLDAGLPQKVAEK.L
	TK040203_NMyc_nuclei2_step01.3322.3322.1	1.4823	0.2077	1596.53	1	3750.0%	1	R.DLFEDELVPLFEK.A

O60304

70.1%

493

55108

7.1

(O60304) Hypothetical protein KIAA0557 (Fragment)

*	TK040203_NMyc_nuclei2_step06.2355.2355.2	1.3583	0.1044	2197.9	37	2110.0%	1	R.ASHGADKPYTCPECGKGFSK.T
*	TK040203_NMyc_nuclei2_step07.4225.4225.1	0.5949	0.045	638.39	3	2500.0%	1	R.GGPPPGR.R
*	TK040203_NMyc_nuclei2_step07.1600.1600.1	1.4819	0.216	1417.94	1	4090.0%	1	R.FSQSSSLVIHRR.T
*	TK040203_NMyc_nuclei2_step03.1954.1954.3	1.5666	0.1489	2901.56	58	1540.0%	1	R.CMDPAQRDAPLENEGPGIQLEDGGDGR.E

Q9NTG2

69.9%

0.6%

1397

157885

7.9

(Q9NTG2) Hypothetical protein (Fragment)

*	TK040203_NMyc_nuclei2_step01.1908.1908.1	1.2325	0.0063	1036.59	23	4380.0%	2	R.EVARPAHKK.K
*	TK040203_NMyc_nuclei2_step02.1966.1966.1	1.7396	0.1564	910.86	1	6430.0%	5	R.EVARPAHK.K

Q8WVN8

69.8%

375

42818

5.0

(Q8WVN8) Similar to NICE-5 protein

*	TK040203_NMyc_nuclei2_step01.1984.1984.1	1.6402	0.1641	1383.82	5	4090.0%	1	K.AELKFLASIFDK.N
*	TK040203_NMyc_nuclei2_step01.2696.2696.1	0.9242	0.0482	938.5	5	5830.0%	1	R.FRIVSWK.L

Q9UKN4

69.8%

564

61747

5.1

(Q9UKN4) Bridging integrator-2

	TK040203_NMyc_nuclei2_step06.1381.1381.1	1.6408	0.1638	1146.92	1	5560.0%	1	R.HHLEAVQNAK.K

Q9D646

69.8%

392

44560

4.8

(Q9D646) 4733401E01Rik protein

	TK040203_NMyc_nuclei2_step03.2109.2109.1	1.7878	0.1323	1369.68	5	4500.0%	1	K.KNHEEEVNTLR.C

K1M3_MOUSE

69.8%

323

36949

4.8

(Q61897) Keratin, type I cuticular HA3 (Hair keratin, type I HA3) (Fragment)

*	TK040203_NMyc_nuclei2_step03.2109.2109.1	1.7878	0.1323	1369.68	5	4500.0%	1	K.QNHEEEVNTLR.C

Q9CW43

69.8%

853

93311

8.5

(Q9CW43) RE1-silencing transcription factor (Fragment)

*	TK040203_NMyc_nuclei2_step09.1489.1489.1	1.9837	0.0168	1179.43	1	6250.0%	1	R.YDHYMAHLK.H
*	TK040203_NMyc_nuclei2_step03.2942.2942.2	1.216	0.1274	2392.75	1	2650.0%	1	R.IYKCIICTYTTVSEYHWR.K

TRDN_HUMAN

69.8%

728

81424

9.4

(Q13061) Triadin

*	TK040203_NMyc_nuclei2_step01.4506.4506.1	1.2155	0.084	1252.58	47	4000.0%	1	K.TKKPAEVEQPK.G
*	TK040203_NMyc_nuclei2_step04.1578.1578.1	1.9928	0.0265	887.57	2	8330.0%	1	R.EKEKPEK.K

Q921I0

69.7%

153

17355

9.5

(Q921I0) Similar to hypothetical protein (Hypothetical 17.4 kDa protein)

	TK040203_NMyc_nuclei2_step10.3077.3077.2	2.0718	0.3002	2301.42	2	3060.0%	1	R.KFFTISPIILYFLASFYTK.Y

CU32_HUMAN

69.7%

206

21360

11.2

(P57056) Putative protein C21orf32

*	TK040203_NMyc_nuclei2_step06.1470.1470.1	1.5107	0.198	1198.67	4	4440.0%	1	R.SLSWKVPDHK.S

Q9CVD9

69.7%

147

16893

6.0

(Q9CVD9) 2200003A07Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step01.3816.3816.1	1.4291	0.2017	1149.67	4	5000.0%	1	K.AFLDYAYTGK.T
*	TK040203_NMyc_nuclei2_step08.2623.2623.1	1.5247	0.1869	1447.17	5	4170.0%	1	K.AVKAFLDYAYTGK.T

TM30_MOUSE

69.6%

496

57330

7.0

(P15533) Tripartite motif protein 30 (Down regulatory protein of interleukin 2 receptor)

*	TK040203_NMyc_nuclei2_step04.2653.2653.2	1.8164	0.1493	2550.13	1	2620.0%	8	R.VPYPFGNLRPNLHVANIVERLK.G
*	TK040203_NMyc_nuclei2_step01.0244.0244.1	0.8432	0.0013	709.3	245	5000.0%	1	K.NPSVYK.A

Q91VL9

69.5%

12.8%

713

81952

6.4

(Q91VL9) Similar to heat shock 70kD protein 2

*	TK040203_NMyc_nuclei2_step12.1502.1502.2	1.025	0.0298	1721.2	15	2810.0%	1	R.EDANQAPDDSASTTGSR.K
	TK040203_NMyc_nuclei2_step06.1601.1601.1	1.2766	0.0671	1388.56	145	3640.0%	1	K.IMTAPSSFEQFK.V
	TK040203_NMyc_nuclei2_step04.3223.3223.3	2.8278	0.25	3890.12	2	1690.0%	1	R.EWGFLCDCCIAIDDIYFQAHKAVLAACSSYFR.M
*	TK040203_NMyc_nuclei2_step07.3166.3166.3	1.6858	0.0477	3589.9	8	1640.0%	1	R.FETENLVVEHMSSCLDQDMFKGAIMEENER.D

PRAX_HUMAN

69.4%

1461

155003

7.7

(Q9BXM0) Periaxin

*	TK040203_NMyc_nuclei2_step08.4238.4238.1	1.0258	0.0128	1311.66	23	3330.0%	2	R.GQEGDAAPKSPVR.E
*	TK040203_NMyc_nuclei2_step11.2764.2764.2	1.8016	0.3276	2641.64	1	2390.0%	1	R.LRMPTFGLSLLEPRPAAPEVVESK.L
*	TK040203_NMyc_nuclei2_step02.1785.1785.3	1.4984	0.2174	4586.73	35	1020.0%	1	K.LVTLPCLQPEVDGEAHVGVPSLTLPSVELDLPGALGLQGQVPAAK.M
*	TK040203_NMyc_nuclei2_step07.3277.3277.2	1.6184	0.0832	3009.91	1	2310.0%	2	R.VPSVEIVTPQLPAVEIEEGRLEMIETK.V
*	TK040203_NMyc_nuclei2_step04.2258.2258.2	1.7358	0.2415	2358.83	7	2500.0%	2	K.MVPGALGVPADLAPVDVEFSFPK.F
*	TK040203_NMyc_nuclei2_step11.3336.3336.2	1.2289	0.0188	2742.7	2	1920.0%	1	R.FTAPQVELVGPRLPGAEVGVPQVSAPK.A

Q8VFS1

69.0%

310

34805

8.9

(Q8VFS1) Olfactory receptor MOR267-8

*	TK040203_NMyc_nuclei2_step12.3603.3603.2	1.8902	0.3163	2551.33	1	2750.0%	1	R.RNHTVISEFVFQGFSSFQEYK.F

DERM_MOUSE

68.9%

201

23995

4.8

(Q9QZZ6) Dermatopontin precursor (Tyrosine rich acidic matrix protein) (TRAMP) (Early quiescence protein-1) (EQ-1)

*	TK040203_NMyc_nuclei2_step07.3688.3688.2	1.7301	0.1228	2497.55	1	2620.0%	2	R.QGFSYQCPHGQVVVAVRSIFSK.K

PPAL_HUMAN

68.8%

423

48344

6.7

(P11117) Lysosomal acid phosphatase precursor (EC 3.1.3.2) (LAP)

*	TK040203_NMyc_nuclei2_step11.3454.3454.3	2.1384	0.149	4576.13	96	880.0%	5	K.DWQQECQLASGPADTEVIVALAVCGSILFLLIVLLLTVLFR.M

TCPQ_HUMAN

68.8%

548

59621

5.6

(P50990) T-complex protein 1, theta subunit (TCP-1-theta) (CCT-theta)

*	TK040203_NMyc_nuclei2_step03.2259.2259.2	2.2947	0.151	2123.83	9	2940.0%	3	K.VADMALHYANKYNIMLVR.L
*	TK040203_NMyc_nuclei2_step12.3950.3950.2	1.1809	0.1252	1946.64	145	2500.0%	1	K.ILGSGISSSSVLHGMVFKK.E

Q9CQS5

68.8%

547

62491

6.4

(Q9CQS5) 2010110K24Rik protein

*	TK040203_NMyc_nuclei2_step10.3516.3516.2	2.2825	0.1251	3007.39	4	2040.0%	1	K.DGGLPEESAHVSSFEVTALSQAVEEMER.Q
*	TK040203_NMyc_nuclei2_step06.2981.2981.2	1.6182	0.0076	3155.12	9	1600.0%	1	K.DDHITMIDFPQMVSTSHPNAEWYFDR.D

Q9Y438

68.7%

892

97823

6.8

(Q9Y438) Hypothetical protein (Fragment)

*	TK040203_NMyc_nuclei2_step03.2898.2898.2	2.273	0.2144	2211.7	1	3420.0%	1	K.SQISFDNLTPSGTLGKDYHK.S
*	TK040203_NMyc_nuclei2_step03.2181.2181.1	1.2844	0.0663	1395.57	11	3180.0%	1	K.VQPPREANSPFR.N

CR1_HUMAN

68.7%

2039

223589

6.9

(P17927) Complement receptor type 1 precursor (C3b/C4b receptor) (CD35 antigen)

	TK040203_NMyc_nuclei2_step05.1875.1875.1	1.9185	0.0987	1490.27	2	4550.0%	1	K.EISYTCDPHPDR.G
	TK040203_NMyc_nuclei2_step07.3740.3740.2	1.2119	0.0049	3193.36	9	1550.0%	1	R.GTSFDLIGESTIRCTSDPQGNGVWSSPAPR.C
	TK040203_NMyc_nuclei2_step04.3683.3683.3	1.2308	0.0189	4119.94	31	1210.0%	1	R.TSFHNGTVVTYQCHTGPDGEQLFELVGERSIYCTSK.D
	TK040203_NMyc_nuclei2_step03.3735.3735.3	1.8979	0.1765	4680.43	20	1000.0%	3	R.AGHCKTPEQFPFASPTIPINDFEFPVGTSLNYECRPGYFGK.M

Q9CVB6

68.6%

170

19913

8.4

(Q9CVB6) 2210023N03Rik protein (Fragment)

	TK040203_NMyc_nuclei2_step03.1937.1937.1	1.5221	0.0483	1088.63	1	7140.0%	2	R.DYLHYHIK.C

Q8VED5

68.6%

547

59180

7.4

(Q8VED5) Similar to keratin 6A (Fragment)

*	TK040203_NMyc_nuclei2_step12.2822.2822.2	1.1137	0.149	2299.5	7	2080.0%	1	K.GGFGSSVSYGAAKGGQVSGGTSILR.K
	TK040203_NMyc_nuclei2_step01.2819.2819.1	1.9417	0.0816	1330.66	4	5000.0%	1	R.NLDLDSIIAEVK.A
*	TK040203_NMyc_nuclei2_step03.3014.3014.2	1.384	0.0307	1935.23	18	2650.0%	1	-.HASDSLLLSAAFSLTIMR.S
*	TK040203_NMyc_nuclei2_step01.3510.3510.3	1.5074	0.0085	4515.22	4	1250.0%	1	K.VDSLTQEIDFLQQLFEMELSQVQTNVSDTNVILSMDNNR.N

K22E_HUMAN

68.6%

645

65865

8.0

(P35908) Keratin, type II cytoskeletal 2 epidermal (Cytokeratin 2e) (K2e) (CK 2e)

*	TK040203_NMyc_nuclei2_step09.2917.2917.2	1.6151	0.3169	2654.74	158	1330.0%	3	R.SLVGLGGTKSISISVAGGGGGFGAAGGFGGR.G
*	TK040203_NMyc_nuclei2_step02.1661.1661.1	1.4455	0.23	1320.56	4	3330.0%	1	R.HGGGGGGFGGGGFGSR.S
*	TK040203_NMyc_nuclei2_step02.2655.2655.3	2.1844	0.1694	2833.58	2	2000.0%	1	R.GGGFGGGSGFGGGSGFGGGSGFSGGGFGGGGFGGGR.F
*	TK040203_NMyc_nuclei2_step04.1491.1491.3	1.3301	0.1161	2312.58	1	2310.0%	1	K.HSSGGGSRGGSSSGGGYGSGGGGSSSVK.G

SMD3_HUMAN

68.5%

126

13916

10.3

(P43331) Small nuclear ribonucleoprotein Sm D3 (snRNP core protein D3) (Sm-D3) (P43331) Small nuclear ribonucleoprotein Sm D3 (snRNP core protein D3) (Sm-D3)

	TK040203_NMyc_nuclei2_step01.2894.2894.1	1.9666	0.0725	1089.66	3	6880.0%	1	R.FLILPDMLK.N

RYR1_HUMAN

68.3%

5038

565184

5.3

(P21817) Ryanodine receptor 1 (Skeletal muscle-type ryanodine receptor) (RyR1) (RYR-1) (Skeletal muscle calcium release channel)

*	TK040203_NMyc_nuclei2_step10.1462.1462.3	1.6402	0.1521	2052.18	2	2940.0%	1	R.QMVDMLVESSSNVEMILK.F
*	TK040203_NMyc_nuclei2_step02.1536.1536.1	1.9726	0.0218	1588.7	3	4580.0%	6	K.VMADDEFTQDLFR.F
*	TK040203_NMyc_nuclei2_step09.1577.1577.2	0.9393	0.015	1735.86	331	1920.0%	1	K.THPMLRPYKTFSEK.D
*	TK040203_NMyc_nuclei2_step05.1887.1887.1	1.3111	0.076	1488.61	36	2690.0%	1	R.VGDDIILVSVSSER.Y
*	TK040203_NMyc_nuclei2_step06.2274.2274.2	1.5035	0.0517	1836.81	39	3000.0%	1	R.ARPELLQSHFIPTIGR.L
*	TK040203_NMyc_nuclei2_step06.2429.2429.2	1.173	0.0366	2142.07	3	2940.0%	1	R.LVYYEGGAVCTHARSLWR.L
*	TK040203_NMyc_nuclei2_step01.1715.1715.1	1.0913	0.0323	1509.65	2	3460.0%	1	R.GAAEMVLQMISACK.G
*	TK040203_NMyc_nuclei2_step06.2898.2898.3	1.5332	0.0080	3242.73	4	1760.0%	1	K.SCHLEEGGENGEAEEEVEVSFEEKQMEK.Q
*	TK040203_NMyc_nuclei2_step05.2740.2740.3	1.8428	0.2341	3227.08	4	1750.0%	1	R.SLVPLEDLVGIISLPLQIPTLGKDGALVQPK.M
*	TK040203_NMyc_nuclei2_step05.3090.3090.2	1.6072	0.3596	2156.71	1	3160.0%	1	R.VSLFGTDAPAVVNCLHILAR.S
*	TK040203_NMyc_nuclei2_step11.2722.2722.2	1.6132	0.0851	2577.23	30	1590.0%	1	R.FAVFVNGESVEENANVVVRLLIR.K
*	TK040203_NMyc_nuclei2_step12.3318.3318.2	1.6594	0.2045	3118.01	7	1670.0%	1	K.ELLDLQKDMVVMLLSLLEGNVVNGMIAR.Q
*	TK040203_NMyc_nuclei2_step12.4333.4333.2	1.4821	0.0284	2824.18	11	1600.0%	1	K.VAMMTQPPATPTLPRLPHDVVPADNR.D

Q13088

68.2%

1.1%

1154

126925

5.0

(Q13088) ZEB (Fragment)

*	TK040203_NMyc_nuclei2_step02.1467.1467.1	1.8078	0.014	1588.62	11	3750.0%	2	R.IPLPEQCLFCPGR.T

Q91ZS8

68.2%

121

2.0%

711

78001

8.9

(Q91ZS8) Adenosine deaminase

	TK040203_NMyc_nuclei2_step01.2628.2628.1	1.5945	0.1069	1572.37	4	3460.0%	11	R.GLALNDCHAEIISR.R

Q9D414

68.1%

212

22646

11.5

(Q9D414) 4933424A20Rik protein

*	TK040203_NMyc_nuclei2_step02.2980.2980.2	2.2501	0.2268	2337.98	4	2830.0%	1	-.MATGSGGERVAAAATESLPAETEK.Q

CA16_HUMAN

68.0%

1028

108547

5.5

(P12109) Collagen alpha 1(VI) chain precursor

*	TK040203_NMyc_nuclei2_step08.3079.3079.2	1.4183	0.1884	1730.99	4	3060.0%	1	R.EGPVGVPGDPGEAGPIGPK.G
*	TK040203_NMyc_nuclei2_step04.1170.1170.1	0.8898	0.0525	962.53	22	3750.0%	1	R.GDPGFEGER.G
*	TK040203_NMyc_nuclei2_step08.3368.3368.1	1.5924	0.1708	1430.66	1	3570.0%	1	R.GAPGINGTKGYPGLK.G
	TK040203_NMyc_nuclei2_step05.2831.2831.2	1.1597	0.0215	2717.09	115	1400.0%	1	R.LLLFSDGNSQGATPAAIEKAVQEAQR.A
	TK040203_NMyc_nuclei2_step06.2242.2242.2	1.4994	0.1821	2190.42	81	1840.0%	1	R.DQLLPPSPNNRIALVITDGR.S
*	TK040203_NMyc_nuclei2_step09.1805.1805.2	1.5328	0.057	2254.16	2	2730.0%	2	R.GEDGPAGNGTEGFPGFPGYPGNR.G

Q9P2F5

68.0%

950

105133

8.5

(Q9P2F5) Hypothetical protein KIAA1392 (Fragment)

*	TK040203_NMyc_nuclei2_step04.2386.2386.1	1.9146	0.0767	1558.75	5	3850.0%	5	K.EDHDTLTLAEGVKK.L
*	TK040203_NMyc_nuclei2_step09.3908.3908.3	1.0255	0.0536	4116.64	17	1140.0%	1	R.KPVTQEALMEHLTTCFPGVPTPSQEILRHTLNTLVR.E
*	TK040203_NMyc_nuclei2_step01.1045.1045.1	1.0309	0.0064	879.64	4	5830.0%	2	K.FGLKLFR.L
*	TK040203_NMyc_nuclei2_step08.3584.3584.3	1.7371	0.1306	3231.97	1	2130.0%	1	K.IYPTPDGYFIVTPQTYFITPSLIRTNSK.W

Q9NYU1

68.0%

1516

174760

6.9

(Q9NYU1) UDP-glucose:glycoprotein glucosyltransferase 2 precursor

*	TK040203_NMyc_nuclei2_step12.4049.4049.2	1.0736	0.0138	2873.09	1	1880.0%	1	K.ILFLDVLFPLAVDKIIFVDADQIVR.H
*	TK040203_NMyc_nuclei2_step12.4082.4082.1	1.7318	0.1451	1074.3	1	5560.0%	5	K.MAQLLVVLGK.I
*	TK040203_NMyc_nuclei2_step02.2175.2175.3	1.4929	0.0255	3243.73	10	1760.0%	1	R.ENHSVIKTNPQENDMFFNVIAIVDPLTR.E
*	TK040203_NMyc_nuclei2_step08.3001.3001.3	1.9096	0.0501	3694.74	58	1290.0%	1	K.LRPGEMGIVSNGRFLGPLDEDFYAEDFYLLEK.I
*	TK040203_NMyc_nuclei2_step11.4210.4210.2	1.0463	0.0521	2172.55	42	2110.0%	1	R.SFLGQLAKEEIATTIYSGDK.I
*	TK040203_NMyc_nuclei2_step03.2891.2891.2	1.1008	0.1105	2175.6	99	1670.0%	1	R.LLLGSTALWLSQLGSGTVAASK.S

RL23_HUMAN

68.0%

25.7%

140

14865

10.5

(P23131) 60S ribosomal protein L23 (L17) (P23131) 60S ribosomal protein L23 (L17)

	TK040203_NMyc_nuclei2_step02.1700.1700.1	1.1409	0.0965	890.85	3	5710.0%	1	K.VHPAVVIR.Q
	TK040203_NMyc_nuclei2_step11.1218.1218.1	1.7346	0.1432	1020.53	2	7500.0%	2	K.KVHPAVVIR.Q
	TK040203_NMyc_nuclei2_step10.3017.3017.2	1.0144	0.1101	2458.71	15	1670.0%	1	K.DGVFLYFEDNAGVIVNNKGEMK.G
	TK040203_NMyc_nuclei2_step02.3848.3848.2	1.5322	0.1856	2016.68	1	3530.0%	1	K.DGVFLYFEDNAGVIVNNK.G
	TK040203_NMyc_nuclei2_step09.3697.3697.1	0.3765	0.0044	617.24	14	2500.0%	1	K.GRLNR.L

NUCG_MOUSE

68.0%

294

32191

9.5

(O08600) Endonuclease G, mitochondrial precursor (EC 3.1.30.-) (Endo G)

*	TK040203_NMyc_nuclei2_step08.1463.1463.1	0.9571	0.1066	1229.45	18	5000.0%	1	R.ESYVLSYDPR.T
	TK040203_NMyc_nuclei2_step05.2114.2114.1	1.77	0.1283	1430.67	4	3750.0%	1	R.ATNADYRGSGFDR.G

EML1_HUMAN

67.8%

717

79027

7.0

(O00423) Echinoderm microtubule-associated protein-like 1 (EMAP-1) (HuEMAP-1)

*	TK040203_NMyc_nuclei2_step09.1867.1867.2	2.1951	0.2453	2015.67	2	2780.0%	1	K.VTSRGPALLNECLLGVEGK.A
*	TK040203_NMyc_nuclei2_step07.1288.1288.2	1.0136	0.0069	1923.3	119	1560.0%	1	K.DQVDSYSLEAKVELPTK.R

SUN1_HUMAN

67.6%

812

90118

7.1

(O94901) Sad1/unc-84 protein-like 1

*	TK040203_NMyc_nuclei2_step07.1397.1397.1	1.1194	0.0021	933.54	11	6430.0%	1	R.EKSEAIQK.E
*	TK040203_NMyc_nuclei2_step11.1810.1810.1	1.0619	0.0501	1365.61	1	4090.0%	1	K.TGCETVDAVQER.V
	TK040203_NMyc_nuclei2_step11.2243.2243.3	2.6774	0.3005	3462.38	2	1770.0%	1	R.QVTSSGVSYGGTVSLQDAVTRRPPVLDESWIR.E

O95949

67.6%

1979

227637

5.3

(O95949) Golgi-associated microtubule-binding protein

*	TK040203_NMyc_nuclei2_step05.4222.4222.2	1.7717	0.3277	2508.43	1	2380.0%	2	R.ASKSEVLSESSELLQQELEELR.K
*	TK040203_NMyc_nuclei2_step09.1671.1671.3	1.7382	0.1028	2513.7	1	2260.0%	1	K.LKNFGQELAQVQHSIGQLCNTK.D
*	TK040203_NMyc_nuclei2_step09.0630.0630.2	1.1652	0.0143	2323.31	57	2110.0%	1	R.NHLLESEDSYTREALAAEDR.E
*	TK040203_NMyc_nuclei2_step11.1639.1639.2	1.1247	0.0187	2003.7	26	2350.0%	1	R.LSSLNQDNSLAEDNLKLK.M
*	TK040203_NMyc_nuclei2_step09.3381.3381.2	1.8283	0.1274	2522.9	4	2500.0%	1	K.QYALSLANLQMVLEHFQQEEK.A
*	TK040203_NMyc_nuclei2_step09.1195.1195.1	0.9867	0.1131	784.47	73	5000.0%	1	R.HIAQTSK.A
*	TK040203_NMyc_nuclei2_step10.2111.2111.2	1.042	0.0109	2498.27	8	2050.0%	1	K.LDIISPQLSSASLLTPQSAECLR.A

LMA3_MOUSE

67.4%

2569

282160

7.0

(Q61789) Laminin alpha-3 chain precursor (Nicein alpha subunit) (Fragment)

*	TK040203_NMyc_nuclei2_step01.0808.0808.1	1.0018	0.0492	1088.34	55	3750.0%	1	R.EELMTVLPR.L
*	TK040203_NMyc_nuclei2_step10.2731.2731.2	1.1334	0.0051	2960.32	214	1110.0%	1	R.GLHFTETQRLTLGEVGLEEASDTGSGPR.A
*	TK040203_NMyc_nuclei2_step04.2431.2431.2	1.2156	0.014	2094.8	146	1760.0%	1	R.QRSGSFLASFCPHLLGCR.D
*	TK040203_NMyc_nuclei2_step03.1603.1603.2	1.0135	0.0076	1816.12	3	3000.0%	1	R.EGSFYLDPTNPKGCTK.C
*	TK040203_NMyc_nuclei2_step05.2694.2694.2	1.9803	0.3021	2505.54	2	2390.0%	1	K.VHLVVDGLRAQEGSLPGNSTISPR.E
*	TK040203_NMyc_nuclei2_step10.0019.0019.1	0.6549	0.0573	988.83	31	1880.0%	1	R.NTSGDELVR.C
*	TK040203_NMyc_nuclei2_step05.1231.1231.2	0.9046	0.0708	1377.71	457	2500.0%	1	K.MEAQLLLHRIR.T
*	TK040203_NMyc_nuclei2_step11.3022.3022.3	1.7768	0.0108	4750.6	4	1250.0%	2	K.DYIGMAVVDGQLTCVYNLGDGEAEVQIDQVLTESESQEAVMDR.V
*	TK040203_NMyc_nuclei2_step06.2247.2247.2	1.1019	0.0484	2555.28	51	1900.0%	1	R.FQLSFGFQTFQPSGTLLNHQTR.T
	TK040203_NMyc_nuclei2_step06.1435.1435.1	1.156	0.0707	538.41	4	8330.0%	1	R.LHIR.G
*	TK040203_NMyc_nuclei2_step09.3319.3319.3	1.8638	0.0153	4626.28	32	1020.0%	1	R.SGVSPCLGGSLEKGIYFSQGGGHVVLANSVSLEPALTLTLSIRPR.S

Q9H0R5

67.4%

563

64127

5.6

(Q9H0R5) Hypothetical protein

*	TK040203_NMyc_nuclei2_step09.3818.3818.1	0.5597	0.0211	668.65	13	3750.0%	1	R.YMSHK.L
*	TK040203_NMyc_nuclei2_step10.1345.1345.3	1.7828	0.0675	1963.31	5	2650.0%	1	K.KPEHTLVLLDTEGLGDVK.K
	TK040203_NMyc_nuclei2_step07.3576.3576.2	1.869	0.0378	2979.18	3	2000.0%	2	K.QNQEASSDRCSALLQVIFSPLEEEVK.A

Q9P2G7

67.4%

1265

141291

7.8

(Q9P2G7) Hypothetical protein KIAA1380 (Fragment)

*	TK040203_NMyc_nuclei2_step11.1478.1478.1	1.9469	0.0789	1470.65	8	4090.0%	3	K.TMMPARYEDLLK.S
*	TK040203_NMyc_nuclei2_step01.3479.3479.1	1.3396	0.0297	1263.38	9	5000.0%	1	R.QRLLEEYGVR.T
*	TK040203_NMyc_nuclei2_step12.3307.3307.3	1.6608	0.1648	4055.52	15	1220.0%	1	R.LCSAYGVVAAKDHDIGTTNLHIEVSDVVNILVYVGIAK.G

CADB_MOUSE

67.3%

796

88112

4.9

(P55288) Cadherin-11 precursor (Osteoblast-cadherin) (OB-cadherin) (OSF-4)

	TK040203_NMyc_nuclei2_step01.1868.1868.1	1.5815	0.1686	1348.9	5	3850.0%	1	K.DMGGHMGGLSGTTK.V
	TK040203_NMyc_nuclei2_step06.1430.1430.1	1.1475	0.104	995.66	15	5000.0%	1	K.KLADLYGSK.D
	TK040203_NMyc_nuclei2_step12.3982.3982.2	1.1574	0.0027	2370.36	2	2620.0%	1	K.FPQSVYQMSVSEAAVPGEEVGR.V
	TK040203_NMyc_nuclei2_step09.3566.3566.3	2.125	0.0185	3151.62	70	1380.0%	1	R.LHSDIDSGDGNIKYILSGEGAGTIFVIDDK.S

Q99PT4

67.2%

147

16225

7.8

(Q99PT4) Kinesin superfamily protein 26A (Fragment)

*	TK040203_NMyc_nuclei2_step04.2133.2133.1	1.4581	0.2119	1281.59	2	5450.0%	1	R.STSRAGCGEEAR.R

Q9D0V2

67.2%

243

26824

6.7

(Q9D0V2) 18 days embryo cDNA, RIKEN full-length enriched library, clone:1110067K14, full insert sequence

	TK040203_NMyc_nuclei2_step01.2851.2851.1	1.5239	0.1749	1597.77	1	4230.0%	1	R.IYLESEHGSPLTPR.V

Q96A65

67.1%

974

110498

6.5

(Q96A65) Hypothetical protein FLJ14782 (Secretory protein SEC8)

*	TK040203_NMyc_nuclei2_step10.3400.3400.3	2.8151	0.2426	4535.79	1	1520.0%	1	R.TKSAFSNLSTSQMLSPAQDSHTNTDLPPVSEQIMQTLSELAK.S

Q8WVT1

67.1%

100.0%

2946

4.5

(Q8WVT1) Hypothetical protein

*	TK040203_NMyc_nuclei2_step03.3814.3814.2	1.7424	0.4348	2948.46	1	2590.0%	1	-.MEALGFPVGRQADQTQLGMSPSSQLLAL.-

O88783

67.1%

0.9%

2183

247228

6.0

(O88783) Murine coagulation factor V

*	TK040203_NMyc_nuclei2_step04.2226.2226.1	1.5747	0.1648	1406.59	1	4580.0%	1	K.ADKPLSIHPQGIK.Y
*	TK040203_NMyc_nuclei2_step09.3902.3902.1	0.4912	0.2538	594.91	10	2000.0%	1	R.GHGGHK.K

PEX_MOUSE

67.1%

749

86419

8.8

(P70669) Metalloendopeptidase homolog PEX (EC 3.4.24.-) (Phosphate regulating neutral endopeptidase) (X-linked hypophosphatemia protein) (HYP) (Vitamin D-resistant hypophosphatemic rickets protein)

	TK040203_NMyc_nuclei2_step06.2849.2849.2	1.2371	0.0119	2172.92	6	2370.0%	2	R.DALYKFMVDTAVLLGANSSR.A
*	TK040203_NMyc_nuclei2_step09.3055.3055.3	1.6597	0.0011	3793.52	371	890.0%	1	K.QEYCLKPECIEAAAAIMSKVNLSVDPCENFFR.F
*	TK040203_NMyc_nuclei2_step08.1837.1837.1	1.5787	0.1704	1374.68	3	4170.0%	1	-.MEAETGSTMETGK.G

O60562

66.9%

719

83164

5.4

(O60562) Hook2 protein

	TK040203_NMyc_nuclei2_step02.3063.3063.3	2.961	0.1276	3861.12	1	1860.0%	2	R.CAQLQPRGLTQADPSLDPTSTPVDNLAAEILPAELR.E
	TK040203_NMyc_nuclei2_step10.3248.3248.3	1.5361	0.0072	3908.87	35	1140.0%	1	R.SLVEYSQDVLAHPVSEEHLPDVSLIGEFSDPAELGK.L

RET_HUMAN

66.8%

1114

124319

6.6

(P07949) Proto-oncogene tyrosine-protein kinase receptor ret precursor (EC 2.7.1.112) (C-ret)

	TK040203_NMyc_nuclei2_step10.2340.2340.2	1.2868	0.0053	2257.68	9	2500.0%	3	R.VYFSFFNTSFPACSSLKPR.E
	TK040203_NMyc_nuclei2_step07.1273.1273.2	1.2581	0.0345	1428.07	25	3500.0%	1	K.ILEDPKWEFPR.K
	TK040203_NMyc_nuclei2_step10.3185.3185.2	1.3726	0.0787	3134.05	136	1250.0%	1	K.LYGMSDPNWPGESPVPLTRADGTNTGFPR.Y
	TK040203_NMyc_nuclei2_step09.2519.2519.2	1.2112	0.02	2662.67	124	1590.0%	2	R.FAQIGKVCVENCQAFSGINVQYK.L
	TK040203_NMyc_nuclei2_step11.2607.2607.3	1.745	0.0433	4017.45	8	1320.0%	2	R.EEVVMVPFPVTVYDEDDSAPTFPAGVDTASAVVEFKR.K

Q9D0Q2

66.8%

509

53854

8.4

(Q9D0Q2) 2600011E07Rik protein

*	TK040203_NMyc_nuclei2_step03.3451.3451.3	2.8696	0.2305	4113.71	1	1490.0%	1	K.VVIPRDSDSGDALCDLYVEPEASPATLPATEDPPCLSR.L
*	TK040203_NMyc_nuclei2_step10.2899.2899.2	1.2161	0.0073	2298.78	118	1670.0%	1	R.HAAGCGDIIADPEEEAGPSCDK.H
*	TK040203_NMyc_nuclei2_step12.1965.1965.2	1.2201	0.0596	2661.82	9	2200.0%	1	R.AAGPGNLVLPGSLTASLECVKEEPPR.A
*	TK040203_NMyc_nuclei2_step12.1994.1994.2	1.363	0.0545	2574.84	29	1820.0%	1	K.HLSNLPSSHPVVHQQPARSEVPR.T

Q9CWA9

66.8%

22.9%

131

14309

11.7

(Q9CWA9) 0610009L18Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step06.2207.2207.1	0.8423	0.035	1486.51	93	2690.0%	1	R.VRSPLCLVPGSSSK.A
*	TK040203_NMyc_nuclei2_step06.2570.2570.2	1.811	0.3162	1805.28	2	4000.0%	1	R.ERETWSPLFLPSGVST.-

Q9P1Z0

66.6%

615

63569

8.0

(Q9P1Z0) Hypothetical protein KIAA1538 (Fragment)

*	TK040203_NMyc_nuclei2_step07.2237.2237.1	1.9009	0.0524	1459.33	2	4670.0%	1	R.GKSGSEGPVGAGEGDR.M

Q9D5U0

66.6%

516

58381

8.9

(Q9D5U0) 4921521K07Rik protein

*	TK040203_NMyc_nuclei2_step12.2413.2413.2	1.2538	0.0421	2839.03	14	1740.0%	1	K.HPAYAKLFHSYIDLQAAYIYSLPR.E
*	TK040203_NMyc_nuclei2_step09.2691.2691.2	2.2095	0.2252	2375.77	2	2750.0%	1	K.SLYPPAVDSPFTLNTHLSAWR.W

PKD1_HUMAN

66.5%

4303

462654

6.7

(P98161) Polycystin precursor (Autosomal dominant polycystic kidney disease protein 1)

*	TK040203_NMyc_nuclei2_step07.2556.2556.2	1.7519	0.3892	2475.68	1	2950.0%	2	R.TLGPALRIPADATELDVSHNLLR.A
	TK040203_NMyc_nuclei2_step11.3815.3815.2	1.1009	0.0083	2817.55	8	1800.0%	1	R.GCGPCEPPCLCGPAPGAACRVNCSGR.G
	TK040203_NMyc_nuclei2_step11.1996.1996.2	1.2398	0.0406	2309.43	21	2370.0%	1	K.GLSPAWFLQHVIVRDLQTAR.S
	TK040203_NMyc_nuclei2_step09.2669.2669.3	1.8273	0.2007	4164.29	16	1080.0%	1	K.SDLFLDDSKSLVCWPSGEGTLSWPDLLSDPSIVGSNLR.Q
	TK040203_NMyc_nuclei2_step09.2317.2317.2	1.0969	0.0686	2373.96	7	1960.0%	1	R.GQAGHGLGPEEDGFSLASPYSPAK.S
*	TK040203_NMyc_nuclei2_step10.3453.3453.3	1.752	0.1285	4383.11	28	1050.0%	1	R.GPTLLQHVFPASPGATLVGPHGPLASGQLAAFHIAAPLPVTDTR.W
*	TK040203_NMyc_nuclei2_step08.2176.2176.2	1.1393	0.0094	1765.82	59	3000.0%	1	R.IPADATELDVSHNLLR.A
	TK040203_NMyc_nuclei2_step05.2479.2479.3	1.6406	0.0176	3921.45	8	1440.0%	1	R.FVFPEPTADVNYIVMLTCAVCLVTYMVMAAILHK.L
	TK040203_NMyc_nuclei2_step06.1678.1678.3	1.8329	0.1038	3833.66	3	1540.0%	1	R.LALPVGHYCFVFVVSFGDTPLTQSIQANVTVAPER.L

Q9D7J7

66.4%

247

27190

5.5

(Q9D7J7) 2310005G05Rik protein

	TK040203_NMyc_nuclei2_step10.3724.3724.2	1.553	0.2242	2942.03	1	2000.0%	2	R.FRQQFTQLAGPDMEVGATDLMNILNK.V

Q96PU4

66.4%

802

89985

8.2

(Q96PU4) Np95-like ring finger protein

*	TK040203_NMyc_nuclei2_step11.4079.4079.3	1.514	0.0556	4396.24	29	1050.0%	1	K.LDSVPSTSNSDCVAADEDVIYHIQYDEYPESGTLEMNVK.D
*	TK040203_NMyc_nuclei2_step12.1190.1190.2	2.2702	0.1049	1993.35	1	3890.0%	1	R.VQVSEAGVHRPHVGGIHGR.S

Q9NZN1

66.4%

696

79983

6.2

(Q9NZN1) X-linked interleukin-1 receptor accessory protein-like 1

*	TK040203_NMyc_nuclei2_step07.1969.1969.3	1.6574	0.1637	2678.0	27	1850.0%	1	R.TTELTVTAPLTDKPPKLLYPMESK.L
*	TK040203_NMyc_nuclei2_step05.2971.2971.3	1.9048	0.1041	4026.33	62	1140.0%	1	K.EHLGEQEVSISLIVDSVEEGDLGNYSCYVENGNGRR.H
*	TK040203_NMyc_nuclei2_step11.2410.2410.3	2.5899	0.3355	4737.91	1	1340.0%	1	R.SYEYDVPPTGTLPLTSIGNQHTYCNIPMTLINGQRPQTKSSR.E

SEPL_HUMAN

66.3%

13.8%

412

43201

4.4

(Q14242) P-selectin glycoprotein ligand 1 precursor (PSGL-1) (Selectin P ligand) (CD162 antigen)

*	TK040203_NMyc_nuclei2_step04.2093.2093.3	1.9474	0.1882	2916.94	9	1800.0%	3	K.QCLLAILILALVATIFFVCTVVLAVR.L
*	TK040203_NMyc_nuclei2_step11.3511.3511.2	1.584	0.0676	3112.34	1	1830.0%	2	R.NYSPTEMVCISSLLPDGGEGPSATANGGLSK.A

ST14_MOUSE

66.3%

23.3%

855

94655

6.8

(P56677) Suppressor of tumorigenicity 14 (EC 3.4.21.-) (Epithin)

*	TK040203_NMyc_nuclei2_step10.3215.3215.3	1.2422	0.0328	4569.69	6	1150.0%	1	K.MSSCGGFLSDTQGTFSSPYYPGHYPPNINCTWNIKVPNNR.N
*	TK040203_NMyc_nuclei2_step07.1621.1621.3	1.8616	0.0082	3462.19	3	1750.0%	1	K.SAVTAFSEGSVIAYYWSEFSIPPHLAEEVDR.A
*	TK040203_NMyc_nuclei2_step11.2476.2476.2	1.8442	0.3081	2900.12	3	2390.0%	1	K.RIITHPSFNDFTFDYDIALLELEK.S
*	TK040203_NMyc_nuclei2_step08.2581.2581.3	1.7558	0.1002	3744.92	33	1250.0%	1	K.VFNGHLRITNEIFLDAYENSTSTEFISLASQVK.E
*	TK040203_NMyc_nuclei2_step04.3627.3627.3	1.7635	0.066	4559.22	46	990.0%	1	K.ITVHFHSDHSYTDTGFLAEYLSYDSNDPCPGMFMCKTGR.C
*	TK040203_NMyc_nuclei2_step11.3803.3803.2	1.4151	0.0657	2532.34	168	1500.0%	1	K.NFKYSDYTMWTAFLGLLDQSK.R
*	TK040203_NMyc_nuclei2_step06.0366.0366.1	0.6689	0.0361	1169.65	131	2000.0%	1	R.SQFVVSSNSSK.I

TBG1_MOUSE

66.3%

451

51101

6.0

(Q9Z310) Tubulin gamma-1 chain (Gamma-1 tubulin) (Gamma-tubulin complex component 1) (GCP-1)

	TK040203_NMyc_nuclei2_step07.1718.1718.2	1.8968	0.3069	3090.09	2	1800.0%	1	R.EIVQQLIDEYHAATRPDYISWGTQEQ.-

Q9Y3M8

66.2%

995

111192

6.9

(Q9Y3M8) Hypothetical protein (46H23.2) (Novel RhoGAP domain protein)

*	TK040203_NMyc_nuclei2_step08.1995.1995.2	1.2811	0.1059	2108.21	3	2500.0%	1	K.SSGESSPSEHSSSGVSTPCLK.E
*	TK040203_NMyc_nuclei2_step01.0675.0675.1	1.9183	0.029	1140.49	4	6110.0%	1	R.EQVPGAREPR.L
*	TK040203_NMyc_nuclei2_step01.4558.4558.3	2.4745	0.1219	4392.37	6	1150.0%	2	R.GGMYLEDLDVLAGTALPDAGDQSRMHEFHSQENLVVHIPK.D

O35284

66.2%

125

14065

8.7

(O35284) B-ATF (Basic leucine zipper transcription factor, ATF-like)

	TK040203_NMyc_nuclei2_step06.1349.1349.1	1.8994	0.0718	1485.54	4	3460.0%	1	R.SPPPGKQDSSDDVR.K

R13A_MOUSE

65.9%

202

23333

11.0

(P19253) 60S ribosomal protein L13a (Transplantation antigen P198) (Tum-P198 antigen)

	TK040203_NMyc_nuclei2_step04.1581.1581.1	1.469	0.1564	652.61	5	7000.0%	4	R.GHLLGR.L
	TK040203_NMyc_nuclei2_step05.1214.1214.1	1.2	0.0617	606.36	27	8330.0%	1	K.MHYR.K

Q9H9J3

65.6%

155

17202

9.6

(Q9H9J3) Hypothetical protein FLJ12700

*	TK040203_NMyc_nuclei2_step01.3082.3082.1	1.3128	0.0173	1254.68	1	4580.0%	4	K.GRSPATGAALTPR.F

GAA4_MOUSE

65.6%

17.0%

552

60878

9.3

(Q9D6F4) Gamma-aminobutyric-acid receptor alpha-4 subunit precursor (GABA(A) receptor)

	TK040203_NMyc_nuclei2_step04.1775.1775.1	1.544	0.1612	1393.64	3	5000.0%	1	R.ILDSLLDGYDNR.L
	TK040203_NMyc_nuclei2_step08.1829.1829.1	0.6337	0.0501	433.03	7	5000.0%	1	K.GPEK.S
	TK040203_NMyc_nuclei2_step03.3375.3375.3	1.5649	0.0087	4286.78	13	1280.0%	1	R.LRPGFGGPVTEVKTDIYVTSFGPVSDVEMEYTMDVFFR.Q
*	TK040203_NMyc_nuclei2_step12.3942.3942.3	1.4467	0.0017	4613.69	72	960.0%	1	K.VSYATAMDWFIAVCFAFVFSALIEFAAVNYFTNIQMQKAK.K

Q9CZ85

65.5%

325

43.9%

114

12715

5.0

(Q9CZ85) 2810038F24Rik protein

*	TK040203_NMyc_nuclei2_step11.3430.3430.2	1.8271	0.1052	3010.38	43	1540.0%	18	R.AQYTLMAQAVDRDTNKPLGPPSEFIDK.D
*	TK040203_NMyc_nuclei2_step01.2800.2800.3	1.427	0.0767	4436.32	1	1280.0%	1	R.DTNKPLGPPSEFIDKDQDINDNPPEFLHEIYHTNVPER.S

O95159

65.5%

310

34142

8.2

(O95159) Zinc-finger protein MCG4

	TK040203_NMyc_nuclei2_step05.1878.1878.2	2.2495	0.013	1531.83	10	5000.0%	1	R.LCNIPLASRETTR.L

Q9DCK5

65.5%

127

14703

8.4

(Q9DCK5) 0610030G03Rik protein

*	TK040203_NMyc_nuclei2_step08.3268.3268.2	1.2972	0.129	2637.99	2	2270.0%	1	-.MPLLFHPAWPLLLGATLTFRALR.R
*	TK040203_NMyc_nuclei2_step03.2981.2981.2	2.2437	0.142	2297.43	9	2630.0%	3	-.MPLLFHPAWPLLLGATLTFR.A

TPOR_MOUSE

65.4%

625

69818

6.8

(Q08351) Thrombopoietin receptor precursor (TPO-R) (Myeloproliferative leukemia protein) (C-mpl)

	TK040203_NMyc_nuclei2_step01.1269.1269.1	1.7023	0.126	1288.45	2	6000.0%	2	K.NVSLNQTLIQR.V
	TK040203_NMyc_nuclei2_step11.2902.2902.2	1.3807	0.0147	2664.91	21	2000.0%	1	R.LELEWQHQSSWAAQETCYQLR.Y
	TK040203_NMyc_nuclei2_step05.2822.2822.2	1.4561	0.1073	2389.4	19	2220.0%	1	K.MVTCQWQQQDRTSSQGFFR.H

O95924

65.4%

255

29789

9.6

(O95924) DJ413H6.1.1 (Hamster androgen-dependent expressed protein like putative protein) (Isoform 1)

*	TK040203_NMyc_nuclei2_step10.1529.1529.1	1.5132	0.1808	1008.34	4	6250.0%	1	K.SPAKHQLVK.N

Q9NSY3

65.4%

168

18090

8.5

(Q9NSY3) Hypothetical protein

*	TK040203_NMyc_nuclei2_step11.3050.3050.2	2.2093	0.207	3087.85	1	1730.0%	2	R.WTRGFPCAPSGGGHHVCPEPHQEVDIR.F

Q9R0B7

65.3%

145

294

32698

8.9

(Q9R0B7) Double-stranded RNA-binding zinc finger protein JAZ

*	TK040203_NMyc_nuclei2_step01.3558.3558.1	1.3744	0.0823	1254.79	10	4170.0%	12	R.LADPAVSDLPAGK.G
	TK040203_NMyc_nuclei2_step06.1085.1085.1	0.6152	0.143	598.64	125	3750.0%	1	K.KHANK.V

Q96F93

65.3%

316

36473

9.8

(Q96F93) Similar to KIAA1198 protein

*	TK040203_NMyc_nuclei2_step07.1728.1728.1	1.4657	0.1962	1047.68	2	5620.0%	1	K.LSCSSSLHR.H

Q9UFA4

65.3%

791

85633

6.1

(Q9UFA4) Hypothetical protein (Fragment)

*	TK040203_NMyc_nuclei2_step03.3117.3117.2	2.1998	0.2199	1508.65	2	5000.0%	1	K.DGKSPLHMTAVHGR.F
*	TK040203_NMyc_nuclei2_step12.2045.2045.2	1.2778	0.0555	2630.22	52	1520.0%	1	K.GHTECVEALINQGASIFVKDNVTK.R

Q15021

65.2%

1401

157121

6.5

(Q15021) Hypothetical protein KIAA0159

*	TK040203_NMyc_nuclei2_step09.2550.2550.3	1.7133	0.0524	3919.22	12	1180.0%	2	R.AKAQALIQNLSLLLVDASVGTIQCLEEILCEFVQK.D
*	TK040203_NMyc_nuclei2_step06.1375.1375.2	1.1019	0.0829	2184.24	22	2000.0%	1	R.GKPEIVGSNLDTLVSIGLDEK.F
*	TK040203_NMyc_nuclei2_step06.3605.3605.3	1.2665	0.0181	4512.97	13	1090.0%	2	K.GFVHPDPLWIPFKEVAVTLIYQLAEGPEVICAQILQGCAK.Q
*	TK040203_NMyc_nuclei2_step10.2183.2183.3	2.7282	0.2479	2982.47	5	1850.0%	1	K.NTSSETTMEEELGLVGATADDTEAELIR.G
*	TK040203_NMyc_nuclei2_step01.1514.1514.1	1.3631	0.0961	881.44	20	5000.0%	1	R.NAHLNALK.M
*	TK040203_NMyc_nuclei2_step12.3354.3354.3	2.0338	0.0604	3390.9	140	1160.0%	1	R.AFQAAFRAQGPLAMLQHFDTIYSILHHFR.S

SAL2_MOUSE

65.2%

1004

104976

6.4

(Q9QX96) Sal-like protein 2 (Spalt-like protein 2) (MSal-2)

*	TK040203_NMyc_nuclei2_step02.4052.4052.2	1.4681	0.0823	2679.87	1	2310.0%	1	K.LPGTGAASSTKPLLPLFSPIKPAQTGK.T
*	TK040203_NMyc_nuclei2_step01.2579.2579.3	1.573	0.0798	4326.28	21	1020.0%	1	K.LPGTGAASSTKPLLPLFSPIKPAQTGKTLASSSSSSSSSGAEPPK.Q
*	TK040203_NMyc_nuclei2_step02.2778.2778.2	1.2739	0.0012	2542.17	8	2270.0%	5	K.QAFFHLYHPLGSQHPFSVGGVGR.S
*	TK040203_NMyc_nuclei2_step08.2583.2583.3	2.072	0.0061	3575.44	1	1740.0%	1	K.LEGISSPMAALTQEGEGTSTPLVEELNLPEAMKK.D

Q9Y2W6

65.1%

17.3%

606

67025

5.1

(Q9Y2W6) Putative RNA binding protein

*	TK040203_NMyc_nuclei2_step05.1927.1927.1	1.8889	0.0542	1265.83	1	5000.0%	1	K.KLDIGLELVHK.G
*	TK040203_NMyc_nuclei2_step02.3208.3208.3	2.2984	0.2208	4156.6	5	1390.0%	1	K.LVNEMTQHYENSVPEDLTVHVGDIVAAPLPTNGSWYR.A
*	TK040203_NMyc_nuclei2_step12.3062.3062.2	1.4337	0.1022	2833.06	2	2000.0%	1	K.AAIHQILTENTPVSEQLSVPQRSVGR.I
*	TK040203_NMyc_nuclei2_step06.1609.1609.3	1.5018	0.0822	3272.21	3	1700.0%	2	R.VLGTLENGNLDLYFVDFGDNGDCPLKDLR.A
*	TK040203_NMyc_nuclei2_step01.3902.3902.3	1.653	0.0675	4382.69	1	1320.0%	1	K.LVNEMTQHYENSVPEDLTVHVGDIVAAPLPTNGSWYRAR.V

Q9H4V1

65.0%

510

56370

6.5

(Q9H4V1) BA338L11.1 (Novel CUB domain protein similar to attractin) (Fragment)

*	TK040203_NMyc_nuclei2_step12.3161.3161.2	1.7959	0.3119	3073.78	3	1880.0%	2	R.CVNSTCLCDPGWVGDQCQHCQGRFK.L

LEG1_MOUSE

64.9%

19.4%

134

14735

5.5

(P16045) Galectin-1 (Beta-galactoside-binding lectin L-14-I) (Lactose-binding lectin 1) (S-Lac lectin 1) (Galaptin) (14 kDa lectin)

	TK040203_NMyc_nuclei2_step04.3444.3444.2	1.6698	0.2347	2926.67	1	2000.0%	2	R.EPAFPFQPGSITEVCITFDQADLTIK.L

CBLB_HUMAN

64.9%

982

109480

7.9

(Q13191) Signal transduction protein CBL-B (SH3-binding protein CBL-B)

*	TK040203_NMyc_nuclei2_step01.2982.2982.1	1.008	0.0327	1218.56	442	2780.0%	1	R.EGFYLYPDGR.S
*	TK040203_NMyc_nuclei2_step09.1926.1926.2	1.4522	0.0878	1892.0	1	3820.0%	2	R.KPHGPEAALENVDAKIAK.L
*	TK040203_NMyc_nuclei2_step11.3784.3784.2	1.3882	0.0304	2382.27	4	2250.0%	1	R.RKPQPDPLQIPHLSLPPVPPR.L
*	TK040203_NMyc_nuclei2_step10.3533.3533.3	1.6976	0.0039	4689.07	10	1050.0%	1	R.SYNPDLTGLCEPTPHDHIKVTQEQYELYCEMGSTFQLCK.I

Q9D7Y3

64.9%

17.3%

162

18406

5.1

(Q9D7Y3) 2210011H10Rik protein

	TK040203_NMyc_nuclei2_step12.2235.2235.2	1.9581	0.2906	2858.19	1	2220.0%	1	R.VSLSDGSDSESSSASSPLHHEPPPPLLK.T

ATY3_HUMAN

64.9%

24.6%

684

76082

5.7

(Q9H7F0) Probable cation-transporting ATPase 3 (EC 3.6.3.-) (Fragment)

*	TK040203_NMyc_nuclei2_step10.3571.3571.3	2.0442	0.0647	4294.01	2	1450.0%	1	K.ELVAQRPPSGLISGALLFSVLSQIIICIGFQSLGFFWVK.Q
	TK040203_NMyc_nuclei2_step05.4257.4257.3	0.9733	0.1089	4487.22	64	920.0%	1	K.INWHYADSLTQCSHPSAIDPEAIPVKLVHDSLEDLQMTR.Y
	TK040203_NMyc_nuclei2_step07.3685.3685.3	1.9397	0.0853	3734.04	391	980.0%	1	R.MAPDQKTQLIEALQNVDYFVGMCGDGANDCGALK.R
	TK040203_NMyc_nuclei2_step03.1711.1711.1	1.4337	0.2279	970.42	1	7140.0%	2	R.YHFAMNGK.S
	TK040203_NMyc_nuclei2_step01.0467.0467.1	1.1126	0.0599	910.44	148	5710.0%	2	R.VIALAHRK.L
*	TK040203_NMyc_nuclei2_step11.3286.3286.3	1.4794	0.0474	4771.06	213	710.0%	1	K.QQPWYEVWHPKSDACNTTGSGFWNSSHVDNETELDELIYK.I

Q9JJK2

64.8%

450

50777

7.3

(Q9JJK2) Testis-specific adriamycin sensitivity protein (Similar to TASP for testis-specific adriamycin sensitivity protein)

*	TK040203_NMyc_nuclei2_step07.3356.3356.1	1.6945	0.139	1575.59	2	3930.0%	1	K.EVVSAIIESGKSLSR.E
	TK040203_NMyc_nuclei2_step07.1166.1166.1	1.1017	0.1135	938.67	3	5000.0%	1	-.MGETMSKR.L

Q9P127

64.8%

13.7%

313

35937

9.5

(Q9P127) HOM-TES-85 tumor antigen (DJ237H22.1)

*	TK040203_NMyc_nuclei2_step08.1285.1285.3	1.0142	0.0455	3252.23	238	1070.0%	1	K.CSDNYEAQAEKNQGQSEGNQHQSEGNPDK.S
*	TK040203_NMyc_nuclei2_step01.1691.1691.1	1.7002	0.1406	1594.42	1	3850.0%	1	R.SHGQSERSHGHSER.S

Q920P1

64.8%

318

35646

8.6

(Q920P1) Odorant receptor (Olfactory receptor MOR174-4)

*	TK040203_NMyc_nuclei2_step11.3943.3943.2	1.322	0.0552	2891.08	1	2400.0%	1	K.VPLFLVFLVIYSITVVGNIGMILVIR.I
*	TK040203_NMyc_nuclei2_step06.3450.3450.1	1.7002	0.1398	1194.35	3	5560.0%	1	R.KIMTLISCVK.N

DCK_MOUSE

64.7%

16.2%

260

30367

5.4

(P43346) Deoxycytidine kinase (EC 2.7.1.74) (dCK)

*	TK040203_NMyc_nuclei2_step01.3211.3211.1	1.7566	0.1236	1569.97	2	4230.0%	1	K.RFCPSPSTSSEGTR.I
	TK040203_NMyc_nuclei2_step02.1744.1744.2	0.9539	0.0391	2058.49	4	2810.0%	1	K.DAEKPVLFFERSVYSDR.Y
	TK040203_NMyc_nuclei2_step06.2345.2345.1	1.711	0.119	1420.75	1	5000.0%	2	K.HESWLLHRTLK.T

SPA1_MOUSE

64.7%

1037

112066

6.4

(P46062) Signal-induced proliferation associated protein 1 (Sipa-1) (GTPase-activating protein Spa-1)

*	TK040203_NMyc_nuclei2_step01.2438.2438.1	1.6482	0.1492	1475.7	2	4550.0%	1	R.RSFSELYMLSLK.E
	TK040203_NMyc_nuclei2_step10.2627.2627.2	1.2366	0.0437	2444.43	8	2380.0%	2	R.QQYLQDLATNEVTTTSLDSASR.F
*	TK040203_NMyc_nuclei2_step11.3539.3539.2	1.5774	0.0637	1772.52	45	2500.0%	1	R.LLAESESAATRLLLASK.H
	TK040203_NMyc_nuclei2_step05.2934.2934.3	1.2224	0.0397	3324.98	10	1420.0%	1	R.QQYLQDLATNEVTTTSLDSASRFGLPSLGGR.R

GDF9_HUMAN

64.5%

454

51444

9.0

(O60383) Growth/differentiation factor 9 precursor (GDF-9)

*	TK040203_NMyc_nuclei2_step12.3414.3414.3	2.9199	0.1714	2979.62	1	2790.0%	1	R.ITTVEHLLKSVLLYNINNSVSFSSAVK.C

Q9BXG8

64.5%

430

49409

7.6

(Q9BXG8) Testis-specific protein NYD-TSP1

*	TK040203_NMyc_nuclei2_step01.4543.4543.2	2.226	0.145	2975.44	2	2290.0%	1	K.LSHDTYSLQLMAALLENECQILQQR.V

Q8WXX0

64.5%

301

4024

461147

6.0

(Q8WXX0) Ciliary dynein heavy chain 7

*	TK040203_NMyc_nuclei2_step08.3216.3216.2	1.2888	0.075	2243.49	2	2780.0%	1	K.SFHTSTIDLSKSFFVELQR.Y
*	TK040203_NMyc_nuclei2_step12.3737.3737.3	1.8715	0.0255	4583.97	1	1380.0%	17	K.MITEWDAVEFVIHSYRETGTFILASVDEIQMLLDDHIIK.T
*	TK040203_NMyc_nuclei2_step01.3270.3270.2	2.2247	0.1484	2908.48	3	2400.0%	1	K.EESFLEDVSNLLNAGEIPNLFALDEK.Q
*	TK040203_NMyc_nuclei2_step09.1595.1595.1	1.2585	0.0514	954.61	1	6670.0%	1	K.REDTNYR.E
*	TK040203_NMyc_nuclei2_step09.2071.2071.3	1.6044	0.0932	4138.51	112	1140.0%	1	R.YYYYIHHGIDTDHVAPMEDSWLEHVLDLVPQHLK.V
	TK040203_NMyc_nuclei2_step10.3917.3917.3	1.3686	0.3492	4013.67	16	1250.0%	1	R.TLENCIQFGTPVLLENVGEELDPILEPLLLKQTFK.Q
*	TK040203_NMyc_nuclei2_step09.3907.3907.3	1.22	0.0937	3943.74	7	1400.0%	1	K.QTDGSPIALFNMFIDHCRSQLHVVLAMSPIGDAFR.N
	TK040203_NMyc_nuclei2_step07.1294.1294.2	1.6629	0.2856	1817.8	19	3120.0%	1	K.IVKADETIANEQAMASK.A
*	TK040203_NMyc_nuclei2_step12.3371.3371.2	1.2315	0.0474	2890.58	118	1400.0%	2	R.ALPQLSMVSTKPHWQQAAPSFHLSVK.Q
*	TK040203_NMyc_nuclei2_step08.3025.3025.2	1.5735	0.0989	2584.09	2	2380.0%	1	R.DHLNAMNPTMLAVLDLWHTNFK.K

O88740

64.5%

158

18192

6.8

(O88740) Protein-tyrosine-phosphatase (EC 3.1.3.48)

*	TK040203_NMyc_nuclei2_step12.1179.1179.1	1.7253	0.1259	1201.31	2	5000.0%	1	K.HGIHMQHIAR.Q

Q60921

64.4%

132

15152

9.2

(Q60921) Zfp79p (Fragment)

*	TK040203_NMyc_nuclei2_step02.1372.1372.2	1.4179	0.1599	1571.65	6	4090.0%	1	-.YREVMLENEQEK.K
*	TK040203_NMyc_nuclei2_step04.1830.1830.1	1.5348	0.1591	1459.41	5	3640.0%	1	K.SQQSGEKAFWCK.Y

M3K1_HUMAN

64.4%

1495

163653

8.2

(Q13233) Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.1.-) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) (Fragment)

*	TK040203_NMyc_nuclei2_step09.3005.3005.3	1.8807	0.0269	3943.93	3	1360.0%	2	R.SHDFYSHELSSPVDSPSSLRAAQQQTVQQQPLAGSR.R
*	TK040203_NMyc_nuclei2_step02.3966.3966.2	1.056	0.0229	2589.74	148	1430.0%	1	K.WRSHDFYSHELSSPVDSPSSLR.A
*	TK040203_NMyc_nuclei2_step06.2277.2277.1	1.0653	0.0244	1194.53	6	5000.0%	1	K.LSASSEDISER.L
*	TK040203_NMyc_nuclei2_step09.0639.0639.2	1.2341	0.2515	2711.14	6	1800.0%	1	R.ISVGPSSSTTTTTTTTEQPKPMVQTK.G

SYM_HUMAN

64.2%

900

101116

6.2

(P56192) Methionyl-tRNA synthetase (EC 6.1.1.10) (Methionine--tRNA ligase) (MetRS)

	TK040203_NMyc_nuclei2_step06.1643.1643.1	1.6813	0.1398	1061.47	1	6670.0%	1	K.KGEDVLGSVR.R
	TK040203_NMyc_nuclei2_step03.1945.1945.3	1.7976	0.1062	2351.87	69	1840.0%	1	R.QWNTLYLCGTDEYGTATETK.A
*	TK040203_NMyc_nuclei2_step08.1805.1805.1	1.5126	0.0013	1565.84	13	3210.0%	3	K.KQLAVAEGKPPEAPK.G

CD1B_HUMAN

64.2%

333

36939

6.3

(P29016) T-cell surface glycoprotein CD1b precursor (CD1b antigen)

*	TK040203_NMyc_nuclei2_step02.1409.1409.2	0.86	0.0585	1418.4	1	4550.0%	1	R.EVQDFAGDFQMK.Y
*	TK040203_NMyc_nuclei2_step12.1517.1517.2	1.5089	0.1331	1886.78	6	3330.0%	1	K.GNFSDKEVAELEEIFR.V
*	TK040203_NMyc_nuclei2_step01.0167.0167.1	1.8132	0.0991	1050.46	1	6110.0%	7	R.YLLGVLNAGK.A

Q91VY1

64.1%

851

94913

6.1

(Q91VY1) Similar to KIAA0195 gene product (Fragment)

	TK040203_NMyc_nuclei2_step07.4299.4299.2	2.2141	0.1655	2641.92	5	2270.0%	1	K.EDCMQALSGQIFMGMVSSQYQAR.L
*	TK040203_NMyc_nuclei2_step11.2708.2708.3	1.9955	0.1262	3854.99	53	1170.0%	1	K.VLDFYQRACLSGYCSAFAYKPMNCTLSSQLNGK.C

O08826

64.1%

204

22449

7.7

(O08826) Axonemal dynein heavy chain (Fragment)

*	TK040203_NMyc_nuclei2_step12.1193.1193.3	1.7506	0.1073	2819.13	1	2100.0%	1	R.INIELLPVVPQKILSILSALSANLTR.F

TF20_MOUSE

64.1%

1983

215283

9.0

(Q9EPQ8) Transcription factor 20 (Stromelysin 1 PDGF-responsive element-binding protein) (SPRE-binding protein) (Nuclear factor SPBP)

	TK040203_NMyc_nuclei2_step05.3832.3832.1	0.5842	0.1041	590.39	47	3750.0%	1	K.RDSSK.D
*	TK040203_NMyc_nuclei2_step03.3967.3967.3	1.7021	0.1062	2762.9	10	2000.0%	1	R.ILQLLPQLSPTPSMMPSPNSHAAGFK.G
	TK040203_NMyc_nuclei2_step12.1905.1905.2	1.7514	0.3539	2613.36	3	2250.0%	1	R.YHYPCAIDADCLLHEENFSVR.C
*	TK040203_NMyc_nuclei2_step01.2512.2512.1	1.5198	0.0682	1126.65	13	4440.0%	1	R.VMQYTNAATK.I

Q9BU47

64.0%

321

34958

4.6

(Q9BU47) Hypothetical protein

*	TK040203_NMyc_nuclei2_step01.0950.0950.3	2.56	0.3487	2138.07	1	2880.0%	1	R.RAALGLLPLLLLLPPAPEAAK.K
*	TK040203_NMyc_nuclei2_step01.4491.4491.3	1.4839	0.0285	4519.05	2	1280.0%	1	K.VCCSPGTYGPDCLACQGGSQRPCSGNGHCSGDGSRQGDGSCR.C

Q9JKV0

64.0%

710

76964

6.9

(Q9JKV0) MJAM

	TK040203_NMyc_nuclei2_step04.3018.3018.3	2.224	0.0426	3421.43	6	1610.0%	2	R.FNLQSADVGVIASSFEIGNLALILFVSYFGAR.G

IL4R_MOUSE

64.0%

810

87627

5.1

(P16382) Interleukin-4 receptor alpha chain precursor (IL-4R-alpha)

*	TK040203_NMyc_nuclei2_step09.2270.2270.3	2.3005	0.1269	3289.55	7	1720.0%	2	K.QGAAQDPGVPGVRPSGDPGYKAFSSLLSSNGIR.G
*	TK040203_NMyc_nuclei2_step02.3351.3351.1	0.81	0.0328	664.19	11	4000.0%	1	K.GGDWVK.A

Q99540

64.0%

454

49336

5.0

(Q99540) Ligase-like protein

*	TK040203_NMyc_nuclei2_step10.2693.2693.2	1.0557	0.0536	2059.8	63	2110.0%	1	R.EADGLEPFANPRNAAAGSLR.Q
*	TK040203_NMyc_nuclei2_step06.2182.2182.1	1.6209	0.1481	1463.69	1	4230.0%	1	K.IDGLAVALTYVDGR.L

FK79_HUMAN

64.0%

13.5%

333

38503

8.4

(Q9BXC1) Putative P2Y purinoceptor FKSG79

*	TK040203_NMyc_nuclei2_step11.2571.2571.1	1.5225	0.0701	1410.59	60	3640.0%	6	K.YPMAQDLGEKQK.A
*	TK040203_NMyc_nuclei2_step02.3471.3471.3	1.7106	0.0417	3922.49	8	1560.0%	1	R.VILIFHSVALCLASLNSCLDPVIYYFSTNEFRR.R

Q9BRG0

63.9%

32.1%

542

58058

5.8

(Q9BRG0) Hypothetical protein (Fragment)

*	TK040203_NMyc_nuclei2_step11.4479.4479.2	1.7701	0.2197	3091.82	1	1830.0%	1	R.AQGPDGGLTASTYSYLGGFDSSSNVLAGQLR.G
*	TK040203_NMyc_nuclei2_step01.1399.1399.1	1.6255	0.0621	1586.68	5	3850.0%	3	R.LDSGDLLQQAQEIR.K
*	TK040203_NMyc_nuclei2_step09.2519.2519.3	1.6484	0.1348	3993.5	59	1000.0%	1	K.AQVWLEQVCAHLGLGVQEPHPGERAAFVAYALAFPR.A
*	TK040203_NMyc_nuclei2_step05.2584.2584.3	1.7604	0.2447	3501.01	5	1610.0%	1	R.AFQGLLDTYSVWRSGLPNFLAVALALGELGYR.A
*	TK040203_NMyc_nuclei2_step08.3189.3189.2	1.2871	0.0174	3141.54	5	1850.0%	1	R.LCLQQGQLCEPLPSLAESRALAQLSLSR.L
*	TK040203_NMyc_nuclei2_step02.1339.1339.1	0.8734	0.0548	898.6	2	7500.0%	1	K.LVAVGGQPR.M
*	TK040203_NMyc_nuclei2_step09.3427.3427.2	1.7722	0.2082	2669.51	1	2390.0%	5	R.AAARPLLTDLYQATMALGYWRAGR.A

Q9ULU7

63.8%

1048

119791

5.7

(Q9ULU7) Hypothetical protein KIAA1122 (Fragment)

*	TK040203_NMyc_nuclei2_step08.3248.3248.3	1.8238	0.1389	4633.64	3	1340.0%	1	K.QVTMLTGNGGGWNIEQPSILNQSLSLKPYQKVGLNWLALVHK.H
*	TK040203_NMyc_nuclei2_step06.3263.3263.2	2.1523	0.2439	2997.22	1	2690.0%	1	K.TFNKDTVIIVSEPSEDEESQGLPTMAR.R

CO1B_MOUSE

63.8%

484

53912

5.8

(Q9WUM3) Coronin 1B (Coronin 2)

	TK040203_NMyc_nuclei2_step03.3522.3522.2	1.8892	0.2933	2809.62	2	2080.0%	1	R.NVLLSAGCDNVVLIWNVGTAEELYR.L

BIRB_MOUSE

63.7%

1447

164034

6.5

(Q9QUK4) Baculoviral IAP repeat-containing protein 1b (Neuronal apoptosis inhibitory protein 2)

*	TK040203_NMyc_nuclei2_step02.2636.2636.2	1.0223	0.059	2241.59	168	1840.0%	1	R.FQLVFYLSLSSITPGQELAK.I
*	TK040203_NMyc_nuclei2_step10.2940.2940.2	1.5195	0.1566	2091.59	1	3440.0%	2	R.LTVHWRWVVPFSPVIQK.-
*	TK040203_NMyc_nuclei2_step04.2378.2378.2	0.9797	0.1466	1601.06	75	2920.0%	1	K.EFPFYNTVSVLRK.L
*	TK040203_NMyc_nuclei2_step05.2719.2719.2	1.3785	0.2045	3086.39	2	1540.0%	1	K.VQPPTIDQDYAIAFQPINEVQKNLSEK.K

Q96MP4

63.7%

21.6%

707

81466

6.2

(Q96MP4) Hypothetical protein FLJ32091

*	TK040203_NMyc_nuclei2_step09.1329.1329.1	1.2709	0.0136	993.61	19	5000.0%	1	K.ESEADSEVK.H
*	TK040203_NMyc_nuclei2_step03.3614.3614.3	1.7879	0.1157	4219.06	80	970.0%	1	K.VNGELWDLDCPLEGDSSLELLTFDNEKVNTATTTVYR.C
*	TK040203_NMyc_nuclei2_step02.3706.3706.3	2.0184	0.0304	4400.6	21	1070.0%	2	R.DFTEVLSPNMYNSKLWEASGHWQHYSENMFTFEIEK.D
*	TK040203_NMyc_nuclei2_step02.3516.3516.3	1.5648	0.1222	4696.73	1	1310.0%	1	R.QVMVIPVGPTCEKYALQVSSEFFEEGFMADVDLDHSCTLNK.K
*	TK040203_NMyc_nuclei2_step12.2793.2793.2	1.8683	0.298	2446.96	1	2270.0%	1	K.GDTSNIITVRAADGQTVQGEVWK.T
*	TK040203_NMyc_nuclei2_step04.1246.1246.1	1.1424	0.1097	883.45	5	6670.0%	1	K.HQPIFIK.E

Q8R1U1

63.7%

785

88661

5.1

(Q8R1U1) Hypothetical 88.7 kDa protein

*	TK040203_NMyc_nuclei2_step02.3003.3003.3	2.034	0.0994	2971.79	16	1800.0%	1	R.ALSSSNIDCLCAMINLATRELEADFR.D
	TK040203_NMyc_nuclei2_step07.2264.2264.1	1.5259	0.1661	1187.65	3	5000.0%	3	K.QEHQKCLDK.L

Q9D1N7

63.6%

286

31444

5.2

(Q9D1N7) 1110002E17Rik protein

	TK040203_NMyc_nuclei2_step07.1370.1370.1	1.4589	0.1998	1395.62	2	4500.0%	1	K.DLLIFRACCLL.-

Q9CYY7

63.5%

22.6%

226

25242

8.8

(Q9CYY7) 2310042G06Rik protein

	TK040203_NMyc_nuclei2_step05.2730.2730.2	1.5419	0.0837	2595.69	15	2170.0%	1	K.YPNPMNPSVVGVDVLDRHVDPSGK.L
	TK040203_NMyc_nuclei2_step12.3457.3457.3	2.9196	0.1655	3149.49	2	2120.0%	1	K.STNISFTNMVSVDERLTYKPHLQDPEK.T

Q8VGP3

63.5%

33.2%

304

34001

8.8

(Q8VGP3) Olfactory receptor MOR227-1

*	TK040203_NMyc_nuclei2_step03.2835.2835.3	1.7317	0.2148	4400.5	24	1090.0%	1	K.LACTDTFVESVIVMANSGLIALCSFLVLVSSYVIILVNLR.K
*	TK040203_NMyc_nuclei2_step04.4223.4223.3	1.8648	0.0918	3936.72	20	1320.0%	1	R.KALSTCASHITVVVLFFGPAIFLYMRPSSTFTEDK.L
	TK040203_NMyc_nuclei2_step09.3513.3513.2	2.2053	0.1186	2983.25	1	1800.0%	7	K.LVAVFYTVITPMLNPIIYTLRNAEVK.N

RCQ4_HUMAN

63.4%

1208

133077

8.1

(O94761) ATP-dependent DNA helicase Q4 (RecQ protein-like 4)

*	TK040203_NMyc_nuclei2_step09.3175.3175.3	2.4079	0.0416	3100.19	1	1940.0%	2	R.RSPCLTLVVSPLLSLMDDQVSGLPPCLK.A
*	TK040203_NMyc_nuclei2_step09.2995.2995.2	1.2076	0.0444	2741.71	5	2080.0%	1	R.YFEEEEGQEPGGMEDAQGPEPGQAR.L

Q9D5G5

63.4%

473

53376

6.4

(Q9D5G5) 4930443G12Rik protein

*	TK040203_NMyc_nuclei2_step01.1870.1870.1	1.864	0.0838	1573.66	4	4230.0%	1	K.LLSFDGDHLGVLQR.F

Q9JHC1

63.4%

1077

116311

4.8

(Q9JHC1) Formin binding protein 30

*	TK040203_NMyc_nuclei2_step10.1372.1372.1	1.1173	0.0374	1038.6	97	4440.0%	1	K.ERTTAASSSK.S
	TK040203_NMyc_nuclei2_step09.1719.1719.1	1.8545	0.085	1144.68	5	5000.0%	1	R.KLQDAAEQLK.Q
*	TK040203_NMyc_nuclei2_step08.3195.3195.2	1.3339	0.0030	2560.6	4	2500.0%	1	R.QSISNFHMLLLQTETRIADWR.E

Q9DBY6

63.4%

24.8%

407

44654

8.5

(Q9DBY6) 1200009K13Rik protein

	TK040203_NMyc_nuclei2_step05.2342.2342.2	1.5335	0.1205	2112.13	1	2940.0%	1	K.SKSEEAHAEDSVMDHHFR.K
	TK040203_NMyc_nuclei2_step12.2159.2159.2	1.24	0.0209	1750.04	15	2670.0%	1	R.HSGSDRSSFSHYSGLK.H
	TK040203_NMyc_nuclei2_step09.1601.1601.1	1.6162	0.0803	1342.56	2	5000.0%	1	K.RGGSGSHNWGTVK.D
	TK040203_NMyc_nuclei2_step03.1634.1634.1	1.846	0.0866	1177.64	3	5620.0%	3	R.RFEKPLEEK.G
	TK040203_NMyc_nuclei2_step05.1936.1936.1	1.7753	0.0436	1515.64	1	4580.0%	2	K.ENEVEEVKEEGPK.E
*	TK040203_NMyc_nuclei2_step06.3195.3195.3	2.1127	0.1912	4597.28	43	1090.0%	1	K.QISYNCSDLDQSNVTEETPEGEEHPVADTENKENEVEEVK.E

O75878

63.4%

410

46002

9.8

(O75878) Cytochrome oxidase assembly factor

	TK040203_NMyc_nuclei2_step10.2136.2136.2	2.2028	0.0267	1970.06	2	3240.0%	1	R.ILGITSVTAITVLYFLSR.R

Q9NVH9

63.4%

493

57298

7.1

(Q9NVH9) Hypothetical protein FLJ10724

*	TK040203_NMyc_nuclei2_step09.3519.3519.2	2.2025	0.0684	2739.15	1	2730.0%	1	R.EHEEELDQEFELETDTLFGGLKK.D
*	TK040203_NMyc_nuclei2_step10.2000.2000.1	1.1536	0.0508	1231.63	7	4090.0%	2	K.ASLCVLALGLGR.L

Y918_HUMAN

63.4%

966

108297

7.1

(O94991) Hypothetical protein KIAA0918 (Fragment)

*	TK040203_NMyc_nuclei2_step06.2911.2911.2	2.2134	0.1855	2514.74	6	2500.0%	1	K.DGILTVSCENRGIISLSEISPPR.F

DBP_MOUSE

63.4%

325

34428

9.4

(Q60925) D-site-binding protein (Albumin D box-binding protein)

*	TK040203_NMyc_nuclei2_step05.2596.2596.3	2.3202	0.1717	2916.64	7	1640.0%	1	K.ATLPTAPVPGPGLETAGPADAPSGAVSGGGSPR.G
*	TK040203_NMyc_nuclei2_step10.3499.3499.2	2.0852	0.0904	3039.72	9	1610.0%	6	-.MARPLSDRTPGPLLLGGPAGAPPGGGALLGLR.S

Q9C0F1

63.4%

23.8%

391

44269

5.2

(Q9C0F1) Hypothetical protein KIAA1712 (Fragment)

*	TK040203_NMyc_nuclei2_step10.3564.3564.3	1.903	0.0898	4531.44	33	1060.0%	1	K.AVVIRHLYNEDNVDISEDTLSPITDVNEAVDVSDLNATEIK.M
*	TK040203_NMyc_nuclei2_step06.3350.3350.2	2.0911	0.1332	3040.04	1	2400.0%	3	K.VMVDENTWTNLLSRVTLLETEMLLSK.K
*	TK040203_NMyc_nuclei2_step10.2972.2972.2	1.0799	0.0035	2711.37	269	1200.0%	1	R.KSEVERPASIPLSSGYSTASSDSTPR.A

Q9EQD4

63.3%

514

55689

5.6

(Q9EQD4) IRA1

	TK040203_NMyc_nuclei2_step01.0850.0850.1	1.8092	0.089	1578.46	1	4580.0%	1	K.QDNCVHDLQAHNK.E

Q9D9X5

63.2%

746

82585

5.3

(Q9D9X5) 1700026A16Rik protein

*	TK040203_NMyc_nuclei2_step04.2521.2521.3	1.3197	0.0141	3556.39	43	1470.0%	1	R.EISPFSALPDSTFQQILMPDEDDEKDLCWK.K
	TK040203_NMyc_nuclei2_step09.4180.4180.1	1.1604	0.1464	1311.93	1	7000.0%	5	K.YPEGNSSWQIK.E
*	TK040203_NMyc_nuclei2_step12.2623.2623.3	1.6097	0.0574	4410.6	116	890.0%	1	K.AVDTSDLEVAEDPMGLQGIDLITAASLFCLGDSPGGRGISDSR.M

Q9BX57

62.8%

118

12716

11.7

(Q9BX57) DJ823N20.1.3 (V-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog, isoform 3) (Fragment)

*	TK040203_NMyc_nuclei2_step02.2618.2618.1	1.8295	0.0841	1592.34	4	4230.0%	1	R.LSTTQRETGGWPTR.S

SYEP_HUMAN

62.6%

1440

163026

7.7

(P07814) Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase (EC 6.1.1.17) (Glutamate--tRNA ligase); Prolyl-tRNA synthetase (EC 6.1.1.15) (Proline--tRNA ligase)]

*	TK040203_NMyc_nuclei2_step10.2469.2469.2	1.0651	0.1698	1878.48	108	2060.0%	1	R.GMTVEGLKQFIAAQGSSR.S
*	TK040203_NMyc_nuclei2_step01.0219.0219.1	1.7732	0.1037	1195.57	1	5560.0%	1	K.QLLSLKAEYK.E
*	TK040203_NMyc_nuclei2_step06.3347.3347.1	1.0306	0.013	920.82	167	5830.0%	1	K.YYTLFGR.S
*	TK040203_NMyc_nuclei2_step05.2056.2056.2	1.1619	0.123	2476.0	5	2250.0%	1	K.LGVENCYFPMFVSQSALEKEK.T

GBB1_HUMAN

62.6%

340

37377

6.0

(P04901) Guanine nucleotide-binding protein G(I)/G(S)/G(T) beta subunit 1 (Transducin beta chain 1) (P04901) Guanine nucleotide-binding protein G(I)/G(S)/G(T) beta subunit 1 (Transducin beta chain 1)

	TK040203_NMyc_nuclei2_step02.1724.1724.1	1.3573	0.3663	805.87	2	5830.0%	1	K.VHAIPLR.S

IM44_MOUSE

62.5%

452

51176

8.3

(O35857) Import inner membrane translocase subunit TIM44, mitochondrial precursor

*	TK040203_NMyc_nuclei2_step04.1890.1890.1	1.5923	0.1545	908.35	1	6430.0%	1	K.ESLDEVSK.S

CPCI_HUMAN

62.5%

490

55741

7.2

(P33260) Cytochrome P450 2C18 (EC 1.14.14.1) (CYPIIC18) (P450-6B/29C)

*	TK040203_NMyc_nuclei2_step01.2564.2564.1	1.8763	0.0336	894.57	1	8330.0%	1	R.FLNLMEK.F
*	TK040203_NMyc_nuclei2_step03.2434.2434.3	1.487	0.059	2743.3	15	1930.0%	1	R.MELFLFLTTILQNFNLKSQVDPK.D

Q923H0

62.4%

563

64742

6.8

(Q923H0) F-box/WD40 repeat-containing protein HOS

	TK040203_NMyc_nuclei2_step11.2012.2012.2	1.3434	0.1223	2255.19	1	3160.0%	1	K.VWDLQAALDPRAPASTLCLR.T
	TK040203_NMyc_nuclei2_step03.2162.2162.1	1.4064	0.2593	1226.84	1	5620.0%	5	R.HNLQRIQCR.S
	TK040203_NMyc_nuclei2_step12.3047.3047.3	1.5665	0.0782	4160.47	6	1360.0%	1	K.TIELMCSVPRSLWLGCANLVESMCALSCLQSMPSVR.C
	TK040203_NMyc_nuclei2_step05.1539.1539.3	1.3111	0.1376	2108.23	25	2790.0%	1	K.NRPTDGPPNSFYRSLYPK.I

Q9D4X0

62.2%

460

52242

7.7

(Q9D4X0) 4930547K17Rik protein

	TK040203_NMyc_nuclei2_step02.1975.1975.2	2.0578	0.271	1511.33	3	4550.0%	1	K.VRAPLSQLYFCR.Y

Q9H252

62.1%

994

109925

7.0

(Q9H252) Eag-related gene member 2

*	TK040203_NMyc_nuclei2_step01.1169.1169.1	1.5777	0.1996	1523.65	11	3210.0%	3	R.YNGSDPASGPSVQDK.Y
*	TK040203_NMyc_nuclei2_step04.2354.2354.3	1.158	0.1449	3421.76	82	1290.0%	1	R.GACSYTCSPLTVVDLIVDIMFVVDIVINFR.T

CG96_HUMAN

62.1%

28.5%

323

35897

9.8

(Q9Y3A4) Hypothetical protein CGI-96 (BK126B4.3)

*	TK040203_NMyc_nuclei2_step04.3465.3465.3	2.1288	0.0436	4574.7	3	1190.0%	1	K.FFHPKPVPGFQVAYVVFQKPSGVSAALALKGPLLVSTESHPVK.S
*	TK040203_NMyc_nuclei2_step04.1254.1254.3	1.2866	0.1274	1836.05	45	2670.0%	1	K.WISDYADSVPDPEALR.V
*	TK040203_NMyc_nuclei2_step02.2855.2855.2	0.9977	0.0338	2124.49	3	3240.0%	1	R.TLFVLNVPPYCTEESLSR.L
*	TK040203_NMyc_nuclei2_step01.3866.3866.1	1.8769	0.0729	1491.59	10	3210.0%	1	R.LAASREQDGASSAAR.K

RGSB_MOUSE

62.1%

438

50431

7.2

(Q9Z2H1) Regulator of G-protein signaling 11 (RGS11) (Fragment)

*	TK040203_NMyc_nuclei2_step01.1842.1842.1	1.7408	0.1058	1571.74	1	4620.0%	1	K.GLLEEAVIPLETKR.W
*	TK040203_NMyc_nuclei2_step11.2422.2422.1	1.1874	0.0143	1318.58	18	3460.0%	1	R.EPAATSSPEGADGE.-

PLSI_HUMAN

62.1%

629

70353

5.5

(Q14651) I-plastin (Intestine-specific plastin)

*	TK040203_NMyc_nuclei2_step05.2879.2879.3	1.5063	0.0327	3406.7	44	1330.0%	1	K.LTPFTISENLNLALNSASAIGCTVVNIGASDLK.E
*	TK040203_NMyc_nuclei2_step03.1986.1986.2	1.7531	0.0157	1696.87	5	4290.0%	1	R.RYTLNVLSDLGEGEK.V
*	TK040203_NMyc_nuclei2_step01.3167.3167.1	1.4702	0.167	1546.71	8	3460.0%	6	R.EIVEKILSVADSNK.D

ANX6_MOUSE

62.1%

672

75755

5.5

(P14824) Annexin VI (Lipocortin VI) (P68) (P70) (Protein III) (Chromobindin 20) (67 kDa calelectrin) (Calphobindin-II) (CPB-II)

	TK040203_NMyc_nuclei2_step01.2938.2938.1	1.7402	0.1097	1160.74	2	6110.0%	1	K.ESILELITSR.S
*	TK040203_NMyc_nuclei2_step03.1998.1998.1	2.0318	0.0443	1359.69	11	4500.0%	1	K.KTNYDIEHVIK.K
	TK040203_NMyc_nuclei2_step03.1546.1546.1	1.1373	0.0909	773.58	8	6000.0%	3	R.SYPHLR.R

Q8R504

62.1%

28.1%

171

18980

8.4

(Q8R504) Na+/Ca2+ exchanger NCX2 isoform (Fragment)

	TK040203_NMyc_nuclei2_step01.3146.3146.1	1.6522	0.129	1252.74	3	4170.0%	1	R.SGIIIGAEGDPPK.S
*	TK040203_NMyc_nuclei2_step09.1205.1205.1	0.8341	0.0148	712.43	37	4170.0%	1	R.HAADAAR.R
*	TK040203_NMyc_nuclei2_step07.2789.2789.3	2.1028	0.1425	3981.36	48	1000.0%	1	R.SGIIIGAEGDPPKSIELDGTFVGTEVPGELGALGTGPAEAR.E

O75145

62.1%

1267

141143

6.1

(O75145) Hypothetical protein KIAA0654 (Fragment)

*	TK040203_NMyc_nuclei2_step07.2294.2294.2	1.34	0.033	1929.33	4	2220.0%	1	K.LQPEGQTSGSSRADGVSVR.T
*	TK040203_NMyc_nuclei2_step08.3255.3255.2	1.2265	0.0357	2214.94	84	1750.0%	1	K.LRLAIQEMVSLTSPSAPASSR.T
*	TK040203_NMyc_nuclei2_step11.2099.2099.2	1.3314	0.1258	2245.45	4	2270.0%	1	R.DSSSLAGTPSDETLATDPLGLAK.L
*	TK040203_NMyc_nuclei2_step11.4443.4443.3	1.9425	0.1463	4773.65	16	940.0%	1	K.HELLEEACRQGLPFAAWDGPTVVSWLELWVGMPAWYVAACR.A
*	TK040203_NMyc_nuclei2_step03.1526.1526.1	1.7601	0.0025	1571.63	2	3850.0%	2	K.AETLPEIEAQLAQR.V
*	TK040203_NMyc_nuclei2_step05.1570.1570.1	0.8589	0.0364	1044.6	5	5560.0%	1	R.SLPGSALELR.Y

Q15751

62.0%

4861

532192

6.0

(Q15751) P532

*	TK040203_NMyc_nuclei2_step05.3410.3410.3	1.7897	0.0604	4495.01	186	990.0%	1	K.TPLFSDGVEMDTPQLDKCMSCLLEVALSGNEEQKPFDYK.L
*	TK040203_NMyc_nuclei2_step07.2789.2789.2	1.3722	0.1046	2654.57	13	2170.0%	1	K.VLAENGHNSDCASSPVVHEDVEMR.A
*	TK040203_NMyc_nuclei2_step03.1449.1449.3	1.5728	0.0203	2827.77	74	1850.0%	1	K.GKLLSSQEGMISFDCFMTILMQMR.R
*	TK040203_NMyc_nuclei2_step10.2069.2069.2	1.1802	0.0069	1597.42	350	2500.0%	1	K.CVYQLRGHITPVR.T
*	TK040203_NMyc_nuclei2_step01.4543.4543.3	2.2061	0.0623	4462.66	4	1220.0%	1	R.CLGGMLQGSPVSPEEQDTAYWMKTPLFSDGVEMDTPQLDK.C
*	TK040203_NMyc_nuclei2_step08.1553.1553.3	1.9292	0.0191	2584.7	5	2160.0%	1	R.CLGGMLQGSPVSPEEQDTAYWMK.T
*	TK040203_NMyc_nuclei2_step03.3805.3805.2	1.2528	0.0784	2842.8	2	2120.0%	1	R.GIAEENKLVTSPNFVVTQALVALLADK.G
*	TK040203_NMyc_nuclei2_step12.2525.2525.2	1.8213	0.2883	2880.79	5	2040.0%	1	K.KVSGLDGIAIQQISAGTSHSLAWTALPR.D

Q96A55

61.9%

336

39155

7.3

(Q96A55) Hypothetical protein

*	TK040203_NMyc_nuclei2_step01.2403.2403.1	1.4818	0.1781	1514.8	3	3330.0%	1	R.LFLAGYELTPTMR.D

NEST_HUMAN

61.9%

1618

176705

4.4

(P48681) Nestin

*	TK040203_NMyc_nuclei2_step08.2600.2600.2	1.136	0.0565	2877.97	11	1670.0%	1	K.GEYQESLRSLEEEGQELPQSADVQR.W
	TK040203_NMyc_nuclei2_step05.1686.1686.3	2.6274	0.2613	2882.96	2	2020.0%	1	K.TALETESQDSAEPSGSEEESDPVSLER.E
*	TK040203_NMyc_nuclei2_step01.0632.0632.1	1.2355	0.0311	838.53	12	5830.0%	1	R.QQLAHLK.M
	TK040203_NMyc_nuclei2_step07.3756.3756.1	0.4076	0.0081	646.51	18	1000.0%	1	R.GGLLER.R

Q99986

61.9%

396

45476

8.9

(Q99986) VRK1

*	TK040203_NMyc_nuclei2_step06.1342.1342.3	2.6203	0.2825	3386.48	1	1800.0%	1	K.VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVK.V
*	TK040203_NMyc_nuclei2_step07.3350.3350.1	1.2278	0.0212	1445.45	6	3460.0%	1	K.LDLSVVENGGLKAK.T

O95850

61.9%

2253

255447

9.1

(O95850) Polycystic kidney disease and receptor for egg jelly related protein

*	TK040203_NMyc_nuclei2_step08.3337.3337.2	1.5993	0.019	1695.66	2	4230.0%	1	K.MCLPAEKFVQNSIR.R
*	TK040203_NMyc_nuclei2_step11.2660.2660.3	2.557	0.2588	3638.11	24	1290.0%	1	R.AIAQYWQVFSVPAVGQAPDWTQPLDLPQLEIR.N
*	TK040203_NMyc_nuclei2_step01.4031.4031.2	1.4021	0.1171	2704.1	7	2140.0%	1	K.LVRISIFSVQCLDMYGIQSEWR.E
*	TK040203_NMyc_nuclei2_step07.3498.3498.3	2.6344	0.2994	4545.77	1	1540.0%	2	K.HLIDQSFLLPVSTLVEIGQVVMTITKLTQKPSEFTWDAQK.R

Q9Y3T6

61.9%

450

50018

6.0

(Q9Y3T6) Hypothetical protein (Fragment)

*	TK040203_NMyc_nuclei2_step08.3471.3471.3	2.6442	0.2872	4503.79	1	1380.0%	1	R.LVAEEEEDEEEVEEDGPSSCSEDDYSELLQEITDNLTKK.E
*	TK040203_NMyc_nuclei2_step09.3505.3505.3	1.7932	0.0898	4530.9	23	1120.0%	1	K.RLVAEEEEDEEEVEEDGPSSCSEDDYSELLQEITDNLTK.K

Q9H8V4

61.9%

216

25464

8.4

(Q9H8V4) Hypothetical protein FLJ13204

*	TK040203_NMyc_nuclei2_step01.3683.3683.3	2.64	0.2781	4403.35	3	1280.0%	1	K.KPTALPAPQYMNLLMDWIEVQINNEEIFPTCVGVPFPK.N

Q9EQ40

61.9%

299

34603

9.3

(Q9EQ40) Vomeronasal receptor V1RC3

*	TK040203_NMyc_nuclei2_step03.3533.3533.3	2.6303	0.2553	4382.38	1	1390.0%	1	K.YTINAFFYIWSFNLSFSSNLIFYVGAYTNVSETNQMK.V

Q8WZ75

61.9%

1007

107457

6.6

(Q8WZ75) Magic roundabout

	TK040203_NMyc_nuclei2_step01.2478.2478.3	1.7569	0.2239	3807.43	2	1600.0%	1	R.SPGVPLLPDTSTFYGSLIAELPSSTPARPSPQVPAVR.R
*	TK040203_NMyc_nuclei2_step11.2700.2700.3	2.6146	0.2792	4406.54	1	1250.0%	1	R.TGGGVGPKGGVLLCPPRPCLTPTPSEGSLANGWGSASEDNAASAR.A
*	TK040203_NMyc_nuclei2_step03.3093.3093.3	1.5236	0.0926	3755.74	1	1460.0%	1	K.GGVLLCPPRPCLTPTPSEGSLANGWGSASEDNAASAR.A
	TK040203_NMyc_nuclei2_step04.2114.2114.3	1.5987	0.0274	4754.87	29	970.0%	1	R.SLLSWDSRSPGVPLLPDTSTFYGSLIAELPSSTPARPSPQVPAVR.R

Q9UPF6

61.9%

12.1%

512

55172

8.4

(Q9UPF6) CD3e-associated protein

	TK040203_NMyc_nuclei2_step06.2543.2543.3	2.6317	0.2934	3420.97	1	1770.0%	1	K.QQDATVEPETEVVGPELPDDLEPQAAPTSTKK.K
	TK040203_NMyc_nuclei2_step03.3463.3463.3	2.4629	0.0418	3095.74	12	1640.0%	1	K.EPEAAGPVGTEPTVETLEPLGVLFPSTTKK.R

I17S_MOUSE

61.9%

499

55617

7.6

(Q9JIP3) Interleukin-17B receptor precursor (IL-17B receptor) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (IL-17ER)

*	TK040203_NMyc_nuclei2_step09.3946.3946.1	0.6873	0.0043	663.58	65	3000.0%	1	K.ICVSGK.N
*	TK040203_NMyc_nuclei2_step06.3095.3095.3	2.6125	0.2668	3818.07	2	1590.0%	1	K.LMRTSVAIPVTEESEGAVVQLTPYLHTCGNDCIR.R

RSG2_HUMAN

61.8%

849

96527

7.2

(Q15283) Ras GTPase-activating protein 2 (GAP1m)

*	TK040203_NMyc_nuclei2_step01.2460.2460.1	1.2566	0.0424	1441.37	3	4550.0%	1	K.SIIEKLDEPHEK.Y
*	TK040203_NMyc_nuclei2_step08.1971.1971.1	1.2558	0.0084	1300.57	12	4000.0%	3	R.IYSLFTLSLLK.L
*	TK040203_NMyc_nuclei2_step09.3582.3582.2	1.5726	0.0040	2233.16	30	2220.0%	1	R.TDSSHQAWYLLQPRDNGNK.S

RSG2_MOUSE

61.8%

848

96472

7.6

(P58069) Ras GTPase-activating protein 2 (GAP1m)

*	TK040203_NMyc_nuclei2_step11.1424.1424.2	1.3272	0.1818	2480.07	9	2270.0%	1	K.SPDVQPVSASAAYILGEICQDQK.D
*	TK040203_NMyc_nuclei2_step08.1971.1971.1	1.2558	0.0084	1300.57	12	4000.0%	3	R.IYSIFTLSLLK.L

LMA3_HUMAN

61.8%

1713

189304

8.1

(Q16787) Laminin alpha-3 chain precursor (Epiligrin 170 kDa subunit) (E170) (Nicein alpha subunit)

*	TK040203_NMyc_nuclei2_step11.1744.1744.2	1.2802	0.178	2385.09	7	2370.0%	1	K.GCIELDDLNENVLSLYNFKK.T
*	TK040203_NMyc_nuclei2_step07.2153.2153.2	1.6065	0.1256	2329.51	9	2500.0%	2	K.ANDITDEVLDGLNPIQTDVER.I
*	TK040203_NMyc_nuclei2_step04.2259.2259.3	1.9171	0.1039	2616.04	211	1630.0%	1	K.SQLQGLSASAGLLEQMRHMETQAK.D
*	TK040203_NMyc_nuclei2_step01.0362.0362.1	1.8619	0.0714	845.32	3	7500.0%	1	K.ELDVKIK.N

Q8VHR5

61.8%

594

65411

9.7

(Q8VHR5) Transcription repressor p66

	TK040203_NMyc_nuclei2_step06.3418.3418.1	1.7258	0.1102	1578.97	2	3850.0%	4	K.DLANLEVPHELPTK.Q

Q8R3S9

61.8%

503

58447

8.8

(Q8R3S9) Hypothetical 58.4 kDa protein (Fragment)

*	TK040203_NMyc_nuclei2_step02.1751.1751.1	1.7249	0.112	995.86	1	5620.0%	1	K.QIVSEYAGK.Q

Q99PL5

61.7%

2404

1605

172878

9.3

(Q99PL5) Ribosome binding protein 1 (Ribosome receptor protein) (RRp) (P180)

*	TK040203_NMyc_nuclei2_step09.3370.3370.3	1.2005	0.1005	1990.72	38	1620.0%	1	K.KGEPGPPDCDGPLFLPYK.T
	TK040203_NMyc_nuclei2_step02.1411.1411.1	0.9178	0.02	1172.67	65	3500.0%	1	K.KPEGTSNQGKK.G
*	TK040203_NMyc_nuclei2_step01.3304.3304.1	1.1104	0.0173	1313.5	10	3750.0%	49	K.EVPMVAVPPVGSK.A
*	TK040203_NMyc_nuclei2_step12.4202.4202.2	1.5151	0.068	2503.49	3	2380.0%	1	K.EEKPNGKIPEHDLDPNVTIILK.E

LMA5_MOUSE

61.7%

3718

404013

6.7

(Q61001) Laminin alpha-5 chain precursor

*	TK040203_NMyc_nuclei2_step08.2521.2521.2	1.1191	0.177	1805.39	291	2500.0%	1	K.DGFFGLDYADYFGCR.S
*	TK040203_NMyc_nuclei2_step10.1296.1296.1	0.9227	0.1148	877.52	20	5000.0%	1	R.RCQCPR.G
*	TK040203_NMyc_nuclei2_step04.4169.4169.2	1.7056	0.3282	2043.01	3	2940.0%	2	R.CKPGYWGLSASNPEGCTR.C
*	TK040203_NMyc_nuclei2_step04.4050.4050.3	1.0861	0.0425	3782.04	40	1210.0%	1	R.EEGKLSSCTNCTEQSQPVAFPPSTEPAFVTVPQR.G
*	TK040203_NMyc_nuclei2_step04.3416.3416.3	2.4119	0.0217	3040.43	38	1700.0%	1	K.DHYLPDLHHMRLELEEAATPEGHAVR.F
*	TK040203_NMyc_nuclei2_step04.2801.2801.3	2.0433	0.0613	3132.39	6	1790.0%	1	K.NQLAAQIQEAQAMLAMDTSETSEKIAHAK.A
*	TK040203_NMyc_nuclei2_step09.1257.1257.3	1.2613	0.2087	2435.49	12	2280.0%	1	R.KLLINGAPVNVTASVQIQGAVGMR.G
*	TK040203_NMyc_nuclei2_step04.2711.2711.3	1.5267	0.0616	3382.05	3	1520.0%	1	K.LLINGAPVNVTASVQIQGAVGMRGCPSGTLALSK.Q
*	TK040203_NMyc_nuclei2_step08.2349.2349.2	1.6341	0.1833	1866.53	1	4380.0%	1	R.CAPGFYGNALLPGNCTR.C
*	TK040203_NMyc_nuclei2_step08.1063.1063.1	0.6495	0.0053	679.51	19	5000.0%	1	R.RPPGPR.Y
*	TK040203_NMyc_nuclei2_step03.2834.2834.3	1.7203	0.1912	3810.66	7	1450.0%	1	R.VPEGRWLWLDYVLIVPEDAYSSSYLQEEPLDK.S
*	TK040203_NMyc_nuclei2_step11.4127.4127.3	1.8103	0.1488	4739.25	29	900.0%	1	R.RCDTCAPGFYGYPSCRPCDCHEAGTMASVCDPLTGQCHCK.E

Q9Z215

61.6%

358

39917

5.3

(Q9Z215) Homer-3 (Fragment)

*	TK040203_NMyc_nuclei2_step10.3091.3091.2	1.3189	0.0791	2304.68	93	1750.0%	1	R.ANTVYGLGFASEQQLTQFAEK.F
*	TK040203_NMyc_nuclei2_step03.1903.1903.1	1.5217	0.1592	1510.66	3	3460.0%	1	R.VAELEAQVAVEPVR.A

NP14_HUMAN

61.6%

699

73720

9.5

(Q14978) Nucleolar phosphoprotein p130 (Nucleolar 130 kDa protein) (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar and coiled-body phosphoprotein 1)

	TK040203_NMyc_nuclei2_step10.2263.2263.3	1.41	0.0971	2758.81	120	1760.0%	1	K.AAESSSDSSDSDSSEDDEAPSKPAGTTK.N
	TK040203_NMyc_nuclei2_step10.1932.1932.2	0.9663	0.0135	2277.88	4	2250.0%	1	K.AESSNSSSSDDSSEEEEEKLK.G
	TK040203_NMyc_nuclei2_step06.2507.2507.2	1.7603	0.3127	2969.28	3	1920.0%	1	K.QQPVESSEDSSDESDSSSEEEKKPPTK.A

EHD2_HUMAN

61.6%

543

61106

6.4

(Q9NZN4) EH-domain containing protein 2

	TK040203_NMyc_nuclei2_step02.3591.3591.2	1.9335	0.2826	2924.01	2	1920.0%	2	R.QEELESTEVGVQGGAFEGTHMGPFVER.G

Q9CYN6

61.5%

711

80852

7.2

(Q9CYN6) 5730405E07Rik protein

*	TK040203_NMyc_nuclei2_step06.3081.3081.2	1.7751	0.1152	2340.14	1	4000.0%	2	K.EDGSYQLPVVVLMLNLPHASR.D
*	TK040203_NMyc_nuclei2_step06.1463.1463.1	1.4487	0.1351	1009.53	5	6250.0%	1	K.IGHPDPAFR.E

CAD2_HUMAN

61.4%

906

99851

4.8

(P19022) Neural-cadherin precursor (N-cadherin) (Cadherin-2)

*	TK040203_NMyc_nuclei2_step05.3367.3367.2	2.2012	0.0843	3107.05	3	1900.0%	3	R.IAGALRTLLPLLLALLQASVEASGEIALCK.T
*	TK040203_NMyc_nuclei2_step10.2833.2833.3	1.6149	0.0356	4606.62	11	1100.0%	1	R.FAIQTDPNSNDGLVTVVKPIDFETNRMFVLTVAAENQVPLAK.G

M3K2_HUMAN

61.4%

618

69538

8.3

(Q9Y2U5) Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.1.-) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2)

*	TK040203_NMyc_nuclei2_step03.3571.3571.2	2.1191	0.2337	1865.42	3	3120.0%	1	R.SSPPPGYIPDELHQVAR.N
*	TK040203_NMyc_nuclei2_step02.3926.3926.3	1.9813	0.1724	4006.51	1	1910.0%	1	K.IAFGQSMDLHYTNNELVIPLTTQDDLDKALELLDR.S
*	TK040203_NMyc_nuclei2_step11.2307.2307.2	1.9213	0.2792	2482.66	1	2890.0%	7	K.YTRQILEGVHYLHSNMILHR.D

Q9CTH6

61.4%

195

23024

9.6

(Q9CTH6) 1110008B24Rik protein (Fragment)

	TK040203_NMyc_nuclei2_step07.2078.2078.1	1.155	0.0598	1297.92	3	4500.0%	4	K.GTYADDCLVQR.V

AOC3_HUMAN

61.3%

763

84622

6.5

(Q16853) Membrane copper amine oxidase (EC 1.4.3.6) (Vascular adhesion protein-1) (VAP-1) (HPAO)

*	TK040203_NMyc_nuclei2_step06.1777.1777.2	1.1275	0.0067	1816.14	8	2810.0%	1	R.NLVTMTTAPRGLQSGDR.A
*	TK040203_NMyc_nuclei2_step12.3975.3975.3	1.1373	0.0055	2168.19	471	1910.0%	1	K.TIRDAFCVFEQNQGLPLR.R
*	TK040203_NMyc_nuclei2_step12.4207.4207.3	1.5316	0.0207	3899.75	16	1250.0%	2	R.LGPGLVDAAQARPSDNCVFSVELQLPPKAAALAHLDR.G
*	TK040203_NMyc_nuclei2_step08.3595.3595.2	1.791	0.0303	2982.98	6	1480.0%	3	R.LGPGLVDAAQARPSDNCVFSVELQLPPK.A
*	TK040203_NMyc_nuclei2_step05.2662.2662.3	1.8844	0.2065	3773.29	1	1820.0%	1	K.EEEPSSSSVFNQNDPWAPTVDFSDFINNETIAGK.D

CAG2_MOUSE

61.3%

147

533

59212

8.6

(Q09200) Beta-1,4 N-acetylgalactosaminyltransferase (EC 2.4.1.92) ((N-acetylneuraminyl)-galactosylglucosylceramide) (GM2/GD2 synthase) (GalNAc-T)

*	TK040203_NMyc_nuclei2_step05.3078.3078.3	2.7506	0.1049	2226.23	5	2640.0%	1	R.RFYPTVTIVIADDSDKPER.I
*	TK040203_NMyc_nuclei2_step01.0937.0937.1	1.1726	0.0794	1031.01	80	4380.0%	1	R.QVRAVDLTK.A
*	TK040203_NMyc_nuclei2_step09.2499.2499.2	1.4323	0.0051	2957.89	4	1920.0%	1	R.EISGYATTYRQLLSVEPGAPGLGNCFR.Q

PLD1_MOUSE

61.3%

1074

123969

8.7

(Q9Z280) Phospholipase D1 (EC 3.1.4.4) (PLD 1) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1) (mPLD1)

	TK040203_NMyc_nuclei2_step03.1247.1247.1	0.9751	0.0198	625.54	63	6250.0%	1	R.YSTPR.M
*	TK040203_NMyc_nuclei2_step11.4031.4031.2	1.3609	0.0090	3158.32	2	1730.0%	5	R.FTSTSRVPSINLYTIELTHGEFTWQVK.R
*	TK040203_NMyc_nuclei2_step11.4191.4191.2	1.103	0.0595	3151.41	1	1730.0%	1	R.GESSILEQLKPELGNKWINYISFCGLR.T
	TK040203_NMyc_nuclei2_step07.1208.1208.1	0.9444	0.0337	1228.44	6	3330.0%	1	R.NATIYDKVFR.C
*	TK040203_NMyc_nuclei2_step01.4238.4238.2	1.3899	0.254	3099.93	3	1850.0%	1	R.SAADWSAGIKHHEESIHAAYIHVIENSK.H

Q9ULG5

61.2%

954

103414

6.2

(Q9ULG5) Hypothetical protein KIAA1255 (Fragment)

*	TK040203_NMyc_nuclei2_step07.1420.1420.3	2.9143	0.146	2538.33	1	2980.0%	1	R.TPLHVSIMAGNEYVFSQLLQCK.Q

O88313

61.2%

348

38320

7.0

(O88313) G-protein coupled receptor

*	TK040203_NMyc_nuclei2_step08.2020.2020.1	1.8204	0.07	1155.76	1	5560.0%	2	R.GPPGRKPECR.A

PIXB_MOUSE

61.2%

705

79832

6.9

(Q9ES28) Rho guanine nucleotide exchange factor 7 (PAK-interacting exchange factor beta) (Beta-Pix) (p85SPR)

*	TK040203_NMyc_nuclei2_step07.3658.3658.3	2.9174	0.1401	3515.57	1	2000.0%	1	R.TLYLAYCANHPSAVSVLTEHSEDLGEFMETK.G
	TK040203_NMyc_nuclei2_step02.1888.1888.2	1.3268	0.0787	1467.55	47	3330.0%	1	K.ESAPQVLLPEEEK.I
	TK040203_NMyc_nuclei2_step08.0414.0414.1	0.3245	0.0129	428.5	4	1670.0%	1	K.SPPK.G

Q9NYR8

61.2%

311

33755

8.4

(Q9NYR8) Photoreceptor outer segment all-trans retinol dehydrogenase

*	TK040203_NMyc_nuclei2_step06.3442.3442.3	2.8849	0.1239	3063.28	1	1900.0%	1	-.MAAAPRTVLISGCSSGIGLELAVQLAHDPK.K
*	TK040203_NMyc_nuclei2_step04.1966.1966.1	1.1026	0.0567	1121.57	114	3750.0%	1	K.RYQVVATMR.D

GDIA_MOUSE

61.1%

106

447

50527

5.1

(P50396) Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (GDI-1)

*	TK040203_NMyc_nuclei2_step09.1501.1501.1	1.2641	0.0714	1123.49	1	6110.0%	1	K.QNDVFGEADQ.-
	TK040203_NMyc_nuclei2_step12.3707.3707.3	2.4026	0.1577	3109.33	84	1440.0%	2	K.FLVFVANFDENDPKTFEGVDPQTTSMR.D
*	TK040203_NMyc_nuclei2_step09.2094.2094.3	1.9988	0.1375	3989.08	1	1290.0%	1	K.FDLGQDVIDFTGHALALYRTDDYLDQPCLETINR.I

Q9DAC9

61.1%

329

36411

8.9

(Q9DAC9) 1700013G10Rik protein

*	TK040203_NMyc_nuclei2_step05.3338.3338.2	1.4945	0.1193	2007.89	35	3000.0%	1	K.MWLEEVDEKNLLGICR.M
*	TK040203_NMyc_nuclei2_step04.3043.3043.3	1.8697	0.0393	3122.83	1	1750.0%	2	R.SSNVFPLSGNSGGGLEVDTPTWLSSQAATSR.L
*	TK040203_NMyc_nuclei2_step06.1501.1501.1	1.8548	0.0149	1565.7	1	4580.0%	1	R.FEAQQLSLANMWK.L

Y053_HUMAN

61.0%

638

72431

6.1

(P42331) Hypothetical protein KIAA0053

*	TK040203_NMyc_nuclei2_step07.2932.2932.3	1.8219	0.0572	3180.39	21	1670.0%	1	R.DLPEPVVPWSQYEGFLLCGQLTNADEAK.A
*	TK040203_NMyc_nuclei2_step09.1894.1894.1	1.8234	0.0504	1301.59	1	4550.0%	2	R.DTDVHTVASLLK.L
*	TK040203_NMyc_nuclei2_step01.2078.2078.1	1.3757	0.0236	1201.07	7	5000.0%	1	R.DHEVLFPKSK.D

Q9H7R5

61.0%

613

70228

9.3

(Q9H7R5) Hypothetical protein FLJ14345

*	TK040203_NMyc_nuclei2_step10.2700.2700.2	1.2951	0.015	2542.79	1	2620.0%	6	K.AFTVRSNLTIHQVIHTGEKPYK.C
*	TK040203_NMyc_nuclei2_step11.3918.3918.2	1.4874	0.1273	1754.8	11	3210.0%	1	K.LTTHQVIHTGEKPYK.C

P78311

61.0%

1224

135932

6.5

(P78311) mRNA, complete cds, clone:RES4-22A,

	TK040203_NMyc_nuclei2_step05.2524.2524.3	1.704	0.0119	3547.55	36	1330.0%	1	R.TEESKADSPPPSYPTQQAEQAPNTCECHVCK.Q
	TK040203_NMyc_nuclei2_step04.3003.3003.3	1.5299	0.0095	2845.82	15	1730.0%	1	R.HMNHSEPRPGLGADGDAADPVDTRDSK.F
	TK040203_NMyc_nuclei2_step01.4207.4207.3	1.4213	0.0084	4530.74	75	940.0%	2	K.CLYNFQDAFMEANKVVMATSSATSSVSCTATTVQSSNSQFR.V
	TK040203_NMyc_nuclei2_step11.1016.1016.2	1.1194	0.2353	2519.6	4	2170.0%	1	R.HMNHSEPRPGLGADGDAADPVDTR.D
	TK040203_NMyc_nuclei2_step01.3686.3686.1	1.925	0.2802	1432.67	15	4000.0%	2	K.KFQVTWELHNK.H

Q9UMZ2

60.9%

1314

140653

5.1

(Q9UMZ2) Gamma-synergin

*	TK040203_NMyc_nuclei2_step03.1243.1243.1	1.2098	0.0482	1065.48	3	6430.0%	1	R.QFEEQKQK.L
*	TK040203_NMyc_nuclei2_step05.1634.1634.1	1.4793	0.1727	964.41	3	7500.0%	3	R.RQFEEQK.Q
*	TK040203_NMyc_nuclei2_step06.2717.2717.3	1.7528	0.1111	3728.03	51	1210.0%	1	K.LADVGGDLKHVMSDSSLDLPTVSGQHPPAADIEDLK.Y
*	TK040203_NMyc_nuclei2_step07.2806.2806.2	1.4123	0.1357	2915.31	11	1850.0%	1	K.SLDLPSIGGSSVGKEDSEDALSVQFDMK.L
*	TK040203_NMyc_nuclei2_step08.1563.1563.1	1.4865	0.0421	1399.61	61	3850.0%	1	K.SSENTVPPGDPGDK.Y
*	TK040203_NMyc_nuclei2_step10.1596.1596.2	0.9241	0.0309	1580.1	47	3180.0%	1	R.FEQQQKLLEEER.K
*	TK040203_NMyc_nuclei2_step11.0992.0992.3	1.2482	0.0844	1614.84	78	2310.0%	1	K.EDSEDALSVQFDMK.L

Q96FR0

60.9%

66.7%

3450

10.0

(Q96FR0) Hypothetical protein

*	TK040203_NMyc_nuclei2_step05.1976.1976.3	2.5434	0.3481	2179.35	2	2370.0%	2	R.LPLFISLLERADSVTAAYAK.Q

Q9WVJ0

60.7%

1087

117537

7.5

(Q9WVJ0) Ether-a-go-go-like potassium channel

	TK040203_NMyc_nuclei2_step06.1610.1610.1	1.3765	0.0026	980.4	6	5000.0%	2	R.RFLYHSR.T
*	TK040203_NMyc_nuclei2_step03.3394.3394.3	1.8981	0.1272	3870.79	14	1280.0%	1	R.VGQSGPECSSSPSPGTESGLLTVPLVPSEARNTDTLDK.L

A1AA_HUMAN

60.7%

466

51487

9.0

(P35348) Alpha-1A adrenergic receptor (Alpha 1A-adrenoceptor) (Alpha-1C adrenergic receptor)

	TK040203_NMyc_nuclei2_step11.2399.2399.2	2.1108	0.2331	2504.61	4	2050.0%	2	K.QSSKHALGYTLHPPSQAVEGQHK.D

CTD1_MOUSE

60.6%

911

101731

6.9

(P30999) Catenin delta-1 (p120 catenin) (p120(ctn)) (Cadherin-associated Src substrate) (CAS) (p120(cas))

*	TK040203_NMyc_nuclei2_step09.3837.3837.2	1.024	0.1741	2626.1	2	2050.0%	1	K.GMPPPSNWRQPELPEVIAMLGFR.L
	TK040203_NMyc_nuclei2_step01.2763.2763.1	1.8118	0.0627	1570.78	3	4580.0%	1	R.YRPSMEGYRAPSR.Q
	TK040203_NMyc_nuclei2_step04.3581.3581.2	1.5809	0.0754	2479.02	10	1900.0%	1	R.DMDLTEVITGTLWNLSSHDSIK.M

Q9UGB5

60.5%

15.6%

141

16292

5.5

(Q9UGB5) DJ718P11.1.2 (Novel class II aminotransferase similar to serine palmotyltransferase (Isoform 2)) (Fragment)

	TK040203_NMyc_nuclei2_step09.2739.2739.2	1.8203	0.2833	2658.27	1	3570.0%	1	R.IRDNWNRPICSAPGPLFDLMER.V
	TK040203_NMyc_nuclei2_step11.1907.1907.2	1.4928	0.125	2389.7	1	2630.0%	1	R.DNWNRPICSAPGPLFDLMER.V

CGE1_HUMAN

60.5%

410

47077

6.0

(P24864) G1/S-specific cyclin E1

*	TK040203_NMyc_nuclei2_step04.4020.4020.1	0.6527	0.0949	618.09	83	3750.0%	1	R.ERDAK.E
*	TK040203_NMyc_nuclei2_step04.1713.1713.1	1.717	0.1036	1078.63	3	5000.0%	1	K.KAMLSEQNR.A
*	TK040203_NMyc_nuclei2_step04.1128.1128.1	0.8648	0.0691	1281.63	59	2270.0%	1	K.EDGGAEFSARSR.K
*	TK040203_NMyc_nuclei2_step09.2106.2106.2	1.2251	0.0658	2851.9	10	1600.0%	1	R.YMATQENVVKTLLQLIGISSLFIAAK.L

Q921D7

60.5%

380

42548

8.9

(Q921D7) Similar to hypothetical protein FLJ20245

*	TK040203_NMyc_nuclei2_step05.3234.3234.2	1.9994	0.271	2045.15	1	3330.0%	2	R.SHPSLEPQAKGPCVIAPVR.A
*	TK040203_NMyc_nuclei2_step05.4142.4142.3	1.8282	0.0162	2580.82	43	1900.0%	1	R.RLLQPGTEPDSGTGTLGPTGSLGTLR.A

O94836

60.5%

1096

122940

9.1

(O94836) Hypothetical protein KIAA0731 (Fragment)

*	TK040203_NMyc_nuclei2_step08.1776.1776.1	1.4458	0.1975	1235.6	1	6110.0%	1	K.FQHPSHELLK.E
*	TK040203_NMyc_nuclei2_step07.4367.4367.2	1.0884	0.0116	1931.89	17	2500.0%	1	R.EDAKWTSQHSNTQTLGK.-
*	TK040203_NMyc_nuclei2_step02.3136.3136.2	2.0288	0.221	2695.76	3	2120.0%	1	R.TASISSSPSEGTPTVGSYGCTPQSLPK.F
*	TK040203_NMyc_nuclei2_step06.2066.2066.2	0.979	0.0117	2193.0	5	2650.0%	1	K.NTFTAWSDEESDYEIDDR.D

PVR2_MOUSE

60.4%

530

57318

4.9

(P32507) Poliovirus receptor related protein 2 precursor (Murine herpesvirus entry protein B) (mHveB) (Nectin 2) (Poliovirus receptor homolog)

*	TK040203_NMyc_nuclei2_step10.1969.1969.2	1.3458	0.0012	1946.78	9	3120.0%	1	K.TPYFDAGVSCADQEMPR.Y
*	TK040203_NMyc_nuclei2_step01.3942.3942.3	2.765	0.2362	4191.32	1	1510.0%	1	R.AEQVILVRESPSTAGAGATGGIIGGIIAAIIATAVAGTGILICR.Q
*	TK040203_NMyc_nuclei2_step07.1529.1529.2	1.2509	0.1309	1744.09	65	3570.0%	1	R.LSFVRARPETNADLR.D
*	TK040203_NMyc_nuclei2_step06.3751.3751.2	1.0452	0.0643	3032.89	42	1430.0%	2	R.ITWISSLGGEAKDTQEPGIQAGTVTIISR.Y

Q8TAA0

60.3%

778

89092

9.0

(Q8TAA0) Similar to PRAM-1 protein, PML-RARA target gene encoding an adaptor molecule-1

*	TK040203_NMyc_nuclei2_step03.3106.3106.3	2.8942	0.0918	2672.48	1	2390.0%	3	R.LEPPDTSQVSNLLLYILKVLDSGR.T
*	TK040203_NMyc_nuclei2_step05.4225.4225.2	1.3618	0.1176	2686.52	5	1960.0%	1	K.TPVSSLRPEPPETGESHLRLEHSK.T

Q9H0F5

60.3%

394

43881

8.5

(Q9H0F5) Hypothetical protein

*	TK040203_NMyc_nuclei2_step12.3338.3338.2	1.5581	0.0823	3007.92	18	1460.0%	1	R.HNSISQDENYHHLPYAQQQAIEEPR.A

HV1C_HUMAN

60.3%

40.8%

147

16503

7.4

(P01744) Ig heavy chain V-I region ND precursor (Fragments)

*	TK040203_NMyc_nuclei2_step11.3568.3568.2	1.3648	0.0544	3168.4	8	1610.0%	2	R.QAPGHGLEWVGWINPNSGGTNYAPRFQGR.V
*	TK040203_NMyc_nuclei2_step09.1762.1762.2	1.2726	0.0201	1836.05	171	2670.0%	1	-.MDWTXXXXFLVAAATR.V
*	TK040203_NMyc_nuclei2_step07.2122.2122.3	1.3836	0.0656	3458.86	76	1250.0%	1	-.MDWTXXXXFLVAAATRVHSQTQLVQSGAEVR.K

Q9CVV3

60.2%

287

32527

12.3

(Q9CVV3) 1700026P10Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step06.1337.1337.1	1.4416	0.1921	711.51	1	7000.0%	2	R.EQAHAR.A

LMA2_HUMAN

60.2%

3110

342772

6.4

(P24043) Laminin alpha-2 chain precursor (Laminin M chain) (Merosin heavy chain)

*	TK040203_NMyc_nuclei2_step09.3114.3114.3	2.8831	0.2792	4622.63	6	1160.0%	1	R.IGPVTYSIDGCVRNLHMAEAPADLEQPTSSFHVGTCFANAQR.G
*	TK040203_NMyc_nuclei2_step04.4119.4119.3	1.9281	0.0205	4633.16	14	1090.0%	1	K.NGIEYHYVTITLDLQQVFQIAYVIVKAANSPRPGNWILER.S
*	TK040203_NMyc_nuclei2_step09.2029.2029.2	1.3335	0.033	2071.63	5	2940.0%	1	R.QIENTLKEGNDILDEANR.L

5H1E_HUMAN

60.2%

19.7%

365

41682

8.8

(P28566) 5-hydroxytryptamine 1E receptor (5-HT-1E) (Serotonin receptor) (5-HT1E) (S31)

*	TK040203_NMyc_nuclei2_step11.2886.2886.3	2.7379	0.2254	3755.07	1	1640.0%	1	R.STDSQNSFASCKLTQTFCVSDFSTSDPTTEFEK.F
*	TK040203_NMyc_nuclei2_step12.0876.0876.1	0.2997	0.0071	700.85	6	2500.0%	1	R.CREHT.-
*	TK040203_NMyc_nuclei2_step02.4075.4075.3	1.4954	0.0758	3722.98	121	1210.0%	1	K.TITEKMLICMTLVVITTLTTLLNLAVIMAIGTTK.K

THI2_MOUSE

60.1%

166

18255

7.9

(P97493) Thioredoxin, mitochondrial precursor (Mt-TRX) (Thioredoxin 2)

	TK040203_NMyc_nuclei2_step01.0391.0391.1	1.5423	0.1491	998.24	5	6250.0%	1	K.QHGKVVMAK.V
	TK040203_NMyc_nuclei2_step08.1977.1977.1	0.3577	0.0476	433.03	15	3330.0%	1	K.KLIG.-

MEI2_MOUSE

60.1%

477

51728

6.4

(P97367) Homeobox protein Meis2 (Meis1-related protein 1)

	TK040203_NMyc_nuclei2_step12.2811.2811.3	2.2813	0.1339	3113.22	3	2020.0%	2	K.QVRAEKPLFSSNPELDNLMIQAIQVLR.F

OTOR_MOUSE

60.0%

34.4%

128

14328

4.8

(Q9JIE3) Otoraplin precursor (Melanoma inhibitory activity-like protein)

*	TK040203_NMyc_nuclei2_step03.3126.3126.2	2.1424	0.2249	2341.75	2	3330.0%	2	R.ILILLLGGLVVLCAGHGVFMDK.L
*	TK040203_NMyc_nuclei2_step08.2432.2432.2	1.237	0.0651	2701.25	42	1460.0%	1	-.MARILILLLGGLVVLCAGHGVFMDK.L
*	TK040203_NMyc_nuclei2_step03.2163.2163.2	1.1872	0.0559	2310.4	2	2500.0%	1	R.VYQEATKEIPTTDIDFFCE.-

Q9D645

59.8%

278

31206

5.4

(Q9D645) 4733401H14Rik protein

*	TK040203_NMyc_nuclei2_step12.2199.2199.2	1.9585	0.2727	2792.85	1	2200.0%	1	K.VSDPDCGSVIAQILAGYDIALVQEVR.D

Q91XU9

59.8%

1021

113441

5.0

(Q91XU9) Calmin alpha

	TK040203_NMyc_nuclei2_step02.1131.1131.2	1.1775	0.1632	1988.81	9	2650.0%	1	K.AIDPSLVDMKQALEDSTR.D
	TK040203_NMyc_nuclei2_step07.3333.3333.1	1.1675	0.0913	922.48	31	5710.0%	1	K.QALEDSTR.D
	TK040203_NMyc_nuclei2_step11.2544.2544.2	1.815	0.2863	2524.73	1	2730.0%	2	R.DLVDFASTSQAFGEDPSSHEKTR.G

FAS_HUMAN

59.8%

2504

273100

6.7

(P49327) Fatty acid synthase (EC 2.3.1.85) [Includes: EC 2.3.1.38; EC 2.3.1.39; EC 2.3.1.41; EC 1.1.1.100; EC 4.2.1.61; EC 1.3.1.10; EC 3.1.2.14]

*	TK040203_NMyc_nuclei2_step09.3325.3325.3	1.7556	0.0632	4468.24	8	1320.0%	1	R.HEEQQVPILEKFCFTPHTEEGCLSEHAALEEELQLCK.G
*	TK040203_NMyc_nuclei2_step01.1418.1418.1	1.5371	0.0078	1165.58	8	5000.0%	4	R.LRAADQYTPK.A
	TK040203_NMyc_nuclei2_step06.2367.2367.2	1.1012	0.0577	3193.76	88	1300.0%	1	R.FPQLDSTSFANSRDTSFEQHVLWHTGGK.G
	TK040203_NMyc_nuclei2_step01.2939.2939.1	1.4131	0.2291	1596.78	4	3570.0%	1	K.GLEERVAAAVDLIIK.S
	TK040203_NMyc_nuclei2_step06.4291.4291.2	1.1311	0.0119	3164.12	30	1540.0%	1	K.LPESENLQEFWDNLIGGVDMVTDDDRR.W
*	TK040203_NMyc_nuclei2_step11.3400.3400.2	1.2167	0.0423	2457.1	142	1460.0%	1	R.DLAAVNLGGSLADLGLDSLMSAPVR.Q
	TK040203_NMyc_nuclei2_step07.0293.0293.2	0.7972	0.0752	2959.93	161	1030.0%	1	R.VRPGETLLIHSGSGGVGQAAIAIALSLGCR.V
*	TK040203_NMyc_nuclei2_step12.1479.1479.3	1.4891	0.1354	4222.09	1	1460.0%	1	R.QGLQVQVSTSNISSLEGARGLIAEAAQLGPVGGVFNLAVVLR.D
*	TK040203_NMyc_nuclei2_step04.2430.2430.3	1.8579	0.0979	3085.18	36	1480.0%	1	R.IGVLGLEVLDLFLNQPHMVLSSFVLAEK.A
	TK040203_NMyc_nuclei2_step07.2581.2581.2	1.9395	0.2672	2044.46	1	3420.0%	1	R.VTVAGGVHISGLHTESAPRR.H

Q9BR26

59.8%

551

60105

8.5

(Q9BR26) DJ257E24.3 (Novel protein) (Fragment)

*	TK040203_NMyc_nuclei2_step08.2123.2123.1	1.1649	0.1019	1522.95	27	2690.0%	3	R.HAIAASFFTAQEAR.R

TRKA_HUMAN

59.7%

11.6%

796

87511

6.6

(P04629) High affinity nerve growth factor receptor precursor (EC 2.7.1.112) (TRK1 transforming tyrosine kinase protein) (p140-TrkA) (Trk-A)

	TK040203_NMyc_nuclei2_step07.2026.2026.3	1.4522	0.1068	4665.61	1	1250.0%	2	R.SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR.D
	TK040203_NMyc_nuclei2_step10.3759.3759.2	1.4066	0.1234	2887.14	1	2290.0%	1	K.WELGEGAFGKVFLAECHNLLPEQDK.M
*	TK040203_NMyc_nuclei2_step08.0382.0382.3	0.7627	0.0128	2208.37	277	660.0%	1	R.GLEQAGWILTELEQSATVMK.S

CD72_HUMAN

59.7%

359

40221

8.3

(P21854) B-cell differentiation antigen CD72 (Lyb-2)

*	TK040203_NMyc_nuclei2_step11.1754.1754.3	2.6053	0.2954	3177.86	1	2130.0%	1	R.TTCLRYLLLGLLLTCLLLGVTAICLGVR.Y

MC3A_MOUSE

59.7%

1971

217138

6.6

(Q9WUU9) 80 kda MCM3-associated protein (GANP protein)

*	TK040203_NMyc_nuclei2_step12.3078.3078.2	1.388	0.0478	3035.89	10	1550.0%	1	K.ESKESGFAEPGESDHAAVPGGSQSTMVPSR.L
*	TK040203_NMyc_nuclei2_step06.1486.1486.2	1.5238	0.068	1778.0	6	3330.0%	1	K.DALRALNVAYTVSTQR.S
*	TK040203_NMyc_nuclei2_step12.3891.3891.3	1.8409	0.1621	4686.4	7	1190.0%	1	R.ELMLTQLSEGLAAELTELTVTECVWETCSQELQSAVKIDQK.V
*	TK040203_NMyc_nuclei2_step03.3759.3759.2	0.9803	0.0129	2561.0	3	1960.0%	1	R.GASAEELLAQSLSSSLLEEKEENK.R
*	TK040203_NMyc_nuclei2_step11.1655.1655.3	2.0081	0.1398	1983.52	2	3170.0%	1	K.TAHQIKVQHFHQQLLR.N
*	TK040203_NMyc_nuclei2_step07.2642.2642.3	2.6034	0.282	3332.63	1	1770.0%	1	K.VKFTGDDSMVGDIGDNAGDIQTLSVFNTLSSK.G
*	TK040203_NMyc_nuclei2_step09.2807.2807.2	1.5665	0.0688	2623.21	42	1820.0%	1	R.LPLYLPQTLVSFPDSIKTQTMVK.T

Q91WL0

59.6%

600

68216

8.0

(Q91WL0) Similar to hypothetical protein FLJ21522 (Epidermal growth factor receptor pathway substrate 8 related protein 3)

*	TK040203_NMyc_nuclei2_step07.3429.3429.3	2.5611	0.1454	3067.02	3	1940.0%	4	R.WWLVKNEAGLTGYIPSNILEPLPAGAPR.G

Q8VDF5

59.6%

401

314

36602

9.0

(Q8VDF5) Hypothetical 36.6 kDa protein (Fragment)

*	TK040203_NMyc_nuclei2_step06.1181.1181.1	1.185	0.0279	1234.62	9	4500.0%	1	R.QLESNSDGNDR.K
*	TK040203_NMyc_nuclei2_step02.1623.1623.1	1.5203	0.1258	809.6	9	5710.0%	20	R.KGAVPAHK.A

APT_MOUSE

59.6%

180

19736

6.8

(P08030) Adenine phosphoribosyltransferase (EC 2.4.2.7) (APRT)

*	TK040203_NMyc_nuclei2_step08.1259.1259.1	1.3684	0.2984	1207.5	2	5000.0%	2	R.ASIRLLASHLK.S

Q9NRY4

59.5%

1514

172175

6.7

(Q9NRY4) Rho GAP p190-A

*	TK040203_NMyc_nuclei2_step11.1676.1676.2	1.692	0.1447	2179.4	2	3160.0%	1	K.QDVRIPTYNISVVGLSGTEK.E
	TK040203_NMyc_nuclei2_step02.4131.4131.3	1.7873	0.0428	4028.24	19	1140.0%	2	K.DFTVNTVAGAMKSFFSELPDPLVPYNMQIDLVEAHK.I
	TK040203_NMyc_nuclei2_step03.2013.2013.1	1.3759	0.0325	892.84	1	7140.0%	3	R.KASLAMLR.A
	TK040203_NMyc_nuclei2_step10.2044.2044.2	1.3206	0.0369	1848.91	21	3000.0%	1	K.GDNAVIPYETDEDPRR.R

Q9D2H2

59.5%

614

70676

5.0

(Q9D2H2) 4930502N02Rik protein

*	TK040203_NMyc_nuclei2_step02.1715.1715.1	1.5927	0.1333	1011.68	4	6250.0%	1	K.QSRGLLPIK.I
*	TK040203_NMyc_nuclei2_step05.2123.2123.1	1.1595	0.163	1572.77	9	2500.0%	1	K.HHPNFLDHINAEK.I

TTF1_MOUSE

59.4%

12.6%

372

38570

9.7

(P50220) Thyroid transcription factor 1 (Thyroid nuclear factor 1) (TTF-1) (Homeobox protein NKX-2.1)

	TK040203_NMyc_nuclei2_step08.2575.2575.2	1.7679	0.2895	2522.14	1	2380.0%	1	K.YLSAPEREHLASMIHLTPTQVK.I
	TK040203_NMyc_nuclei2_step10.3344.3344.2	1.3016	0.117	2813.38	37	1670.0%	1	-.MSMSPKHTTPFSVSDILSPLEESYK.K

FAK1_MOUSE

59.4%

1052

119217

6.7

(P34152) Focal adhesion kinase 1 (EC 2.7.1.112) (FADK 1) (pp125FAK)

	TK040203_NMyc_nuclei2_step01.1073.1073.1	1.1326	0.0984	470.25	1	8330.0%	1	K.LPIK.W
	TK040203_NMyc_nuclei2_step11.1667.1667.3	2.1459	0.1	2672.41	2	2500.0%	1	K.LIGVITENPVWIIMELCTLGELR.S
	TK040203_NMyc_nuclei2_step01.3186.3186.1	1.6501	0.1239	1110.46	1	6880.0%	1	K.FLQEALTMR.Q

DJB1_MOUSE

59.4%

340

38167

8.6

(Q9QYJ3) DnaJ homolog subfamily B member 1 (Heat shock 40 kDa protein 1) (Heat shock protein 40) (HSP40)

	TK040203_NMyc_nuclei2_step01.1538.1538.1	1.6626	0.1205	1009.45	5	6110.0%	2	K.VPGEGLPLPK.T

TY3H_MOUSE

59.3%

498

55993

6.1

(P24529) Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH)

*	TK040203_NMyc_nuclei2_step05.1527.1527.1	1.7998	0.0742	1565.64	1	4580.0%	1	R.NYASRIQRPFSVK.F
	TK040203_NMyc_nuclei2_step07.2180.2180.1	1.1808	0.1849	1038.48	3	5000.0%	1	R.DFLASLAFR.V
*	TK040203_NMyc_nuclei2_step07.2296.2296.2	1.0503	9.0E-4	2573.75	19	2380.0%	1	K.LIAEIAFQYKQGEPIPHVEYTK.E

Q8VF79

59.2%

312

35325

7.2

(Q8VF79) Olfactory receptor MOR135-14

*	TK040203_NMyc_nuclei2_step08.1844.1844.1	1.489	0.1696	1323.47	4	4550.0%	1	R.DMRDALFGVLGK.K
*	TK040203_NMyc_nuclei2_step12.3482.3482.3	1.4974	0.0036	4729.12	1	1190.0%	1	K.ISSAHVLHKIFSTCGSHLSVVSLFYGTIFALYLCPSANNSTVK.E

Q9D4G0

59.2%

844

95725

7.2

(Q9D4G0) Adult male testis cDNA, RIKEN full-length enriched library, clone:4932441D06, full insert sequence

*	TK040203_NMyc_nuclei2_step12.3141.3141.3	2.0072	0.0899	4515.61	19	1190.0%	1	R.TQDATGPELILPASIEFRESSEDSFLSAIINYTNSSTVHFK.L
*	TK040203_NMyc_nuclei2_step09.2335.2335.2	1.2895	0.0803	2764.01	24	1730.0%	1	R.HKPGAVQETTFELGGDVHSGTALPASR.S
*	TK040203_NMyc_nuclei2_step09.2793.2793.2	1.0374	0.0933	2357.68	41	1750.0%	1	R.ENRTQDATGPELILPASIEFR.E
	TK040203_NMyc_nuclei2_step09.1435.1435.1	1.491	0.1627	865.49	1	7000.0%	1	K.RMQEFR.S

Q8VFI1

59.2%

319

36587

8.9

(Q8VFI1) Olfactory receptor MOR110-6

*	TK040203_NMyc_nuclei2_step02.3515.3515.2	1.9112	0.2706	2922.23	4	2080.0%	1	K.AFSTCTSHMVVVSITYGSCIFMYMK.T

Q8R156

59.2%

542

58574

6.7

(Q8R156) Similar to xylulokinase homolog (H. influenzae) (Fragment)

*	TK040203_NMyc_nuclei2_step12.3363.3363.2	1.8992	0.2716	3140.87	2	1670.0%	1	K.STAMGNNGNLGFYFDVMEITPEIIGRHR.F
*	TK040203_NMyc_nuclei2_step12.2030.2030.3	2.1868	0.0364	3933.46	2	1800.0%	1	R.CCLGWDFSTQQVKVVAVDAELNVFYEDSVHFDR.D

Q99JJ9

59.2%

271

30732

8.4

(Q99JJ9) Hypothetical 30.7 kDa protein (Fragment)

*	TK040203_NMyc_nuclei2_step09.2818.2818.2	1.046	0.0051	2630.03	15	1900.0%	1	R.VINLMVPKDQVLDTVYLFHMPR.K
*	TK040203_NMyc_nuclei2_step05.1986.1986.1	1.8104	0.0416	1331.63	1	5500.0%	1	K.DFRVINLMVPK.D

Q9P2L2

59.0%

989

111030

6.3

(Q9P2L2) Hypothetical protein KIAA1334 (Fragment)

*	TK040203_NMyc_nuclei2_step09.1794.1794.1	1.6166	0.124	1432.52	4	4550.0%	1	K.QDLQNALEESER.N
*	TK040203_NMyc_nuclei2_step03.3275.3275.2	1.1964	0.0755	2488.14	24	2000.0%	1	K.STTDNDVRIQQLQEILQDLQK.R

Z298_HUMAN

58.9%

951

106517

8.5

(P57071) Zinc finger protein 298 (PR-domain zinc finger protein 15) (Fragment)

*	TK040203_NMyc_nuclei2_step09.2321.2321.3	1.7892	0.0761	3801.53	1	1710.0%	1	K.IANGGGTGAGKAECGYETESHLLEPHEIPLNVNTHK.F
*	TK040203_NMyc_nuclei2_step04.2381.2381.2	1.7966	0.1651	1410.0	7	5000.0%	1	R.FFSTNSNLSKHK.K
*	TK040203_NMyc_nuclei2_step11.2822.2822.2	1.3118	0.0328	3059.13	25	1430.0%	1	R.VSEQLLETSLGNEVSDTEPLSPASAGLRR.N
*	TK040203_NMyc_nuclei2_step02.1336.1336.3	1.2349	0.0786	3481.84	24	1050.0%	1	K.LLGMSGVEGVWNQHSRSASMHTFLNHSATGIR.E

Q9ESJ5

58.9%

1024

112579

6.9

(Q9ESJ5) GluR-delta2 philic-protein

*	TK040203_NMyc_nuclei2_step04.2381.2381.3	1.6079	0.0866	2114.49	214	1810.0%	1	K.AYNTSILLAHLKLTPGELR.Q
*	TK040203_NMyc_nuclei2_step04.2071.2071.2	1.7004	0.3098	2243.61	5	2620.0%	1	R.GHGPVWIESVLPGSPAENASLK.S
*	TK040203_NMyc_nuclei2_step03.3635.3635.2	1.3207	0.0619	2470.39	70	1820.0%	1	R.ASALTSLQWVADILPSSIRVQGR.T
*	TK040203_NMyc_nuclei2_step11.2691.2691.2	1.6788	0.0205	3055.86	1	2140.0%	1	K.SFGFTLRGHGPVWIESVLPGSPAENASLK.S

Q9D803

58.9%

1.7%

473

52003

5.1

(Q9D803) 2200003E03Rik protein

	TK040203_NMyc_nuclei2_step07.1281.1281.1	1.6892	0.1073	978.37	4	6430.0%	1	K.AFNDLKNR.N

JAG2_HUMAN

58.8%

148

1238

133366

5.9

(Q9Y219) Jagged 2 precursor (Jagged2) (HJ2)

*	TK040203_NMyc_nuclei2_step10.2924.2924.2	1.8143	0.0323	1769.18	2	3750.0%	1	R.DHVPQGTTVGAICSGIR.S
*	TK040203_NMyc_nuclei2_step06.3745.3745.2	1.575	0.1146	3010.91	1	1880.0%	12	R.SFTLIVEAWDWDNDTTPNEELLIER.V
*	TK040203_NMyc_nuclei2_step09.3177.3177.3	2.1605	0.1139	4404.06	5	1320.0%	1	K.APGQCLRPPCEAWGECGAEEPPSTPCLPRSGHLDNNCAR.L
*	TK040203_NMyc_nuclei2_step10.2939.2939.3	1.5918	0.0427	3018.28	36	1770.0%	1	R.CYNLEGDYYCACPDDFGGKNCSVPR.E
*	TK040203_NMyc_nuclei2_step04.3436.3436.3	2.8191	0.1705	3142.86	1	2210.0%	1	R.RLLLLLALWVQAARPMGYFELQLSALR.N

SYI_HUMAN

58.8%

1266

144958

6.2

(P41252) Isoleucyl-tRNA synthetase, cytoplasmic (EC 6.1.1.5) (Isoleucine--tRNA ligase) (IleRS) (IRS)

*	TK040203_NMyc_nuclei2_step12.2263.2263.3	1.3945	0.0107	4500.77	16	1010.0%	1	K.GSELEITLTRGSSLPGPACAYVNLNICANGSEQGGVLLLENPK.G
*	TK040203_NMyc_nuclei2_step05.1839.1839.1	1.2406	0.0623	983.45	8	5000.0%	1	R.FPGAYLKGK.K
*	TK040203_NMyc_nuclei2_step10.4064.4064.1	0.6974	0.0040	663.4	22	4000.0%	1	R.LKGAFK.A
*	TK040203_NMyc_nuclei2_step05.1607.1607.1	1.5839	0.1317	1316.73	1	5000.0%	1	R.YAHQSGFHVDR.R

Q9Y564

58.7%

568

65876

6.1

(Q9Y564) Cell division control protein 16

	TK040203_NMyc_nuclei2_step12.3419.3419.2	1.6305	0.0151	2746.24	2	2050.0%	1	R.QYLDQQQYQSALFWADKVASLSR.E
	TK040203_NMyc_nuclei2_step02.2059.2059.1	1.471	0.1583	1487.67	1	4090.0%	1	K.MCYKLTSVVMEK.D

Q9H725

58.7%

501

57518

8.5

(Q9H725) Hypothetical protein FLJ21477

*	TK040203_NMyc_nuclei2_step07.3121.3121.3	2.6666	0.2416	2308.18	2	3030.0%	1	R.RCTIMGSEYSHQENGIEAPK.G
*	TK040203_NMyc_nuclei2_step02.2404.2404.3	1.457	0.0946	3857.73	4	1470.0%	1	K.CNEIVPADILLLFSSDPNGICHLETASLDGETNLK.Q

Q9CSF9

58.7%

368

41385

9.9

(Q9CSF9) 2410005K20Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step09.3338.3338.3	1.4378	0.0137	2918.88	93	1670.0%	1	K.NNNELLLSGSENLFLMVILWKIPEK.E
*	TK040203_NMyc_nuclei2_step01.3400.3400.2	2.087	0.247	2757.71	1	2710.0%	1	R.IGHTGMETEHIVDNILAVSEMLSEK.L

Q99J65

58.7%

754

80614

8.0

(Q99J65) Hypothetical 80.6 kDa protein

*	TK040203_NMyc_nuclei2_step04.2465.2465.2	2.0411	0.2604	2275.41	1	3180.0%	1	-.MDLPAVLAAPATRGDQHGGGPSR.L

Q9BYK8

58.5%

2567

285824

7.4

(Q9BYK8) DJ697K14.6 (Novel protein, KIAA1769)

	TK040203_NMyc_nuclei2_step05.2164.2164.3	1.5838	0.1483	3831.66	32	1250.0%	1	R.QILVDEAGMATEPETLIPLVQFPQAEKVVLLGDHK.Q
	TK040203_NMyc_nuclei2_step09.2675.2675.3	1.7697	0.0323	3746.79	332	910.0%	1	R.VPVGFFSHILIDEAAQMLECEALTPLAYASHGTR.L
	TK040203_NMyc_nuclei2_step01.3951.3951.2	1.0937	0.0521	2676.22	3	2080.0%	1	R.LGGPCILYCGPSNKSVDVLAGLLLR.R
	TK040203_NMyc_nuclei2_step02.1872.1872.1	1.1191	0.0054	972.74	32	5710.0%	1	R.QAFRPPTR.A
	TK040203_NMyc_nuclei2_step10.3129.3129.3	2.4919	0.4083	3927.31	1	1520.0%	1	R.DMSMASWLNLAEIAQVVEKVQEAYNTWPSCWGGR.E
	TK040203_NMyc_nuclei2_step05.2767.2767.3	1.6607	0.1299	3826.61	17	1320.0%	1	K.VMVTVGEDGLLDTVARPESLQQARLYENLPPAALR.K
	TK040203_NMyc_nuclei2_step07.2970.2970.2	1.3173	0.0304	2305.61	12	2500.0%	1	R.LRSDCFYEQPDEDGTLGFR.A
	TK040203_NMyc_nuclei2_step10.3882.3882.2	1.0179	0.0564	2013.05	50	1560.0%	1	R.CTDAIVSFISRHFYVAK.G
*	TK040203_NMyc_nuclei2_step05.2800.2800.2	1.4993	0.1503	1868.7	2	3530.0%	1	K.QELAVALIAGWGPGDGRR.V
*	TK040203_NMyc_nuclei2_step01.0428.0428.2	0.9324	0.0179	1379.54	14	4230.0%	1	R.GDLLTPPAPDGDGR.T
	TK040203_NMyc_nuclei2_step05.3072.3072.3	1.6098	0.0498	3305.34	7	1750.0%	1	R.VPLSLHLGHHLHGGGGSPPDTRLHLLASLWK.Q

DPOZ_MOUSE

58.5%

3122

350659

8.3

(Q61493) DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Seizure related protein 4)

	TK040203_NMyc_nuclei2_step11.2900.2900.2	1.2353	0.0193	1947.39	5	2940.0%	6	K.LGFLSERSTSPINSSPPR.C
	TK040203_NMyc_nuclei2_step10.2189.2189.2	1.0898	0.0599	2295.28	2	2500.0%	1	R.LDIEAQIGGNPGLQAIWEDEK.Q
*	TK040203_NMyc_nuclei2_step04.1451.1451.1	0.744	2.0E-4	747.6	1	7000.0%	1	K.RNQTTK.L
	TK040203_NMyc_nuclei2_step11.0921.0921.3	1.3139	0.0014	2056.27	18	1910.0%	1	K.WGARVVYGDTDSMFVLLK.G
*	TK040203_NMyc_nuclei2_step07.3871.3871.3	1.192	0.0867	3912.78	6	1470.0%	1	R.WEEDEIPSSLLLEGVEPLSTCELEVDAVAADILNR.L
*	TK040203_NMyc_nuclei2_step12.1301.1301.3	1.2782	0.0828	3772.7	29	1290.0%	1	K.LSSEGNEKGNSTSLSGVFPSSLTENCDLLPSSGENR.S
*	TK040203_NMyc_nuclei2_step12.2306.2306.2	1.364	0.0401	2552.79	19	1900.0%	1	K.HHVSDSSPWIRASTLNPELFEK.V
*	TK040203_NMyc_nuclei2_step07.3022.3022.2	1.5682	0.125	2730.29	7	1800.0%	1	K.EMSQTGPAVDHPLLPAQPTGISAQQR.L
*	TK040203_NMyc_nuclei2_step02.3026.3026.3	1.6284	0.0012	3795.68	1	1690.0%	1	K.SIFDLSNHLSQVAQSTQVCSGIISPKTEESSSTQK.N
*	TK040203_NMyc_nuclei2_step10.1473.1473.3	1.5529	0.0932	2516.65	79	1700.0%	1	K.EQSFKIGQEIAEAVTATNPRPVK.L
*	TK040203_NMyc_nuclei2_step10.3231.3231.3	1.4818	0.1797	4556.68	2	1220.0%	1	R.DLQPDPEFDPICALFYCISSDTPLPDTEKTELTGVIVIDK.D
*	TK040203_NMyc_nuclei2_step03.1181.1181.3	1.4127	0.1323	2375.18	13	1700.0%	1	K.SAENVSPSLNPGDTCAVSPQVDK.C

Q9D352

58.5%

20.4%

191

21529

7.9

(Q9D352) 6530413P12Rik protein

*	TK040203_NMyc_nuclei2_step12.3697.3697.3	2.5708	0.3144	4402.7	2	1320.0%	1	K.VFWENHDPTQGMRQGNDFGTQYPSAVYPTSAVQMEAALR.S

GLP1_HUMAN

58.4%

463

53060

8.1

(P43220) Glucagon-like peptide 1 receptor precursor (GLP-1 receptor) (GLP-1-R) (GLP-1R)

*	TK040203_NMyc_nuclei2_step04.3220.3220.3	2.7989	0.2131	3065.27	3	2140.0%	3	R.LALLLLGMVGRAGPRPQGATVSLWETVQK.W

CIN1_HUMAN

58.3%

0.7%

2009

228970

5.8

(P35498) Sodium channel protein, brain I alpha subunit

*	TK040203_NMyc_nuclei2_step05.2040.2040.1	1.7993	0.0671	1578.7	2	4230.0%	1	K.KDSCMSNHTAEIGK.D

TYY1_HUMAN

58.3%

414

44713

6.3

(P25490) Transcriptional repressor protein YY1 (Yin and yang 1) (YY-1) (Delta transcription factor) (NF-E1)

*	TK040203_NMyc_nuclei2_step06.2566.2566.2	1.68	0.4111	1663.94	3	2630.0%	2	K.SYLSGGAGAAGGGGADPGNK.K

V1AR_HUMAN

58.2%

418

46800

9.3

(P37288) Vasopressin V1a receptor (V1aR) (Vascular/hepatic-type arginine vasopressin receptor) (Antidiuretic hormone receptor 1a) (AVPR V1a)

*	TK040203_NMyc_nuclei2_step07.2646.2646.2	1.6809	0.3913	2714.22	4	2220.0%	1	R.LSAGPDAGPSGNSSPWWPLATGAGNTSR.E

GAK_HUMAN

58.0%

1311

143190

5.7

(O14976) Cyclin G-associated kinase (EC 2.7.1.-)

*	TK040203_NMyc_nuclei2_step02.3508.3508.3	2.0946	0.1176	3983.73	1	1510.0%	1	-.MSLLQSALDFLAGPGSLGGASGRDQSDFVGQTVELGELR.L
*	TK040203_NMyc_nuclei2_step06.3737.3737.3	1.5807	0.0291	3774.49	9	1280.0%	2	K.SQNPDPFADLGDLSSGLQGSPAGFPPGGFIPKTATTPK.G
*	TK040203_NMyc_nuclei2_step03.3365.3365.3	1.7208	0.053	3841.43	42	1250.0%	1	K.AAGQPYEQHAKMIFMELNDAWSEFENQGSRPLF.-
*	TK040203_NMyc_nuclei2_step01.3808.3808.3	1.6589	0.0017	3393.26	22	1360.0%	1	R.GPPPPVGPAGSGYSGGLALAEYDQPYGGFLDILR.G
*	TK040203_NMyc_nuclei2_step01.2407.2407.1	1.6672	0.0513	1181.73	2	6110.0%	4	R.CPPGIWPSHK.R

Q8VD11

57.9%

562

59616

9.2

(Q8VD11) Similar to hypothetical protein FLJ10700

	TK040203_NMyc_nuclei2_step01.0279.0279.1	1.0886	0.136	976.1	2	6110.0%	1	R.ELAGPGFVGK.A
	TK040203_NMyc_nuclei2_step01.2336.2336.1	1.7853	0.0853	1181.79	5	5000.0%	1	K.AGLLAIVKVPAK.S

ERR1_HUMAN

57.9%

519

55440

6.7

(P11474) Steroid hormone receptor ERR1 (Estrogen-related receptor, alpha) (ERR-alpha) (Estrogen receptor-like 1)

*	TK040203_NMyc_nuclei2_step11.4027.4027.2	1.7045	0.3	2064.55	1	2750.0%	1	K.GSSETETEPPVALAPGPAPTR.C

NCR1_MOUSE

57.8%

2453

270640

6.9

(Q60974) Nuclear receptor co-repressor 1 (N-CoR1) (N-CoR) (Retinoid X receptor interacting protein 13) (RIP13)

	TK040203_NMyc_nuclei2_step05.1704.1704.1	1.2316	0.0182	1277.72	1	4090.0%	2	R.ALPRGSPHSDLK.E
*	TK040203_NMyc_nuclei2_step01.2420.2420.3	1.2179	0.0080	2720.97	11	1850.0%	1	R.SGYEQFHPGPSPVDHDSLESKRPR.L
	TK040203_NMyc_nuclei2_step10.2083.2083.3	1.7115	0.0311	3025.47	4	1980.0%	1	K.VEDHGVVMSHPVGIMPGSASTSVVTSSEAR.R
*	TK040203_NMyc_nuclei2_step01.4535.4535.2	1.1618	0.121	3100.51	308	890.0%	2	K.SPVPGVDPIVSHSPFDPHHRSSAAGEVYR.S
	TK040203_NMyc_nuclei2_step03.2411.2411.2	0.9923	0.0294	1585.2	10	2860.0%	1	R.GSPMMNRTSDVSSSK.S
*	TK040203_NMyc_nuclei2_step05.2878.2878.2	1.8096	0.2708	1772.28	5	3330.0%	1	R.SYEAVEGSIKQGMSMR.E
	TK040203_NMyc_nuclei2_step12.3362.3362.3	1.761	0.0291	4269.4	4	1280.0%	1	R.QYEGPLHHYRSQQESPSPQQQPPLPPSSQSEGMGQVPR.T
	TK040203_NMyc_nuclei2_step12.4418.4418.2	0.7859	0.0794	1916.25	19	2000.0%	1	R.NQQIARPSQEEKVEEK.E
*	TK040203_NMyc_nuclei2_step12.1527.1527.3	1.426	0.1173	3936.52	20	1290.0%	1	R.VFPMDAKPSLLTPPGSILISSPIKPNLLDLPQLQHR.A

Q9BVH8

57.7%

1001

106194

6.3

(Q9BVH8) Hypothetical protein (Fragment)

*	TK040203_NMyc_nuclei2_step02.4170.4170.2	1.8017	0.2725	2211.85	1	3240.0%	1	R.HWDQNLQLHLLCYSPANV.-

Q8R2J0

57.7%

2144

243140

6.7

(Q8R2J0) L-type voltage-gated calcium channel Cav1.3(1a) subunit

	TK040203_NMyc_nuclei2_step05.3024.3024.2	1.1403	0.0514	2518.62	24	2110.0%	1	R.YYETYIRSESGDEQFPTICR.E
	TK040203_NMyc_nuclei2_step12.2395.2395.3	1.8629	0.2363	4019.67	75	1180.0%	1	K.RNTSMPTSETESVNTENVSGEGETQGCCGTLCQAISK.S
	TK040203_NMyc_nuclei2_step11.2328.2328.2	0.9173	0.0105	1719.94	5	3330.0%	1	R.NGALLGNHVNHVNSDR.R
	TK040203_NMyc_nuclei2_step01.4347.4347.2	2.1204	0.2106	2852.8	1	2500.0%	3	K.GYLDWITQVEDIDPENEEEGGEEGK.R
	TK040203_NMyc_nuclei2_step10.2857.2857.2	1.4157	0.1088	2889.87	4	1960.0%	1	R.CLGEQEYFSSEECCGDDSSPTWSR.Q

Q9BW27

57.6%

656

75019

5.6

(Q9BW27) Similar to Male-specific RNA 84Dd (Frount protein)

*	TK040203_NMyc_nuclei2_step10.3483.3483.2	1.7219	0.09	3067.03	3	2000.0%	5	R.DYCERGCFSDLDLIDNLGPAMMLSDR.L
*	TK040203_NMyc_nuclei2_step10.2725.2725.2	1.4096	0.1452	2905.73	144	1400.0%	1	R.IMGDLMRTMPILSPGNTQTLTELELK.W

GLI3_HUMAN

57.6%

1596

172069

7.7

(P10071) Zinc finger protein GLI3

*	TK040203_NMyc_nuclei2_step12.1295.1295.1	0.7953	0.0516	1350.71	23	3750.0%	1	R.TGSEGLALPRVPR.F
*	TK040203_NMyc_nuclei2_step12.4147.4147.2	1.1632	0.0912	2936.39	18	1540.0%	3	R.NAITMQPQNVQGLSKVSEEPSTSSDER.A
*	TK040203_NMyc_nuclei2_step08.1343.1343.2	1.4821	3.0E-4	1526.67	24	3330.0%	1	K.QRGDIHPRPPPPR.D
*	TK040203_NMyc_nuclei2_step11.1423.1423.2	1.5894	0.2503	2107.04	84	2000.0%	1	R.LALLGDALEPGVALPPVHAPR.R
*	TK040203_NMyc_nuclei2_step11.1850.1850.2	1.5031	0.0847	2794.58	1	2800.0%	1	K.IKPDEDLPSPGARGQQEQPEGTTLVK.E
*	TK040203_NMyc_nuclei2_step11.4103.4103.3	2.5581	0.1571	4730.51	4	1110.0%	3	K.APAVSPLIGNGTQSNNTCSLGGPMTLLPGRSDLSGVDVTMLNMLNR.R

Q8R0B6

57.5%

277

30407

8.9

(Q8R0B6) Similar to hypothetical gene LOC127733

*	TK040203_NMyc_nuclei2_step11.1033.1033.2	0.9953	0.2204	1465.5	16	3460.0%	1	R.RSLEVGAMDTVASK.T

IRS2_MOUSE

57.5%

1321

136527

8.7

(P81122) Insulin receptor substrate-2 (IRS-2) (4PS)

*	TK040203_NMyc_nuclei2_step12.2317.2317.2	1.3971	0.151	2775.0	59	1400.0%	1	R.QVPQPSSASLDEYTLMRATFSGSSGR.L
*	TK040203_NMyc_nuclei2_step03.3458.3458.2	1.5671	0.082	2504.28	27	1740.0%	1	R.SGGPNSCKSDDYMPMSPTSVSAPK.Q
*	TK040203_NMyc_nuclei2_step08.3052.3052.3	1.7823	0.0592	2695.68	18	1980.0%	1	R.RHSSETFSSTTTVTPVSPSFAHNSK.R
	TK040203_NMyc_nuclei2_step05.1483.1483.1	1.3504	0.3063	1166.5	3	4440.0%	1	K.RTYSLTTPAR.Q

Q9D007

57.3%

236

27494

6.0

(Q9D007) 2610209L14Rik protein

*	TK040203_NMyc_nuclei2_step07.4296.4296.3	2.1148	0.0531	2978.43	2	1770.0%	2	K.EEESEEESNEEEEEDDEEESESEAK.S
	TK040203_NMyc_nuclei2_step01.1499.1499.1	1.605	0.1168	1525.65	1	4170.0%	2	K.QMNAIIDTVINYK.D

FOH1_HUMAN

57.3%

750

84331

7.0

(Q04609) Glutamate carboxypeptidase II (EC 3.4.17.21) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Pteroylpoly-gamma-glutamate carboxypeptidase) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Folate hydrolase 1) (Prostate-specific membrane antigen) (PSMA) (PSM)

	TK040203_NMyc_nuclei2_step01.4406.4406.1	1.5417	0.0412	1254.64	30	4500.0%	6	R.HVIYAPSSHNK.Y

Q9NXD7

57.2%

1001

111693

6.8

(Q9NXD7) Hypothetical protein FLJ20307

*	TK040203_NMyc_nuclei2_step05.1239.1239.1	0.8211	0.0226	1177.16	9	4500.0%	1	K.DDELASTTTPK.R
*	TK040203_NMyc_nuclei2_step11.1491.1491.1	1.5976	0.1223	1452.28	3	4000.0%	1	R.KHSHQYSYLCK.V

Q9GZU5

57.2%

481

52000

8.7

(Q9GZU5) Nyctalopin precursor (CSBN1) (DJ169I5.2)

*	TK040203_NMyc_nuclei2_step06.1471.1471.3	1.4059	0.1025	1940.26	78	2670.0%	1	R.AWFADLAELELLYLDR.N
*	TK040203_NMyc_nuclei2_step06.3327.3327.3	2.469	0.429	3421.15	1	1940.0%	1	R.AVHAGAFGDCGVLEHLLLNDNLLAELPADAFR.G

BP28_HUMAN

57.2%

2144

242355

6.6

(Q9H583) Protein BAP28

*	TK040203_NMyc_nuclei2_step11.0975.0975.2	1.0541	0.1056	1264.81	4	3640.0%	1	R.GLVGNPLPSVRR.K
*	TK040203_NMyc_nuclei2_step07.1722.1722.3	1.5985	0.0515	3992.53	33	1100.0%	1	K.EEILSENDQLSNQVVVCLLPFVVINNDDTESAEMK.I
*	TK040203_NMyc_nuclei2_step09.2161.2161.2	1.2005	0.0619	2502.58	6	2140.0%	1	K.AYDLLDKVNALLPTETFIPVIR.G
*	TK040203_NMyc_nuclei2_step01.3988.3988.2	1.4735	0.0906	2986.96	1	2120.0%	1	R.RAAIQCLQALSGVASPFYLIIDHLISK.A
*	TK040203_NMyc_nuclei2_step01.3618.3618.2	1.3278	0.0188	2674.54	11	2050.0%	1	R.DYLHLLIGLFEMMLNGADAVHFR.V
*	TK040203_NMyc_nuclei2_step10.3436.3436.2	1.6258	0.069	2896.56	37	1540.0%	1	K.LIGVANQKMIELLADNINLGDPSSMLK.M
*	TK040203_NMyc_nuclei2_step05.3748.3748.3	1.4672	0.1507	4788.28	5	1310.0%	1	R.LSEMPQTHHHALLLLGTVAGIFPDKVLHNIMSIFTFMGANVMR.L
*	TK040203_NMyc_nuclei2_step01.2854.2854.1	1.2761	0.0484	1311.68	2	4500.0%	9	K.LPEEKEETIPK.A

OSB2_HUMAN

57.2%

15.3%

878

97666

6.3

(Q969R2) Oxysterol-binding protein 2 (Oxysterol binding protein-related protein 4) (OSBP-related protein 4) (ORP-4)

*	TK040203_NMyc_nuclei2_step11.3687.3687.3	2.203	0.1374	4115.74	19	1220.0%	1	R.SEPVSETTSEPEPGAGQPSELLQGSRPGSESSSGVGAGPFTK.A
*	TK040203_NMyc_nuclei2_step03.2855.2855.2	1.153	0.0884	2806.64	8	1960.0%	1	K.YISIMPLGAIHLEFQASGNHYVWR.K
*	TK040203_NMyc_nuclei2_step09.3667.3667.2	1.7065	0.2971	3005.8	2	1730.0%	1	K.STSTVHNIIVGKLWIDQSGDIEIVNHK.T
*	TK040203_NMyc_nuclei2_step11.4083.4083.3	2.698	0.0242	4580.64	35	1000.0%	2	K.SFIEGSLLTPKGEDSEEDEDTEYFDAMEDSTSFITVITEAK.E

Q99JG6

57.2%

473

55550

8.1

(Q99JG6) Nuclear export factor-a isoform 1 (Fragment)

	TK040203_NMyc_nuclei2_step09.3039.3039.2	1.7169	0.2915	2923.07	4	1880.0%	1	R.AFMRIFIALLGSSNMYIVNDQLFVR.N
	TK040203_NMyc_nuclei2_step01.4519.4519.2	0.9412	0.0263	2962.58	34	1880.0%	1	K.IHNEYFQKIPIFVNPSVAPYSVQNR.F

Q9CUB6

57.2%

223

25596

7.6

(Q9CUB6) 4933428L19Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step08.1596.1596.2	1.7373	0.2907	1934.32	5	2810.0%	1	K.SMAISLSKMYIEQNACS.-

BSS4_HUMAN

57.0%

317

33732

7.6

(Q9GZN4) Brain-specific serine protease 4 precursor (EC 3.4.21.-) (BSSP-4) (SP001LA)

*	TK040203_NMyc_nuclei2_step01.1818.1818.1	1.4511	0.0718	1575.89	15	3460.0%	2	K.EGACADIALVRLER.S

Q96D09

57.0%

838

93773

5.0

(Q96D09) Similar to KIAA0443 gene product

	TK040203_NMyc_nuclei2_step01.0611.0611.3	1.8546	0.1104	2204.38	6	2760.0%	1	R.DSGVVSLIETLLNYPSSRVR.T
*	TK040203_NMyc_nuclei2_step01.4051.4051.2	1.3276	0.177	3184.7	7	1670.0%	1	K.SSLGAVAREEAKPESEEEAIFGSWFWDR.D
*	TK040203_NMyc_nuclei2_step11.2594.2594.3	1.4417	0.0031	4313.39	5	1160.0%	3	K.DEAQAWAQSEFGTEAVSQAEGVSQTNAVAWPLATAESGSVTK.S
*	TK040203_NMyc_nuclei2_step11.4176.4176.2	1.3756	0.0739	2858.26	22	1880.0%	1	R.EFEELAKQLQAQIDNQNDPEVGQQS.-
*	TK040203_NMyc_nuclei2_step04.3432.3432.2	1.1477	0.0777	2918.81	6	1880.0%	1	K.MSLIDDDFSLEPLISAFREFEELAK.Q

SB10_HUMAN

57.0%

22.4%

397

45403

6.2

(P48595) Bomapin (Protease inhibitor 10) (Serpin B10)

*	TK040203_NMyc_nuclei2_step12.1975.1975.3	1.8285	0.2048	3953.6	1	1570.0%	1	K.NIFFSSWSISTSLTIVYLGAKGTTAAQMAQVLQFNR.D
*	TK040203_NMyc_nuclei2_step07.3520.3520.3	1.5521	0.1285	3785.89	101	1050.0%	1	K.MEFNLSNSEEIHSDFQTLISEILKPNDDYLLK.T
*	TK040203_NMyc_nuclei2_step04.2314.2314.1	1.6597	0.1076	1465.77	2	5000.0%	1	R.HNKTNTILFYGR.L
*	TK040203_NMyc_nuclei2_step11.3579.3579.3	2.3537	0.159	4733.97	19	1190.0%	1	K.MEFNLSNSEEIHSDFQTLISEILKPNDDYLLKTANAIYGEK.T

A10C_HUMAN

57.0%

1499

167687

8.4

(O60312) Potential phospholipid-transporting ATPase VC (EC 3.6.3.1) (ATPVC) (Aminophospholipid translocase VC)

*	TK040203_NMyc_nuclei2_step09.3391.3391.2	1.2615	0.0621	2924.2	185	1150.0%	1	R.LETNLHLLGATGIEDRLQDGVPETISK.L
*	TK040203_NMyc_nuclei2_step09.1565.1565.2	1.282	0.1044	1713.76	1	3330.0%	1	-.MEREPAGTEEPGPPGR.R
*	TK040203_NMyc_nuclei2_step01.3028.3028.1	1.6617	0.1082	1494.55	1	5000.0%	1	R.SLAYALEKNLEDK.F

Q9BYG8

57.0%

33.7%

508

57692

5.8

(Q9BYG8) MLZE

*	TK040203_NMyc_nuclei2_step08.3007.3007.2	1.4658	0.1695	2594.56	4	2170.0%	1	R.SEGLLPSFHTISPTLFNASSNDMK.L
*	TK040203_NMyc_nuclei2_step08.3231.3231.3	1.8674	0.0866	4747.63	1	1220.0%	1	R.TFQDEYEISEMVGYCAARSEGLLPSFHTISPTLFNASSNDMK.L
*	TK040203_NMyc_nuclei2_step09.4211.4211.2	1.2405	0.0462	2936.09	20	1730.0%	1	R.STWDVEAKMPLSALYGTLSLLQQLAEA.-
*	TK040203_NMyc_nuclei2_step12.3850.3850.3	1.4311	0.0223	4285.83	10	1250.0%	1	R.GDNLYVVTEAVELINNTVLYDSSSVNILGKIALWITYGK.G
*	TK040203_NMyc_nuclei2_step04.1347.1347.1	1.1467	0.0741	958.52	159	4290.0%	1	K.GMVMAYKR.K
*	TK040203_NMyc_nuclei2_step12.2837.2837.1	1.6558	0.1007	1447.72	1	4580.0%	1	K.DLTPVKYLLSATK.L
*	TK040203_NMyc_nuclei2_step11.1875.1875.3	1.8291	0.0291	4479.35	4	1220.0%	1	K.ADMGVNVGIEVSVSGEASVDHGCSLEFQIVTIPSPNLEDFQK.R

Q9JJF3

57.0%

603

67587

8.5

(Q9JJF3) Brain cDNA, clone MNCb-7109, similar to AF000198, weak similarity to HSP90 (Caenorhabditis elegans)

*	TK040203_NMyc_nuclei2_step06.3599.3599.2	0.8302	0.0832	1267.51	157	2000.0%	1	R.KRPAELLEASR.S
*	TK040203_NMyc_nuclei2_step07.3317.3317.1	1.6453	0.1158	1334.43	1	4550.0%	1	R.ERALSVHGLPVR.W

PSPB_MOUSE

56.9%

34.5%

377

41728

6.2

(P50405) Pulmonary surfactant-associated protein B precursor (SP-B) (Pulmonary surfactant-associated proteolipid SPL(Phe))

*	TK040203_NMyc_nuclei2_step12.1919.1919.2	1.5333	0.1985	2772.72	13	2170.0%	1	K.SVINQAWNTSEQAMPQAMHQACLR.F
*	TK040203_NMyc_nuclei2_step11.3486.3486.3	1.9981	0.1422	4694.29	8	1190.0%	1	K.LVLPVLPGALLARPGPHTQDFSEQQLPIPLPFCWLCRTLIK.R
*	TK040203_NMyc_nuclei2_step12.2274.2274.2	1.2024	0.0324	2315.69	27	2140.0%	1	R.GQAKPEQNPGMPDAVPNPLLDK.L
*	TK040203_NMyc_nuclei2_step12.3689.3689.3	2.4202	0.1779	3735.79	11	1450.0%	1	R.CSTEDAMGPALPAVEPLIEEWPLQDTECHFCK.S
*	TK040203_NMyc_nuclei2_step05.1660.1660.1	1.4636	0.1643	1296.66	2	4500.0%	1	K.AICNHVGLCPR.G

Q9BXM2

56.9%

16.3%

153

17668

8.3

(Q9BXM2) ARG99

	TK040203_NMyc_nuclei2_step01.3614.3614.2	2.0593	0.2522	2976.04	5	2290.0%	1	K.MTNHIVSEETGCLECYRLLSAIYSK.Q

Q9R1I1

56.8%

18.3%

388

44636

8.6

(Q9R1I1) L-selectin ligand sulfotransferase

	TK040203_NMyc_nuclei2_step03.3517.3517.2	1.4556	0.2138	2210.07	7	2500.0%	1	R.SVFLCDMSVFDAYMNPGPR.K
*	TK040203_NMyc_nuclei2_step10.3619.3619.2	2.0802	0.2454	2855.47	2	2500.0%	1	R.SREHTTIELVVDSHIVLGQHLETIK.E
	TK040203_NMyc_nuclei2_step02.2718.2718.3	2.3028	0.0635	3131.31	17	1730.0%	1	R.LLMFLGSQVIVVALFIHMSVHRHLSQR.E

Q92514

56.8%

983

105052

8.1

(Q92514) Hypothetical protein KIAA0240 (Fragment)

*	TK040203_NMyc_nuclei2_step09.2614.2614.1	1.4315	0.0191	1470.76	20	3640.0%	6	R.MFNQEERASLSR.D

Q9BWS8

56.7%

170

19238

10.1

(Q9BWS8) Similar to HSPC135 protein

*	TK040203_NMyc_nuclei2_step02.2364.2364.1	1.4548	0.1682	1331.54	2	4090.0%	1	K.ALFSLAPEVEVR.V

PER1_MOUSE

56.7%

1291

136403

6.1

(O35973) Period circadian protein 1 (Circadian pacemaker protein Rigui) (mPER) (M-Rigui)

*	TK040203_NMyc_nuclei2_step02.2128.2128.2	0.957	0.0277	1860.16	4	2650.0%	1	K.YFGSIDSSEAEAGAARAR.T
	TK040203_NMyc_nuclei2_step12.2405.2405.2	0.9422	0.0311	2968.07	138	1620.0%	1	R.SGTGSAASGSLGSGLGSGSGSGSHEGGSTSASITR.S
*	TK040203_NMyc_nuclei2_step05.2548.2548.3	1.7274	0.0561	3827.38	16	1320.0%	1	K.VRTAPLNEDVFTPPAPSPAPSLDSDIQELSEQIHR.L
*	TK040203_NMyc_nuclei2_step07.3361.3361.3	1.5552	0.0705	3150.12	32	1520.0%	1	R.LVEVTESSNQDALSGSSDLLELLLQEDSR.S
	TK040203_NMyc_nuclei2_step05.3279.3279.2	1.657	0.0683	2298.35	131	1590.0%	2	R.SSHSSSSGNGKDSALLETTESSK.S
*	TK040203_NMyc_nuclei2_step01.1024.1024.1	1.6439	0.0469	1081.43	20	4500.0%	2	K.QRAGPVPVGAK.K

Q9BW74

56.7%

246

25274

11.3

(Q9BW74) Hypothetical protein (Fragment)

	TK040203_NMyc_nuclei2_step06.2939.2939.2	1.4898	0.1713	2415.37	241	1520.0%	1	R.APPATETPGPEKAATDLPAPETPR.K
	TK040203_NMyc_nuclei2_step02.1471.1471.1	1.5121	0.1476	1416.71	1	4230.0%	1	R.SAPEAASMLAAELR.G

O14712

56.7%

375

44320

9.4

(O14712) Cell cycle progression restoration 8 protein

	TK040203_NMyc_nuclei2_step01.2848.2848.1	1.543	0.1402	1195.36	2	5620.0%	7	R.QIIQRYMLK.E

Q9D3T3

56.6%

19.5%

302

32860

9.3

(Q9D3T3) 4933436G17Rik protein

*	TK040203_NMyc_nuclei2_step09.2851.2851.3	1.6684	0.0136	4687.68	6	1040.0%	2	K.DSAAAVTSATASASAGASGGLQPPQLSSCDGELAVAPLPEGDLPGQFTR.V
	TK040203_NMyc_nuclei2_step01.2675.2675.1	1.4176	0.2149	1168.66	2	5560.0%	1	R.KTLLDISGYR.Q

MTN3_MOUSE

56.6%

481

51859

7.5

(O35701) Matrilin-3 precursor

*	TK040203_NMyc_nuclei2_step12.3618.3618.3	2.052	0.1489	4610.01	7	1060.0%	1	R.TCAALDKCASGTHGCQHICVNDGAGSHHCECFEGYTLNADK.K
*	TK040203_NMyc_nuclei2_step09.2794.2794.3	2.8484	0.1369	2602.36	1	2740.0%	2	K.MMASKPLEEHVFYVETYGVIEK.L

TDR1_HUMAN

56.5%

777

86763

5.2

(Q9BXT4) Tudor domain containing protein 1

*	TK040203_NMyc_nuclei2_step10.2201.2201.2	1.2882	0.0055	2522.6	11	1750.0%	1	K.QVEKHEHILLFLLNNSTNQNK.F
*	TK040203_NMyc_nuclei2_step01.3824.3824.3	1.9031	0.0348	4317.46	3	1390.0%	1	K.YTSDDFWYRAVVLGTSDTDVEVLYADYGNIETLPLCR.V
*	TK040203_NMyc_nuclei2_step02.1934.1934.1	1.6076	0.0146	1009.45	1	6880.0%	5	K.EILPNGHVK.V
*	TK040203_NMyc_nuclei2_step10.2769.2769.2	1.2636	0.0070	3176.05	25	1670.0%	1	K.HELQVHVQGLQATSSAEQWKTIELPVDK.T

Q9UI45

56.5%

2039

229479

7.0

(Q9UI45) PHD finger protein 3

*	TK040203_NMyc_nuclei2_step01.0671.0671.1	1.544	0.0294	995.62	3	5620.0%	6	K.IQSCNSGVK.S
*	TK040203_NMyc_nuclei2_step01.2739.2739.1	1.1997	0.0076	1358.76	23	4000.0%	1	R.YIGPQNFYQVK.D
*	TK040203_NMyc_nuclei2_step02.1757.1757.1	1.2317	0.1127	1290.56	1	5000.0%	1	R.FYSDSHHLKR.E
*	TK040203_NMyc_nuclei2_step06.2154.2154.2	1.1137	0.0989	2304.15	34	1840.0%	1	K.SFSLDEPPLFIPDNIATIRR.E

CPSA_MOUSE

56.4%

1441

160818

6.4

(Q9EPU4) Cleavage and polyadenylation specificity factor, 160 kDa subunit (CPSF 160 kDa subunit)

	TK040203_NMyc_nuclei2_step11.1887.1887.2	1.4598	0.2327	1947.77	3	3120.0%	1	R.ISVLPAYLSYDAPWPVR.K
	TK040203_NMyc_nuclei2_step08.2676.2676.2	1.3685	0.0201	2455.4	147	1580.0%	1	R.ENGTMEIYQLPDWRLVFLVK.N
*	TK040203_NMyc_nuclei2_step01.1636.1636.1	1.4976	0.0666	1571.81	9	2920.0%	7	R.MTGEEKEFEAIER.D
*	TK040203_NMyc_nuclei2_step12.3333.3333.2	1.3192	0.1056	3150.25	6	1670.0%	1	R.ESLAEEHEGLMGEGQRSSFLPSYIIDVR.A
	TK040203_NMyc_nuclei2_step05.4314.4314.1	0.7948	0.0922	1454.45	3	2730.0%	1	K.SISLLRYQEESK.T

Q99LG1

56.4%

249

27398

7.0

(Q99LG1) Similar to hypothetical protein FLJ10199

*	TK040203_NMyc_nuclei2_step08.1853.1853.1	1.4405	0.1719	1368.54	1	4580.0%	1	R.AETETSPGHAPDR.Q

ECEL_MOUSE

56.2%

775

87993

7.8

(Q9JMI0) Endothelin-converting enzyme-like 1 (EC 3.4.24.-) (Xce protein) (Damage-induced neuronal endopeptidase)

*	TK040203_NMyc_nuclei2_step11.4136.4136.2	2.1666	0.1873	2665.41	2	2270.0%	1	R.IDQDGLTLPERTLYLAQDEESEK.I
*	TK040203_NMyc_nuclei2_step09.3171.3171.3	1.8209	0.0763	3723.76	1	1590.0%	1	R.LGPRPMLEVIEDCGGWDLGGAADRPGAARWDLNR.L

BLM_HUMAN

56.2%

1417

159000

7.5

(P54132) Bloom's syndrome protein (EC 3.6.1.-) (RecQ protein-like 3) (DNA helicase, RecQ-like, type 2)

*	TK040203_NMyc_nuclei2_step10.3607.3607.3	1.6386	0.0494	4578.48	119	850.0%	1	K.SSSIIGSSSASHTSQATSGANSKLGIMAPPKPINRPFLKPSYAFS.-
*	TK040203_NMyc_nuclei2_step08.1184.1184.1	1.1357	0.0044	878.61	52	5000.0%	1	K.EDVLSTSK.D
*	TK040203_NMyc_nuclei2_step12.3914.3914.2	1.3689	0.0068	2610.32	31	1880.0%	1	K.YSEWTSPAEDSSPGISLSSSRGPGR.S
*	TK040203_NMyc_nuclei2_step04.1558.1558.1	1.3797	0.2379	765.48	1	5710.0%	2	R.KTASSGSK.A
*	TK040203_NMyc_nuclei2_step10.2628.2628.3	1.6635	0.0782	3410.42	3	1530.0%	1	K.ELNFSHLPSNSVSPGDCLLTTTLGKTGFSATR.K
*	TK040203_NMyc_nuclei2_step12.2955.2955.2	1.4418	0.1366	3181.18	5	1670.0%	1	K.LILDKILDEDLYINANDQAIAYVMLGNK.A

Q9UIG0

56.2%

1527

176033

8.2

(Q9UIG0) Bromodomain adjacent to zinc finger domain 1B

	TK040203_NMyc_nuclei2_step12.1634.1634.2	1.9634	0.2641	1997.64	2	3240.0%	1	K.APPVDDAEVDELVLQTKR.S

ACDM_MOUSE

56.2%

421

46481

8.4

(P45952) Acyl-CoA dehydrogenase, medium-chain specific, mitochondrial precursor (EC 1.3.99.3) (MCAD)

*	TK040203_NMyc_nuclei2_step03.1765.1765.2	1.8438	0.3478	1470.13	26	4290.0%	3	R.TRPTVAAGAVGLAQR.A

BRC2_HUMAN

56.2%

3418

384227

6.7

(P51587) Breast cancer type 2 susceptibility protein

*	TK040203_NMyc_nuclei2_step02.2774.2774.3	1.5108	0.0665	3733.77	49	1180.0%	1	K.EDSLCPNLIDNGSWPATTTQNSVALKNAGLISTLK.K
*	TK040203_NMyc_nuclei2_step03.1367.1367.1	0.9067	0.0887	806.55	2	6670.0%	1	K.QDTITTK.K
*	TK040203_NMyc_nuclei2_step05.2982.2982.2	1.2583	0.0534	2783.23	1	2080.0%	1	K.NNDYMNKWAGLLGPISNHSFGGSFR.T
	TK040203_NMyc_nuclei2_step03.1809.1809.1	0.7491	0.0092	1090.38	171	2500.0%	1	K.VIKENNENK.S
*	TK040203_NMyc_nuclei2_step06.3259.3259.2	1.702	0.0104	3075.85	2	2040.0%	1	K.ISKEVVPSLACEWSQLTLSGLNGAQMEK.I
*	TK040203_NMyc_nuclei2_step03.3547.3547.2	2.0363	0.2521	2293.55	1	3000.0%	1	K.DFETSDTFFQTASGKNISVAK.E

Q9D052

56.1%

22.6%

190

21051

9.9

(Q9D052) 2610103J23Rik protein

*	TK040203_NMyc_nuclei2_step02.3231.3231.2	2.0286	0.2503	2470.76	1	3410.0%	1	R.ELLSVGLGFLRTELGLDLGLEPK.R
*	TK040203_NMyc_nuclei2_step12.4354.4354.3	1.1341	0.077	2146.45	146	1450.0%	1	R.EEAAPPTPAPDDLAQLKNLR.S

I5P1_HUMAN

56.1%

13.8%

412

47820

7.0

(Q14642) Type I inositol-1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.56) (5PTASE)

*	TK040203_NMyc_nuclei2_step07.2522.2522.3	2.5066	0.3402	4433.29	1	1280.0%	1	R.WCIADCAFDLVNIHLFHDASNLVAWETSPSVYSGIRHK.A
	TK040203_NMyc_nuclei2_step12.2906.2906.2	1.5364	0.1853	2263.95	1	3060.0%	1	R.LYELDISFPPSYPYSEDAR.Q

GCP5_HUMAN

56.0%

1024

118321

5.9

(Q96RT8) Gamma-tubulin complex component 5 (GCP-5)

*	TK040203_NMyc_nuclei2_step01.2700.2700.3	1.3313	0.0021	3368.58	4	1720.0%	1	K.TDAHYSILSLLLCLSDSPSNSSYVETPRNK.E
*	TK040203_NMyc_nuclei2_step01.2750.2750.1	1.4998	0.1547	1163.8	4	6250.0%	1	K.EPVRQQIHR.M

Q63918

56.0%

418

46764

5.2

(Q63918) Serum deprivation response (Sdpr protein)

	TK040203_NMyc_nuclei2_step03.1767.1767.1	1.5481	0.0178	1365.8	12	4000.0%	2	K.RLENNHAQLLR.R
*	TK040203_NMyc_nuclei2_step03.3302.3302.2	1.169	0.0492	2856.85	7	2040.0%	1	R.EEGSFTEGLSEASLPSGLMEGSAEDAEK.S
*	TK040203_NMyc_nuclei2_step11.3719.3719.2	1.1111	0.0206	3174.06	57	1170.0%	1	R.EEGSFTEGLSEASLPSGLMEGSAEDAEKSAR.R

DIA3_MOUSE

56.0%

1171

133686

7.6

(Q9Z207) Diaphanous protein homolog 3 (Diaphanous-related formin 3) (DRF3) (mDIA2) (p134mDIA2)

*	TK040203_NMyc_nuclei2_step12.2422.2422.3	1.7913	0.0437	4088.05	112	970.0%	2	R.VSLTSHPVSWVQSFGHEGLGLLLDILEKLINGQIQEK.V
	TK040203_NMyc_nuclei2_step06.1435.1435.1	1.156	0.0707	538.41	4	8330.0%	1	R.LHLR.N
	TK040203_NMyc_nuclei2_step01.0734.0734.1	1.3031	0.0081	827.73	2	6670.0%	1	K.EILPNLK.G
*	TK040203_NMyc_nuclei2_step05.1248.1248.1	1.2242	0.0010	865.48	6	5000.0%	4	K.TGSLRSSR.Q

BGAL_MOUSE

56.0%

647

73121

7.5

(P23780) Beta-galactosidase precursor (EC 3.2.1.23) (Lactase) (Acid beta-galactosidase)

*	TK040203_NMyc_nuclei2_step11.4138.4138.2	1.2335	0.0664	3002.37	9	1730.0%	1	K.CGTLQDLYATVDFGTGNNITQAFLVQR.K
*	TK040203_NMyc_nuclei2_step08.3401.3401.1	1.476	0.1564	1350.19	2	4170.0%	1	K.EVPEGPIPPSTPK.F
*	TK040203_NMyc_nuclei2_step11.3119.3119.2	1.3895	0.1832	2773.55	1	2610.0%	1	K.GPLINSEFYTGWLDHWGKPHSTVK.T

DPY5_HUMAN

55.8%

564

61421

7.2

(Q9BPU6) Dihydropyrimidinase related protein-5 (DRP-5) (ULIP6 protein) (Collapsin response mediator protein-5) (CRMP-5)

*	TK040203_NMyc_nuclei2_step05.2927.2927.2	2.1312	0.1872	2070.18	1	4120.0%	1	K.IPHGVSGVQDRMSVIWER.G

Q13116

55.7%

353

36935

10.3

(Q13116) Membrane protein-like protein (Fragment)

	TK040203_NMyc_nuclei2_step01.3402.3402.1	1.6076	0.1132	1256.71	1	5000.0%	1	R.GGSPRSQASRPR.R

SACS_MOUSE

55.6%

3830

436758

7.1

(Q9JLC8) Sacsin

*	TK040203_NMyc_nuclei2_step10.3245.3245.3	2.8369	0.0879	3110.44	1	2310.0%	1	K.DAEESEFEVEGLPLLITLDSVLQIFDGK.R
*	TK040203_NMyc_nuclei2_step09.1302.1302.1	0.9406	0.0102	1117.49	18	4380.0%	1	K.LENFIQQKV.-
	TK040203_NMyc_nuclei2_step10.2481.2481.2	1.2454	0.0534	2204.68	275	1670.0%	1	K.SVDDGITLYQENITNACYK.Y
*	TK040203_NMyc_nuclei2_step12.1559.1559.2	1.2579	0.0659	2362.9	2	2370.0%	1	K.DDILWDDMLERAESVAEINK.S
*	TK040203_NMyc_nuclei2_step12.2729.2729.2	1.2352	0.0327	3167.89	58	1480.0%	1	K.SATDNLISDTSYLIAMLGCNDIYRISEK.L
*	TK040203_NMyc_nuclei2_step08.1755.1755.2	1.0609	0.117	2252.54	2	2630.0%	1	K.VNALPEILKEVTSVVEQAWK.L
*	TK040203_NMyc_nuclei2_step11.4523.4523.2	1.1161	0.1232	2632.31	1	2500.0%	1	-.MNTFWPGRELVVQWYPFSEDK.R
	TK040203_NMyc_nuclei2_step07.3250.3250.2	1.2503	0.0613	1803.56	34	2670.0%	1	R.FGNAVILLYIQHSDSK.D
	TK040203_NMyc_nuclei2_step01.0668.0668.3	1.2164	0.0173	2279.48	140	2060.0%	1	K.YSFQRFYTSWNQEATSHK.S
*	TK040203_NMyc_nuclei2_step02.2683.2683.2	1.4299	0.0847	2634.4	19	2050.0%	1	K.QVAKSVDDGITLYQENITNACYK.Y
	TK040203_NMyc_nuclei2_step07.1149.1149.1	0.7927	0.0471	853.54	2	5830.0%	1	K.RLLPVVR.A
	TK040203_NMyc_nuclei2_step01.1470.1470.1	1.0536	0.0799	1088.61	6	4440.0%	2	K.AGCIQLALNK.I
	TK040203_NMyc_nuclei2_step08.3397.3397.1	1.3667	0.0705	1462.51	58	2920.0%	1	K.DINFLLALAMTLK.S
*	TK040203_NMyc_nuclei2_step01.1054.1054.1	1.0577	0.0946	1135.43	1	5000.0%	1	K.GFYEDIAHGK.G
	TK040203_NMyc_nuclei2_step11.2870.2870.2	1.3609	0.0213	2470.03	2	2250.0%	1	R.SFLMTFSSPDTNCHIGKLPCR.L
	TK040203_NMyc_nuclei2_step04.3632.3632.3	1.7915	0.0443	4098.78	47	1180.0%	1	K.FGLGFNSVYHITDIPIIMSREFMIMFDPNINHISK.H

Q96SL1

55.6%

12.6%

478

52088

8.5

(Q96SL1) Hypothetical protein FLJ14784

*	TK040203_NMyc_nuclei2_step02.3432.3432.2	1.9197	0.2611	2990.31	2	1920.0%	1	R.ITVLLTSFLMVLGTGLRCIPISDLILK.R
*	TK040203_NMyc_nuclei2_step02.2980.2980.3	1.9233	0.0269	3506.47	27	1250.0%	1	R.LIHGGQMLNGLAGPTVMNAAPFLSTTWFSADER.A

Q9NTW9

55.6%

918

103145

8.1

(Q9NTW9) DJ794I6.2 (Novel protein similar to solute carrier family 4, anion exchanger, member 1 (Erythrocyte membrane protein band 3, Diego blood group)(SLC4A1))

*	TK040203_NMyc_nuclei2_step05.1507.1507.1	1.2704	0.1218	1257.39	6	4440.0%	1	K.KSPYLHPCVR.E
*	TK040203_NMyc_nuclei2_step01.4232.4232.3	2.0701	0.1691	4603.96	1	1380.0%	1	R.LVKGTAYHWDLLLLAIINTGLSLFGLPWIHAAYPHSPLHVR.A
*	TK040203_NMyc_nuclei2_step06.3203.3203.3	2.4759	0.4188	3680.62	2	1770.0%	1	K.VHLLSDTIQGVTATVTGVRYQQSWLCIICTMK.A

Q14789

55.5%

3259

376078

5.0

(Q14789) GIANTIN (GCP372) (MACROGOLGIN) (Golgi autoantigen, golgin subfamily B, 1)

*	TK040203_NMyc_nuclei2_step01.0623.0623.1	1.1278	0.0077	879.42	7	6430.0%	1	K.STKQDGDK.S
*	TK040203_NMyc_nuclei2_step04.4232.4232.2	1.0079	0.0158	2655.94	3	2170.0%	1	R.DALLSETAFSMNSTEENSLSHLEK.L
*	TK040203_NMyc_nuclei2_step01.3502.3502.1	1.0779	0.0044	1592.71	98	2920.0%	1	K.RDVETLQQTIEEK.D
*	TK040203_NMyc_nuclei2_step05.2000.2000.3	2.8141	0.1191	2188.61	1	4170.0%	1	K.EAALTKIQTEIIEQEDLIK.A
*	TK040203_NMyc_nuclei2_step06.3887.3887.3	0.9768	0.026	2695.51	6	1360.0%	1	K.DEQLLHLSSQLEDSYNQVQSFSK.A
*	TK040203_NMyc_nuclei2_step07.3864.3864.2	1.0879	0.1037	2592.24	10	2140.0%	1	K.SEEVFQLQEQINKQGLEIESLK.T

CD53_MOUSE

55.5%

218

24033

7.1

(Q61451) Leukocyte surface antigen CD53 (Cell surface glycoprotein CD53)

*	TK040203_NMyc_nuclei2_step02.3226.3226.3	2.4956	0.3592	3897.5	1	1720.0%	1	K.ENKCLLMSFFVLLLIILLAEVTIAILLFVYEQK.L

MY9B_MOUSE

55.5%

2114

238832

8.6

(Q9QY06) Myosin IXb (Unconventional myosin-9b)

*	TK040203_NMyc_nuclei2_step10.3133.3133.2	1.4154	0.0162	2442.04	1	2750.0%	4	R.GEKDTNLVLNVFQSLLDEFTR.S
	TK040203_NMyc_nuclei2_step12.2259.2259.2	1.3262	0.0347	2560.76	20	1900.0%	1	K.NMDYMRPDIVALLRGSDSSYVR.Q
*	TK040203_NMyc_nuclei2_step08.4302.4302.2	1.4433	0.0481	3156.27	15	1540.0%	1	K.QQHEDNKYFLGTPVLEPAFIIQHFAGR.V
*	TK040203_NMyc_nuclei2_step11.4390.4390.3	2.0583	0.0362	3804.47	7	1480.0%	1	R.LVERGLLPRPQADFDDLCNLPELTEANLLQNLK.L
	TK040203_NMyc_nuclei2_step11.1774.1774.3	1.7455	0.0313	2997.88	47	1600.0%	1	K.ASVPIVLEKLLEHVEMHGLYTEGLYR.K
*	TK040203_NMyc_nuclei2_step05.3314.3314.2	1.1062	0.0912	2940.69	93	1400.0%	1	K.HYVLVEVKESGGEEWVLDASDSPVHR.V
*	TK040203_NMyc_nuclei2_step11.3442.3442.3	2.3595	0.0734	3503.43	5	1750.0%	1	R.AVELPEKQEQLSAIYAVLDHLPEANHTSLER.L
*	TK040203_NMyc_nuclei2_step02.4156.4156.2	1.3265	0.047	1971.86	9	3120.0%	1	R.QLIGMDPVAVFRWAVLR.A
*	TK040203_NMyc_nuclei2_step10.3894.3894.3	1.3864	0.1095	4367.54	23	1290.0%	1	K.QERAVQEHNGHVFASYQVNIPQSCEQCLSYIWLMDK.A
*	TK040203_NMyc_nuclei2_step12.2427.2427.2	0.977	0.1453	2892.02	244	910.0%	1	R.NYHVFYYLLLGVSEEERLEFQLK.Q

Q9D246

55.5%

19.5%

200

20930

6.3

(Q9D246) Nuclear factor, erythroid derived 2, like 3

*	TK040203_NMyc_nuclei2_step10.3237.3237.3	1.8177	0.0451	3066.02	10	1700.0%	2	K.AAEPTAQVPDAGGCGSQFQANLTPSCCLR.E
*	TK040203_NMyc_nuclei2_step11.1975.1975.3	1.8204	0.1245	4299.33	9	1120.0%	1	K.AAEPTAQVPDAGGCGSQFQANLTPSCCLREHCIHSMPLK.R

GLMT_HUMAN

55.5%

22.8%

294

32611

7.0

(Q14749) Glycine N-methyltransferase (EC 2.1.1.20)

*	TK040203_NMyc_nuclei2_step11.1834.1834.3	2.8135	0.1534	3476.12	5	1480.0%	1	R.VLDVACGTGVDSIMLVEEGFSVTSVDASDKMLK.Y
*	TK040203_NMyc_nuclei2_step02.3974.3974.3	1.8471	0.1423	3716.28	19	1440.0%	1	K.DVPQSAEGGFDAVICLGNSFAHLPDCKGDQSEHR.L

Q8TB84

55.4%

14.5%

172

20490

8.8

(Q8TB84) Hypothetical protein

*	TK040203_NMyc_nuclei2_step06.3341.3341.2	1.2989	0.1412	2637.82	33	1670.0%	3	K.KLLVGALVALGLSEPEPDLNLCSKP.-

Q9JLV6

55.4%

494

54263

8.1

(Q9JLV6) Polynucleotide kinase 3'-phosphatase

*	TK040203_NMyc_nuclei2_step08.3112.3112.3	2.3691	0.1115	3001.78	61	1600.0%	1	K.STFIQEHLVSAGYVHVNRDTLGSWQR.C
*	TK040203_NMyc_nuclei2_step04.2611.2611.2	2.0113	0.2553	2058.32	1	3530.0%	1	K.STFIQEHLVSAGYVHVNR.D

Q96JT3

55.4%

2277

256973

7.4

(Q96JT3) ATP-binding cassette transporter family A member 12

*	TK040203_NMyc_nuclei2_step01.2387.2387.1	0.9183	0.0028	1080.73	88	3750.0%	1	R.NPFVQVFVK.F
	TK040203_NMyc_nuclei2_step12.2093.2093.2	1.2266	0.0282	2670.3	249	1460.0%	1	K.SYETADTSSQGSTISVDSQDDQMES.-
*	TK040203_NMyc_nuclei2_step10.2909.2909.3	1.8337	0.1279	3592.31	14	1470.0%	2	K.SQEWMDKSPLFMNSFHLLNQAIPMLQNTLR.N
*	TK040203_NMyc_nuclei2_step12.3518.3518.2	1.1779	0.0233	2694.79	7	1600.0%	1	K.TTTISMLTGLFGASAGTIFVYGKDIK.T
	TK040203_NMyc_nuclei2_step01.0539.0539.1	1.2394	0.1086	911.49	33	5710.0%	1	R.FGRGFTVK.V
	TK040203_NMyc_nuclei2_step03.1970.1970.1	1.4153	0.0181	1330.63	6	4000.0%	1	K.FQCIGSLQHIK.S
*	TK040203_NMyc_nuclei2_step06.2895.2895.2	1.5652	0.1375	2571.94	49	1670.0%	2	K.IGNSNANGISTPDDLSVSSSNFTDR.D

Q9H7N5

55.4%

22.9%

253

28659

8.2

(Q9H7N5) FLJ00033 protein (Fragment)

	TK040203_NMyc_nuclei2_step08.3133.3133.3	1.767	0.0097	4205.42	23	1250.0%	1	K.SSDYCEYLRPPIDSYSTLDFGKFNEICEVGYQHGR.T
	TK040203_NMyc_nuclei2_step03.2667.2667.3	2.5905	0.2649	2449.13	2	2500.0%	1	K.KPASAVLTCPNASFTDLAEIVSR.I

Q8TEH2

55.3%

2.0%

402

45777

9.4

(Q8TEH2) FLJ00225 protein (Fragment)

*	TK040203_NMyc_nuclei2_step10.1537.1537.1	1.5084	0.1432	860.46	3	6430.0%	1	R.QLVSGSLR.T

Q8TEE0

55.3%

820

93315

7.8

(Q8TEE0) FLJ00257 protein (Fragment)

*	TK040203_NMyc_nuclei2_step11.3267.3267.3	2.79	0.1659	4302.95	1	1550.0%	1	K.WVGMMTDTDPDLLQLSEDFECQLSLSSGPPLSRPVYSK.K
*	TK040203_NMyc_nuclei2_step03.2069.2069.3	1.6897	0.0935	2622.75	190	1630.0%	1	K.IALSSPAFAASVLHYTCRSETSVR.S
	TK040203_NMyc_nuclei2_step01.2860.2860.2	1.562	0.1799	2898.1	2	1880.0%	1	R.SLLSDQLGCEVLNLLTAQQYEIFSR.S

Q9BY88

55.2%

23.3%

395

45751

6.2

(Q9BY88) Hypothetical protein KIAA1672 (Fragment)

*	TK040203_NMyc_nuclei2_step06.2399.2399.2	1.7631	0.2728	2702.57	1	2610.0%	1	R.VQILTDEQVRNASQSSPCTPLAER.Q
	TK040203_NMyc_nuclei2_step12.3607.3607.2	1.1246	0.0173	3012.48	5	1850.0%	1	K.IQEVVESSQLALSTAFSALDKEDTGFVK.A
*	TK040203_NMyc_nuclei2_step08.2715.2715.3	1.9072	0.2996	4708.68	6	1090.0%	1	K.MQEVLEECGCSLTEGELTHLLNSWGVSRHDNAINYLDFLR.A
*	TK040203_NMyc_nuclei2_step08.2051.2051.1	1.1348	0.0757	1515.73	58	2690.0%	1	R.NASQSSPCTPLAER.Q

Q07900

55.2%

1156

125353

6.0

(Q07900) M130 antigen cytoplasmic variant 2 precursor

*	TK040203_NMyc_nuclei2_step12.3695.3695.2	1.3365	0.0131	3097.88	171	1070.0%	1	R.SSRQSSFIAVGILGVVLLAIFVALFFLTK.K
*	TK040203_NMyc_nuclei2_step07.2802.2802.2	1.495	0.0655	2165.95	1	3330.0%	1	K.EAEFGQGTGPIWLNEVKCK.G
*	TK040203_NMyc_nuclei2_step03.2301.2301.2	1.0022	0.028	1761.18	14	2670.0%	1	K.EADVVCRQLGCGSALK.T
*	TK040203_NMyc_nuclei2_step12.0764.0764.3	0.9694	0.0165	3642.43	260	1050.0%	1	K.VQEEWGTVCNNGWSMEAVSVICNQLGCPTAIK.A
*	TK040203_NMyc_nuclei2_step07.2614.2614.2	1.7647	0.2744	2605.76	1	2050.0%	2	K.HSNCTHQQDAGVTCSDGSNLEMR.L
*	TK040203_NMyc_nuclei2_step12.1974.1974.3	1.6367	0.0305	3624.01	77	1330.0%	1	R.HFVNLSPFTITVVLLLSACFVTSSLGGTDKELR.L

Q8WXG9

55.1%

6307

692686

4.6

(Q8WXG9) Very large G protein-coupled receptor 1b

*	TK040203_NMyc_nuclei2_step02.2839.2839.3	1.6108	0.0086	4002.02	30	1180.0%	1	K.AFSVSVLSVSSGSLGAHINATLTVLASDDPYGIFIFSEK.N
*	TK040203_NMyc_nuclei2_step07.3113.3113.2	1.4903	0.3135	2974.16	27	1600.0%	1	R.ATVIYNLAVLDDEVPENDEIFLIQLK.S
*	TK040203_NMyc_nuclei2_step06.3611.3611.2	1.3827	0.1411	1753.33	49	2670.0%	1	R.SESVFIELLNSTLVAK.V
*	TK040203_NMyc_nuclei2_step08.2876.2876.3	1.7347	0.0135	4149.93	6	1280.0%	1	K.DTLQGDAVLISPSVVQVTIKPNDKPYGVLSFNSVLFER.T
*	TK040203_NMyc_nuclei2_step03.3911.3911.1	0.7702	0.0079	829.27	64	2500.0%	1	R.VNITIIR.S
*	TK040203_NMyc_nuclei2_step02.2559.2559.2	1.504	0.1581	2886.26	2	1920.0%	1	K.VETIAQLIIIANDDAFGTLQLSAPIVR.V
*	TK040203_NMyc_nuclei2_step10.2973.2973.3	2.2117	0.2265	3751.68	24	1320.0%	1	K.VELLNLEGGVAELFRVDGSGSGDGDMEFFLPTIHK.R
*	TK040203_NMyc_nuclei2_step07.2284.2284.3	2.0488	0.0842	3277.29	3	1670.0%	1	R.LGPKVETIAQLIIIANDDAFGTLQLSAPIVR.V
*	TK040203_NMyc_nuclei2_step06.2158.2158.3	2.3196	0.0375	3492.22	29	1410.0%	1	K.VNLPIIRNSGTLGNVTVQWVATINGQLATGDLR.V
*	TK040203_NMyc_nuclei2_step10.3704.3704.3	1.7643	0.1584	3911.26	1	1740.0%	1	R.GAGEVITAYEVPPPLNVLQVPVVRLAGSFGAVNVYWK.A
*	TK040203_NMyc_nuclei2_step01.0068.0068.1	1.5506	0.0102	1359.63	2	4580.0%	1	R.TGGSLGQVAVEWR.V
*	TK040203_NMyc_nuclei2_step01.2814.2814.3	1.7066	0.1217	4382.99	75	1000.0%	1	K.VETIAQLIIIANDDAFGTLQLSAPIVRVAENHVGPIINVTR.T
*	TK040203_NMyc_nuclei2_step01.2035.2035.1	1.5363	0.1352	1443.74	1	4580.0%	1	R.YLSLSFTRLGGTK.G
*	TK040203_NMyc_nuclei2_step04.2462.2462.3	1.4367	0.0155	3122.49	10	1610.0%	1	R.EKGTYGMVMVTFEVEGGPNPPDEDLSPVK.G

Q8VCC8

55.1%

876

99231

8.1

(Q8VCC8) Similar to cAMP-regulated guanine nucleotide exchange factor I (cAMP-GEFI)

	TK040203_NMyc_nuclei2_step08.2825.2825.1	0.5184	0.037	485.83	5	6670.0%	1	R.ELEP.-
	TK040203_NMyc_nuclei2_step03.3677.3677.2	1.6872	0.3005	2461.91	3	2380.0%	1	K.EQKNLNSFFAVMFGLSNSAISR.L

OXI2_HUMAN

55.0%

312

35002

8.7

(Q9H344) Olfactory receptor 51I2 (HOR5'beta12)

*	TK040203_NMyc_nuclei2_step12.3793.3793.3	2.6135	0.246	3804.25	1	1850.0%	1	R.NITFDACLIQMFLIHFFSMMESGILLAMSFDR.Y
*	TK040203_NMyc_nuclei2_step09.3139.3139.3	1.8467	0.0106	4662.86	1	1380.0%	1	R.TFCLNARNITFDACLIQMFLIHFFSMMESGILLAMSFDR.Y

ILF3_MOUSE

55.0%

911

98042

9.2

(Q9Z1X4) Interleukin enhancer-binding factor 3

	TK040203_NMyc_nuclei2_step08.1552.1552.1	1.4904	0.1479	1199.14	3	4500.0%	1	K.EATDAIGHLDR.Q

Q9D5W2

55.0%

23.9%

113

12508

7.6

(Q9D5W2) 4921513I03Rik protein

*	TK040203_NMyc_nuclei2_step07.3729.3729.2	1.7312	0.2794	2914.78	5	1920.0%	1	R.AHLCLLEVSQGTLRGGALENFQTTEAP.-

O88849

55.0%

1062

117128

9.2

(O88849) Inv

	TK040203_NMyc_nuclei2_step07.1658.1658.1	1.2859	0.0285	1021.52	33	5000.0%	1	R.FMKLLLTR.R
	TK040203_NMyc_nuclei2_step09.4248.4248.2	1.7257	0.2814	2415.63	1	2950.0%	1	K.APAVLHLSSVNSLQSIHLDNSGR.S
	TK040203_NMyc_nuclei2_step12.3006.3006.2	1.407	0.0976	2550.3	1	2730.0%	1	K.HDSNIGIPDVEGKIPLHWAANHK.D
	TK040203_NMyc_nuclei2_step07.2042.2042.1	1.1212	0.0908	1337.4	3	4550.0%	1	K.FMAPGEVDTQDK.N
	TK040203_NMyc_nuclei2_step10.3468.3468.2	1.0591	0.0378	1246.24	28	4500.0%	1	K.INPNVQDYAGR.T
	TK040203_NMyc_nuclei2_step11.2280.2280.2	1.2921	0.0369	2717.64	94	1400.0%	1	K.SSKAPAVLHLSSVNSLQSIHLDNSGR.S

H2AZ_HUMAN

55.0%

127

13422

10.6

(P17317) Histone H2A.z (H2A/z) (P17317) Histone H2A.z (H2A/z)

	TK040203_NMyc_nuclei2_step08.1976.1976.1	1.5245	0.1316	1372.73	1	4620.0%	1	K.ATIAGGGVIPHIHK.S

PSD7_MOUSE

54.9%

321

36540

6.8

(P26516) 26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit S12) (Proteasome subunit p40) (Mov34 protein)

	TK040203_NMyc_nuclei2_step05.1085.1085.1	0.9026	0.0034	473.74	1	8330.0%	1	K.IANR.D
	TK040203_NMyc_nuclei2_step12.2554.2554.2	1.5644	0.131	1945.67	1	3750.0%	1	K.VVVHPLVLLSVVDHFNR.I
	TK040203_NMyc_nuclei2_step05.2494.2494.2	1.8366	0.2651	1904.4	1	4000.0%	1	K.RYCPNSVLVIIDVKPK.D

Q9UPA5

54.9%

3926

416471

7.5

(Q9UPA5) Neuronal double zinc finger protein

*	TK040203_NMyc_nuclei2_step11.4327.4327.2	1.0471	0.0053	2516.82	105	2110.0%	1	R.ELQELQTIKHHVLQQQQEER.Q
*	TK040203_NMyc_nuclei2_step10.3521.3521.2	1.5203	0.0498	3085.84	1	1920.0%	1	R.AICPLCQAELNVGSKSPANYNTCTTCR.L
*	TK040203_NMyc_nuclei2_step11.3322.3322.2	1.6759	0.2225	2859.34	4	2000.0%	1	K.HSYSLGFADGRYLGQGLQYGSVTDLR.H
*	TK040203_NMyc_nuclei2_step10.3834.3834.2	1.0029	0.0898	2618.47	1	2610.0%	1	R.AMSSVGIQTISDCSVQTEPDQLPR.V
*	TK040203_NMyc_nuclei2_step08.3096.3096.3	1.925	0.0312	4601.03	13	1080.0%	2	R.ATAEFSTQTPSPAPASDMPRSPGAPTPSPMVAQGTQTPHRPSTPR.L
*	TK040203_NMyc_nuclei2_step05.1896.1896.1	1.1632	0.0077	1370.53	20	3750.0%	2	R.EEPLPTTTPAAIK.E
*	TK040203_NMyc_nuclei2_step02.3680.3680.3	1.975	0.1122	3920.47	31	1150.0%	1	K.LHSSPASPSSASKEIGMPFSQGPGTPATTAVAPCPAGLPR.G
*	TK040203_NMyc_nuclei2_step11.2572.2572.3	1.696	0.0268	3931.53	8	1380.0%	1	R.FPIASSVPPAEGPVYLGKPAAAKAPGAGGPSRPEMPVGAAR.E
*	TK040203_NMyc_nuclei2_step07.2189.2189.1	1.3053	0.147	1406.6	3	3930.0%	1	K.GPQGLGQPSGPLPAK.A
*	TK040203_NMyc_nuclei2_step07.4303.4303.2	1.4536	0.069	3153.31	1	1900.0%	1	R.RDVLITQMGTAQSIGLKPGPVPEPGAEPHR.A
*	TK040203_NMyc_nuclei2_step03.1281.1281.1	1.3786	0.0197	982.55	6	5620.0%	1	R.IYGGSSRSR.A
*	TK040203_NMyc_nuclei2_step02.3428.3428.3	2.1506	0.1973	4558.41	7	1080.0%	1	R.EKPLSASDGEGGTPQPSRAYSYFASSSPPLSPSSPSESPTFSPGK.M
*	TK040203_NMyc_nuclei2_step07.2409.2409.2	1.7721	0.1262	2165.31	6	2370.0%	2	K.AGPKPSSLSMAHSRVRPPMR.S
*	TK040203_NMyc_nuclei2_step05.2115.2115.2	1.1763	0.0681	1764.11	23	3000.0%	1	K.AHVSPQKHFTADSALR.Q

P53_HUMAN

54.9%

393

43653

6.8

(P04637) Cellular tumor antigen p53 (Tumor suppressor p53) (Phosphoprotein p53) (Antigen NY-CO-13)

	TK040203_NMyc_nuclei2_step04.3487.3487.3	2.4815	0.2163	4594.37	1	1190.0%	3	K.LLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPR.M

Q9CPT8

54.8%

33.6%

131

14649

9.8

(Q9CPT8) 4933429L05Rik protein (4833424I06Rik protein)

*	TK040203_NMyc_nuclei2_step10.3028.3028.2	2.1651	0.1339	2355.19	1	3750.0%	1	R.GFNHPSGYVCSPLKENPAYSK.L
*	TK040203_NMyc_nuclei2_step02.3472.3472.2	1.7744	0.2046	2548.23	3	2270.0%	1	R.NVDIISTKSVDFPGYAPTSTYIR.G

Q9NVH2

54.8%

962

106834

8.0

(Q9NVH2) Hypothetical protein

*	TK040203_NMyc_nuclei2_step03.4155.4155.2	1.2244	0.0257	3030.27	2	1920.0%	6	K.FYHKGIASLTAASTPLNPLSFQCEFVK.L

TLR8_MOUSE

54.8%

1032

119338

7.2

(P58682) Toll-like receptor 8 precursor

*	TK040203_NMyc_nuclei2_step05.2379.2379.2	1.3119	0.0255	2780.22	13	1960.0%	1	K.KHFEHLQSLPNLATINLGINFIEK.I
*	TK040203_NMyc_nuclei2_step10.2816.2816.2	1.5573	0.0543	2687.57	4	2170.0%	1	R.VLNLSHNGIYTLTEESELKSISLK.E
*	TK040203_NMyc_nuclei2_step08.2511.2511.2	1.8303	0.264	2704.02	1	2170.0%	1	K.LDVIYLSGNRIASVLDGTDYSSWR.N

Q9P2P5

54.8%

1581

176650

5.4

(Q9P2P5) Hypothetical protein KIAA1301 (Fragment)

*	TK040203_NMyc_nuclei2_step10.3954.3954.3	1.2324	0.0212	3584.25	8	1130.0%	1	R.TMTNERPEENTNAIDGAGEEADFHQASADFRR.E
	TK040203_NMyc_nuclei2_step09.2863.2863.2	1.1728	0.0585	3090.51	66	1200.0%	1	R.FSGRILGLALIHQYLLDAFFTRPFYK.A
*	TK040203_NMyc_nuclei2_step10.2721.2721.3	2.788	0.1267	3066.61	1	2100.0%	1	K.EEVDPSDWIGLYHIDENSPANFWDSK.N
*	TK040203_NMyc_nuclei2_step12.1803.1803.3	2.0569	0.0142	3368.97	8	1830.0%	1	K.ALLRILCDLSDLEYLDEEFHQSLQWMK.D

Q8TAH1

54.8%

668

76382

6.8

(Q8TAH1) Hypothetical protein

*	TK040203_NMyc_nuclei2_step10.3651.3651.3	1.7188	0.0667	4263.94	170	770.0%	4	R.SSTTSTATTQMFHEDAAGGWQLVAVDVNKPQGRAPACLQK.M
*	TK040203_NMyc_nuclei2_step04.2425.2425.3	2.4666	0.3754	2740.87	2	2270.0%	1	R.QYDEFYLAEVAFTVLFDLEALLK.I

UDB4_HUMAN

54.8%

15.0%

528

60513

8.5

(P06133) UDP-glucuronosyltransferase 2B4 precursor, microsomal (EC 2.4.1.17) (UDPGT) (Hyodeoxycholic acid) (HLUG25) (UDPGTH-1)

*	TK040203_NMyc_nuclei2_step03.2790.2790.3	1.6951	0.066	3751.27	2	1640.0%	1	R.VAAHDLTWFQYHSLDVTGFLLACVATVIFIITK.C
*	TK040203_NMyc_nuclei2_step12.1799.1799.2	1.5662	0.1581	1888.9	1	3570.0%	1	K.VLVWPTEFSHWMNIK.T
*	TK040203_NMyc_nuclei2_step11.4228.4228.2	1.6499	0.0418	2446.01	233	1520.0%	1	R.GHEVTVLASSASISFDPNSPSTLK.F
*	TK040203_NMyc_nuclei2_step11.4330.4330.3	1.7141	0.0279	4747.99	1	1280.0%	9	R.VAAHDLTWFQYHSLDVTGFLLACVATVIFIITKCLFCVWK.F

O60622

54.8%

934

100988

5.2

(O60622) Protocadherin 43

	TK040203_NMyc_nuclei2_step09.1499.1499.2	1.1617	0.1233	1936.04	28	2810.0%	1	K.VLDANDNAPVFNQSLYR.A
	TK040203_NMyc_nuclei2_step06.3515.3515.3	2.4482	0.1185	3029.31	1	2050.0%	2	R.EREPSLQLVLTALDGGTPALSASLPIHIK.V
	TK040203_NMyc_nuclei2_step08.2911.2911.3	1.855	0.0828	3579.06	5	1540.0%	1	K.DNGEPSLSTTATLTVSVTEDSPEARAEFPSGSAPR.E

CIK4_MOUSE

54.8%

654

73474

5.3

(Q61423) Voltage-gated potassium channel protein Kv1.4

	TK040203_NMyc_nuclei2_step07.1369.1369.1	0.8199	0.0254	958.53	426	4380.0%	1	R.VVINVSGLR.F
*	TK040203_NMyc_nuclei2_step11.1627.1627.2	1.1764	0.0867	2790.31	61	1170.0%	1	R.AAAAAAVAAATAAVEGTGGSGGGPHHHHQTR.G
	TK040203_NMyc_nuclei2_step03.3247.3247.3	2.7778	0.1397	3008.73	1	2700.0%	1	R.ETENEEQTQLTQNAVSCPYLPSNLLK.K

Q96N16

54.8%

626

73209

6.1

(Q96N16) Hypothetical protein FLJ31564

*	TK040203_NMyc_nuclei2_step03.2441.2441.2	0.8714	0.0097	1834.14	363	2190.0%	1	R.AYALLQEQVGGTLDAER.E
*	TK040203_NMyc_nuclei2_step06.1578.1578.1	1.5931	0.1042	1316.62	3	5000.0%	1	K.WVEEKQLLIR.T

Q9JMJ9

54.8%

1957

213178

5.0

(Q9JMJ9) Vomeroglandin precursor

	TK040203_NMyc_nuclei2_step07.3104.3104.3	1.5146	0.0161	4648.08	3	1220.0%	1	R.FITDHSITARGFQAHYYSDFDNNTTNLLCQSNHMQASVSR.S
	TK040203_NMyc_nuclei2_step08.2103.2103.3	1.6235	0.0211	3174.92	12	1830.0%	2	R.VEILYQGSWGTVCDDSWDTKDANVVCR.Q
	TK040203_NMyc_nuclei2_step12.3790.3790.3	2.4699	0.3723	4724.62	1	1370.0%	1	R.QLGCGWAVSAPGNAYFGPGSGSIVLDDVACTGHEDYLWRCSHR.G

Q15170

54.7%

157

18307

11.2

(Q15170) Transcription factor S-II-related protein (PP21)

*	TK040203_NMyc_nuclei2_step01.3830.3830.1	1.5094	0.0682	1254.81	2	4500.0%	6	R.WSTLPKSSPPR.S
*	TK040203_NMyc_nuclei2_step07.1136.1136.1	0.6873	0.0086	915.56	85	3120.0%	2	R.TPSAGLSRK.D

Q9EQT8

54.7%

1074

121485

5.8

(Q9EQT8) DNA helicase B

*	TK040203_NMyc_nuclei2_step04.2987.2987.3	1.6151	0.0038	2924.26	8	2000.0%	1	R.LLTINNEAGLEVTVDFSKLMANCQIK.H
*	TK040203_NMyc_nuclei2_step11.3602.3602.2	1.5931	0.0691	3066.32	2	2120.0%	1	R.LISSSSDWVLGCIEDVLGTQPWKLGFR.R
*	TK040203_NMyc_nuclei2_step04.2115.2115.1	1.5861	0.1086	1369.53	2	5000.0%	1	R.QCAIELKTNHR.T

CA1H_HUMAN

54.7%

1516

153841

5.7

(P39060) Collagen alpha 1(XVIII) chain precursor [Contains: Endostatin]

*	TK040203_NMyc_nuclei2_step11.4392.4392.3	1.8523	0.2241	4466.37	3	1060.0%	1	R.QGPPGPPGPPGPPSFPGPHRQTISVPGPPGPPGPPGPPGTMGASSGVR.L
*	TK040203_NMyc_nuclei2_step06.4217.4217.1	0.537	0.0080	650.38	39	3000.0%	1	K.GDRGSR.G
*	TK040203_NMyc_nuclei2_step12.0806.0806.3	0.8286	0.0793	3875.51	26	620.0%	1	R.QAMLGQVHEVPEGWLIFVAEQEELYVRVQNGFR.K
*	TK040203_NMyc_nuclei2_step02.2127.2127.3	1.3318	0.187	2529.15	19	1630.0%	1	K.GEVGADGIPGFPGLPGREGIAGPQGPK.G
*	TK040203_NMyc_nuclei2_step05.2444.2444.3	1.502	0.0485	3389.52	8	1410.0%	1	R.AETLVLETPVGPLALAGPSSTPQENGTTLWPSR.G
*	TK040203_NMyc_nuclei2_step10.2349.2349.2	1.4679	0.1283	2338.92	14	2140.0%	1	K.LTFIDMEGSGFGGDLEALRGPR.G
*	TK040203_NMyc_nuclei2_step06.2891.2891.3	2.4969	0.3491	4051.73	1	1790.0%	1	R.LPAFVGQWTHLALSVAGGFVALYVDCEEFQRMPLAR.S
*	TK040203_NMyc_nuclei2_step06.3678.3678.2	1.4793	0.0695	3156.77	50	1380.0%	1	K.LSGVQDGHQDISLLYTEPGAGQTHTAASFR.L
*	TK040203_NMyc_nuclei2_step10.3212.3212.2	1.1978	0.1564	2423.7	349	1400.0%	1	K.GERGEPGGGGFFGSSLPGPPGPPGPR.G
*	TK040203_NMyc_nuclei2_step07.1137.1137.2	0.7338	0.0097	2027.2	42	1670.0%	1	K.LTFIDMEGSGFGGDLEALR.G

Q9CX66

54.6%

25.4%

185

19967

4.8

(Q9CX66) C430041I18Rik protein

*	TK040203_NMyc_nuclei2_step01.3130.3130.1	1.5049	0.142	1256.67	1	4550.0%	1	K.GKIEILDSPASK.K
*	TK040203_NMyc_nuclei2_step01.4146.4146.3	1.4101	0.0394	3859.36	4	1470.0%	1	K.EEDSPEESSRDSSGDSSESEEDVCVPSEVTIENIK.L

Q9ER67

54.5%

616

65400

9.1

(Q9ER67) Hypothetical 65.4 kDa protein

*	TK040203_NMyc_nuclei2_step05.2284.2284.3	2.8283	0.0509	2906.73	2	2310.0%	1	K.ASEKDSGSVMQDLLTVTQNLEVSETPK.A

Q9H314

54.5%

1634

187187

6.8

(Q9H314) Polybromo-1

	TK040203_NMyc_nuclei2_step12.2243.2243.3	2.0076	0.0497	3371.63	39	1480.0%	1	K.CAVLSFKDFLSCRPTEIPENDILLCESR.Y
	TK040203_NMyc_nuclei2_step12.2870.2870.2	1.0234	0.1058	2241.56	4	2500.0%	1	K.EVFLSNLEETCPMTCILGK.C
	TK040203_NMyc_nuclei2_step10.3392.3392.3	2.8114	0.0415	3192.56	3	2120.0%	1	K.VWVRDGAAYFYGPIFIHPEETEHEPTK.M

TRHY_HUMAN

54.5%

0.8%

1898

247217

5.7

(Q07283) Trichohyalin

*	TK040203_NMyc_nuclei2_step10.4155.4155.1	0.6856	0.0125	636.86	18	6250.0%	1	R.DGKYR.W
*	TK040203_NMyc_nuclei2_step08.1836.1836.1	1.4382	0.1625	1439.67	1	3500.0%	1	R.AHRQQQEEEQR.R

Q8WZ73

54.4%

363

40514

5.5

(Q8WZ73) Fring

*	TK040203_NMyc_nuclei2_step06.4250.4250.2	1.9517	0.2569	2783.45	1	3080.0%	2	K.GLQHLVSGAEDQNGGAVPSGLEENLCK.I

O75136

54.4%

1207

126967

4.5

(O75136) Hypothetical protein KIAA0641

*	TK040203_NMyc_nuclei2_step10.1775.1775.1	1.3614	0.2619	1162.8	1	4580.0%	1	R.GPEAGAGGESKEA.-
*	TK040203_NMyc_nuclei2_step05.3328.3328.3	1.6267	0.1368	4448.66	1	1280.0%	1	R.LPLPSVPSPSQEGAPLPSEEASAPDAPDALPDSPTPATGGEVSAIK.L
*	TK040203_NMyc_nuclei2_step07.1566.1566.3	1.6467	0.1206	3553.6	20	1290.0%	1	K.AAFAMALDPAAPAPAAPTPTPAPFSRFTVSPAPTSR.F

Q9WUE5

54.4%

388

44694

8.6

(Q9WUE5) N-acetylglucosamine 6-O-sulfotransferase (Carbohydrate (Chondroitin 6/keratan) sulfotransferase 4)

*	TK040203_NMyc_nuclei2_step12.3890.3890.2	1.8094	0.2679	2642.7	2	2270.0%	1	R.EHTTIELMVDSHIVLGQHLETIK.E

NKC1_HUMAN

54.4%

1212

131447

6.4

(P55011) Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1 (Basolateral Na-K-Cl symporter)

*	TK040203_NMyc_nuclei2_step11.3174.3174.2	1.8165	0.265	2865.89	5	1830.0%	1	-.MEPRPTAPSSGAPGLAGVGETPSAAALAAAR.V
*	TK040203_NMyc_nuclei2_step01.3548.3548.2	1.1121	0.0342	3154.46	35	1080.0%	1	R.AAAAAAAAAAAAAAAGAGAGAKQTPADGEASGESEPAK.G
*	TK040203_NMyc_nuclei2_step12.4371.4371.2	1.0301	0.1526	2685.74	181	1300.0%	1	K.SDLDTSKPLSEKPITHKVEEEDGK.T

Q9D5D9

54.4%

33.5%

203

22729

5.0

(Q9D5D9) 4930451G09Rik protein

*	TK040203_NMyc_nuclei2_step08.3225.3225.3	2.0103	0.0263	4555.92	25	1010.0%	1	R.NEPVLIPDLTEELAEDPVGVDESGTWVTAGRSPSPEPLLIPGR.L
*	TK040203_NMyc_nuclei2_step07.2009.2009.2	1.8055	0.2656	2960.15	2	2290.0%	1	K.NQLPSLDSDSSLSDCEEEELFIFQR.N

Q8VHQ0

54.3%

385

43787

6.4

(Q8VHQ0) SPI3L2

*	TK040203_NMyc_nuclei2_step12.2098.2098.2	1.9068	0.2373	1256.97	1	6500.0%	2	K.QGLFLSNVIHK.S

Q9QXN5

54.3%

17.9%

285

33134

5.3

(Q9QXN5) Hypothetical 33.1 kDa protein

	TK040203_NMyc_nuclei2_step05.1359.1359.2	1.9915	0.1579	2311.0	2	3060.0%	2	R.VFTTYKLMHTHQTVDFVSR.K
	TK040203_NMyc_nuclei2_step07.3125.3125.3	2.3376	0.3554	3912.77	2	1770.0%	1	R.YSTELGMYQPHCGLENVLMSWGHDEYLYQMMK.F

Q9QZJ4

54.2%

12.8%

901

100677

5.7

(Q9QZJ4) TPR-containing protein involved in spermatogenesis TPIS

*	TK040203_NMyc_nuclei2_step12.1955.1955.3	1.4954	0.0255	4458.71	44	1030.0%	1	R.LPPIPAVPTSEPLRVWLPAAETPDQDPCPNNCMPSITDEK.M
*	TK040203_NMyc_nuclei2_step03.2787.2787.2	1.8588	0.113	2622.3	2	2730.0%	1	K.LGQFEEAKLDCDQALQIDGENVK.A
*	TK040203_NMyc_nuclei2_step06.2391.2391.3	2.438	0.3975	4267.4	5	1400.0%	1	R.IQVQEVDGSSDEEPERPAEASATSAPARDGVEDGGSAEPAEK.L
*	TK040203_NMyc_nuclei2_step01.1379.1379.1	1.3905	0.1333	1161.17	216	3330.0%	3	K.EEGNQLVKDK.N

RYR3_HUMAN

54.2%

4870

551939

5.7

(Q15413) Ryanodine receptor 3 (Brain-type ryanodine receptor) (RyR3) (RYR-3) (Brain ryanodine receptor-calcium release channel)

*	TK040203_NMyc_nuclei2_step09.2137.2137.2	1.8005	0.2574	2146.12	1	3330.0%	1	K.NYMMSNGYKPAPLDLSDVK.L
*	TK040203_NMyc_nuclei2_step06.3771.3771.3	1.2347	0.0413	2631.39	37	1410.0%	1	K.LPSLNKDGSVSEPDMAANFCPDHK.A
*	TK040203_NMyc_nuclei2_step09.3241.3241.2	1.8136	0.057	2607.84	5	2380.0%	1	R.LFHGHDECLTIPSTDQNDSQHR.R
*	TK040203_NMyc_nuclei2_step11.1298.1298.2	0.9896	0.055	2252.1	173	2110.0%	1	R.MGKEEELLMINGLGDIMNNK.V
*	TK040203_NMyc_nuclei2_step11.3688.3688.3	1.7803	0.0415	4696.34	75	1010.0%	1	R.HGWVVQCLEPLQMMALHIPEENRCVDILELCEQEDLMR.F
*	TK040203_NMyc_nuclei2_step03.2001.2001.3	1.5819	0.0581	2831.95	8	2050.0%	1	K.KWYFELIIDQVDPFLTAEPTHLR.V
*	TK040203_NMyc_nuclei2_step07.3733.3733.3	1.4852	0.0061	4383.29	1	1250.0%	1	K.ILGDMPDPTQFGIHDDTMEAERAEVMEPGITTELVHFIK.G
*	TK040203_NMyc_nuclei2_step11.1704.1704.2	1.26	0.0988	1621.2	14	3000.0%	1	K.HGPEVGLGDLSEIIGK.D
*	TK040203_NMyc_nuclei2_step08.1599.1599.1	1.146	0.0248	1573.35	19	3080.0%	1	R.IPRAVASVNQHLLR.S
*	TK040203_NMyc_nuclei2_step01.4200.4200.3	1.8102	0.039	4182.74	74	1010.0%	1	R.DADGIRDLLGTTQFLSQASFIPCPVDTSQVILPPHLEK.I
*	TK040203_NMyc_nuclei2_step08.2425.2425.3	1.5748	0.0488	3557.18	181	1330.0%	1	R.IVFDITFFFFVIVILLAIIQGLIIDAFGELR.D
*	TK040203_NMyc_nuclei2_step09.1946.1946.1	1.0819	0.1192	1298.56	56	3180.0%	1	R.RIFYEAGGAGTR.A
*	TK040203_NMyc_nuclei2_step06.2067.2067.3	2.1212	0.0765	2221.61	3	2780.0%	2	R.VQRISAAVFHLEQVEQPLR.S

Q8VHM5

54.0%

632

70888

8.1

(Q8VHM5) Heterogeneous nuclear ribonucleoprotein R

	TK040203_NMyc_nuclei2_step04.3609.3609.2	1.2733	0.0555	2098.5	2	2650.0%	3	R.LDEIFQTGLVAYVDLDER.A

ADT3_HUMAN

54.0%

14.1%

298

32866

9.7

(P12236) ADP,ATP carrier protein, liver isoform T2 (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)

*	TK040203_NMyc_nuclei2_step01.2548.2548.1	1.4537	0.1574	1235.68	1	4580.0%	1	K.DFLAGGIAAAISK.T
*	TK040203_NMyc_nuclei2_step12.3877.3877.2	1.3606	0.0114	3166.02	36	1430.0%	1	K.NTHIVVSWMIAQTVTAVAGVVSYPFDTVR.R

Q8R5G7

54.0%

1538

169692

6.8

(Q8R5G7) Dual-specificity Rho-and Arf-GTPase activating protein 1

	TK040203_NMyc_nuclei2_step04.1198.1198.1	0.954	0.1154	1144.48	15	3330.0%	1	K.FGTMPLLPIR.G
	TK040203_NMyc_nuclei2_step06.1990.1990.1	1.424	0.1873	1281.68	1	4500.0%	1	K.KEHLVLVETGR.T
	TK040203_NMyc_nuclei2_step10.1464.1464.2	1.3512	0.114	1508.1	8	3080.0%	1	K.VFAALIPGELALYK.S
	TK040203_NMyc_nuclei2_step06.1499.1499.3	1.487	0.0153	3683.5	56	1360.0%	1	R.FPFSFELILTGGRIQHFATDGADSLEAWISAVGK.W

O75071

54.0%

495

55032

6.3

(O75071) Hypothetical protein KIAA0494

*	TK040203_NMyc_nuclei2_step12.3938.3938.3	2.1394	0.033	2657.14	8	2160.0%	1	K.VWINITEMNKQISLLTSAVNHLK.A
*	TK040203_NMyc_nuclei2_step01.1740.1740.1	1.1997	0.0142	1061.62	120	4380.0%	1	K.EDLDALKEK.F
*	TK040203_NMyc_nuclei2_step01.0615.0615.1	1.6922	0.0364	804.39	22	7500.0%	1	K.EDLDALK.E
*	TK040203_NMyc_nuclei2_step08.2175.2175.1	1.4425	0.1575	1426.65	1	5420.0%	1	K.QISLLTSAVNHLK.A

Q96L34

54.0%

752

82520

9.7

(Q96L34) MARK4 serine/threonine protein kinase

	TK040203_NMyc_nuclei2_step10.2217.2217.1	1.424	0.1898	1039.42	1	6000.0%	1	K.ASCSTAGSGSR.G
	TK040203_NMyc_nuclei2_step11.1654.1654.2	1.4654	0.1063	2017.93	89	2110.0%	1	R.VPPASPSSHSLAPPSGERSR.L
	TK040203_NMyc_nuclei2_step07.2556.2556.3	1.5609	0.1087	3713.01	2	1530.0%	1	K.LFEVIETEKTLYLVMEYASAGEVFDYLVSHGR.M

Q9UNE2

54.0%

13.0%

315

34464

9.0

(Q9UNE2) CANDIDATE tumor suppressor protein NOC2 (Hypothetical protein FLJ20462)

*	TK040203_NMyc_nuclei2_step09.1411.1411.1	1.0695	0.0658	731.4	86	5000.0%	1	K.GDKPWK.E
*	TK040203_NMyc_nuclei2_step08.1733.1733.2	1.6537	0.0776	1942.49	43	2500.0%	1	K.DTPGRAPAADAAPAGPSSCLG.-
*	TK040203_NMyc_nuclei2_step01.1800.1800.1	1.576	0.1023	1537.63	3	3850.0%	1	K.VCTKCGIEASPGQK.R

Q8VH16

54.0%

318

35711

9.0

(Q8VH16) Olfactory receptor MOR8-1

*	TK040203_NMyc_nuclei2_step04.3545.3545.3	2.1025	0.2703	4464.03	20	1120.0%	1	R.IFVFNATGISPNACFAQEFFIHGFTDMESSVLLIMSFDR.F
*	TK040203_NMyc_nuclei2_step01.1658.1658.1	1.5711	0.1117	931.52	1	6880.0%	1	K.TVMGIGSHK.E

Q9DBP9

54.0%

949

105833

6.6

(Q9DBP9) 1200017E13Rik protein

	TK040203_NMyc_nuclei2_step04.1402.1402.1	1.3213	0.0228	955.47	5	5620.0%	1	-.MAASTGYVR.L
*	TK040203_NMyc_nuclei2_step01.2067.2067.1	1.4834	0.0838	1571.85	5	3850.0%	2	K.RAGVTCIILPAENR.K
*	TK040203_NMyc_nuclei2_step02.4047.4047.2	1.1103	0.0363	3100.54	111	1150.0%	1	K.HVMDVVDEELSKLALLDNHSSEFNVTR.N

Q9D7Y8

53.9%

21.9%

425

48406

6.7

(Q9D7Y8) 2210009N18Rik protein

	TK040203_NMyc_nuclei2_step08.3699.3699.3	1.8808	0.0687	4528.44	52	940.0%	1	K.FITMSDGATSTFDLFEPLAEHCVGDDITMVICPGIANHSEK.Q
	TK040203_NMyc_nuclei2_step06.3679.3679.3	2.0425	0.2525	4275.89	11	1320.0%	1	R.CAVLNHLGALPNIELTSPRMFTYGCTWEFGAMVNYIK.R
	TK040203_NMyc_nuclei2_step06.1379.1379.2	1.6473	0.3343	1733.38	1	3570.0%	1	K.IILSHRQALFGDHVK.K

Q8TC26

53.9%

289

31469

7.5

(Q8TC26) Similar to RIKEN cDNA 2610024A01 gene

	TK040203_NMyc_nuclei2_step07.3472.3472.2	1.8785	0.129	2983.54	1	2310.0%	2	K.KALWVSWFSIIVTLALAVAAFTVSVMR.Y

TCF8_MOUSE

53.9%

16.7%

1117

122465

4.9

(Q64318) Transcription factor 8 (Zinc finger homeobox protein 1a) (MEB1) (Delta EF1)

*	TK040203_NMyc_nuclei2_step11.3703.3703.2	1.3645	0.0266	2715.3	24	1600.0%	1	R.SGLKTSQCSSPSLSTSPGSPTRPQIR.Q
*	TK040203_NMyc_nuclei2_step07.2830.2830.3	1.9601	0.1271	4019.43	19	1350.0%	1	K.TDGTVEVGAAQQAGSLEQKASESEMESESESEQLSEEK.T
*	TK040203_NMyc_nuclei2_step02.2878.2878.3	2.0689	0.2781	3910.24	54	1180.0%	1	R.NPQGYSCVAEGAQEEPQVEPLDLSLPKQQGELLER.S
*	TK040203_NMyc_nuclei2_step12.2242.2242.3	1.3392	0.0125	4313.31	241	790.0%	1	K.LHIVEEESITDAADCEGGMPDDELPADQTVLPGGSDRGGGAK.N
*	TK040203_NMyc_nuclei2_step10.1861.1861.3	1.2831	0.0169	3111.08	91	1520.0%	2	K.AYYALNAQPSTEELSKIADSVNLPLDGVK.K
*	TK040203_NMyc_nuclei2_step05.2571.2571.2	2.1661	0.1755	1854.04	9	3330.0%	1	K.IENKPLQEPLSVNQIK.T

EMR1_MOUSE

53.8%

931

102130

5.1

(Q61549) Cell surface glycoprotein EMR1 precursor (EMR1 hormone receptor) (Cell surface glycoprotein F4/80)

	TK040203_NMyc_nuclei2_step11.1838.1838.2	1.0002	0.0561	2244.18	16	2220.0%	1	K.EDLILQSEQIQQCQAVQGR.D
*	TK040203_NMyc_nuclei2_step04.2043.2043.1	1.3615	0.2358	1353.72	1	4090.0%	1	R.QKLCSVSSEVSK.L
*	TK040203_NMyc_nuclei2_step01.1968.1968.1	1.3063	0.0175	1133.59	14	5000.0%	1	R.FFEDGQSFR.K
*	TK040203_NMyc_nuclei2_step11.3698.3698.3	2.0053	0.0404	4642.79	5	1130.0%	1	K.EETSTLGTILLETVESTMLAALLIPSGNASQMIQTEYLDIESK.V

Q9BPU7

53.8%

465

53247

7.9

(Q9BPU7) Hypothetical protein

*	TK040203_NMyc_nuclei2_step01.1347.1347.1	1.3366	0.0655	1353.54	15	3890.0%	2	R.TTYMAYHYFR.S
*	TK040203_NMyc_nuclei2_step07.3545.3545.3	2.7965	0.0687	2980.87	2	2300.0%	2	R.KGPPFYHASYSVIIELVDDHFEGSLR.R
*	TK040203_NMyc_nuclei2_step06.1930.1930.2	1.5216	0.1107	2660.04	35	1820.0%	1	R.VSVNVSKELMLCYLIKPSTMTDK.E
*	TK040203_NMyc_nuclei2_step04.2746.2746.2	1.2572	0.0825	1832.59	15	3000.0%	1	R.NAEDIEQLYGKGYFGK.G

MGR7_HUMAN

53.8%

915

102251

7.9

(Q14831) Metabotropic glutamate receptor 7 precursor (mGluR7)

*	TK040203_NMyc_nuclei2_step05.1580.1580.3	1.6231	0.2522	2132.05	36	2220.0%	1	K.RADQVGHFLWVGSDSWGSK.I
*	TK040203_NMyc_nuclei2_step09.2617.2617.3	2.7916	0.0993	3690.87	3	1640.0%	1	R.LEAMLYALDQINSDPNLLPNVTLGARILDTCSR.D
*	TK040203_NMyc_nuclei2_step07.1888.1888.2	1.1557	0.0242	2232.07	216	1840.0%	1	R.VFLGLGMCISYAALLTKTNR.I
*	TK040203_NMyc_nuclei2_step04.3292.3292.3	1.8169	0.1462	4545.11	2	1250.0%	1	R.LISPTSQLAITSSLISVQLLGVFIWFGVDPPNIIIDYDEHK.T

SON_MOUSE

53.8%

2404

261428

5.6

(Q9QX47) SON protein

*	TK040203_NMyc_nuclei2_step09.3298.3298.2	1.318	0.0389	3094.05	17	1610.0%	1	K.GMNLLGGDENLGPEVGMQETLLHPGEEPR.D
*	TK040203_NMyc_nuclei2_step10.2901.2901.3	1.9341	0.1269	3317.77	10	1530.0%	1	R.SLSSQLALELDTVGTSKGFEFVTASALISESK.Y
	TK040203_NMyc_nuclei2_step02.3318.3318.3	2.803	0.2258	4173.29	6	1250.0%	1	R.IDAWAQLNSIPGQFTGSTGVQVLTQEQLANTGAQAWIKK.D

PAX1_MOUSE

53.8%

361

37859

9.3

(P09084) Paired box protein Pax-1

	TK040203_NMyc_nuclei2_step02.3220.3220.2	1.6891	0.1957	1842.67	18	3000.0%	1	R.IVELAQLGIRPCDISR.Q
*	TK040203_NMyc_nuclei2_step12.4319.4319.3	2.7824	0.0892	4537.78	7	1160.0%	1	K.IGSLAQPGPYEASKQPPPQPALPYNHIYQYPYPSPVSPTGTK.M

Q9P273

53.8%

1769

199209

6.5

(Q9P273) Hypothetical protein KIAA1455 (Fragment)

*	TK040203_NMyc_nuclei2_step01.4459.4459.2	2.062	0.235	2976.08	1	2220.0%	1	R.ISFLIGSDSTHVIPGESPFNKSLASVIR.G

Q9WTS6

53.8%

2715

303065

6.5

(Q9WTS6) Ten-m3

*	TK040203_NMyc_nuclei2_step09.2210.2210.3	1.9392	0.0065	3356.66	4	1700.0%	2	K.VQGYDGYYVLSVEQYPELADSANNIQFLR.Q
	TK040203_NMyc_nuclei2_step03.4191.4191.3	1.6767	0.0094	3700.13	13	1290.0%	1	K.VDQNGIISTLLGSNDLTSARPLTCDTSMHISQVR.L
	TK040203_NMyc_nuclei2_step12.1750.1750.3	1.8681	0.1031	3225.98	5	1810.0%	1	K.HAVQTTLESATAIAVSYSGVLYITETDEKK.I
	TK040203_NMyc_nuclei2_step07.2953.2953.2	1.387	0.0393	2476.57	18	2370.0%	1	R.LFQKWFPASPNLAYTFIWDK.T
	TK040203_NMyc_nuclei2_step09.1519.1519.2	1.1254	0.0078	2098.35	6	2650.0%	1	K.DPAPFNLYMFRNNNPASK.I
	TK040203_NMyc_nuclei2_step06.3653.3653.2	1.4668	0.0757	2777.03	46	1590.0%	1	K.WFPASPNLAYTFIWDKTDAYNQK.V
	TK040203_NMyc_nuclei2_step03.3947.3947.3	1.3797	0.138	2576.24	2	2070.0%	1	K.GNGENQFISQQPPVVSSIMGNGRR.R
	TK040203_NMyc_nuclei2_step11.2534.2534.2	1.744	0.0894	2882.91	40	1400.0%	1	R.VTSMQGVINETPLPIDLYQFDDISGK.V
*	TK040203_NMyc_nuclei2_step01.4459.4459.2	2.062	0.235	2976.08	1	2220.0%	1	R.ISFLIGSDSTHVLPGESPFNKSLASVIR.G

Q924H5

53.7%

34.2%

366

40675

5.9

(Q924H5) RAD51L2/RAD51C protein

*	TK040203_NMyc_nuclei2_step11.1468.1468.3	1.6152	0.0562	2033.37	39	2500.0%	1	R.ECLTNKPRCAGTSVANEK.C
	TK040203_NMyc_nuclei2_step01.3051.3051.1	1.7842	0.2642	1333.68	6	4090.0%	1	R.LAVILTNQMTTK.I
*	TK040203_NMyc_nuclei2_step11.2672.2672.3	2.0799	0.0158	3484.07	2	1770.0%	1	K.ESTIPFQITPQGFRDAVVTAASSQTESSLNFR.K
*	TK040203_NMyc_nuclei2_step05.2703.2703.2	1.1786	0.0795	2922.46	1	2400.0%	1	R.VVSLATACIQHLHLIAGTHTEEEHQK.A
*	TK040203_NMyc_nuclei2_step11.3335.3335.3	1.9059	0.1424	4343.94	25	1180.0%	1	R.CHDYTELLAQVYLLPDFLSDHPKVQLVIIDGIAFPFR.H

Q9D6I6

53.6%

828

93619

9.1

(Q9D6I6) 2900024E01Rik protein

	TK040203_NMyc_nuclei2_step10.3711.3711.1	0.5368	0.0058	616.53	3	2500.0%	1	R.GLRIR.K
	TK040203_NMyc_nuclei2_step12.1225.1225.3	2.682	0.2057	2672.47	2	2280.0%	1	R.ELTPDSPIPVVKPIHDPNTKDLSR.N
*	TK040203_NMyc_nuclei2_step09.3233.3233.2	1.2104	0.0305	2636.55	1	2080.0%	1	K.NQQQGSEQGKPGTSRDPITLTVPAK.V
	TK040203_NMyc_nuclei2_step08.3227.3227.3	2.3865	0.1357	4513.84	65	970.0%	1	R.EIMMENYSNMISVEHHFSKPNVISQLEKAEDCWPMQR.E
	TK040203_NMyc_nuclei2_step03.1251.1251.1	1.0056	0.1589	812.23	48	4170.0%	1	K.KFSESSK.S
	TK040203_NMyc_nuclei2_step11.2739.2739.3	1.8572	0.0090	3990.51	46	1140.0%	1	K.AEDCWPMQREIPQDTLPECSWPSPDPGMNSFPSK.S

KLR5_MOUSE

53.6%

266

30843

7.9

(Q60652) Killer cell lectin-like receptor 5 (T-cell surface glycoprotein LY-49E) (LY49-E antigen)

*	TK040203_NMyc_nuclei2_step06.3146.3146.2	2.1259	0.1114	2311.2	1	3060.0%	1	K.FLQFQVISDSYWIGLSYDK.K

PCD8_HUMAN

53.6%

613

66901

9.0

(O95831) Programmed cell death protein 8, mitochondrial precursor (EC 1.-.-.-) (Apoptosis-inducing factor)

*	TK040203_NMyc_nuclei2_step07.2582.2582.2	1.3474	8.0E-4	2347.07	452	1360.0%	1	R.EVKSITIIGGGFLGSELACALGR.K
*	TK040203_NMyc_nuclei2_step03.1914.1914.2	1.6422	0.3584	2042.1	1	3160.0%	1	K.VMPNAIVQSVGVSSGKLLIK.L

Q91WL5

53.6%

508

58332

9.1

(Q91WL5) Similar to cytochrome P450, 4a10 (Hypothetical 58.3 kDa protein)

*	TK040203_NMyc_nuclei2_step03.1377.1377.1	1.3227	0.1014	1108.53	25	6110.0%	1	R.MENGKSLSDK.D
*	TK040203_NMyc_nuclei2_step01.0753.0753.1	1.4001	0.2129	1021.96	1	6110.0%	1	-.MSASALSSIR.F

Q9WV89

53.5%

557

61689

5.3

(Q9WV89) Syntaxin4-interacting protein synip

*	TK040203_NMyc_nuclei2_step12.1557.1557.1	1.5176	0.1365	1374.46	1	5450.0%	1	R.EALREQVQADSK.G
*	TK040203_NMyc_nuclei2_step09.1650.1650.1	1.1491	0.0209	1260.7	20	3890.0%	1	K.RVTVLDCQLR.K

Q9JII1

53.5%

647

71915

9.2

(Q9JII1) Inositol polyphosphate 5-phosphatase

*	TK040203_NMyc_nuclei2_step12.4338.4338.3	1.6697	0.1231	3759.35	20	1250.0%	1	K.ELPASLDEFLLPTEADYTQDLYVIGIQEGCSDR.R
*	TK040203_NMyc_nuclei2_step12.3069.3069.2	1.5994	0.0297	3167.15	6	2040.0%	2	R.LQETLGPQYVLLSSAAHGVLYMSLFIRR.D
*	TK040203_NMyc_nuclei2_step05.1498.1498.2	1.3856	0.0965	3010.07	25	1540.0%	1	R.LQETLGPQYVLLSSAAHGVLYMSLFIR.R

Q8R3U2

53.5%

324

37120

8.7

(Q8R3U2) Similar to hypothetical protein FLJ22693 (Fragment)

*	TK040203_NMyc_nuclei2_step10.3083.3083.3	2.3666	0.2955	3890.79	1	1640.0%	3	-.IWYWMDEFGSWQEYGRQGSGHPVTTISSSDVER.A

Q9Y309

53.4%

11.6%

320

35954

5.4

(Q9Y309) CGI-20 protein

*	TK040203_NMyc_nuclei2_step01.3543.3543.3	2.729	0.1376	4125.29	1	1670.0%	1	K.HTEARELMYSGALLFFSHGQQNSAADLSMLVLESLEK.A

NGN2_MOUSE

53.4%

25.9%

263

28216

7.8

(P70447) Neurogenin 2 (Atonal protein homolog 4) (Helix-loop-helix protein mATH-4A) (MATH4A)

*	TK040203_NMyc_nuclei2_step09.3437.3437.3	2.709	0.1963	4556.16	1	1460.0%	3	K.SETLELKEEEEVLMLLGSASPASATLTPMSSSADEEEDEELR.R
*	TK040203_NMyc_nuclei2_step06.4225.4225.2	1.1706	0.0312	2497.24	4	2000.0%	1	R.GQRGAEAEQGVQGSPASGAGGCRPGR.L

Q96N23

53.4%

685

78131

7.6

(Q96N23) Hypothetical protein FLJ31514 (Fragment)

*	TK040203_NMyc_nuclei2_step05.3463.3463.3	2.7044	0.1966	2807.62	1	2190.0%	1	R.SSLLQWTCPEDSLPLAVFYGPLDAK.N
*	TK040203_NMyc_nuclei2_step05.3164.3164.3	2.2417	0.1635	2999.31	2	2020.0%	1	R.RILQTGPIVTDEVEIHDVVSELFMAGK.E

Q9QY81

53.3%

1886

204138

6.6

(Q9QY81) Nuclear pore membrane glycoprotein POM210

*	TK040203_NMyc_nuclei2_step06.3189.3189.2	2.1244	0.0727	2593.95	3	2920.0%	1	K.VFGAVESLENLEVKSGSPAVLAFVK.E
*	TK040203_NMyc_nuclei2_step11.3003.3003.3	1.8073	0.0854	4324.01	2	1220.0%	1	K.APIVHTDEKGFLVSGSGIGVSTLEVIAQEPFGTNQTILVAVK.V
*	TK040203_NMyc_nuclei2_step08.1600.1600.2	1.0682	0.0613	2164.3	8	2350.0%	1	R.WVLETGHLYAITIEVFDR.S
*	TK040203_NMyc_nuclei2_step11.2846.2846.3	1.7188	0.0395	3829.01	9	1410.0%	1	R.AQHVQNPLHFGEMKVYVIEPSSMEFAPCQVEAR.V
*	TK040203_NMyc_nuclei2_step09.2931.2931.3	1.9039	0.0685	3473.99	2	1640.0%	1	K.AVDPSSVAVVTLGSSKEMLFEGGPRPWVLEPSK.F
*	TK040203_NMyc_nuclei2_step05.2244.2244.1	1.1885	0.081	1194.78	4	4090.0%	1	K.GVMTTSGDTGLR.E
*	TK040203_NMyc_nuclei2_step10.3339.3339.3	1.7664	0.1107	4441.82	84	880.0%	1	R.LTQPARLTSIIFAEDITTGQVVACDAIVDLIHGIQIVSTTR.E
*	TK040203_NMyc_nuclei2_step11.4044.4044.3	1.8576	0.069	2579.01	63	2020.0%	1	R.WVLETGHLYAITIEVFDRSSNK.V

HBE_HUMAN

53.3%

146

16072

8.6

(P02100) Hemoglobin epsilon chain

*	TK040203_NMyc_nuclei2_step01.1531.1531.1	1.6908	0.0975	1195.74	3	5000.0%	4	K.LVSAVAIALAHK.Y

Q14215

53.3%

1.4%

3007

348969

9.1

(Q14215) NEBULIN (Fragment)

*	TK040203_NMyc_nuclei2_step01.4539.4539.2	2.1384	0.0773	2935.41	1	2600.0%	1	K.FTSIVDTPEVIQAKINAVQISEPLYR.D
*	TK040203_NMyc_nuclei2_step05.3799.3799.2	1.0762	0.0204	2001.92	13	2330.0%	1	R.YQQAWEDVKMTGYDLR.A

Q9H3X8

53.3%

1188

133149

6.8

(Q9H3X8) DJ927M24.2 (KIAA1219) (Fragment)

*	TK040203_NMyc_nuclei2_step10.1429.1429.2	1.9059	0.0662	1350.29	96	4090.0%	1	K.TGEEILPAYLSR.F
*	TK040203_NMyc_nuclei2_step12.3602.3602.3	1.3525	0.0342	4295.95	4	1110.0%	1	K.HSFRYFVLDNSVILAMLEQPLGNEQNDFFPSVTVLVR.G
*	TK040203_NMyc_nuclei2_step11.2802.2802.2	1.4688	0.0825	2327.43	5	2630.0%	1	K.WTMEVICYGLTLPLDGETVK.Y
*	TK040203_NMyc_nuclei2_step11.3435.3435.2	1.6323	0.0063	2299.11	1	3160.0%	1	K.DSIPLPVIKEPNQYVQTILK.H
*	TK040203_NMyc_nuclei2_step01.0664.0664.1	1.1573	0.0646	1129.29	39	3890.0%	1	K.EPNPASMRVK.D
*	TK040203_NMyc_nuclei2_step05.1903.1903.3	1.7563	0.1706	3065.9	8	1640.0%	2	R.EVANAVVRPLGQVLGTPSVAGSENLLKTDK.E
	TK040203_NMyc_nuclei2_step11.3468.3468.2	1.1496	0.0284	1957.82	60	2500.0%	1	R.GMSGRLAWAQQLCLLPR.G

O75762

53.3%

1119

127379

7.0

(O75762) Ankyrin-like protein

*	TK040203_NMyc_nuclei2_step10.3356.3356.2	1.7743	0.2607	2740.24	1	2270.0%	1	K.WGCFPIHQAAFSGSKECMEIILR.F
*	TK040203_NMyc_nuclei2_step01.4259.4259.2	1.395	0.0756	2924.16	15	1670.0%	3	R.SPLILATASASWNIVNLLLSKGAQVDIK.D
*	TK040203_NMyc_nuclei2_step10.2817.2817.2	1.149	0.1425	1428.98	11	4000.0%	1	K.YLQCPLEFTKK.T

Q9NVE7

53.3%

773

85991

6.3

(Q9NVE7) Hypothetical protein FLJ10782

*	TK040203_NMyc_nuclei2_step11.3999.3999.3	2.3612	0.3823	4697.85	1	1280.0%	1	R.SGTFDLLEMDRLERPLVDLPLLLDPPSYVPDTVDLTDDALAR.K
*	TK040203_NMyc_nuclei2_step06.3267.3267.2	2.131	0.0291	3063.08	1	2690.0%	1	K.CALIFADNSGIDIILGVFPFVRELLLR.G
	TK040203_NMyc_nuclei2_step04.1263.1263.1	0.8804	0.0609	538.43	54	5000.0%	1	K.GPPHK.C

Q9DC92

53.3%

29.2%

318

34990

7.0

(Q9DC92) 0710008M05Rik protein (Non-canonical ubiquitin conjugating enzyme 1)

	TK040203_NMyc_nuclei2_step08.2621.2621.3	1.428	0.0064	4429.25	7	1280.0%	1	K.DPTDHYHAQPLEDNLFEWHFTVRGPPDSDFDGGVYHGR.I
	TK040203_NMyc_nuclei2_step08.2871.2871.3	2.1755	0.1488	2951.03	13	1940.0%	1	R.TALLAIIGFMPTKGEGAIGSLDYTPEER.R
	TK040203_NMyc_nuclei2_step11.3467.3467.2	1.8547	0.0953	2984.37	1	2120.0%	6	R.IVLPPEYPMKPPSIILLTANGRFEVGK.K

Q9BVC3

53.3%

393

44844

5.2

(Q9BVC3) Hypothetical protein

	TK040203_NMyc_nuclei2_step05.3126.3126.2	2.0869	0.1102	2224.05	11	3240.0%	6	K.YVDEGEVYFELDADKICR.A
	TK040203_NMyc_nuclei2_step03.1943.1943.3	1.3107	0.0347	3024.29	240	1400.0%	1	K.FNLAEFQEVWQQSVPEGMVTSLDQLK.G

SM6A_MOUSE

53.3%

888

99076

7.8

(O35464) Semaphorin 6A precursor (Semaphorin VIA) (Sema VIA) (Semaphorin Q) (Sema Q)

	TK040203_NMyc_nuclei2_step06.2310.2310.2	1.4259	0.0848	3121.93	7	1670.0%	1	R.ASPSHIPSVVVLPITQQGYQHEYVDQPK.M
	TK040203_NMyc_nuclei2_step01.3016.3016.1	1.6392	0.0346	1336.63	185	3180.0%	1	K.NDMGGSQRVLEK.Q
*	TK040203_NMyc_nuclei2_step08.2952.2952.2	2.1121	0.072	2549.28	1	2730.0%	3	R.IGSSGFLNGSLFLEEMNVYNPEK.C
	TK040203_NMyc_nuclei2_step01.4407.4407.3	1.7976	0.1347	4247.95	5	1430.0%	1	K.YATSNEFPDDTLNFIKTHPLMDEAVPSIINRPWFLR.T

MATP_HUMAN

53.3%

530

58302

7.5

(Q9UMX9) Membrane-associated transporter protein (AIM-1 protein) (Melanoma antigen AIM1)

*	TK040203_NMyc_nuclei2_step10.3480.3480.2	2.139	0.0492	3063.67	2	2410.0%	1	K.GIPPQQTPQDPPLSSDGMYEYGSIEKVK.N

Q96P26

53.3%

610

68934

8.9

(Q96P26) Cytosolic nucleotidase Ib alpha

	TK040203_NMyc_nuclei2_step11.2839.2839.2	2.1201	0.0497	2549.55	1	3330.0%	1	R.GIYPASTQLDRNSLSEQQQQQR.E
	TK040203_NMyc_nuclei2_step03.0533.0533.1	0.7356	0.1312	1423.9	252	1540.0%	1	R.NTSAKLPSSSTSSR.T
	TK040203_NMyc_nuclei2_step05.2022.2022.3	1.323	0.0229	2507.33	21	2110.0%	1	R.EDEDDYEAAYWASMRSFYEK.N
	TK040203_NMyc_nuclei2_step03.1945.1945.2	1.6115	0.0376	1568.25	1	4620.0%	1	R.FCLTGGKDPIGYLK.A
	TK040203_NMyc_nuclei2_step09.1589.1589.1	1.2019	0.0592	805.49	57	5000.0%	1	K.DPIGYLK.A
*	TK040203_NMyc_nuclei2_step04.2690.2690.3	1.963	0.0505	2769.83	74	1540.0%	1	K.LPSSSTSSRTPSTSPSLHDSSPPPLSR.Q

ST31_HUMAN

53.3%

1019

115730

5.2

(Q9BXU1) Serine/threonine protein kinase 31 (EC 2.7.1.37) (Serine/threonine-protein kinase NYD-SPK)

*	TK040203_NMyc_nuclei2_step06.3219.3219.2	2.1427	0.0501	2310.47	1	3750.0%	1	K.TESSVCKELEIALVDQGDADK.E
*	TK040203_NMyc_nuclei2_step12.3303.3303.3	1.9463	0.0598	3160.23	5	1610.0%	1	K.GVAQGLHTLHKADIIHGSLHQNNVFALNR.E
*	TK040203_NMyc_nuclei2_step01.1620.1620.2	1.2981	0.0472	2583.7	15	1670.0%	1	K.ATSEDGTVIAQAEYGSVDIGEEVLK.K
*	TK040203_NMyc_nuclei2_step08.1096.1096.2	1.2248	0.1351	1756.11	34	2500.0%	1	K.TCEYVSEGNILIAQR.N
	TK040203_NMyc_nuclei2_step09.3277.3277.3	2.2418	0.0415	3066.85	20	1630.0%	1	R.SSMTAEQVLNAECFLMPKEQSVPNPEK.D

Q8WTW4

53.3%

380

43675

6.5

(Q8WTW4) Homologous to yeast nitrogen permease (candidate tumor suppressor)

	TK040203_NMyc_nuclei2_step06.2727.2727.2	2.1265	0.041	2465.13	1	3100.0%	1	K.KLAGYLTTLELESSFVSMEESK.Q

KEAP_MOUSE

53.2%

18.3%

624

69553

6.4

(Q9Z2X8) Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2)

*	TK040203_NMyc_nuclei2_step03.4231.4231.3	1.3898	0.1091	4130.55	34	1210.0%	1	K.IYVLGGYDGHTFLDSVECYDPDSDTWSEVTRMTSGR.S
	TK040203_NMyc_nuclei2_step01.4363.4363.2	1.6818	0.3002	2598.27	1	2400.0%	1	R.LADLQVPRSGLAGCVVGGLLYAVGGR.N
*	TK040203_NMyc_nuclei2_step06.3689.3689.2	1.3461	0.0461	3004.06	27	1480.0%	1	K.CPEGAGDAVMYASTECKAEVTPSQDGNR.T
*	TK040203_NMyc_nuclei2_step04.4256.4256.3	1.1525	0.1473	2946.78	8	1520.0%	1	R.CKDYLVQIFQELTLHKPTQAVPCR.A

Q922C1

53.1%

641

69296

5.5

(Q922C1) Unknown (Protein for MGC:8256)

*	TK040203_NMyc_nuclei2_step05.2455.2455.2	1.709	0.2715	2809.92	1	2310.0%	2	R.THSRQASSAGDTVSMTASPPILDDFSK.S
*	TK040203_NMyc_nuclei2_step12.2834.2834.1	0.9523	0.1152	1021.5	5	5000.0%	1	K.RNQTMDEK.Y
*	TK040203_NMyc_nuclei2_step11.3884.3884.3	1.7692	0.0178	4706.02	44	830.0%	1	K.AGGIAAVGPALGGAYVDPAPIASHIVSADAIEALTAYSPAVLALNDMLK.Q

W146_HUMAN

53.1%

1336

145921

9.2

(Q9C0J8) WD-repeat protein WDC146

*	TK040203_NMyc_nuclei2_step07.1722.1722.2	1.3026	0.202	2662.03	6	1670.0%	3	R.GPQEIRGMQGPPPQGSMLGPPQELR.G
*	TK040203_NMyc_nuclei2_step11.3864.3864.2	1.5839	0.2041	2697.33	7	1880.0%	1	R.GRDGFPGPEDFGPEENFDASEEAAR.G
*	TK040203_NMyc_nuclei2_step07.3321.3321.1	1.554	0.0655	1264.98	1	5000.0%	3	K.TGQSLATLHAHK.N
*	TK040203_NMyc_nuclei2_step03.2431.2431.3	1.8329	0.0432	2822.62	133	1520.0%	1	K.TQAEIEQEMATLQYTNPQLLEQLK.I

Q9DBE0

53.1%

493

55145

6.6

(Q9DBE0) Adult male liver cDNA, RIKEN full-length enriched library, clone:1300015E02, full insert sequence

*	TK040203_NMyc_nuclei2_step03.3702.3702.3	1.8585	0.0155	3742.4	4	1540.0%	1	-.MADSKPLRTLDGDPVAVEALLQDVFGIVVDEAILK.G
	TK040203_NMyc_nuclei2_step06.2505.2505.1	1.5536	0.1134	1592.76	1	4330.0%	1	K.GAAFLGLGTDSVRVVK.A

Q91WA7

53.0%

1223

136486

8.4

(Q91WA7) Hypothetical 136.5 kDa protein

	TK040203_NMyc_nuclei2_step12.4015.4015.3	2.1491	0.1044	2657.14	20	2160.0%	1	R.NNEPLTHAMYNLASLRELGETQR.R
*	TK040203_NMyc_nuclei2_step12.4118.4118.3	1.992	0.0349	3771.38	53	1180.0%	1	R.LQSDDILPLGKDSGPLSDPITGKPYMPLSEAEEVR.L
	TK040203_NMyc_nuclei2_step07.2448.2448.2	1.3722	0.0895	1761.93	85	1880.0%	1	K.NLLNSVIGRALGISHAK.D
	TK040203_NMyc_nuclei2_step01.1904.1904.1	1.5419	0.1055	1042.63	3	6250.0%	1	R.YFGGCPVIK.V
	TK040203_NMyc_nuclei2_step11.1279.1279.3	1.7592	0.0747	3041.7	31	1830.0%	1	K.AVDEAVILLQEIGVLDQREYLTTLGQR.L
*	TK040203_NMyc_nuclei2_step08.2559.2559.2	1.1733	0.0057	2589.8	95	1740.0%	1	K.DSGPLSDPITGKPYMPLSEAEEVR.L

Q91VY5

53.0%

1086

121604

7.4

(Q91VY5) Similar to KIAA0677 gene product

	TK040203_NMyc_nuclei2_step04.2749.2749.2	1.3682	0.0533	2340.77	9	2250.0%	1	R.LERLAIGFFPGSSQGCDAFLR.H
*	TK040203_NMyc_nuclei2_step09.1426.1426.1	1.3042	0.0717	1036.45	1	6250.0%	1	R.RPGPASHRR.R
*	TK040203_NMyc_nuclei2_step12.4370.4370.2	1.2354	0.034	2536.33	25	2000.0%	1	R.WIHVICAIAVPEVRFLNVIER.N
*	TK040203_NMyc_nuclei2_step06.3575.3575.2	2.0471	0.2333	3150.32	1	2070.0%	1	K.TPSPSSPPLLSAPPALFPTEEVLRPPPQPK.S
*	TK040203_NMyc_nuclei2_step11.3754.3754.3	2.146	0.0573	4033.43	18	1250.0%	1	R.VIGTTAQTFYEVNFDDGSYSDNLYPESITSRDCLR.L

SAL3_MOUSE

52.9%

1323

139071

7.5

(Q62255) Sal-like protein 3 (Spalt-like protein 3) (MSal) (Fragment)

*	TK040203_NMyc_nuclei2_step06.1963.1963.3	1.6779	0.0759	2518.72	40	2400.0%	1	R.TGSSPPIVSLDKASSETGASRPFAR.F
*	TK040203_NMyc_nuclei2_step03.2509.2509.2	1.6695	0.3104	2990.35	1	2070.0%	1	K.TERLDSPPPGPGNGGALDLTAGHPGRPLIK.E
	TK040203_NMyc_nuclei2_step06.1435.1435.1	1.156	0.0707	538.41	4	8330.0%	1	Q.IHLR.S

CAH1_MOUSE

52.9%

260

28189

7.0

(P13634) Carbonic anhydrase I (EC 4.2.1.1) (Carbonate dehydratase I) (CA-I)

*	TK040203_NMyc_nuclei2_step05.2528.2528.2	2.0289	0.2396	1640.33	1	4620.0%	1	R.YSGELHLVHWNSAK.Y

MEI1_MOUSE

52.8%

18.7%

390

43002

6.3

(Q60954) Homeobox protein Meis1 (Myeloid ecotropic viral integration site-1)

	TK040203_NMyc_nuclei2_step03.2707.2707.2	1.2857	0.1513	2898.47	46	1520.0%	1	K.VATNIMRAWLFQHLTHPYPSEEQK.K
	TK040203_NMyc_nuclei2_step09.1958.1958.3	1.7113	0.1265	4437.29	2	1190.0%	1	R.SMQPVHHLNHGPPLHSHQYPHTAHTNAMAPSMGSSVNDALK.R
	TK040203_NMyc_nuclei2_step05.2898.2898.2	1.5958	0.4382	2113.95	1	3750.0%	1	R.AWLFQHLTHPYPSEEQK.K
	TK040203_NMyc_nuclei2_step01.0829.0829.1	1.19	0.0146	970.4	7	6430.0%	1	R.YISCLKGK.M

Q9EPZ5

52.8%

2.7%

445

49096

7.7

(Q9EPZ5) T-box transcription factor TBX20

	TK040203_NMyc_nuclei2_step07.3261.3261.1	1.3722	0.2288	1421.28	1	4090.0%	1	K.FHELGTEMIITK.S

MM09_HUMAN

52.8%

707

78427

6.1

(P14780) 92 kDa type IV collagenase precursor (EC 3.4.24.35) (92 kDa gelatinase) (Matrix metalloproteinase-9) (MMP-9) (Gelatinase B) (GELB)

*	TK040203_NMyc_nuclei2_step01.2906.2906.2	1.2311	0.0276	3114.95	52	1480.0%	1	R.FGNADGAACHFPFIFEGRSYSACTTDGR.S
*	TK040203_NMyc_nuclei2_step10.3116.3116.2	1.3937	0.0814	2856.88	2	2000.0%	1	R.VYSRDADIVIQFGVAEHGDGYPFDGK.D
*	TK040203_NMyc_nuclei2_step07.3214.3214.2	1.458	0.019	3176.7	14	1900.0%	1	K.DGLLAHAFPPGPGIQGDAHFDDDELWSLGK.G
*	TK040203_NMyc_nuclei2_step04.3901.3901.2	0.7927	0.0381	2725.71	102	1250.0%	1	K.GVVVPTRFGNADGAACHFPFIFEGR.S
*	TK040203_NMyc_nuclei2_step02.1535.1535.1	1.3717	0.2267	870.25	5	6670.0%	7	K.WPALPRK.L

TX18_MOUSE

52.8%

613

65464

8.4

(Q9EPZ6) T-box transcription factor TBX18 (T-box protein 18)

	TK040203_NMyc_nuclei2_step07.3261.3261.1	1.3722	0.2288	1421.28	1	4090.0%	1	R.FHEIGTEMIITK.A
*	TK040203_NMyc_nuclei2_step02.3011.3011.2	1.1562	0.1833	2036.73	47	2000.0%	1	K.GSPVPGLARPGTPLPAPQAPR.V

SORC_HUMAN

52.8%

198

21676

5.6

(P30626) Sorcin (22 kDa protein) (CP-22) (V19)

*	TK040203_NMyc_nuclei2_step11.1208.1208.1	1.3705	0.2266	1126.51	5	4500.0%	1	R.LSPQAVNSIAK.R

HEXB_HUMAN

52.7%

556

63111

6.8

(P07686) Beta-hexosaminidase beta chain precursor (EC 3.2.1.52) (N-acetyl-beta-glucosaminidase) (Beta-N-acetylhexosaminidase) (Hexosaminidase B)

*	TK040203_NMyc_nuclei2_step12.2411.2411.2	1.6759	0.1817	2360.36	39	1750.0%	1	K.LAPGTIVEVWKDSAYPEELSR.V
*	TK040203_NMyc_nuclei2_step03.3577.3577.3	2.5804	0.2838	4464.16	1	1540.0%	1	K.TQVQQLLVSITLQSECDAFPNISSDESYTLLVKEPVAVLK.A

Q07563

52.7%

1433

144088

8.7

(Q07563) Procollagen, type XVII, alpha 1 (Bullous pemphigoid autoantigen BP180) (Collagen XVII)

*	TK040203_NMyc_nuclei2_step03.2963.2963.2	1.9588	0.2521	2311.11	2	2610.0%	1	K.GSIGDPGMEGPIGQRGLAGPMGPR.G
*	TK040203_NMyc_nuclei2_step08.2312.2312.3	1.8697	0.1986	4174.46	4	1420.0%	1	R.GEQGLTGMPGTRGPPGPAGDPGKPGLTGPQGPQGLPGSPGRPGTK.G
*	TK040203_NMyc_nuclei2_step06.1120.1120.3	1.2398	0.0609	2225.09	16	1750.0%	1	R.LEKQSLTHGSSGYINSSGSIR.G
*	TK040203_NMyc_nuclei2_step03.1166.1166.2	0.8635	0.0977	1140.22	228	2270.0%	1	R.GDVGLPGVKGDK.G

Q96LZ7

52.7%

573

65228

7.0

(Q96LZ7) Hypothetical protein FLJ32954

*	TK040203_NMyc_nuclei2_step01.0027.0027.1	1.7791	0.165	952.51	10	5620.0%	1	K.TSSNTDAKK.H

MCR_HUMAN

52.7%

984

107067

7.4

(P08235) Mineralocorticoid receptor (MR)

*	TK040203_NMyc_nuclei2_step01.2544.2544.1	1.4553	0.1508	1322.07	3	4550.0%	1	K.CLQAGMNLGARK.S
	TK040203_NMyc_nuclei2_step08.2356.2356.3	1.8083	0.0431	3666.6	26	1210.0%	1	R.SVSTGSSRPSKICLVCGDEASGCHYGVVTCGSCK.V
	TK040203_NMyc_nuclei2_step06.1354.1354.1	1.4171	0.107	1585.51	32	3460.0%	1	K.QESTKHSCSGTSFK.G
	TK040203_NMyc_nuclei2_step06.3231.3231.2	1.0183	9.0E-4	2182.14	137	1900.0%	1	R.SHSPAHASNVGSPLSSPLSSMK.S
*	TK040203_NMyc_nuclei2_step11.4030.4030.3	1.8362	0.0775	3815.95	55	1250.0%	1	K.LKGIHEEQPQQQQPPPPPPPPQSPEEGTTYIAPAK.E
*	TK040203_NMyc_nuclei2_step12.2709.2709.3	1.8833	0.143	4195.24	6	1360.0%	1	K.MHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMK.V
*	TK040203_NMyc_nuclei2_step03.1811.1811.1	1.1718	0.3619	1095.65	23	4440.0%	1	K.VLLLLSTIPK.D
*	TK040203_NMyc_nuclei2_step09.2726.2726.3	1.6435	0.0108	3813.98	51	1370.0%	1	K.VLPGFKNLPLEDQITLIQYSWMCLSSFALSWR.S

Q8R1C0

52.7%

27.2%

628

68655

7.1

(Q8R1C0) Similar to potassium voltage-gated channel, Shaw-related subfamily, member 4

	TK040203_NMyc_nuclei2_step06.4298.4298.3	1.7407	0.0353	4487.35	6	1100.0%	1	K.TWSGMLVGALCALAGVLTIAMPVPVIVNNFGMYYSLAMAKQK.L
*	TK040203_NMyc_nuclei2_step03.4206.4206.3	1.8326	0.0765	3821.82	3	1440.0%	1	R.LAWLADPDGGGRPESDGGGAGSSGSSGGGGGGGGCEFFFDR.H
*	TK040203_NMyc_nuclei2_step08.4311.4311.2	1.6429	0.3222	2907.54	4	1900.0%	1	R.DAEEALDIFESPDGGGGGAGPGDEAGDDER.E
	TK040203_NMyc_nuclei2_step04.3529.3529.3	1.384	0.048	4619.3	97	880.0%	1	R.TGKLHCPADVCGPLFEEELTFWGIDETDVEPCCWMTYR.Q
*	TK040203_NMyc_nuclei2_step12.3611.3611.2	1.5308	0.0163	2073.43	5	2630.0%	1	K.AAACFLLSAGDYACADGSVR.K

O75485

52.7%

664

76008

6.4

(O75485) Multiple membrane spanning receptor TRC8 (Patched related protein TRC8)

*	TK040203_NMyc_nuclei2_step04.2090.2090.3	2.5703	0.2708	2282.35	3	2920.0%	2	R.VFWLTRVTAQATVLMYILR.M

Q9UQD1

52.7%

16.4%

377

41654

8.6

(Q9UQD1) R33423_1

	TK040203_NMyc_nuclei2_step08.2491.2491.3	1.7819	0.047	2579.17	27	2080.0%	1	R.NADLSITLGTSLQIRPSGNLPLATK.R
	TK040203_NMyc_nuclei2_step04.3552.3552.3	2.5743	0.2749	4003.26	4	1460.0%	2	R.LVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEER.G

Q9CTA0

52.7%

16.4%

262

28549

11.4

(Q9CTA0) 1110037F02Rik protein (Fragment)

*	TK040203_NMyc_nuclei2_step03.3382.3382.2	1.9535	0.2471	2909.63	2	1730.0%	1	R.GGQSNFNRGPLPPLRPLSSTGYRPSPR.D
	TK040203_NMyc_nuclei2_step04.3107.3107.2	1.1192	0.0179	1839.98	15	3000.0%	1	R.GGFGQGIRPHDIFRQR.K

Q91Z35

52.7%

607

64648

6.0

(Q91Z35) Hypothetical 64.6 kDa protein

	TK040203_NMyc_nuclei2_step03.2171.2171.3	1.9246	0.0126	2529.18	2	2200.0%	1	K.KPTRPAAASQDSQAADGAGRASLATK.R
*	TK040203_NMyc_nuclei2_step10.1936.1936.2	1.4328	0.1273	1847.19	1	3330.0%	1	R.SSGLSTPVAPSAGHLAHVR.E
	TK040203_NMyc_nuclei2_step07.1210.1210.2	1.968	0.2459	1955.5	1	3160.0%	1	K.KPTRPAAASQDSQAADGAGR.A

FA5_HUMAN

52.7%

2224

251699

6.0

(P12259) Coagulation factor V precursor (Activated protein C cofactor)

	TK040203_NMyc_nuclei2_step11.2063.2063.3	1.67	0.0842	3506.02	29	1500.0%	1	R.QFYVAAQGISWSYRPEPTNSSLNLSVTSFKK.I
	TK040203_NMyc_nuclei2_step12.4303.4303.2	1.2265	0.177	2626.08	1	2250.0%	1	K.MHDRLEPEDEESDADYDYQNR.L
	TK040203_NMyc_nuclei2_step01.4080.4080.3	1.7129	0.0727	4476.45	216	810.0%	1	K.GSYEIIQDTDEDTAVNNWLISPQNASRAWGESTPLANKPGK.Q
	TK040203_NMyc_nuclei2_step03.2909.2909.3	1.9588	0.0489	3985.79	480	810.0%	1	K.IVFKNMASRPYSIYPHGVTFSPYEDEVNSSFTSGR.N
	TK040203_NMyc_nuclei2_step03.0850.0850.3	0.8033	0.0408	4216.53	25	640.0%	1	K.MYEQEWVRLHLLNIGGSQDIHVVHFHGQTLLENGNK.Q
*	TK040203_NMyc_nuclei2_step04.0345.0345.1	0.9338	0.0257	1558.85	17	2920.0%	1	R.VIPKTWNQSITLR.L
	TK040203_NMyc_nuclei2_step08.3179.3179.3	1.9687	0.0081	3448.3	11	1640.0%	1	K.ASKPGWWLLNTEVGENQRAGMQTPFLIMDR.D
	TK040203_NMyc_nuclei2_step10.3132.3132.2	1.5312	0.065	2073.34	90	2110.0%	2	K.APSHQQATTAGSPLRHLIGK.N

KPT3_HUMAN

52.7%

472

54210

8.7

(Q07002) Serine/threonine protein kinase PCTAIRE-3 (EC 2.7.1.-)

*	TK040203_NMyc_nuclei2_step10.3085.3085.2	1.9554	0.2496	2114.17	4	2650.0%	2	K.NLKHANIVTLHDLIHTDR.S

MCCA_HUMAN

52.6%

725

80433

7.8

(Q96RQ3) Methylcrotonyl-CoA carboxylase alpha chain, mitochondrial precursor (EC 6.4.1.4) (3-Methylcrotonyl-CoA carboxylase 1) (MCCase alpha subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase alpha subunit)

*	TK040203_NMyc_nuclei2_step12.3822.3822.2	0.988	0.0658	1561.32	31	3000.0%	1	-.MAAASAVSVLLVAAER.N
*	TK040203_NMyc_nuclei2_step05.3471.3471.3	2.1885	0.1022	3086.63	21	1760.0%	1	R.NSMHVDMADEAYSIGPAPSQQSYLSMEK.I
*	TK040203_NMyc_nuclei2_step04.1817.1817.1	1.5071	0.1269	901.48	1	7140.0%	1	R.QAALTKLR.Y

Q9D742

52.5%

170

18806

7.2

(Q9D742) 2310035K24Rik protein

*	TK040203_NMyc_nuclei2_step07.2025.2025.2	2.1092	0.1945	1481.93	1	5380.0%	2	R.LLTPAVSTGAAYCR.A

Q8TF63

52.5%

26.6%

244

26704

9.9

(Q8TF63) DCNP1

*	TK040203_NMyc_nuclei2_step08.1429.1429.3	1.7662	0.1845	2139.13	7	2640.0%	2	R.AWSSHLISLSLTCSDSQSR.R
*	TK040203_NMyc_nuclei2_step03.1507.1507.3	1.6926	0.0088	4757.99	1	1110.0%	1	R.GAGGETPEFPGCHSPAPPENFGNELLPLSAPLQGLSEGLYPPGRNK.T

Q9NTM7

52.5%

19.3%

368

42119

6.1

(Q9NTM7) BA541N10.1 (Novel protein)

	TK040203_NMyc_nuclei2_step03.3343.3343.3	2.0307	0.1368	4097.83	12	1290.0%	1	R.LSIRPGLSEAVLQQVLELLEDQSDIVSTMEHYYTAF.-
	TK040203_NMyc_nuclei2_step09.3414.3414.3	1.5627	0.0145	3788.87	21	1250.0%	5	K.VYDQPFHSSALEKEEALSNPGALDLPSLTSLLSEK.A

CLR1_MOUSE

52.5%

3034

330481

5.9

(O35161) Cadherin EGF LAG seven-pass G-type receptor 1 precursor

*	TK040203_NMyc_nuclei2_step03.3169.3169.2	1.4873	0.0313	2587.48	244	1090.0%	1	R.VQATDRDQGQNAAIHYSIVSGNLK.G
*	TK040203_NMyc_nuclei2_step08.3792.3792.3	1.1636	0.0499	4609.12	25	1010.0%	1	R.ENVAVYNLWALAVDRGSPNPLSASVGIQVSVLDINDNPPVFEK.D
*	TK040203_NMyc_nuclei2_step11.1562.1562.3	1.8423	0.0175	3306.27	4	1720.0%	1	R.SKPVCVFWNHSLDTGGTGGWSAKGCELLSR.N
*	TK040203_NMyc_nuclei2_step11.3508.3508.2	0.932	0.0049	3031.7	4	1850.0%	1	K.IITYAALSLSLVALLVAFVLLSLVRTLR.S
*	TK040203_NMyc_nuclei2_step05.2474.2474.3	1.7241	0.041	3692.76	73	1210.0%	1	K.VAVVTVDDCDAAVAVHFGSYVGNYSCAAQGTQSGSK.K
*	TK040203_NMyc_nuclei2_step10.3489.3489.2	1.534	0.0286	2151.79	3	3000.0%	1	R.FALSSQSGGGLITLALPLDYK.Q
*	TK040203_NMyc_nuclei2_step12.4217.4217.3	1.622	0.0895	4467.32	35	1060.0%	1	K.VSVELHRQAQGNHCGDRPSDPESGVLAKPVAVLSSQPQEQR.K
*	TK040203_NMyc_nuclei2_step02.3472.3472.3	2.76	0.1893	3821.84	10	1390.0%	2	K.VAVVTVDDCDAAVAVHFGSYVGNYSCAAQGTQSGSKK.S
	TK040203_NMyc_nuclei2_step02.3879.3879.2	1.3524	0.1632	1984.04	52	2060.0%	1	R.DRDANSVITYQLTGGNTR.N

Q9ULQ9

52.5%

18.0%

217

24251

4.7

(Q9ULQ9) Hypothetical protein KIAA1161 (Fragment)

*	TK040203_NMyc_nuclei2_step03.3741.3741.3	2.7421	0.0124	4043.56	1	1780.0%	1	R.SLIPAVLTVSMLGYPFILPDMVGGNAVPQRTAGGDVPER.E

WS14_MOUSE

52.5%

864

94875

7.9

(Q99MZ3) Williams-Beuren syndrome chromosome region 14 protein homolog (Mlx interactor)

*	TK040203_NMyc_nuclei2_step01.4191.4191.2	1.1963	0.0607	2634.33	7	1740.0%	1	R.WCEQLFSSVVPVLLGGSEEEPGGR.Q
	TK040203_NMyc_nuclei2_step02.1693.1693.3	2.7545	0.0437	2402.77	1	3070.0%	1	K.LGFDTLHGLVSTLSAQPSLKVSK.A

CADD_MOUSE

52.4%

714

78286

5.1

(Q9WTR5) Cadherin-13 precursor (Truncated-cadherin) (T-cadherin) (T-cad) (Heart-cadherin) (H-cadherin)

*	TK040203_NMyc_nuclei2_step10.3553.3553.2	1.7935	0.0995	1775.0	2	3440.0%	3	R.VEEGAVGVIVNLTVEDK.D

CYCK_MOUSE

52.4%

32.5%

206

24071

8.6

(O88874) Cyclin K (Fragment)

	TK040203_NMyc_nuclei2_step08.2441.2441.2	1.3142	0.0164	2585.66	77	1500.0%	1	R.ILLQTIKFDLQVEHPYQFLLK.Y
	TK040203_NMyc_nuclei2_step11.4363.4363.2	1.9377	0.2504	2924.41	3	2080.0%	1	R.FIFDVGTRLGLHYDTLATGIIYFHR.F
	TK040203_NMyc_nuclei2_step04.3117.3117.2	1.7736	0.0374	2342.54	11	2500.0%	1	K.DLAHTPSQLEGLDPATEARYR.R

NMA_HUMAN

52.4%

260

29108

7.8

(Q13145) Putative transmembrane protein NMA precursor

*	TK040203_NMyc_nuclei2_step12.2537.2537.2	1.9386	0.2513	2828.79	5	2050.0%	3	K.LDLECMVPVSGHENCCLTCDKMR.Q

DYNA_MOUSE

52.3%

1281

141727

6.0

(O08788) Dynactin 1 (150 kDa dynein-associated polypeptide) (DP-150) (DAP-150) (p150-glued)

*	TK040203_NMyc_nuclei2_step11.1634.1634.2	1.5191	0.0823	2203.19	269	1670.0%	1	R.LHISQLQHENSILRGAQMK.A
	TK040203_NMyc_nuclei2_step10.1943.1943.2	1.0622	0.0502	1920.89	3	3120.0%	1	R.VEAAQETVADYQQTIKK.Y
*	TK040203_NMyc_nuclei2_step08.3320.3320.3	1.5188	0.0061	4296.04	11	1190.0%	1	R.KHLTWVVAVLQEVAAAAAQLIAPLAENEGLPVAALEELAFK.A
	TK040203_NMyc_nuclei2_step05.2074.2074.2	1.4297	0.0913	1703.92	22	4230.0%	3	R.LVLTQEQLHQLHSR.L

PGDS_HUMAN

52.2%

1089

122670

5.2

(P16234) Alpha platelet-derived growth factor receptor precursor (EC 2.7.1.112) (PDGF-R-alpha) (CD140a antigen)

*	TK040203_NMyc_nuclei2_step06.2681.2681.2	1.9086	0.2478	1545.76	1	4000.0%	1	R.DGLVLGRVLGSGAFGK.V
*	TK040203_NMyc_nuclei2_step08.1513.1513.3	1.3626	0.0557	2978.53	292	1560.0%	1	R.MAKPDHATSEVYEIMVKCWNSEPEK.R
*	TK040203_NMyc_nuclei2_step02.1628.1628.1	1.2712	0.0613	1221.42	106	3500.0%	1	K.GKGITMLEEIK.V
*	TK040203_NMyc_nuclei2_step12.4111.4111.3	2.363	0.1128	2571.83	3	2280.0%	1	R.TTDPETPVTLHNSEGVVPASYDSR.Q

Q9DAS2

52.2%

200

23070

9.7

(Q9DAS2) 1700001C02Rik protein

*	TK040203_NMyc_nuclei2_step01.0905.0905.1	1.4891	0.1312	1469.73	1	4170.0%	1	R.YPLPTDLPPLSEK.S

Q9HCD9

52.1%

1561

177416

5.7

(Q9HCD9) Hypothetical protein KIAA1633 (Fragment)

*	TK040203_NMyc_nuclei2_step11.2798.2798.2	1.2476	0.0969	2572.19	1	2620.0%	2	K.QKGELVHFVQTNSFSKPHDELK.L
*	TK040203_NMyc_nuclei2_step09.3439.3439.3	1.8057	0.0945	2974.96	66	1630.0%	1	R.EEESFSLYSDQTFYLSICLEENNR.F
	TK040203_NMyc_nuclei2_step04.3605.3605.2	1.2939	0.0053	2434.85	12	1900.0%	1	K.VSVMGTDQSESINTSNETEYLK.Q
*	TK040203_NMyc_nuclei2_step06.4225.4225.3	1.5997	0.1291	3745.36	1	1670.0%	1	R.HTESKISDCDGAHAPGCLEEGAFINLLAPLFNEK.A
*	TK040203_NMyc_nuclei2_step04.2095.2095.1	1.5245	0.1035	1542.82	1	3850.0%	1	K.QNQALNAMLIKGSR.D
	TK040203_NMyc_nuclei2_step10.2207.2207.2	1.3722	0.0429	2410.06	2	2500.0%	1	R.HVLGLIEDYEALLKQISQGQR.L
	TK040203_NMyc_nuclei2_step06.4335.4335.2	0.6583	0.0031	1450.21	186	1250.0%	1	R.SIETSSTLQSRLK.E

CYG4_HUMAN

52.1%

732

81750

7.7

(P33402) Guanylate cyclase soluble, alpha-2 chain (EC 4.6.1.2) (GCS-alpha-2)

*	TK040203_NMyc_nuclei2_step01.2794.2794.1	1.6672	0.0968	1417.13	1	4550.0%	1	R.VLLRLSTPFVIR.T

O54988

52.1%

1233

141485

5.1

(O54988) Serine/threonine protein kinase

	TK040203_NMyc_nuclei2_step10.3679.3679.2	1.3804	0.0684	3022.12	122	1350.0%	1	R.VEDKQPEQQPAVCEAEGQLTSTSETTR.A
	TK040203_NMyc_nuclei2_step09.2061.2061.3	1.8321	0.0553	3098.22	1	2120.0%	1	K.ADVWSLGITLIEMAEIEPPHHELNPMR.V
	TK040203_NMyc_nuclei2_step11.4394.4394.2	1.8898	0.2538	3094.27	1	1790.0%	3	K.AVDEHASDVNLETGAELNDQTVGIHENGR.E
	TK040203_NMyc_nuclei2_step10.3365.3365.1	1.1476	0.0084	1430.79	33	2730.0%	1	K.EEQRAQQQLNGK.L

SAH3_HUMAN

52.0%

16.5%

611

66721

7.4

(Q96HN2) Putative adenosylhomocysteinase 3 (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)

*	TK040203_NMyc_nuclei2_step08.1173.1173.1	0.9673	0.0951	1027.56	3	3750.0%	1	K.RIVLLAEGR.L
*	TK040203_NMyc_nuclei2_step12.4113.4113.2	1.3206	0.083	2978.91	3	2000.0%	3	K.MDEYVASLHLPTFDAHLTELTDEQAK.Y
*	TK040203_NMyc_nuclei2_step02.3244.3244.3	2.0319	0.0407	4660.13	12	1150.0%	1	K.GESEDDFWWCIDRCVNVEGWQPNMILDDGGDLTHWIYK.K
*	TK040203_NMyc_nuclei2_step05.2064.2064.3	1.6553	0.1404	3162.32	6	1670.0%	1	K.AMGSIVYVTEIDPICALQACMDGFRLVK.L
*	TK040203_NMyc_nuclei2_step12.4018.4018.2	1.5046	0.107	2960.4	21	1460.0%	1	R.CVNVEGWQPNMILDDGGDLTHWIYK.K

Q9H7S0

52.0%

0.6%

1811

207191

6.5

(Q9H7S0) Hypothetical protein FLJ14329

*	TK040203_NMyc_nuclei2_step06.2111.2111.1	1.1076	0.0177	1238.44	3	4440.0%	3	K.RCQLPDGSFR.R

Q96LQ7

52.0%

493

53618

5.4

(Q96LQ7) Hypothetical protein FLJ25193

*	TK040203_NMyc_nuclei2_step04.3391.3391.3	2.7105	0.1624	3076.14	2	2050.0%	1	K.YLLTGEGAGTVFVIDEATGNIHVTKSLDR.E

Q9NZH2

52.0%

567

63458

9.8

(Q9NZH2) Dhfr oribeta-binding protein RIP60

	TK040203_NMyc_nuclei2_step11.1354.1354.3	2.709	0.1195	2840.55	1	2930.0%	1	R.DGAFCCAICGQTFDDEERLLAHQK.K
*	TK040203_NMyc_nuclei2_step04.3415.3415.3	2.2626	0.0535	3063.28	1	2120.0%	1	R.FSQGSHLAAHRPDHAPDRPFVCPDCGK.A

Q9CPR7

51.9%

207

23522

5.4

(Q9CPR7) 5730470L24Rik protein (RIKEN cDNA 5730470L24 gene)

*	TK040203_NMyc_nuclei2_step05.2147.2147.2	2.0734	0.2545	1483.48	10	4550.0%	5	R.RAVQVDDNQFCK.V

Q8QZW8

51.9%

406

45753

8.0

(Q8QZW8) Hypothetical 45.8 kDa protein

*	TK040203_NMyc_nuclei2_step06.1371.1371.1	1.478	0.1339	1107.67	3	5560.0%	1	R.EGDTVPSFVR.L
*	TK040203_NMyc_nuclei2_step01.1934.1934.1	1.1677	0.1337	1257.64	3	4440.0%	1	R.LDRENPLELR.L

Q99P73

51.8%

521

55899

8.8

(Q99P73) Kruppel-like zinc finger protein GLIS2

	TK040203_NMyc_nuclei2_step01.1246.1246.1	0.9895	0.0209	1127.44	33	4440.0%	1	K.CLSPELPLAK.Q
	TK040203_NMyc_nuclei2_step01.3960.3960.1	1.1599	0.0147	1299.7	63	3000.0%	1	-.MHSLDEPLDLK.L
	TK040203_NMyc_nuclei2_step12.2663.2663.2	1.5807	0.3628	3078.21	4	1720.0%	1	K.NPLLPSPFGAGGLGLPVVSLLGGSAGSKAEGEK.G

Q9UPC9

51.8%

1412

154114

7.4

(Q9UPC9) Nuclear receptor coactivator

	TK040203_NMyc_nuclei2_step10.1736.1736.2	1.2005	0.077	1551.38	14	3850.0%	1	K.ESKESSVEGAENQR.G
	TK040203_NMyc_nuclei2_step02.3663.3663.3	1.7986	0.0545	4503.27	3	1190.0%	1	K.IKTETSEEGSGDLDNLDAILGDLTSSDFYNNSISSNGSHLGTK.Q
*	TK040203_NMyc_nuclei2_step01.3744.3744.2	1.5933	0.3682	2947.0	2	2220.0%	1	R.YGGSSNIASLTPGPGMQSPSSYQNNNYR.L

Q9EQ18

51.7%

33.7%

389

43256

5.4

(Q9EQ18) SIR2L2

*	TK040203_NMyc_nuclei2_step04.1622.1622.1	1.4699	0.0098	1175.61	1	6250.0%	2	R.KEYTMGWMK.E
*	TK040203_NMyc_nuclei2_step09.2730.2730.2	1.5598	0.2412	2717.51	4	2000.0%	1	K.VQEAQDSDSDTEGGATGGEAEMDFLR.N
*	TK040203_NMyc_nuclei2_step07.3793.3793.3	1.6586	0.0058	4443.45	39	1080.0%	2	R.CYTQNIDTLERVAGLEPQDLVEAHGTFYTSHCVNTSCR.K
*	TK040203_NMyc_nuclei2_step06.3269.3269.3	1.4477	0.0398	2565.31	4	2080.0%	1	R.REHANIDAQSGSQAPNPSTTISPGK.S
*	TK040203_NMyc_nuclei2_step11.3916.3916.2	1.0275	2.0E-4	2060.25	4	2630.0%	3	R.KVICLVGAGISTSAGIPDFR.S
*	TK040203_NMyc_nuclei2_step09.2541.2541.3	1.8179	0.0482	4108.15	97	1050.0%	1	K.VQEAQDSDSDTEGGATGGEAEMDFLRNLFTQTLGLGSQK.E

M172_MOUSE

51.7%

988

109958

5.1

(P97432) Membrane component, chromosome 17, surface marker 2 (Next to BRCA1 gene 1 protein)

*	TK040203_NMyc_nuclei2_step04.4203.4203.2	1.2101	0.0891	3158.72	50	1350.0%	1	K.YLDEENEEISINSQGEYEEALKMANIK.Q
	TK040203_NMyc_nuclei2_step08.2743.2743.3	2.5682	0.291	3917.93	2	1610.0%	1	R.YQCSLCPSYNICEDCEAGPYTHDTNHVLLKLR.R
*	TK040203_NMyc_nuclei2_step11.3087.3087.3	1.6569	0.0453	4440.1	202	810.0%	1	R.VPHNTPVDMTPCMSPLPHDSPLIEKPGLGQIQEESEGAGFK.A
	TK040203_NMyc_nuclei2_step08.1772.1772.3	2.0463	0.295	3134.16	12	1770.0%	1	K.HNYNILQVVTELLQVNNNDWYSHRY.-
	TK040203_NMyc_nuclei2_step05.2611.2611.2	1.0357	0.0551	2338.31	3	2630.0%	1	R.ELQLYSTEGQQPLVLPGFCR.K

Q9JK31

51.7%

1306

138488

4.8

(Q9JK31) ATFa-associated factor

*	TK040203_NMyc_nuclei2_step10.2497.2497.3	2.0926	0.1034	2918.6	12	2020.0%	1	K.IAEDPIAEPALEEEAISSSMEVDQSEK.D
*	TK040203_NMyc_nuclei2_step01.2876.2876.3	1.3482	0.0129	4629.29	173	710.0%	2	R.NSSTTAAPLGTTLAVQAVPTAHSIVQATRTSLPTVGPSGLYSSSSSR.G
	TK040203_NMyc_nuclei2_step10.1857.1857.2	1.8312	0.2478	1816.97	4	3440.0%	2	R.LPPEAASTSLPQKPHLK.L

Q9NRT9

51.7%

103

947

104406

5.0

(Q9NRT9) Protocadherin 13 (Fragment)

*	TK040203_NMyc_nuclei2_step09.3894.3894.1	0.5609	0.0907	632.41	1	4000.0%	1	K.VPQASK.D
*	TK040203_NMyc_nuclei2_step05.3287.3287.2	1.0472	0.0903	2715.33	20	1600.0%	1	R.ATELLYSLNEGLPAGVLIGSLAEDLR.L
*	TK040203_NMyc_nuclei2_step07.0402.0402.1	0.991	0.0136	1326.07	13	3000.0%	1	K.VIFRPPEIVPR.Y
*	TK040203_NMyc_nuclei2_step12.3974.3974.2	1.6176	0.227	2750.63	16	1460.0%	10	R.GLSGQYVTLDNRSGELHTSAQEIDR.E

O35082

51.7%

1014

116426

8.3

(O35082) Klotho protein

	TK040203_NMyc_nuclei2_step11.3784.3784.3	2.5568	0.2634	3572.9	1	1800.0%	1	R.CMISELVHANITPVVALWQPAAPHQGLPHALAK.H
	TK040203_NMyc_nuclei2_step02.3266.3266.3	1.7421	0.0255	3938.31	19	1320.0%	1	R.FARAPAPEAAGLLHDTFPDGFLWAVGSAAYQTEGGWR.Q

PSA3_HUMAN

51.6%

254

28302

5.3

(P25788) Proteasome subunit alpha type 3 (EC 3.4.25.1) (Proteasome component C8) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8)

*	TK040203_NMyc_nuclei2_step12.1691.1691.2	1.6253	0.3119	2528.85	5	2380.0%	1	K.AFELELSWVGELTNGRHEIVPK.D

PLTP_MOUSE

51.6%

493

54453

6.6

(P55065) Phospholipid transfer protein precursor (Lipid transfer protein II)

*	TK040203_NMyc_nuclei2_step03.2145.2145.2	0.9828	0.027	1801.63	40	2220.0%	1	K.NRPADVAASHVPPPSAAAA.-
*	TK040203_NMyc_nuclei2_step01.0737.0737.1	0.8214	0.0303	1129.56	3	5000.0%	3	K.MNMAFGGTFR.R

CBFC_MOUSE

51.5%

335

37298

4.9

(P70353) Nuclear transcription factor Y subunit gamma (NF-Y protein chain C) (Nuclear factor YC) (NF-YC) (CCAAT-binding transcription factor subunit C) (CBF-C)

	TK040203_NMyc_nuclei2_step09.2974.2974.2	1.5858	0.1068	2647.55	3	1880.0%	1	-.MSTEGGFGGTSSSDAQQSLQSFWPR.V
	TK040203_NMyc_nuclei2_step07.3274.3274.1	1.4231	0.1735	979.28	4	5620.0%	1	R.NDIAMAITK.F

O54774

51.4%

1199

135081

7.4

(O54774) MBLVR

*	TK040203_NMyc_nuclei2_step09.3767.3767.3	1.433	0.0598	4012.85	21	1410.0%	2	K.IIDICSQSNYQHITNFEWYISILVELTRLEGTR.H
	TK040203_NMyc_nuclei2_step11.4531.4531.2	0.9298	0.0402	2512.51	14	1820.0%	1	K.EKLEDPDPGVQSAAVNVICELAR.R
*	TK040203_NMyc_nuclei2_step01.4146.4146.2	1.016	0.0064	2573.25	47	2050.0%	1	K.RYQDAPGVEHIPVVQIDLSVPLK.V
*	TK040203_NMyc_nuclei2_step11.3340.3340.3	1.8373	0.1507	4557.4	1	1190.0%	1	K.GEDLDFWLSTTPPPAAAPIPAPSTEELAASTITSPKDECEVLK.G
	TK040203_NMyc_nuclei2_step02.1931.1931.1	1.5106	0.1129	965.63	4	5710.0%	1	K.KAVLIMYK.V

O76040

51.4%

29.8%

131

15012

6.7

(O76040) ORF2: function unknown

*	TK040203_NMyc_nuclei2_step01.3728.3728.2	1.1592	0.0636	3069.63	6	1790.0%	1	K.LPQPPQPSATTTLISQQPSTSRQDPPPAK.R
*	TK040203_NMyc_nuclei2_step05.1968.1968.1	1.5106	0.1158	1215.62	1	5560.0%	1	R.QTSLLSYFKK.L

DYI1_MOUSE

51.4%

628

70679

5.1

(O88485) Dynein intermediate chain 1, cytosolic (DH IC-1) (Cytoplasmic dynein intermediate chain 1)

	TK040203_NMyc_nuclei2_step10.3583.3583.2	1.6423	0.0075	2545.01	13	2140.0%	2	R.TLQWDTDPSVLQLQSDSELGRR.L

Q8VFG5

51.3%

308

34329

8.7

(Q8VFG5) Olfactory receptor MOR222-2

*	TK040203_NMyc_nuclei2_step11.2931.2931.3	2.6111	0.2365	4684.8	2	1400.0%	2	K.AVVISLTGSGVISYQECAAQLYIFLTFSSSECFLLTAMAYDR.C

Q9UFD2

51.3%

106

11770

4.5

(Q9UFD2) Hypothetical protein

*	TK040203_NMyc_nuclei2_step09.2301.2301.2	1.7695	0.2572	2309.02	1	2500.0%	1	-.MTLPASSVPHITVEEEDGEIR.L

Q9NYM9

51.3%

111

12388

8.2

(Q9NYM9) GS15

*	TK040203_NMyc_nuclei2_step02.3520.3520.2	1.5982	0.3238	2423.02	3	2620.0%	1	R.YLDGMDSDFTSMTSLLTGSVKR.F

Q9BVI7

51.3%

218

25650

10.0

(Q9BVI7) Hypothetical protein

*	TK040203_NMyc_nuclei2_step02.4192.4192.2	1.6027	0.3191	1983.95	5	2810.0%	1	R.LTRVRPDYTAQNLDHGK.A

HKR3_HUMAN

51.2%

688

77054

8.2

(P10074) Krueppel-related zinc finger protein 3 (HKR3 protein)

*	TK040203_NMyc_nuclei2_step11.4155.4155.2	1.817	0.2502	2779.02	1	2880.0%	1	K.SNVIRKPCAAEPALSAGSLAAEPAENR.K

TRFM_HUMAN

51.1%

738

80242

6.0

(P08582) Melanotransferrin precursor (Melanoma-associated antigen p97) (CD228 antigen)

*	TK040203_NMyc_nuclei2_step11.2618.2618.3	1.4161	0.0439	4175.12	1	1400.0%	1	R.GWLGLDYVAALEGMSSQQCSGAAAPAPGAPLLPLLLPALAAR.L
*	TK040203_NMyc_nuclei2_step06.3622.3622.3	2.4977	0.1612	3988.38	39	1140.0%	1	R.AEVSQFAACNLAQIPPHAVMVRPDTNIFTVYGLLDK.A
*	TK040203_NMyc_nuclei2_step08.2587.2587.2	1.2697	0.0904	2440.58	2	2730.0%	1	K.RSCHAGFGSPAGWDVPVGALIQR.G
*	TK040203_NMyc_nuclei2_step01.2006.2006.1	1.7234	0.0153	1074.53	1	6880.0%	1	K.CGNMSEAFR.E

Q9JKX4

51.1%

526

59482

4.9

(Q9JKX4) Traube

*	TK040203_NMyc_nuclei2_step12.1541.1541.2	1.2832	0.0993	2057.7	4	2780.0%	1	R.EEDRNSEDDGVVAAFSSVK.V
*	TK040203_NMyc_nuclei2_step09.2391.2391.1	1.6335	0.0958	1302.13	1	5000.0%	1	R.KLAPVSLLDTDK.R

Q9Z243

51.1%

457

50648

5.2

(Q9Z243) NNX3

	TK040203_NMyc_nuclei2_step01.2130.2130.1	1.6252	0.0983	1136.83	2	5560.0%	4	K.QAVGLVEHRK.E
*	TK040203_NMyc_nuclei2_step10.3881.3881.2	0.7693	0.0252	1620.36	7	2690.0%	1	R.VFVDVVNGEYVPRK.S
*	TK040203_NMyc_nuclei2_step06.4235.4235.3	1.6447	0.0476	2446.35	4	2380.0%	1	R.QEELLGELESKPDTVIANGEDR.V

K2C1_MOUSE

51.1%

627

65092

8.8

(P04104) Keratin, type II cytoskeletal 1 (Cytokeratin 1) (67 kDa cytokeratin)

	TK040203_NMyc_nuclei2_step01.0886.0886.1	1.723	0.0172	827.66	2	7500.0%	1	K.FASFIDK.V
*	TK040203_NMyc_nuclei2_step06.1259.1259.1	1.3244	0.1146	760.71	12	4380.0%	1	R.RSGGGGGGR.F
*	TK040203_NMyc_nuclei2_step08.1376.1376.1	0.8024	2.0E-4	1269.65	247	2500.0%	1	K.LALDMEIATYK.K

Q91VK6

51.1%

13.7%

673

73270

5.8

(Q91VK6) Unknown (Protein for IMAGE:3482264) (Fragment)

*	TK040203_NMyc_nuclei2_step11.4466.4466.3	1.7141	0.027	4124.73	12	1190.0%	1	R.MAEAGRSPEMSPDQPAGQEAAAAEALDPEPEAPGPPVPSLR.W
*	TK040203_NMyc_nuclei2_step08.4331.4331.2	0.9255	0.0106	3059.72	6	1430.0%	1	K.DELGPQLLTPGQMGDSSESFSAPEDEAPR.E
	TK040203_NMyc_nuclei2_step09.1979.1979.1	1.6539	0.0454	1472.64	57	3330.0%	5	R.ADKPWARLTPADK.A
*	TK040203_NMyc_nuclei2_step06.3534.3534.3	1.2764	0.2048	4514.78	31	1050.0%	1	R.SPEMSPDQPAGQEAAAAEALDPEPEAPGPPVPSLRWLPGDPSPR.G

Q60920

51.1%

196

134

15673

9.3

(Q60920) Zfp78p (Fragment)

	TK040203_NMyc_nuclei2_step01.2718.2718.1	1.2316	0.0555	1573.74	189	2500.0%	14	K.AFIRSSQLLIHER.I

O70495

51.0%

897

101167

11.9

(O70495) Plenty-of-prolines-101

*	TK040203_NMyc_nuclei2_step04.3864.3864.1	0.9629	0.2106	829.75	68	2500.0%	1	R.GASASPQGR.Q
	TK040203_NMyc_nuclei2_step09.2075.2075.1	1.2963	0.1279	1371.58	12	4090.0%	2	K.SPELPEPSVRMK.D
*	TK040203_NMyc_nuclei2_step09.2882.2882.3	2.2797	0.054	4245.27	2	1340.0%	1	K.AVTIATPATAAPAAVSAATTTSAQEEPAAAPEPREVFTPPLPAV.-

O75023

51.0%

590

64126

7.3

(O75023) Leucocyte immunoglobulin-like receptor-8

*	TK040203_NMyc_nuclei2_step07.1960.1960.1	1.4664	0.1398	1449.71	3	3750.0%	1	K.FHIPSTVYDSAGR.Y

MPRI_MOUSE

51.0%

2483

273814

5.7

(Q07113) Cation-independent mannose-6-phosphate receptor precursor (CI Man-6-P receptor) (CI-MPR) (Insulin-like growth factor II receptor) (300 kDa mannose 6-phosphate receptor) (MPR 300) (MPR300)

*	TK040203_NMyc_nuclei2_step08.2692.2692.2	1.4187	0.1227	2253.94	4	2750.0%	1	K.LSSDVCSAHDGSKAVSSCQEK.K
	TK040203_NMyc_nuclei2_step10.1955.1955.2	1.3207	0.01	1756.87	6	2860.0%	1	K.LVSFHDDSDEDLLHI.-
*	TK040203_NMyc_nuclei2_step12.3431.3431.3	2.7129	0.099	3308.31	5	1700.0%	1	R.HQNQTLRYSDGDLTLIYSGGDECSSGFQR.M
*	TK040203_NMyc_nuclei2_step09.1230.1230.1	1.4501	0.0551	1158.54	27	4500.0%	2	R.GVSMGTPKLIR.T
*	TK040203_NMyc_nuclei2_step05.1787.1787.2	0.9629	0.0711	2642.88	21	1670.0%	1	K.LTYYDGMIQLSYRNGTPYNNEK.H
*	TK040203_NMyc_nuclei2_step09.2586.2586.3	1.7752	0.1082	4364.94	1	1540.0%	1	K.VPVDGPPIDIGRVTGPPIFNPVANEVYLNFESSTHCLADR.Y
*	TK040203_NMyc_nuclei2_step07.3690.3690.3	1.8702	0.1033	4509.24	33	1030.0%	2	R.TNGDNYLYEIQLSSITSSSYPACAGANICQVKPNDQHFSR.K

CBG_HUMAN

51.0%

16.3%

405

45141

6.0

(P08185) Corticosteroid-binding globulin precursor (CBG) (Transcortin)

*	TK040203_NMyc_nuclei2_step07.2101.2101.1	1.4214	0.0445	1477.91	1	4170.0%	1	K.GTWTQPFDLASTR.E
*	TK040203_NMyc_nuclei2_step11.3070.3070.3	2.7243	0.0937	3109.1	1	1810.0%	1	K.AVLQLNEEGVDTAGSTGVTLNLTSKPIILR.F
*	TK040203_NMyc_nuclei2_step09.2943.2943.3	1.7283	0.1769	4044.62	10	1290.0%	1	K.IVDLFSGLDSPAILVLVNYIFFKGTWTQPFDLASTR.E

Q9NQS7

51.0%

919

105537

9.5

(Q9NQS7) Inner centromere protein INCENP

*	TK040203_NMyc_nuclei2_step10.4206.4206.2	1.24	0.0589	3157.18	59	1460.0%	1	K.LMEFLCNMDNKDLVWLEEIQEEAER.M
*	TK040203_NMyc_nuclei2_step10.3084.3084.3	2.6999	0.0020	3997.28	1	1620.0%	2	R.GTPLSQAIIHQYYQPPNLLELFGTILPLDLEDIFK.K
*	TK040203_NMyc_nuclei2_step05.3230.3230.2	1.7845	0.2149	2642.67	82	1400.0%	1	R.ILESITVSSLMATPQDPKGQGVGTGR.S

Q9D2G6

51.0%

30.9%

110

11756

8.8

(Q9D2G6) 4930520F12Rik protein

*	TK040203_NMyc_nuclei2_step12.2370.2370.3	2.712	0.2625	3755.26	7	1520.0%	1	K.AASVDGPPFCAIVVGEVASLYTEDLVTNYHSWQR.D

GC3_MOUSE

51.0%

329

36228

8.3

(P22436) Ig gamma-3 chain C region, secreted form

	TK040203_NMyc_nuclei2_step04.3343.3343.3	2.7238	0.1295	3010.83	9	1800.0%	3	R.NGELEQDYKNTPPILDSDGTYFLYSK.L
	TK040203_NMyc_nuclei2_step07.1645.1645.2	1.3994	0.0855	1934.4	7	2500.0%	1	K.NTPPILDSDGTYFLYSK.L
	TK040203_NMyc_nuclei2_step05.3050.3050.3	1.6848	0.0047	2759.84	35	1960.0%	1	K.VTCVVVDVSEDDPDVHVSWFVDNK.E

BRF3_HUMAN

51.0%

1214

136599

6.7

(Q9ULD4) Bromodomain and PHD finger-containing protein 3 (Fragment)

*	TK040203_NMyc_nuclei2_step08.2431.2431.2	1.3814	0.162	2833.96	6	1540.0%	1	R.VLENGEDHGVAGSPASPASIEEERHSR.K
*	TK040203_NMyc_nuclei2_step11.2526.2526.2	1.1406	0.0226	2906.93	6	1850.0%	1	R.SPDRVLENGEDHGVAGSPASPASIEEER.H
	TK040203_NMyc_nuclei2_step11.1931.1931.3	2.7104	0.4629	2563.33	6	2070.0%	1	R.EGLLHNGVPIPVPPLDVLKLGEQK.Q
	TK040203_NMyc_nuclei2_step12.1925.1925.3	1.6325	0.0738	3755.85	17	1360.0%	1	K.TVSNGELPAGPQGDAAVLEQALQEEPEDDGDRDDSK.L
*	TK040203_NMyc_nuclei2_step06.3319.3319.2	1.2823	0.0817	2236.45	20	2110.0%	1	R.QAENIGYDPERGTHLPESPK.L

Q9NWP0

50.9%

211

22130

8.3

(Q9NWP0) Hypothetical protein FLJ20712

*	TK040203_NMyc_nuclei2_step09.1993.1993.2	1.2811	0.0084	1853.23	23	2500.0%	2	-.MPDPPKFLLLLPQGAGR.A

Q9JLL4

50.9%

498

53261

8.8

(Q9JLL4) Iroquois-class homeobox protein Irx6 (Fragment)

*	TK040203_NMyc_nuclei2_step09.1775.1775.2	1.6782	0.2749	2238.17	1	3250.0%	1	-.MSYPQLPVPSARLAGALLVPR.V
*	TK040203_NMyc_nuclei2_step06.1867.1867.2	1.438	0.198	1637.63	29	2810.0%	1	R.GAGAFGVGLAFSPYPAR.R
*	TK040203_NMyc_nuclei2_step08.1276.1276.1	1.2503	0.1692	909.79	1	6250.0%	1	R.LAGALLVPR.V

GRFR_HUMAN

50.9%

423

47402

6.7

(Q02643) Growth hormone-releasing hormone receptor precursor (GHRH receptor) (GRF receptor) (GRFR)

	TK040203_NMyc_nuclei2_step09.2594.2594.3	1.509	0.0688	4058.38	15	1250.0%	1	K.VSVAASHFATMTNFSWLLAEAVYLNCLLASTSPSSRR.A
	TK040203_NMyc_nuclei2_step12.3858.3858.2	1.6811	0.282	3096.39	5	1540.0%	2	R.LPLELGLGSFQGFIVAILYCFLNQEVR.T

Q91Y37

50.9%

623

69566

5.6

(Q91Y37) Cytosolic aminopeptidase P

*	TK040203_NMyc_nuclei2_step11.4324.4324.3	2.6856	0.1646	4220.42	4	1510.0%	1	K.TFSDEPLEAGMIVTDEPGYYEDGAFGIRIENVVLVVAAK.T

Q99NB5

50.9%

468

52743

5.7

(Q99NB5) MLZE

*	TK040203_NMyc_nuclei2_step07.3390.3390.1	1.4494	0.1476	1333.27	3	5000.0%	1	R.KLLDQLPTFMK.T
*	TK040203_NMyc_nuclei2_step04.1729.1729.2	1.1235	0.0131	1935.9	25	1940.0%	1	K.LKADLDVETIAGGEAGFVK.S

PA2X_HUMAN

50.8%

58.1%

155

17132

6.5

(O15496) Group X secretory phospholipase A2 precursor (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase GX) (GX sPLA2) (sPLA2-X)

*	TK040203_NMyc_nuclei2_step06.2579.2579.3	1.5515	0.0649	3956.57	143	1130.0%	1	K.CDQEIANCLAQTEYNLKYLFYPQFLCEPDSPK.C
*	TK040203_NMyc_nuclei2_step02.2880.2880.3	1.8331	0.0487	3672.89	86	1210.0%	2	K.YGCFCGLGGHGQPRDAIDWCCHGHDCCYTR.A
*	TK040203_NMyc_nuclei2_step12.4351.4351.2	1.7128	0.2668	2972.32	1	1850.0%	1	-.MLLLLLPSLLLLLLLPGPGSGEASRILR.V

Q9BQX2

50.8%

146

16759

6.4

(Q9BQX2) DJ691N24.1.3 (KIAA0980 protein, isoform 3) (Fragment)

	TK040203_NMyc_nuclei2_step06.2245.2245.1	1.0136	0.015	1208.39	52	3330.0%	1	K.ACSEMEVLNR.Q
	TK040203_NMyc_nuclei2_step09.3517.3517.2	1.8238	0.1117	1986.93	1	4000.0%	4	K.ACSEMEVLNRQNQNYK.D

Q96LP9

50.8%

326

36004

7.5

(Q96LP9) Hypothetical protein FLJ25316

*	TK040203_NMyc_nuclei2_step09.2981.2981.2	1.7117	0.2648	2716.07	2	2050.0%	1	R.SGMWLSCEETVEEPALLHPQSWK.Q

Q13356

50.8%

520

58823

8.8

(Q13356) Cyclophilin-like protein CYP-60

	TK040203_NMyc_nuclei2_step12.1355.1355.2	1.7335	0.2597	2048.08	1	3160.0%	1	K.SSQPQAGSQGPQTFRQGVGK.Y

Q9H3S7

50.8%

1636

178972

6.9

(Q9H3S7) Protein tyrosine phosphatase HD-PTP (Protein tyrosine phosphatase TD14)

*	TK040203_NMyc_nuclei2_step11.3347.3347.3	2.3718	0.1135	4783.26	1	1250.0%	1	K.DNDFIYHEAVPALDTLQPVKGAPLVKPLPVNPTDPAVTGPDIFAK.L
*	TK040203_NMyc_nuclei2_step12.3399.3399.2	1.186	0.0109	2354.13	6	2250.0%	1	R.ATRPSDDPLSLLDPLWTLNKT.-
*	TK040203_NMyc_nuclei2_step11.3979.3979.2	1.7523	0.263	3007.92	2	2070.0%	1	R.APGPHAMPVAPGPALYPAPAYTPELGLVPR.S
*	TK040203_NMyc_nuclei2_step03.1679.1679.2	0.9804	0.0066	1795.97	357	2140.0%	1	K.NYGENPEAYNEELKK.L

Q9D0F6

50.8%

17.1%

339

38096

7.8

(Q9D0F6) 2610020K06Rik protein

*	TK040203_NMyc_nuclei2_step09.2438.2438.2	1.4777	0.1672	2349.67	2	2860.0%	1	R.LSVGTSEKIQLSSLIAAFQVTR.D
	TK040203_NMyc_nuclei2_step06.1662.1662.2	1.7414	0.0709	1737.29	32	2860.0%	1	K.VTEETVYTCTGHPLK.T
*	TK040203_NMyc_nuclei2_step04.3180.3180.2	1.7263	0.2605	2444.17	5	2500.0%	1	K.YRPQTLADLISHQDILSTIQK.F

Q64702

50.7%

925

103686

8.3

(Q64702) SMK/PLK-AKIN kinase (Protein kinase SMK/PLK-AKIN) (EC 2.7.1.-)

*	TK040203_NMyc_nuclei2_step02.2112.2112.3	1.2664	0.0022	2469.97	54	2110.0%	1	R.DFQDYPDLQDTLRNAWTDTR.A
*	TK040203_NMyc_nuclei2_step01.2722.2722.1	1.5063	0.1078	1401.73	2	4170.0%	1	K.ALSAPPVDPSCCK.G
*	TK040203_NMyc_nuclei2_step07.3057.3057.3	2.0752	0.0981	4205.18	15	1220.0%	1	K.EVLQISSDGTMITVYYPNDGRGFPLADRPPLPTDNISR.Y

Q8TEK2

50.7%

491

52837

7.6

(Q8TEK2) FLJ00193 protein (Fragment)

*	TK040203_NMyc_nuclei2_step06.2203.2203.1	1.5038	0.1036	1465.67	1	4170.0%	1	K.EHHHLAVAYSSGR.L

O75402

50.7%

22.1%

131

14311

4.8

(O75402) Symplekin (Fragment)

*	TK040203_NMyc_nuclei2_step09.1706.1706.1	0.9384	0.0122	1564.55	55	2500.0%	1	R.AALTAAMASGSGDSVTR.R
	TK040203_NMyc_nuclei2_step10.2632.2632.1	1.5028	0.1053	1470.5	5	4550.0%	1	K.FVIGFIEEACKR.D

Q9DAT9

50.7%

660

71063

5.6

(Q9DAT9) 1600025H15Rik protein (RIKEN cDNA 1600025H15 gene)

*	TK040203_NMyc_nuclei2_step10.2245.2245.3	1.8042	0.0915	3153.9	19	1480.0%	1	R.KASHQDSELHTPHNSNSSVWDTLCLSAK.D
*	TK040203_NMyc_nuclei2_step06.2143.2143.2	1.5809	0.3257	2854.47	1	1920.0%	1	K.VLGLHTHGGEGHTHEEEVGVGGQATWR.L

TLR7_HUMAN

50.7%

1049

120922

8.2

(Q9NYK1) Toll-like receptor 7 precursor

*	TK040203_NMyc_nuclei2_step08.3577.3577.2	1.6625	4.0E-4	1991.8	2	3120.0%	2	K.NINKLQELDLSQNFLAK.E
*	TK040203_NMyc_nuclei2_step03.2709.2709.3	1.5031	0.1541	3933.21	64	1210.0%	1	K.ENLTELANIEILYLGQNCYYRNPCYVSYSIEK.D
*	TK040203_NMyc_nuclei2_step01.1668.1668.1	1.5014	0.1087	814.49	5	8000.0%	1	R.YLQLFK.N
*	TK040203_NMyc_nuclei2_step07.3129.3129.3	1.488	0.1299	3554.24	48	1420.0%	1	R.CYNAPFPCAPCKNNSPLQIPVNAFDALTELK.V
*	TK040203_NMyc_nuclei2_step02.2371.2371.2	1.23	0.0555	2016.27	5	2810.0%	1	K.VDVIILIFLEKPFQKSK.F

Q9BZ66

50.7%

504

55817

8.6

(Q9BZ66) Cytochrome P450 2S1

	TK040203_NMyc_nuclei2_step08.2625.2625.2	1.3383	0.216	2677.04	16	1740.0%	1	R.LPYTDAVLHEAQRLLALVPMGIPR.T
	TK040203_NMyc_nuclei2_step11.4388.4388.1	1.7603	0.2169	1375.81	7	3640.0%	5	R.KHEAFLPFSLGK.R

Q9H992

50.7%

704

78051

6.8

(Q9H992) Hypothetical protein FLJ12911

*	TK040203_NMyc_nuclei2_step08.1360.1360.3	1.649	0.1756	1622.5	21	2860.0%	1	R.NVGNGLNTLSDSSWR.H
*	TK040203_NMyc_nuclei2_step12.2029.2029.2	1.6279	0.2891	3075.31	2	1920.0%	1	R.RWGLSSLSHNHSSESDSENFNQESEGR.N
*	TK040203_NMyc_nuclei2_step11.1942.1942.3	1.8994	0.1579	3241.73	2	1880.0%	1	K.ENSMSTLQLNTSSTNHQLPSEHQTILSSR.D

ORP6_HUMAN

50.7%

934

106306

6.9

(Q9BZF3) Oxysterol binding protein-related protein 6 (OSBP-related protein 6) (ORP-6)

*	TK040203_NMyc_nuclei2_step05.3471.3471.2	1.4159	0.0022	2058.09	213	1760.0%	1	K.QMVSEQDHSKGHSTQMAR.L
*	TK040203_NMyc_nuclei2_step03.3499.3499.2	1.116	0.0221	1729.16	6	3120.0%	1	K.GKVHGSIDVGLSVMSIK.K
*	TK040203_NMyc_nuclei2_step03.1685.1685.1	1.4807	0.127	1185.71	1	6110.0%	3	R.FFVLDNGMLK.Y

Q9BXT9

50.7%

21.1%

957

107238

4.8

(Q9BXT9) Testis protein TEX14

*	TK040203_NMyc_nuclei2_step08.3108.3108.3	2.0451	0.1925	4610.98	3	1130.0%	1	R.EFTNAYKLPLAVGPPSLNYIPPVLQLSGGQKPDTSGNYPTLPR.F
*	TK040203_NMyc_nuclei2_step05.2254.2254.3	2.0636	0.0012	2720.08	58	1850.0%	1	K.EKDISLTDIQDLSSISYEPDSSFK.E
*	TK040203_NMyc_nuclei2_step06.3035.3035.2	1.3802	0.0711	2560.52	37	1670.0%	1	K.QQQGSSTVLHENTASDGGGTANDQR.H
*	TK040203_NMyc_nuclei2_step06.2415.2415.2	1.5709	0.3176	3168.18	1	2000.0%	1	K.TEFASCWNSQEFIQTLSDDFISVRER.A
*	TK040203_NMyc_nuclei2_step06.3129.3129.3	1.6242	0.02	4697.7	43	1000.0%	1	R.EACCFGSEDESSSKAETEYSFDDWDWQNGSLSSLSLPESTR.E
*	TK040203_NMyc_nuclei2_step07.3148.3148.3	1.6031	0.1169	2009.27	77	2340.0%	2	K.MEREACCFGSEDESSSK.A
*	TK040203_NMyc_nuclei2_step08.2728.2728.2	1.394	0.1759	2303.8	63	1750.0%	1	K.EQPEHSEAFQASSDTLVAVEK.S
*	TK040203_NMyc_nuclei2_step09.2102.2102.3	1.5254	7.0E-4	4719.47	17	1050.0%	1	R.IDELPPPSQELLDDIELLKQQQGSSTVLHENTASDGGGTANDQR.H

Q922I2

50.6%

819

92627

6.8

(Q922I2) Similar to conserved membrane protein at 44E

	TK040203_NMyc_nuclei2_step06.0410.0410.1	0.9746	0.1733	1580.0	3	2670.0%	2	R.AGIIQVLLEAVAIAAK.G
*	TK040203_NMyc_nuclei2_step07.2170.2170.1	1.2187	0.0649	1525.6	146	2920.0%	3	K.EENPAVLAESCFR.E

Q9CXF7

50.5%

900

101438

6.6

(Q9CXF7) 4432404A22Rik protein

*	TK040203_NMyc_nuclei2_step02.2310.2310.3	0.9091	0.0037	3174.53	180	1110.0%	1	K.CVDHPYLFDGVEPEPFEVGEHLIEASGK.L
*	TK040203_NMyc_nuclei2_step08.1761.1761.1	1.5091	0.0999	1505.52	2	3930.0%	1	K.GSVLIPGLAEGPIKR.K

Q9UPX0

50.5%

763

82322

8.2

(Q9UPX0) Hypothetical protein KIAA1030 (Fragment)

*	TK040203_NMyc_nuclei2_step10.4243.4243.3	2.4708	0.3414	4601.54	1	1220.0%	1	R.SGSPSYRPAMGFTTLATGYPSPPPGPAPAGPGDSLDVFGQTPSPRR.T

Q96SS0

50.5%

486

54386

7.8

(Q96SS0) Hypothetical protein FLJ14677

*	TK040203_NMyc_nuclei2_step11.4008.4008.2	2.1072	0.1725	3098.03	2	1920.0%	4	R.LVALQIQALKEDFPLSHVISPFTNQER.R

Q9HBL3

50.4%

270

29595

9.0

(Q9HBL3) HT019

*	TK040203_NMyc_nuclei2_step01.1952.1952.1	1.7294	0.0125	1364.2	1	5770.0%	1	R.RPLGDAGGGQGHSR.G

Q9NWH4

50.4%

148

16903

11.1

(Q9NWH4) Hypothetical protein

*	TK040203_NMyc_nuclei2_step09.1757.1757.2	2.0279	0.2174	2076.26	1	3000.0%	1	R.TVSVDPGHPPASALAAPAFLR.R

Q63870

50.4%

2944

295114

6.3

(Q63870) Type VII collagen

*	TK040203_NMyc_nuclei2_step02.2448.2448.2	1.2896	0.0964	1956.76	2	2630.0%	1	R.GEPGPPGPPGRLVDAGIESR.D
*	TK040203_NMyc_nuclei2_step11.1880.1880.2	1.1543	0.0010	2804.12	87	1410.0%	1	R.GLAGPPGREGAPGPLGPPGPPGSAGAPGASGLK.G
*	TK040203_NMyc_nuclei2_step01.2727.2727.1	1.1709	0.0778	1444.56	130	2500.0%	1	K.GEAGFPGRPGLAGKK.G
*	TK040203_NMyc_nuclei2_step07.2434.2434.2	1.4711	0.1261	2841.5	1	1720.0%	1	R.GTPGPVGSHGDPGPPGAPGLAGPAGPQGPSGLK.G
*	TK040203_NMyc_nuclei2_step02.2198.2198.2	1.26	0.2	1890.9	77	2110.0%	1	R.GETGQPGPVGERGLAGPPGR.E
*	TK040203_NMyc_nuclei2_step12.2138.2138.3	2.0467	0.213	4520.06	44	980.0%	1	R.LTLYTLLEGREVATPATVVPTGLEQLVSPVMNLQAIELPGQR.V
*	TK040203_NMyc_nuclei2_step02.2318.2318.1	1.1216	0.1526	992.69	5	5000.0%	3	R.RVPGANGYR.V
*	TK040203_NMyc_nuclei2_step03.2559.2559.3	1.6378	0.135	2532.09	2	2190.0%	1	R.VHLTQAGSSSVSITWTGVPGATGYR.V
*	TK040203_NMyc_nuclei2_step11.0977.0977.3	1.1906	0.0604	1948.09	90	1880.0%	1	R.RQQVPGVMVLLVDEPLR.G
	TK040203_NMyc_nuclei2_step06.3726.3726.1	0.1831	0.0061	616.87	4	2000.0%	3	R.GEPGVR.G
*	TK040203_NMyc_nuclei2_step03.1419.1419.1	1.2447	0.1348	1370.91	1	4230.0%	1	R.GLAGEPGSLPNAER.L

Q9JI11

50.3%

487

55541

5.2

(Q9JI11) STE20-like kinase MST1

	TK040203_NMyc_nuclei2_step07.1460.1460.1	1.4053	0.1887	1036.52	1	6250.0%	1	K.ENQINSFGK.N

Q9H0J1

50.3%

224

25224

8.7

(Q9H0J1) Hypothetical protein

*	TK040203_NMyc_nuclei2_step03.2349.2349.1	1.4019	0.19	1404.74	1	4230.0%	2	K.HQVKGHGGDDGAAR.A

Q9BYT9

50.3%

981

114655

8.6

(Q9BYT9) Hypothetical protein

*	TK040203_NMyc_nuclei2_step05.3544.3544.2	1.4279	0.1527	2864.89	44	1740.0%	1	R.LEECHPSGCLIDLCLQMGVIMFLK.Q
*	TK040203_NMyc_nuclei2_step11.1272.1272.3	1.5407	0.0174	2695.37	21	2000.0%	1	R.EKYLVQEMMYEAELEHLQQQR.R
*	TK040203_NMyc_nuclei2_step07.1712.1712.3	2.1799	0.0536	3413.31	8	1830.0%	1	R.RSILTYTWDLIEWEEEEETLRPQFEAK.Y
*	TK040203_NMyc_nuclei2_step02.0446.0446.1	1.3346	0.3066	1475.16	2	3330.0%	1	K.SEITKETSLKPSR.R
*	TK040203_NMyc_nuclei2_step05.3086.3086.3	2.5374	0.2503	3507.13	5	1720.0%	1	K.DWMAQNPMVLDKSAFPDLEESDCYTGPFSR.A
*	TK040203_NMyc_nuclei2_step01.4008.4008.3	1.7983	0.0566	4544.92	4	1280.0%	1	R.SLPCLAQSYAYSKSLSQSTSLFQSTESESQAPTSITLISTDK.A

RADI_MOUSE

50.3%

583

68452

6.1

(P26043) Radixin

	TK040203_NMyc_nuclei2_step04.1489.1489.1	1.3759	0.1717	1248.67	4	5000.0%	2	R.IQNWHEEHR.G

Y555_HUMAN

50.3%

810

94934

6.2

(Q96AA8) Hypothetical protein KIAA0555

*	TK040203_NMyc_nuclei2_step10.3417.3417.2	1.6555	0.0313	2179.33	8	2370.0%	2	R.AYALLQEQTGGIIDAEREAK.A
*	TK040203_NMyc_nuclei2_step12.2231.2231.2	1.2213	0.1052	3110.83	169	1350.0%	1	R.IQELEATLYNALQQETVIKFGELLSEK.Q

TN15_HUMAN

50.2%

23.6%

174

20131

8.7

(O95150) Tumor necrosis factor ligand superfamily member 15 (Vascular endothelial cell growth inhibitor) (TNF ligand-related molecule 1)

*	TK040203_NMyc_nuclei2_step12.3423.3423.3	1.9908	0.0751	4645.98	3	1250.0%	8	K.SVCEVGSNWFQPIYLGAMFSLQEGDKLMVNVSDISLVDYTK.E

CALX_MOUSE

50.2%

591

67278

4.6

(P35564) Calnexin precursor

	TK040203_NMyc_nuclei2_step09.1289.1289.1	1.4003	0.1831	763.47	5	6670.0%	1	K.HHAISAK.L

CLUS_MOUSE

50.2%

448

51656

5.7

(Q06890) Clusterin precursor (Sulfated glycoprotein 2) (SGP-2) (Clustrin) (Apolipoprotein J) (Apo-J)

*	TK040203_NMyc_nuclei2_step12.2815.2815.2	1.8674	0.2337	2963.47	1	2390.0%	4	R.ELHDPHYFSPIGFPHKRPHFLYPK.S

Q9EP53

50.2%

1161

128746

6.4

(Q9EP53) Hamartin

*	TK040203_NMyc_nuclei2_step06.2651.2651.2	1.2354	0.0266	2682.52	2	2000.0%	1	R.VTGGSSSSSSELSTPEKPPSQRFSSR.W
*	TK040203_NMyc_nuclei2_step09.2417.2417.3	1.6371	0.0156	3512.47	20	1290.0%	1	K.GTPSGTPATSPPPAPPCPQDDCVHGSAAQASATAPR.K
*	TK040203_NMyc_nuclei2_step11.1636.1636.2	1.3601	0.035	2458.25	168	1820.0%	1	K.EEAAISKELSEITTAEADPVVPR.G
*	TK040203_NMyc_nuclei2_step07.2753.2753.2	1.582	0.3086	2840.98	1	2780.0%	1	R.SADVTTSPYVDTQNSYGGSTSTPSSSSR.L

Z222_HUMAN

50.2%

13.3%

451

52532

8.6

(Q9UK12) Zinc finger protein 222

*	TK040203_NMyc_nuclei2_step01.0712.0712.1	1.6825	0.0311	1008.53	30	5620.0%	4	R.HASSILNHK.K
*	TK040203_NMyc_nuclei2_step07.3809.3809.2	0.9451	0.0034	2724.17	40	1520.0%	1	R.SQDTTISNSQLFEQDDNPSQIKAR.L
*	TK040203_NMyc_nuclei2_step09.3174.3174.2	1.8646	0.1025	3067.84	3	2120.0%	1	K.LYEAVTFKDVAVIFTEEELGLLDPAQR.K

Q9NSE6

50.2%

734

79463

7.0

(Q9NSE6) C21orf258 protein

*	TK040203_NMyc_nuclei2_step07.1270.1270.3	1.5892	0.0569	3017.3	4	2120.0%	1	K.EAQNLQCAASTAQESCPPKPPRAHELK.L
*	TK040203_NMyc_nuclei2_step09.3525.3525.2	1.9001	0.241	2007.68	2	3160.0%	2	K.HLAGSASPSVVLITKPTTVK.E

PLCA_MOUSE

50.2%

285

31709

9.1

(O35083) 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase-alpha) (LPAAT-alpha) (1-acylglycerol-3-phosphate O-acyltransferase 1)

	TK040203_NMyc_nuclei2_step03.1609.1609.3	1.4026	0.0407	2216.62	2	2640.0%	1	R.VWVFPEGTRNHNGSMLPFK.R
*	TK040203_NMyc_nuclei2_step05.3112.3112.2	1.5571	0.4036	2348.25	2	2270.0%	2	R.VLPPVSTEGLTPDDVPALADSVR.H

Q99MT6

50.1%

317

36701

9.0

(Q99MT6) G-protein coupled receptor GPR91

*	TK040203_NMyc_nuclei2_step02.2076.2076.1	1.7316	0.2676	1352.62	6	4090.0%	1	K.GTYGDVLCISNR.Y

Q12839

50.0%

597

66385

5.2

(Q12839) H326 protein

*	TK040203_NMyc_nuclei2_step04.2154.2154.1	1.5631	0.018	1375.61	7	4550.0%	3	R.KIDENENNGVLK.K
*	TK040203_NMyc_nuclei2_step12.4086.4086.3	2.0873	0.1248	4289.81	6	1250.0%	2	K.SSCQIIQFMEGDKGGVVNCLEPHPHLPVLATSGLDHDVK.I
	TK040203_NMyc_nuclei2_step10.1244.1244.1	1.1889	0.0182	1002.41	53	5620.0%	1	R.ERELGSSAR.F
*	TK040203_NMyc_nuclei2_step06.3371.3371.3	1.3862	0.0391	3191.26	9	1520.0%	1	R.GTDTESSGEDKDSDSMEDTGHYSINDENR.V

AS3B_HUMAN

50.0%

465

51899

5.6

(Q92485) Acid sphingomyelinase-like phosphodiesterase 3b precursor (EC 3.1.4.-) (ASM-like phosphodiesterase 3b)

	TK040203_NMyc_nuclei2_step01.2094.2094.1	1.4125	0.1772	1301.88	1	5450.0%	1	K.LGEAAVLEIVER.L

Q9BSY6

50.0%